<SEC-DOCUMENT>0001333493-21-000069.txt : 20210510
<SEC-HEADER>0001333493-21-000069.hdr.sgml : 20210510
<ACCEPTANCE-DATETIME>20210510170012
ACCESSION NUMBER:		0001333493-21-000069
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210510
DATE AS OF CHANGE:		20210510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			eHealth, Inc.
		CENTRAL INDEX KEY:			0001333493
		STANDARD INDUSTRIAL CLASSIFICATION:	INSURANCE AGENTS BROKERS & SERVICES [6411]
		IRS NUMBER:				770470789
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33071
		FILM NUMBER:		21908145

	BUSINESS ADDRESS:	
		STREET 1:		2625 AUGUSTINE DRIVE, SECOND FLOOR
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95054
		BUSINESS PHONE:		650-584-2700

	MAIL ADDRESS:	
		STREET 1:		2625 AUGUSTINE DRIVE, SECOND FLOOR
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95054
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ehth-20210331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:31f4f7fb-855a-4e3e-841b-479b93e1e603,g:93b223c9-0d4d-4bbf-9f72-5268ef99062c,d:534e5b0d995440019776d9538b893f71--><html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ehth="http://www.ehealthinsurance.com/20210331" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ehth-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80L2ZyYWc6OTU0N2MwOTExMTE5NGE0YmI1MzBjM2RiNTczMDRlMzQvdGFibGU6NjE5YWIxM2E2NTA1NGM3NThiZjU5ZDJmMThhOTA5ZDEvdGFibGVyYW5nZTo2MTlhYjEzYTY1MDU0Yzc1OGJmNTlkMmYxOGE5MDlkMV8zLTEtMS0xLTA_56e36d41-5799-48ef-94ed-dc4c39d1bf52">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80L2ZyYWc6OTU0N2MwOTExMTE5NGE0YmI1MzBjM2RiNTczMDRlMzQvdGFibGU6NjE5YWIxM2E2NTA1NGM3NThiZjU5ZDJmMThhOTA5ZDEvdGFibGVyYW5nZTo2MTlhYjEzYTY1MDU0Yzc1OGJmNTlkMmYxOGE5MDlkMV81LTEtMS0xLTA_822a49fc-af97-42d3-bfd4-e1d023b71cab">2021</ix:nonNumeric><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80L2ZyYWc6OTU0N2MwOTExMTE5NGE0YmI1MzBjM2RiNTczMDRlMzQvdGFibGU6NjE5YWIxM2E2NTA1NGM3NThiZjU5ZDJmMThhOTA5ZDEvdGFibGVyYW5nZTo2MTlhYjEzYTY1MDU0Yzc1OGJmNTlkMmYxOGE5MDlkMV82LTEtMS0xLTA_bea6982d-b3f0-4285-a345-4ec7ab0aadfd">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80L2ZyYWc6OTU0N2MwOTExMTE5NGE0YmI1MzBjM2RiNTczMDRlMzQvdGFibGU6NjE5YWIxM2E2NTA1NGM3NThiZjU5ZDJmMThhOTA5ZDEvdGFibGVyYW5nZTo2MTlhYjEzYTY1MDU0Yzc1OGJmNTlkMmYxOGE5MDlkMV85LTEtMS0xLTA_4a976d86-abd0-4143-bf90-50dbb6baab2b">0001333493</ix:nonNumeric><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80L2ZyYWc6OTU0N2MwOTExMTE5NGE0YmI1MzBjM2RiNTczMDRlMzQvdGFibGU6NjE5YWIxM2E2NTA1NGM3NThiZjU5ZDJmMThhOTA5ZDEvdGFibGVyYW5nZTo2MTlhYjEzYTY1MDU0Yzc1OGJmNTlkMmYxOGE5MDlkMV8xMC0xLTEtMS0w_584e6462-314d-4197-b317-4db9cb35500d">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i1405f1905b0c495f9efd2474b8fadded_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC0wLTEtMS0xNjk5_9cb35bf6-6ad9-454a-94f9-8fd78c9d7e52">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ehth-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i6bb60180d74e484091d2db3e841cf5d9_I20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i5dc87305aa114463a821897ca747dcca_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8337239e8dda4274bdb5081198725cf8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a17b2f577fb4a0994b259f4a7c00fac_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8680ff82e8684663ac818bd969dadd40_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fe1a9fc09dc4d98894c2f05859cd3f1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib63247d699eb44bfb201774d6fef56b5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29014aa44f224a9e8e5ca25d6c81661b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibacf081650de495da52a05e4eed69d81_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if350613e6abd438882a29524ad8a5858_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5a91006c9d446fbb4d678b836971da0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieeba31f3c1b84580993db317c01046dd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74c4a51c8df7461fb85f66341986ca02_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65cdbe8443b34580b8422ede51568ad8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadef4a55d90e438a8f79adf8bc288200_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib464d05e6c054ac8bcb58e7dcb4504fe_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7881058e6391413da79a1df94978a40a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5468c73d2e34194b9c572c7aba7dfbe_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1c5c1ce40314084a6517c4ee8f604b7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i571009d8684244af94c420ce801431c3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85b5b55d4a9c4f76ac527000958b9eae_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a043e2b26b14ab29cc5ac268c78e6cb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28f6aba0243b421b803fe3861b663e07_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d29d5730c7349ea9d1ef955dd844f0d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf42840deb504490a24f18226ae769ac_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i464582b3717f48fb8fb924189caabeae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i283d90d05c8744f3a67f23305e4f839c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1405f1905b0c495f9efd2474b8fadded_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie89c5f32945844b5b95944d102880a24_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0466642154754b80bcf918c034fb3b1d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b1b9ba849b4eb49f00439861a88682_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6107d03659748ec91163598cd67842f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibce1977df45a4166aacac2533753fef2_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffa4ea2bf46843c8a3b8c76230e7aece_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77e456c86a2c4c2298f67ccceb97b818_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e488604a58499a810b6c51f24f6985_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51bc9d212152476f9e50aaa3f71da0a8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96bc1b9468db422cbae505e283d62180_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18dcb5c7e7f74362b1df0c50dfaf35c3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3222346a5aab4a859b8e9a0c70c4fccb_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94e4cd2c63294501a97ce58cbb8f0ad9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="insurance_carrier"><xbrli:measure>ehth:insurance_carrier</xbrli:measure></xbrli:unit><xbrli:unit id="state"><xbrli:measure>ehth:state</xbrli:measure></xbrli:unit><xbrli:context id="id2018b7213bd4f93a2804c6b1e207d62_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:UnderRecognitionOfStockBasedCompensationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12b84f6b238d4f379f4615fedc93f6c7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:OverRecognitionOfLicensingCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c0615329c3645ffb15c379b3b25d3f0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:OutOfPeriodAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic074a03c1a5d4d7a95fc6e02d21edc3c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f37dc2286ab479b9deeec6ddbc3c296_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia56162d3488f4c19a21ddf86ec0517c5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i914b51c6a88d43f39d8a45d6ac452f9e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bfdbea61c3f4e42a23d93df8eba5745_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a43b88c46a14d2586a38ff40e44b3e1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3af61ab21d2346a89f9a5ad7aa6ccc38_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3c7487c68db4d359d42ffe4d98f76dc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98825a9b9bd74beab1e1565f9d8c3a39_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c1c83a033544814919a8b29643cf827_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0df0a17281e45098fa957d99e0eda7e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i766e68295a1640f6bfa0ebbffa00c23d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38748c1b62c34305b0a1a89a4df6b8df_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia063259a108742fa90b79bd2bb186380_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cb65108e971405598e91d213801b128_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69d8365ca0b4435c8c9fc4bfcb26c1e5_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8437e53979d64bf498cbace5ca6b66f7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b8fb9dde9d741ea8f3aa61c942f3b55_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73b6352f11b648d2b4bf5b5a9da1bc8e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4b97cd36b9948c1b9d6366c24f2829f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3aa9fda678445a3bd10fe0b7fd75046_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i056610eba6074846ae406d019066f627_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1faf373456cf44dc92cec480bfe789a7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a023d993134272a9b194c6b2030640_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeba0cba96b145f09097dbdfa7c23a18_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d34909e75b34d79ba8c25ed29d1868c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c7afb8d32cb44aaad349d4aed1c13de_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1a4a92ac7d845c1abccf7a138083679_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19c1136bfda347ce93cbbd8ef6c0fd36_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i086deedc14e2467498f875d11fdb3e28_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i392771caeedf4c20a1e28f80da41f0a1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12c4bfe5dd12406b951b26fdaa6cc5f3_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i258c42ec705f4ce991947aa47fbbbf47_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie95c786e8b374e319d0e49801d852c1d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7447592d6f934de2add1f16c34c68de4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0569d360651844759fd84f9324b1f5fc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dd2975216654605bebf75779fff0768_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82877d4449c844be8040697eb7839adb_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide29d460660a40fc90b884baf4856429_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f0172f4e15b46b8a18d6d683e1893e9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cba655be2dc465f92495dc76b412c95_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb2d1cb13bc848d4926601ef8f33c966_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie454fda4a6da410c90ae24e2c79aa917_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2561ea4ce6f450684892494464adbb2_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ead011a22aa4528839846da9fa5ebba_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a9a800e930241a2b680d5d254a9937d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i673d5b337f984e35bd708e9c6d0ad645_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib431ec26de88456f8bb27169dbd5532e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6501103b1abc4417b6d24bb9f56e71a3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcc531094265425da2fe8fba9f7dd2bd_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32bc9e31d57342a5a9f949dcac3eea99_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i734d6738ac914fbf9d7214b291481a87_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33ff039155da47c1bac390800f28d958_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id999ede8247d4775b2a9495082649e71_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc9590a5ab4145079eec4462d026a62f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieffd4f331de646efb6782e0777c3b8c2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b23f8c9553a4acb92f22c678a011ded_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id93a27ec2b354123ac129b85e58d6a9a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice1fcaf5d15c4b1ea8e6b1988490be33_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40741e0095b1456aac94b2215f85e8da_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6501121272e7438dbfacad9d5f209af7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffc7786d6a3b4b88a4fe78c3c639b879_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida736d90cfd14b6287fb18903e493b76_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c282c2b9a3a4f2da838e7c285e04bde_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88b0f87d92a74c6aa41c7e6b1c891758_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic62f4e5ed1c64cc5aa09a9d6a29086c8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82364b4b38294beeabf364cb83d2dfb2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ibcc2eede21d74403b2556f36cea8967e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i745034ccac204d289da6154afd851a9b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c027fa629114f34973fe988abef44d2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a0875b0633646fe8e4a223242ab0547_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0b72a5d261d4ed3a6a247dab5e66565_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic698507ebbbe479bafd6c12cc0b40d70_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41d2536fcee54432bbf4d763116ab430_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id692f7a929c543f88a8ba8e371f1ec69_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifad24860642c447f8be6b0786b6192d9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0448f7480d204667af54338f775f2ae4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6e65f9607874cf7b91a607047873439_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78e297ab8ca948aeaf86a525f773e4dc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i838a01c8c51c489fb25f65450a703cb5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie413cb59abe441fba3e0b2a4bb9dc04e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e6a517c6ba84088a72a30f5e9d287b3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf9be97cab2640ed84bd86ad77f9d205_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f32284f7468465fad0a56de1b2e5c6b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4c8e440d2f64e6399fa1adc1002bb2e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2303fe7994cf42d1b268b27bc2a7c119_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8935e0f0e3b647c0bca26a9f197dc6ef_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i593cfa44a23f4636b9ad96eb4e4a80e1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i929513fba5e248fb98922bd0516e124c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02a6624511a64fcf98ef80ed91927f61_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d2f66f410ea4bf19367fa5bed725fe8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1adbea6e18d34c05afe06e141815262b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc820c7319514d4cbf55712548350db5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d090e9d3465481c959ca1ca4c0ad0bf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14c5f8eba33b414c8e7ed0c7d2de5aa6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5665cbe280f449b7906c5831fa1e3d59_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a5410f369fa4fe6b29e53a1e38b9c4e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48cb251ac11344e78669d7f080d49c43_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fb33dbb73bf4f02a5ffec5640fa31c9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ea53ab5f7ec479683fa4b9a5645b576_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ed7325f8ced428d818fce32b031d79b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18ff6074d86849a5b23047e339437eda_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie93a9074eb224ae4ab49ad9db008e5ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73e0b97fc5864480b5903a29a54557b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c9b517443d64a00aba7aff3b698c11f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id666b5ba6f9f42f8a0cf56c4b398bcc8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife7ea5f7ec2b4816b3f9a85e81ea156b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4befba2d3d44fb1a621a7790ad0356c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5df54f27e2e4404d8fe0cd357e46301e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8882a30cac444bf5ba856bd4a8372177_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54823e65473645c194940e0076f74ff5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e8dec4452ff4308b5fbdd90aeed6dc9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib59dd70dd25942cd92be78336520da90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc2244c603b14657b34cf7227bbd7fe5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96477b91e6c046df98a6eb283930c399_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib988b174dc5b49888bc9c12a66f95b33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id971a56afa2d46c58587cf6f00f48794_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8499f20cd2c1456a840c92df3935eb19_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5beec7c5934346d88793a58261bd3ed7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64b2eec84ef04575a0d89d957828316e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16def725ed4c4de287be9546b21381c4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94c20d249a134eafba8d1b1e39d25904_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i655b0d8763b747d280d873a86aa886f2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i961aaf7e9dd04265a6efcb537457ced7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>ehth:security</xbrli:measure></xbrli:unit><xbrli:context id="if92b4bb5fc794dd1bc6e637bdad2d099_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e97394555f148638042ce9215c2d1dc_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b0d49f69d854783b426b4a82d9b7617_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ehth:PreviousRepurchaseProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id010efd09ca848fea67ac7a219d97b98_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6023935a90c0449daef342cb4a899125_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic87e10e1f657440db47c80a44d54eb25_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e7aff4671154fc19c202272ab565eea_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ba493194d8a487984964d8793886556_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica2d0bfff5854068ac9d5627ff476134_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d267c47dbbb4319b6f0bd3c335192ad_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia264f014078a40918be67135b664845e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07cea5b44a3a459e9e229df532ff47f5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2735879a981f4934a31a2ff030996122_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87ef0c3e12a247ffb3645a639fa9a28d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb78056511e744e692b0f0a6870a2b54_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ffef56a313d4362acff848ae985e050_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifed776c5bdf242e8b71b1bd21709ceb6_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if080cb3649dc43f092dd38c47b2c3694_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61773e2e91094158a69f52208476be9c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3729439cfe534105b22358a497155089_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>ehth:claim</xbrli:measure></xbrli:unit><xbrli:context id="i4f10282c4a164b3ba49248e358109fda_D20200408-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-08</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plaintiff"><xbrli:measure>ehth:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="idba160cc7e824a82bf89be1c244ad874_D20200707-20201013"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-07</xbrli:startDate><xbrli:endDate>2020-10-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63e707f4d80c456a88c23a8539ab5605_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ehth:LeViasCompliantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>ehth:segment</xbrli:measure></xbrli:unit><xbrli:context id="i847b02865e0e482289ce85c02f9b4e61_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45589c5d091d42fa856a74b05e6a684b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iece3c4feb7ba4852ae934e622f0fc222_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5f5742b50c34e6eb0d14c32db2d8983_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96a1c3f122b54e5c910199f9e10062ae_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58d74f4f4ee14e1fba9c88300782d7ff_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7766c8b514940a3adac069dcabfa7f5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dcc0aaf01a44218b29859ee8d52669f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae135e664d984295bbf64c3bbe7c4a11_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33ac7f7fd03c47acb53fa3d4bb1753db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i023ce78002434d8cad1d8f97aa442d34_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4d88e2c29bd4ed1a1c6b4b23e1884dc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i220bb9cb676540b4aeb3a914e250fe06_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8a052d919884528be429b16feacfa3c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3966096b4cf940f5ab5e3bdf08677217_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd072559e8714571bf142682157e4908_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ac77c183dc946279d677be3a4d4156e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44a77aea53a9467e962038a9620c620b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07cffec9adda4d338d0d362e4623e96b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d18c978c29e46f2a12a23d7312bca62_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae1734dfbd7b4fffa4a61071f126a5be_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0964fabcb4d4203950f730100ea33dc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>ehth:employee</xbrli:measure></xbrli:unit><xbrli:context id="i5cf30dc17def4256a761123e6f60a569_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2923c5383c841499a972300bbf7f35a_I20180917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6844992191446ce8e5eb767a6d14280_I20180917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i071c226c04364e0c9c1937a5320495ed_I20191220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7fc3ad8803c48dba5b19cd94571052d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesPrecedingThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2de67982b8047c4945d793ade8e4b30_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesSucceedingThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb110a0ed8474c12b0f9d57120ec9b8b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesSucceedingSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib22aa805134544d8b3f646ee20f2d401_D20180917-20180917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-17</xbrli:startDate><xbrli:endDate>2018-09-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44dd187585b74e779c773066ae7d855f_D20191220-20191220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-20</xbrli:startDate><xbrli:endDate>2019-12-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccd604bc2ad5443287367d09698c1237_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30714fb2e7da43798055174115a19c9f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6cae47fd71f4a738ddcb10f68e682c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c1d434f2124892a124c74f776eff75_D20210430-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-30</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib293ecab870b425a8366eb79aa2bf444_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i534e5b0d995440019776d9538b893f71_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMjk4_276392c5-b761-4f7c-b803-605293dd2bd0">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzAy_d0b528e1-7e41-4a68-9a7f-f26cb5658e1f">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE&#160;SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMTI_2e26b6f0-6653-4d8d-a166-daef17c57f4a">March 31, 2021</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMjk5_944572c7-0ee3-422a-953b-4735f4eb3081">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE&#160;SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the transition period from     to</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commission File Number: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzA2_8f32a161-82a0-4009-896e-846328ddd63f">001-33071</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzEw_9c9e3fec-13b7-4240-a19c-efe6b49a0e6f">EHEALTH, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6NThlNWQ2ZTYzMDBjNGM5NWFiYTI2MTc4MjYxZDkyMmYvdGFibGVyYW5nZTo1OGU1ZDZlNjMwMGM0Yzk1YWJhMjYxNzgyNjFkOTIyZl8wLTAtMS0xLTA_820620df-5e88-4102-ab25-9395e48c9818">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6NThlNWQ2ZTYzMDBjNGM5NWFiYTI2MTc4MjYxZDkyMmYvdGFibGVyYW5nZTo1OGU1ZDZlNjMwMGM0Yzk1YWJhMjYxNzgyNjFkOTIyZl8wLTItMS0xLTA_5e930886-13d3-496a-8a8f-d0b96ea0da20">56-2357876</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(I.R.S Employer Identification No)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzEx_67c43767-9e51-4310-9026-1202b5b56e2f">2625 AUGUSTINE DRIVE, SECOND FLOOR</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzA3_890c7dd3-b3a7-4344-a1f1-da175dd1850b">SANTA CLARA</ix:nonNumeric>, <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzAz_4a7f862f-22d0-4b48-bf59-6787a9aafea2">CA</ix:nonNumeric> <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzA4_6cb3845e-94f1-4f65-855c-972e98494205">95054</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzAw_6ae4424a-d4ed-4fdd-9376-4e7e0b0a096d">650</ix:nonNumeric>) <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl82NTU_b9338edc-9283-41f9-9744-6dfb12f6bf3d">584-2700</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.065%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6MDU1ODlkYTE4YzIxNDI5OGI1MWE3YTZhZmEwZjljMDQvdGFibGVyYW5nZTowNTU4OWRhMThjMjE0Mjk4YjUxYTdhNmFmYTBmOWMwNF8xLTAtMS0xLTA_390c4bc3-8cbd-41c3-baa9-2d4449fe2e41">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6MDU1ODlkYTE4YzIxNDI5OGI1MWE3YTZhZmEwZjljMDQvdGFibGVyYW5nZTowNTU4OWRhMThjMjE0Mjk4YjUxYTdhNmFmYTBmOWMwNF8xLTEtMS0xLTA_b9be5e06-1e73-4ae1-af34-f3a2598ce0f8">EHTH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6MDU1ODlkYTE4YzIxNDI5OGI1MWE3YTZhZmEwZjljMDQvdGFibGVyYW5nZTowNTU4OWRhMThjMjE0Mjk4YjUxYTdhNmFmYTBmOWMwNF8xLTItMS0xLTA_fbf25cb4-57e4-44c0-9dee-ae0b214ecd6b">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzAx_8829ef7b-5029-4ffe-9324-c0df24b11caf">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulations S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzA0_2272842b-9b37-4d80-83ee-5238abaffa4f">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221;&#160;&#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6NmQ2ZGIzZGU5ZGE1NDYzMjk4YTZjMDQ5MjIzNjBjZDkvdGFibGVyYW5nZTo2ZDZkYjNkZTlkYTU0NjMyOThhNmMwNDkyMjM2MGNkOV8wLTAtMS0xLTA_c1146e34-39b3-414b-93a6-646d36d933f1">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6NmQ2ZGIzZGU5ZGE1NDYzMjk4YTZjMDQ5MjIzNjBjZDkvdGFibGVyYW5nZTo2ZDZkYjNkZTlkYTU0NjMyOThhNmMwNDkyMjM2MGNkOV8xLTQtMS0xLTA_092ac9ae-3c57-42df-84f6-9d75518ebf5e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6NmQ2ZGIzZGU5ZGE1NDYzMjk4YTZjMDQ5MjIzNjBjZDkvdGFibGVyYW5nZTo2ZDZkYjNkZTlkYTU0NjMyOThhNmMwNDkyMjM2MGNkOV8yLTQtMS0xLTA_03050c13-2f2a-4cf0-b66e-77472e750c1f">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzEy_a4e79d7a-4c38-4114-aa77-620b65f869e8">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock, par value $0.001 per share, outstanding as of April&#160;23, 2021 was&#160;<ix:nonFraction unitRef="shares" contextRef="i6bb60180d74e484091d2db3e841cf5d9_I20210423" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMjg2_e770d036-534a-4168-bf4b-3397028cd08d">26,091,024</ix:nonFraction> shares.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EHEALTH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_1198">Summary of Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_1198">2</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_13">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_13">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_16">Condensed Consolidated Balance Sheets as of </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_16">March</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_16"> 3</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_16">1</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_16">, 202</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_16">1</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_16"> and December 31, 20</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_16">2</a>0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_16">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19">Condensed Consolidated Statements of Comprehensive </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19">Income</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19"> (</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19">L</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19">oss)</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19"> for the Three</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19"> Months Ended </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19">March</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19"> 3</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19">1</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19">, 202</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19">1</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19"> and 20</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19">2</a>0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_19">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_25">Condensed Consolidated Statements of Stockholders' Equity for the Three </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_25">Months Ended </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_25">March</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_25"> 3</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_25">1</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_25">, 202</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_25">1</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_25"> and 20</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_25">2</a>0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_25">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_28">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_28">Three </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_28">Months Ended </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_28">March</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_28"> 3</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_28">1</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_28">, 202</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_28">1</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_28"> and 20</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_28">2</a>0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_28">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_31">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_76">24</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_103">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_103">45</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_106">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_106">46</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INFORMATION</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_112">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_112">47</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_115">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_115">47</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_118">Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_118">71</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_121">Signatures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i534e5b0d995440019776d9538b893f71_121">72</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_1198"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary of Risk Factors</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Our business is subject to numerous risks and uncertainties, including those risks discussed at length in Part II, Item 1A below. The following is a summary of the principal risks we face, any of which could adversely affect our business, operating results, financial condition or prospects:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If our ability to enroll individuals during enrollment periods is impeded or if investments we make in enrollment periods do not result in the returns we expected when making those investments, our business, operating results and financial condition would be harmed.  </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may be unsuccessful in competing effectively against current and future competitors, including government-run health insurance exchanges.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our business may be harmed if we lose our relationship with health insurance carriers or our relationship with health insurance carriers is modified.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our financial results will be adversely impacted if our membership does not grow or if we are not able to successfully retain our existing members and limit health insurance plan termination.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we are not able to maintain and enhance our brand, our business and operating results will be harmed.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The ongoing COVID-19 pandemic and public health crises, illness, epidemics or pandemics could adversely impact our business, operating results and financial condition.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our business may be harmed if we are not successful in executing on our strategic investments and initiatives, including our growth strategy and retention initiatives.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The success of our customer care center operations depends upon our ability to timely hire, train, retain and ensure the productivity of our licensed health insurance agents.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we are not successful in cost-effectively converting visitors to our website&#160;and customers who call into our call centers&#160;into members for whom we receive commissions, our business and operating results would be harmed.&#160;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We depend upon Internet search engines and social media platforms to attract a significant portion of the consumers who visit our website, and if we are unable to effectively advertise on search engines or social media platforms on a cost-effective basis, our business and operating results would be harmed.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely significantly on marketing partners and our business and operating results would be harmed if we are unable to maintain effective relationships with our existing marketing partners or if we do not establish successful relationships with new marketing partners.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our future operating results are likely to fluctuate and could fall short of expectations.&#160;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The marketing and sale of Medicare plans are subject to numerous, complex and frequently changing laws, regulations and guidelines, and non-compliance with or changes in laws, regulations and guidelines could harm our business, operating results and financial condition.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Changes and developments in the health insurance industry or system as a result of health care reform could harm our business, operating results and financial condition.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our success in selling health insurance is dependent in part on the actions of federal and state governments. Changes in the laws and regulations governing the offer, sale and purchase of health insurance could harm our business and operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our business is subject to security risks and, if we experience cyberattacks, security breaches or are otherwise unable to safeguard the security and privacy of confidential data, including personal health information, our business will be harmed.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our operating results will be impacted by factors that impact our estimate of the constrained lifetime value, or LTV, of commissions per approved member.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I.&#160;&#160;&#160;&#160;FINANCIAL INFORMATION</span></div><div id="i534e5b0d995440019776d9538b893f71_13"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL STATEMENTS</span></div><div id="i534e5b0d995440019776d9538b893f71_16"></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands) </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMy0xLTEtMS0w_56dbd1b4-d64c-481a-b035-aee0f2f8bc10">92,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMy0zLTEtMS0w_550dcca8-0b33-41c2-9fe0-8fdbd26b8b6f">43,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNC0xLTEtMS0w_ddacd028-d433-4392-81d4-828b1c74202a">33,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNC0zLTEtMS0w_caff7d44-29dd-46ba-a000-e3190f9ada09">49,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNS0xLTEtMS0w_a3d0a606-3761-40ad-82c0-77e23082499d">1,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNS0zLTEtMS0w_22f9cdbf-e3f5-49e1-b7e1-41d774897199">1,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract assets &#8211; commissions receivable &#8211; current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNi0xLTEtMS0w_d18d5010-f1bd-4e38-b21e-f6dd312e9327">180,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNi0zLTEtMS0w_90fcff5e-ed04-42ed-bb22-baa80de4e546">219,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNy0xLTEtMS0w_6365c71c-d211-4538-91a5-70262c53a4c8">12,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNy0zLTEtMS0w_47472dea-e155-46b5-9eec-3a13f4349a1b">16,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfOC0xLTEtMS0w_0ea98d0f-7d53-4c12-ae5d-ed0fa1fe409f">320,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfOC0zLTEtMS0w_b1110285-eb8f-40ae-9427-f507bd375fb7">330,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract assets &#8211; commissions receivable &#8211; non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfOS0xLTEtMS0w_002c3e2a-67c4-4b1d-af8b-82a1c228e46f">561,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfOS0zLTEtMS0w_c6cf253d-2c59-43ca-aca6-bcd4e49c689b">573,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTAtMS0xLTEtMA_e76eeb2d-3e82-4583-bb66-3c17df85359b">14,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTAtMy0xLTEtMA_15f0c373-7e47-4b27-a7a1-ca94b2426db5">14,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTItMS0xLTEtMA_836798cd-1595-483c-a0cf-0015532f60a8">41,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTItMy0xLTEtMA_de57290b-db4e-4924-989f-08e76e4d3a03">42,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTMtMS0xLTEtMA_61d24d8d-86e7-4826-9b5d-02595ef4f166">3,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTMtMy0xLTEtMA_dd9f2caf-34b5-41ff-8068-7f12742d8226">3,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTUtMS0xLTEtMA_5c5c6727-37ea-4e39-b917-e685c8f0207b">8,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTUtMy0xLTEtMA_ffeaa154-7bb9-4a01-8216-060c2a2d2f68">8,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTYtMS0xLTEtMA_b2f99ced-5dc5-4b5d-891d-3298447fd890">40,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTYtMy0xLTEtMA_b2f3cb57-8234-4895-ab0b-85aa07457838">40,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTctMS0xLTEtNTY1OQ_a1902ca6-860f-46b0-b8df-6a14fd201bd8">27,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTctMy0xLTEtNTY1OQ_ff5bd5e6-217c-4137-bec4-e37d762f2bf9">26,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTctMS0xLTEtMA_cef373aa-eacb-4126-a322-f8734b6a8fa9">1,017,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTctMy0xLTEtMA_9216e76c-8153-4e92-8cad-150836b4c4a6">1,040,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjAtMS0xLTEtMA_3718178c-1026-4d97-8349-b24be358daf4">10,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjAtMy0xLTEtMA_0fbe341b-cbe0-4cbb-bba9-08cd05de63a4">36,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjEtMS0xLTEtMA_e6bfd5b3-71bc-4108-930e-a43ef5617ba3">24,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjEtMy0xLTEtMA_785e7b2c-8736-4269-b76a-85e87324fda3">20,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:AccruedMarketingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjItMS0xLTEtMA_26c699c8-dd0d-4ac5-a7b5-2a6e0cf175fc">11,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="ehth:AccruedMarketingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjItMy0xLTEtMA_7af6e1e8-8b91-4930-8129-ba46ed380cf4">17,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities &#8211; current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjQtMS0xLTEtMA_cff55501-87fd-427f-94d0-6f5b36959265">5,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjQtMy0xLTEtMA_b2084996-28f9-4463-b76d-1c8615afbbf7">5,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjUtMS0xLTEtMA_490095dd-ac81-447d-bcd2-f379e35891da">877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjUtMy0xLTEtMA_856be86f-6dc9-489c-ace0-8715eb1d4f6c">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjYtMS0xLTEtMA_ba898f44-dac4-4ca7-98e3-43179655c9e7">4,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjYtMy0xLTEtMA_1fd0841d-2461-4537-b9c5-f28a1f2fecfe">3,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjctMS0xLTEtMA_27aa8d91-7c59-43b6-81f5-c740d7fefafa">57,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjctMy0xLTEtMA_4c1fdfc0-0d42-4b89-9066-03bc17ba6848">84,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzAtMS0xLTEtMzk1NQ_205bc82a-93ca-4810-b3e3-f011aba7f981"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzAtMy0xLTEtMzk1NQ_23c8e2c2-cbb5-41d6-95d6-bf8eacf5668b"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes &#8211; non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzAtMS0xLTEtMA_39924617-d7fc-4b99-838b-9e38419c6d8e">71,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzAtMy0xLTEtMA_1280c484-f3e6-4fca-b742-5a05b5d20a3b">72,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities &#8211; non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzEtMS0xLTEtMA_496ca180-8081-4a9c-8eb6-e9929a74a304">39,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzEtMy0xLTEtMA_e18e48e9-ddcc-4896-9828-c3395c9d91b7">41,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzItMS0xLTEtMA_dd4b61a6-0cb8-4008-baf1-9628f0029be1">5,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzItMy0xLTEtMA_50a4ccdf-3789-488e-b21e-e6bb1d7c04d0">4,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzQtMS0xLTEtMA_6ea0fc9c-6b15-4347-b8df-b8e7e0671210">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzQtMy0xLTEtMA_3856be7b-7ef8-4469-b109-a14197bc142d">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzUtMS0xLTEtMA_c4753180-4391-4005-a8dc-e4b87fc5c4a9">728,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzUtMy0xLTEtMA_9a37d9b7-c11f-4d67-b983-f15e149a970f">721,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock, at cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzYtMS0xLTEtMA_eafcc37f-540a-4577-a5bf-86463b221ec0">199,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzYtMy0xLTEtMA_5bd67c59-5de6-49fa-9803-531311afbb16">199,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzctMS0xLTEtMA_45e3520b-16c4-4c4c-9051-89a725b5cc0b">315,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzctMy0xLTEtMA_8baefbe3-3a0f-44f3-ad3f-90ee55c4dd4c">316,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzgtMS0xLTEtMA_58524719-3772-41b8-bfcf-e9797708925c">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzgtMy0xLTEtMA_b575f019-d831-4fcd-9db2-863121775af4">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzktMS0xLTEtMA_3e229e80-2ff6-4600-9d07-296ae8c373df">843,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzktMy0xLTEtMA_480d3696-d03b-40ee-9df8-95184bb15d85">837,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNDAtMS0xLTEtMA_62be2324-614e-4759-b9ee-26695593e02e">1,017,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNDAtMy0xLTEtMA_b3fd2453-cf28-4dca-81f9-6cfaa7e25f6f">1,040,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="margin-bottom:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts, unaudited)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.683%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commission</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8337239e8dda4274bdb5081198725cf8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMy01LTEtMS0w_a09d72bc-da1e-48e5-8e11-96dda546d589">127,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a17b2f577fb4a0994b259f4a7c00fac_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMy03LTEtMS0w_3ddba876-2275-4db6-9ea8-f241cb616bd1">99,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8680ff82e8684663ac818bd969dadd40_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNC01LTEtMS0w_72f8f999-e883-4667-85d3-1e875d29b7a9">7,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe1a9fc09dc4d98894c2f05859cd3f1_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNC03LTEtMS0w_86510bca-8308-4d35-8ab0-5a81fb581960">6,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNS01LTEtMS0w_ed10dc91-cf1f-479e-88ad-d64d03dd9ad7">134,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNS03LTEtMS0w_f7105567-d787-46d9-9773-ea4f2a610e8f">106,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNy01LTEtMS0w_b7d9ccef-0995-4844-a2dc-0c862f8f4af3">996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNy03LTEtMS0w_175ceec2-384f-4218-80f4-f6e226d462c9">1,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfOC01LTEtMS0w_640e70f0-efac-4199-a99b-708180dfceb1">50,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfOC03LTEtMS0w_22dbd097-dafe-4652-b454-9742be218013">37,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:CustomerCareAndEnrollmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfOS01LTEtMS0w_b45b41be-e5bc-469d-9571-c3a108de83b3">34,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="ehth:CustomerCareAndEnrollmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfOS03LTEtMS0w_3bec271e-fa70-4bfe-9fe4-8af965ba76e8">30,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:TechnologyAndContentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTAtNS0xLTEtMA_57da72f0-3fde-4879-8018-d2feb0b0b9da">23,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="ehth:TechnologyAndContentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTAtNy0xLTEtMA_65d2aef2-07de-4fd1-9e73-0d103192ebc7">15,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTEtNS0xLTEtMA_001ab001-adba-4e8b-beee-881078461cb3">23,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTEtNy0xLTEtMA_7ea4fc7e-16ba-46e8-8035-c636e2702a4e">19,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTItNS0xLTEtMA_cc7674b6-415f-4188-82b7-7c781133babf">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTItNy0xLTEtMA_61ec6930-b340-4ff6-9d88-49b72cb9b250">547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTQtNS0xLTEtMA_c4ce929e-9bed-469e-a983-e96a8a3ca3ba">2,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTQtNy0xLTEtMA_d0161363-8282-4986-a043-a56f03d96c0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTYtNS0xLTEtMA_f2d8dc75-f281-402a-87fe-97741ba20121">134,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTYtNy0xLTEtMA_c680586b-f5c1-4b9a-8479-6f670e313880">105,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTctNS0xLTEtMA_5c242220-bac1-4106-8c32-53badd11ed78">642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTctNy0xLTEtMA_f417c0b6-f6a8-438f-bf7b-6d268b7653b9">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTgtNS0xLTEtMA_d41eb882-09bd-4a03-88ec-17a2978fba44">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTgtNy0xLTEtMA_d4a5f518-e6bb-4fe4-8dc9-3e73682e6830">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income (loss) before provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTktNS0xLTEtMA_4375c594-1b77-4411-99d0-8430c1448420">492</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTktNy0xLTEtMA_cf54e09b-d026-42cd-818b-b2f199eb3f31">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjAtNS0xLTEtMA_e261a109-09ae-4675-91df-3444c48a0eed">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjAtNy0xLTEtMA_ad71807b-d889-4056-a702-c6fffc652e00">2,048</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjEtNS0xLTEtMA_72e3fa8e-9bda-4351-be96-adfb3d76df23">800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjEtNy0xLTEtMA_27aae8ce-30c4-45b5-bd4b-f50a9954532f">3,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjQtNS0xLTEtMA_8c77c357-a7e8-44ac-8148-1845aaf591d8">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjQtNy0xLTEtMA_d313b3ce-e8ab-430c-8f5d-98b467b3ce65">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjUtNS0xLTEtMA_1942de4f-32a7-4afd-8335-136cd972de98">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjUtNy0xLTEtMA_e64f5a11-89a4-4dde-8fdd-b6048cb94ca5">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-average number of shares used in per share amounts:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjctNS0xLTEtMA_b627536b-3eae-499a-a159-a5745da3e9a4">26,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjctNy0xLTEtMA_ef7759fb-5c80-4aca-ad7a-64e1ebdf2425">24,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjgtNS0xLTEtMA_4481ab83-c178-4469-8ccf-fdd59cd4c93f">26,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjgtNy0xLTEtMA_7e3b7034-4ea7-4fc8-aeda-d52bfee63965">26,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive income (loss):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzAtNS0xLTEtMA_86ed6cb7-01b7-46c9-8852-28017815a1d3">800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzAtNy0xLTEtMA_d55ede7a-a3ee-4360-876a-9b57db2fd090">3,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized holding gain (loss) for available for sales debt securities, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzEtNS0xLTEtMA_0d9b115d-0b6b-4a4f-aac8-a3069583309b">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzEtNy0xLTEtMA_856cdad7-84a2-4026-ac3c-a19444edcc91">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzItNS0xLTEtMA_b3552d73-af7b-463f-bdfa-54081f86915f">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzItNy0xLTEtMA_818b18cb-6894-4e78-a61c-47bfd14b6672">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzMtNS0xLTEtMA_e6381d2f-b828-4789-8290-a5ddbed5db59">833</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzMtNy0xLTEtMA_52c5293d-10df-4ba2-aa81-7ea485d92cfc">3,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.891%"><tr><td style="width:1.0%"></td><td style="width:33.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib63247d699eb44bfb201774d6fef56b5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy0xLTEtMS0w_2a4bfc61-455b-47c1-9310-0af35ddc0c16">37,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib63247d699eb44bfb201774d6fef56b5_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy0zLTEtMS0w_2a19317b-1ca9-4e2d-9812-0c83eb7957ae">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29014aa44f224a9e8e5ca25d6c81661b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy01LTEtMS0w_fe6e745e-532e-4cf2-bca7-28d38bb7c31b">721,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibacf081650de495da52a05e4eed69d81_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy03LTEtMS0w_154206c7-bee9-4541-996c-2ea8614ab302">11,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibacf081650de495da52a05e4eed69d81_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy05LTEtMS0w_b35012c2-544d-4aad-baba-65e100ac4057">199,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if350613e6abd438882a29524ad8a5858_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy0xMS0xLTEtMA_00d29ea6-b6d8-41c7-adb1-4f7673791092">316,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a91006c9d446fbb4d678b836971da0_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy0xMy0xLTEtMA_9c64f48e-cf29-411b-b378-e0e084102441">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy0xNS0xLTEtMA_cef78aab-bf84-478d-8326-6770c28d5cd2">837,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with equity incentive plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieeba31f3c1b84580993db317c01046dd_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNS0xLTEtMS0w_fc51235a-3ae4-4384-9d70-a0a256fb851c">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74c4a51c8df7461fb85f66341986ca02_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNS01LTEtMS0w_d8071f21-0079-49cd-af53-45528cb8cd89">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNS0xNS0xLTEtMA_334e7272-2ef0-4c4d-a5c0-be7588b3f872">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of shares to satisfy employee tax withholding obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74c4a51c8df7461fb85f66341986ca02_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNi01LTEtMS0w_54aa02be-aaee-40dd-a91a-6914f45dfc21">5,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65cdbe8443b34580b8422ede51568ad8_D20210101-20210331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNi03LTEtMS0w_01e52a1c-4d4f-4583-8b8d-20d1e707b91f">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNi0xNS0xLTEtMA_7a5a5d6a-302d-451e-b5ea-97b791390904">5,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74c4a51c8df7461fb85f66341986ca02_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfOS01LTEtMS0w_5adfc382-6c4e-4c84-9178-c0806e037a46">11,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfOS0xNS0xLTEtMA_feb71c06-b6e1-4095-9972-6da5ca0d38e8">11,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadef4a55d90e438a8f79adf8bc288200_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTAtMTMtMS0xLTA_1b982b1f-2f1f-4399-8e6b-79de79a2633f">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTAtMTUtMS0xLTA_fd2031fa-9b47-4007-bd3b-92b6a78bb902">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib464d05e6c054ac8bcb58e7dcb4504fe_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTEtMTEtMS0xLTA_cccd84d3-06b4-4d82-a324-b57d9579c9fb">800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTEtMTUtMS0xLTA_deda504c-3541-422c-b2af-8a64583b0027">800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7881058e6391413da79a1df94978a40a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItMS0xLTEtMA_18f3cbd8-540a-47df-a51b-c33f3d5e1ff4">37,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7881058e6391413da79a1df94978a40a_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItMy0xLTEtMA_b1d19692-3c4d-496d-8971-21ada99a0be5">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5468c73d2e34194b9c572c7aba7dfbe_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItNS0xLTEtMA_f94441ab-9d38-43f5-a2e7-4165700c26f8">728,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1c5c1ce40314084a6517c4ee8f604b7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItNy0xLTEtMA_3260308c-d7e0-4140-9ef2-5d7f63ec13ce">11,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1c5c1ce40314084a6517c4ee8f604b7_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItOS0xLTEtMA_385c6750-8d63-4099-a6fc-bf19ddb721f9">199,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571009d8684244af94c420ce801431c3_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItMTEtMS0xLTA_f83e976d-652a-4eab-9edf-36775036991d">315,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85b5b55d4a9c4f76ac527000958b9eae_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItMTMtMS0xLTA_6155efc2-f569-45b3-b5d4-5f5010b1f3d2">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItMTUtMS0xLTA_6575788b-4f36-4a08-aebf-102c0901b51d">843,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.783%"><tr><td style="width:1.0%"></td><td style="width:33.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a043e2b26b14ab29cc5ac268c78e6cb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy0xLTEtMS0w_69091c22-1550-4da8-b6de-a834a31d5807">34,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a043e2b26b14ab29cc5ac268c78e6cb_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy0zLTEtMS0w_dc920ecf-51fd-46d5-af99-77478a3a777e">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f6aba0243b421b803fe3861b663e07_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy01LTEtMS0w_157ce630-5b13-4ee0-94c7-b9463e7c083b">455,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d29d5730c7349ea9d1ef955dd844f0d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy03LTEtMS0w_5ac29b01-6ebe-44a3-9162-d208c04b0e36">11,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d29d5730c7349ea9d1ef955dd844f0d_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy05LTEtMS0w_a657cec7-892e-47fc-965d-673837b1defd">199,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf42840deb504490a24f18226ae769ac_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy0xMS0xLTEtMA_2c51ae99-4bef-4ccf-98f1-b8d01b526ef0">271,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i464582b3717f48fb8fb924189caabeae_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy0xMy0xLTEtMA_4b888386-80ac-4924-8dad-005a639424f2">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i283d90d05c8744f3a67f23305e4f839c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy0xNS0xLTEtMA_a445f698-32a4-4bab-a731-b176c44f13b9">527,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC0wLTEtMS0xNjk5_9cb35bf6-6ad9-454a-94f9-8fd78c9d7e52">Cumulative effect from the adoption of ASU 2016-13</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie89c5f32945844b5b95944d102880a24_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC0xMS0xLTEtMTcwNg_76279445-1e3d-4894-aae7-3344456fcb81">1,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0466642154754b80bcf918c034fb3b1d_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC0xNS0xLTEtMTcwNg_f195f095-374b-4266-9d51-f4347687cc7a">1,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with equity incentive plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6b1b9ba849b4eb49f00439861a88682_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC0xLTEtMS0w_0464d43e-a0c7-48af-a5fd-b97b249dac01">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6107d03659748ec91163598cd67842f_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC01LTEtMS0w_a6f407cc-af51-4260-828b-92344c5440e6">1,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC0xNS0xLTEtMA_8179ea9b-22d3-4fcf-86a6-65f35e7be87a">1,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of shares to satisfy employee tax withholding obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6107d03659748ec91163598cd67842f_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNS01LTEtMS0w_0147696e-258e-4c45-aa90-534bec813cde">4,375</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibce1977df45a4166aacac2533753fef2_D20200101-20200331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNS03LTEtMS0w_15f1b400-9cd3-4c79-bb76-ad07503b6cbf">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNS0xNS0xLTEtMA_36f7c1cb-993a-49b8-ad47-5a1e49518f60">4,375</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares issued in equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6b1b9ba849b4eb49f00439861a88682_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNi0xLTEtMS0w_159f57d1-ecaa-4cdd-8852-cee180aca30f">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b1b9ba849b4eb49f00439861a88682_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNi0zLTEtMS0w_64e4c161-f8b8-422c-af82-3ad60d83f439">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6107d03659748ec91163598cd67842f_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNi01LTEtMS0w_a1dc97f8-13ee-423c-9e42-b3af4335e19c">228,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNi0xNS0xLTEtMA_21cdd065-4a93-486e-9eb3-390d09f06d2b">228,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlement of earnout liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6b1b9ba849b4eb49f00439861a88682_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNy0xLTEtMS0w_9bf8ac72-701e-473f-9366-656e1c248c7d">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6107d03659748ec91163598cd67842f_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNy01LTEtMS0w_c381e34d-a707-466d-89e7-acaeb075f4f1">28,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNy0xNS0xLTEtMA_b121706a-82fe-41a1-9a03-9ce656b9e061">28,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6107d03659748ec91163598cd67842f_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfOC01LTEtMS0w_d622f170-98a6-42e8-8c73-5a5034256cd4">8,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfOC0xNS0xLTEtMA_be1027aa-6750-42ea-8790-d0b6af56091d">8,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffa4ea2bf46843c8a3b8c76230e7aece_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfOS0xMy0xLTEtMA_99a103f8-d6ba-441c-bd2e-16def571c76d">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfOS0xNS0xLTEtMA_dc07e7f4-ca4c-4dd6-948a-7e8077dcfab4">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77e456c86a2c4c2298f67ccceb97b818_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTAtMTEtMS0xLTA_cbfeb036-f95b-4926-b913-702a58242e6d">3,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTAtMTUtMS0xLTA_8916680e-b9b8-4265-8f7b-e06a343f5925">3,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98e488604a58499a810b6c51f24f6985_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtMS0xLTEtMA_ffab2215-26e2-47ef-80c8-3e83304a7215">37,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e488604a58499a810b6c51f24f6985_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtMy0xLTEtMA_e08f3f9b-dad8-4805-a6e9-3d6d226e179f">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51bc9d212152476f9e50aaa3f71da0a8_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtNS0xLTEtMA_495b1fce-ea0d-4a4e-be08-2bc0bbab57bb">717,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96bc1b9468db422cbae505e283d62180_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtNy0xLTEtMA_ec78a8d9-1872-4032-b994-6960885da232">11,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96bc1b9468db422cbae505e283d62180_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtOS0xLTEtMA_434a8295-377c-4a7f-9ec9-8ea951a58f14">199,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18dcb5c7e7f74362b1df0c50dfaf35c3_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtMTEtMS0xLTA_a41c448c-cf4e-41f2-905a-0cb41e6cc6c7">274,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3222346a5aab4a859b8e9a0c70c4fccb_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtMTMtMS0xLTA_cb80c552-04d5-4a6b-9121-a9ea7d7493d9">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e4cd2c63294501a97ce58cbb8f0ad9_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtMTUtMS0xLTA_b55f2b0e-7918-4631-8330-48ef68fc04fa">791,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMy0xLTEtMS0w_29aaf876-4f14-4893-ae05-c604170503a5">800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMy0zLTEtMS0w_f530d72b-99d5-443f-8383-eff616246a72">3,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNS0xLTEtMS0w_d208fffb-ace6-4d41-b3d7-443328fdd215">1,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNS0zLTEtMS0w_9e7a6ce1-b455-4747-9d8e-1e4d0e2d9f32">823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of internally developed software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNi0xLTEtMS0w_87aa06ad-070f-40f5-ba3a-06f057cd51aa">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNi0zLTEtMS0w_246594f4-1cba-4508-9b0f-038d75a14071">1,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNy0xLTEtMS0w_d8597281-d58c-4ea1-9788-c9dc8c77d661">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNy0zLTEtMS0w_36fcc184-0c6f-4792-8b44-b3c9a48c392b">547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfOC0xLTEtMS0w_bedb75e8-ed44-4d19-873c-7136e072a5d6">11,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfOC0zLTEtMS0w_24031bc6-c4ba-4f32-9c50-2973824c6625">8,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfOS0xLTEtMS0w_49b5bff6-3fd3-411c-8405-2d82df3929c3">570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfOS0zLTEtMS0w_34675c1d-19f8-4177-8cae-23d00d5dd00f">2,141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTItMS0xLTEtMA_6971c7ac-60f1-4973-8d20-58b9eef1ace1">420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTItMy0xLTEtMA_3bf6ae8b-8495-4988-a0b5-6a3f2819c7ed">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTQtMS0xLTEtMA_6d6762de-5581-4793-874c-0a55ec9af53c">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTQtMy0xLTEtMA_8f89fcb0-1edc-419f-989b-2140c2440bc9">1,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets &#8211; commissions receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:IncreaseDecreaseInCommissionsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTUtMS0xLTEtMA_6e19712d-8d2a-4cec-a23d-2deae2916fe6">50,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="ehth:IncreaseDecreaseInCommissionsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTUtMy0xLTEtMA_2753324d-4d64-48ac-9707-416f29d35a88">26,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTYtMS0xLTEtMA_35db2fe7-0841-4996-bf5e-4e1d8455fb96">4,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTYtMy0xLTEtMA_a76654c9-8260-4ff2-b138-59bda7a3d9f3">159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTctMS0xLTEtMA_d08c3f68-b588-4daa-9a1d-4b2b81df59ee">25,826</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTctMy0xLTEtMA_4ada8fb8-fdf7-4162-ad7a-307986865af9">16,279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTgtMS0xLTEtMA_146dab59-712e-411c-bf5a-8ea41f07f7e3">4,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTgtMy0xLTEtMA_770f1ea6-0b68-446d-ba09-d5e061517674">11,104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="ehth:IncreaseDecreaseInAccruedMarketingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTktMS0xLTEtMA_a0b4c5c1-7373-451f-a947-b44200534230">6,712</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="ehth:IncreaseDecreaseInAccruedMarketingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTktMy0xLTEtMA_e1715479-fd3f-4e9b-81ac-9181df3d732f">7,329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjAtMS0xLTEtMA_0d0dfe04-765d-480e-a3ac-33126ffb9d7c">570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjAtMy0xLTEtMA_caa5b2d6-2cc5-4861-90bd-0adac4faab45">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjEtMS0xLTEtMA_dd62545d-acc5-4157-bc3d-48274c00dbc9">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjEtMy0xLTEtMA_1652ffa0-8f06-4097-bbf4-d99475885aff">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjItMS0xLTEtMA_22ae50ba-edf7-4eb8-863a-95828e4b3ddf">42,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjItMy0xLTEtMA_34b50b29-2f0f-41b1-a0ae-643be7e3967d">8,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized internal-use software and website development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToDevelopSoftware" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjQtMS0xLTEtMA_30beed28-9c7c-4677-ae1f-a778c6a3d343">3,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToDevelopSoftware" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjQtMy0xLTEtMA_f44552f1-edbe-472b-a1e9-e929d2a103fc">3,564</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjUtMS0xLTEtMA_2181ae59-f3a7-4242-8968-767edbf196d3">1,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjUtMy0xLTEtMA_6ca176d5-52df-486e-961f-449fcaf9bc13">2,508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjYtMS0xLTEtMA_30326a7c-b177-4d82-99e8-5cf8072dd667">7,771</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjYtMy0xLTEtMA_79471e20-63e7-42d5-b27c-048f2c9f0815">58,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from redemption and maturities of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjctMS0xLTEtMA_d539b716-9ed0-4fa4-885c-aa51eeed13d2">23,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjctMy0xLTEtMA_cecbb599-bf46-4a52-9b4e-83f7187a6e36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzAtMS0xLTEtMA_a08725d2-baf2-461d-8318-99519afd15ac">10,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzAtMy0xLTEtMA_5e90f19a-6237-4db8-8fab-132a83fe6376">64,136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzItMS0xLTEtMA_d39b62d7-274e-4907-9b67-2db15a13956b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzItMy0xLTEtMA_6fe2e0c5-2aea-4ad4-a0a9-954291e59f1e">228,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from exercise of common stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzMtMS0xLTEtMA_8c0db310-9d51-4448-8858-be030cc6ae11">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzMtMy0xLTEtMA_5e525846-7e23-4bc1-8c84-2560dff75962">1,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of shares to satisfy employee tax withholding obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzQtMS0xLTEtMA_5c79f08f-d28a-4cf1-9ce9-f36e28029d90">5,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzQtMy0xLTEtMA_0945737c-9bca-4ead-910c-593fe1a807fb">4,375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition-related contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzgtMS0xLTEtMA_a5627426-fa23-478c-acab-e37c5ad4a742">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzgtMy0xLTEtMA_22d7319f-1020-47e8-aec9-9b48a30afb3e">8,751</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal payments in connection with leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzktMS0xLTEtMA_69eb7e05-00f5-40d0-ba94-76ad6b20cdb1">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzktMy0xLTEtMA_656aae58-22c9-4c89-9605-2f23f89edd70">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDAtMS0xLTEtMA_b7731e0e-6ef7-4c27-b220-ae32d566cf51">4,790</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDAtMy0xLTEtMA_c94f62ff-3e2c-4ea2-a895-71c6d4974558">215,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDEtMS0xLTEtMA_5873a946-ba7c-47c5-8531-e29bcde9a77d">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDEtMy0xLTEtMA_903021ef-d2ef-442a-9e80-e44b7ac76843">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDItMS0xLTEtMA_6d45a968-f1f0-454f-8090-5483b2aa3863">48,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDItMy0xLTEtMA_688c3998-cad8-43f5-90d6-599d37ba4213">160,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDMtMS0xLTEtMA_f929aa45-c2da-4c82-b6fa-fa97752f37a1">47,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i283d90d05c8744f3a67f23305e4f839c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDMtMy0xLTEtMA_595d257f-e887-4fbb-8441-281c270646ce">26,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDQtMS0xLTEtMA_29bb993f-96c3-4be5-8e91-f75f62f4299c">95,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e4cd2c63294501a97ce58cbb8f0ad9_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDQtMy0xLTEtMA_c8ec4f09-514d-41ef-8f61-3c3420e13ec0">187,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_31"></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><div><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyODI_760b23e8-8358-4665-9d36-618ddd22ad5c" continuedAt="if407400f68704c0780de47b16455bbfc" escape="true">Summary of Business and Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if407400f68704c0780de47b16455bbfc" continuedAt="iad689517d6ac4d83a2b5d20ae9e63952"><div style="text-indent:36pt"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="ehth:DescriptionOfBusinessPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyNzY_ba3831e8-28a7-4200-a216-0f92c9983cb0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eHealth, Inc. (the &#8220;Company,&#8221; &#8220;eHealth,&#8221; &#8220;we&#8221; or &#8220;us&#8221;) is a leading health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform is designed to meet the consumer wherever they prefer to engage with us, and enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over <ix:nonFraction unitRef="insurance_carrier" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="INF" name="ehth:NumberOfHealthInsuranceCarriers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTMwMA_b04b5d47-6586-490a-8c14-756968dcddbd">200</ix:nonFraction> health insurance carriers across all <ix:nonFraction unitRef="state" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTM0MA_1db0b858-fa4d-464f-b371-d2a41628f0d4">fifty</ix:nonFraction> states and the District of Columbia.</span></ix:nonNumeric></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyNjk_0922650f-0ce0-4702-b49d-c355d981de97" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Basis of Presentation &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accompanying condensed consolidated balance sheets as of March 31, 2021 and December 31, 2020 and the condensed consolidated statements of comprehensive income (loss), stockholders&#8217; equity, and cash flows for the three months ended March 31, 2021 and 2020, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2020 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 26, 2021. The accompanying financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and reflect all normal recurring adjustments that are necessary to present fairly the results for the interim periods presented. The condensed consolidated financial statements include the accounts of eHealth, Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with those rules and regulations. Certain prior period amounts have been reclassified to conform with our current period presentation. However, we believe that the disclosures made are adequate to make the information not misleading. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 and include all adjustments necessary for the fair presentation of our financial position as of March 31, 2021 and December 31, 2020, and our results of operations for the periods presented. Our financial position as of March 31, 2021 and results of operations and cash flows for the three months ended March 31, 2021 were not materially impacted by the COVID-19 pandemic but the Company is continuously assessing the evolving situation related to the pandemic. The results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for any subsequent period or for the year ending December 31, 2021 and therefore should not be relied upon as an indicator of future results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2020, we identified certain errors, including a $<ix:nonFraction unitRef="usd" contextRef="id2018b7213bd4f93a2804c6b1e207d62_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTA5OTUxMTkxODY5Mw_f8f52893-0037-44ce-9040-00cb777e4c6d">3.0</ix:nonFraction>&#160;million under-recognition of stock-based compensation expense and a $<ix:nonFraction unitRef="usd" contextRef="i12b84f6b238d4f379f4615fedc93f6c7_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTA5OTUxMTkxODY3OQ_b0608125-a5f7-41b2-9e38-88cc35fc6735">1.5</ix:nonFraction>&#160;million over-recognition of licensing costs for the year ended December 31, 2020. We adjusted for these items in the first quarter of 2021 and the adjustments reduced our net income (loss) by approximately $<ix:nonFraction unitRef="usd" contextRef="i5c0615329c3645ffb15c379b3b25d3f0_D20210101-20210331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTA5OTUxMTkyMDU0MA_d7fa8b8e-e522-476a-b9fc-770c921ab50b">1.5</ix:nonFraction>&#160;million in our Condensed Consolidated Statement of Comprehensive Income (Loss) for the three months ended March 31, 2021.</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluated the effects of these out-of-period adjustments, both qualitatively and quantitatively, and concluded that the errors and the correction thereof were immaterial both individually and in the aggregate to the current reporting period and the periods in which they originated, including quarterly reporting.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyNzA_6c332c41-f6d3-4ccf-bde4-49d7a4e02887" continuedAt="ib7a6bc4e70e445ac848f118202368ffe" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies, Estimates and Judgments &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates, judgments and </span></ix:nonNumeric></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="iad689517d6ac4d83a2b5d20ae9e63952"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib7a6bc4e70e445ac848f118202368ffe">assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to, but not limited to, the useful lives of intangible assets, fair value of investments, recoverability of intangible assets, the commissions we expect to collect for each approved member cohort, valuation allowance for deferred income taxes, provision (benefit) for income taxes and the assumptions used in determining stock-based compensation. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. Actual results may differ from these estimates.</ix:continuation> There have been no material changes to our significant accounting policies discussed in our Annual Report on Form 10-K for the year ended December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="ehth:SeasonalityPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyODQ_fc376c5d-e7f8-44f3-9aa8-a0609bb3a603" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Seasonality &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open enrollment periods drive the seasonality of our business. A greater number of our Medicare-related health insurance plans are sold in our fourth quarter during the Medicare annual enrollment period when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, our Medicare plan-related commission revenue is highest in our fourth quarter. Any changes or additional enrollment periods may change the seasonality of our business. For instance, due to the reintroduction of the Medicare Advantage open enrollment period that takes place in the first quarter of the year, our first quarter is generally the second-highest revenue generating quarter.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our individual and family health insurance plans are sold in the fourth quarter during the annual open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. Individuals and families generally are not able to purchase individual and family health insurance outside of these open enrollment periods, unless they qualify for a special enrollment period as a result of certain qualifying events, such as losing employer-sponsored health insurance or moving to another state due to the recent COVID-19 pandemic.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyNjc_03fd60b8-d8cb-4c0e-aa7d-c5d8bebb24af" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncement</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Income Taxes (Topic 740) &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In December 2019, the FASB issued ASU No. 2019-12, Income Tax, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">, which aims to simplify the accounting for income taxes. We adopted this guidance in the first quarter of 2021 and it did not have a material impact on our condensed consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">. ASU 2020-10 is intended to facilitate codification updates for technical corrections, such as conforming amendments, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements. It contains amendments that improve the consistency of the codification by including all disclosure guidance in the appropriate disclosure section and other updates that varies in nature. We adopted this guidance in the first quarter of 2021 with no material impact on our condensed consolidated financial statements and disclosures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Debt with Conversion and Other Options (Topic 470) and Contracts in Entity's Own Equity (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> &#8211; In June 2020, the FASB issued ASU No. 2020-06 to simplify the accounting for convertible instruments and improve the usefulness and relevance of information regarding convertible instruments. This ASU reduces the number of accounting models for converting debt instruments and convertible preferred stock. ASU No. 2020-06 is effective for us in 2022, with early adoption permitted. We have early adopted this guidance in the first quarter of 2021 and it did not have a material impact on our condensed consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_37"></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfMjE5OTAyMzI5MDE4OA_22953f38-6662-44bb-ba12-b87f8f0aef4b" continuedAt="ib4de92eef0144b61a927675c284274c9" escape="true">Revenue</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib4de92eef0144b61a927675c284274c9" continuedAt="i95c3893a0eea4cf2b9b3ea7c1864563b"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfOTI4OQ_2bab8d77-688a-45f9-b66f-714f96147da6" continuedAt="i859d3774e68b4c78bcab11c635483f4b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below depicts the disaggregation of revenue by product and is consistent with how we evaluate our financial performance (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic074a03c1a5d4d7a95fc6e02d21edc3c_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMy01LTEtMS0w_904a7708-bba8-4ef4-ac9a-770ef624b448">103,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f37dc2286ab479b9deeec6ddbc3c296_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMy03LTEtMS0w_2e21fab0-6522-4558-96d1-b8d0b42799d4">68,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia56162d3488f4c19a21ddf86ec0517c5_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNC01LTEtMS0w_73ecf0c1-bc9e-4610-babf-2083d0f9f10a">8,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914b51c6a88d43f39d8a45d6ac452f9e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNC03LTEtMS0w_aca2f416-5466-412a-814d-653f7c34ed18">15,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfdbea61c3f4e42a23d93df8eba5745_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNS01LTEtMS0w_2d9477c0-ae16-4d8b-8da4-fe6ff6c822e9">1,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a43b88c46a14d2586a38ff40e44b3e1_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNS03LTEtMS0w_44f499fc-0394-4244-8f5b-92773b648878">5,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af61ab21d2346a89f9a5ad7aa6ccc38_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNi01LTEtMS0w_2b349e13-bd44-4fc2-9c70-79eff71b4320">113,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c7487c68db4d359d42ffe4d98f76dc_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNi03LTEtMS0w_72abc466-1b37-43be-94fa-4a4426ed5879">89,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual and Family </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Health Plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98825a9b9bd74beab1e1565f9d8c3a39_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfOC01LTEtMS0w_e242942e-a94a-4ecd-9246-735d45d40458">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1c83a033544814919a8b29643cf827_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfOC03LTEtMS0w_a3fd5629-379a-429e-b955-400e2f7ed672">1,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0df0a17281e45098fa957d99e0eda7e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfOS01LTEtMS0w_6b8c13c8-7e2f-4996-94cb-a43e21f4a22e">2,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766e68295a1640f6bfa0ebbffa00c23d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfOS03LTEtMS0w_7799db9d-648a-479b-816e-aeadd51764be">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Individual and Family</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38748c1b62c34305b0a1a89a4df6b8df_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTAtNS0xLTEtMA_c9284165-5671-4aee-942b-81a2d4b55796">5,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia063259a108742fa90b79bd2bb186380_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTAtNy0xLTEtMA_111a3316-9500-403d-9224-78dfe71b70e5">2,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ancillary</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb65108e971405598e91d213801b128_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTItNS0xLTEtMA_772538aa-0e6e-4f27-9e16-44e574815866">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d8365ca0b4435c8c9fc4bfcb26c1e5_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTItNy0xLTEtMA_47ba4d31-fdc1-4bee-bf3d-280bd8909c6a">2,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8437e53979d64bf498cbace5ca6b66f7_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTMtNS0xLTEtMA_a49f623b-3a13-4443-8c48-de215abd9509">1,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b8fb9dde9d741ea8f3aa61c942f3b55_D20200101-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTMtNy0xLTEtMA_dc6205b2-edd1-49e0-9d40-cb0262b4b6bb">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73b6352f11b648d2b4bf5b5a9da1bc8e_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTQtNS0xLTEtMA_964e1652-d11d-4043-862f-f9d510721a1c">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b97cd36b9948c1b9d6366c24f2829f_D20200101-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTQtNy0xLTEtMA_34bb003f-2f72-476a-9e01-1e18cd59b224">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3aa9fda678445a3bd10fe0b7fd75046_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTUtNS0xLTEtMA_473bce12-2373-4503-8335-ffa9f2e8e042">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056610eba6074846ae406d019066f627_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTUtNy0xLTEtMA_9035accf-48e3-419f-965b-3dde1fa75493">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Ancillary</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1faf373456cf44dc92cec480bfe789a7_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTYtNS0xLTEtMA_a2af46a5-643b-45aa-b752-4c9d21f5fd02">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0a023d993134272a9b194c6b2030640_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTYtNy0xLTEtMA_f4279a71-aecc-4687-aa0c-4f4cd832b6be">4,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeba0cba96b145f09097dbdfa7c23a18_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTctNS0xLTEtMA_b8b1786c-61b3-42b1-bc18-bbc51789ca21">3,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d34909e75b34d79ba8c25ed29d1868c_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTctNy0xLTEtMA_6fe27807-a556-4c90-ac29-172eecb9e5a2">2,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commission Bonus</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7afb8d32cb44aaad349d4aed1c13de_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTgtNS0xLTEtMA_e7d97bb2-5140-4c46-b821-cca652519a2b">1,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a4a92ac7d845c1abccf7a138083679_D20200101-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTgtNy0xLTEtMA_2b218ea1-ae4b-4630-bdf3-6b834a38da79">613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8337239e8dda4274bdb5081198725cf8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTktNS0xLTEtMA_cc830ac2-0ca3-4860-9278-1366afb66d90">127,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a17b2f577fb4a0994b259f4a7c00fac_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTktNy0xLTEtMA_7ca5f58d-96c8-4f79-ad55-d3ed08e8b058">99,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsorship and Advertising Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19c1136bfda347ce93cbbd8ef6c0fd36_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjEtNS0xLTEtMjg5_13126855-dc41-4dd5-b518-fd996102a8b9">5,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i086deedc14e2467498f875d11fdb3e28_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjEtNy0xLTEtMjg5_876c7267-5a3f-4874-8b15-24211a6eed7c">5,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i392771caeedf4c20a1e28f80da41f0a1_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjItNS0xLTEtMjg5_cf2a668a-4ad9-49c6-b877-3dfe47cd638c">1,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12c4bfe5dd12406b951b26fdaa6cc5f3_D20200101-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjItNy0xLTEtMjg5_5098ddb0-6197-4bfc-b855-8742fb9761d7">849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8680ff82e8684663ac818bd969dadd40_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjAtNS0xLTEtMA_b1d5738b-f76e-417d-ad1d-5ff92b6018ad">7,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe1a9fc09dc4d98894c2f05859cd3f1_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjAtNy0xLTEtMA_f1a12999-18da-460e-8101-107ecc11d8bb">6,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjEtNS0xLTEtMA_8ff72da2-9090-4cf8-b572-03d276d2fb81">134,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjEtNy0xLTEtMA_5d17b2a7-33a2-4f92-a5cf-16a53dbc5f45">106,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">We define our individual and family plan offerings as major medical individual and family health insurance plans, which does not include Medicare-related, small business or ancillary plans. Individual and family health insurance plans include both qualified and non-qualified plans. Qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are offered through the government-run health insurance exchange in the relevant jurisdiction. Non-qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are not offered through the exchange in the relevant jurisdiction. Individuals that purchase non-qualified health plans cannot receive a subsidy in connection with the purchase of non-qualified plans.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i95c3893a0eea4cf2b9b3ea7c1864563b"><ix:continuation id="i859d3774e68b4c78bcab11c635483f4b"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commission revenue by segment is presented in the table below (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i258c42ec705f4ce991947aa47fbbbf47_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMy01LTEtMS0w_41346393-8e9d-45fb-8a82-e44a8869ff14">114,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie95c786e8b374e319d0e49801d852c1d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMy03LTEtMS0w_8c1e22ad-b3fa-447a-a998-9737557e89a2">81,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7447592d6f934de2add1f16c34c68de4_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNC01LTEtMS0w_677b793b-5d8a-461a-b894-74c1d56190ef">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0569d360651844759fd84f9324b1f5fc_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNC03LTEtMS0w_fdb7e8a9-33a8-470f-aa32-72fb55ea0f36">8,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare Segment Commission Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dd2975216654605bebf75779fff0768_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNS01LTEtMS0w_f654b376-3953-430a-8cf1-b87c4bc0e578">114,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82877d4449c844be8040697eb7839adb_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNS03LTEtMS0w_4a711268-cb9e-46e4-9241-abb322f25c45">90,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual, Family and Small Business</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide29d460660a40fc90b884baf4856429_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNy01LTEtMS0w_ec6fdaeb-560c-4963-b9e0-2547ce1cbdf4">6,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0172f4e15b46b8a18d6d683e1893e9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNy03LTEtMS0w_0a0dbe2e-dedb-41c7-98cf-db5ef1507900">5,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cba655be2dc465f92495dc76b412c95_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOC01LTEtMS00Njcw_376baa27-8f71-43ae-9788-ac4483413a5d">2,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2d1cb13bc848d4926601ef8f33c966_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOC03LTEtMS00Njcw_9e49d45e-f12e-43b4-a32b-46965d232b0d">2,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie454fda4a6da410c90ae24e2c79aa917_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOC01LTEtMS0w_41cc5866-e2ca-4f6a-b684-6082648fb2db">3,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2561ea4ce6f450684892494464adbb2_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOC03LTEtMS0w_4cfaff8a-bf0f-49a7-945e-6b3eef837af1">1,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total IFP/SMB Segment Commission Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ead011a22aa4528839846da9fa5ebba_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOS01LTEtMS0w_61d95c55-8054-4f28-9f30-d1b1fb5819ba">12,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a9a800e930241a2b680d5d254a9937d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOS03LTEtMS0w_bae3b922-b733-4199-9704-9d4b047a1dd2">9,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673d5b337f984e35bd708e9c6d0ad645_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTEtNS0xLTEtMA_08ca2e5b-12f7-4dbf-80fe-0916efe8c9fe">121,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib431ec26de88456f8bb27169dbd5532e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTEtNy0xLTEtMA_8d17c961-80e2-4753-931d-b07ac8af3003">86,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6501103b1abc4417b6d24bb9f56e71a3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTMtNS0xLTEtNjkyNg_24ca3690-8f88-4dfa-b31b-984897925480">2,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc531094265425da2fe8fba9f7dd2bd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTMtNy0xLTEtNjkyNg_c080fec1-ec20-46ef-83e9-b8b9db8a06c5">2,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32bc9e31d57342a5a9f949dcac3eea99_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTItNS0xLTEtMA_ab8c5819-30c5-410e-b342-21d76023b45a">3,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i734d6738ac914fbf9d7214b291481a87_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTItNy0xLTEtMA_984f0b9e-1abd-4ca2-8ef3-b6a99000ab72">10,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8337239e8dda4274bdb5081198725cf8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTMtNS0xLTEtMA_f532aadb-427f-4cdb-9fa9-52a88ac776d0">127,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a17b2f577fb4a0994b259f4a7c00fac_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTMtNy0xLTEtMA_4374419a-a696-4e62-8096-aacd8c1aad5a">99,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts include commission bonus revenue.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts reflect our revised estimates of cash collections for certain members approved prior to the relevant reporting period that are recognized as adjustments to revenue within the relevant reporting period. The net adjustment revenue includes both increases in revenue for certain prior period cohorts as well as reductions in revenue for certain prior period cohorts. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">The impacts of total net commission revenue from members approved in prior periods were $<ix:nonFraction unitRef="usdPerShare" contextRef="i32bc9e31d57342a5a9f949dcac3eea99_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfODkzNg_7cf2ce08-5503-40d8-b220-3fc44bbf8b91">0.12</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i734d6738ac914fbf9d7214b291481a87_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfODk0Mw_298cc321-12b0-4a10-bf1f-d7a0178c5ad3">0.42</ix:nonFraction> per basic share, respectively, or $<ix:nonFraction unitRef="usdPerShare" contextRef="i32bc9e31d57342a5a9f949dcac3eea99_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfOTAwMw_dcc6078b-21e2-438e-bc39-8f79f35543fd">0.12</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i734d6738ac914fbf9d7214b291481a87_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfMzI5ODUzNDg5NTE4MA_c3585eff-0c35-4215-bc7a-a805fced09e5">0.40</ix:nonFraction> per diluted share, respectively, for the three months ended March 31, 2021 and 2020, respectively. The total reductions to revenue from members approved in prior periods were $<ix:nonFraction unitRef="usd" contextRef="ie454fda4a6da410c90ae24e2c79aa917_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfMzI5ODUzNDkxODQ0NQ_9964e644-ac5d-4d35-b924-f95c646a24dd">0.9</ix:nonFraction> million</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for the three months ended March 31, 2021 and immaterial for the three months ended March 31, 2020. These reductions to revenue primarily related to the Individual, Family and Small Business segment.</span></div></ix:continuation></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDIwNQ_57305c83-3ecd-463c-9f30-864448d773a8" continuedAt="i96e7b6fe474741f0a25c77b518e597ff" escape="true">Supplemental Financial Statement Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i96e7b6fe474741f0a25c77b518e597ff" continuedAt="i5a9372b62b1a4fb0b924a6025c19987c"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all investments with an original maturity of 90 days or less from the date of purchase to be cash equivalents. Cash and cash equivalents are stated at fair value. We also invest in marketable securities that are measured and recorded at fair value. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion about our marketable securities. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i5a9372b62b1a4fb0b924a6025c19987c" continuedAt="ie7cbf350ef7a40a68b8d95cf6e76a855"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDE5MA_db892946-4683-4444-ba86-4b2c5a41d143" escape="true"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDE5Nw_b151988c-36f7-40db-bb41-471d58bcbfd1" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:65.078%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMS0xLTEtMS0w_c95ebc0d-3609-455d-8785-8df4559cda44">72,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMS0zLTEtMS0w_cd8cca08-4250-4903-b043-114e220eaa8d">39,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMi0xLTEtMS0w_47ae4b10-ff8e-4aec-9968-941f9b139c14">19,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMi0zLTEtMS0w_af049e99-3773-4163-886d-41785d0c7196">4,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMy0xLTEtMS01Nzk_d3032a91-687e-4d55-beab-5af989bc79c5">92,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMy0zLTEtMS01Nzk_0c74210c-c116-4e98-8d3f-93ffd091edcf">43,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMy0xLTEtMS0w_7a99379e-8726-49cc-b2a2-7f8c9eb44056">3,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMy0zLTEtMS0w_b8f3ce07-3b90-4a61-abe6-d414184d1e4d">3,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfNC0xLTEtMS0w_f058d99f-a443-4b98-990a-c2c9bae48230">95,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfNC0zLTEtMS0w_031078c1-8803-43cb-b0e1-02cb467702f7">47,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021 and December 31, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNTMw_1e8f0e7c-7b92-4562-9d04-1705b01cb453"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNTMw_9caa1a27-6cc5-4d58-ac31-6221f02e425f">3.4</ix:nonFraction></ix:nonFraction> million of restricted cash which was classified as a non-current asset on our Condensed Consolidated Balance Sheets. This amount collateralizes letters of credit related to certain lease commitments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Accounts Receivable</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not require collateral or other security for our contract assets and accounts receivable. We believe the potential for collection issues with any of our customers was minimal as of March 31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimate an allowance for credit losses using relevant available information from internal and external sources, related to past events, current conditions, and reasonable and supportable forecasts. Specifically, for the purpose of measuring the probability of default parameters, we utilize Capital IQ&#8217;s, Standard &amp; Poor&#8217;s and Moody&#8217;s analytics. Our estimates of loss given default are determined by using our historical collections data as well as historical information obtained through our research and review of other insurance related companies. Our estimated exposure at default is determined by applying these internal and external data sources to our commission receivable balances. As such, we apply an immediate reversion method and revert to historical loss information when computing our credit loss exposure. Credit loss expenses are assessed quarterly and included in general and administrative expense on our Condensed Consolidated Statement of Comprehensive Income (Loss). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered the impact of recent events and global economic conditions when evaluating the appropriate adjustments to our allowance for credit losses as of March 31, 2021. Determining the extent of these adjustments in the three months ended March 31, 2021 was especially challenging because we do not have any historical loss information for a period of similar economic uncertainty. We also considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfMjE5OTAyMzI2MTYzMQ_141265cf-e07b-48e2-ab49-c966aeb11e9b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the allowance for credit losses for the three months ended March 31, 2021 is summarized as follows (in thousands):&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.199%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjQxYjg1NzlkNzI0NjQ0MmZiYzFkZmZhOTlmOTRlOGRkL3RhYmxlcmFuZ2U6NDFiODU3OWQ3MjQ2NDQyZmJjMWRmZmE5OWY5NGU4ZGRfMi0xLTEtMS0zNTY_4dc1b4db-9531-4fe8-8440-c5fd15279252">2,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjQxYjg1NzlkNzI0NjQ0MmZiYzFkZmZhOTlmOTRlOGRkL3RhYmxlcmFuZ2U6NDFiODU3OWQ3MjQ2NDQyZmJjMWRmZmE5OWY5NGU4ZGRfNi0xLTEtMS00NzYw_3afd2c35-fbd2-4989-9e0a-68e586f9b79d">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjQxYjg1NzlkNzI0NjQ0MmZiYzFkZmZhOTlmOTRlOGRkL3RhYmxlcmFuZ2U6NDFiODU3OWQ3MjQ2NDQyZmJjMWRmZmE5OWY5NGU4ZGRfOC0xLTEtMS0zNTY_dce2b1fb-467e-46a8-9a0d-fad988af04c4">1,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="ie7cbf350ef7a40a68b8d95cf6e76a855" continuedAt="i4953518d7a324ec39a4da34dca5c471f"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDE4Ng_00f4c813-ec17-45aa-9c59-c3a228f9e3dd" continuedAt="id55787d6718b42b68cfbdc6bbae43af8" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract assets &#8211; commission receivable activities, net of credit loss allowances&#160;are summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33ff039155da47c1bac390800f28d958_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMi0xLTEtMS0w_32c82531-3807-4e82-8b8d-a36f16caf3e0">739,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id999ede8247d4775b2a9495082649e71_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMi0zLTEtMS0w_a4239ced-efd4-41fd-b08e-0c3aa3354319">52,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMi01LTEtMS0w_2dada280-34a0-4a6c-878a-ac63ee36525e">792,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i258c42ec705f4ce991947aa47fbbbf47_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMy0xLTEtMS0w_8d08c9df-4024-48f9-a0b6-01a6020b58e4">114,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide29d460660a40fc90b884baf4856429_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMy0zLTEtMS0w_95cf9c24-4d9f-495a-bbcc-1a67027fa877">6,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673d5b337f984e35bd708e9c6d0ad645_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMy01LTEtMS0w_a42f4a3d-d694-49c4-8c16-6b16828d4cfe">121,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9590a5ab4145079eec4462d026a62f_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC0xLTEtMS01NjE1_cfd617b1-f3a7-4b4c-9a6f-95ccbc6fa870">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cba655be2dc465f92495dc76b412c95_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC0zLTEtMS01NjE1_629deb74-82eb-48af-a5fc-ac67be61edc3">2,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6501103b1abc4417b6d24bb9f56e71a3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC01LTEtMS01NjE1_ea9c47be-a72e-4106-932c-d2067cc0c904">2,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue adjustments from members approved in prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7447592d6f934de2add1f16c34c68de4_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC0xLTEtMS0w_627b45a8-1c25-4ca3-af60-e937142ead9b">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie454fda4a6da410c90ae24e2c79aa917_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC0zLTEtMS0w_bff76894-7a54-4eb1-a050-4827146896db">3,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32bc9e31d57342a5a9f949dcac3eea99_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC01LTEtMS0w_c9b7830d-a473-4eb6-8a09-1cdf18a5c69d">3,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieffd4f331de646efb6782e0777c3b8c2_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNS0xLTEtMS0w_22158226-fdae-49bc-ad2e-3e7291f83be2">165,520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b23f8c9553a4acb92f22c678a011ded_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNS0zLTEtMS0w_9207f5d2-4f54-4562-8251-aba4db902b6c">12,012</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNS01LTEtMS0w_966bc4f4-435a-4454-b6dc-c3f825a693c0">177,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieffd4f331de646efb6782e0777c3b8c2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNi0xLTEtMS0w_36d67474-b338-4855-be6c-32fde30714bf">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b23f8c9553a4acb92f22c678a011ded_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNi0zLTEtMS0w_db7c60d4-79a5-4049-9758-d3151e3b920b">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNi01LTEtMS0w_ec070507-2db2-4240-b63b-a1473a1dd254">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93a27ec2b354123ac129b85e58d6a9a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNy0xLTEtMS0w_ff99ae60-b835-4c80-87fd-16540962a49c">688,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice1fcaf5d15c4b1ea8e6b1988490be33_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNy0zLTEtMS0w_393bd74e-5658-4d49-9aa7-62470a0bacc8">53,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNy01LTEtMS0w_f55e397f-4bf5-4b36-95d3-ba686402d6f4">741,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40741e0095b1456aac94b2215f85e8da_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMi0xLTEtMS0w_0974e004-25b0-4442-b02e-3ddfa8b5e0d0">550,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6501121272e7438dbfacad9d5f209af7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMi0zLTEtMS0w_07ea16fb-a01b-44a8-b50a-559b4fd717f7">38,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i283d90d05c8744f3a67f23305e4f839c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMi01LTEtMS0w_005bb259-2c2c-44cf-ac71-a0309703d432">589,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie95c786e8b374e319d0e49801d852c1d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMy0xLTEtMS0w_3616fd20-2d16-4e5f-a2dc-d55a29be6b68">81,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0172f4e15b46b8a18d6d683e1893e9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMy0zLTEtMS0w_afcfe323-43b7-4179-ae20-95f896f45cf2">5,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib431ec26de88456f8bb27169dbd5532e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMy01LTEtMS0w_5bb40364-d1e9-4b90-9537-5bdb52068c4f">86,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc7786d6a3b4b88a4fe78c3c639b879_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC0xLTEtMS01NjIw_348300b8-3048-427f-9d28-b2840b29a7b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2d1cb13bc848d4926601ef8f33c966_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC0zLTEtMS01NjIw_a2753472-c69c-4377-888a-acbc40af3c90">2,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc531094265425da2fe8fba9f7dd2bd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC01LTEtMS01NjIw_3bda2770-703b-4d92-9819-d9e449244286">2,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue adjustments from members approved in prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0569d360651844759fd84f9324b1f5fc_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC0xLTEtMS0w_a869f6b7-c9aa-4b4c-88cd-309c63aac521">8,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2561ea4ce6f450684892494464adbb2_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC0zLTEtMS0w_7aa95694-adf9-41fa-820a-a531baaa06b7">1,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i734d6738ac914fbf9d7214b291481a87_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC01LTEtMS0w_54fbcb1b-ed0b-43c7-abec-09a290ee5f77">10,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida736d90cfd14b6287fb18903e493b76_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNS0xLTEtMS0w_aa919d48-c747-4f5f-99d4-61ddf128cf1a">112,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c282c2b9a3a4f2da838e7c285e04bde_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNS0zLTEtMS0w_c42d9ee5-0545-4181-94ec-5835cd3d02f3">13,811</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNS01LTEtMS0w_f2b3adfb-723b-4c2b-8e03-139f364f62f6">126,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida736d90cfd14b6287fb18903e493b76_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNi0xLTEtMS0w_f74e006f-64d3-47e0-bc8b-d5f53348981e">1,574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c282c2b9a3a4f2da838e7c285e04bde_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNi0zLTEtMS0w_bc75af91-cd79-4b6d-b89a-f44573396f99">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNi01LTEtMS0w_cb891a9e-f2c0-4401-8052-b5ad946edecb">1,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b0f87d92a74c6aa41c7e6b1c891758_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNy0xLTEtMS0w_595ebbed-0c10-4b66-8a8a-f63eb9b4314d">526,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic62f4e5ed1c64cc5aa09a9d6a29086c8_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNy0zLTEtMS0w_4d7ec6e5-ffe6-4721-9a3c-ef050157a54c">33,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><ix:nonFraction unitRef="usd" contextRef="i94e4cd2c63294501a97ce58cbb8f0ad9_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNy01LTEtMS0w_e55334bb-300c-49a8-8f61-eeea56be33f7">560,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div></ix:nonNumeric><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"><ix:continuation id="id55787d6718b42b68cfbdc6bbae43af8" continuedAt="idc099705b8804f21b88c68e1b8954036">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"><ix:continuation id="idc099705b8804f21b88c68e1b8954036">Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item.</ix:continuation> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments that are exposed to concentrations of credit risk principally consist of cash, cash equivalents, marketable securities, contract assets &#8211; commissions receivable, and accounts receivable. We invest our cash and cash equivalents with major banks and financial institutions and, at times, such investments are in excess of federally insured limits. We also have deposits with major banks in China that are denominated in both U.S. dollars and Chinese Yuan Renminbi and are not insured by the U.S. federal government. The deposits in China were $<ix:nonFraction unitRef="usd" contextRef="i82364b4b38294beeabf364cb83d2dfb2_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Deposits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfMzY0Nw_0e9b2e60-e86e-40ea-8bfa-5255e3a7ca51">3.5</ix:nonFraction>&#160;million as of March 31, 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information regarding our marketable securities.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i4953518d7a324ec39a4da34dca5c471f"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not require collateral or other security for either our contract assets or accounts receivable. <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDE4Nw_eae5a30d-cfee-4ff7-94f7-5b00a6a1bc5c" continuedAt="ie45c9a964e4c4866a127f14469abb1a5" escape="true">Carriers that represented 10% or more of our total contract assets and accounts receivable balance are summarized as of the dates presented below:</ix:nonNumeric></span></div><ix:continuation id="ie45c9a964e4c4866a127f14469abb1a5"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthCare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibcc2eede21d74403b2556f36cea8967e_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMS0xLTEtMS00Njk1_2ddbbf07-c5d5-434c-b772-c150ee5758c0">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i745034ccac204d289da6154afd851a9b_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMS0zLTEtMS00Njk1_b01de63f-1122-4214-8307-cf6c0ba24199">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c027fa629114f34973fe988abef44d2_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMS0xLTEtMS0w_415a982c-786c-4516-89d1-32e4dd316148">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0875b0633646fe8e4a223242ab0547_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMS0zLTEtMS0w_29298a1f-3186-49ae-93bc-971224a163e5">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib0b72a5d261d4ed3a6a247dab5e66565_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMi0xLTEtMS0w_92f8414c-0ac2-457f-8306-50661871df87">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic698507ebbbe479bafd6c12cc0b40d70_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMi0zLTEtMS0w_a33095df-6257-491f-9bde-294eaba4daa8">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41d2536fcee54432bbf4d763116ab430_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfNC0xLTEtMS02NzE2_27bb63b6-9ac4-4aae-b194-84a8e19c3ed5">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id692f7a929c543f88a8ba8e371f1ec69_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfNC0zLTEtMS02NzIw_b0a3f894-f17a-40c8-96c5-7363f3b65df3">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the contract assets and accounts receivable of WellCare are included in the percentage calculation for March 31, 2021 and December 31, 2020.</span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid Expenses and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets &#8211; <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDE4OA_57b868cf-f55c-4654-9907-335d24a7a69f" continuedAt="i47b5f761499b4b8db82e172d3d6cbc78" escape="true">Our </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i47b5f761499b4b8db82e172d3d6cbc78" continuedAt="i4d28f7d506514984856793124d791101">prepaid expenses and other current assets are summarized as of the periods presented as follows (in thousands):</ix:continuation></span></div><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="i4d28f7d506514984856793124d791101"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid maintenance contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:PrepaidMaintenanceContractsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMS0xLTEtMS0w_f6384927-aa16-4843-ab69-ebb7a3c6afe6">6,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="ehth:PrepaidMaintenanceContractsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMS0zLTEtMS0w_a3ec2414-333e-4229-a7da-84ec5edbd9fd">7,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMi0xLTEtMS0w_0ecead4e-19d2-4bc1-a6f6-cd5290d14c5f">4,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMi0zLTEtMS0w_cbe56538-8f5b-4ed3-93ff-8a2dced0484b">6,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMy0xLTEtMS0w_00daac50-4a30-4842-97b2-0070b6522eed">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMy0zLTEtMS0w_421c3ca5-6fec-4210-9c30-dfbf9b051713">1,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfNi0xLTEtMS0w_de0456d2-778a-46a6-8f82-e85abd37cb01">616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfNi0zLTEtMS0w_8ebda092-c9cc-4ea5-ae4f-2c6f8f5d74a3">646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfNy0xLTEtMS0w_e84522f9-695e-448e-85f6-38a3f25182d8">12,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfNy0zLTEtMS0w_653988bc-a5a0-4959-98d3-34346b4438e9">16,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMzEyMw_2dd6541c-0f08-4153-89d0-0e4b42435b92" continuedAt="if8d58a87b40d48c5a8d1f02ff66ba81c" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if8d58a87b40d48c5a8d1f02ff66ba81c" continuedAt="i0771ad59de6f48e1b6088bb3dece5ea8"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define fair value as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques we use to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMzEyMQ_249d6bd3-495d-4319-8d44-54aebe9a41c1" continuedAt="id5cc1a4eb61f4a50baa49a8abe4763e4" escape="true">We classify the inputs used to measure fair value into the following hierarchy:</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><ix:continuation id="id5cc1a4eb61f4a50baa49a8abe4763e4"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.129%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for identical assets or liabilities.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs for the asset or liability.</span></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i0771ad59de6f48e1b6088bb3dece5ea8" continuedAt="i59fd55f2d05f404bbe7b8165447443bf"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMzEzMw_1397981d-2bc6-4a08-b4e1-d37188fabe4b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial assets measured at fair value on a recurring basis are summarized below by their classification within the fair value hierarchy as of the dates presented below (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifad24860642c447f8be6b0786b6192d9_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNC0xLTEtMS0w_df75e609-120f-4996-946b-1504c244da28">5,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0448f7480d204667af54338f775f2ae4_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNC0zLTEtMS0w_fbcfb11e-ddb2-4f20-9341-b23f1594c0c9">5,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6e65f9607874cf7b91a607047873439_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNC01LTEtMS0w_854a17fa-2575-4e79-9043-a331d46e9d38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78e297ab8ca948aeaf86a525f773e4dc_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNC03LTEtMS0w_82a07798-bbce-4e2f-874f-0c3218c8bb97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838a01c8c51c489fb25f65450a703cb5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNC05LTEtMS0w_d3aee546-5894-4a34-a806-a241f3633fd2">5,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie413cb59abe441fba3e0b2a4bb9dc04e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNS0xLTEtMS0w_70e93ebe-14ef-4701-a147-b2d5df20b768">14,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6a517c6ba84088a72a30f5e9d287b3_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNS0zLTEtMS0w_dbcf9b11-24a5-4a8b-959f-34792f008262">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf9be97cab2640ed84bd86ad77f9d205_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNS01LTEtMS0w_da9624c2-5d7b-48ff-9d20-25ac1605a4d4">14,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f32284f7468465fad0a56de1b2e5c6b_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNS03LTEtMS0w_27d21aa2-4596-4da9-8fe1-0c7068104727">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4c8e440d2f64e6399fa1adc1002bb2e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNS05LTEtMS0w_a58bcd50-0768-4984-9991-ba96387e99fb">14,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2303fe7994cf42d1b268b27bc2a7c119_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC0xLTEtMS02ODAy_ec15a47a-25dc-4f9d-97d6-7766e51fc699">26,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8935e0f0e3b647c0bca26a9f197dc6ef_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC0zLTEtMS02ODAy_fe5ca7b4-b158-45be-a9c5-c5187f87d530">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593cfa44a23f4636b9ad96eb4e4a80e1_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC01LTEtMS02ODAy_f820f652-4088-43db-a85b-27bc0d894b1a">26,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i929513fba5e248fb98922bd0516e124c_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC03LTEtMS02ODAy_16c84a36-82ca-42f2-932c-a7542854d0fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a6624511a64fcf98ef80ed91927f61_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC05LTEtMS02ODAy_c85f6f62-ca54-40ee-97ff-17f5f8786780">26,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d2f66f410ea4bf19367fa5bed725fe8_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC0xLTEtMS0w_6b3bdc96-b6c3-4941-95b3-61c3e2c98435">7,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1adbea6e18d34c05afe06e141815262b_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC0zLTEtMS0w_43d947c3-0d58-44fa-b527-2c19ac66b03c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc820c7319514d4cbf55712548350db5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC01LTEtMS0w_f36a8de2-6b14-4efa-b445-5e50024fb8aa">7,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d090e9d3465481c959ca1ca4c0ad0bf_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC03LTEtMS0w_c3195110-a9be-43e7-a8aa-0b21a1c83c6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14c5f8eba33b414c8e7ed0c7d2de5aa6_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC05LTEtMS0w_9bc05b1b-f205-4d00-a6a0-260ff20e50a1">7,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5665cbe280f449b7906c5831fa1e3d59_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfMTMtMS0xLTEtMA_fd28195b-0971-4daa-89ed-ed5261e07796">53,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a5410f369fa4fe6b29e53a1e38b9c4e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfMTMtMy0xLTEtMA_f8bbd352-c364-43fc-aadc-c025d972b2b7">5,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48cb251ac11344e78669d7f080d49c43_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfMTMtNS0xLTEtMA_4eb4de71-1eed-44ab-acbe-9334a00b42b0">48,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb33dbb73bf4f02a5ffec5640fa31c9_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfMTMtNy0xLTEtMA_bb39a76f-d8b0-4186-b5d2-b1b229cc5e55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea53ab5f7ec479683fa4b9a5645b576_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfMTMtOS0xLTEtMA_822bcdf6-2199-485d-9969-047e7da6c1af">53,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:50.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.142%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed7325f8ced428d818fce32b031d79b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNC0xLTEtMS02Nzg_8275f305-a815-4ef1-82f9-92e0a482bd8f">4,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18ff6074d86849a5b23047e339437eda_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNC0zLTEtMS02Nzg_b82f2342-9908-4558-9e8e-a2be4513324c">4,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie93a9074eb224ae4ab49ad9db008e5ec_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNC01LTEtMS02Nzg_665aa89c-264e-4885-ae60-20a151ef1138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e0b97fc5864480b5903a29a54557b2_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNC03LTEtMS02Nzg_d4ca89b6-a917-484d-af37-1c5ac2c87c4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c9b517443d64a00aba7aff3b698c11f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNC05LTEtMS02Nzg_ca62fdb6-78a4-487b-948b-8cdec1a7d76e">4,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id666b5ba6f9f42f8a0cf56c4b398bcc8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy0xLTEtMS02ODA3_5159737c-7c8e-40da-8ae7-c60d2cd5fd43">35,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7ea5f7ec2b4816b3f9a85e81ea156b_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy0zLTEtMS02ODA3_ea2e837e-7a79-4a44-a9fb-d1f1feddb323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4befba2d3d44fb1a621a7790ad0356c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy01LTEtMS02ODA3_f536512d-606d-4325-bdf9-2303bcfb8281">35,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df54f27e2e4404d8fe0cd357e46301e_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy03LTEtMS02ODA3_f4250876-b78d-4019-90bd-4e1e010a1d3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8882a30cac444bf5ba856bd4a8372177_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy05LTEtMS02ODA3_e6d8af74-2372-4fe3-ab9f-a70666fd24d7">35,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54823e65473645c194940e0076f74ff5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy0xLTEtMS02Nzg_1bbe19bc-3507-48d0-a0e0-c17c423f02e9">14,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e8dec4452ff4308b5fbdd90aeed6dc9_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy0zLTEtMS02Nzg_5aae3f76-5ba6-4761-a38a-6b16d7552fd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib59dd70dd25942cd92be78336520da90_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy01LTEtMS02Nzg_bd5bc0be-2002-4e79-ad01-58a0f0fb218e">14,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc2244c603b14657b34cf7227bbd7fe5_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy03LTEtMS02Nzg_860deb72-3eaf-415e-825d-04044cfed8b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96477b91e6c046df98a6eb283930c399_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy05LTEtMS02Nzg_97153d9d-1a2f-4e27-8f78-a7485ada2d5f">14,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib988b174dc5b49888bc9c12a66f95b33_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfMTItMS0xLTEtNjc4_540818cd-1b6a-46c6-a8ec-d9413be5c5c0">53,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id971a56afa2d46c58587cf6f00f48794_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfMTItMy0xLTEtNjc4_363d9606-271b-4ce9-94b8-136fb287ab1a">4,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8499f20cd2c1456a840c92df3935eb19_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfMTItNS0xLTEtNjc4_74c063f7-cd0a-4cf3-929c-3fc1816bc69d">49,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5beec7c5934346d88793a58261bd3ed7_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfMTItNy0xLTEtNjc4_307b3f39-623a-4e7e-8f36-cd846d6cf94e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b2eec84ef04575a0d89d957828316e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfMTItOS0xLTEtNjc4_e8ecc28d-6fc3-4d96-bea6-7e48b855af10">53,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash equivalents were invested in money market funds and commercial paper with original maturity of 90 days or less were classified as Level 1. We endeavor to utilize the best available information in measuring fair value. We used observable prices in active markets in determining the classification of our money market funds as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, our Level 2 assets included our available for sale marketable securities, which consisted of commercial paper and agency bonds with maturity less than one year. We classify our marketable debt securities within Level 2 in the fair value hierarchy, because we use quoted market prices to the extent available or alternative pricing sources and models utilizing market observable inputs to determine fair value. Our portfolio primarily consisted of financial instruments with a credit rating of AA or equivalent by S&amp;P Rating and Moody's Investor Services. There were no transfers between the hierarchy levels during the three months ended March 31, 2021 and year ended December 31, 2020. </span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMzEzNQ_08ea8077-7f9f-404c-b85d-00ec08fbbf4d" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash equivalents and available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmIxNGM1NmYwOWQ1MTQ3ZTFhNzFhNzcyN2Y4OTI3ZDE5L3RhYmxlcmFuZ2U6YjE0YzU2ZjA5ZDUxNDdlMWE3MWE3NzI3Zjg5MjdkMTlfMi0xLTEtMS0w_87ba402a-35e2-4a0d-9906-3fd894062fbc">53,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmIxNGM1NmYwOWQ1MTQ3ZTFhNzFhNzcyN2Y4OTI3ZDE5L3RhYmxlcmFuZ2U6YjE0YzU2ZjA5ZDUxNDdlMWE3MWE3NzI3Zjg5MjdkMTlfMi0zLTEtMS0w_296f6849-c2d1-4d54-97e8-1e2432c0f5c4">53,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i59fd55f2d05f404bbe7b8165447443bf" continuedAt="ibd0c7d48ef2e43d88da57036fc4d648d"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMzEzNg_36ccc5bb-3cbb-4c3a-b0c9-228db0c2814c" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains and losses on available-for-sale debt securities that are not credit related are included in accumulated other comprehensive income and summarized as follows as of March 31, 2021 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16def725ed4c4de287be9546b21381c4_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMi0xLTEtMS0w_d116c566-4421-4da9-8aa4-ce3be5b559c7">5,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16def725ed4c4de287be9546b21381c4_I20210331" decimals="-3" format="ixt:zerodash" name="ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMi0zLTEtMS0w_234ae823-5a21-4e95-9dbd-dceaa9ca5b48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16def725ed4c4de287be9546b21381c4_I20210331" decimals="-3" format="ixt:zerodash" name="ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMi01LTEtMS0w_b66d3f7d-11ab-4033-a0e0-441aef7b178c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16def725ed4c4de287be9546b21381c4_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMi03LTEtMS0w_1cf0e514-d13b-4009-8769-de409f8ecdf9">5,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c20d249a134eafba8d1b1e39d25904_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMy0xLTEtMS0w_9ecab1b6-f202-4462-800a-d40989a79981">14,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c20d249a134eafba8d1b1e39d25904_I20210331" decimals="-3" format="ixt:zerodash" name="ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMy0zLTEtMS0w_88dfe776-7533-4e01-9aff-0761cb62cfdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94c20d249a134eafba8d1b1e39d25904_I20210331" decimals="-3" name="ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMy01LTEtMS0w_d26ed9ee-6c52-4695-ab30-66fbfc40c9c4">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c20d249a134eafba8d1b1e39d25904_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMy03LTEtMS0w_ca7e28d1-a979-43af-86ee-b88f8e32f740">14,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655b0d8763b747d280d873a86aa886f2_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi0xLTEtMS03MDQw_c8b6b15a-0fe0-460b-bcd9-b77e41c1eed9">26,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655b0d8763b747d280d873a86aa886f2_I20210331" decimals="-3" name="ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi0zLTEtMS03MDQw_039e2d71-9eca-4db8-9bde-ea0e5f6db408">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655b0d8763b747d280d873a86aa886f2_I20210331" decimals="-3" format="ixt:zerodash" name="ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi01LTEtMS03MDQw_cbaee8ff-c499-4bdd-8a3c-d59d769df0bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655b0d8763b747d280d873a86aa886f2_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi03LTEtMS03MDQw_0dd3bc3f-f0db-475e-a8fd-94afbd543083">26,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961aaf7e9dd04265a6efcb537457ced7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi0xLTEtMS0w_ccf6724b-fbee-46bd-bab6-d47e61de518a">7,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961aaf7e9dd04265a6efcb537457ced7_I20210331" decimals="-3" format="ixt:zerodash" name="ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi0zLTEtMS0w_798c58bd-2c0e-497d-95b3-e0596d92449f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961aaf7e9dd04265a6efcb537457ced7_I20210331" decimals="-3" name="ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi01LTEtMS0w_cc1a6ab7-126b-4d6c-8ce3-8dd70fc05de7">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961aaf7e9dd04265a6efcb537457ced7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi03LTEtMS0w_d400ec48-dce9-423c-bd70-b3572c089a9c">7,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMTEtMS0xLTEtMA_280ceb39-a93d-4cc9-9da8-7847388cc85c">53,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMTEtMy0xLTEtMA_8d5ac1fa-8b07-4d8e-a517-eaf939c7f9f5">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMTEtNS0xLTEtMA_60dcf50d-7025-453c-b22c-7a5a498e9d60">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:CashCashEquivalentsAndAvailableForSaleDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMTEtNy0xLTEtMA_58fec773-1499-4211-acc7-f9a9c2fac79a">53,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibd0c7d48ef2e43d88da57036fc4d648d">As of March 31, 2021, there were <ix:nonFraction unitRef="security" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMjAwNg_4057aa9b-c8d2-46d0-bdcb-377932cc8593">twelve</ix:nonFraction> securities in net loss positions and their unrealized losses were immaterial. We did not record any credit losses regarding our available-for-sales debt securities during the three months ended March 31, 2021. We do not intend to sell these securities and it is more likely than not that we will not be required to sell these securities before the recovery of their amortized cost basis.</ix:continuation> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMTU5MQ_c63cfb45-c803-4cef-9754-1acbcc24a9c7" continuedAt="ica9375cf7a764d44a2e13475158648ac" escape="true">Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ica9375cf7a764d44a2e13475158648ac" continuedAt="ib4bb22e921b3464c88ebb8ce5ff33a88"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Offering of Common Stock &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to an effective registration statement that was filed on December 17, 2018, and amended on January 22, 2019 and March 2, 2020, we entered into an underwriting agreement in March 2020 to issue a total of <ix:nonFraction unitRef="shares" contextRef="if92b4bb5fc794dd1bc6e637bdad2d099_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMjYx_68abf339-996c-4382-85b6-b880915a3e6d">2.1</ix:nonFraction> million shares of common stock, which included the exercise in full of the underwriters&#8217; option to purchase <ix:nonFraction unitRef="shares" contextRef="i9e97394555f148638042ce9215c2d1dc_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMzY0_3f72e875-4065-4342-ad2b-4d394beb9582">0.3</ix:nonFraction> million additional shares of common stock, at a price to the public of&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i94e4cd2c63294501a97ce58cbb8f0ad9_I20200331" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfNDMw_2bc6b8c0-5141-435c-86c4-7c564c91cbd7">115.00</ix:nonFraction>&#160;per share in March 2020. Net proceeds from the offering were approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="if92b4bb5fc794dd1bc6e637bdad2d099_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfNDk0_7e8e5b19-0670-4759-9dad-fd98f6d02937">228.0</ix:nonFraction> million&#160;after deducting underwriting discounts, commissions and expenses of the offering.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Programs &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="shares" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfNzI1_40e4ffbf-531f-420d-acd8-68508f5c2125">no</ix:nonFraction> stock repurchase activity during the three months ended March 31, 2021. In addition to <ix:nonFraction unitRef="shares" contextRef="i8b0d49f69d854783b426b4a82d9b7617_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfNzcz_6896479c-d5d3-4c42-bd00-7842d1bb6af2">10.7</ix:nonFraction> million shares repurchased under our previous repurchase programs, we have in treasury <ix:nonFraction unitRef="shares" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="ehth:TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfODU1_8929da78-76e2-4f40-b48e-e2d95e70de63">1.2</ix:nonFraction> million shares as of March 31, 2021 that were previously surrendered by employees to satisfy tax withholding due in connection with the vesting of certain restricted stock units. As of March 31, 2021 and December 31, 2020, we had a total of <ix:nonFraction unitRef="shares" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMTA1Mg_b6f349c1-a2f5-43b6-b6a4-4cd9a2c2e84f">11.9</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMTA2Ng_6b164591-28b1-4ee4-b6aa-23fbb0374435">11.8</ix:nonFraction> million shares, respectively, held in treasury.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. Such repurchased shares are held in treasury and are presented using the cost method.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="ehth:ScheduleOfStockBasedCompensationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMTYwNA_428bfa74-53c1-4c55-9873-10546778542a" continuedAt="if24dd4c7de57418bba46a23627e64d9e" escape="true">Our stock-based compensation expense is summarized as follows by award types (in thousands):&#160;</ix:nonNumeric></span></div><ix:continuation id="if24dd4c7de57418bba46a23627e64d9e"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id010efd09ca848fea67ac7a219d97b98_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfMi01LTEtMS0w_0da347b6-e86b-4c04-acfd-62fbd81cb77e">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023935a90c0449daef342cb4a899125_D20200101-20200331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfMi03LTEtMS0w_cc4cb6c2-d74b-4262-a60a-7a2a680696a9">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic87e10e1f657440db47c80a44d54eb25_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfMy01LTEtMS0w_caf9ebd6-b22a-4e91-a60d-62f65fca88bd">10,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e7aff4671154fc19c202272ab565eea_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfMy03LTEtMS0w_1fc6dd72-9715-4709-b1ff-f5c1843d21d5">8,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba493194d8a487984964d8793886556_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfNC01LTEtMS04Mjk_255ff8e0-98e8-42f1-a6fe-5a4e0deb46bb">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2d0bfff5854068ac9d5627ff476134_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfNC03LTEtMS04Mjk_56c5f2f6-7512-4461-8918-6393f79071cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfNC01LTEtMS0w_de029cad-c4b1-4b18-9944-9e5a7b462577">11,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfNC03LTEtMS0w_e6da83aa-cfb9-4bf2-bfbf-331be80c3030">8,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Amounts include market-based and performance-based RSUs.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="ib4bb22e921b3464c88ebb8ce5ff33a88"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="ehth:ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMTYxNQ_03ae5e97-6926-42ef-b1f0-32b5903fb076" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense by operating function for the periods presented below&#160;(in thousands):&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d267c47dbbb4319b6f0bd3c335192ad_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfMi01LTEtMS0w_e5dec307-d324-4926-b71d-fe826fa037de">2,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia264f014078a40918be67135b664845e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfMi03LTEtMS0w_f616b178-2cc7-4757-bd0f-c50c77befe8a">1,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cea5b44a3a459e9e229df532ff47f5_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfMy01LTEtMS0w_bbd277c5-5320-4f8a-8729-e572ad642e0e">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2735879a981f4934a31a2ff030996122_D20200101-20200331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfMy03LTEtMS0w_bbf10f8b-71ba-4893-8d81-c10eb1c9b587">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87ef0c3e12a247ffb3645a639fa9a28d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNC01LTEtMS0w_322f3119-6b13-4d5a-8589-19b1d74eed75">2,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb78056511e744e692b0f0a6870a2b54_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNC03LTEtMS0w_263bd51e-5965-4a5e-baa2-c8fed4abd300">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ffef56a313d4362acff848ae985e050_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNS01LTEtMS0w_251d65f1-8029-48e6-9544-66ef56c27dda">5,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifed776c5bdf242e8b71b1bd21709ceb6_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNS03LTEtMS0w_01ddd54b-9833-457d-8612-a52b4ef984ee">4,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNy01LTEtMS0w_84421387-642d-4667-bb2f-25b543abce71">11,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNy03LTEtMS0w_101d96fe-5302-4144-a4ad-157baad10f98">8,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount capitalized in internal-use software</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfOC01LTEtMS0w_9a49754c-a4d8-4e76-b776-ef99f4963100">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfOC03LTEtMS0w_1f9ef317-2ff3-4f1b-b1d5-b1266eaf801c">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfOS01LTEtMS0w_a7a10a33-5d71-4166-8c52-7a4743c890aa">11,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfOS03LTEtMS0w_07a1c844-7bb0-47a0-98d9-50213901d532">8,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RleHRyZWdpb246ZWRlYzg4OTBjYTc4NDJiY2IxNzc4NGEyMzE1ZGU3N2ZfMTE5MA_15e95c02-01bd-41ac-a7fb-92e823404f8f" continuedAt="ic0b8230cf92a4cf0b4417295110cd801" escape="true">Net Income (Loss) Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic0b8230cf92a4cf0b4417295110cd801" continuedAt="i3b3fc24b533b40f5975f00ce6ec3272a"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding for the period. Diluted net income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all potential dilutive common stock equivalent shares, including options, restricted stock units and shares to be issued under our ESPP. The dilutive effect of outstanding awards is reflected in diluted net income (loss) per share by application of the treasury stock method.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RleHRyZWdpb246ZWRlYzg4OTBjYTc4NDJiY2IxNzc4NGEyMzE1ZGU3N2ZfMTE5Mw_1037c1ea-7267-476f-bc20-1d1f75186f36" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share amounts):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.724%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMy01LTEtMS0w_96ef9022-56b1-4261-a5dd-fbdef43cbf7f">800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMy03LTEtMS0w_d495799d-7044-463e-af94-8d19373644e1">3,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation &#8211; basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfNC01LTEtMS0w_fe10d664-822d-47ed-9e3d-e100847f3a13">26,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfNC03LTEtMS0w_c619f736-baf6-4c56-b818-c19e0d588dd3">24,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of common stock</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="ehth:IncrementalCommonSharesAttributableToOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfOS01LTEtMS0w_9184ffe6-8d59-4fc6-99eb-1b31fcf83272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="ehth:IncrementalCommonSharesAttributableToOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfOS03LTEtMS0w_5da47b3b-cbba-416c-889b-2237a6b3521d">1,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in diluted share calculation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTAtNS0xLTEtMA_8db31232-338d-4b0c-9f27-d1978a9ac6c5">26,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTAtNy0xLTEtMA_7daf109b-7d82-4b0d-879e-90a03f0c2a5a">26,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per share &#8211; basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTEtNS0xLTEtOTAyOA_582f9794-0c4f-42d2-869c-c6112418d246">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTEtNy0xLTEtOTAyOA_4d1d135e-39ee-466a-8ca4-e0572158cd03">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per share &#8211; diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTEtNS0xLTEtMA_e800b090-e366-4130-b6cb-757d8f2287f6">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTEtNy0xLTEtMA_efee8aa3-6f4f-4e51-8b68-fdae422870f2">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i3b3fc24b533b40f5975f00ce6ec3272a"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each of the three months ended March 31, 2021 and 2020, we had securities outstanding that could potentially dilute per share amounts, but the shares from the assumed conversion or exercise of these securities were excluded in the computation of diluted net income (loss) per share as their effect would have been anti-dilutive. <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RleHRyZWdpb246ZWRlYzg4OTBjYTc4NDJiY2IxNzc4NGEyMzE1ZGU3N2ZfMTE5NQ_fc532791-abf2-48ac-b0eb-c6e632d93fa5" continuedAt="ib0f57f579a15431fad395f6c4d9f9179" escape="true">The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share consisted of the following (in thousands):</ix:nonNumeric></span></div><ix:continuation id="ib0f57f579a15431fad395f6c4d9f9179"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.724%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if080cb3649dc43f092dd38c47b2c3694_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmFjMDQzMTQ5NGMzZTQ0MWI5MDZiMjNjMDYzYTY0OTQ0L3RhYmxlcmFuZ2U6YWMwNDMxNDk0YzNlNDQxYjkwNmIyM2MwNjNhNjQ5NDRfMi01LTEtMS0w_4fccd44d-cddd-4660-83b8-1c5dc2d3c280">363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61773e2e91094158a69f52208476be9c_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmFjMDQzMTQ5NGMzZTQ0MWI5MDZiMjNjMDYzYTY0OTQ0L3RhYmxlcmFuZ2U6YWMwNDMxNDk0YzNlNDQxYjkwNmIyM2MwNjNhNjQ5NDRfMy01LTEtMS0w_66e3f9a7-0e70-4776-a3bc-840a6dd6ebc7">1,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3729439cfe534105b22358a497155089_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmFjMDQzMTQ5NGMzZTQ0MWI5MDZiMjNjMDYzYTY0OTQ0L3RhYmxlcmFuZ2U6YWMwNDMxNDk0YzNlNDQxYjkwNmIyM2MwNjNhNjQ5NDRfNC01LTEtMS00ODg0_34e9e3e5-65fa-4e8b-b7be-3fcc2621f36a">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmFjMDQzMTQ5NGMzZTQ0MWI5MDZiMjNjMDYzYTY0OTQ0L3RhYmxlcmFuZ2U6YWMwNDMxNDk0YzNlNDQxYjkwNmIyM2MwNjNhNjQ5NDRfNC01LTEtMS0w_62a880ac-c09e-4af3-abf9-873ce268d3e5">1,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;There were no antidilutive shares for this period.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RleHRyZWdpb246ZDllMmNiYzUzZTI2NGNkMmExNzk4OGQwNTQ2MmEzMjBfNzMzMg_d508b87a-162e-4eaf-8e9a-7db69b5b33cc" continuedAt="id1e78130f17a40ffba01609975769c34" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id1e78130f17a40ffba01609975769c34" continuedAt="ib312cf75e0434608a471b1c988b08a81"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service and Licensing Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into service and licensing agreements with third party vendors to provide various services, including network access, equipment maintenance, and software licensing. As the benefits of these agreements are experienced uniformly over the applicable contractual periods, we record the related service and licensing expenses on a straight-line basis, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. </span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RleHRyZWdpb246ZDllMmNiYzUzZTI2NGNkMmExNzk4OGQwNTQ2MmEzMjBfMzI5ODUzNDg5NzgxMA_ca58c1a0-4751-4241-b2e4-8e59943c7541" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future minimum payments under non-cancellable contractual service and licensing obligations as of March 31, 2021 (in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.444%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfMS0xLTEtMS0zMDY3_229f6674-be75-412a-9a40-966ea495ad0e">4,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfMi0xLTEtMS0zMDY3_df046319-1a0c-4472-b2f0-7885ab8e7fc8">3,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInSecondYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfMy0xLTEtMS0zMDY3_80923a0a-d5a5-4b66-83ff-b5e4e4767723">2,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInThirdYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfNC0xLTEtMS0zMDY3_8308964f-0053-48b7-aaaf-01a42a1f06cd">2,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligationDueInFourthYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfNS0xLTEtMS0zMDY3_70d6f197-a369-4af3-8074-797ee4b5f126">1,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:ContractualObligationToBePaidAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfNi0xLTEtMS0zMDY3_c600303d-90e2-4815-9ad0-5b2a537d3188">1,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractualObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfNy0xLTEtMS0zMDY3_992b75d1-2e54-4cc6-86f7-f7ccb60d6002">15,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for commitments related to our operating leases.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, we receive inquiries from governmental bodies and also may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our condensed consolidated financial statements. An estimated loss contingency is accrued in the condensed consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. There was no material litigation-related accrual during the three months ended March 31, 2021. Legal proceedings or other contingencies could result in material costs, even if we ultimately prevail.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="ib312cf75e0434608a471b1c988b08a81"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Securities Class Action </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8211; On April 8, 2020 and April 30, 2020, <ix:nonFraction unitRef="claim" contextRef="i4f10282c4a164b3ba49248e358109fda_D20200408-20200430" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RleHRyZWdpb246ZDllMmNiYzUzZTI2NGNkMmExNzk4OGQwNTQ2MmEzMjBfODIw_09376d1a-4459-45c2-b617-5bb12ec1ec0c">two</ix:nonFraction> purported class action lawsuits were filed against us, our chief executive officer, Scott N. Flanders, our chief financial officer, Derek N. Yung, and our then-chief operating officer, David K. Francis, in the United States District Court for the Northern District of California. The cases are captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Patel v. eHealth, Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">., Case No. 5:20-cv-02395 (N.D. Cal.) and Bertrand v. eHealth, Inc. et al., Case No. 4:20-cv-02967 (N.D. Cal.). The complaints allege, among other things, that we and Messrs. Flanders, Yung and Francis made materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn and our profitability during the alleged class period of March 19, 2018 to April 7, 2020. The complaints allege that we and Messrs. Flanders, Yung and Francis violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The complaints seek compensatory and (in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Patel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuit) punitive damages, attorneys&#8217; fees and costs, and such other relief as the court deems proper. On June 24, 2020, the Court consolidated the above-referenced matters under the caption</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> In re eHealth Securities Litig.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Master File No. 4:20-cv-02395-JST (N.D. Cal.). The Court also appointed a lead plaintiff and lead counsel for the consolidated matter. The lead plaintiff filed an amended complaint on August 25, 2020, which Defendants moved to dismiss.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The motion to dismiss has been fully briefed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Derivative Actions &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 7, 2020 and October 13, 2020, <ix:nonFraction unitRef="plaintiff" contextRef="idba160cc7e824a82bf89be1c244ad874_D20200707-20201013" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RleHRyZWdpb246ZDllMmNiYzUzZTI2NGNkMmExNzk4OGQwNTQ2MmEzMjBfMjQ0Mw_c2071c95-10dd-4ce5-916b-1bda806a9102">two</ix:nonFraction> derivative lawsuits were filed against our chief executive officer, Mr. Flanders, our chief financial officer, Mr. Yung, our then-chief operating officer, Mr. Francis, and the members of our Board of Directors (collectively, the &#8220;Individual Defendants&#8221;), in the United States District Court for the Northern District of California and the Superior Court of California, County of Santa Clara. The cases are captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet v. Flanders et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">., Case No. 3:20-cv-04477-SK (N.D. Cal.), and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire Police Pension Fund v. Flanders et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Case No. 20CV371555 (Cal. Super. Ct.), and also name the Company as a nominal defendant. The complaints allege, among other things, that beginning on March 19, 2018, the Individual Defendants made or caused the Company to make materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn, profitability, and internal controls. Both complaints purport to assert claims for breach of fiduciary duty, unjust enrichment and waste of corporate assets. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuit also alleges that the Individual Defendants violated Sections 14(a), 10(b), and 20(a) of the Securities Exchange Act of 1934, and asserts claims for abuse of control and gross mismanagement. The complaints seek damages, restitution, attorneys&#8217; fees and costs, and certain measures with respect to the Company&#8217;s corporate governance and internal procedures, and (in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuit) equitable and/or injunctive relief. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuits have both been stayed pending the resolution of the motion to dismiss in the Securities Class Action, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re eHealth Securities Litig</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">., Master File No. 4:20-cv-02395-JST (N.D. Cal.).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The Gonzalez and Le</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Vias Complaints</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; On April 6, 2018, a former employee, Lupita Gonzalez, filed a complaint against us in the Superior Court of the State of California for the County of Sacramento (the &#8220;Gonzalez Complaint&#8221;). On July 1, 2019, <ix:nonFraction unitRef="plaintiff" contextRef="i63e707f4d80c456a88c23a8539ab5605_D20190701-20190701" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RleHRyZWdpb246ZDllMmNiYzUzZTI2NGNkMmExNzk4OGQwNTQ2MmEzMjBfMjE5OTAyMzI4Mzg0MA_81360787-97f3-4e73-95f5-de784952c3b0">two</ix:nonFraction> other current or former employees, Michael Le&#8217;Vias and Ramona Meadows, filed a related complaint against us and eHealth Ins. Serv. Co., in the Superior Court of the State of California for the County of Santa Clara (the &#8220;Le&#8217;Vias Complaint&#8221;). Both complaints asserted claims under the California Private Attorney General Act (&#8220;PAGA&#8221;) on behalf of all current and former hourly-paid or non-exempt employees who work or have worked for us in California, based on alleged failures to comply with California wage and hour laws.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties have entered into a court-approved settlement agreement that resolves both matters related to the Gonzalez and Le'Vias Complaints, and Plaintiffs Michael Le&#8217;Vias and Ramona Meadows have sought dismissal with prejudice of the Le&#8217;Vias Complaint. Upon the completion of the distribution of the settlement funds in accordance with the settlement agreement and the court order approving the settlement agreement, the parties will seek a dismissal with prejudice of the Gonzalez Complaint.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMTczNA_5de8e58b-4576-4455-9860-956848fc82ab" continuedAt="i214bcc29ed944134853cec30120dfc0f" escape="true">Segment and Geographic Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i214bcc29ed944134853cec30120dfc0f" continuedAt="i3d417bab6499418d9949ee119f9520e9"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Segments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report segment information based on how our chief executive officer, who is our chief operating decision maker ("CODM"), regularly reviews our operating results, allocates resources and makes decisions regarding our business operations. The performance measures of our segments include total revenue and profit. Our business structure is comprised </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i3d417bab6499418d9949ee119f9520e9" continuedAt="i25d42fc5e77a44b78878624d4e6409a7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of&#160;<ix:nonFraction unitRef="segment" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMzg4_ad1e2c3e-8ae6-4e69-b21d-897fad968a41">two</ix:nonFraction>&#160;operating segments: Medicare and Individual, Family and Small Business. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Business and Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Part II, Item 8 of the Annual Report on Form 10-K for the year ended December 31, 2020 for our accounting policies relating to operating segments.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMTczNw_90e2f23f-eb13-4187-86ff-a042d4df1995" continuedAt="ic0a596c1217f43368684f3261acf6885" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of our operating segments are summarized for the periods presented below (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847b02865e0e482289ce85c02f9b4e61_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMy01LTEtMS0w_535332cf-3bca-465c-abb0-1b3592b7b1b8">121,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45589c5d091d42fa856a74b05e6a684b_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMy03LTEtMS0w_9f3560fd-dc33-484c-b019-d410e7507696">96,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iece3c4feb7ba4852ae934e622f0fc222_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfNC01LTEtMS0w_657eb802-3d42-420b-8097-ad33bedc2e29">13,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f5742b50c34e6eb0d14c32db2d8983_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfNC03LTEtMS0w_7968f943-c00e-4271-92d9-896979408210">10,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96a1c3f122b54e5c910199f9e10062ae_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfNS01LTEtMS0w_7a584177-232a-4731-bcc2-637a8a109ec3">134,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d74f4f4ee14e1fba9c88300782d7ff_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfNS03LTEtMS0w_399f05af-db1d-4bad-bac2-f0b90d4ecb55">106,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment profit:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847b02865e0e482289ce85c02f9b4e61_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfOC01LTEtMS0w_65b8bb7c-08b3-4a40-ae9e-3e9fcdd58364">24,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45589c5d091d42fa856a74b05e6a684b_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfOC03LTEtMS0w_07029c9f-2a31-4113-933e-6f2716b5e6af">23,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iece3c4feb7ba4852ae934e622f0fc222_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfOS01LTEtMS0w_e74f64bf-d63c-47d6-9b71-41dc993678a1">8,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f5742b50c34e6eb0d14c32db2d8983_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfOS03LTEtMS0w_10a41953-a543-4156-9b9f-2f6928441528">2,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96a1c3f122b54e5c910199f9e10062ae_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTAtNS0xLTEtMA_97cd3769-51d9-4f4a-8ac4-701c304947fc">32,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d74f4f4ee14e1fba9c88300782d7ff_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTAtNy0xLTEtMA_65cc5114-e504-49a2-8e3f-3f4ad0760e37">26,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7766c8b514940a3adac069dcabfa7f5_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTEtNS0xLTEtMA_7c81e199-5742-4e0f-bf3a-7445947003de">15,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dcc0aaf01a44218b29859ee8d52669f_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTEtNy0xLTEtMA_319e748b-8b43-4ea8-9607-d179d0cceb16">13,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTItNS0xLTEtMA_ca89e8ab-611a-47f8-b966-80daddc93b16">11,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTItNy0xLTEtMA_be40a789-5f88-4943-a641-95e89e4fc203">8,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTQtNS0xLTEtMA_37750635-f3f1-4d37-84e5-32182249a704">3,944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTQtNy0xLTEtMA_b8f1b728-97ef-4a6c-a0c8-07ba132288e3">2,324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTUtNS0xLTEtMA_6b74d58d-b5c1-45c4-a0fd-7016cd0f4a7a">176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTUtNy0xLTEtMA_2a46e1bb-161a-4a6d-86f7-0863ddcde4cd">547</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTctNS0xLTEtMA_3f3eebb8-f425-4968-82d5-d197c0c1b296">2,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTctNy0xLTEtMA_00970ade-415d-4b49-8b37-177d34abb5f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTgtNS0xLTEtMA_2955f440-73b1-47e0-b73a-8eada4335b9e">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTgtNy0xLTEtMA_30c42ff8-0935-46e6-b90b-dd163b9be742">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTktNS0xLTEtMA_90205d53-609e-4c2e-880e-2929f4509ef3">492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTktNy0xLTEtMA_dab9d3b9-d955-4956-9ec7-2fc2f8d561dc">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMzI5ODUzNDg4NzE0MA_34dbc85c-1b35-49dd-95cf-9058e95fee4a">2.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMzI5ODUzNDg4NzE0OA_2ff3e3c9-be99-4c8a-a56c-1c2f1847dd89">1.5</ix:nonFraction> million for the first quarter of 2021 and 2020, respectively.</span></div></ix:nonNumeric><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"><ix:continuation id="ic0a596c1217f43368684f3261acf6885" continuedAt="ia574b37393cd49118fe008c9b802a75d">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"><ix:continuation id="ia574b37393cd49118fe008c9b802a75d">Depreciation and amortization has been adjusted to include amortization of software development costs.</ix:continuation> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no inter-segment revenue transactions for the periods presented. With the exception of contract assets &#8211; commissions receivable, which is presented by segment in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Financial Statement Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our CODM does not separately evaluate assets by segment, and therefore, assets by segment are not presented. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-lived assets primarily consist of property and equipment and internally-developed software. Our long-lived assets are attributed to the geographic location in which they are located. <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="ehth:ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMTc0NA_ad85f3ed-87b2-4279-b291-c6a8086d7439" continuedAt="if8f6bb88597c49ae8f662b6d42de4f78" escape="true">Long-lived assets by geographical area are summarized as follows (in thousands):</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><ix:continuation id="if8f6bb88597c49ae8f662b6d42de4f78"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae135e664d984295bbf64c3bbe7c4a11_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMS0xLTEtMS0w_cbdcdb3a-99e1-4dae-9c46-03274de2ea25">41,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33ac7f7fd03c47acb53fa3d4bb1753db_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMS0zLTEtMS0w_af8c8104-a09b-4e7b-8aa2-5f044c1fe01b">40,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82364b4b38294beeabf364cb83d2dfb2_I20210331" decimals="-3" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMi0xLTEtMS0w_3e0502ef-4f0f-4653-8c5c-c7e37fbf9f09">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023ce78002434d8cad1d8f97aa442d34_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMi0zLTEtMS0w_658c47f0-700e-400b-afbb-02fc9bb68872">565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMy0xLTEtMS0w_150c33b1-e89b-44d2-8c91-f0a13d518869">42,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMy0zLTEtMS0w_2693dc91-f647-4bb6-a26b-4ee29055f827">41,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i25d42fc5e77a44b78878624d4e6409a7"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all revenue for the three months ended March 31, 2021 and 2020&#160;was generated from customers located in the United States. <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMTczMg_cb40dbaa-04b8-44b5-974e-53a4b0a894b7" continuedAt="ie33e1e26652e4e0290f66b7257855b23" escape="true">Carriers representing 10% or more of our total revenue are summarized as follows:&#160;</ix:nonNumeric></span></div><ix:continuation id="ie33e1e26652e4e0290f66b7257855b23"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4d88e2c29bd4ed1a1c6b4b23e1884dc_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfMy01LTEtMS0w_58ec4ecb-4b23-4264-841f-9f7c03899af1">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i220bb9cb676540b4aeb3a914e250fe06_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfMy03LTEtMS0w_d919a465-1ac9-4def-89c4-fd29f60bb78c">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8a052d919884528be429b16feacfa3c_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNC01LTEtMS0w_deb19de2-2508-45b8-9ef6-ec04514d0267">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3966096b4cf940f5ab5e3bdf08677217_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNC03LTEtMS0w_6aa4bad2-7aba-4868-9de3-8ced16efbb4c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd072559e8714571bf142682157e4908_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNS01LTEtMS00ODk2_ba3416be-5ea5-448a-802d-e30e44dde7f3">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ac77c183dc946279d677be3a4d4156e_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNS03LTEtMS00ODk2_ebf250f4-864f-48b9-a697-451e18e31113">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44a77aea53a9467e962038a9620c620b_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNS01LTEtMS02ODQ2_20e470e2-bf2b-4f43-8b60-c33977e4d19e">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i07cffec9adda4d338d0d362e4623e96b_D20200101-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNS03LTEtMS02ODQ2_28a672c9-4fb4-44bd-9d0b-98c593e0b4c7">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the revenue of WellCare is included in the percentage calculation for March 31, 2021 and 2020.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMjY0Mw_1b20d1ea-c6f7-4df1-a9f8-39ad89427d35" continuedAt="ib888172d635740d3926d791323be69a5" escape="true">Leases</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="ib888172d635740d3926d791323be69a5" continuedAt="i5bf6a791a7954a2ab29d4966d334bc79"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases have remaining lease terms of <ix:nonNumeric contextRef="i7d18c978c29e46f2a12a23d7312bca62_I20210331" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg4NjAyNA_b3213c1d-6f87-4e3b-848b-c696d6fdbac9">3</ix:nonNumeric> to <ix:nonNumeric contextRef="iae1734dfbd7b4fffa4a61071f126a5be_I20210331" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg4NjAzMQ_0a1a8c62-a141-402f-a45a-dc5f56c4e620">9</ix:nonNumeric> years. Certain of these leases have free or escalating rent payment provisions. We recognize lease expense on a straight-line basis over the terms of the leases, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. Most leases include options to renew, and the exercise of these options is at our discretion.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expenses were $<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg4OTQ3Mw_1f705772-5fde-4f2d-a740-88ea7a41dce3">2.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg4OTQ4NQ_b0ba23d5-74fe-46bf-86af-dd9c84b1e86b">2.1</ix:nonFraction> million for the three months ended March 31, 2021 and 2020, respectively and sublease income was immaterial for both periods.  </span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="ehth:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMjE5OTAyMzI2Mjc3NQ_b8c0af47-8b6f-4813-934b-76e0652ce211" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the lease-related assets and liabilities recorded on the Condensed Consolidated Balance Sheets as of the dates presented below (in thousands):</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfMS0xLTEtMS05NzE_4c34d8a1-966c-40fa-84fb-ce5f927ef040">41,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfMS0zLTEtMS05NzE_3d4e6b3f-1e4f-49b8-bbac-d06df687a81b">42,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities &#8211; current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfMy0xLTEtMS05NzE_169fd719-cf78-4bf5-ab51-a6efb300efc9">5,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfMy0zLTEtMS05NzE_5ef28a4f-f5aa-4afe-82a5-7ec44cd58847">5,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities &#8211; non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfNC0xLTEtMS05NzE_0948f462-8fbf-4b5a-b041-4349c49287e4">39,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfNC0zLTEtMS05NzE_a3e7cf4b-1aea-43a6-966e-24bacfa8bdc8">41,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfNS0xLTEtMS0xMDkx_632fdf82-0385-453b-8bc6-ea58994216fe">45,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfNS0zLTEtMS0xMDkx_a9b664fa-baf2-46c8-be15-21505d193b1e">46,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMjE5OTAyMzI2Mjc3Nw_96b0f6b5-7c6a-4973-9318-3e0fca44f4b0" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases are as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfMS0xLTEtMS0xMTA4_77af5a36-73ea-4849-8ee9-b5905e3d7a1f">1,900</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0964fabcb4d4203950f730100ea33dc_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfMS0zLTEtMS0xMTA4_f2ab41f8-4b76-4db6-b68f-2a6ad40c4ce8">7,090</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term of operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfMy0xLTEtMS0xMTA4_bf49ab92-1b00-488d-9e21-f2339197ff28">7.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfMy0zLTEtMS0xMTA4_d1a2a473-7a3b-4ff9-bd70-cb999d474951">7.2</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate used to recognize operating lease right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfNC0xLTEtMS0xMTA4_fbe1331a-68b8-454a-a79a-a4acbe76b708">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfNC0zLTEtMS0xMTA4_741885a9-4918-4701-8ad5-95449a8dd134">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i5bf6a791a7954a2ab29d4966d334bc79"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMjY0OA_57756754-c418-4762-9b69-58c5cbbb104d" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, maturities of operating lease liabilities are as follows (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfMS0xLTEtMS0w_d6d1d686-9c2a-4269-82f4-e975424fb4cb">5,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfMi0xLTEtMS0w_e184ee17-f680-4d7b-a505-d2c13031f9f6">7,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfMy0xLTEtMS0w_a468b84c-0271-430d-a193-12c206266bf4">8,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfNC0xLTEtMS0w_72a20fb0-9a29-4c91-83e2-5dd81fc0de22">7,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfNS0xLTEtMS0w_d65cf7d3-1958-423c-9b3c-b01bf2e9fef7">8,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="ehth:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfNi0xLTEtMS0w_962f8aa7-ec5c-4e18-9d65-d0e22578a24d">19,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfNy0xLTEtMS0w_a0f7f7de-29fb-48f4-ae97-530e71badf58">56,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfOC0xLTEtMS0w_adde07fe-13fd-440c-9ec7-629d093044f7">11,426</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfOS0xLTEtMS0w_b42dac45-596f-4dbd-8ffc-52d307f29bed">45,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Noncancellable sublease income for the remainder of 2021 and years ending December 31, 2022 and 2023 of $<ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg5MDQ1NA_3f6a132e-13b2-49bc-a140-056d9c78bf69">0.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg5MDQ1OA_e0d42a3f-de9f-4882-b8a4-f912e5339e22">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg5MDQ2Mg_37f22fad-afdf-49fc-854d-4a3bac1a3fab">0.4</ix:nonFraction> million, respectively, is not included in the table above.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_64"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82NC9mcmFnOjg0ZTk0ZjFkNDcyYTQxMTk4MjA3YjU0NmRiNjZhYjYxL3RleHRyZWdpb246ODRlOTRmMWQ0NzJhNDExOTgyMDdiNTQ2ZGI2NmFiNjFfOTI1_872c8f28-888d-423c-aeee-15f2576a6a05" continuedAt="ieb104555853846ea9337953aca26fb06" escape="true">Restructuring</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="ieb104555853846ea9337953aca26fb06"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, we eliminated approximately <ix:nonFraction unitRef="employee" contextRef="i5cf30dc17def4256a761123e6f60a569_D20210201-20210228" decimals="INF" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82NC9mcmFnOjg0ZTk0ZjFkNDcyYTQxMTk4MjA3YjU0NmRiNjZhYjYxL3RleHRyZWdpb246ODRlOTRmMWQ0NzJhNDExOTgyMDdiNTQ2ZGI2NmFiNjFfNDM5ODA0NjUxMjU0OA_1e0d8f36-1f88-4ef8-91fa-f53880448622">89</ix:nonFraction> full-time positions, primarily in the United States, representing approximately <ix:nonFraction unitRef="number" contextRef="i5cf30dc17def4256a761123e6f60a569_D20210201-20210228" decimals="2" name="ehth:RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82NC9mcmFnOjg0ZTk0ZjFkNDcyYTQxMTk4MjA3YjU0NmRiNjZhYjYxL3RleHRyZWdpb246ODRlOTRmMWQ0NzJhNDExOTgyMDdiNTQ2ZGI2NmFiNjFfNDM5ODA0NjUxMjU1Mg_7618e21a-49a0-4d93-b40a-634d8a3cbcb2">5</ix:nonFraction>% of our workforce, primarily within our customer care and enrollment group, and to a lesser extent, in our marketing and advertising, technology and content, and general and administrative groups.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total pre-tax restructuring charges for the three months ended March 31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82NC9mcmFnOjg0ZTk0ZjFkNDcyYTQxMTk4MjA3YjU0NmRiNjZhYjYxL3RleHRyZWdpb246ODRlOTRmMWQ0NzJhNDExOTgyMDdiNTQ2ZGI2NmFiNjFfMzI5ODUzNDg4NTY1OA_2bd86cdb-41be-4b4f-8990-90ef2dad16b5">2.4</ix:nonFraction>&#160;million, which primarily related to employee termination benefits. Substantially all of the restructuring charges resulted in cash expenditures. The restructuring activities were completed by March&#160;31, 2021. Accrued restructuring charges balance was $<ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82NC9mcmFnOjg0ZTk0ZjFkNDcyYTQxMTk4MjA3YjU0NmRiNjZhYjYxL3RleHRyZWdpb246ODRlOTRmMWQ0NzJhNDExOTgyMDdiNTQ2ZGI2NmFiNjFfNDM5ODA0NjUxMjk2MQ_7c26e24b-c75b-468f-a746-1743c20ee93b">0.3</ix:nonFraction>&#160;million as of March 31, 2021.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzg4Ng_c69418eb-c3b2-4831-baa9-f24b6bc5c72f" continuedAt="ica18f50258f54650806b951033057cf4" escape="true">Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ica18f50258f54650806b951033057cf4" continuedAt="i8143501b435446738826b9b799b6bf72"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 17, 2018, we entered into a Credit Agreement with Royal Bank of Canada (&#8220;RBC&#8221;), as administrative agent and collateral agent (the &#8220;Credit Agreement&#8221;). The Credit Agreement provides for a $<ix:nonFraction unitRef="usd" contextRef="if2923c5383c841499a972300bbf7f35a_I20180917" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjE0_aefea080-84a4-4a00-b2a9-b5d6727e3d1e">40.0</ix:nonFraction> million secured asset-backed revolving credit facility with a $<ix:nonFraction unitRef="usd" contextRef="ie6844992191446ce8e5eb767a6d14280_I20180917" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjcx_beb4cfee-96b7-4b2e-9eee-c37199381ce1">5.0</ix:nonFraction> million letter of credit sub-facility. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2019, we amended our revolving credit facility agreement with RBC (the &#8220;Amendment&#8221;) and increased the borrowing amount from $<ix:nonFraction unitRef="usd" contextRef="if2923c5383c841499a972300bbf7f35a_I20180917" decimals="INF" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfNDQ3_4623fc3c-464c-403b-8422-38543a3f744d">40.0</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfNDUz_e0bf5c1a-a60a-46a3-b9af-2b4f9605fe99">75.0</ix:nonFraction>&#160;million. The maturity date has been extended to December 20, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowing base under the Credit Agreement is comprised of an amount equal to (a) the lesser of (i) eighty percent (<ix:nonFraction unitRef="number" contextRef="ic7fc3ad8803c48dba5b19cd94571052d_D20210101-20210331" decimals="INF" name="ehth:LineOfCreditFacilityBorrowingBasePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfNjM1_00038003-e390-43c9-9435-f8019919983b">80</ix:nonFraction>%) of Eligible Commissions Receivables (as defined in the Credit Agreement) we actually collected during the immediately preceding period of three months or (ii) eighty percent (<ix:nonFraction unitRef="number" contextRef="id2de67982b8047c4945d793ade8e4b30_D20210101-20210331" decimals="INF" name="ehth:LineOfCreditFacilityBorrowingBasePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfODE3_619e64ce-fbc5-411e-bab6-0d1e89a80ff9">80</ix:nonFraction>%) of our Eligible Commission Receivables for the immediately succeeding period of three months, plus (b) fifty percent (<ix:nonFraction unitRef="number" contextRef="idb110a0ed8474c12b0f9d57120ec9b8b_D20210101-20210331" decimals="INF" name="ehth:LineOfCreditFacilityBorrowingBasePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfOTM5_4bc484d3-1a5d-46b7-bae5-ea21539cbf8c">50</ix:nonFraction>%) of our Eligible Commission Receivables for the immediately succeeding period of six months (excluding the immediately succeeding period of three months), in each case subject to reserves established by RBC (the &#8220;Borrowing Base&#8221;). The proceeds of the loans under the Credit Agreement may be used for working capital and general corporate purposes. The borrowers have the right to prepay the loans under the Credit Agreement in whole or in part at any time without penalty. Subject to availability under the Borrowing Base, amounts repaid may be reborrowed. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i8143501b435446738826b9b799b6bf72" continuedAt="ib37fafd4e65d4e47a507fa4038198603"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts not borrowed under the Credit Agreement will be subject to a commitment fee of <ix:nonFraction unitRef="number" contextRef="ib22aa805134544d8b3f646ee20f2d401_D20180917-20180917" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMTU4NA_b9414283-b868-4d5b-b30a-ddfe334c1be5">0.5</ix:nonFraction>% per annum on the daily unused portion of the credit facility, to be paid in arrears on the first business day of each calendar quarter. At the closing of the Credit Agreement, we paid a one-time facility fee of <ix:nonFraction unitRef="number" contextRef="ib22aa805134544d8b3f646ee20f2d401_D20180917-20180917" decimals="INF" name="ehth:LineOfCreditFacilityFacilityFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMTc3MA_e1b64455-0985-402a-97e7-59f50298100e">1.75</ix:nonFraction>% of the total commitments of $<ix:nonFraction unitRef="usd" contextRef="if2923c5383c841499a972300bbf7f35a_I20180917" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMTgwMQ_d11c0e50-5e67-4098-b1c2-bc21d2d9e003">40.0</ix:nonFraction>&#160;million. We also paid a one-time closing fee of <ix:nonFraction unitRef="number" contextRef="i44dd187585b74e779c773066ae7d855f_D20191220-20191220" decimals="INF" name="ehth:LineOfCreditFacilityFacilityFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMTg0NA_8cf54cd4-3a7a-44a6-9ec3-442d827b4504">0.5</ix:nonFraction>% of the new commitment of $<ix:nonFraction unitRef="usd" contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMTg3Mg_a95e1796-50bb-4bbb-8bb8-fd49557cf602">75.0</ix:nonFraction>&#160;million in connection with the Amendment. The Company is also obligated to pay other customary administration fees for a credit facility of this size and type. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability under the credit facility was up to the lesser of $<ix:nonFraction unitRef="usd" contextRef="if2923c5383c841499a972300bbf7f35a_I20180917" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjA4Nw_725ad32f-8321-414d-b8aa-ce311ac5f62a">40.0</ix:nonFraction> million or the Borrowing Base in the original credit agreement. The Amendment increased the availability up to the lesser of $<ix:nonFraction unitRef="usd" contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjI0Nw_6c789cf6-ec68-48ae-97f0-6362b2db637d">75.0</ix:nonFraction> million or the Borrowing Base, which may be reduced from time to time pursuant to the Credit Agreement.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial covenants in the original Credit Agreement required that we maintain Excess Availability (as defined in the Credit Agreement) at or above $<ix:nonFraction unitRef="usd" contextRef="if2923c5383c841499a972300bbf7f35a_I20180917" decimals="-5" format="ixt:numdotdecimal" name="ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjQ5NQ_08371b06-08a0-426d-9ad3-ae2fdd9ea448">6.0</ix:nonFraction> million at any time. The Amendment also changed the financial covenants to require us to maintain at least $<ix:nonFraction unitRef="usd" contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220" decimals="-5" format="ixt:numdotdecimal" name="ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjU5Nw_0debb5d8-1c2d-4ed4-bdd1-af0067611d89">6.0</ix:nonFraction>&#160;million of Excess Availability at all times or, if greater, up to $<ix:nonFraction unitRef="usd" contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220" decimals="-5" format="ixt:numdotdecimal" name="ehth:LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjY1OA_78b5626c-e5a0-47c4-af77-1c1677bf95d6">11.3</ix:nonFraction>&#160;million depending on our borrowing base as determined by eligible past and future commissions receivable. In addition, the Amendment also included changes in the payment conditions to, among other things, require us to have at least $<ix:nonFraction unitRef="usd" contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220" decimals="-5" format="ixt:numdotdecimal" name="ehth:LineOfCreditFacilityCovenantMinimumLiquidity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjg4Ng_0983a624-7bc5-467b-9f29-1db8402529f7">10.0</ix:nonFraction>&#160;million of liquidity or, if greater, up to $<ix:nonFraction unitRef="usd" contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220" decimals="-5" format="ixt:numdotdecimal" name="ehth:LineOfCreditFacilityCovenantMaximumLiquidity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjkyNA_22dfe116-336d-44b0-b8df-f623ae4fe04f">18.8</ix:nonFraction>&#160;million depending on our borrowing base as determined by eligible past and future commissions receivable, in order for us to make certain permitted acquisitions, investments, distributions and payments of indebtedness. The Amendment also stated the seasonal amount thresholds used in connection with the cash dominion and field examination covenants in the Credit Agreement. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred $<ix:nonFraction unitRef="usd" contextRef="if2923c5383c841499a972300bbf7f35a_I20180917" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzMwOA_5608df47-a6fd-4054-8e18-082e0e18220b">1.2</ix:nonFraction> million of issuance costs in connection with the Credit Agreement, which were capitalized as part of other assets on our Consolidated Balance Sheet in the period we entered into the Credit Agreement. The Amendment did not change the interest rate. In connection with the Amendment, we incurred closing costs totaling $<ix:nonFraction unitRef="usd" contextRef="iccd604bc2ad5443287367d09698c1237_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzYyMA_aab632b3-3e99-482f-b32f-b5f50fe701b8">0.5</ix:nonFraction>&#160;million, which were capitalized and recorded as other assets on our Condensed Consolidated Balance Sheet as of March 31, 2021. The remaining balance of unamortized issuance costs was $<ix:nonFraction unitRef="usd" contextRef="i30714fb2e7da43798055174115a19c9f_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzc3Ng_2db2b319-7705-405b-bbe1-9002d7bcd51a"><ix:nonFraction unitRef="usd" contextRef="ia6cae47fd71f4a738ddcb10f68e682c4_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzc3Ng_5beb566a-a93a-4adb-a39c-adb4c4e53d3b">0.7</ix:nonFraction></ix:nonFraction>&#160;million as of March 31, 2021 and December 31, 2020. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib37fafd4e65d4e47a507fa4038198603">As of March 31, 2021, we had <ix:nonFraction unitRef="usd" contextRef="i5dc87305aa114463a821897ca747dcca_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzgyMg_f4cfa0e4-2e8d-455c-9f9c-25d88b8302d9">no</ix:nonFraction> outstanding borrowings under our revolving credit facility.</ix:continuation> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfMjg2Mw_be636c83-35a7-411c-885c-15f2ee46abfc" continuedAt="i10990b696edf4a52953e929102bc974a" escape="true">Income Taxes </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i10990b696edf4a52953e929102bc974a" continuedAt="i30402e0a3791459b99514089e34ddb91"><ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfMjg2Nw_2a69526c-866f-4207-a7e8-934314e67175" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes our provision for (benefit from) income taxes and our effective tax rates for the periods presented below (in thousands, except effective tax rate):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfMi01LTEtMS0w_55af4cd6-6eed-4785-bffb-e9e3cb52640b">492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfMi03LTEtMS0w_1544120c-7aba-4a4d-a87a-d1941e92b0e1">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfMy01LTEtMS0w_ac19f13f-3d18-40ac-96c2-abbdfdda31cb">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfMy03LTEtMS0w_3a96b4cf-6166-48cf-a1d0-760b0405e091">2,048</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfNC01LTEtMS0w_ac09a784-9344-4654-b6a3-1becaa9cdbcf">62.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfNC03LTEtMS0w_817e60ff-63f4-40de-980d-6696db9eb668">145.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three months ended March 31, 2021, we recognized a provision for income taxes of $<ix:nonFraction unitRef="usd" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfNzY0_5935a5af-1139-4af3-9212-cd05ac121bf8">0.3</ix:nonFraction>&#160;million, representing an effective tax rate of (<ix:nonFraction unitRef="number" contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfODA2_ac09a784-9344-4654-b6a3-1becaa9cdbcf">62.6</ix:nonFraction>)%, which was lower than the statutory federal tax rate due primarily to one-time state tax adjustments. For the three months ended March 31, 2020, we recognized a benefit from income taxes of $<ix:nonFraction unitRef="usd" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfMTA0Ng_f3f36a12-31c2-4f93-ab21-2a1bbd78cf31">2.0</ix:nonFraction>&#160;million, representing an effective tax rate of (<ix:nonFraction unitRef="number" contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfMTA4OA_817e60ff-63f4-40de-980d-6696db9eb668">145.9</ix:nonFraction>)%, which was lower than the statutory federal tax rate due primarily to stock-based compensation windfalls.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assessing the realizability of our deferred tax assets is dependent upon several factors, including the likelihood and amount, if any, of future taxable income in relevant jurisdictions during the periods in which those temporary differences become deductible. We forecast taxable income by considering all available positive and negative evidence, including our history of operating income and losses and our financial plans and estimates that we use to manage the business. These assumptions require significant judgment about future taxable income. As a result, the amount of deferred tax assets considered realizable is subject to adjustment in future periods if estimates of future taxable income change. We continue to recognize our </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i30402e0a3791459b99514089e34ddb91">deferred tax assets as of March 31, 2021, as we believe it is more likely than not that the net deferred tax assets will be realized, with the exception of certain net operating losses and credits that are expected to expire unutilized which have a valuation allowance.</ix:continuation></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_1253"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13 &#8211; <ix:nonNumeric contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjU2MzA1_56d59c64-0779-4c42-b741-79ce4201d288" continuedAt="ied6bab88fc904d05a5569a5a79c747ca" escape="true">Subsequent Event</ix:nonNumeric></span><span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="ied6bab88fc904d05a5569a5a79c747ca" continuedAt="i6be9c9d50a6e4b15bba4e75dc6cdb258"> </ix:continuation></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6be9c9d50a6e4b15bba4e75dc6cdb258">On April 30, 2021, we issued and sold to Echelon Health SPV, LP ("H.I.G."), an investment vehicle of H.I.G. Capital, in a private placement, <ix:nonFraction unitRef="shares" contextRef="ib2c1d434f2124892a124c74f776eff75_D20210430-20210430" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjU2MzA5_7bc5e910-a220-4aaf-87bd-78de3936650c">2,250,000</ix:nonFraction> shares of our newly designated Series A convertible preferred stock, in par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib293ecab870b425a8366eb79aa2bf444_I20210430" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjU4Mzk5_dbff6f42-3684-4733-8df0-d967bef885e7">0.001</ix:nonFraction> per share (&#8220;Series A Preferred Stock&#8221;), at an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="ib2c1d434f2124892a124c74f776eff75_D20210430-20210430" decimals="-5" format="ixt:numdotdecimal" name="ehth:SaleOfStockConsiderationReceivedOnTransactionGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjU2MzIw_0ce5af13-77eb-463e-a390-14f893b3cb2a">225.0</ix:nonFraction>&#160;million, at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib293ecab870b425a8366eb79aa2bf444_I20210430" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjU4NDA3_16a2b338-0999-4e8c-a644-919eddd4c46d">100</ix:nonFraction> per share. We received $<ix:nonFraction unitRef="usd" contextRef="ib2c1d434f2124892a124c74f776eff75_D20210430-20210430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjYzMjc2_2a67a5a1-561c-4fd4-9241-014f65b430c3">216.2</ix:nonFraction>&#160;million in proceeds from the private placement with H.I.G., net of sales commissions and certain transaction fees.</ix:continuation>  </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In addition to historical information, this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The words &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;target,&#8221; &#8220;goal,&#8221; &#8220;project,&#8221; &#8220;hope,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;seek,&#8221; &#8220;continue,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;might,&#8221; &#8220;forecast,&#8221; and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements include, among other things, statements regarding our expectations relating to approved members, new paying members and estimated membership; our estimates regarding the constrained lifetime value of commissions; our expectations relating to revenue, operating costs, cash flows and profitability; our expectations regarding our strategy and investments; our expectations regarding our Medicare business, including market opportunity, consumer demand and our competitive advantage; our expectations regarding our individual and family business, including anticipated trends and our ability to enroll individuals and families into qualified health plans; the impact of future and existing healthcare laws and regulations on our business; the expected impact of the COVID-19 on our business; our expectations regarding commission rates, payment rates, conversion rates, plan termination rates and duration, membership retention rates and membership acquisition costs; our expectations regarding health insurance agents licensing and productivity; our expectations relating to the seasonality of our business; expected competition from government-run health insurance exchanges and other sources; our expectations relating to marketing and advertising expense and expected contributions from our marketing and strategic partnership channels; the timing of our receipt of commission and other payments; our critical accounting policies and related estimates; liquidity and capital needs; political, legislative, regulatory and legal challenges; the merits or potential impact of any lawsuits filed against us; as well as other statements regarding our future operations, financial condition, prospects and business strategies. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have based these forward-looking statements on our current expectations about future events. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Our actual results may differ materially from those suggested by these forward-looking statements for various reasons, including our ability to retain existing members and enroll new members during the annual healthcare open enrollment period, the Medicare annual enrollment period and a COVID-19-related or other special enrollment period; changes in laws, regulations and guidelines, including in connection with healthcare reform or with respect to the marketing and sale of Medicare plans; competition, including competition from government-run health insurance exchanges; the seasonality of our business and the fluctuation of our operating results; our ability to accurately estimate membership and lifetime value of commissions; changes in product offerings among carriers on our ecommerce platform and the resulting impact on our commission revenue; our ability to execute on our growth strategy in the Medicare market; the continued impact of the COVID-19 pandemic on our operations, business, financial condition and growth prospects, as well as on the general economy; changes in our management and key employees; exposure to security risks and our ability to safeguard the security and privacy of confidential data; our relationships with health insurance carriers; customer concentration; our success in marketing and selling health insurance plans and our unit cost of acquisition; our ability to hire, train, retain and ensure the productivity of licensed health insurance agents and other employees; changes in the market for private health insurance; consumer satisfaction of our service; changes in member conversion rates; changes in commission rates; our ability to sell qualified health insurance plans to subsidy-eligible individuals and to enroll subsidy-eligible individuals through government-run health insurance exchanges; our ability to maintain and enhance our brand identity; our ability to derive desired benefits from investments in our business, including membership growth and retention initiatives; reliance on marketing partners; the impact of our direct-to-consumer email, telephone and television marketing efforts; timing of receipt and accuracy of commission reports; payment practices of health insurance carriers; dependence on our operations in China; the restrictions in our debt obligations; the restrictions in our investment agreement with H.I.G; compliance with insurance and other laws and regulations; the outcome of litigation in which we are involved; and the performance, reliability and availability of our information technology systems, ecommerce platform and underlying network infrastructure and those identified under the heading &#8220;Risk Factors&#8221; in Part II, Item 1A. of this report and those discussed in our other Securities and Exchange Commission filings. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included in this report are made only as of the date hereof. Except as required by applicable law, we do not undertake, and specifically decline, any obligation to update any of these statements or to publicly announce the results of any revisions to any forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise. The following discussion should be read in conjunction with our Annual Report on Form 10-K as filed with the Securities and Exchange Commission in February 2021, and the audited consolidated financial statements and related notes contained therein.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_79"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are a leading private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform is designed to meet the consumer wherever they prefer to engage with us, and enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that include thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over 200 health insurance carriers across all fifty states and the District of Columbia.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact from COVID-19</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March 31, 2021, some of our offices in the United States remained closed, while some locations have opened at a reduced capacity with additional safety and social distancing measures. Based on our experience in shifting existing agents to work from home and launching a remote agent model in 2020, we expect this remote agent model to provide us with geographic hiring flexibility as we grow our telesales capacity. We believe the COVID-19 pandemic had an impact on consumer behavior in selecting and utilizing health insurance. We believe that the way people shop for health coverage is changing with more seniors that are now likely to shop for Medicare products online or over the phone versus a face-to-face meeting with a traditional broker. We anticipate that this will have a positive impact on comparison Medicare platforms such as ours. Notwithstanding the anticipated positive change in the manner in which consumers purchase health insurance, the pandemic could adversely impact our business, including as a result of changes in consumer behavior, decreased ability to afford health insurance, an increased desire to change plans, an adverse impact on our ability to recruit and onboard sales agents and decreased productivity of our employees. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in Part II, Item 1A of this Quarterly Report on Form 10-Q for a discussion of risks related to the COVID-19 pandemic.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">H.I.G. Investment</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 30, 2021, upon the terms and subject to the conditions set forth in our investment agreement with H.I.G., we issued and sold 2,250,000 shares of newly designated Series A convertible preferred stock to H.I.G. in a private placement at an aggregate purchase price of $225 million, at a price of $100 per share.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Selected Metrics</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely upon certain metrics to estimate and recognize commission revenue, evaluate our business performance and facilitate strategic planning. Our commission revenue is influenced by a number of factors including but not limited to:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of individuals on applications for Medicare-related, individual and family, small business and ancillary health insurance plans that are approved by the relevant health insurance carriers;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of approved members for Medicare-related, individual and family, small business and ancillary health insurance plans from whom we have received an initial commission payment; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the constrained lifetime value, or LTV, of approved members for Medicare-related, individual and family and ancillary health insurance plans we sell, as well as the estimated annual value of approved members for small business plans we sell.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Approved Members</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approved members represent the number of individuals on submitted applications that were approved by the relevant insurance carrier for the identified product during the current period. The applications may be submitted in either the current period or prior periods. Not all approved members ultimately become paying members.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows approved members by product for&#160;the period presented:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.922%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Qualified Health Plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Individual and Family</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ancillaries:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Ancillaries</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,948&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,603&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Approved Members</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,344&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Medicare approved members increased 45% in the three months ended March 31, 2021 compared to the same period in 2020. The increase in total Medicare approved members was primarily attributable to a 65% growth in Medicare Advantage plan members, partially offset by a 28% decline in Medicare Supplement plan members and an 11% decline in Medicare Part D plan members in the three months ended March 31, 2021 compared to the same period in 2020. The increase in approved Medicare Advantage members was primarily driven by strong consumer demand and an increase in our internal agent productivity and online enrollment growth. We expect our year-over-year Medicare enrollment growth will slow down in the second quarter of 2021, as compared to the first quarter of 2021 growth rate, due to the introduction of a COVID-related special enrollment period for the Medicare Advantage market in the second quarter of 2020 that is not in place during the second quarter of 2021. The COVID-related special enrollment period had a favorable impact on consumer demand and agent conversion rates in 2020 as more consumers were allowed to transact due that enrollment period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual and Family Plan approved members grew 21% in the three months ended March 31, 2021 compared to the same period in 2020 due to a 26% increase in approved members for qualified health plans and a 16% increase in approved members in non-qualified health plans. Recent growth in approved major medical individual and family plan members is partially a result to the current administration&#8217;s decision to extend the open enrollment period outside of the fourth quarter when it typically takes place, and to make these plans more affordable to certain consumer segments through a more extensive premium subsidy program. Ancillary plan approved members declined 14% in the three months ended March 31, 2021 compared to the same period in 2020 primarily due to a 35% decline in approved members for short-term health plans and a 44% decrease in approved members for other ancillary plans, partially offset by an increase in approved members for dental and vision insurance. Small business group health insurance approved members declined 18% in the three months ended March 31, 2021 compared to the same period in 2020 mainly due to the shift of our focus away from the sale of small business products.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Paying Members</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New Paying Members consist of approved members from the period presented and any periods prior to the period presented from whom we have received an initial commission payment during the period presented. The following table shows our new paying members by product for&#160;the periods presented below:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.652%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Qualified Health Plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Individual and Family</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ancillaries:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Ancillaries</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,557&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,156&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total New Paying Members</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233,455&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Medicare total new paying members grew 11% in the three months ended March 31, 2021 compared to the same period in 2020, primarily driven by a 63% increase Medicare Advantage plan new paying members, partially offset by a 54% decrease in Medicare Part D prescription drug plan and a 14% decrease in Medicare Supplement plan new paying members</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Individual and family plan new paying members grew 14% in the three months ended March 31, 2021 compared to the same period in 2020 due to increases in new paying members for non-qualified plans and new paying members for qualified plans. Ancillary new paying members declined 3% in the three months ended March 31, 2021 compared to the same period in 2020 primarily due to a decline in approved members for short-term and other health plans. Small business new paying members declined 20% in the three months ended March 31, 2021 compared to the same period in 2020 primarily due to a decrease in approved members</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated Constrained Lifetime Value of Commissions Per Approved Member</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table shows our estimated constrained LTV of commissions per approved member by product for&#160;the periods presented below:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.539%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Advantage </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Part D </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Qualified Health Plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qualified Health Plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ancillaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dental </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vision </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Small Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Constrained LTV of commissions per approved member represents commissions estimated to be collected over the estimated life of an approved member&#8217;s policy after applying constraints in accordance with our revenue recognition policy. The estimate is driven by multiple factors, including but not limited to, contracted commission rates, carrier mix, estimated average plan duration, the regulatory environment, and cancellations of insurance plans offered by health insurance carriers with which we have a relationship. These factors may result in varying values from period to period. For additional information on constrained LTV, see Critical Accounting Policies and Estimates in our Annual Report on Form 10-K for the year ended December 31, 2020.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">For small business, the amount represents the estimated commissions we expect to collect from the plan over the following twelve months. The estimate is driven by multiple factors, including but not limited to, contracted commission rates, carrier mix, estimated average plan duration, the regulatory environment, and cancellations of insurance plans offered by health insurance carriers with which we have a relationship and applied constraints. These factors may result in varying values from period to period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Medicare </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The constrained LTV of commissions per approved member for Medicare Part D prescription drug, Medicare Supplement and Medicare Advantage plans declined by 17%, 9% and 4%, respectively, during the three months ended March 31, 2021 compared to the same period in 2020. The decline in constrained LTVs for Medicare Advantage plans was primarily due to a decrease in estimated average plan duration driven by various market factors, including the reintroduction of the open enrollment period in 2019, which provided an additional opportunity for Medicare Advantage plan members to change plans. The negative impact of these factors was partially offset by an increase in broker commission rates and higher commission rates for new Medicare Advantage enrollments compared to the commissions for enrollments of existing members changing their plans. The decline in constrained LTV for Medicare Part D prescription drug plans was primarily due to a shift in consumer demand away from these plans and towards Medicare Advantage plans with prescription drug coverage.  We believe that, similar to our Medicare Advantage plan members, a larger number of Medicare Part D prescription drug plan members terminated their plans due to the additional opportunities for consumers to shop and switch Medicare Part D prescription drug plans during the recently introduced open enrollment periods. The decline in constrained LTV of commissions per approved member was driven by telephonic enrollments from our more recent member cohorts enrolled prior to the last annual enrollment period. Our telephonic enrollments historically have had a shorter average plan duration compared to our online enrollments, which continue to have a higher average plan duration.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Individual and Family and Ancillaries </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The constrained LTV of commissions per qualified health plan approved member increased 24% during the three months ended March 31, 2021 compared with the same period in 2020 mostly due to increased estimates of average plan duration. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constrained LTV of commissions per short-term health insurance approved member increased 20% during the three months ended March 31, 2021 compared to the same period in 2020 primarily as a result of our selling of plans with  higher premiums and resulting in increased commissions and an increase in estimated average plan duration.</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constrained LTV of commissions per approved member for dental and vision plans increased by 36% and 13%, respectively, during the three months ended March 31, 2021 compared with the same period in 2020 primarily due to an increase in estimated average plan duration and lower constraints as a result of reduced volatility based on historical trends.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constraints applied to the total estimated lifetime commissions we expect to receive for selling the plan after the carrier approves an application in order to derive the constrained LTV of commissions for approved members recognized for the periods presented below are summarized as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Qualified Health Plans </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ancillaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The constraints for small business plans and short-term health insurance plans increased during the three months ended March 31, 2021, as compared to the same period in the prior year, due to an increase in volatility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated Membership</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated membership represents the estimated number of members active as of the date indicated based on the number of members for whom we have received or applied a commission payment during the period of estimation. The following table shows estimated membership by product for the periods presented below:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.652%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Advantage </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873,041&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">725,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ancillaries </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Ancillaries</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Small Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Estimated Membership</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,263,507&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,136,954&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">To estimate the number of members on Medicare-related health insurance plans, we take the sum of (i) the number of members for whom we have  applied or expected to receive a commission payment for a month that may be up to three months prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations over the period being estimated); and (ii) the number of approved members over that period (after reducing that number using historical experience for an assumed number of members who do not accept their approved policy and for estimated member cancellations through the date of the estimate). To the extent we determine we have received substantially all of the commission payments related to a given month during the period being estimated, we will take the number of members for whom we have received or applied a commission payment during the month of estimation.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">As previously disclosed, we learned subsequent to reporting for the three months ended March 31, 2020 that Medicare Advantage membership as of March 31, 2020 was 384,513, a decrease of 19,749 or 4.9% relative to the previously reported estimated membership of 404,262, due to additional membership attrition during the quarter ended March 31, 2020 that was observed after the reporting period.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">To estimate the number of members on Individual and Family health insurance plans (&#8220;IFP&#8221;), we take the sum of (i) the number of IFP members for whom we have received or applied a commission payment for a month that may be up to three months prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations over the period being estimated); and (ii) the number of approved members over that period (after reducing that number using historical experience for an assumed number of members who do not accept their approved policy and for estimated member cancellations through the date of the estimate). To the extent we determine we have received substantially all of the commission payments related to a given month during the period being estimated, we will take the number of members for whom we have received or applied a commission payment during the month of estimation.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">To estimate the number of members on ancillary health insurance plans (such as short-term, dental and vision insurance), we take the sum of (i) the number of members for whom we have received or applied a commission payment for a month that may be up to three months prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations over the period being estimated); and (ii) the number of approved members over that period (after reducing that number using historical experience for an assumed number of members who do not accept their approved policy and for estimated member cancellations through the date of the estimate). To the extent we determine we have received substantially all of the commission payments related to a given month during the period being estimated, we will take the number of members for whom we have received or applied a commission payment during the month of estimation. The one to three-month period varies by insurance product and is largely dependent upon the timeliness of commission payment and related reporting from the related carriers.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">To estimate the number of members on small business health insurance plans, we use the number of initial members at the time the group was approved, and we update this number for changes in membership if such changes are reported to us by the group or carrier. However, groups generally notify the carrier directly of policy cancellations and increases or decreases in group size without informing us. Health insurance carriers often do not communicate policy cancellation information or group size changes to us. We often are made aware of policy cancellations and group size changes at the time of annual renewal and update our membership statistics accordingly in the period they are reported.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health insurance carriers bill and collect insurance premiums paid by our members. The carriers do not report to us the number of members that we have as of a given date. The majority of our members who terminate their plans do so by discontinuing their premium payments to the carrier and do not inform us of the cancellation. Also, some of our members pay their premiums less frequently than monthly. Given the number of months required to observe non-payment of commissions in order to confirm cancellations, we estimate the number of members who are active on insurance policies as of a specified date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After we have estimated membership for a period, we may receive information from health insurance carriers that would have impacted the estimate if we had received the information prior to the date of estimation. We may receive commission payments or other information that indicates that a member who was not included in our estimates for a prior period was in fact an active member at that time, or that a member who was included in our estimates was in fact not an active member of ours. For instance, we reconcile information carriers provide to us and may determine that we were not historically paid commissions owed to us, which would cause us to have underestimated membership. Conversely, carriers may require us to return commission payments paid in a prior period due to policy cancellations for members we previously estimated as being active. We do not update our estimated membership numbers reported in previous periods. Instead, we reflect updated information regarding our historical membership in the membership estimate for the current period. If we experience a significant variance in historical membership as compared to our initial estimates, we keep the prior period data consistent with previously reported amounts, while we may provide the updated information in other communications or disclosures. As a result of the delay in our receipt of information from insurance carriers, actual trends in our membership are most discernible over periods longer than from one quarter to the next. As a result of the delay we experience in receiving information about our membership, it is difficult for us to determine with any certainty the impact of current conditions on our membership retention. Various circumstances could cause the assumptions and estimates that we make in connection with estimating our membership to be inaccurate, which would cause our membership estimates to be inaccurate. A member who purchases and is active on multiple standalone insurance plans will be counted as a member more than once. For example, a member who is active on both an individual and family health insurance plan and a standalone dental plan will be counted as two continuing members.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our membership estimates in a particular quarter have not been significantly different when compared to membership data received from carriers in a subsequent quarter. However, we experienced a larger deviation in the actual Medicare Advantage membership, which was lower than our initial estimate, for the first quarter of 2020. This deviation was primarily due to the time delay in receiving information from our carriers and a higher level of plan cancellations than expected. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare-related plan estimated membership as of March 31, 2021 grew 20% compared to estimated membership as of March 31, 2020 due to a 33% growth in Medicare Advantage estimated membership, a 7% growth in Medicare Supplement plan estimated membership, and a 2% growth in Medicare Part D prescription drug plan estimated membership. The overall growth in Medicare estimated membership was due to increased sales of Medicare-related plans and improved member retention for new members approved during the fourth quarter of 2020, as well as a higher recapture rate during the full year 2020 as compared to 2019. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual and family plan estimated membership as of March 31, 2021 declined 8% compared to estimated membership as of March 31, 2020 due to market conditions in the individual and family plan market and our decision to shift our investment to our Medicare business. Ancillary plan estimated membership as of March 31, 2021 declined 5% compared to estimated membership as of March 31, 2020 primarily as a result of the decline in dental and short-term health plans estimated membership.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Member Acquisition</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Marketing initiatives are an important component of our strategy to increase revenue and are primarily designed to encourage consumers to complete an application for health insurance. Variable marketing cost represents direct costs incurred in member acquisition from our direct, marketing partners and online advertising channels. In addition, we incur customer care and enrollment expenses (&#8220;CC&amp;E&#8221;) in assisting applicants during the enrollment process. Variable marketing costs exclude fixed overhead costs, such as personnel related costs, consulting expenses, facilities and other operating costs allocated to the marketing and advertising department.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the estimated variable marketing cost per approved member and the estimated customer care and enrollment expense per approved member metrics for&#160;the periods presented below. The numerator used to calculate </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each metric is the portion of the respective operating expenses for marketing and advertising and customer care and enrollment that is directly related to member acquisition for our sale of Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans (collectively, &#8220;Medicare Plans&#8221;) and for all individual and family major medical plans and short-term health insurance (collectively, &#8220;IFP Plans&#8221;), respectively. The denominator used to calculate each metric is based on a derived metric that represents the relative value of the new members acquired. For Medicare Plans, we call this derived metric Medicare Advantage (&#8220;MA&#8221;)-equivalent members, and for IFP Plans, we call this derived metric IFP-equivalent members. The calculations for MA-equivalent members and for IFP-equivalent members are based on the weighted number of approved members for Medicare Plans and IFP Plans during the period, with the number of approved members adjusted based on the relative LTV of the product they are purchasing. Since the LTV for any product fluctuates from period to period, the weight given to each product was determined based on their relative LTVs at the time of our adoption of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Standards Codification 606 &#8211; Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 606").</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.652%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated CC&amp;E cost per approved MA-equivalent approved member </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated variable marketing cost per MA-equivalent approved member</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Medicare estimated cost per approved member</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family Plan:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated CC&amp;E cost per IFP-equivalent approved member</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated variable marketing cost per IFP-equivalent approved member</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total IFP estimated cost per approved member</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">MA-equivalent approved members is a derived metric with a Medicare Part D approved member being weighted at 25% of a Medicare Advantage member and a Medicare Supplement member based on their relative LTVs at the time of our adoption of ASC 606. We calculate the number of approved MA-equivalent members by adding the total number of approved Medicare Advantage and Medicare Supplement members and 25% of the total number of approved Medicare Part D members during the period presented.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">IFP-equivalent approved members is a derived metric with a short-term approved member being weighted at 33% of a major medical individual and family health insurance plan member based on their relative LTVs at the time of our adoption of ASC 606. We calculate the number of approved IFP-equivalent members by adding the total number of approved qualified and non-qualified health plan members and 33% of the total number of short-term approved members during the period presented.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Estimated CC&amp;E costs per approved MA-equivalent member decreased 24%&#160;in the three months ended March 31, 2021&#160;compared to the same period in 2020 due to an increase in productivity of our internal agents, and an increase in the percentage of online enrollments, as well as our operational and technology enhancements. Estimated variable marketing cost per MA-equivalent member remained flat due to a higher conversion rate being offset by a shift towards online marketing channels that have a higher cost per lead.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated CC&amp;E cost per approved IFP-equivalent member decreased 20% in the three months ended March 31, 2021&#160;compared to the same period in 2020&#160;due primarily to an increase in agent productivity. Estimated variable marketing cost per IFP-equivalent member increased 22% in the three months ended March 31, 2021 compared to the same period in 2020 due to an increase in marketing costs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_85"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="text-indent:40.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements and related disclosures in conformity with U.S. generally accepted accounting principles, or U.S. GAAP, requires us to make judgments, assumptions, and estimates that affect the amounts reported in the consolidated financial statements and the accompanying notes. These estimates and assumptions are based on current facts, historical experience, and various other factors that we believe are reasonable under the circumstances to determine reported amounts of assets, liabilities, revenue and expenses that are not readily apparent from other sources. To the extent there are material differences between our estimates and the actual results, our future consolidated results of comprehensive income may be affected.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An accounting policy is considered to be critical if the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change, and the effect of the estimates and assumptions on financial condition or operating performance. The accounting policies we believe to reflect our more significant estimates, judgments and assumptions and are most critical to understanding and evaluating our reported financial results are as follows:&#160;</span></div><div style="text-indent:40.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue Recognition and contract assets - commission receivable;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock-Based Compensation; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Accounting for Income Taxes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to our critical accounting policies and estimates described in our Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on February 26, 2021, that have had a significant impact on our condensed consolidated financial statements and related notes. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contained in Part II, Item&#160;7 of our Annual Report on Form 10-K for the year ended December 31, 2020, for a complete discussion of our other critical accounting policies and estimates. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results and related percentage of total revenue are summarized below for the periods presented (dollars in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.339%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commission</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,408&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total operating costs and expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(642)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income (loss) before provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(492)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,048)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,452&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Operating costs and expenses include the following amounts of stock-based compensation expense (in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.683%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commission revenue, other revenue and total revenue are summarized as (dollars in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commission</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,214&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commission revenue increased $27.4 million, or 27%, during the three months ended March 31, 2021 compared to the same period in 2020 due to a $24.6 million increase in commission revenue from the Medicare segment and a $2.8 million increase in commission revenue from Individual, Family and Small Business segment. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The increase in commission revenue from the Medicare segment was driven by a 45% increase in Medicare plan approved members, primarily attributable to a 65% growth in Medicare Advantage plan approved members compared to 2020, partially offset by lower LTVs and a decrease in net commission revenue from Medicare members approved in prior periods. The increase in commission revenue from Individual, Family and Small Business segment was primarily driven by a $1.9 million increase in net adjustment revenue, 21% increase in individual and family major medical plan approved members, 15% increase in dental plan approved members and 12% increase in vision plan approved members. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> below for further discussion.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue increased $0.4 million, or 6%, during the three months ended March 31, 2021 compared to the same period in 2020 due to an increase in sponsorship and advertising revenue.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists of payments related to health insurance plans sold to members who were referred to our website by marketing partners with whom we have revenue-sharing arrangements. In order to enter into a revenue-sharing arrangement, marketing partners must be licensed to sell health insurance in the state where the policy is sold. Costs related to revenue-sharing arrangements are expensed as the related revenue is recognized.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, cost of revenue includes the amortization of consideration we paid to certain broker partners in connection with the transfer of their health insurance members to us as the new broker of record on the underlying plans. These transfers include primarily Medicare plan members. Consideration for all book-of-business transfers is being amortized to cost of revenue as we recognize commission revenue related to the transferred members.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cost of revenue is summarized as follows (dollars in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cost of revenue decreased by $0.1 million during the three months ended March 31, 2021, compared to the same period in 2020, primarily due to decreased activity from our revenue sharing arrangements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing and Advertising</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing and advertising expenses consist primarily of member acquisition expenses associated with our direct, marketing partner and online advertising member acquisition channels, in addition to compensation and other expenses related to marketing, business development, partner management, public relations and carrier relations personnel who support our offerings.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing and advertising expenses are summarized as follows (dollars in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketing and advertising</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Marketing and advertising expenses increased $13.1 million, or 35%, during the three months ended March 31, 2021 compared to the same period in 2020, primarily driven by a $14.0 million increase in Medicare plan related variable advertising and $0.8 million in stock-based compensation expenses, partially offset by decreases of $1.0 million in consulting expenses and $0.7 million in personnel and compensation costs. The increase in variable advertising expenses was due to an increase in our advertising expense through our partner and online channels.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Customer Care and Enrollment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer care and enrollment expenses primarily consist of compensation, benefits, and licensing costs for personnel engaged in assistance to applicants who call our customer care center and for enrollment personnel who assist applicants during the enrollment process. Our customer care and enrollment expenses also include third-party call center costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customer care and enrollment expenses are summarized as follows (dollars in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Customer care and enrollment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Customer care and enrollment expenses increased $3.6 million, or 12%, during the three months ended March 31, 2021 compared to the same period in 2020, primarily due to an increase of $6.1 million in personnel costs associated with an increase in customer care and enrollment headcount, partially offset by decreases of $1.7 million in licensing costs and $1.0 million in consulting expenses. The decrease in licensing costs was primarily due to previously over-recognized licensing costs that were adjusted during the three months ended March 31, 2021. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have shifted to a predominantly internal agent model and intend to employ and maintain the majority of our health insurance agent force year-round. In 2021, we are starting internal agent hiring and training earlier in the year compared to prior years, with the largest headcount increase planned for the second and third quarters. As a result, our customer care and enrollment costs will increase accordingly during the second and third quarters of 2021. We believe that a combination of a longer training period and an increased percentage of internal agents will have a significant positive impact on agent productivity, enrollment volumes and acquisition cost per approved member during the annual enrollment period in the fourth quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technology and Content</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Technology and content expenses consist primarily of compensation and benefits costs for personnel associated with developing and enhancing our website technology as well as maintaining our website. A portion of our technology and content group is located at our wholly-owned subsidiary in China, where technology development costs are generally lower than in the United States.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology and content expenses are summarized as follows (dollars in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Technology and content</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Technology and content expenses increased $7.4 million, or 47%, during the three months ended March 31, 2021 compared to the same period in 2020 primarily driven by increases of $3.2 million in personnel and compensation costs due to higher headcount, $1.3 million in amortization of internal software development costs, $1.3 million in facilities, and $1.1 million in stock-based compensation expenses.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">General and Administrative</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses include compensation and benefits costs for personnel working in our executive, finance, investor relations, government affairs, legal, human resources, internal audit, facilities and internal information technology departments. These expenses also include fees paid for outside professional services, including audit, tax, legal, government affairs and information technology fees. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative expenses are summarized as follows (dollars in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,401&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative expenses increased $3.4 million, or 17%, during the three months ended March 31, 2021 compared to the same period in 2020, primarily driven by increases of $1.0 million stock-based compensation expenses, $0.9 million in personnel and compensation costs, $0.7 million in shareholder engagement costs, $0.4 million in consulting expenses, and $0.4 million in facilities and other operating costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our intangible asset amortization expense is summarized as follows (dollars in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was primarily related to intangible assets purchased through our acquisitions. Amortization expense decreased during the three months ended March 31, 2021 compared to the same periods in 2020 due to certain intangible assets being fully amortized during the three months ended March 31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring Charges</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, our Board of Directors approved a plan to terminate the employment of certain employees in certain locations. As part of this plan, we eliminated approximately 89 full-time positions, primarily in the United States, representing approximately 5% of our workforce primarily within customer care and enrollment groups, and to a lesser extent, in our marketing and advertising and general and administrative groups.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our restructuring charges is summarized as follows (dollars in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our restructuring charges primarily consist of severance and other termination benefits provided to employees as part of the restructuring plan.  </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* &#160;&#160;&#160;&#160;Percentage calculated is not meaningful.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net, primarily consisted of interest income, sublease income and margin earned on commissions received from Medicare plan members transferred to us in 2010 through 2012 by a broker partner, partially offset by interest expense on finance leases and debt and other bank fees.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other income, net is summarized as follows (dollars in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other income, net decreased $0.2 million during the three months ended March 31, 2021 compared to the same period in 2020 due primarily to a decrease in interest income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for (Benefit from) Income Taxes&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision (benefit) for income taxes are summarized as follows (dollars in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,048)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(145.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">_______</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* &#160;&#160;&#160;&#160;Percentage calculated is not meaningful.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective tax rate increased for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020, primarily due to a decrease in stock-based compensation windfalls partially offset by a one-time state tax adjustment in the first quarter of 2021. During the three months ended March 31, 2021, we recorded a provision for income taxes of $0.3 million representing an effective tax rate of (62.6)% which was lower than the statutory federal tax rate due primarily to one-time state tax adjustments. During the three months ended March 31, 2020, we recorded a benefit from income taxes of $2.0 million representing an effective tax rate of (145.9)% which was lower than the statutory federal tax rate primarily due to stock-based compensation windfalls.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_1305"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report segment information based on how our chief executive officer, who is our chief operating decision maker, or CODM, regularly reviews our operating results, allocates resources and makes decisions regarding our business operations. The performance measures of our segments include total revenue and profit. Our business structure is comprised of&#160;two&#160;operating segments:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare; and</span></div><div style="padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Individual, Family and Small Business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CODM does not separately evaluate assets by segment, with the exception of commissions receivable, and therefore assets by segment are not presented.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicare segment consists primarily of commissions earned from our sale of Medicare-related health insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans, and to a lesser extent, ancillary products sold to our Medicare-eligible applicants, including but not limited to, dental and vision plans, as well as our advertising program that allows Medicare-related carriers to purchase advertising on a separate website developed, hosted and maintained by us and to purchase other marketing and advertising services, as well as our delivery and sale to third parties of Medicare-related health insurance leads generated by our ecommerce platforms and our marketing activities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Individual, Family and Small Business segment consists primarily of commissions earned from our sale of individual, family and small business health insurance plans and ancillary products sold to our non-Medicare-eligible applicants, including but not limited to, dental, vision, and short-term health insurance. To a lesser extent, the Individual, Family and Small Business segment consists of amounts earned from our online sponsorship program that allows carriers to purchase advertising space in specific markets in a sponsorship area on our website, our licensing to third parties the use of our health insurance ecommerce technology, and our delivery and sale to third parties of individual and family health insurance leads generated by our ecommerce platforms and our marketing activities. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing and advertising, customer care and enrollment, technology and content, and general and administrative operating expenses that are directly attributable to a segment are reported within the applicable segment. Indirect marketing and advertising, customer care and enrollment, and technology and content operating expenses are allocated to each segment based on usage. Other indirect general and administrative operating expenses are managed in a corporate shared services environment and, since they are not the responsibility of segment operating management, are not allocated to the operating segments and instead reported within Corporate. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment profit is calculated as total revenue for the applicable segment less direct and allocated marketing and advertising, customer care and enrollment, technology and content, and general and administrative operating expenses, excluding stock-based compensation expense, change in fair value of earnout liability, depreciation and amortization expense, and amortization of intangible assets. During the first quarter of 2021, we modified the calculation of segment profit to exclude the amortization of capitalized software development cost to enhance comparability of our financial metrics with peer companies.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating segment revenue and profit are summarized as follows (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.303%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Individual, Family and Small Business</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment profit:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Individual, Family and Small Business segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total segment profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,688)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,944)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(547)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income (loss) before provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(492)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,896)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* &#160;&#160;&#160;&#160;Percentage calculated is not meaningful.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $2.8 million and $1.5 million for the first quarter of 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Depreciation and amortization has been adjusted to include amortization of software development costs.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenue from our Medicare segment grew $24.9 million, or 26%, during the three months ended March 31, 2021 compared to the same period in 2020, primary attributable to an increase in Medicare Advantage plan related commission revenue of $35.2 million, partially offset by lower LTVs and a decrease in net adjustment revenue. The increase in Medicare Advantage commission revenue was driven by 65% growth in Medicare Advantage plan approved members. The overall growth of our Medicare business was a result of an increase in our agent productivity and strong consumer demand.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from our Individual, Family and Small Business segment grew $2.9 million, or 29%, during the three months ended March 31, 2021 compared to the same period in 2020, primarily attributable to a $2.8 million increase in commission revenue. Despite the uncertainties with respect to the extension of the open enrollment period through August 15, 2021 combined with greater government incentives, we continued to observe stronger member retention rates in our LTV assessments for the majority of the earlier period cohorts of certain products in our Individual, Family and Small Business segment. Based on our evaluation of the updated LTV models and retention trends, we recognized $3.3 million in net adjustment revenue, an increase $1.9 million during the three months ended March 31, 2021 compared to the same period in 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Profit</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our Medicare segment profit was $24.5 million during the three months ended March 31, 2021, an increase of $1.4 million, or 6%, compared to the same period in 2020. This was primarily due to a $24.9 million increase in revenue, partially offset by a $23.5 million increase in operating expenses, excluding stock-based compensation expense, depreciation and amortization expenses, and amortization of intangible assets. The increase in operating expenses was mostly attributable to increases in marketing costs and customer care and enrollment costs as we continued to invest in telesales capacity, internal agent counts, agent productivity tools and incentives, customer engagement and retention initiatives, and enhancements to our technology platform.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Individual, Family and Small Business segment profit was $8.1 million during the three months ended March 31, 2021, an increase of $5.1 million, or 175% compared to the same period in 2020. The increase was primarily driven by a $2.9 million increase in revenue and a $2.2 million decrease in operating expenses, excluding stock-based compensation expense, depreciation and amortization expenses, and amortization of intangible assets.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents, and short-term marketable securities are summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents, and short-term marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,379&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our current cash and cash equivalents, credit facility and expected cash collections will be sufficient to fund our operations for at least twelve&#160;months after the filing date of this Quarterly Report on Form 10-Q. Our future capital requirements will depend on many factors, including our expected membership, retention rates and our level of investment in technology, marketing and advertising and our customer care initiatives. In addition, our cash position could be impacted by further acquisitions and investments we make to pursue our growth strategy. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we recognize constrained LTV as revenue at the time applications are approved, our collection of the cash commissions resulting from approved applications generally occurs over a number of years. The expense associated with approved applications, however, is generally incurred at the time of enrollment. As a result, the net cash flow resulting from approved applications is generally negative in the period of revenue recognition and generally becomes positive over the lifetime of the member. In periods of membership growth, cash receipts associated with new and continuing members may be less than the cash outlays to acquire new members. We expect a reduction in cash and cash equivalents in the future resulting from our continued investments to grow our business. To the extent that available funds are insufficient to fund</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our future activities or to execute our financial strategy, we may raise additional capital through bank debt, or public or private equity or debt financing to the extent such funding sources are available.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, our cash and cash equivalents totaled $92.3 million. Cash equivalents,&#160;which are comprised of financial instruments with an original maturity of 90 days or less from the date of purchase, primarily consist of money market funds. The increase in cash and cash equivalents reflects $42.8 million of net cash provided by operating activities and $10.5 million of net cash provided by investing activities, partially offset by $4.8 million of net cash used in financing activities. We also maintained $3.4 million in restricted cash as of March 31, 2021 and December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of our cash flows for the three months ended March 31, 2021 (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,809&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:58.5pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities primarily consists of net income (loss), adjusted for certain non-cash items, including, deferred income taxes, stock-based compensation expense, depreciation and amortization, amortization of intangible assets and internally developed software, other non-cash items, and the effect of changes in working capital and other activities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collection of commissions receivable depends upon the timing of our receipt of commission payments and associated commission reports from health insurance carriers. If we were to experience a delay in receiving a commission payment from a health insurance carrier within a quarter, our operating cash flows for that quarter could be adversely impacted. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our marketing and advertising expense is driven by the number of health insurance applications submitted on our ecommerce platforms. Since our marketing and advertising costs are expensed and generally paid as incurred, and since commission revenue is recognized upon approval of a member but commission payments are paid to us over time, our operating cash flows could be adversely impacted by a substantial increase in the volume of applications submitted during a quarter or positively impacted by a substantial decline in the volume of applications submitted during a quarter. During the Medicare annual enrollment period which takes place during the last quarter of each year and the reintroduced Medicare Advantage open enrollment period in the first quarter of the year, we experience an increase in the number of submitted Medicare-related health insurance applications and marketing and advertising expenses compared to outside of these enrollment periods. Similarly, during the open enrollment period for individual and family health insurance plans which typically takes place during the fourth quarter of each year, with the exception of a special enrollment period that runs through May 15, 2021 due to the pandemic, we experience an increase in the number of submitted individual and family plan health insurance applications and marketing and advertising expenses compared to outside of open enrollment periods. The timing of enrollment periods for individual and family health insurance plans, the Medicare annual enrollment period and the open enrollment period for Medicare-related health insurance can positively or negatively affect our cash flows during each quarter. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash provided by operating activities was $42.8 million during the three months ended March 31, 2021, primarily driven by changes in net operating assets and liabilities of $28.2 million and a net loss of $0.8 million, partially offset by adjustments for non-cash items of $15.4 million. Adjustments for non-cash items primarily consisted of $11.4 million of stock-based compensation expense, $3.0 million of amortization of intangible assets and internally-developed software, and $1.1 million of depreciation and amortization. Cash used from changes in net operating assets and liabilities during the three months ended March 31, 2021 primarily consisted of decreases of $50.6 million in contract assets &#8211; commissions receivable and $4.2 million in prepaid expenses and other current asset, increases of $4.1 million in accrued compensation and benefits and $1.3 million in accrued expenses and other liabilities, partially offset by decreases of $25.8 million in accounts payable and $6.7 million in accrued marketing expense. Cash collection during the three months ended March 31, 2021 increased primarily driven by enrollment growth and increases in commission rates for new enrollments, as compared to the three months ended March 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March 31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash provided by operating activities was $8.9 million during the three months ended March 31, 2020, primarily driven by net income of $3.5 million and adjustments for non-cash items of $9.7 million, partially offset by changes in net operating assets and liabilities of $4.2 million. Adjustments for non-cash items primarily consisted of $8.7 million of stock-based compensation expense, $2.0 million of amortization of intangible assets and internally developed software, $0.8 million of depreciation and amortization, partially offset by a $2.1 million decrease due to the change in deferred income taxes. Cash used from changes in net operating assets and liabilities during the three months ended March 31, 2020 primarily consisted of decreases of $16.3 million in accounts payable, $11.1 million in accrued compensation and benefits, and $7.3 million in accrued marketing expenses, partially offset by decreases of $26.9 million in contract assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> commissions receivable and $1.7 million in accounts receivable and an increase of $2.0 million in accrued expenses and other liabilities.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investing activities primarily consist of purchases, maturities, and redemptions of marketable securities as well as purchases of computer hardware and software to enhance our website and customer care operations, leasehold improvements related to facilities expansion, capitalized internal-use software and website development costs and security deposit payments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash provided by investing activities of $10.5 million for the three months ended March 31, 2021 mainly consisted $23.4 million proceeds from the maturities and redemptions of marketable securities, partially offset by $7.8 million used to purchase marketable securities, $3.2 million in capitalized internal-use software and website development costs and $1.9 million used to purchase property and equipment and other assets.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March 31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash used in investing activities of $64.1 million for the three months ended March 31, 2020 was due to $58.1 million in purchases of marketable securities, $3.6 million in capitalized internal-use software and website development costs and $2.5 million used to purchase property and equipment and other assets.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash used in financing activities of $4.8 million for the three months ended March 31, 2021 was primarily due to repurchase of shares to satisfy employee tax withholding obligation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March 31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash provided by financing activities of $215.9 million for the three months ended March 31, 2020 was primarily due to $228.0 million net proceeds from the issuance of common stock in a public equity offering and $1.1 million of net proceeds from the exercise of common stock options, partially offset by $8.8 million of acquisition-related contingent payments and $4.4 million repurchase of shares to satisfying employee tax withholding obligations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Preferred Stock </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 30, 2021, upon the terms and subject to the conditions set forth in our investment agreement with H.I.G., we issued and sold 2,250,000 shares of our newly designated Series A convertible preferred stock at an aggregate purchase price of $225.0 million, at a price of $100 (the &#8220;Stated Value&#8221; per share of Series A preferred stock) per share. We received $216.2&#160;million in proceeds from the private placement with H.I.G., net of sales commissions and certain transaction fees.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dividends on our outstanding shares of Series A preferred stock accrue daily at 8% per annum on the Stated Value per share and compound semiannually, payable in kind until April 30, 2023, which is the second anniversary of the closing date of the Private Placement, on June 30 and December 31 of each year, beginning on June 30, 2021, and will thereafter become 6% payable in kind and 2% payable in cash in arrears on June 30 and December 31 of each year, beginning on June 30, 2023 (each, a &#8220;Cash Dividend Payment Date&#8221;). Dividends payable in kind will be cumulative. The Series A preferred stock also participates, on an as-converted basis (without regard to conversion limitations) in all dividends paid to the holders of our common stock. If we fail to declare and pay full cash dividend payments as required by the certificate of designations for the Series A preferred stock for two consecutive Cash Dividend Payment Dates, the cash dividend rate then in effect shall increase one time by 2%, retroactive to the first day of the semiannual period immediately preceding the first Cash Dividend Payment Date at which we failed to pay such accrued cash dividends, until such failure to pay full cash dividends is cured (at which time the dividend rate shall return to the rate prior to such increase). The dividend rights of the Series A preferred stock are senior to all of our other equity securities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on April 30, 2027, which is the sixth anniversary of the closing date of the Private Placement, each holder of Series A preferred stock will have the right to require us to redeem all or any portion of the Series A preferred stock for cash at a price calculated as set forth in the certificate of designations. In addition, upon certain change of control events, holders of Series A preferred stock can require us, subject to certain exceptions, to repurchase any or all of their Series A preferred stock.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a credit agreement with Royal Bank of Canada, or RBC, as administrative agent and collateral agent, (the &#8220;Credit Agreement&#8221;) in September 2018. The Credit Agreement provides for a $40.0 million secured asset-backed revolving credit facility with a $5 million letter of credit sub-facility. On December 20, 2019, we amended our revolving credit facility agreement with RBC (the &#8220;Amendment&#8221;) and increased the maximum borrowing amount to $75.0 million and extended the expiration to December 20, 2022. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowing base under the Credit Agreement is comprised of an amount equal to (a) the lesser of (i) eighty percent (80%) of Eligible Commissions Receivables (as defined in the Credit Agreement) we actually collected during the immediately preceding period of three months or (ii) eighty percent (80%) of our Eligible Commission Receivables for the immediately succeeding period of three months, plus (b) fifty percent (50%) of our Eligible Commission Receivables for the immediately succeeding period of six months (excluding the immediately succeeding period of three months), in each case subject to reserves established by RBC, or the Borrowing Base. The proceeds of the loans under the Credit Agreement may be used for working capital and general corporate purposes. We have the right to prepay the loans under the Credit Agreement in whole or in part at any time without penalty. Subject to availability under the Borrowing Base, amounts repaid may be reborrowed. Amounts not borrowed under the Credit Agreement are subject to a commitment fee of&#160;0.5%&#160;per annum on the daily unused portion of the credit facility, to be paid in arrears on the first business day of each calendar quarter. At closing of the Credit Agreement, we paid a one-time facility fee of&#160;1.75%&#160;of the total commitments of $40 million. We also paid a one-time closing fee of 0.5% of the new commitment of $75.0 million in connection with the Amendment. We are also obligated to pay other customary administration fees for a credit facility of this size and type.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, we had no outstanding principal amount under our revolving credit facility. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Notes to Condensed Consolidated Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included in this Quarterly Report on Form 10-Q for additional information regarding this credit agreement and subsequent amendment.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Issuance</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to an effective registration statement that was filed on December 17, 2018, and amended on January 22, 2019 and March 2, 2020, we entered into an underwriting agreement in March 2020 to issue a total of 2,070,000 shares of common stock, which included the exercise in full of the underwriters&#8217; option to purchase 270,000 additional shares of common stock, at a price to the public of&#160;$115.00&#160;per share. Net proceeds from the offering were approximately&#160;$228.0 million&#160;after deducting underwriting discounts, commissions and expenses of the offering. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material contractual obligation generally include operating lease liabilities and non-cancellable contractual service and licensing obligations. See Note 9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information about our operating lease obligations. See Note 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the information about our non-cancellable contractual service and licensing obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, we did not have any off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K, that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues, or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_100"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-indent:40.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Business and Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Quarterly Report on Form 10-Q for recently issued accounting standards that could have an effect on us.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. &#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit and Interest Rate Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments that are exposed to concentrations of credit risk principally consist of cash and cash equivalents, marketable securities, accounts receivable, and contract assets &#8211; commission receivable. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents, short-term marketable securities, and restricted cash are summarized as follows (in thousands):&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) (2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term marketable securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash, cash equivalents, short-term marketable securities, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,526&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,733&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">We deposit our cash and cash equivalents in accounts with major banks and financial institutions and such deposits are in excess of federally insured limits. We also have deposits with major banks in China that are denominated in both U.S. dollars and Chinese Yuan Renminbi and are not insured by the U.S. federal government.&#160;</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:11.94pt">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Notes to Condensed Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> for more information on our cash and cash equivalents and marketable securities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio of available-for-sale debt securities is exposed to credit and interest rate risk. As of March 31, 2021, we invested $33.9 million in marketable securities primarily consisting of commercial paper and agency bonds with credit rating of AA or equivalent by S&amp;P Rating and Moody's Investor Services. The maturity of these securities were less than one year. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fair Value Measurements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Notes to Condensed Consolidated Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further discussion on our available-for-sale debt securities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, our net contract assets consisted of commissions receivable balance of $741.8 million. Our contracts with carriers expose us to credit risk that a financial loss could be incurred if the counterparty does not fulfill its financial obligation. While we are exposed to credit losses due to the non-performance of our counterparties, we consider the risk of this remote. We estimate our maximum credit risk in determining the commissions receivable amount recorded on the balance sheet. We had a $1.9 million allowance for credit losses for our commissions receivable balance as of March 31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total contract assets and accounts receivable as of March 31, 2021&#160;and December 31, 2020 are summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets &#8211; commissions receivable &#8211; current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets &#8211; commissions receivable &#8211; non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">561,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">573,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total contract assets and accounts receivable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">743,694&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">794,204&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, substantially all of our revenue has been derived from transactions denominated in United States Dollars. We have exposure to adverse changes in exchange rates associated with operating expenses of our foreign operations, which are </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">denominated in Chinese Yuan Renminbi. Foreign currency fluctuations have not had a material impact historically on our results of operations; however, they may in the future. We have not engaged in any foreign currency hedging or other derivative transactions to date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div style="text-indent:40.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Our Disclosure Controls and Procedures</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Quarterly Report on Form 10-Q.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on management&#8217;s evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were no changes in our internal control over financial reporting that occurred during the three months ended March 31, 2021&#160;that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our chief executive officer and chief financial officer, believes that our disclosure controls and our internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_109"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">PART II.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we have received and may continue to receive inquiries from state and federal regulators relating to various matters. We have become, and may in the future become, involved in litigation in the ordinary course of our business. If we are found to have violated laws or regulations in any jurisdiction, we could be subject to various fines and penalties, including revocation of our license to sell insurance in those states, and our business, operating results and financial condition would be harmed. Revocation of any of our licenses or penalties in one jurisdiction could cause our license to be revoked or for us to face penalties in other jurisdictions. In addition, without a health insurance license in a jurisdiction, carriers would not pay us commissions for the products we sold in that jurisdiction, and we would not be able to sell new health insurance products in that jurisdiction. We could also be harmed to the extent that related publicity damages our reputation as a trusted source of objective information relating to health insurance and its affordability. It could also be costly to defend ourselves regardless of the outcome. Our material legal proceedings are described in Part I, Item I of this Quarterly Report on Form 10-Q in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_1312"></div><div><span><br/></span></div><div id="i534e5b0d995440019776d9538b893f71_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In addition to other information in this Quarterly Report on Form 10-Q and in other filings we make with the Securities and Exchange Commission, the following risk factors should be carefully considered in evaluating our business as they may have a significant impact on our business, operating results and financial condition. If any of the following risks actually occurs, our business, financial condition, results of operations and future prospects could be materially and adversely affected. Because of the following factors, as well as other variables affecting our operating results, past financial performance should not be considered as a reliable indicator of future performance and investors should not use historical trends to anticipate results or trends in future periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our ability to enroll individuals during enrollment periods is impeded or if investments we make in enrollment periods do not result in the returns we expected when making those investments, our business, operating results and financial condition would be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an attempt to attract and enroll a large number of individuals during the Medicare annual enrollment period and to a lesser extent, the Medicare Advantage open enrollment period and the health care reform open enrollment period under the Affordable Care Act, we may invest in areas of our business, including technology and content, customer care and enrollment, and marketing and advertising. We have in the past made investments in areas of our business in advance of enrollment periods that have not yielded the results we expected when making those investments. Any investment we make in any enrollment period may not result in a significant number of approved and paying members or may not be as cost-effective as we anticipated. If it does not, or is not, our business, operating results and financial condition would be harmed. If our ability to market and sell Medicare-related health insurance and individual and family health insurance is constrained during an enrollment period for any reason, such as technology failures, interruptions in the operation of our e-commerce or telephony platforms, reduced allocation of resources, any inability to timely employ, license, train, certify and retain our employees and our outsourced call centers and their health insurance agents to sell health insurance, we could acquire fewer members, suffer a reduction in our membership, and our business, operating results and financial condition could be harmed. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unsuccessful in competing effectively against current and future competitors, including government-run health insurance exchanges.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The market for selling health insurance plans is highly competitive. We compete with government-run health insurance exchanges, among others, with respect to our sale of Medicare-related and individual and family health insurance. The federal government operates a website where Medicare beneficiaries can purchase Medicare Advantage and Medicare Part D prescription drug plans or be referred to carriers to purchase Medicare Supplement plans. We also compete with the original Medicare program. The Affordable Care Act exchanges have websites where individuals and small businesses can purchase </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">health insurance, and they also have offline customer support and enrollment capabilities. Our competitors also include local insurance agents across the United States who sell health insurance plans in their communities, companies that advertise primarily through television, and companies that operate websites that provide quote information or the opportunity to purchase health insurance online, including lead aggregator services. Many health insurance carriers also directly market and sell their plans to consumers through call centers, Internet advertising and their own websites. Although we offer health insurance plans for many of these carriers, they also compete with us by offering their plans directly to consumers.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To remain competitive against our current and future competitors, we will need to market our services effectively and continue to improve the online shopping experience and functionalities of our website and other platforms that our current and future customers may access to purchase health insurance products from us.&#160;If we cannot predict, develop and deliver the right shopping experience and functionality in a timely and cost-effective manner, or if we are not effective in cost-effectively driving a substantial number of consumers interested in purchasing health insurance to our website and customer care centers, we may not be able to compete successfully against our current or future competitors and our business, operating results and financial condition may be adversely affected.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our current and potential competitors have longer operating histories, larger customer bases, greater brand recognition and significantly greater financial, technical, marketing and other resources than we do. As compared to us, our current and future competitors may be able to undertake more extensive marketing campaigns for their brands and services, devote more resources to website and systems development, negotiate more favorable commission rates and commission override payments, and make more attractive offers to potential employees, marketing partners and third-party service providers.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitive pressures from government-run health insurance exchanges and other competitors may result in our experiencing increased marketing costs, decreased demand and loss of market share, increased health insurance plan termination, reduction in our membership or revenue and may otherwise harm our business, operating results and financial condition.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business may be harmed if we lose our relationship with health insurance carriers or our relationship with health insurance carriers is modified.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically enter into contractual relationships with health insurance carriers that are non-exclusive and terminable on short notice by either party for any reason.&#160;In many cases, health insurance carriers also may amend the terms of our agreements unilaterally, including commission rates, on short notice. Carriers may be unwilling to allow us to sell their existing or new health insurance plans, or desire to amend our agreements with them for a variety of reasons, including for competitive or regulatory reasons, dissatisfaction with the economics of the members that we place with them or because they do not want to be associated with our brand. The termination of our relationship with a health insurance carrier, the reduction of commission rates, or the amendment of or change in our relationship with a carrier could reduce the variety, quality and affordability of health insurance plans we offer, cause a loss of commission payments, including commissions for past and/or future sales, cause a reduction in the estimated constrained LTVs, we use for revenue recognition purposes, result in a loss of existing and potential members, adversely impact our profitability or have other adverse impacts, which could harm our business, operating results and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Health insurance carriers can unilaterally amend the commission rates that they pay to us. For example, given the significant losses that carriers sustained in connection with their sale of individual and family health insurance as a result of health care reform, many health insurance carriers with which we have a relationship, including large national health insurance carriers, reduced or eliminated our commissions for selling individual and family health insurance, and in a limited number of cases, our renewal commissions. As a result, we experienced a meaningful reduction in our average commission rates for our aggregate individual and family health insurance plan membership. In addition, the reduction in contractual commission rates and these carriers&#8217; desire to not sell individual and family health insurance reduced the number of plans that we are able to offer on our websites, which resulted in less consumer demand for the individual and family health insurance that we sell and a reduction in our membership. In the future, health insurance carriers may decide to reduce our commissions, rely on their own internal distribution channels to sell their own plans, determine not to sell their plans or otherwise limit or prohibit us from selling their plans. In addition to reducing commission rates, health insurance carriers may determine to exit certain states or increase premiums to a significant degree, which could cause our members&#8217; health insurance to be terminated or our members to purchase new health insurance or determine not to pay for health insurance at all. If we lose these members, our business, operating results and financial condition could be harmed.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare plan-related revenue is concentrated in a small number of health insurance carriers. The success of our Medicare-related health insurance business depends upon our ability to enter into new and maintain existing relationships with health insurance carriers on favorable economic terms. We expect that a small number of health insurance carriers will account for a significant portion of our revenue for the foreseeable future and any impairment of our relationship with, or the material financial impairment of, these health insurance carriers could adversely affect our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We may also temporarily or permanently lose the ability to market and sell Medicare plans for one or more of our Medicare plan carriers.&#160;The regulations applicable to the business of selling Medicare-related health insurance are complex and frequently change. If we or our health insurance agents violate any of the requirements imposed by CMS, state laws or regulations, a health insurance carrier may terminate our relationship or CMS may penalize a health insurance carrier by suspending or terminating the carrier's ability to market and sell Medicare plans. Given the concentration of our Medicare plan sales in a small number of carriers, if we lose a relationship with a health insurance carrier to market their Medicare plans, even temporarily, or if the health insurance carrier loses its Medicare product membership, our business, operating results and financial condition would be harmed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial results will be adversely impacted if our membership does not grow or if we are not able to successfully retain our existing members and limit health insurance plan termination.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We receive commissions from health insurance carriers for health insurance plans sold through us. When one of these plans is canceled, or if we otherwise do not remain the agent on the plan, we no longer receive the related commission payment. Our members and/or health insurance carriers may choose to discontinue their health insurance plans for a variety of reasons. Consumers may also purchase individual and family and Medicare-related health insurance plans directly from other sources, such as our competitors, and we would not remain the agent on the policy and receive the related commission. Medicare Advantage plan and Medicare Part D prescription drug plan enrollees may select another plan during the Medicare annual enrollment period that occurs in the fourth quarter every year. Medicare Advantage plan enrollees may also select another plan during the Medicare Advantage open enrollment period that occurs in the first quarter of the year. In addition, certain individuals are permitted to enroll, disenroll or change their Medicare Advantage or Medicare Part D prescription drug plans during special enrollment periods. We experienced an increased attrition rate in our Medicare Advantage and Medicare prescription drug plan membership in 2020 above historical levels prior to that time. While we have implemented measures to improve the attrition rate, if our Medicare Advantage and other health insurance plan termination rates do not decline in subsequent quarters, our business, operating results and financial condition would be harmed. In addition, enrollment periods could cause us to further experience increased termination rates in the future, which could adversely impact our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any decrease in the amount of time we retain our members on the health insurance plans that they purchased through us could adversely impact the estimated constrained LTVs we use for purposes of recognizing revenue, which would harm our business, operating results and financial condition. For example, our Medicare Advantage plan and Medicare Part D prescription drug plan LTVs have been negatively impacted by increased plan termination rates. While we have recently placed a stronger operational focus on member retention, there are no assurances that investments we make to pursue retention initiatives will result in a decline in health insurance plan termination rate and/or improvement in our constrained LTVs in the future.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we are not able to successfully retain our existing members and limit health insurance plan termination, our business, operating results and financial condition would be harmed. If we experience higher health insurance plan termination rates than we estimated when we recognized commission revenue, we may not collect all of the related commissions receivable, which could result in a reduction in LTV and a write-off of contract assets - commissions receivable, which would harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the growth of our membership is highly dependent upon our success in attracting new members during the Medicare annual enrollment period and to a lesser extent, the Medicare Advantage open enrollment period and the health care reform open enrollment period. The Medicare-related commission rates that we receive may be higher in the first calendar year of a plan if the plan is the first Medicare-related plan issued to the member. Similarly, the individual and family plan commission rates that we receive are typically higher in the first twelve months of a policy. After the first twelve months, the commission rates generally decline significantly. As a result, if we do not add a sufficient number of members to new plans, our business, operating results and financial condition would be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we are not able to maintain and enhance our brand, our business and operating results will be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that maintaining and enhancing our brand identity is critical to our relationships with existing members, marketing partners and health insurance carriers and to our ability to attract new members, marketing partners and health insurance carriers. The promotion of our brand in these and other ways may require us to make substantial investments and we anticipate that, as our market becomes increasingly competitive, these branding initiatives may become increasingly difficult and expensive. Our brand promotion activities may not be successful or yield increased revenue, and to the extent that these activities yield increased revenue, the increased revenue may not offset the expenses we incur and our operating results could be harmed.&#160;If we do not successfully maintain and enhance our brand, our business may not grow and we could lose our relationships with health insurance carriers, marketing partners and/or members, which would harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The ongoing COVID-19 pandemic and public health crises, illness, epidemics or pandemics could adversely impact our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">COVID-19 and public health crises, illness, epidemics or pandemics, in general, and any associated disruption to our call center and service operations, in particular, could materially impact our business, operations and financial condition. In an effort to mitigate the spread of COVID-19, and to comply with applicable government directives, we generally have directed employees to work from home and implemented new business protocols for employees who have resumed work in our offices. A potential COVID-19 infection of any of our employees could adversely impact our operations, including resulting in the sudden closure of any of our offices. Our business operations may be disrupted if key personnel or significant portions of our employees are unable to work effectively, especially if such disruption occurs during or in our preparation for the Medicare annual enrollment period. We have had to adjust our business operations, including onboarding and training new health insurance agents remotely and asking employees to work from home, which could cause operational difficulties, reduce the effectiveness of our agents in selling health insurance and impair our ability to manage our business. An increased number of employees in a remote work environment may exacerbate certain risks to our business, including an increased demand for information technology resources, increased risk of phishing and other cybersecurity attacks, and increased risk of unauthorized dissemination of sensitive personal information or proprietary or confidential information about us or our customers or other third-parties. Our business operations and recruitment efforts could be impacted if government offices, including CMS and state departments of insurance, are adversely impacted by COVID-19 given that some of our marketing materials require CMS approval and health insurance agent licensing and licensing renewals are dependent on state department of insurance processing. Our product development initiatives could also be negatively impacted by extended office closures. Furthermore, if any of our health insurance carriers, business partners or vendors increase the prices of or become unable to continue to provide their products or services as a result of COVID-19, or if health insurance carriers reduce our commission rates or the amount they pay us, our business, operating results and financial condition would be harmed. The impact of COVID-19 to our Individual, Family and Small Business segment is especially uncertain because of increases in unemployment rate, potential delays in customer premium payments and/or health insurance carrier commission payments, potential changes to the open enrollment period, and potential changes to qualified health plans subsidies, among others. COVID-19 presents uncertainties and risks with respect to the demand for and pricing of health insurance plans, which could negatively impact our business, operating results and financial condition. The extent to which the COVID-19 pandemic impacts our business will depend on future developments, which are highly uncertain and cannot be predicted.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Changes in our management and key employees could affect our business and financial results.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success is dependent upon our ability to attract and retain qualified personnel for all areas of our organization. We may not be successful in attracting and retaining personnel on a timely basis, on competitive terms or at all. If we are unable to attract and retain the necessary personnel, our business would be harmed. Our executive officers and employees can terminate their employment at any time.&#160;The transition and the departure of members of our senior management could result in attrition in our senior management and key personnel and any significant change in leadership over a short period of time could harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The loss of the services of any of our executive officers or key employees could harm our business. For example, we are required to appoint a single designated writing agent with each insurance carrier. A small number of our employees act as writing agent and each employee that acts as writing agent does so for a number of carriers. When an employee that acts as writing agent terminates their employment with us, we need to replace such writing agent with another employee who has health insurance licenses. Due to our national reach and the large number of carriers whose plans are purchased by our members, the process of changing writing agents has in the past taken and could take a significant period of time to complete. If </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the transition is not successful, our ability to sell health insurance plans may be interrupted, our agency relationship with particular insurance carriers may be terminated, our commission payments could be discontinued or delayed and, as a result, our business, operating results and financial condition would be harmed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business may be harmed if we are not successful in executing on our strategic investments and initiatives, including our growth strategy and retention initiatives.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategy, we have determined to invest in initiatives to accelerate growth in our Medicare product sales, to enhance post-enrollment consumer engagement and increase customer retention, to increase online enrollment and enhance operating leverage, to expand our strategic partner relationships, improve our technology platform to optimize the consumer experience and relationship, and to utilize data analytics to increase the productivity of our customer care employees. Pursuing and investing in these and other initiatives we develop will require significant investments in marketing and advertising, technology and product offerings, and customer care and enrollment, among others, and involves risks and uncertainties described elsewhere in this Risk Factors section, including the initiatives not achieving our retention, growth or profitability targets, inadequate return of capital on our investments, legal and regulatory compliance risks, potential changes in laws and regulations and other issues that could cause us to fail to realize the anticipated benefits of our investments and incur unanticipated liabilities. Our pursuit of these strategic initiatives may not be successful. Our cash flow from operations is expected to be negative in the year ending December 31, 2021 and was negative in each of the years ended December 31, 2020, 2019 and 2018. If we are not successful in executing on our business strategy, our business, operating results and financial condition would be harmed. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Seasonality may cause fluctuations in our financial results.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Open enrollment periods drive the seasonality of our business. The Medicare annual enrollment period occurs from October 15 to December 7 each year and the individual and family health insurance open enrollment period typically runs from November 1 through December 15 each year. In addition, the Medicare Advantage open enrollment period, where Medicare-eligible individuals who enrolled in a Medicare Advantage plan can switch to the original Medicare program or switch to a different Medicare Advantage plan, runs from January 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> through March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of each year. We experience an increase in the number of submitted Medicare-related applications and approved members during the fourth quarter and, to a lesser extent, in the first quarter, and an increase in Medicare plan related expense during the third and fourth quarters in connection with the open enrollment periods. In addition, we typically experience the highest plan termination rates from our Medicare Advantage plan members in the first year following the effective date of plan enrollment. If we experience significant growth in Medicare Advantage approved members resulting in an increased number of first year members as a percentage of our total estimated membership, we may also experience increased health insurance plan terminations in the year following such periods of growth.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The seasonality of our business could change in the future due to other factors, including as a result of changes in timing of the Medicare or individual and family health plan enrollment periods, adoption of new enrollment periods such as the COVID-related special enrollment period that was adopted in the second quarter of 2020 for Medicare Advantage and Medicare Part D prescription drug plans, and changes in the laws and regulations that govern the sale of health insurance. We may not be able to timely adjust to changes in customer demand and the seasonality of our business. If we are not successful in responding to changes in the seasonality of our business, our business, operating results and financial condition could be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The success of our customer care center operations depends upon our ability to timely hire, train, retain and ensure the productivity of our licensed health insurance agents.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to our websites, we rely upon our customer care centers and, during the Medicare annual enrollment period, outsourced call centers to sell Medicare plans. The success of our customer care center operations is largely dependent on licensed health insurance agents and other employees.&#160;In order to sell Medicare-related health insurance plans, our health insurance agent employees and employees of outsourced call centers must be licensed by the states in which they are selling plans and certified and appointed with the health insurance carrier that offers the plans in each applicable state. Because a significant number of Medicare plans are sold in the fourth quarter each year during the Medicare annual enrollment period, we contract with outsourced call centers and hire additional employees on a temporary or seasonal basis in a limited period of time to address the expected increase in the volume of health insurance transactions during this period. We depend upon our employees, state departments of insurance, government exchanges and health insurance carriers for the licensing, certification and appointment of our health insurance agents. The COVID-19 pandemic and resulting containment measures have negatively </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">impacted the capacity of health insurance license testing facilities and have caused delays in the completion of background checks and fingerprinting requirements. As a result, these health insurance agents may experience delays in obtaining health insurance licenses and certifications and health insurance carrier appointments.&#160;We and our outsourced call centers may experience difficulties hiring a sufficient number of additional licensed agents and retaining existing licensed agents for the Medicare annual enrollment period. If we and our outsourced call centers are not successful in these regards, our ability to sell Medicare-related health insurance plans will be impaired during the Medicare annual enrollment period, which would harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Even if we or our outsourced call centers are successful in hiring licensed health insurance agents, our success depends on the productivity of these health insurance agents. Health insurance agents may not perform to the standard we expect of them, which could result in lower than expected conversion rates and revenue, higher costs of acquisition per member and higher plan termination rates. We have observed that our health insurance agent employees are more productive than the employees of our outsourced call centers and that experienced health insurance agents are more productive than less-tenured health insurance agents. As a result, the success of our business depends upon our ability to retain existing health insurance agents and hiring and training a sufficient number of internal health insurance agent employees who can perform to the standard we expect of them.  Failure to retain, train and ensure the productivity of our health insurance agent employees and employees of outsourced call centers would harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the 2020 annual enrollment period, we experienced reduced conversion rates from health insurance agents that work at an outsourced call center, which impacted our revenue and cost of acquisition during the fourth quarter of 2020. As a result, we have determined to increase the number of our health insurance agent employees to a much more significant degree than we have in the past.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our ability to do so successfully will depend on the success of our recruiting efforts and our ability to train, license and appoint with carriers the newly employed agents so that they are effective in selling plans in time for the Medicare annual enrollment period occurring in 2021. If we are not successful in these efforts, we may need to rely more than we have planned on outsourced health insurance agents or rely on a fewer number of employed agents, which could harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not successful in cost-effectively converting visitors to our website</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and customers who call into our call centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">into members for whom we receive commissions, our business and operating results would be harmed.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth depends in large part upon growth in approved members in a given period. The rate at which consumers visiting our ecommerce platforms and customer care centers seeking to purchase health insurance are converted into approved members directly impacts our revenue. In addition, the rate at which consumers who are approved become paying members impacts the constrained LTV of our approved members, which impacts the revenue that we are able to recognize. A number of factors have influenced, and could in the future influence, these conversion rates for any given period, some of which are outside of our control. These factors include, but are not limited to:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in consumer shopping behavior due to circumstances outside of our control, such as economic conditions, the COVID-19 pandemic, consumers&#8217; ability or willingness to pay for health insurance, adverse weather conditions or natural disasters, availability of unemployment benefits or proposed or enacted legislative or regulatory changes impacting our business, including health care reform; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the quality of and changes to the consumer experience on our ecommerce platforms or with our customer care centers; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory requirements, including those that make the experience on our ecommerce platforms cumbersome or difficult to navigate or reduce the ability of consumers to purchase plans outside of enrollment periods; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the variety, competitiveness and affordability of the health insurance plans that we offer; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">system failures or interruptions in the operation of our ecommerce platform or call center operations; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the mix of consumers who are referred to us through our direct, marketing partner and online advertising member acquisition channels;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">health insurance carriers offering the health insurance plans for which consumers have expressed interest, and the degree to which our technology is integrated with those carriers; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">health insurance carrier guidelines applicable to applications submitted by consumers, the amount of time a carrier takes to make a decision on that application and the percentage of submitted applications approved by health insurance carriers; </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effectiveness of health insurance agents in assisting consumers, including the tenure of the health insurance agent and whether the health insurance agent is an employee or works with an outsourced call center with which we have a relationship; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enroll subsidy-eligible individuals in qualified health plans through government-run health insurance exchanges and the efficacy of the process we are required to use to do so.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our conversion rates can be impacted by changes in the mix of consumers referred to us through our member acquisition channels</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and whether they interact with a more seasoned health insurance agent or a health insurance agent that works with an outsourced call center. We may make changes to our ecommerce platforms in response to regulatory requirements or undertake other initiatives in an attempt to improve consumer experience or for other reasons. These changes have in the past, and may in the future have the unintended consequence of adversely impacting our conversion rates. A decline in the percentage of consumers who submit health insurance applications on our ecommerce platforms or telephonically via our customer care centers and are converted into approved and paying members could cause an increase in our cost of acquiring members on a per member basis and impact our revenue in any given period. To the extent the rate at which we convert consumers visiting our ecommerce platforms or telephonically via our customer care centers into members suffers, our membership may decline, which would harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend upon Internet search engines and social media platforms to attract a significant portion of the consumers who visit our website, and if we are unable to effectively advertise on search engines or social media platforms on a cost-effective basis, our business and operating results would be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a significant portion of our website traffic from consumers who search for health insurance through Internet search engines, such as Google, Bing and Yahoo!, and through social media platforms, such as Facebook. A critical factor in attracting consumers to our website is whether we are prominently displayed in response to an Internet search relating to health insurance or on a social media platform. Search engines typically provide two types of search results, algorithmic listings and paid advertisements. We rely on both to attract consumers to our websites and otherwise generate demand for our services.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Algorithmic search result listings are determined and displayed in accordance with a set of formulas or algorithms developed by the particular Internet search engine. The algorithms determine the order of the listing of results in response to the consumer&#8217;s Internet search. From time to time, search engines revise these algorithms. In some instances, these modifications have caused our website to be listed less prominently in algorithmic search results, which has resulted in decreased traffic to our website. We may also be listed less prominently as a result of other factors, such as new websites, changes we make to our website or technical issues with the search engine itself. For example, government health insurance exchange websites appear prominently in algorithmic search results. In addition, search engines have deemed the practices of some companies to be inconsistent with search engine guidelines and decided not to list their website in search result listings at all. If we are listed less prominently in, or removed altogether from, search result listings for any reason, the traffic to our websites would decline and we may not be able to replace this traffic, which would harm our business, operating results and financial condition. If we decide to attempt to replace this traffic, we may be required to increase our marketing expenditures, which would also increase our cost of member acquisition and harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We purchase paid advertisements on search engines and social media platforms in order to attract consumers to our platforms. We typically pay a search engine for prominent placement of our website when particular health insurance-related terms are searched for on the search engine, regardless of the algorithmic search result listings. The prominence of the placement of our advertisement is determined by a combination of factors, including the amount we are willing to pay and algorithms designed to determine the relevance of our paid advertisement to a particular search term. As with algorithmic search result listings, search engines may revise the algorithms relevant to paid advertisements, and websites other than our ecommerce platform may become more optimized for the algorithms. These changes may result in our having to pay increased amounts to maintain our paid advertisement placement in response to a particular search term. We could also have to pay increased amounts should the market share of major search engines continue to become more concentrated with a single search engine. Additionally, we bid against our competitors, insurance carriers, government health insurance exchanges and others for the display of these paid search engine or social media platform advertisements. We have experienced increased competition for both algorithmic search result listings and for paid advertisements, which competition increases substantially during the enrollment periods for Medicare related health insurance and for individual and family health insurance. The competition has increased the cost of paid internet search advertising and has increased our marketing and advertising expenses. If paid search advertising costs increase or become cost prohibitive, whether as a results of competition, algorithm changes or otherwise our </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">advertising expenses could rise significantly or we could reduce or discontinue our paid search advertisements, either of which would harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely significantly on marketing partners and our business and operating results would be harmed if we are unable to maintain effective relationships with our existing marketing partners or if we do not establish successful relationships with new marketing partners.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We frequently enter into contractual marketing relationships with partners that drive consumers to our ecommerce platform and call centers. These marketing partners include financial and online services companies, affiliate organizations, online advertisers and content providers, and other marketing vendors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also have relationships with strategic marketing partners, including hospitals and pharmacy chains that promote our Medicare platforms to their customers as well as pharmacy service providers and other affinity groups. We compensate many of our marketing partners for their referrals on a submitted health insurance application basis and, if they are licensed to sell health insurance, may share a percentage of the commission we earn from the health insurance carrier for each member referred by the marketing partner. The success of our relationship is dependent on a number of factors, including but not limited to the continued positive market presence, reputation and growth of the marketing partner, the effectiveness of the marketing partner in marketing our website and services, the compliance of each marketing partner with applicable laws, regulations and guidelines, and the contractual terms we negotiate with our marketing partners, including the marketing fees we agree to pay.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have relationships with a large number of marketing partners, we depend upon referrals from a limited number of marketing partners for a significant portion of the submitted applications we receive from our marketing partner customer acquisition channel. Given our reliance on our marketing partners, our business operating results and financial condition would be harmed if we are unable to maintain successful relationships with these companies, if we fail to establish successful relationships with new marketing partners, if we experience competition in our receipt of referrals from high volume marketing partners, and if we are required to pay increased amounts to our marketing partners.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition for referrals from our marketing partners has increased particularly during the enrollment periods for Medicare-related health insurance and individual and family health insurance. We may lose marketing partner referrals if our competitors pay marketing partners more than we do or be forced to pay increased fees to our marketing partners, which could harm our business, operating results and financial condition. If we lose marketing partner referrals during the Medicare or individual and family health insurance enrollment periods, the adverse impact on our business would be particularly pronounced. In addition, the promulgation of laws, regulations or guidelines, or the interpretation of existing laws, regulations and guidelines, by state departments of insurance or by CMS, could cause our relationships with our marketing partners to be in non-compliance with those laws, regulations and guidelines. We also have relationships with hospital systems and pharmacy chains that utilize aspects of our platform and tools.&#160;Our relationships with these hospital systems and pharmacy chains result in the referral of a significant number of individuals to us who are interested in purchasing Medicare-related health insurance plans.&#160;If CMS or state departments of insurance were to change existing laws, regulations or guidelines, or interpret existing laws, regulations or guidelines, to prohibit these arrangements, or if hospital systems or pharmacy partners otherwise decided to no longer utilize aspects of our platform and tools, we could experience a significant decline in the number of Medicare-eligible individuals who are referred to our platforms and customer care centers, which would harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future operating results are likely to fluctuate and could fall short of expectations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results are likely to fluctuate as a result of a variety of factors, including the factors described elsewhere in this Risk Factors section, many of which are outside of our control. For example and among these factors, the assumptions underlying our estimates of commission revenue as required by ASC 606&#160;may vary significantly over time. As a result, comparing our operating results on a period-to-period basis may not be meaningful and you should not rely on our past results as an indication of our future performance, particularly in light of the fact that our business and industry are undergoing substantial change as a result of health care reform, competition and initiatives we determined to pursue. If our revenue or operating results differ from our guidance or fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially. In the past, when our revenue and operating results differed from our guidance and the expectations of investors or securities analysts, the price of our common stock was impacted.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If commission reports we receive from carriers are inaccurate or not sent to us in a timely manner, our business and operating results could be harmed and we may not recognize trends in our membership.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on health insurance carriers to timely and accurately report the amount of commissions earned by us, and we calculate our commission revenue, prepare our financial reports, projections and budgets and direct our marketing and other operating efforts based on the reports we receive from health insurance carriers. There have been instances where we have determined that plan cancellation data reported to us by a health insurance carrier has not been accurate. The extent to which health insurance carriers are inaccurate in their reporting of plan cancellations could cause us to change our cancellation estimates, which could adversely impact our revenue. We have designed controls to assess the completeness and accuracy of the data received, whereby we apply judgment and make estimates based on historical data and current trends to independently determine whether or not carriers are accurately reporting commissions due to us. We also operate procedures with carriers on an ongoing basis whereby potential under or over reporting is reconciled and discrepancies are resolved. For instance, we reconcile information health insurance carriers provide to us and may determine that we were not historically paid commissions owed to us, which would cause us to have underestimated our membership. Conversely, health insurance carriers may require us to return commission payments paid in a prior period due to plan cancellations for members we previously estimated as being active. To the extent that health insurance carriers understate or fail to accurately report the amount of commissions due to us in a timely manner or at all, our estimates of constrained LTV may be adversely impacted, which would harm our business, operating results and financial condition. In addition, any inaccuracies in the reporting from and reconciliations with insurance carriers may also impact our estimates of constrained LTV or our estimates of commission revenue for future periods which is based on historical trends, including trends relating to contracted commission rates and expected health insurance plan cancellation.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not receive information about membership cancellations from our health insurance carriers directly, which makes it difficult for us to determine the impact of current conditions on our membership retention and to accurately estimate membership as of a specific date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on health insurance carriers and others for data related to our membership. For instance, with respect to health insurance plans other than small business health insurance, health insurance carriers do not directly report member cancellations to us, resulting in the need for us to determine cancellations using payment data that carriers provide. We infer cancellations from this payment data by analyzing whether payments from members have ceased for a period of time, and we may not learn of a cancellation for several months. The majority of our members who terminate their plans do so by discontinuing their insurance premium payments to the health insurance carrier and do not inform us of the cancellation. With respect to our small business membership, many groups notify the carrier directly with respect to increases or decreases in group size and policy cancellations. Our insurance carrier partners often do not communicate this information to us, and it often takes a significant amount of time for us to learn about small business group cancellations and changes in our membership within the group itself. We often are not made aware of policy cancellations until the time of the group&#8217;s annual renewal.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Given the number of months required to observe non-payment of commissions in order to confirm cancellations, we estimate the number of members who are active on health insurance plans as of a specified date. After we have estimated membership for a period, we may receive information from health insurance carriers that would have impacted the estimate if we had received the information prior to the date of estimation. We may receive commission payments or other information that indicates that a member who was not included in our estimates for a prior period was in fact an active member at that time, or that a member who was included in our estimates was in fact not an active member of ours. As a result of the Medicare annual enrollment and other open enrollment periods, we may not receive information from our carriers on as timely a basis due to the significant increase in health insurance transaction volume, which could impair the accuracy of our membership estimates. For these and other reasons, including if current trends in membership cancellation are inconsistent with past cancellation trends that we use to estimate our membership or if carriers subsequently report changes to the commission payments that they previously reported to us, our actual membership could be different from our estimates, perhaps materially. If our actual membership is different from our estimates, the constrained LTV component of our revenue recognition could also be inaccurate, including as a result of an inaccurate estimate of the average amount of time our members maintain their health insurance plans. As a result of the delay we experience in receiving information about our membership, it is difficult for us to determine with any certainty the impact of current conditions on our membership retention. For example, our estimated membership reported as of March 31, 2020 was higher than our actual membership, because we experienced increased membership cancellation compared to the historical cancellation rates we used to estimate our membership as of March 31, 2020. We were not able to observe the increased membership cancellations that occurred during the first quarter of 2020 until after we reported our estimated membership for the period. Various circumstances, including market-related factors such as </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">changes in timing of enrollment periods and other factors specific to our business, could cause the assumptions and estimates that we make in connection with estimating our membership and constrained LTV to be inaccurate, which would harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our carrier advertising and sponsorship business may not be successful.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We develop, host and maintain carrier dedicated Medicare plan websites and may undertake other marketing and advertising initiatives through our Medicare plan advertising program. We also allow health insurance carriers to purchase advertising space for non-Medicare products on our website through our sponsorship program. To the extent that economic conditions, health care reform or other factors impact the amount health insurance carriers are willing to pay for advertising, our advertising and sponsorship program will be adversely impacted. In addition, since we maintain relationships with a limited number of health insurance carriers to sell their Medicare plans, our Medicare plan-related advertising revenue is concentrated in a small number of health insurance carriers and our ability to generate Medicare plan-related advertising revenue would be harmed by the termination or non-renewal of any of these relationships as well as by a reduction in the amount a health insurance carrier is willing to pay for these services. Moreover, in light of the regulations applicable to the marketing and sale of Medicare plans, and given that these regulations are often unclear, change frequently and are subject to changing interpretations, we may in the future not be permitted to sell Medicare plan-related advertising. If we are not successful in these areas or these factors are unfavorable to us, our business, operating results and financial condition could be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The success of our sponsorship and advertising program depends on a number of factors, including the amount health insurance carriers are willing to pay for advertising, the effectiveness of the sponsorship and advertising program as a cost-effective method for carriers to obtain additional members, consumer demand for the health insurance carrier&#8217;s product, our ability to attract consumers to our ecommerce platform, our call centers or the dedicated Medicare plan websites and convert those consumers into members, and the cost, benefit and brand recognition of the health insurance plan that is the subject of the advertising, among others. If we are not successful in these areas or these factors are unfavorable to us, our business, operating results and financial condition could be harmed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our business may be harmed if we do not enroll subsidy-eligible individuals through government-run health insurance exchanges efficiently.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to offer the qualified health plans that individuals and families must purchase to receive Affordable Care Act subsidies, agents and brokers must meet certain conditions, such as receiving permission to do so from the applicable government health insurance exchange, entering into an agreement with the health insurance exchange or a partner of the exchange, ensuring that the enrollment and subsidy application is completed through the health insurance exchange and complying with privacy, security and other standards. In the event Internet-based agents and brokers such as us use the Internet for&#160;completion of qualified health plan selection purposes, their websites are required to meet certain additional requirements. To the extent we enroll individuals and families into qualified health plans, we do so through the Federally Facilitated Marketplace, or FFM, which runs all or part of the health insurance exchange in 36 states. We may experience difficulty in satisfying the conditions and requirements to offer qualified health plans to our existing members and new potential members, and in getting them enrolled through the FFM.&#160;If we are not able to satisfy these conditions and requirements, or if we are not able to successfully adopt and maintain solutions that allow us to enroll large numbers of individuals and families in qualified plans over the Internet both during and outside of open enrollment periods, we will lose existing members and new members, and may incur additional expense, which would harm our business, operating results and financial condition. Beginning in the open enrollment period that occurred in the fourth quarter of 2018, CMS adopted a new enhanced direct enrollment pathway for CMS-approved partners to enroll individuals into qualified health plans and complete all steps in the eligibility and enrollment process on a single website. Before enhanced direct enrollment partners are approved, extensive security and privacy reviews are conducted by an independent third-party auditor and CMS reviews the audit results to ensure the entity satisfies numerous additional privacy and security standards. We entered into an agreement to outsource certain aspects of the enrollment process for qualified health plans to a third party in light of the expense and burden associated with the additional requirements. However, if we do not develop the ability to satisfy the requirements to use the improved qualified health plan enrollment process in the future, or if we are unsuccessful in entering into or maintaining a relationship with a third party who is approved to use the process, we may not be able to enroll individuals into qualified health plans through the FFM or could be required to use an inferior process to do so, which could cause a reduction in our individual and family health insurance plan membership and commission revenue. In addition, if we are not able to adopt or contract with and maintain solutions to integrate with government-run health insurance exchanges or if the health insurance exchange websites and other processes are unstable or not consumer friendly, efficient and compatible with the process we have adopted for enrolling individuals and families into </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">qualified health plans through the exchanges, we would not be successful in retaining and acquiring members, and our business, operating results and financial condition would be harmed. The FFM may at any time cease allowing us to enroll individuals in qualified health plans or change the requirements for doing so. If it does so or if the FFM platform does not function properly, our ability to retain existing members and add new members could be negatively impacted, which would harm our business, operating results and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">There are many risks associated with our operations in China.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our operations is conducted by our subsidiary in China. Among other things, we use employees in China to maintain and update our ecommerce platform and perform certain tasks within our finance and customer care and enrollment functions. We rely on the Internet to communicate with our subsidiary in China. Our business would be harmed if our ability to communicate over the Internet with these employees failed, and we were prevented from promptly updating our software or implementing other changes to our database and systems, among other things. From time-to-time we receive inquiries from health insurance carriers relating to our operations in China and the security measures we have implemented to protect data that our employees in China may be able to access. As a part of these inquiries, we have implemented additional security measures relating to our operations in China.&#160;We may be required to implement further security measures to continue aspects of our operations in China or health insurance carriers may require us to bring aspects of our operations in China back to the United States, which could be time consuming and expensive and harm our operating results and financial condition.&#160;Health insurance carriers may also terminate our relationship due to concerns surrounding protection of data that our employees in China are able to access, which would harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations in China also expose us to different and unfamiliar laws, rules and regulations, including different intellectual property laws, which are not as protective of our intellectual property as the laws in the United States. United States and Chinese trade laws may also impose restrictions on the importation of programming or technology to or from the United States. We are also subject to anti-bribery and anti-corruption laws, privacy and data security laws, labor laws, tax laws, foreign exchange controls and cash repatriation restrictions in China. On June 1, 2017, a national cybersecurity law came into effect in China. The law, along with its implementation regulations, applies to the establishment, operation, maintenance and usage of networks within China and the supervision and management of cybersecurity. Under the law, network operators are required to comply with certain tiered security obligations based on the networks&#8217; relative impact on national security, social order, public interest and individuals&#8217; privacy rights. There remains considerable uncertainty as to how the cybersecurity law will be applied, and the regulatory environment continues to evolve with new draft regulations and standards published frequently. Such laws, regulations and standards are complex, ambiguous and subject to change or interpretation, which create uncertainty regarding compliance. Pursuant to the draft regulations, we may be required to perform self-assessments, obtain third party certifications, report cybersecurity incidents and make filings with public security authorities. We could also be subject to security inspections and evaluations by public security authorities and be restricted to use only network products and services that meet certain standards based on the level of risk applicable to us.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with these laws and regulations could cause us to incur substantial costs or require us to change our business operations in China. Violation of applicable laws and regulations could adversely affect our brand, affect our relationship with our health insurance carriers, and could result in regulatory enforcement actions and the imposition of civil or criminal penalties and fines, which would harm our business, operating results and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business may be adversely impacted by changes in China&#8217;s economic or political condition. We have experienced greater competition for qualified personnel in China, which has raised market salaries and increased our compensation costs related to employees in China. If competition for personnel increases further, our compensation expenses could rise considerably or, if we determine to not increase compensation levels, our ability to attract and retain qualified personnel in China may be impaired, which could harm our business, operating results and financial condition. These risks could cause us to incur increased expenses and could harm our ability to effectively and successfully manage our operations in China. Moreover, any significant or prolonged deterioration in the relationship between United States and China could adversely affect our operations in China. Certain risks and uncertainties of doing business in China are solely within the control of the Chinese government, and Chinese law regulates the scope of our foreign investments and business conducted within China. The escalation of trade tensions initiated by the current administration has increased the risk associated with our operations in China. Either the United States or the Chinese government may sever our ability to communicate with our China operations or may take actions that force us to close our operations in China. We employ a large number of our technology and content employees in China, and we have other employees in China that support our business. Any sudden disruption of our operations in China would adversely impact our business. If we are required to move aspects of our operations from China to our offices in the </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States as a result of political instability, changes in laws, inquiries from health insurance carriers or for other reasons, we could incur increased expenses, and our business, operating results and financial condition could be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We cannot predict the impact that changing climate conditions, including legal, regulatory and social responses thereto, may have on our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global climate change has added, and will continue to add, to the unpredictability, frequency and severity of natural disasters, including but not limited to hurricanes, tornadoes, freezes, droughts, other storms and fires in certain parts of the world. In response, a number of legal and regulatory measures and social initiatives have been introduced in an effort to reduce greenhouse gas and other carbon emissions that are chief contributors to global climate change. We cannot predict the impact that changing climate conditions will have on our business, though extreme weather events could impact our facilities, technological assets, business continuity and reputation. The legal, regulatory and social responses to climate change could also adversely affect our results of business, operating results and financial conditions.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success in selling Medicare-related health insurance will depend upon a number of factors some of which are outside of our control.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success in selling Medicare-related health insurance is dependent upon a number of factors, including:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to continue to adapt our ecommerce platforms to market Medicare plans, including our development or acquisition of marketing tools and features important in the sale of Medicare plans online and the effective modification of our user experience; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our success in marketing to Medicare-eligible individuals, including television advertising, online marketing and direct mail marketing, and in entering into and maintaining marketing partner relationships to drive Medicare-eligible individuals to our ecommerce platforms or customer care centers on a cost-effective basis; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to hire and retain additional employees with experience in Medicare, including our ability to timely implement Medicare sales expertise into our customer care centers; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to implement and maintain an effective information technology infrastructure for the sale of Medicare plans, including the infrastructure and systems that support our websites, call centers and call recording; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to leverage technology in order to sell, and otherwise become more efficient at selling, Medicare-related plans over the telephone;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with the numerous, complex and changing laws, regulations, guidelines and policies of the federal and state government, including CMS guidelines and policies relating to the marketing and sale of Medicare plans and health care reform; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effectiveness with which our competitors market the availability of Medicare plans from sources other than our ecommerce platforms.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of these and other factors, we may prove unsuccessful in marketing Medicare plans and acting as a health insurance agent in connection with their sale, which would harm our business, operating results and financial condition. In addition, if our efforts to market Medicare plans during enrollment periods were impeded due to lack of timely health insurance carrier or CMS approval, or for other reasons, the impact on our business, operating results and financial condition would be significantly greater given the seasonality of our Medicare-related revenue, membership acquisition and expenses and the fact that much of the sales of Medicare plans occur during this period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Laws and Regulations</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The marketing and sale of Medicare plans are subject to numerous, complex and frequently changing laws, regulations and guidelines, and non-compliance with or changes in laws, regulations and guidelines could harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The marketing and sale of Medicare plans are subject to numerous laws, regulations and guidelines at the federal and state level. The marketing and sale of Medicare Advantage and Medicare Part D prescription drug plans are principally regulated by the CMS but are also subject to state laws. The marketing and sale of Medicare Supplement plans are principally regulated on a state-by-state basis by state departments of insurance. The laws and regulations applicable to the marketing and sale of Medicare plans are numerous, ambiguous and complex, and, particularly with respect to regulations and guidance issued by CMS for Medicare Advantage and Medicare Part D prescription drug plans, change frequently.&#160;We have altered, and likely will have to continue to alter, our marketing and sales process to comply with these laws, regulations and guidelines. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Health insurance carriers whose Medicare plans we sell approve our websites, our call center scripts and some of our marketing material. We must receive these approvals in order for us market and sell Medicare plans to Medicare-eligible individuals as a health insurance agent. We are also required to file many of these materials on a regular basis with CMS.&#160;In addition, certain aspects of our Medicare plan marketing partner relationships have been in the past, and will be in the future, subjected to CMS and health insurance carrier review.&#160;CMS, state departments of insurance or health insurance carriers may determine to object to or not to approve aspects of our online platforms, sales function or marketing material and processes and may determine that certain existing aspects of our Medicare-related business are not in compliance with legal requirements. Health insurance carriers may terminate our relationship with them or take other corrective action if our Medicare product sales, marketing and operations are not in compliance or give rise to too many complaints. The termination of or change in our relationship with health insurance carriers for this reason would reduce the products we are able to offer, could result in the loss of commissions for past and future sales and would otherwise harm our business, operating results and financial condition. Changes to the laws, regulations and guidelines relating to the sale of Medicare plans, their interpretation or the manner in which they are enforced could impact the manner in which we conduct our Medicare business, our ecommerce platforms or our sale of Medicare plans, or we could be prevented from operating aspects of our Medicare revenue generating activities altogether, which would harm our business, operating results and financial condition. We have received, and may in the future receive, inquiries from CMS or state departments of insurance regarding our marketing and business practices and compliance with laws and regulations. Inquiries and proceedings initiated by the government could adversely impact our health insurance licenses, require us to pay fines, require us to modify marketing and business practices, result in litigation and otherwise harm our business, operating results or financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">CMS recently indicated that it is changing its process for the submission and approval of marketing materials related to Medicare Advantage and Medicare Part D prescription drug plans. The practical application of the current process allows for a lead carrier to handle most of the review and filing of Medicare plan marketing materials with CMS.  If the manner in which any new process is implemented requires multiple carriers to review and potentially comment on our marketing materials, it could harm our ability to efficiently change and implement new marketing materials, including call center scripts, which could harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Changes and developments in the health insurance industry or system as a result of health care reform could harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The United States health insurance system is subject to a changing regulatory environment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The future financial performance of our business will depend in part on our ability to adapt to regulatory developments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For example, the federal Patient Protection and Affordable Care Act of 2010 and related regulatory reforms have and will continue to change the industry in which we operate in substantial ways.&#160;The implementation of health care reform has increased, and could further increase, our competition in the individual and family health insurance market, reduce demand for the health insurance for individuals and families that we sell, decrease the number of health insurance plans that we sell as well as the number of health insurance carriers offering them,&#160;cause carriers to increase premiums or reduce commissions and other amounts they pay for our services, any of which could materially harm our business, operating results and financial condition.&#160;These and other impacts of health care reform caused a significant decline in our individual and family plan revenue and membership and other changes in the future could have a similar impact on our Medicare related health insurance business. Our business, operating results, financial condition and prospects may be materially and adversely affected if we are unable to adapt to developments in healthcare reform in the United States.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Affordable Care Act contains a mandate requiring individuals to maintain health insurance plans that comply with the Affordable Care Act or face a tax penalty. As a part of the tax reform law that came into effect in December 2017, the tax penalty for violating the mandate was set at zero effective in 2019, essentially repealing it. The essential repeal of the individual mandate could cause individuals to determine not to purchase or maintain individual and family health insurance and could cause carriers to increase premiums, reduce commissions or exit the business of selling individual and family health insurance, any of which would adversely impact our business, operating results and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Since the enactment of the Affordable Care Act, there have been judicial and Congressional challenges to certain aspects of the law. In December 2018, a federal district court in Texas determined that the individual mandate in the Affordable Care Act is unconstitutional, because it was not within Congress&#8217;s tax power or interstate commerce power. It also determined that the remaining provisions of the Affordable Care Act were inseverable and therefore invalid. The court, however, did not rule that the operation of the Affordable Care Act be enjoined, so the law continues to operate until determined otherwise by the court or an appellate court. The Fifth Circuit Court of Appeals agreed with the district court that the mandate is unconstitutional, but remanded the case back to the district court to address whether the unconstitutionality of the mandate should impact the rest of the law. In March 2020, the Supreme Court agreed to review the case, including whether the individual mandate is unconstitutional, and if the mandate is unconstitutional whether the rest of the Affordable Care Act can survive. Oral argument of the case before the Supreme Court occurred and we are awaiting the court's decision. If the Affordable Care Act were finally determined to be unconstitutional and no longer operated, it is unclear what impact it or its replacement would have on our business. However, it or its replacement could adversely impact our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our business depends upon the private sector of the United States health insurance system, which is subject to a changing environment. Changes and developments in the health insurance system in the United States could reduce demand for our services and harm our business. Ongoing healthcare reform efforts and measures may expand the role of government-sponsored coverage, including single payer or so called &#8220;Medicare-for-All&#8221; proposals, which could have far-reaching implications for the health insurance industry if enacted. Some proposals would seek to eliminate the private marketplace, while others would expand a government-sponsored option to a larger population. We are unable to predict the full impact of healthcare reform initiatives on our operations in light of the uncertainty of whether initiatives will be successful and the uncertainty regarding the terms and timing of any provisions enacted and the impact of any of those provisions on various healthcare and insurance industry participants. Changes to the health insurance system as a result of the change in the balance of power in Congress or as a result of the Biden administration could harm our business, operating results and financial condition. In the event that laws, regulations or rules that eliminate or reduce private sources of health insurance are adopted, the demand for our products could be adversely impacted and our business, operating results and financial condition would be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">From time to time we are subject to various legal proceedings which could adversely affect our business.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are, and may in the future become, involved in various legal proceedings and governmental inquiries, including labor and employment-related claims, claims relating to our marketing or sale of health insurance, intellectual property claims and claims relating to our compliance with securities laws. Any claims asserted against us, with or without merit, could be time-consuming, expensive to settle or litigate and divert management&#8217;s attention and other resources. These claims also could subject us to significant liability for damages and harm our reputation. Our insurance and indemnities may not cover all claims that may be asserted against us. If we are unsuccessful in our defense in these legal proceedings, we may be forced to pay damages or fines, enter into consent decrees, stop offering our services or change our business practices, any of which would harm our business, operating results or financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our success in selling health insurance is dependent in part on the actions of federal and state governments. Changes in the laws and regulations governing the offer, sale and purchase of health insurance could harm our business and operating results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The laws and regulations governing the offer, sale and purchase of health insurance are complex and subject to change, and future changes may be adverse to our business. For example, a long-standing provision in most applicable state laws that we believe is&#160;advantageous to our business is that once health insurance premiums are set by the carrier and approved by state regulators, they are fixed and not generally subject to negotiation or discounting by insurance companies or agents. Additionally, state regulations generally prohibit carriers, agents and brokers from providing financial incentives, such as rebates, to their members in connection with the sale of health insurance. As a result, we do not currently compete with carriers or other agents and brokers on the price of the health insurance plans offered on our website. If these regulations change, we could be forced to reduce prices or provide rebates or other incentives for the health insurance plans sold through our ecommerce platform, which would harm our business, operating results and financial condition. In addition, a federal law was </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">recently passed that requires disclosure of commissions paid to us to the purchaser of small business, major medical individual and family and short-term health insurance plans.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The provisions of the law have not gone into effect.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is unclear what impact the law will have when it goes into effect, but it could cause health insurance carriers to lower our commission rates, which could reduce our revenue. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">States and federal governments may adopt laws and regulations that are adverse to our business, including laws and regulations that impact the types of health insurance coverage available to consumers, the product features and benefits, our marketing and selling of plans and the role and compensation of agents and brokers in the sale of health insurance.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to the rules and regulations that apply to our sale of Medicare related health insurance are more likely given that the Biden administration recently took office.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS may change the rules and regulations applicable to us in connection with our Medicare plan business, and those changes could harm our business, operating results and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Biden administration has also indicated that it is in support of changes to the Affordable Care Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is difficult to predict what changes the Biden administration may make in the rules and regulations relating to our sale of the products that we sell, but the changes could harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with the numerous&#160;state</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">laws and regulations that are applicable to the sale of health insurance, our business and operating results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">could be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to maintain a valid license in each state in which we transact health insurance business and to adhere to sales, documentation and administration practices specific to that state. We must maintain our health insurance licenses to continue selling plans and to continue to receive commissions from health insurance carriers. In addition, each employee who transacts health insurance business on our behalf must maintain a valid license in one or more states. Because we do business in all 50 states and the District of Columbia, compliance with health insurance-related laws, rules and regulations is difficult and imposes significant costs on our business. Each jurisdiction&#8217;s insurance department typically has the power, among other things, to:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">grant, limit, suspend and revoke licenses to transact insurance business; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conduct inquiries into the insurance-related activities and conduct of agents and agencies; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require and regulate disclosure in connection with the sale and solicitation of health insurance; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorize how, by which personnel and under what circumstances insurance premiums can be quoted and published and an insurance policy sold; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approve which entities can be paid commissions from carriers and the circumstances under which they may be paid; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulate the content of insurance-related advertisements, including web pages, and other marketing practices; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approve policy forms, require specific benefits and benefit levels and regulate premium rates; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impose fines and other penalties; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impose continuing education requirements.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the complexity, periodic modification and differing interpretations of state insurance laws and regulations, we may not have always been, and we may not always be, in compliance with them. New state insurance laws, regulations and guidelines also may not be compatible with the sale of health insurance over the Internet or with various aspects of our platform or manner of marketing or selling health insurance plans. Failure to comply with insurance laws, regulations and guidelines or other laws and regulations applicable to our business could result in significant liability, additional department of insurance licensing requirements, required modification of our advertising and business practices, changes to our existing technology or platforms, the limitation, suspension and/or revocation of our licenses in a particular jurisdiction, termination of our relationship with health insurance carriers or loss of commissions and/or our inability to sell health insurance plans, which would harm our business, operating results and financial condition.&#160;Moreover, an adverse regulatory action in one jurisdiction could result in penalties and adversely affect our license status, business or reputation in other jurisdictions due to the requirement that adverse regulatory actions in one jurisdiction be reported to other jurisdictions. Even if the allegations in any regulatory or other action </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">against us are proven false, any surrounding negative publicity could harm consumer, marketing partner or health insurance carrier confidence in us, which could significantly damage our brand.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is subject to security risks and, if we experience cyberattacks, security breaches or are otherwise unable to safeguard the security and privacy of confidential data, including personal health information, our business will be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our services involve the collection and storage of confidential and personally identifiable information of consumers and the transmission of this information to their chosen health insurance carriers and to government. For example, we collect names, addresses, credit card and social security numbers and protected health information such as information regarding the medical history of consumers. As a result, we are subject to various laws and regulations and contractual requirements regarding the collection, maintenance, protection, use, transmission, disclosure and disposal of sensitive personal information. We also hold a significant amount of information relating to our current and former employees. We cannot guarantee that our facilities and systems, and those of our third party service providers, will be free of security breaches, cyberattacks, acts of vandalism, computer viruses, malware, misplaced or lost data, programming and/or human errors or other similar events. Compliance with privacy and security laws, requirements and regulations, particularly new state legislation such as the California Consumer Privacy Act, may result in cost increases due to new constraints on our business, the development of new processes, the effects of potential non-compliance by us or third party service providers, and enforcement actions.&#160;We may be required to expend significant amounts and other resources to protect against security breaches or to alleviate problems caused by security breaches. Despite our implementation of security measures, techniques used to obtain unauthorized access or to sabotage systems change frequently. As a result, we may be unable to anticipate these techniques or to implement adequate preventative measures. Additionally, our third party service providers may cause security breaches for which we are&#160;responsible.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any compromise or perceived compromise of our security or the security of one of our vendors could damage our reputation, cause the termination of relationships with government-run health insurance exchanges and our members, marketing partners and health insurance carriers, reduce demand for our services and subject us to significant liability and expense as well as regulatory action and lawsuits, which would harm our business, operating results and financial condition. The COVID-19 pandemic generally is increasing the attack surface available to criminals, as more companies and individuals work remotely and otherwise work online.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consequently, the risk of a cybersecurity incident has increased. We cannot provide assurances that our preventative efforts, or those of our vendors or service providers, will be successful. In addition, in the event that additional data security laws are implemented, or our health insurance carrier or other partners determine to impose requirements on us relating to data security, we may not be able to timely comply with such requirements or such requirements may not be compatible with our current processes. Changing our processes could be time consuming and expensive, and failure to timely implement required changes could result in our inability to sell health insurance plans in a particular jurisdiction or for a particular health insurance carrier or subject us to liability for non-compliance, any of which would damage our business, operating results and financial condition.&#160;For instance, health insurance carriers may require us to be compliant with additional security standards in order to accept credit card information from consumers or require us to comply with additional privacy and security standards to do business with us at all. Compliance with privacy and security standards is regularly assessed, and we may not always be compliant with the standards. If we are not in compliance, we may not be able to accept credit card information from consumers or conduct health insurance business, and our relationship with health insurance carriers could be adversely impacted or terminated, which would harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Any legal liability, regulatory penalties, or negative publicity for the information on our website or that we otherwise provide could harm our business and operating results.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We provide information on our website, through our customer care centers, in our marketing materials and in other ways regarding health insurance in general and the health insurance plans we market and sell, including information relating to insurance premiums, coverage, benefits, provider networks, exclusions, limitations, availability, plan comparisons and insurance company ratings. A significant amount of both automated and manual effort is required to maintain the considerable amount of insurance plan information on our website. We also use the information provided on our website and otherwise collected by us to publish reports designed to educate consumers, facilitate public debate, and facilitate reform at the state and federal level. If the information we provide on our website, through our customer care centers, in our marketing materials or otherwise is not accurate or is construed as misleading, or if we do not properly assist individuals and businesses in purchasing health insurance, members, health insurance carriers and others could attempt to hold us liable for damages, our relationships with health insurance carriers could be terminated or impaired and regulators could attempt to subject us to penalties, force us to </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">stop using our websites, marketing material or certain aspects of them, revoke our licenses to transact health insurance business in a particular jurisdiction, and/or compromise the status of our licenses to transact health insurance business in other jurisdictions, which could result in our loss of our commission revenue and harm our business, operating results and financial condition. In the ordinary course of operating our business, we have received complaints that the information we provided was not accurate or was misleading. We have received, and may in the future receive, inquiries from CMS or state departments of insurance regarding our marketing and business practices and compliance with laws and regulations. Although in the past we have resolved these complaints and governmental inquiries without significant financial cost or impact to our brand or reputation, we cannot guarantee that we will be able to do so in the future. Our sales of short-term health insurance plans that lack the same benefits as major medical health insurance plans may increase the risk that we receive complaints regarding our marketing and business practices due to the potential for consumer confusion between short-term health insurance and major medical health insurance. In addition, these types of claims could be time-consuming and expensive to defend, could divert our management&#8217;s attention and other resources, and could cause a loss of confidence in our services. As a result, whether or not we are able to successfully resolve these claims, they could harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our business could be harmed if we are unable to contact our consumers or market the availability of our products through specific channels.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use email and telephone, among other channels, to market our services to potential members and as the primary means of communicating with our existing members. The laws and regulations governing the use of email and telephone calls for marketing purposes continue to evolve, and changes in technology, the marketplace or consumer preferences may lead to the adoption of additional laws or regulations or changes in interpretation of existing laws or regulations. If new laws or regulations are adopted, or existing laws and regulations are interpreted or enforced, to impose additional restrictions on our ability to send email or telephone messages to our members or potential members, we may not be able to communicate with them in a cost-effective manner. In addition to legal restrictions on the use of email, Internet service providers, e-mail service providers and others attempt to block the transmission of unsolicited email, commonly known as &#8220;spam.&#8221; Many Internet and e-mail service providers have relationships with organizations whose purpose it is to detect and notify the Internet and e-mail service providers of entities that the organization believes is sending unsolicited e-mail.&#160;If an Internet or e-mail service provider identifies email from us as &#8220;spam&#8221; as a result of reports from these organizations or otherwise, we can be placed on a restricted list that will block our email to members or potential members. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use telephones to communicate with customers and prospective customers and some of these communications may be subject to the Telephone Consumer Protection Act, or TCPA, and other telemarketing laws. The TCPA and other laws, including state laws, relating to telemarketing restrict our ability to market using the telephone in certain respects. For instance, the TCPA prohibits us from using an automatic telephone dialing system to make certain telephone calls to consumers without prior express consent. We have policies in place to comply with the TCPA and other telemarketing laws. However, despite our legal compliance, we have in the past and may in the future become subject to claims that we have violated the TCPA. The TCPA provides for statutory damages of $500 for each violation and $1,500 for each willful violation. In the event that we were found to have violated the TCPA, our business, operating results and financial condition could be harmed. In addition, telephone carriers may block or put consumer warnings on calls originating from call centers. Consumers increasingly screen their incoming emails and telephone calls, including by using screening tools and warnings, and therefore our members or potential members may not reliably receive our emails or telephone messages. If we are unable to communicate effectively by email or telephone with our members and potential members as a result of legislation, blockage, screening technologies or otherwise, our business, operating results and financial condition would be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Finance, Accounting and Tax Matters</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our operating results will be impacted by factors that impact our estimate of the constrained LTV of commissions per approved member.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective January 1, 2018, we adopted Accounting Standards Update 2014-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Revenue from Contracts with Customers (ASC 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. As a result of the adoption of ASC 606, we recognize revenue for plans approved during the period by applying the latest estimated constrained LTVs for that product. Constrained LTVs are estimates and are based on a number of assumptions, which include, but are not limited to, estimates of the conversion rates of approved members into paying members, forecasted average plan duration and forecasted commission rates we expect to receive per approved member's plan. These assumptions are based on historical trends and require significant judgment by our management in interpreting those </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">trends and in applying the constraints. Changes in our historical trends will result in changes to our constrained LTV estimates in future periods and therefore could adversely affect our revenue and financial results in those future periods. As a result, negative changes in the factors upon which we estimate constrained LTVs, such as reduced conversion of approved members to paying members, increased health insurance plan terminations or a reduction in the lifetime commission amounts we expect to receive for selling the plan to a member or other changes could harm our business, operating results and financial condition. Changes in LTV may result in an increase or a decrease to revenue and a corresponding increase or decrease to commission receivables. In addition, if we ultimately receive commission payments that are less than the amount we estimated when we recognized commission revenue, we would need to write off the remaining commission receivable balance, which would adversely impact our business, operating results, and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rate at which approved members become paying members is a significant factor in our estimation of constrained LTVs. To the extent we experience a decline in the rate at which approved members turn into our paying members, our business, operating results, and financial condition would be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The forecasted average plan duration is another important factor in our estimation of constrained LTV. We receive commissions from health insurance carriers for health insurance plans sold through us. When one of these plans is canceled, or if we otherwise do not remain the agent on the policy, we no longer receive the related commission payment. Our forecasted average plan duration and health insurance plan termination rate are calculated based on our historical data by plan type.&#160;As a result, a reduction in our forecasted average plan duration or an inability to produce accurate forecasted average plan duration may adversely impact our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission rates are also a significant factor in our estimation of constrained LTVs. The commission rates we receive are impacted by a variety of factors, including the particular health insurance plans chosen by our members, the carriers offering those plans, our members&#8217; states of residence, the laws and regulations in those jurisdictions, the average premiums of plans purchased through us and health care reform. Our commission revenue per member has in the past decreased, and could in the future decrease, as a result of reductions in contractual commission rates, a change in the mix of carriers whose products we sell during a given period, and increased health insurance plan termination rates, all of which are beyond our control and may occur on short notice. To the extent these and other factors cause our commission revenue per member to decline, our revenue may decline and our business, operating results and financial condition would be harmed. Given that Medicare-related and individual and family health insurance purchasing is concentrated during enrollment periods, we may experience a shift in the mix of Medicare-related and individual and family health insurance products selected by our members over a short period of time. Any reduction in our average commission revenue per member caused by such a shift or otherwise would harm our business, operating results and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of constraints is also a factor that requires significant management judgment. Constraints are applied to LTVs for revenue recognition purposes and help ensure that the total estimated lifetime commissions expected to be collected from an approved member's plan are recognized as revenue only to the extent that is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with future commissions receivable from the plan is subsequently resolved. We determine the constraint for each product by comparing prior calculations of LTV to actual cash received and review the reasons for any variations. We then apply judgment in assessing whether the difference between historical cash collections and LTV is representative of differences that can be expected in future periods. We also analyze whether circumstances have changed and consider any known or potential modifications to the inputs into LTV in light of the factors that can impact the amount of cash expected to be collected in future periods including but not limited to commission rates, carrier mix, plan duration, changes in laws and regulations, and cancellations of insurance plans offered by health insurance carriers with which we have a relationship. We evaluate the appropriateness of our constraints on an ongoing basis, and we update our assumptions when we observe a sufficient amount of evidence that would suggest that the long-term expectation underlying the assumptions has changed. If we underestimate the initial constraint applied to LTVs, we might be required to increase the constraint or record an impairment in a future period which would harm our business, operating results and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our debt obligations contain restrictions that impact our business and expose us to risks that could materially adversely affect our liquidity and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are party to a credit agreement with Royal Bank of Canada and other lenders that enables us to borrow up to $75 million pursuant to a revolving credit facility. This credit agreement imposes certain covenants and restrictions on our business and our ability to obtain additional financing. As of March 31, 2021, we had no outstanding debt under our revolving credit facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The credit agreement contains customary affirmative covenants, including covenants regarding the payment of taxes and other obligations, maintenance of insurance, reporting requirements and compliance with applicable laws and regulations. The credit agreement also contains restrictions that, subject to certain exceptions, limit our ability to merge or consolidate, sell or transfer assets outside the ordinary course of business, make certain types of investments and restricted payments, pay dividends, incur additional indebtedness, grant liens, or enter into transactions with affiliates without the lender&#8217;s consent. Further, the credit agreement contains a financial covenant requiring the Company to maintain a minimum level of excess availability at any time. The facility contains events of default, including, among others, non-payment defaults, inaccuracy of representations and warranties, covenant defaults, cross-defaults to other indebtedness, judgment defaults, collateral defaults, bankruptcy and insolvency defaults and a change of control default. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we experience a decline in cash flow due to any of the factors described in this &#8220;Risk Factors&#8221; section or otherwise, we could have difficulty paying interest and principal amounts due on our indebtedness and meeting the financial covenants set forth in our loan facility. If we are unable to generate sufficient cash flow or otherwise obtain the funds necessary to make required payments under the credit facility, or if we fail to comply with the requirements of our indebtedness, we could default under our credit facility. Any default that is not cured or waived could result in the acceleration of the obligations under the credit facility, an increase in the applicable interest rate under the credit facility, and would permit our lender to exercise rights and remedies with respect to all of the collateral that is securing the credit facility, which includes substantially all of our assets. Any such default could materially adversely affect our liquidity and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Even if we comply with all of the applicable covenants, the restrictions on the conduct of our business could materially adversely affect our business by, among other things, limiting our ability to take advantage of financings, mergers, acquisitions and other corporate opportunities that may be beneficial to the business. Even if the credit facility were terminated, additional debt we could incur in the future may subject us to similar or additional covenants, which could place restrictions on the operation of our business. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements could be impaired, which could adversely affect our operating results, our ability to operate our business and our stock price.</span></div><div style="text-indent:56.25pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a complex business organization. Ensuring that we have adequate internal financial and accounting controls and procedures in place to help ensure that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be re-evaluated frequently and is complicated by the expansion of our business operations and changing accounting requirements. Our management, including our chief executive officer and chief financial officer, does not expect that our internal control over financial reporting will prevent all errors or all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. Over time, controls may become inadequate because changes in conditions or deterioration in the degree of compliance with policies or procedures may occur. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. We cannot assure that significant deficiencies or material weaknesses in our internal control over financial reporting will not be identified in the future. Any failure to maintain or implement required new or improved controls, or any difficulties we encounter in their implementation, could result in significant deficiencies or material weaknesses, cause us to fail to timely meet our periodic reporting obligations, or result in material misstatements in our financial statements. Any such failure could also adversely affect the results of periodic management evaluations and annual auditor attestation reports regarding disclosure controls and the effectiveness of our internal control over financial reporting required under Section&#160;404 of the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder. The existence of a material weakness could result in errors in our financial statements that could result in a restatement of financial statements, cause us to fail to timely meet our reporting obligations and cause </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investors to lose confidence in our reported financial information, leading to a decline in our stock price and potential lawsuits against us.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in our provision for income taxes or adverse outcomes resulting from examination of our income or other tax returns or changes in tax legislation could adversely affect our results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes is subject to volatility and could be adversely affected by earnings differing materially from our projections, changes in the valuation of our deferred tax assets and liabilities, tax effects of stock-based compensation, outcomes as a result of tax examinations or by changes in tax laws, regulations, accounting principles, including accounting for uncertain tax positions, or interpretations thereof.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that our provision for income taxes is subject to volatility or adverse outcomes as a result of tax examinations, our operating results could be harmed. Significant judgment is required to determine the recognition and measurement attribute prescribed in U.S. generally accepted accounting principles, or GAAP, relating to accounting for income taxes. In addition, we are subject to examinations of our income tax returns by the Internal Revenue Service, or IRS, and other tax authorities. We assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. There may be exposure that the outcomes from these examinations will have an adverse effect on our operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use net operating losses to offset future taxable income may be subject to certain limitations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have net operating loss carryforwards for federal and state income tax purposes to offset future taxable income. Our federal and state net operating loss carryforwards begin expiring in 2034 and 2021, respectively. A lack of future taxable income would adversely affect our ability to utilize these net operating loss carryforwards. In addition, utilization of the net operating loss carryforwards may be subject to a substantial annual limitation due to ownership changes that may have occurred or that could occur in the future, as required by Section 382 of the Code and similar state provisions. These ownership change limitations may limit the amount of net operating loss carryforwards and other tax attributes that can be utilized annually to offset future taxable income and tax, respectively. In general, an &#8220;ownership change&#8221; as defined by Section 382 of the Internal Revenue Code of 1986, as amended, or the Code, results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points (by value) of the outstanding stock of a company by certain stockholders. Our ability to use the remaining net operating loss carryforwards may be further limited if we experience a Section 382 ownership change as a result of future changes in our stock ownership.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Technology</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to sell Medicare-related health insurance plans as a health insurance agent depends upon maintenance of functioning information technology systems.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The success of our Medicare plan customer care center operations is dependent upon information technology systems.&#160;Many of our Medicare plan members utilize our customer care center in connection with their purchase of a Medicare plan.&#160;CMS rules require that our health insurance agent employees utilize CMS-approved scripts in connection with the sale of Medicare plans and that we record and maintain the recording of telephonic interactions relating to the sale of Medicare plans.&#160;We rely on telephone, call recording, customer relationship management and other systems and technology in our Medicare customer care center operations, and we are dependent upon third parties for some of them, including our telephone and call recording systems.&#160;These systems have failed temporarily in the past and may experience additional disruption due to systems upgrades, power outages, an increase in remote work or other impacts as a result of the COVID-19 pandemic. The effectiveness and stability of our Medicare customer care center systems and technology are critical to our ability to sell Medicare plans, particularly during the Medicare enrollment periods, and the failure or interruption of any of these systems and technology or any inability to handle increased volume would harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">System failures or capacity constraints could harm our business and operating results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The performance, reliability and availability of our ecommerce and telephony platforms and underlying network infrastructures are critical to our financial results, our brand and our relationship with members, marketing partners and health insurance carriers. Although we regularly attempt to enhance our platforms and system infrastructure, system failures and </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">interruptions may occur if we are unable to accurately project the rate or timing of increases in our website or call center traffic or for other reasons, some of which are completely outside our control. We could experience significant failures and interruptions, which would harm our business, operating results and financial condition. If these failures or interruptions occurred during the Medicare annual enrollment period, the Medicare Advantage open enrollment period or during the open enrollment period under health care reform, the negative impact on us would be particularly pronounced.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely in part upon third-party vendors, including data center, cloud infrastructure, and bandwidth providers, to operate our ecommerce and telephony platforms. We cannot predict whether additional network capacity will be available from these vendors as we need it, and our network or our suppliers&#8217; networks might be unable to achieve or maintain a sufficiently high capacity of data transmission. Any system failure that causes an interruption in or decreases the responsiveness of our services would impair our revenue-generating capabilities and harm our business and operating results and damage our reputation. In addition, any loss of data could result in loss of customers and subject us to potential liability. Our facilities and our database and systems are vulnerable to damage or interruption from human error, fire, floods, power loss, telecommunications failures, physical or electronic break-ins, computer viruses, acts of terrorism, other attempts to harm our systems and similar events. In addition, our operations are vulnerable to earthquakes, fire, severe weather conditions, including those brought about by climate change, and other natural disasters in the San Francisco Bay Area and elsewhere in Northern California,  China, and as well as in other parts of the U.S. where we or our outsourced health insurance agents maintain offices.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may not be able to adequately protect our intellectual property, which could harm our business and operating results.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our intellectual property is an essential asset of our business and that our technology currently gives us a competitive advantage in the distribution of Medicare-related, individual and family and small business health insurance. We rely on a combination of copyright, trademark and trade secret laws as well as confidentiality procedures and contractual provisions to establish and protect our intellectual property rights in the United States. The efforts we have taken to protect our intellectual property may not be sufficient or effective, and our trademarks may be held invalid or unenforceable. Moreover, the law relating to intellectual property is not as developed in China, and our intellectual property rights may not be as respected in China as they are in the United States. We may not be effective in policing unauthorized use of our intellectual property, trade secrets and other confidential information, and even if we do detect violations, litigation may be necessary to enforce our intellectual property rights. Any enforcement efforts we undertake, including litigation, could be time-consuming and expensive, could divert our management&#8217;s attention and may result in a court determining that our intellectual property or other rights are unenforceable. If we are not successful in cost-effectively protecting our intellectual property rights, trade secrets and confidential information, our business, operating results and financial condition could be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumers depend upon third-party service providers to access our website and services, and our business and operating results could be harmed as a result of technical difficulties experienced by these service providers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumers using our website and accessing our services depend upon Internet, online and other service providers for access to our website and services. Many of these service providers have experienced significant outages, delays and other difficulties in the past and could experience them in the future. Any significant interruption in access to our call centers or our website or increase in our website&#8217;s response time as a result of these difficulties could damage our relationship with insurance carriers, marketing partners and existing and potential members and could harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Common Stock</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our actual operating results may differ significantly from our guidance.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, we have released, and may continue to release guidance in earnings conference calls, earnings releases, or otherwise, regarding our future performance that represents our management's estimates as of the date of release. This guidance, which includes forward-looking statements, has been and will be based on projections prepared by our management. Guidance is necessarily speculative in nature, and it can be expected that some or all of the assumptions underlying the guidance furnished by us will not materialize or will vary significantly from actual results. Accordingly, our </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">guidance is only an estimate of what management believes is realizable as of the date of release. Our actual results have, and may in the future, vary from our guidance and the variations may be material. In light of the foregoing, investors are urged not to rely upon our guidance in making an investment decision regarding our common stock.</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Projections are based upon a number of assumptions and estimates that, while presented with numerical specificity, are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control and are based upon specific assumptions with respect to future business decisions, some of which will change. Among these factors, the assumptions underlying our estimates of commission revenue as required by ASC 606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">may vary significantly over time. We may state possible outcomes as high and low ranges. Any range we provide is not intended to imply that actual results could not fall outside of the suggested ranges. Any failure to successfully implement our operating strategy or the occurrence of any of the events or circumstances set forth in this &#8220;Risk Factors&#8221; section could result in the actual operating results being different from our guidance, and the differences may be adverse and material. The principal reason that we release guidance is to provide a basis for our management to discuss our business outlook with analysts and investors and we may decide to suspend guidance at any time. We do not accept any responsibility for any projections or reports published by any such third parties.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of our common stock has been and may continue to be volatile, and the value of your investment could decline.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock has been volatile and is likely to continue to fluctuate substantially. For the quarter ended March 31, 2021, the closing price of our common stock fluctuated from $47.85 to $85.09 per share. The trading price of our common stock depends on a number of factors, including those described in this &#8220;Risk Factors&#8221; section, many of which are beyond our control and may not be related to our operating performance. These fluctuations could cause you to lose all or part of your investment in our common stock since you might be unable to sell your shares at or above the price you paid. Factors that could cause fluctuations in the trading price of our common stock include the following:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price and volume fluctuations in the overall stock market from time to time, including as a result of the COVID-19 pandemic;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">volatility in the market prices and trading volumes of our competitors' shares, including high technology stocks, which have historically experienced high levels of volatility;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new laws or regulations or new interpretations of existing laws or regulations applicable to our business, including developments relating to the health care industry and the marketing and sale of Medicare plans;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated changes in our operating results or the growth rate of our business;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in operating performance and stock market valuations of other technology companies generally, and of our competitors;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of securities analysts to maintain coverage of us, changes in financial estimates by any securities analysts who follow our company, or our failure to meet these estimates or the expectations of investors;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of shares of our common stock by us or our stockholders;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of new products or services;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the public reaction to our press releases, other public announcements, and filings with the SEC;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">rumors and market speculation involving us or other companies in our industry;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">negative publicity about us, including accurate and inaccurate third-party commentary or reports regarding us;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated developments in our business, our competitors' businesses, or the competitive landscape generally;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to control costs, including our operating expenses;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning our intellectual property or other proprietary rights;</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announced or completed acquisitions of businesses or technologies by us or our competitors;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting standards, policies, guidelines, interpretations, or principles;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any significant change in our management; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic conditions and slow or negative growth of our markets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of such factors on the trading market for our stock may be enhanced by the lack of a large and established trading market for our stock. In addition, the stock market in general, and the market for technology companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors may seriously affect the market price of our common stock, regardless of our actual operating performance. Additionally, as a public company, we face the risk of shareholder lawsuits, particularly if we experience declines in the price of our common stock. In the past, following periods of volatility in the overall market and the market prices of a particular company's securities, securities class action lawsuits have often been instituted against affected companies. We have been, and may in the future be, subject to such legal actions.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The issuance of shares of common stock underlying our Series A preferred stock would dilute the ownership and relative voting power of holders of our common stock and may adversely affect the market price of our common stock.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Series A preferred stock is convertible at the option of the holders at any time after May 31, 2021 into shares of common stock based on the then applicable conversion rate as determined in the certificate of designations for the Series A preferred stock, which conversion would dilute the ownership interest of existing holders of our common stock. In addition, because holders of our Series A preferred stock are entitled to vote, on an as-converted basis (subject to certain voting limitations and conversion calculations set forth in the certificate of designations for the Series A preferred stock), together with holders of our common stock on all matters submitted to a vote of the holders of our common stock, the issuance of the Series A preferred stock effectively reduces the relative voting power of the holders of our common stock.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any sales in the public market of the common stock issuable upon conversion of the Series A preferred stock could adversely affect prevailing market prices of our common stock. Pursuant to the investment agreement, holders of our Series A preferred stock will receive customary resale registration rights for common stock issued upon conversion of the Series A preferred stock upon closing.  Any resale of our common stock would increase the number of shares of our common stock available for public trading. Sales by our Series A preferred stockholder of a substantial number of shares of our common stock in the public market, or the perception that such sales might occur, could have a material adverse effect on the price of our common stock.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Series A preferred stock has rights, preferences and privileges that are not held by, and are preferential to, the rights of our common stockholders, which could adversely affect our liquidity and financial condition, result in the interests of holders of our Series A preferred stock differing from those of our common stockholders and make an acquisition of us more difficult.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of our Series A preferred stock have (i) a liquidation preference (ii) rights to dividends, which are senior to all of our other equity securities, (iii) redemption rights beginning on April 30, 2027, (iv) the right to require us to repurchase any or all of their Series A preferred stock in connection with certain change of control events, and (v) conversion price adjustments in connection with certain corporate transactions, each subject to the terms, conditions and exceptions contained in the certificate of designations for the Series A preferred stock.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These dividend and share repurchase and redemption obligations could impact our liquidity and reduce the amount of cash flows available for working capital, capital expenditures, growth opportunities, acquisitions, and other general corporate purposes. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of our investment agreement with H.I.G., the initial purchaser of our Series A Preferred Stock, could also limit our ability to obtain additional financing or increase our borrowing costs, which could have an adverse effect on our financial condition. The preferential rights could also result in divergent interests between H.I.G. and holders of our common stock. Furthermore, a sale of our company, as a change of control event, may require us to repurchase Series A preferred stock, which could have the effect of making an acquisition of our company more expensive and potentially deterring proposed transactions that may otherwise be beneficial to our stockholders.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">H.I.G. may exercise influence over us, including through its ability to designate up to two directors on our board of directors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment agreement with H.I.G. contains certain negative operating covenants that will remain in effect for so long as H.I.G. continues to own at least 30% of the shares of Series A preferred stock originally issued to it. As of the date of this report, H.I.G. has conditionally waived certain of these negative operating covenants. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Further, the investment agreement entitles H.I.G. to nominate one individual for election to our board of directors for so long as it continues to own at least 30% of the common stock issuable or issued upon conversion of the Series A preferred stock originally issued to it. In addition, if we fail to maintain certain levels of commissions receivable and liquidity, H.I.G. will be entitled to nominate one additional director. The director designated by H.I.G. will also be entitled to serve on committees of our board of directors, subject to applicable law and stock exchange rules. Notwithstanding the fact that all directors will be subject to fiduciary duties to us and to applicable law, the interests of the director designated by H.I.G. of our Series A preferred stock may differ from the interests of our security holders as a whole or of our other directors. As of the date of this report, H.I.G. has conditionally waived its director nomination rights.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Anti-takeover provisions contained in our certificate of incorporation and bylaws, as well as provisions of Delaware law, could impair a takeover attempt.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation, bylaws, and Delaware law contain provisions which could have the effect of rendering more difficult, delaying, or preventing an acquisition deemed undesirable by our board of directors. Our corporate governance documents include provisions:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">creating a classified board of directors whose members serve staggered three-year terms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorizing undesignated preferred stock, which could be issued by our board of directors without stockholder approval and may contain voting, liquidation, dividend, and other rights superior to our common stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting the liability of, and providing indemnification to, our directors and officers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting the ability of our stockholders to call and bring business before special meetings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring advance notice of stockholder proposals for business to be conducted at meetings of our stockholders and for nominations of candidates for election to our board of directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">controlling the procedures for the conduct and scheduling of board of directors and stockholder meetings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing our board of directors with the express power to postpone previously scheduled annual meetings and to cancel previously scheduled special meetings.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a Delaware corporation, we are also subject to provisions of Delaware law, including Section 203 of the Delaware General Corporation law, which prevents some stockholders holding more than 15% of our outstanding common stock from engaging in certain business combinations without approval of the holders of substantially all of our outstanding common stock. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of our certificate of incorporation, bylaws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for our common stock.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_118"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Exhibits</span></div><div style="margin-bottom:16pt;margin-top:9pt;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as so indicated in Exhibits 32.1 and 32.2, the following exhibits are filed as part of, or incorporated by reference into, this&#160;Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.108%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation by Reference Herein</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1333493/000119312506087959/dex31.htm">Amended and Restated Certificate of Incorporation of the Registrant</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Registration Statement on Form S-1, as amended (File No. 333-133526)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 25, 2006</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1333493/000133349321000061/exhibit31certificateofdesi.htm">Certificate of Designations of Series A Preferred Stock, par value $0.001, of eHealth, Inc.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current Report on Form 8-K (File No. 001-33071)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/0001333493/000133349321000013/investmentagreementdatedas.htm">Investment Agreement, dated as of February 17, 2021, by and between eHealth, Inc. and Echelon Health SPV, LP</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current Report on Form 8-K (File No. 001-33071)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 18, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1333493/000133349321000024/cooperationagreement.htm">Cooperation Agreement, dated March 10, 2021 by</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1333493/000133349321000024/cooperationagreement.htm"> and </a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1333493/000133349321000024/cooperationagreement.htm">between eHealth, Inc. and Hudson Executive Capital LP, on behalf of itself and its affiliates</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1333493/000133349321000024/cooperationagreement.htm"> and </a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1333493/000133349321000024/cooperationagreement.htm">its affiliated funds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current Report on Form 8-K<br/>(File No. 001-33071)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 10, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/0001333493/000133349321000019/ex102formindemnificationag.htm">Form of Indemnification Agreement adopted in 2021</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Annual Report on Form&#160;10-K (File&#160;No.&#160;001-33071)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/0001333493/000133349321000019/exhibit108severanceagreeme.htm">Severance Agreement, dated as of February 10, 2021, between Timothy Hannan and eHealth, Inc.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Annual Report on Form&#160;10-K (File&#160;No.&#160;001-33071)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="exhibit105severanceagreeme.htm">Severance Agreement, dated as of February 8, 2021, between Phillip Morelock and eHealth, Inc.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="exhibit106severanceagreeme.htm">Severance Agreement, dated as of March 15, 2021, between Gregg Ratkovic and eHealth, Inc.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="a2021q1ex311.htm">Certification of Scott N. Flanders, Chief Executive Officer of eHealth, Inc., pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="a2021q1ex312.htm">Certification of Derek N. Yung, Chief Financial Officer of eHealth, Inc., pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8225;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="a2021q1ex321.htm">Certification of Scott N. Flanders, Chief Executive Officer of eHealth, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8225;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="a2021q1ex322.htm">Certification of Derek N. Yung, Chief Financial Officer of eHealth, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">The cover page from the Company&#8217;s Quarterly Report on Form 10-Q for the three months ended March 31, 2021, formatted in Inline XBRL and contained in Exhibit 101</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:174%">&#8225;&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:174%">*&#160;&#160;&#160;&#160;Indicates a management contract or compensatory plan or arrangement.</span></div><div style="padding-left:13.5pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i534e5b0d995440019776d9538b893f71_121"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-indent:40.5pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EHEALTH, INC.<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Scott N. Flanders</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott N. Flanders<br/>Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Derek N. Yung</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derek N. Yung<br/>Chief Financial Officer<br/>(Principal Financial Officer)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>2
<FILENAME>exhibit105severanceagreeme.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7a922b0110b74e48a00b6c96b5f15142_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EHEALTH, INC.<br>SEVERANCE AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;This Severance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is by and between </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">eHealth, Inc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. (together with its subsidiary, eHealthInsurance Services, Inc., the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and Phillip Morelock (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive and the Company agree that Executive&#8217;s employment with Company constitutes &#8220;at-will&#8221; employment.  Executive and the Company acknowledge that this employment relationship may be terminated at any time, upon written notice to the other party, with or without Cause or Good Reason (as each such term is defined in Section 4 below), at the option either of the Company or Executive.  However, as described in this Agreement, Executive may be entitled to severance benefits depending upon the circumstances of Executive&#8217;s termination of employment.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Involuntary Termination Other than for Cause or Voluntary Termination for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If (i) Executive terminates his employment with the Company (or any parent or subsidiary of the Company) for &#8220;Good Reason&#8221; (as defined herein), or (ii) the Company (or any parent or subsidiary of the Company) terminates Executive&#8217;s employment for other than &#8220;Cause&#8221; (as defined herein), and Executive signs and does not revoke a standard release of claims with the Company in a form substantially similar to that attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then Executive shall receive the following severance benefits from the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:65.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:31.5pt">Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall receive a single lump-sum cash severance payment (less applicable withholding taxes) in an amount equal to twelve (12) months of Executive&#8217;s then current annual base salary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.86pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:31.5pt">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to Executive timely electing continuation coverage under Title X of the Consolidated Budget Reconciliation Act of 1985 (&#8220;COBRA&#8221;), Executive shall receive one-hundred percent (100%) Company-paid group health, dental and vision coverage (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company-Paid Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). If such coverage included Executive&#8217;s dependents immediately prior to the termination, such dependents shall also be covered at Company expense. Company-Paid Coverage shall continue until the earlier of (i) twelve (12) months following the date of termination, or (ii) the date upon which Executive and his dependents become covered under another employer&#8217;s group health, dental and vision plans that provide Executive and his dependents with comparable benefits and levels of coverage (such earlier date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COBRA Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it cannot provide the Company-Paid Coverage without a substantial risk of violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company shall in lieu thereof provide to Executive a taxable monthly payment in an amount equal to the monthly COBRA premium that Executive would be required to pay to continue Executive&#8217;s (and Executive&#8217;s dependents&#8217;, as applicable) group health, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">dental and vision coverage in effect on the date of Executive&#8217;s employment termination (which amount shall be based on the premium for the first month of COBRA coverage), which payments shall be made to Executive regardless of whether Executive elects COBRA continuation coverage and shall end on the COBRA Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Involuntary Termination Other than for Cause or Voluntary Termination for Good Reason During the One-Year Period Following a Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If (i) Executive terminates his employment with the Company (or any parent or subsidiary of the Company) for &#8220;Good Reason&#8221; (as defined herein), or (ii) the Company (or any parent or subsidiary of the Company) terminates Executive&#8217;s employment for other than &#8220;Cause&#8221; (as defined herein) during the one-year period following a Change in Control, and Executive signs and does not revoke the Release, then in addition to the severance benefits provided in Section 2(a) above, Executive shall receive the following severance benefits from the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:65.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:31.5pt">Bonus Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall receive a single lump-sum cash payment (less applicable withholding taxes) in an amount equal to one hundred percent (100%) of Executive&#8217;s then current target annual bonus.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.86pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:31.5pt">Equity Award Vesting.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  One hundred percent (100%) of Executive&#8217;s then outstanding and unvested time-based equity awards (whether stock options, stock appreciation rights, shares of restricted stock, restricted stock units or otherwise) shall become vested and shall otherwise remain subject to the terms and conditions of the applicable equity incentive plan and the award agreements pursuant to which the time-based equity awards were granted. Executive&#8217;s then outstanding and unvested performance-based equity awards, shall vest in accordance with the terms of the applicable equity incentive plan and the award agreements pursuant to which the performance-based equity awards were granted and not pursuant to the terms of this Agreement.  For the avoidance of doubt, all performance-based equity awards, including those where performance goals have been achieved but which remain subject to time-based vesting, shall not be considered time-based awards under the terms of this Agreement and shall be governed by the applicable incentive plan and the award agreements pursuant to which the performance-based equity awards were granted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Voluntary Resignation&#59; Termination for Cause&#59; Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If Executive&#8217;s employment with the Company terminates (i) voluntarily by Executive other than for Good Reason (ii) for Cause by the Company, or (iii) due to Executive&#8217;s death or Disability (as defined hereunder), then Executive shall not be entitled to receive severance or other benefits except for those (if any) as may then be established under the Company&#8217;s then existing severance and benefits plans and practices or pursuant to other written agreements with the Company.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Exclusive Remedy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions of this Section 2 are intended to be and are Executive&#8217;s exclusive rights to severance payments and benefits in the event of termination of service.  The parties hereto agree that nothing herein is intended to result in duplication of severance or any other benefits.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:18.2pt">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:65.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">Any amount paid under this Agreement that satisfies the requirements of the &#8220;short-term deferral&#8221; rule set forth in Section 1.409A-l(b)(4) of the regulations issued under Section 409A of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Treasury Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall not constitute Deferred Compensation Separation Benefits for purposes of Section 2(e)(ii) below, and consequently shall be paid to Executive promptly following termination as otherwise required by this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.86pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">Notwithstanding anything to the contrary in this Agreement, if Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A of the Code, and the final regulations and any guidance promulgated thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) at the time of Executive&#8217;s separation from service (as such term is defined in Section 409A), then the cash severance benefits payable to Executive under this Agreement along with any other severance payments or separation benefits that may be considered deferred compensation under Section 409A (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) that are otherwise due to Executive on or within the six (6) month period following Executive&#8217;s separation from service shall accrue during such six (6) month period and shall become payable in a lump sum payment on the date six (6) months and one (1) day following the date of Executive&#8217;s separation from service.  All subsequent payments, if any, shall be payable in accordance with the payment schedule applicable to each payment or benefit.  Notwithstanding anything herein to the contrary, if Executive dies following his separation from service but prior to the six (6) month anniversary of his date of separation from service, then any payments delayed in accordance with this Section shall be payable in a lump sum as soon as administratively practicable after the date of Executive&#8217;s death and all other Deferred Compensation Separation Benefits shall be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:58.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">Any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-l(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit (as defined below) shall not constitute Deferred Compensation Separation Benefits for purposes of Section 2(e)(ii) above.  For purposes of this Section 2(e), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Section 409A Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; will mean the lesser of two (2) times&#58; (i) Executive&#8217;s annualized compensation based upon the annual rate of pay paid to Executive during the Company&#8217;s taxable year preceding the Company&#8217;s taxable year of Executive&#8217;s termination of employment as determined under Treasury Regulation 1.409A-l(b)(9)(iii)(A)(l)&#59; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive&#8217;s employment is terminated.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:59.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">It is the intent of this Agreement to comply with the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder shall be subject to the additional tax imposed under Section 409A, and any ambiguities herein shall be interpreted to so comply.  The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of any additional tax or income recognition under Section 409A prior to actual payment to Executive.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:62.52pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">Notwithstanding any other provisions of this Agreement, Executive&#8217;s receipt of severance payments and benefits under this Agreement is conditioned upon Executive signing and not revoking the Release and subject to the Release becoming effective within sixty (60) days following Executive&#8217;s termination of employment (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Release Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  No severance will be paid or provided unless the Release becomes effective during the Release Period.  Any severance payments to which Executive is entitled under this Agreement shall be paid by the Company to Executive in cash and in full arrears on the date on which the Release becomes effective or such later date as is required to comply with Section 409A&#59; provided however, that if the Release Period straddles two calendar years, the severance payments to which Executive is entitled under this Agreement shall be paid on the latest of (A) the date on which the Release becomes effective, (B) the first business day of the calendar year following the year in which Executive terminates employment with the Company or (C) such later date as is required to comply with Section 409A. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:59.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">With respect to reimbursements or in-kind benefits provided to Executive hereunder (or otherwise) that are not exempt from Section 409A, the following rules shall apply&#58; (A) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during any one of Executive&#8217;s taxable years shall not affect the expenses eligible for reimbursement, or in-kind benefit to be provided in any other taxable year, (B) in the case of any reimbursements of eligible expenses, reimbursement shall be made on or before the last day of Executive&#8217;s taxable year following the taxable year in which the expense was incurred and (C) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Golden Parachute Excise Tax Best Results</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any payment or benefit Executive would receive pursuant to this Agreement or otherwise (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) would (i) constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then such Payment shall be reduced to the Reduced Amount.  The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Reduced Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Executive&#8217;s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.  If a reduction in payments or benefits constituting &#8220;parachute payments&#8221; is necessary so that the Payment equals the Reduced Amount, reduction shall occur in the following order&#58; (A) cash payments shall be reduced first and in reverse chronological order such that the cash payment owed on the latest date following the occurrence of the event triggering such excise tax will be the first cash payment to be reduced&#59; (B) accelerated vesting of stock awards shall be cancelled&#47;reduced next and in the reverse order </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of the date of grant for such stock awards (i.e., the vesting of the most recently granted stock awards will be reduced first)&#59; and (C) employee benefits shall be reduced last and in reverse chronological order such that the benefit owed on the latest date following the occurrence of the event triggering such excise tax will be the first benefit to be reduced.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall appoint a nationally recognized accounting firm or consulting firm to make the determinations required hereunder and perform the foregoing calculations.  The Company shall bear all expenses with respect to the determinations by such accounting or consulting firm required to be made hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The accounting or consulting firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting documentation, to the Company and Executive within fifteen (15) calendar days after the date on which right to a Payment is triggered (if requested at that time by the Company or Executive) or such other time as requested by the Company or Executive.  If the accounting or consulting firm determines that no Excise Tax is payable with respect to a Payment, either before or after the application of the Reduced Amount, it shall furnish the Company and Executive with an opinion reasonably acceptable to Executive that no Excise Tax will be imposed with respect to such Payment.  Any good faith determinations of the accounting or consulting firm made hereunder shall be final, binding and conclusive upon the Company and Executive.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Definition of Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The following terms referred to in this Agreement shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (i) Executive&#8217;s commission of any act of fraud, embezzlement or dishonesty, (ii) Executive&#8217;s conviction of, or plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">nolo contendere</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> to, a felony under the laws of the United States or any state thereof, (iii) Executive&#8217;s continued failure to perform lawfully assigned duties for 30 days after receiving written notification from the  Company, (iv) Executive&#8217;s unauthorized use or disclosure of confidential information or trade secrets of the Company, or (v) any other intentional misconduct by Executive that adversely affects the business of the Company in a material manner.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following, in one or a series of related transactions&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:65.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">Any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company&#8217;s then outstanding voting securities&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.86pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the total voting power represented by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:58.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">The consummation of the sale, lease or other disposition by the Company of all or substantially all the Company&#8217;s assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Executive (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to last for a continuous period of not less than twelve (12) months, receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering Company employees,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means that Executive resigns his employment within 120 days after any of the following is undertaken by the Company (or its acquirer) without Executive&#8217;s express written consent&#58; (i) a reduction in Executive&#8217;s title, (ii) a material reduction of Executive&#8217;s duties, authority or responsibilities&#59; (iii) any material reduction of Executive&#8217;s base salary or potential target bonus equal to 60% of Executive&#8217;s base salary (other than a proportionate reduction in Executive&#8217;s base salary or potential bonus that affects all senior management of the Company)&#59; or (iv) a material change in the geographic location at which Executive must perform services&#59; provided that in no instance will the relocation of Executive to a facility or location of thirty-five (35) miles or less from either the Company&#8217;s office located at 2625 Augustine Drive, Santa Clara, California or the Company&#8217;s then current office location in San Francisco, California, or from Executive&#8217;s then current office location (or one of Executive&#8217;s then-current office locations, if applicable) be deemed material for purposes of this Agreement&#59; provided, however, that Good Reason shall not exist unless Executive has provided written notice to the Board of Directors of the purported grounds for the Good Reason within 90 days of its initial existence and the Company has been provided at least 30 days to remedy the condition.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">The Company&#8217;s Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company&#8217;s business and&#47;or assets shall assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession.  For all purposes under this Agreement, the term &#8220;Company&#8221; shall include any successor to the Company&#8217;s business and&#47;or assets which executes and delivers the assumption agreement described in this Section 5(a) or which becomes bound by the terms of this Agreement by operation of law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Executive&#8217;s Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The terms of this Agreement and all rights of Executive hereunder shall inure to the benefit of, and be enforceable by, Executive&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All notices and other communications required or permitted hereunder shall be in writing, shall be effective when given, and shall in any event be deemed to be given upon receipt or, if earlier, (a) five (5) days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by first class mail, postage prepaid, (b) upon delivery, if delivered by hand, (c) one (1) business day after the business day of deposit with Federal Express or similar overnight courier, freight prepaid, (d) one (1) business day after the business day of facsimile transmission, if delivered by facsimile transmission with copy by first class mail, postage prepaid, (e) upon transmission, if sent by email, and shall be addressed (i) if to Executive, at his or her last known residential address or email address and (ii) if to the Company, at the address of its principal corporate offices (attention&#58; Secretary), or in any such case at such other address as a party may designate by ten (10) days&#8217; advance written notice to the other party pursuant to the provisions above.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any termination by the Company for Cause or by Executive for Good Reason or as a result of a voluntary resignation shall be communicated by a notice of termination to the other party hereto given in accordance with Section 6 of this Agreement.  Such notice shall indicate the specific termination provision in this Agreement relied upon, shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and shall specify the termination date (which shall be not more than thirty (30) days after the giving of such notice).  The failure by Executive to include in the notice any fact or circumstance which contributes to a showing of Good Reason shall not waive any right of Executive hereunder or preclude Executive from asserting such fact or circumstance in enforcing his or her rights hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">No Duty to Mitigate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall not be required to mitigate the amount of any payment contemplated by this Agreement, nor shall any such payment be reduced by any earnings that Executive may receive from any other source.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive).  No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement represents the entire agreement between Executive and the Company regarding Executive&#8217;s severance agreement with the Company, and supersede in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied), of the parties with respect to the subject matter hereof.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of California (with the exception of its conflict of laws provisions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.03pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All payments made pursuant to this Agreement will be subject to withholding of applicable income and employment taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together will constitute one and the same instrument.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font></div></div></div><div id="i7a922b0110b74e48a00b6c96b5f15142_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">In Witness Whereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, each of the parties has executed this amended and restated Agreement, in the case of the Company by its duly authorized officer, as of the last date signed below.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:225pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">COMPANY</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:225pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EHEALTH, INC.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:225pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:8.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Scott Flanders</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Scott Flanders</font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:12.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Chief Executive Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Feb 8, 2021</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:225pt;text-align:right"><font><br></font></div><div style="margin-top:12pt;padding-left:225pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:225pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:8.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Phillip Morelock</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Phillip Morelock</font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:12.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Feb 8, 2021</font></td></tr></table></div><div style="margin-top:24pt;padding-left:252pt;text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font></div></div></div><div id="i7a922b0110b74e48a00b6c96b5f15142_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A<br><br>eHealth, Inc.<br>Release of Claims</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">This Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is made by and between eHealth, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and _______________ (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Whereas</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Executive has agreed to enter into a release of claims in favor of the Company upon certain events specified in the Severance Agreement by and between Company and Executive (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Severance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Now Therefore</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in consideration of the mutual promises made herein, the Parties hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive&#8217;s employment from the Company terminated on ___________________________.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall continue to maintain the confidentiality of all confidential and proprietary information of the Company and shall continue to comply with the terms and conditions of the Proprietary Information and Inventions Agreement between Executive and the Company.  Executive shall return all the Company property and confidential and proprietary information in his possession to the Company on the Effective Date of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Payment of Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive acknowledges and represents that the Company has paid all salary, wages, bonuses, accrued vacation, commissions and any and all other benefits due to Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as set forth in the last paragraph of this Section 4, Executive agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company.  Executive, on behalf of himself, and his respective heirs, family members, executors and assigns, hereby fully and forever releases the Company and its past, present and future officers, agents, directors, employees, investors, shareholders, administrators, affiliates, divisions, subsidiaries, parents, predecessor and successor corporations, and assigns, from, and agrees not to sue or otherwise institute or cause to be instituted any legal or administrative proceedings concerning any claim, duty, obligation or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that he may possess arising from any omissions, acts or facts that have occurred up until and including the Effective Date of this Agreement including, without limitation,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">any and all claims relating to or arising from Executive&#8217;s employment relationship with the Company and the termination of that relationship&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">any and all claims relating to, or arising from, Executive&#8217;s right to purchase, or actual purchase of shares of stock of the Company, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">any and all claims for wrongful discharge of employment&#59; termination in violation of public policy&#59; discrimination&#59; breach of contract, both express and implied&#59; breach of a covenant of good faith and fair dealing, both express and implied&#59; promissory estoppel&#59; negligent or intentional infliction of emotional distress&#59; negligent or intentional misrepresentation&#59; negligent or intentional interference with contract or prospective economic advantage&#59; unfair business practices&#59; defamation&#59; libel&#59; slander&#59; negligence&#59; personal injury&#59; assault&#59; battery&#59; invasion of privacy&#59; false imprisonment&#59; and conversion&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">any and all claims for violation of any federal, state or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act of 1990, the Fair Labor Standards Act, Executive Retirement Income Security Act of 1974, The Worker Adjustment and Retraining Notification Act, the California Fair Employment and Housing Act, and Labor Code section 201, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. and section 970, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. and all amendments to each such Act as well as the regulations issued thereunder&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">any and all claims for violation of the federal, or any state, constitution&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">any and all claims arising out of any other laws and regulations relating to employment or employment discrimination&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">any and all claims for attorneys&#8217; fees and costs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released.  This release does not extend to any severance obligations due Executive under the Severance Agreement or to any vested rights to benefits Executive has under any employee benefit plans of the Company.  Nothing in this Agreement waives Executive&#8217;s rights to indemnification or any payments under any fiduciary or directors &#38; officers insurance policy, if any, provided by any act or agreement of the Company, state or federal law or policy of insurance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Acknowledgment of Waiver of Claims under ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive acknowledges that he is waiving and releasing any rights he may have under the Age Discrimination in Employment Act of 1967 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and that this waiver and release is knowing and voluntary.  Executive and the Company agree that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement, Executive acknowledges that the consideration given for this waiver and release Agreement is in addition to anything of value to which Executive was already entitled.  Executive further acknowledges that he has been advised by this writing that (a) he should consult with an attorney prior to executing this Agreement&#59; (b) he has at least twenty-one (21) days within which to consider this Agreement&#59; (c) he has seven (7) days following the execution of this Agreement by the parties to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">revoke the Agreement&#59; (d) this Agreement shall not be effective until the revocation period has expired&#59; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs for doing so, unless specifically authorized by federal law.  Any revocation should be in writing and delivered to the Vice-President of Human Resources at the Company by close of business on the seventh day from the date that Executive signs this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Civil Code Section 1542</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive represents that he is not aware of any claims against the Company other than the claims that are released by this Agreement.  Executive acknowledges that he has been advised by legal counsel and is familiar with the provisions of California Civil Code 1542, below, which provides as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive, being aware of said code section, agrees to expressly waive any rights he may have thereunder, as well as under any statute or common law principles of similar effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">No Pending or Future Lawsuits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive represents that he has no lawsuits, claims, or actions pending in his name, or on behalf of any other person or entity, against the Company or any other person or entity referred to herein.  Executive also represents that he does not intend to bring any claims on his own behalf or on behalf of any other person or entity against the Company or any other person or entity referred to herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Application for Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive understands and agrees that, as a condition of this Agreement, he shall not be entitled to any employment with the Company, its subsidiaries, or any successor, and he hereby waives any right, or alleged right, of employment or re-employment with the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">No Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive agrees that he will not counsel or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against the Company and&#47;or any officer, director, employee, agent, representative, shareholder or attorney of the Company, unless under a subpoena or other court order to do so.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">No Admission of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No action taken by the Company, either previously or in connection with this Agreement shall be deemed or construed to be (a) an admission of the truth or falsity of any claims heretofore made or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Executive or to any third party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Parties shall each bear their own costs, expert fees, attorneys&#8217; fees and other fees incurred in connection with this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive represents and warrants that he has the capacity to act on his own behalf and on behalf of all who might claim through him to bind them to the terms and conditions of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">No Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive represents that he has had the opportunity to consult with an attorney, and has carefully read and understands the scope and effect of the provisions of this Agreement.  Neither party has relied upon any representations or statements made by the other party hereto which are not specifically set forth in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS AGREEMENT, THEIR INTERPRETATION, AND ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION IN SANTA CLARA COUNTY, BEFORE JUDICIAL ARBITRATION &#38; MEDIATION SERVICES, INC. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">JAMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES &#38; PROCEDURES (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">JAMS RULES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  THE ARBITRATOR MAY GRANT INJUNCTIONS AND OTHER RELIEF IN SUCH DISPUTES.  THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH CALIFORNIA LAW, INCLUDING THE CALIFORNIA CODE OF CIVIL PROCEDURE, AND THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL CALIFORNIA LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO ANY CONFLICT-OF-LAW PROVISIONS OF ANY JURISDICTION.  TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH CALIFORNIA LAW, CALIFORNIA LAW SHALL TAKE PRECEDENCE.  THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE, AND BINDING ON THE PARTIES TO THE ARBITRATION.  THE PARTIES AGREE THAT THE PREVAILING PARTY IN ANY ARBITRATION SHALL BE ENTITLED TO INJUNCTIVE RELIEF IN ANY COURT OF COMPETENT JURISDICTION TO ENFORCE THE ARBITRATION AWARD.  THE PARTIES TO THE ARBITRATION SHALL EACH PAY AN EQUAL SHARE OF THE COSTS AND EXPENSES OF SUCH ARBITRATION, AND EACH PARTY SHALL SEPARATELY PAY FOR ITS RESPECTIVE COUNSEL FEES AND EXPENSES&#59; PROVIDED, HOWEVER, THAT THE ARBITRATOR SHALL AWARD ATTORNEYS&#8217; FEES AND COSTS TO THE PREVAILING PARTY, EXCEPT AS PROHIBITED BY LAW.  THE PARTIES HEREBY AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY.  NOTWITHSTANDING THE FOREGOING, THIS SECTION WILL NOT PREVENT EITHER PARTY FROM SEEKING INJUNCTIVE RELIEF (OR ANY OTHER PROVISIONAL REMEDY) FROM ANY COURT HAVING JURISDICTION OVER THE PARTIES AND THE SUBJECT MATTER OF THEIR DISPUTE RELATING TO THIS AGREEMENT AND THE AGREEMENTS INCORPORATED HEREIN BY REFERENCE.  SHOULD ANY PART OF THE ARBITRATION AGREEMENT CONTAINED IN THIS PARAGRAPH CONFLICT WITH ANY OTHER ARBITRATION AGREEMENT BETWEEN </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THE PARTIES, THE PARTIES AGREE THAT THIS ARBITRATION AGREEMENT SHALL GOVERN.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement, along with the Severance Agreement, the Proprietary Information and Inventions Agreement, and Executive&#8217;s written equity compensation agreements with the Company, represents the entire agreement and understanding between the Company and Executive concerning Executive&#8217;s separation from the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">No Oral Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may only be amended in writing signed by Executive and the Chief Executive Officer of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by the internal substantive laws, but not the choice of law rules, of the State of California.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement is effective eight (8) days after it has been signed by both Parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be executed in counterparts, and each counterpart shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Voluntary Execution of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement is executed voluntarily and without any duress or undue influence on the part or behalf of the Parties hereto, with the full intent of releasing all claims.  The Parties acknowledge that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">They have read this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">They have had the opportunity of being represented in the preparation, negotiation, and execution of this Agreement by legal counsel of their own choice or that they have voluntarily declined to seek such counsel&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">They understand the terms and consequences of this Agreement and of the releases it contains&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">They are fully aware of the legal and binding effect of this Agreement.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">In Witness Whereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Parties have executed this Agreement on the respective dates set forth below.</font></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">eHealth, Inc.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.619%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;name, title&#93;</font></td></tr></table></div><div style="margin-top:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.619%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;name&#93;</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>3
<FILENAME>exhibit106severanceagreeme.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i81521132988845d087c69ada5f648d6a_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EHEALTH, INC.<br>SEVERANCE AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;This Severance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is by and between </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">eHealth, Inc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. (together with its subsidiary, eHealthInsurance Services, Inc., the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and Gregg Ratkovic (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive and the Company agree that Executive&#8217;s employment with Company constitutes &#8220;at-will&#8221; employment.  Executive and the Company acknowledge that this employment relationship may be terminated at any time, upon written notice to the other party, with or without Cause, at the option either of the Company or Executive.  However, as described in this Agreement, Executive may be entitled to severance benefits depending upon the circumstances of Executive&#8217;s termination of employment.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Involuntary Termination Other than for Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Company (or any parent or subsidiary of the Company) terminates Executive&#8217;s employment for other than &#8220;Cause&#8221; (as defined herein), and Executive signs and does not revoke a standard release of claims with the Company in a form substantially similar to that attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then Executive shall receive the following severance benefits from the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:65.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:31.5pt">Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall receive continued payment (less applicable withholding taxes) of Executive&#8217;s base salary as in effect immediately prior to the termination of Executive&#8217;s employment with the Company, for a period of six (6) months following the termination of Executive&#8217;s employment with the Company, payable in accordance with the Company&#8217;s normal payroll practices.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.86pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:31.5pt">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to Executive timely electing continuation coverage under Title X of the Consolidated Budget Reconciliation Act of 1985 (&#8220;COBRA&#8221;), Executive shall receive one-hundred percent (100%) Company-paid group health, dental and vision coverage (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company-Paid Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). If such coverage included Executive&#8217;s dependents immediately prior to the termination, such dependents shall also be covered at Company expense. Company-Paid Coverage shall continue until the earlier of (i) six (6) months following the date of termination, or (ii) the date upon which Executive and his dependents become covered under another employer&#8217;s group health, dental and vision plans that provide Executive and his dependents with comparable benefits and levels of coverage (such earlier date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COBRA Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it cannot provide the Company-Paid Coverage without a substantial risk of violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company shall in lieu thereof provide to Executive a taxable monthly payment in an amount equal to the monthly COBRA premium that Executive would be required to pay to continue Executive&#8217;s (and Executive&#8217;s dependents&#8217;, as applicable) group health, dental and vision coverage in effect on the date of Executive&#8217;s employment termination </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(which amount shall be based on the premium for the first month of COBRA coverage), which payments shall be made to Executive regardless of whether Executive elects COBRA continuation coverage and shall end on the COBRA Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Involuntary Termination Other than for Cause During the One-Year Period Following a Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Company (or any parent or subsidiary of the Company) terminates Executive&#8217;s employment for other than &#8220;Cause&#8221; (as defined herein) during the one-year period following a Change in Control, and Executive signs and does not revoke the Release, then in addition to the severance benefits provided in Section 2(a) above, Executive shall receive the following severance benefits from the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:65.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:31.5pt">Bonus Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall receive a single lump-sum cash payment (less applicable withholding taxes) in an amount equal to fifty percent (50%) of Executive&#8217;s then current target annual bonus.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.86pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:31.5pt">Equity Award Vesting.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  One hundred percent (100%) of Executive&#8217;s then outstanding and unvested time-based equity awards (whether stock options, stock appreciation rights, shares of restricted stock, restricted stock units or otherwise) shall become vested and shall otherwise remain subject to the terms and conditions of the applicable equity incentive plan and the award agreements pursuant to which the time-based equity awards were granted. Executive&#8217;s then outstanding and unvested performance-based equity awards, shall vest in accordance with the terms of the applicable equity incentive plan and the award agreements pursuant to which the performance-based equity awards were granted and not pursuant to the terms of this Agreement. For the avoidance of doubt, all performance-based equity awards, including those where performance goals have been achieved but which remain subject to time-based vesting, shall not be considered time-based awards under the terms of this Agreement and shall be governed by the applicable incentive plan and the award agreements pursuant to which the performance-based equity awards were granted. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Voluntary Resignation&#59; Termination for Cause&#59; Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If Executive&#8217;s employment with the Company terminates (i) voluntarily by Executive (ii) for Cause by the Company, or (iii) due to Executive&#8217;s death or Disability (as defined hereunder), then Executive shall not be entitled to receive severance or other benefits except for those (if any) as may then be established under the Company&#8217;s then existing severance and benefits plans and practices or pursuant to other written agreements with the Company.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Exclusive Remedy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions of this Section 2 are intended to be and are Executive&#8217;s exclusive rights to severance payments and benefits in the event of termination of service.  The parties hereto agree that nothing herein is intended to result in duplication of severance or any other benefits.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:18.2pt">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:65.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">Any amount paid under this Agreement that satisfies the requirements of the &#8220;short-term deferral&#8221; rule set forth in Section 1.409A-l(b)(4) of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">regulations issued under Section 409A of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Treasury Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall not constitute Deferred Compensation Separation Benefits for purposes of Section 2(e)(ii) below, and consequently shall be paid to Executive promptly following termination as otherwise required by this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.86pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">Notwithstanding anything to the contrary in this Agreement, if Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A of the Code, and the final regulations and any guidance promulgated thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) at the time of Executive&#8217;s separation from service (as such term is defined in Section 409A), then the cash severance benefits payable to Executive under this Agreement along with any other severance payments or separation benefits that may be considered deferred compensation under Section 409A (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) that are otherwise due to Executive on or within the six (6) month period following Executive&#8217;s separation from service shall accrue during such six (6) month period and shall become payable in a lump sum payment on the date six (6) months and one (1) day following the date of Executive&#8217;s separation from service.  All subsequent payments, if any, shall be payable in accordance with the payment schedule applicable to each payment or benefit.  Notwithstanding anything herein to the contrary, if Executive dies following his separation from service but prior to the six (6) month anniversary of his date of separation from service, then any payments delayed in accordance with this Section shall be payable in a lump sum as soon as administratively practicable after the date of Executive&#8217;s death and all other Deferred Compensation Separation Benefits shall be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:58.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">Any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-l(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit (as defined below) shall not constitute Deferred Compensation Separation Benefits for purposes of Section 2(e)(ii) above.  For purposes of this Section 2(e), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Section 409A Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; will mean the lesser of two (2) times&#58; (i) Executive&#8217;s annualized compensation based upon the annual rate of pay paid to Executive during the Company&#8217;s taxable year preceding the Company&#8217;s taxable year of Executive&#8217;s termination of employment as determined under Treasury Regulation 1.409A-l(b)(9)(iii)(A)(l)&#59; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive&#8217;s employment is terminated.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:59.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">It is the intent of this Agreement to comply with the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder shall be subject to the additional tax imposed under Section 409A, and any ambiguities herein shall be interpreted to so comply.  The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition under Section 409A prior to actual payment to Executive.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:62.52pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">Notwithstanding any other provisions of this Agreement, Executive&#8217;s receipt of severance payments and benefits under this Agreement is conditioned upon Executive signing and not revoking the Release and subject to the Release becoming effective within sixty (60) days following Executive&#8217;s termination of employment (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Release Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  No severance will be paid or provided unless the Release becomes effective during the Release Period.  Any severance payments to which Executive is entitled under this Agreement shall be paid by the Company to Executive in cash and in full arrears on the date on which the Release becomes effective or such later date as is required to comply with Section 409A&#59; provided however, that if the Release Period straddles two calendar years, the severance payments to which Executive is entitled under this Agreement shall be paid on the latest of (A) the date on which the Release becomes effective, (B) the first business day of the calendar year following the year in which Executive terminates employment with the Company or (C) such later date as is required to comply with Section 409A. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:59.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">With respect to reimbursements or in-kind benefits provided to Executive hereunder (or otherwise) that are not exempt from Section 409A, the following rules shall apply&#58; (A) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during any one of Executive&#8217;s taxable years shall not affect the expenses eligible for reimbursement, or in-kind benefit to be provided in any other taxable year, (B) in the case of any reimbursements of eligible expenses, reimbursement shall be made on or before the last day of Executive&#8217;s taxable year following the taxable year in which the expense was incurred and (C) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Golden Parachute Excise Tax Best Results</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any payment or benefit Executive would receive pursuant to this Agreement or otherwise (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) would (i) constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then such Payment shall be reduced to the Reduced Amount.  The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Reduced Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Executive&#8217;s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.  If a reduction in payments or benefits constituting &#8220;parachute payments&#8221; is necessary so that the Payment equals the Reduced Amount, reduction shall occur in the following order&#58; (A) cash payments shall be reduced first and in reverse chronological order such that the cash payment owed on the latest date following the occurrence of the event triggering such excise tax will be the first cash payment to be reduced&#59; (B) accelerated vesting of stock awards shall be cancelled&#47;reduced next and in the reverse order of the date of grant for such stock awards (i.e., the vesting of the most recently granted stock awards will be reduced first)&#59; and (C) employee benefits shall be reduced last and in reverse </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">chronological order such that the benefit owed on the latest date following the occurrence of the event triggering such excise tax will be the first benefit to be reduced.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall appoint a nationally recognized accounting firm or consulting firm to make the determinations required hereunder and perform the foregoing calculations.  The Company shall bear all expenses with respect to the determinations by such accounting or consulting firm required to be made hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The accounting or consulting firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting documentation, to the Company and Executive within fifteen (15) calendar days after the date on which right to a Payment is triggered (if requested at that time by the Company or Executive) or such other time as requested by the Company or Executive.  If the accounting or consulting firm determines that no Excise Tax is payable with respect to a Payment, either before or after the application of the Reduced Amount, it shall furnish the Company and Executive with an opinion reasonably acceptable to Executive that no Excise Tax will be imposed with respect to such Payment.  Any good faith determinations of the accounting or consulting firm made hereunder shall be final, binding and conclusive upon the Company and Executive.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Definition of Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The following terms referred to in this Agreement shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (i) Executive&#8217;s commission of any act of fraud, embezzlement or dishonesty, (ii) Executive&#8217;s conviction of, or plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">nolo contendere</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> to, a felony under the laws of the United States or any state thereof, (iii) Executive&#8217;s continued failure to perform lawfully assigned duties for 30 days after receiving written notification from the  Company, (iv) Executive&#8217;s unauthorized use or disclosure of confidential information or trade secrets of the Company, or (v) any other intentional misconduct by Executive that adversely affects the business of the Company in a material manner.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following, in one or a series of related transactions&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:65.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">Any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company&#8217;s then outstanding voting securities&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.86pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:58.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.5pt">The consummation of the sale, lease or other disposition by the Company of all or substantially all the Company&#8217;s assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Executive (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to last for a continuous period of not less than twelve (12) months, receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering Company employees,</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">The Company&#8217;s Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company&#8217;s business and&#47;or assets shall assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession.  For all purposes under this Agreement, the term &#8220;Company&#8221; shall include any successor to the Company&#8217;s business and&#47;or assets which executes and delivers the assumption agreement described in this Section 5(a) or which becomes bound by the terms of this Agreement by operation of law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Executive&#8217;s Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The terms of this Agreement and all rights of Executive hereunder shall inure to the benefit of, and be enforceable by, Executive&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All notices and other communications required or permitted hereunder shall be in writing, shall be effective when given, and shall in any event be deemed to be given upon receipt or, if earlier, (a) five (5) days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by first class mail, postage prepaid, (b) upon delivery, if delivered by hand, (c) one (1) business day after the business day of deposit with Federal Express or similar overnight courier, freight prepaid, (d) one (1) business day after the business day of facsimile transmission, if delivered by facsimile transmission with copy by first class mail, postage prepaid, (e) upon transmission, if sent by email, and shall be addressed (i) if to Executive, at his or her last known residential address or email address and (ii) if to the Company, at the address of its principal corporate offices (attention&#58; Secretary), or in any such case at such other address as a party may designate by ten (10) days&#8217; advance written notice to the other party pursuant to the provisions above.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any termination by the Company for Cause or by Executive as a result of a voluntary resignation shall be communicated by a notice of termination to the other party hereto given in accordance with Section 6 of this Agreement.  Such notice shall indicate the specific termination provision in this Agreement relied upon, shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">indicated, and shall specify the termination date (which shall be not more than thirty (30) days after the giving of such notice).  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">No Duty to Mitigate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall not be required to mitigate the amount of any payment contemplated by this Agreement, nor shall any such payment be reduced by any earnings that Executive may receive from any other source.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive).  No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement represents the entire agreement between Executive and the Company regarding Executive&#8217;s severance agreement with the Company, and supersede in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied), of the parties with respect to the subject matter hereof. This Agreement supersedes and replaces in its entirety the Severance Agreement entered into between Executive and the Company on February 4, 2021.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of California (with the exception of its conflict of laws provisions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.03pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All payments made pursuant to this Agreement will be subject to withholding of applicable income and employment taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together will constitute one and the same instrument.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font></div></div></div><div id="i81521132988845d087c69ada5f648d6a_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">In Witness Whereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, each of the parties has executed this amended and restated Agreement, in the case of the Company by its duly authorized officer, as of the last date signed below.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:225pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">COMPANY</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:225pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EHEALTH, INC.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:225pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:8.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Scott Flanders</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Scott Flanders</font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:12.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Chief Executive Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mar 15, 2021</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:225pt;text-align:right"><font><br></font></div><div style="margin-top:12pt;padding-left:225pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:225pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:8.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Gregg Ratkovic</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Gregg Ratkovic</font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:12.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mar 15, 2021</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font></div></div></div><div id="i81521132988845d087c69ada5f648d6a_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A<br><br>eHealth, Inc.<br>Release of Claims</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">This Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is made by and between eHealth, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and _______________ (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Whereas</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Executive has agreed to enter into a release of claims in favor of the Company upon certain events specified in the Severance Agreement by and between Company and Executive (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Severance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Now Therefore</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in consideration of the mutual promises made herein, the Parties hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive&#8217;s employment from the Company terminated on ___________________________.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall continue to maintain the confidentiality of all confidential and proprietary information of the Company and shall continue to comply with the terms and conditions of the Proprietary Information and Inventions Agreement between Executive and the Company.  Executive shall return all the Company property and confidential and proprietary information in his possession to the Company on the Effective Date of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Payment of Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive acknowledges and represents that the Company has paid all salary, wages, bonuses, accrued vacation, commissions and any and all other benefits due to Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as set forth in the last paragraph of this Section 4, Executive agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company.  Executive, on behalf of himself, and his respective heirs, family members, executors and assigns, hereby fully and forever releases the Company and its past, present and future officers, agents, directors, employees, investors, shareholders, administrators, affiliates, divisions, subsidiaries, parents, predecessor and successor corporations, and assigns, from, and agrees not to sue or otherwise institute or cause to be instituted any legal or administrative proceedings concerning any claim, duty, obligation or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that he may possess arising from any omissions, acts or facts that have occurred up until and including the Effective Date of this Agreement including, without limitation,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">any and all claims relating to or arising from Executive&#8217;s employment relationship with the Company and the termination of that relationship&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">any and all claims relating to, or arising from, Executive&#8217;s right to purchase, or actual purchase of shares of stock of the Company, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">any and all claims for wrongful discharge of employment&#59; termination in violation of public policy&#59; discrimination&#59; breach of contract, both express and implied&#59; breach of a covenant of good faith and fair dealing, both express and implied&#59; promissory estoppel&#59; negligent or intentional infliction of emotional distress&#59; negligent or intentional misrepresentation&#59; negligent or intentional interference with contract or prospective economic advantage&#59; unfair business practices&#59; defamation&#59; libel&#59; slander&#59; negligence&#59; personal injury&#59; assault&#59; battery&#59; invasion of privacy&#59; false imprisonment&#59; and conversion&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">any and all claims for violation of any federal, state or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act of 1990, the Fair Labor Standards Act, Executive Retirement Income Security Act of 1974, The Worker Adjustment and Retraining Notification Act, the California Fair Employment and Housing Act, and Labor Code section 201, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. and section 970, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. and all amendments to each such Act as well as the regulations issued thereunder&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">any and all claims for violation of the federal, or any state, constitution&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">any and all claims arising out of any other laws and regulations relating to employment or employment discrimination&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">any and all claims for attorneys&#8217; fees and costs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released.  This release does not extend to any severance obligations due Executive under the Severance Agreement or to any vested rights to benefits Executive has under any employee benefit plans of the Company.  Nothing in this Agreement waives Executive&#8217;s rights to indemnification or any payments under any fiduciary or directors &#38; officers insurance policy, if any, provided by any act or agreement of the Company, state or federal law or policy of insurance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Acknowledgment of Waiver of Claims under ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive acknowledges that he is waiving and releasing any rights he may have under the Age Discrimination in Employment Act of 1967 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and that this waiver and release is knowing and voluntary.  Executive and the Company agree that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement, Executive acknowledges that the consideration given for this waiver and release Agreement is in addition to anything of value to which Executive was already entitled.  Executive further acknowledges that he has been advised by this writing that (a) he should consult with an attorney prior to executing this Agreement&#59; (b) he has at least twenty-one (21) days within which to consider this Agreement&#59; (c) he has seven (7) days following the execution of this Agreement by the parties to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">revoke the Agreement&#59; (d) this Agreement shall not be effective until the revocation period has expired&#59; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs for doing so, unless specifically authorized by federal law.  Any revocation should be in writing and delivered to the Vice-President of Human Resources at the Company by close of business on the seventh day from the date that Executive signs this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Civil Code Section 1542</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive represents that he is not aware of any claims against the Company other than the claims that are released by this Agreement.  Executive acknowledges that he has been advised by legal counsel and is familiar with the provisions of California Civil Code 1542, below, which provides as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive, being aware of said code section, agrees to expressly waive any rights he may have thereunder, as well as under any statute or common law principles of similar effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">No Pending or Future Lawsuits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive represents that he has no lawsuits, claims, or actions pending in his name, or on behalf of any other person or entity, against the Company or any other person or entity referred to herein.  Executive also represents that he does not intend to bring any claims on his own behalf or on behalf of any other person or entity against the Company or any other person or entity referred to herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Application for Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive understands and agrees that, as a condition of this Agreement, he shall not be entitled to any employment with the Company, its subsidiaries, or any successor, and he hereby waives any right, or alleged right, of employment or re-employment with the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">No Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive agrees that he will not counsel or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against the Company and&#47;or any officer, director, employee, agent, representative, shareholder or attorney of the Company, unless under a subpoena or other court order to do so.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">No Admission of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No action taken by the Company, either previously or in connection with this Agreement shall be deemed or construed to be (a) an admission of the truth or falsity of any claims heretofore made or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Executive or to any third party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Parties shall each bear their own costs, expert fees, attorneys&#8217; fees and other fees incurred in connection with this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive represents and warrants that he has the capacity to act on his own behalf and on behalf of all who might claim through him to bind them to the terms and conditions of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">No Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive represents that he has had the opportunity to consult with an attorney, and has carefully read and understands the scope and effect of the provisions of this Agreement.  Neither party has relied upon any representations or statements made by the other party hereto which are not specifically set forth in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS AGREEMENT, THEIR INTERPRETATION, AND ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION IN SANTA CLARA COUNTY, BEFORE JUDICIAL ARBITRATION &#38; MEDIATION SERVICES, INC. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">JAMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES &#38; PROCEDURES (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">JAMS RULES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  THE ARBITRATOR MAY GRANT INJUNCTIONS AND OTHER RELIEF IN SUCH DISPUTES.  THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH CALIFORNIA LAW, INCLUDING THE CALIFORNIA CODE OF CIVIL PROCEDURE, AND THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL CALIFORNIA LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO ANY CONFLICT-OF-LAW PROVISIONS OF ANY JURISDICTION.  TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH CALIFORNIA LAW, CALIFORNIA LAW SHALL TAKE PRECEDENCE.  THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE, AND BINDING ON THE PARTIES TO THE ARBITRATION.  THE PARTIES AGREE THAT THE PREVAILING PARTY IN ANY ARBITRATION SHALL BE ENTITLED TO INJUNCTIVE RELIEF IN ANY COURT OF COMPETENT JURISDICTION TO ENFORCE THE ARBITRATION AWARD.  THE PARTIES TO THE ARBITRATION SHALL EACH PAY AN EQUAL SHARE OF THE COSTS AND EXPENSES OF SUCH ARBITRATION, AND EACH PARTY SHALL SEPARATELY PAY FOR ITS RESPECTIVE COUNSEL FEES AND EXPENSES&#59; PROVIDED, HOWEVER, THAT THE ARBITRATOR SHALL AWARD ATTORNEYS&#8217; FEES AND COSTS TO THE PREVAILING PARTY, EXCEPT AS PROHIBITED BY LAW.  THE PARTIES HEREBY AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY.  NOTWITHSTANDING THE FOREGOING, THIS SECTION WILL NOT PREVENT EITHER PARTY FROM SEEKING INJUNCTIVE RELIEF (OR ANY OTHER PROVISIONAL REMEDY) FROM ANY COURT HAVING JURISDICTION OVER THE PARTIES AND THE SUBJECT MATTER OF THEIR DISPUTE RELATING TO THIS AGREEMENT AND THE AGREEMENTS INCORPORATED HEREIN BY REFERENCE.  SHOULD ANY PART OF THE ARBITRATION AGREEMENT CONTAINED IN THIS PARAGRAPH CONFLICT WITH ANY OTHER ARBITRATION AGREEMENT BETWEEN </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THE PARTIES, THE PARTIES AGREE THAT THIS ARBITRATION AGREEMENT SHALL GOVERN.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement, along with the Severance Agreement, the Proprietary Information and Inventions Agreement, and Executive&#8217;s written equity compensation agreements with the Company, represents the entire agreement and understanding between the Company and Executive concerning Executive&#8217;s separation from the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">No Oral Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may only be amended in writing signed by Executive and the Chief Executive Officer of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by the internal substantive laws, but not the choice of law rules, of the State of California.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement is effective eight (8) days after it has been signed by both Parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be executed in counterparts, and each counterpart shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt">Voluntary Execution of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement is executed voluntarily and without any duress or undue influence on the part or behalf of the Parties hereto, with the full intent of releasing all claims.  The Parties acknowledge that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">They have read this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">They have had the opportunity of being represented in the preparation, negotiation, and execution of this Agreement by legal counsel of their own choice or that they have voluntarily declined to seek such counsel&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">They understand the terms and consequences of this Agreement and of the releases it contains&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">They are fully aware of the legal and binding effect of this Agreement.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">In Witness Whereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Parties have executed this Agreement on the respective dates set forth below.</font></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">eHealth, Inc.</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.619%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;name, title&#93;</font></td></tr></table></div><div style="margin-top:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.619%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;name&#93;</font></td></tr></table></div><div style="padding-left:2.16pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>a2021q1ex311.htm
<DESCRIPTION>EX-31.1 CEO CERTIFICATION
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7d540145dba6461f98581158815d2695_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:5pt;text-align:right;text-indent:72pt"><font><br></font></div><div style="margin-top:5pt;text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Scott N. Flanders, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of eHealth, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;SCOTT N. FLANDERS&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott N. Flanders</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer<br></font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>a2021q1ex312.htm
<DESCRIPTION>EX-31.2 CFO CERTIFICATION
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id97ccdbd8d464fb69ab5eec562c560bd_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Derek N. Yung,  certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of eHealth, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;DEREK N. YUNG</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derek N. Yung</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer<br></font></td></tr></table></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>a2021q1ex321.htm
<DESCRIPTION>EX-32.1 CEO SECTION 906 CERTIFICATION
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie9ad2c334a7c4af3982e80fe8fdc1bc3_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer, Pursuant to</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. Section 1350,</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted Pursuant to</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 906 of the Sarbanes-Oxley Act of 2002&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of eHealth, Inc. on Form 10-Q (the &#8220;Form 10-Q&#8221;) for the quarter ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Scott N. Flanders, Chief Executive Officer of eHealth, Inc., certify, pursuant to 18 U.S.C.&#160;Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58; &#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Form 10-Q, to which this certification is attached as Exhibit&#160;32.1, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and &#160;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of eHealth, Inc.</font></div><div style="margin-top:10pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:32.051%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;SCOTT N. FLANDERS</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott N. Flanders</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer<br></font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2021</font></td></tr></table></div><div style="padding-left:9pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to eHealth, Inc. and will be retained by eHealth, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>a2021q1ex322.htm
<DESCRIPTION>EX-32.2 CFO SECTION 906 CERTIFICATION
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6ac1a55feb9e4b689832864d0aca0ea0_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer, Pursuant to</font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. Section 1350,</font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted Pursuant to</font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 906 of the Sarbanes-Oxley Act of 2002&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of eHealth, Inc. on Form 10-Q (the &#8220;Form 10-Q&#8221;) for the quarter ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Derek N. Yung, Chief Financial Officer of eHealth, Inc., certify, pursuant to 18 U.S.C.&#160;Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Form 10-Q, to which this certification is attached as Exhibit&#160;32.2, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and &#160;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of eHealth, Inc.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:31.410%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160; &#160;DEREK N. YUNG</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derek N. Yung</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer <br></font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2021</font></td></tr></table></div><div style="text-indent:9pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to eHealth, Inc. and will be retained by eHealth, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>ehth-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:31f4f7fb-855a-4e3e-841b-479b93e1e603,g:93b223c9-0d4d-4bbf-9f72-5268ef99062c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ehth="http://www.ehealthinsurance.com/20210331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ehealthinsurance.com/20210331">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.ehealthinsurance.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofBusinessandSignificantAccountingPolicies" roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Summary of Business and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofBusinessandSignificantAccountingPoliciesPolicies" roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of Business and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2403401 - Disclosure - Summary of Business and Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.ehealthinsurance.com/role/Revenue">
        <link:definition>2104102 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.ehealthinsurance.com/role/RevenueTables">
        <link:definition>2305301 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofRevenueDetails" roleURI="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails">
        <link:definition>2406402 - Disclosure - Revenue - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueCommissionRevenuebySegmentDetails" roleURI="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails">
        <link:definition>2407403 - Disclosure - Revenue - Commission Revenue by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformation" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation">
        <link:definition>2108103 - Disclosure - Supplemental Financial Statement Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationTables" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables">
        <link:definition>2309302 - Disclosure - Supplemental Financial Statement Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>2410404 - Disclosure - Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails">
        <link:definition>2411405 - Disclosure - Supplemental Financial Statement Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails">
        <link:definition>2412406 - Disclosure - Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails">
        <link:definition>2413407 - Disclosure - Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails">
        <link:definition>2414408 - Disclosure - Supplemental Financial Statement Information - Schedule of Credit Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>2415409 - Disclosure - Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurements">
        <link:definition>2116104 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsTables">
        <link:definition>2317303 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSummaryofFinancialAssetsDetails" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails">
        <link:definition>2418410 - Disclosure - Fair Value Measurements - Summary of Financial Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsContractualMaturitiesDetails" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails">
        <link:definition>2419411 - Disclosure - Fair Value Measurements - Contractual Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsUnrealizedGainsandLossesDetails" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails">
        <link:definition>2420412 - Disclosure - Fair Value Measurements - Unrealized Gains and Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsUnrealizedGainsandLossesDetails_1" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1">
        <link:definition>2420412 - Disclosure - Fair Value Measurements - Unrealized Gains and Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2421413 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://www.ehealthinsurance.com/role/Equity">
        <link:definition>2122105 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTables" roleURI="http://www.ehealthinsurance.com/role/EquityTables">
        <link:definition>2323304 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/EquityNarrativeDetails">
        <link:definition>2424414 - Disclosure - Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityScheduleofStockBasedCompensationExpenseDetails" roleURI="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>2425415 - Disclosure - Equity - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShare" roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShare">
        <link:definition>2126106 - Disclosure - Net Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareTables" roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables">
        <link:definition>2327305 - Disclosure - Net Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails" roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails">
        <link:definition>2428416 - Disclosure - Net Income (Loss) Per Share - Computation of Basic and Diluted Net Income per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails">
        <link:definition>2429417 - Disclosure - Net Income (Loss) Per Share - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingencies">
        <link:definition>2130107 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables">
        <link:definition>2331306 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2432418 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformation" roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformation">
        <link:definition>2133108 - Disclosure - Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationTables" roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables">
        <link:definition>2334307 - Disclosure - Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationSegmentOperatingResultsDetails" roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails">
        <link:definition>2435419 - Disclosure - Segment and Geographic Information - Segment Operating Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails">
        <link:definition>2436420 - Disclosure - Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails">
        <link:definition>2437421 - Disclosure - Segment and Geographic Information - Schedule of Revenue by Major Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.ehealthinsurance.com/role/Leases">
        <link:definition>2138109 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.ehealthinsurance.com/role/LeasesTables">
        <link:definition>2339308 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails">
        <link:definition>2440422 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>2441423 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalInformationDetails" roleURI="http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails">
        <link:definition>2442424 - Disclosure - Leases - Supplemental Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>2443425 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>2443425 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring" roleURI="http://www.ehealthinsurance.com/role/Restructuring">
        <link:definition>2144110 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringDetails" roleURI="http://www.ehealthinsurance.com/role/RestructuringDetails">
        <link:definition>2445426 - Disclosure - Restructuring (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.ehealthinsurance.com/role/Debt">
        <link:definition>2146111 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetails" roleURI="http://www.ehealthinsurance.com/role/DebtDetails">
        <link:definition>2447427 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.ehealthinsurance.com/role/IncomeTaxes">
        <link:definition>2148112 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesTables">
        <link:definition>2349309 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofIncomeTaxBenefitDetails" roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails">
        <link:definition>2450428 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2451429 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvent" roleURI="http://www.ehealthinsurance.com/role/SubsequentEvent">
        <link:definition>2152113 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventDetails" roleURI="http://www.ehealthinsurance.com/role/SubsequentEventDetails">
        <link:definition>2453430 - Disclosure - Subsequent Event (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ehth_IncrementalCommonSharesAttributableToOptions" abstract="false" name="IncrementalCommonSharesAttributableToOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ehth_LeViasCompliantMember" abstract="true" name="LeViasCompliantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" abstract="false" name="ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ehth_MedicarePartDMember" abstract="true" name="MedicarePartDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_OutOfPeriodAdjustmentsMember" abstract="true" name="OutOfPeriodAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityBorrowingBasePercentage" abstract="false" name="LineOfCreditFacilityBorrowingBasePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ehth_ShorttermMember" abstract="true" name="ShorttermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" abstract="true" name="EligibleCommissionsReceivablesSucceedingSixMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_ContractualObligationToBePaidAfterYearFour" abstract="false" name="ContractualObligationToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_HumanaMember" abstract="false" name="HumanaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_UnitedhealthcareMember" abstract="false" name="UnitedhealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_SaleOfStockConsiderationReceivedOnTransactionGross" abstract="false" name="SaleOfStockConsiderationReceivedOnTransactionGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" abstract="false" name="LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" abstract="false" name="CashCashEquivalentsAndAvailableForSaleDebtSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_TechnologyAndContentExpense" abstract="false" name="TechnologyAndContentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityFacilityFeePercentage" abstract="false" name="LineOfCreditFacilityFacilityFeePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ehth_CommissionBonusMember" abstract="true" name="CommissionBonusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_SponsorshipAndAdvertisingMember" abstract="true" name="SponsorshipAndAdvertisingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" abstract="false" name="AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_AccruedMarketingExpenses" abstract="false" name="AccruedMarketingExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_MedicareSegmentMember" abstract="true" name="MedicareSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_IndividualandFamilyMember" abstract="true" name="IndividualandFamilyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" abstract="false" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_DescriptionOfBusinessPolicyPolicyTextBlock" abstract="false" name="DescriptionOfBusinessPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ehth_CustomerCareAndEnrollmentExpenseMember" abstract="false" name="CustomerCareAndEnrollmentExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_VisionMember" abstract="true" name="VisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_DisaggregatedOtherDomain" abstract="true" name="DisaggregatedOtherDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_CommissionMembersApprovedInPriorPeriodsMember" abstract="true" name="CommissionMembersApprovedInPriorPeriodsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" abstract="true" name="UnderRecognitionOfStockBasedCompensationExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" abstract="false" name="CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_OverRecognitionOfLicensingCostsMember" abstract="true" name="OverRecognitionOfLicensingCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_CommissionMembersApprovedDuringCurrentPeriodMember" abstract="true" name="CommissionMembersApprovedDuringCurrentPeriodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_TechnologyAndContentExpenseMember" abstract="false" name="TechnologyAndContentExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_CustomerCareAndEnrollmentExpense" abstract="false" name="CustomerCareAndEnrollmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" abstract="false" name="RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityCovenantMinimumLiquidity" abstract="false" name="LineOfCreditFacilityCovenantMinimumLiquidity" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_NumberOfHealthInsuranceCarriers" abstract="false" name="NumberOfHealthInsuranceCarriers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityCovenantMaximumLiquidity" abstract="false" name="LineOfCreditFacilityCovenantMaximumLiquidity" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_CreditAgreementAmendmentMember" abstract="true" name="CreditAgreementAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_PreviousRepurchaseProgramsMember" abstract="true" name="PreviousRepurchaseProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_AncillariesMember" abstract="true" name="AncillariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_BorrowingBasePercentageAxis" abstract="true" name="BorrowingBasePercentageAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ehth_DisaggregatedIndividualandFamilyDomain" abstract="true" name="DisaggregatedIndividualandFamilyDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_MedicareMember" abstract="true" name="MedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_IncreaseDecreaseInAccruedMarketingExpenses" abstract="false" name="IncreaseDecreaseInAccruedMarketingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_DisaggregatedOtherAxis" abstract="true" name="DisaggregatedOtherAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ehth_QualifiedHealthPlansMember" abstract="true" name="QualifiedHealthPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_ChangeInContractWithCustomerAssetRollForward" abstract="true" name="ChangeInContractWithCustomerAssetRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ehth_IncreaseDecreaseInCommissionsReceivable" abstract="false" name="IncreaseDecreaseInCommissionsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_CommissionRevenueFromRenewalsMember" abstract="true" name="CommissionRevenueFromRenewalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_PrepaidMaintenanceContractsCurrent" abstract="false" name="PrepaidMaintenanceContractsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_DisaggregatedAncillariesAxis" abstract="true" name="DisaggregatedAncillariesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ehth_DisaggregatedAncillariesDomain" abstract="true" name="DisaggregatedAncillariesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_DisaggregatedMedicareAxis" abstract="true" name="DisaggregatedMedicareAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ehth_DentalMember" abstract="true" name="DentalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" abstract="false" name="LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" abstract="true" name="EligibleCommissionsReceivablesSucceedingThreeMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_DisaggregatedIndividualandFamilyAxis" abstract="true" name="DisaggregatedIndividualandFamilyAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ehth_MiscellaneousOtherMember" abstract="true" name="MiscellaneousOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_NonQualifiedHealthPlansMember" abstract="true" name="NonQualifiedHealthPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_BorrowingBasePercentageDomain" abstract="true" name="BorrowingBasePercentageDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_SeasonalityPolicyPolicyTextBlock" abstract="false" name="SeasonalityPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ehth_DisaggregatedMedicareDomain" abstract="true" name="DisaggregatedMedicareDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_SegmentOperatingIncomeLoss" abstract="false" name="SegmentOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" abstract="false" name="TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfStockBasedCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ehth_AetnaMember" abstract="true" name="AetnaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_SmallBusinessMember" abstract="true" name="SmallBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_CenteneMember" abstract="true" name="CenteneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_MedicareAdvantageMember" abstract="true" name="MedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_MedicareSupplementMember" abstract="true" name="MedicareSupplementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" abstract="false" name="ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" abstract="true" name="EligibleCommissionsReceivablesPrecedingThreeMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_CommissionMember" abstract="true" name="CommissionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ehth_IndividualFamilyAndSmallBusinessSegmentsMember" abstract="true" name="IndividualFamilyAndSmallBusinessSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>ehth-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:31f4f7fb-855a-4e3e-841b-479b93e1e603,g:93b223c9-0d4d-4bbf-9f72-5268ef99062c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="simple" xlink:href="ehth-20210331.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2afe5688-df0e-4db0-b55f-45a032c6e705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_35361a72-2442-425c-ab76-4cb7a3098699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2afe5688-df0e-4db0-b55f-45a032c6e705" xlink:to="loc_us-gaap_AssetsCurrent_35361a72-2442-425c-ab76-4cb7a3098699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_37c8b67e-a33b-47fb-992d-4c4fb23f0a93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2afe5688-df0e-4db0-b55f-45a032c6e705" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_37c8b67e-a33b-47fb-992d-4c4fb23f0a93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_73c1fc5d-9e66-4bba-bca4-aafff753e5f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2afe5688-df0e-4db0-b55f-45a032c6e705" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_73c1fc5d-9e66-4bba-bca4-aafff753e5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5c1ea2f8-d0d1-44eb-bc94-2cf01c889c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2afe5688-df0e-4db0-b55f-45a032c6e705" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5c1ea2f8-d0d1-44eb-bc94-2cf01c889c24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bbc5b2f4-1e9a-47fd-96b3-0afd109532b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2afe5688-df0e-4db0-b55f-45a032c6e705" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bbc5b2f4-1e9a-47fd-96b3-0afd109532b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_73026bf6-e41d-4ec7-9b75-43f10cd88930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2afe5688-df0e-4db0-b55f-45a032c6e705" xlink:to="loc_us-gaap_Goodwill_73026bf6-e41d-4ec7-9b75-43f10cd88930" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_c2e4d100-85a7-45aa-b5b7-26d3ed8fbaae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2afe5688-df0e-4db0-b55f-45a032c6e705" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_c2e4d100-85a7-45aa-b5b7-26d3ed8fbaae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_7be590e0-b396-4c9a-97f4-f5449e340e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2afe5688-df0e-4db0-b55f-45a032c6e705" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_7be590e0-b396-4c9a-97f4-f5449e340e8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7d5da22d-2371-4318-8d80-cd76e8741aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_abcafee5-8bcd-4e19-8f64-186b1dcba6d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7d5da22d-2371-4318-8d80-cd76e8741aae" xlink:to="loc_us-gaap_AccountsPayableCurrent_abcafee5-8bcd-4e19-8f64-186b1dcba6d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e4f08fa7-54ba-469c-9350-104edeafb93a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7d5da22d-2371-4318-8d80-cd76e8741aae" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e4f08fa7-54ba-469c-9350-104edeafb93a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AccruedMarketingExpenses_4bd24953-ee27-4d22-9bc2-0cc5dc1db8a6" xlink:href="ehth-20210331.xsd#ehth_AccruedMarketingExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7d5da22d-2371-4318-8d80-cd76e8741aae" xlink:to="loc_ehth_AccruedMarketingExpenses_4bd24953-ee27-4d22-9bc2-0cc5dc1db8a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_4f27ccc8-1dcc-414e-8c06-7abd0d2a394b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7d5da22d-2371-4318-8d80-cd76e8741aae" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_4f27ccc8-1dcc-414e-8c06-7abd0d2a394b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1af888b2-6a37-4d7e-a8a9-e8be0f9ac2c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7d5da22d-2371-4318-8d80-cd76e8741aae" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1af888b2-6a37-4d7e-a8a9-e8be0f9ac2c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a88c3630-fcad-42b8-a444-6f434f269c1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7d5da22d-2371-4318-8d80-cd76e8741aae" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a88c3630-fcad-42b8-a444-6f434f269c1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7e66c10c-1f37-4b7b-ba94-d20d295e9ed8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_98321dbd-8b2f-421c-a42e-aa84a626f990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7e66c10c-1f37-4b7b-ba94-d20d295e9ed8" xlink:to="loc_us-gaap_CommonStockValue_98321dbd-8b2f-421c-a42e-aa84a626f990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_06265fa5-2a01-4f52-a456-857bb2540459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7e66c10c-1f37-4b7b-ba94-d20d295e9ed8" xlink:to="loc_us-gaap_AdditionalPaidInCapital_06265fa5-2a01-4f52-a456-857bb2540459" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f9e8b1b4-5b78-4e03-8ea8-27d7db49a30d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7e66c10c-1f37-4b7b-ba94-d20d295e9ed8" xlink:to="loc_us-gaap_TreasuryStockValue_f9e8b1b4-5b78-4e03-8ea8-27d7db49a30d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2e250783-7486-4d55-a77e-5b8f46797248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7e66c10c-1f37-4b7b-ba94-d20d295e9ed8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2e250783-7486-4d55-a77e-5b8f46797248" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f29d3e6f-0d9f-474c-8390-c1af495dd51c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7e66c10c-1f37-4b7b-ba94-d20d295e9ed8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f29d3e6f-0d9f-474c-8390-c1af495dd51c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f58be67f-3974-4e48-a5d4-a620fd2faab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cdd8e2c8-0188-4fe2-9cd5-86c567cc9383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f58be67f-3974-4e48-a5d4-a620fd2faab8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cdd8e2c8-0188-4fe2-9cd5-86c567cc9383" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ae93e5ff-e345-401d-bfc4-4e98d7bfa080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f58be67f-3974-4e48-a5d4-a620fd2faab8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ae93e5ff-e345-401d-bfc4-4e98d7bfa080" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f3b3c03d-99fc-4f58-95b1-a5ce203f2e72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f58be67f-3974-4e48-a5d4-a620fd2faab8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f3b3c03d-99fc-4f58-95b1-a5ce203f2e72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_b88a9217-2ca5-42ab-b2a7-845819fc7db9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f58be67f-3974-4e48-a5d4-a620fd2faab8" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_b88a9217-2ca5-42ab-b2a7-845819fc7db9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_b0779ae1-c8cb-4663-94e3-3599f042f9d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f58be67f-3974-4e48-a5d4-a620fd2faab8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_b0779ae1-c8cb-4663-94e3-3599f042f9d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_6f46cad1-f582-436a-b0d2-9bdb4355afc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_aa7d84b2-7119-4da9-a455-8b0176c1be63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6f46cad1-f582-436a-b0d2-9bdb4355afc2" xlink:to="loc_us-gaap_LiabilitiesCurrent_aa7d84b2-7119-4da9-a455-8b0176c1be63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2db7eb1b-6d49-4056-93c1-469ec42b1f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6f46cad1-f582-436a-b0d2-9bdb4355afc2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2db7eb1b-6d49-4056-93c1-469ec42b1f37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c634331d-fba4-4158-b951-a50cc2df2c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6f46cad1-f582-436a-b0d2-9bdb4355afc2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c634331d-fba4-4158-b951-a50cc2df2c57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ce792eb0-d09b-4c17-8945-d97d3bee2981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6f46cad1-f582-436a-b0d2-9bdb4355afc2" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ce792eb0-d09b-4c17-8945-d97d3bee2981" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_aca5b539-7592-4738-9a02-dd62c9d0370b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6f46cad1-f582-436a-b0d2-9bdb4355afc2" xlink:to="loc_us-gaap_StockholdersEquity_aca5b539-7592-4738-9a02-dd62c9d0370b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_4827c49e-c324-4e9b-9428-ddec81ce3afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6f46cad1-f582-436a-b0d2-9bdb4355afc2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_4827c49e-c324-4e9b-9428-ddec81ce3afc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ea5d0cbb-d220-466a-ba11-0087c7e5c11c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b1437e3-c260-4dfa-993e-53079a09ffec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ea5d0cbb-d220-466a-ba11-0087c7e5c11c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b1437e3-c260-4dfa-993e-53079a09ffec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0d8ac9fc-7c40-4785-af0b-38456f69f976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ea5d0cbb-d220-466a-ba11-0087c7e5c11c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0d8ac9fc-7c40-4785-af0b-38456f69f976" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6233e9b5-ccb1-4a7b-9b2f-bc9b063b4f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b4b9abc1-96c9-42a4-b9db-2da3997e97f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6233e9b5-ccb1-4a7b-9b2f-bc9b063b4f1e" xlink:to="loc_us-gaap_NetIncomeLoss_b4b9abc1-96c9-42a4-b9db-2da3997e97f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2d1a75ce-b85d-4925-8325-388692230470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6233e9b5-ccb1-4a7b-9b2f-bc9b063b4f1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2d1a75ce-b85d-4925-8325-388692230470" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_174dcf57-d0d9-4309-bcda-4c6dd3311c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6233e9b5-ccb1-4a7b-9b2f-bc9b063b4f1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_174dcf57-d0d9-4309-bcda-4c6dd3311c93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_c61c5da8-76ef-4364-972e-f5720d14c088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_2655e1b6-bc67-4963-8f84-0105c946cc97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_c61c5da8-76ef-4364-972e-f5720d14c088" xlink:to="loc_us-gaap_CostOfRevenue_2655e1b6-bc67-4963-8f84-0105c946cc97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_7c9ab4b6-7ce7-4eda-9ce6-65cd6f0d7381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_c61c5da8-76ef-4364-972e-f5720d14c088" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_7c9ab4b6-7ce7-4eda-9ce6-65cd6f0d7381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpense_f747da6d-513f-4f81-a900-8a43aa9d05e1" xlink:href="ehth-20210331.xsd#ehth_CustomerCareAndEnrollmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_c61c5da8-76ef-4364-972e-f5720d14c088" xlink:to="loc_ehth_CustomerCareAndEnrollmentExpense_f747da6d-513f-4f81-a900-8a43aa9d05e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpense_e640bff7-91e1-4c4a-a7b8-851997a4fc02" xlink:href="ehth-20210331.xsd#ehth_TechnologyAndContentExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_c61c5da8-76ef-4364-972e-f5720d14c088" xlink:to="loc_ehth_TechnologyAndContentExpense_e640bff7-91e1-4c4a-a7b8-851997a4fc02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_712cd9e2-0384-4e41-ba04-974e15857a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_c61c5da8-76ef-4364-972e-f5720d14c088" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_712cd9e2-0384-4e41-ba04-974e15857a1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_94eac665-48f6-493a-9fe0-b9558b387895" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_c61c5da8-76ef-4364-972e-f5720d14c088" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_94eac665-48f6-493a-9fe0-b9558b387895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_bf727af7-0663-44a2-96ce-893bb71f21a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_c61c5da8-76ef-4364-972e-f5720d14c088" xlink:to="loc_us-gaap_RestructuringCharges_bf727af7-0663-44a2-96ce-893bb71f21a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5189e0f9-55ac-43a1-a5a0-ca51cd3b458d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_1175ed77-50b8-4d41-b274-ffe206e51762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5189e0f9-55ac-43a1-a5a0-ca51cd3b458d" xlink:to="loc_us-gaap_CostsAndExpenses_1175ed77-50b8-4d41-b274-ffe206e51762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c691c92-ea34-45fd-a8a0-2f5444c0c99e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5189e0f9-55ac-43a1-a5a0-ca51cd3b458d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c691c92-ea34-45fd-a8a0-2f5444c0c99e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0fa693d8-7bf3-4eee-b953-d0bfab00c68c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_27bcbba7-2c81-4b37-b131-3be6e9d2f0a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0fa693d8-7bf3-4eee-b953-d0bfab00c68c" xlink:to="loc_us-gaap_OperatingIncomeLoss_27bcbba7-2c81-4b37-b131-3be6e9d2f0a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_422f8c02-d6e2-4209-9726-a4101a872991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0fa693d8-7bf3-4eee-b953-d0bfab00c68c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_422f8c02-d6e2-4209-9726-a4101a872991" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_139ebce7-730b-4440-ae0d-81c045dbc427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_739cca05-1ebf-489d-b71c-c1db0a922776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_139ebce7-730b-4440-ae0d-81c045dbc427" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_739cca05-1ebf-489d-b71c-c1db0a922776" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3cefe25f-a2f6-4e46-b0e1-df940a363aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_139ebce7-730b-4440-ae0d-81c045dbc427" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3cefe25f-a2f6-4e46-b0e1-df940a363aa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_98452f9a-51a1-4dc2-a4b6-c4d46734aab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_139ebce7-730b-4440-ae0d-81c045dbc427" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_98452f9a-51a1-4dc2-a4b6-c4d46734aab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_8dd6f60a-b7c5-4f64-a4a3-940b9fadb602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_139ebce7-730b-4440-ae0d-81c045dbc427" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_8dd6f60a-b7c5-4f64-a4a3-940b9fadb602" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2cbf1aeb-44e0-4baf-aef6-b2cb9b3c0ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_NetIncomeLoss_2cbf1aeb-44e0-4baf-aef6-b2cb9b3c0ec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7592a0e2-e426-4f56-89bc-f1e4470419f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7592a0e2-e426-4f56-89bc-f1e4470419f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_e5906570-1fa9-4bff-a24b-1d0889255c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_Depreciation_e5906570-1fa9-4bff-a24b-1d0889255c1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_1026f2c6-e6e2-4564-afbb-38c22d4479de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_1026f2c6-e6e2-4564-afbb-38c22d4479de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b1183405-ba7a-406e-90b1-515dca13f43d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b1183405-ba7a-406e-90b1-515dca13f43d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_f20eaf32-1289-413e-b0bb-b54178b74508" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_f20eaf32-1289-413e-b0bb-b54178b74508" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d6656239-fee0-4b0e-a6a1-f830bdb14b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d6656239-fee0-4b0e-a6a1-f830bdb14b84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInCommissionsReceivable_93ebc682-1f74-4d02-9fbe-c6dc7630ac7a" xlink:href="ehth-20210331.xsd#ehth_IncreaseDecreaseInCommissionsReceivable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_ehth_IncreaseDecreaseInCommissionsReceivable_93ebc682-1f74-4d02-9fbe-c6dc7630ac7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_aed04d73-05ea-4e4b-93c2-c57d9c7b6945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_aed04d73-05ea-4e4b-93c2-c57d9c7b6945" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cf408198-71e1-4c10-984b-5b4f81d56a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cf408198-71e1-4c10-984b-5b4f81d56a58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_61680abb-a5fd-4aff-9373-9ed5dc824a72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_61680abb-a5fd-4aff-9373-9ed5dc824a72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses_ccb11ec7-ed9e-46a7-8de7-2064def73929" xlink:href="ehth-20210331.xsd#ehth_IncreaseDecreaseInAccruedMarketingExpenses"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses_ccb11ec7-ed9e-46a7-8de7-2064def73929" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_b91b06b1-a60b-4462-a77d-04a7be75f6ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_b91b06b1-a60b-4462-a77d-04a7be75f6ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_57c18a9c-08cd-473f-bece-9c2dcba6e720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_57c18a9c-08cd-473f-bece-9c2dcba6e720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_abca17a5-df7e-4bfd-9246-3802ce000866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bb0c376-35c2-4dc6-9a19-045a7cd1280e" xlink:to="loc_us-gaap_ShareBasedCompensation_abca17a5-df7e-4bfd-9246-3802ce000866" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ee4d4380-61b2-4405-8558-68604fb9f4f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d1f08c05-0101-4dfb-ae6c-edb735bfa79a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ee4d4380-61b2-4405-8558-68604fb9f4f9" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d1f08c05-0101-4dfb-ae6c-edb735bfa79a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_42ad6b17-b411-4ec8-9c0d-616e11b6562f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ee4d4380-61b2-4405-8558-68604fb9f4f9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_42ad6b17-b411-4ec8-9c0d-616e11b6562f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_500cabf3-afb4-4f8e-b566-7d843cf4d006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ee4d4380-61b2-4405-8558-68604fb9f4f9" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_500cabf3-afb4-4f8e-b566-7d843cf4d006" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_ce7f45f3-6cfb-4696-ab13-465854bb89c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ee4d4380-61b2-4405-8558-68604fb9f4f9" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_ce7f45f3-6cfb-4696-ab13-465854bb89c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8ba82e2a-202e-45ee-baaa-0fe22609e76f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ee4d4380-61b2-4405-8558-68604fb9f4f9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8ba82e2a-202e-45ee-baaa-0fe22609e76f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5c47d78c-7c1b-40f7-a6e0-e89f9fc5f092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5a04f433-e5f5-4fe7-9350-5cf968a11abc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5c47d78c-7c1b-40f7-a6e0-e89f9fc5f092" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5a04f433-e5f5-4fe7-9350-5cf968a11abc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1f6dd74-07b3-4672-ada9-86abec0f19d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5c47d78c-7c1b-40f7-a6e0-e89f9fc5f092" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1f6dd74-07b3-4672-ada9-86abec0f19d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2ecc9b24-d3c9-485e-a208-febc6948e363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5c47d78c-7c1b-40f7-a6e0-e89f9fc5f092" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2ecc9b24-d3c9-485e-a208-febc6948e363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ec68a147-68a2-4fb8-bbd9-bab1afbe7567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5c47d78c-7c1b-40f7-a6e0-e89f9fc5f092" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ec68a147-68a2-4fb8-bbd9-bab1afbe7567" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies" xlink:type="simple" xlink:href="ehth-20210331.xsd#SummaryofBusinessandSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ehth-20210331.xsd#SummaryofBusinessandSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Revenue" xlink:type="simple" xlink:href="ehth-20210331.xsd#Revenue"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#RevenueTables"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/RevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#RevenueDisaggregationofRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#RevenueCommissionRevenuebySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformation"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationTables"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6a8e09e4-85c8-4f3e-a129-f2540b68212d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_435e8047-31b5-4849-be6a-ab55e6f3bee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6a8e09e4-85c8-4f3e-a129-f2540b68212d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_435e8047-31b5-4849-be6a-ab55e6f3bee0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_950c4cc2-f8fd-44a3-a850-fcf50770721a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6a8e09e4-85c8-4f3e-a129-f2540b68212d" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_950c4cc2-f8fd-44a3-a850-fcf50770721a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b5b0ba3-2c75-4c8b-b506-359ee86ff2d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_abe80c2b-3f0b-4fe6-88a4-24fda760b5da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b5b0ba3-2c75-4c8b-b506-359ee86ff2d5" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_abe80c2b-3f0b-4fe6-88a4-24fda760b5da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_f4dfb3e0-6fc8-4895-9795-8e5baae5450e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b5b0ba3-2c75-4c8b-b506-359ee86ff2d5" xlink:to="loc_us-gaap_Cash_f4dfb3e0-6fc8-4895-9795-8e5baae5450e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_00b19ec8-1165-46b7-ac1b-0b92af17c8d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PrepaidMaintenanceContractsCurrent_56689362-7d34-43f3-ab80-8b91b85e355e" xlink:href="ehth-20210331.xsd#ehth_PrepaidMaintenanceContractsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_00b19ec8-1165-46b7-ac1b-0b92af17c8d8" xlink:to="loc_ehth_PrepaidMaintenanceContractsCurrent_56689362-7d34-43f3-ab80-8b91b85e355e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_306aa65b-d0c0-471c-b61f-0d1f4ec934d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_00b19ec8-1165-46b7-ac1b-0b92af17c8d8" xlink:to="loc_us-gaap_PrepaidInsurance_306aa65b-d0c0-471c-b61f-0d1f4ec934d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_d775736c-d5e4-4b83-9a0c-b9b9bacd0b4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_00b19ec8-1165-46b7-ac1b-0b92af17c8d8" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_d775736c-d5e4-4b83-9a0c-b9b9bacd0b4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_5b740c18-cdb7-41ab-9200-f22966b4dd66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_00b19ec8-1165-46b7-ac1b-0b92af17c8d8" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_5b740c18-cdb7-41ab-9200-f22966b4dd66" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsSummaryofFinancialAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_8ba4a494-363b-445b-a12f-f7f2ddbe0748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9b846655-770d-4ffb-92e9-c898c8b85df0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_8ba4a494-363b-445b-a12f-f7f2ddbe0748" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9b846655-770d-4ffb-92e9-c898c8b85df0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ba345ef0-6fa9-4c31-8624-a968469b12f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_8ba4a494-363b-445b-a12f-f7f2ddbe0748" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ba345ef0-6fa9-4c31-8624-a968469b12f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsContractualMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsUnrealizedGainsandLossesDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_95628545-0d6e-486a-892a-98cfc36c1113" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_9aff4f91-65db-4787-b26f-9f2b4ddc5363" xlink:href="ehth-20210331.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_95628545-0d6e-486a-892a-98cfc36c1113" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_9aff4f91-65db-4787-b26f-9f2b4ddc5363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_57a51c53-95dd-4706-ac35-2a5309eb758a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_95628545-0d6e-486a-892a-98cfc36c1113" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_57a51c53-95dd-4706-ac35-2a5309eb758a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_d4a3319f-267c-42d8-b174-07b31550fb44" xlink:href="ehth-20210331.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_95628545-0d6e-486a-892a-98cfc36c1113" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_d4a3319f-267c-42d8-b174-07b31550fb44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5ca91c1d-80c6-4084-837f-5087deed608e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ec956181-0c9f-4be0-becb-97cd44ec9f66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5ca91c1d-80c6-4084-837f-5087deed608e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ec956181-0c9f-4be0-becb-97cd44ec9f66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_bf966851-49ad-4ee5-aafc-64095d144476" xlink:href="ehth-20210331.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5ca91c1d-80c6-4084-837f-5087deed608e" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_bf966851-49ad-4ee5-aafc-64095d144476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_3788073e-2d02-417d-89bb-02b122c9d746" xlink:href="ehth-20210331.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5ca91c1d-80c6-4084-837f-5087deed608e" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_3788073e-2d02-417d-89bb-02b122c9d746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c6e0dc47-d572-4b22-b143-2c5d539e039f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_5c691ac2-6d20-4381-8151-80d26ef67cc9" xlink:href="ehth-20210331.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c6e0dc47-d572-4b22-b143-2c5d539e039f" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_5c691ac2-6d20-4381-8151-80d26ef67cc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_b29068a7-01dc-4653-afe2-49a8d968f7b9" xlink:href="ehth-20210331.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b18bef81-5e21-435b-9fac-dcb082d5412d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_b29068a7-01dc-4653-afe2-49a8d968f7b9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b18bef81-5e21-435b-9fac-dcb082d5412d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b34e9264-bff9-43cb-ba11-2fb491d6c9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_b29068a7-01dc-4653-afe2-49a8d968f7b9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b34e9264-bff9-43cb-ba11-2fb491d6c9e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_5ad7584e-6a6d-4cb9-b0a6-539523a8dfb7" xlink:href="ehth-20210331.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_b29068a7-01dc-4653-afe2-49a8d968f7b9" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_5ad7584e-6a6d-4cb9-b0a6-539523a8dfb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_5ef4b5c0-3a84-4c91-9727-5ce8e6d3ecd1" xlink:href="ehth-20210331.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_95d791d5-31ca-4efd-84e2-6eb1914900fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_5ef4b5c0-3a84-4c91-9727-5ce8e6d3ecd1" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_95d791d5-31ca-4efd-84e2-6eb1914900fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e28c16ee-9aab-4253-af4a-464f76c6a2dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_5ef4b5c0-3a84-4c91-9727-5ce8e6d3ecd1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e28c16ee-9aab-4253-af4a-464f76c6a2dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_68d9f8b4-b139-4d38-8518-9848a7deefc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_22b48a9b-a176-4c41-9007-0216e666d702" xlink:href="ehth-20210331.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_68d9f8b4-b139-4d38-8518-9848a7deefc4" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_22b48a9b-a176-4c41-9007-0216e666d702" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsUnrealizedGainsandLossesDetails_1"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_0ceb8c58-2e26-4e5a-85f2-263c822366f4" xlink:href="ehth-20210331.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2a6fb9c5-c36b-4bb5-a2fa-9687df7670f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_0ceb8c58-2e26-4e5a-85f2-263c822366f4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2a6fb9c5-c36b-4bb5-a2fa-9687df7670f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_ece9aad5-79a3-4a66-82cf-243af60ab346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_0ceb8c58-2e26-4e5a-85f2-263c822366f4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_ece9aad5-79a3-4a66-82cf-243af60ab346" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Equity" xlink:type="simple" xlink:href="ehth-20210331.xsd#Equity"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/Equity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#EquityTables"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/EquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#EquityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/EquityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#EquityScheduleofStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_9ef8d006-9cee-4b21-a907-2236bd52bdc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_f7ab0a36-f05e-4989-a1f1-fe3edae8b385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_9ef8d006-9cee-4b21-a907-2236bd52bdc9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_f7ab0a36-f05e-4989-a1f1-fe3edae8b385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9e253bc9-6f79-446c-a405-c84f994dba57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_9ef8d006-9cee-4b21-a907-2236bd52bdc9" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9e253bc9-6f79-446c-a405-c84f994dba57" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShare"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShareTables"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_76a0954d-5e05-43f3-9260-ece7e0f164ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncrementalCommonSharesAttributableToOptions_bd4bc5ff-abd5-4702-a262-0361d38370f8" xlink:href="ehth-20210331.xsd#ehth_IncrementalCommonSharesAttributableToOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_76a0954d-5e05-43f3-9260-ece7e0f164ab" xlink:to="loc_ehth_IncrementalCommonSharesAttributableToOptions_bd4bc5ff-abd5-4702-a262-0361d38370f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aadeadbc-38d0-4457-9623-6bda2da144bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_76a0954d-5e05-43f3-9260-ece7e0f164ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aadeadbc-38d0-4457-9623-6bda2da144bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="ehth-20210331.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#CommitmentsandContingenciesTables"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#CommitmentsandContingenciesDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_0457cc96-5ed6-4889-8603-8c2b9af9c375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_a615b3ae-caad-4aca-bb99-ed91b19e0d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_0457cc96-5ed6-4889-8603-8c2b9af9c375" xlink:to="loc_us-gaap_ContractualObligationDueInFourthYear_a615b3ae-caad-4aca-bb99-ed91b19e0d4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_4f6b2810-6dd5-46ff-9162-3abe25468f30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_0457cc96-5ed6-4889-8603-8c2b9af9c375" xlink:to="loc_us-gaap_ContractualObligationDueInThirdYear_4f6b2810-6dd5-46ff-9162-3abe25468f30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_d1f15e46-d6d6-47f5-bbcf-754b279f14ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_0457cc96-5ed6-4889-8603-8c2b9af9c375" xlink:to="loc_us-gaap_ContractualObligationDueInSecondYear_d1f15e46-d6d6-47f5-bbcf-754b279f14ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_64a64d6c-991c-4dcb-96d5-a780ca2edeba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_0457cc96-5ed6-4889-8603-8c2b9af9c375" xlink:to="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_64a64d6c-991c-4dcb-96d5-a780ca2edeba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_0d03a876-b2b9-4cd8-b5a5-c20c75604617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_0457cc96-5ed6-4889-8603-8c2b9af9c375" xlink:to="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_0d03a876-b2b9-4cd8-b5a5-c20c75604617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ContractualObligationToBePaidAfterYearFour_6b709b29-db77-4067-b649-22faa99dec61" xlink:href="ehth-20210331.xsd#ehth_ContractualObligationToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_0457cc96-5ed6-4889-8603-8c2b9af9c375" xlink:to="loc_ehth_ContractualObligationToBePaidAfterYearFour_6b709b29-db77-4067-b649-22faa99dec61" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformation"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationTables"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationSegmentOperatingResultsDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_652b99a2-4bc0-4b08-8c98-bb2323aa43a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0ff2f54a-8646-46fe-9f4c-33ea652bc8a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_652b99a2-4bc0-4b08-8c98-bb2323aa43a5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0ff2f54a-8646-46fe-9f4c-33ea652bc8a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_9c619031-3f74-43de-a258-b6118914862b" xlink:href="ehth-20210331.xsd#ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_652b99a2-4bc0-4b08-8c98-bb2323aa43a5" xlink:to="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_9c619031-3f74-43de-a258-b6118914862b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3026c8d9-1e32-4fb9-b20d-32ec21777aff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_652b99a2-4bc0-4b08-8c98-bb2323aa43a5" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3026c8d9-1e32-4fb9-b20d-32ec21777aff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SegmentOperatingIncomeLoss_568741e1-e7f7-41e1-a390-4d2d3f648d32" xlink:href="ehth-20210331.xsd#ehth_SegmentOperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_652b99a2-4bc0-4b08-8c98-bb2323aa43a5" xlink:to="loc_ehth_SegmentOperatingIncomeLoss_568741e1-e7f7-41e1-a390-4d2d3f648d32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8ba1e6ff-faaa-4ca3-9622-cbca6f48dbea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_652b99a2-4bc0-4b08-8c98-bb2323aa43a5" xlink:to="loc_us-gaap_RestructuringCharges_8ba1e6ff-faaa-4ca3-9622-cbca6f48dbea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6d725f41-bf61-445a-9778-082df7c640a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_652b99a2-4bc0-4b08-8c98-bb2323aa43a5" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6d725f41-bf61-445a-9778-082df7c640a7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Leases" xlink:type="simple" xlink:href="ehth-20210331.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_14f3cc50-f20c-4c5a-85d2-738adcd96a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f32440eb-148c-49e4-8f1f-f6a1c223c265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_14f3cc50-f20c-4c5a-85d2-738adcd96a9f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f32440eb-148c-49e4-8f1f-f6a1c223c265" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f4653344-28be-460c-9047-542ba505eea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_14f3cc50-f20c-4c5a-85d2-738adcd96a9f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f4653344-28be-460c-9047-542ba505eea2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesSupplementalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ae0de5e8-02a4-4ec3-8ce2-c31dd7c4a30a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f869ec2a-5933-4020-8253-6acf28c44f33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ae0de5e8-02a4-4ec3-8ce2-c31dd7c4a30a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f869ec2a-5933-4020-8253-6acf28c44f33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_03c8bdb1-4f4f-45e0-993b-840241f7e13b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ae0de5e8-02a4-4ec3-8ce2-c31dd7c4a30a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_03c8bdb1-4f4f-45e0-993b-840241f7e13b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_58d5c212-ec01-4a0b-aead-d8b7eef7fbb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ae0de5e8-02a4-4ec3-8ce2-c31dd7c4a30a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_58d5c212-ec01-4a0b-aead-d8b7eef7fbb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c0d56e80-530b-46e6-bdf3-e2cdeef85e94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ae0de5e8-02a4-4ec3-8ce2-c31dd7c4a30a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c0d56e80-530b-46e6-bdf3-e2cdeef85e94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_396199ef-5dae-4658-9828-773c99d77692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ae0de5e8-02a4-4ec3-8ce2-c31dd7c4a30a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_396199ef-5dae-4658-9828-773c99d77692" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_0feefd33-3a10-4353-afe4-96f801e51db2" xlink:href="ehth-20210331.xsd#ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ae0de5e8-02a4-4ec3-8ce2-c31dd7c4a30a" xlink:to="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_0feefd33-3a10-4353-afe4-96f801e51db2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4275872e-0f72-40b8-9695-92ce0455b819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_66380782-bba8-4492-81d5-5d3d1ac0cd47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4275872e-0f72-40b8-9695-92ce0455b819" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_66380782-bba8-4492-81d5-5d3d1ac0cd47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b265b5ab-b802-4b55-943d-1fa5d7bd9d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4275872e-0f72-40b8-9695-92ce0455b819" xlink:to="loc_us-gaap_OperatingLeaseLiability_b265b5ab-b802-4b55-943d-1fa5d7bd9d00" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Restructuring" xlink:type="simple" xlink:href="ehth-20210331.xsd#Restructuring"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/Restructuring" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RestructuringDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#RestructuringDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/RestructuringDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Debt" xlink:type="simple" xlink:href="ehth-20210331.xsd#Debt"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/DebtDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#DebtDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/DebtDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxes" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxesSummaryofIncomeTaxBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SubsequentEvent" xlink:type="simple" xlink:href="ehth-20210331.xsd#SubsequentEvent"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SubsequentEvent" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SubsequentEventDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SubsequentEventDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>ehth-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:31f4f7fb-855a-4e3e-841b-479b93e1e603,g:93b223c9-0d4d-4bbf-9f72-5268ef99062c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="simple" xlink:href="ehth-20210331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="extended" id="i36572eba63814b48a2f6d028f6bc7ddb_CoverPage"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="id0f75e8474e546ddb7f661a77bf4008b_CondensedConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="i155f4c1b79a04c7dae607250aeecdf5f_CondensedConsolidatedStatementsofComprehensiveIncomeLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_58efee66-0ea0-405f-aa57-eb44103e2f1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_RevenuesAbstract_58efee66-0ea0-405f-aa57-eb44103e2f1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_09e08f93-a124-47bf-878f-9c080e1ec997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_58efee66-0ea0-405f-aa57-eb44103e2f1d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_09e08f93-a124-47bf-878f-9c080e1ec997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_7181f955-342d-40a4-ac5f-c295189d1aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_CostOfRevenue_7181f955-342d-40a4-ac5f-c295189d1aa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_69ab45df-7b2c-46f3-9eb5-cdecff260d8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_69ab45df-7b2c-46f3-9eb5-cdecff260d8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpense_b1afa599-3c15-4111-9169-1f3e00db846c" xlink:href="ehth-20210331.xsd#ehth_CustomerCareAndEnrollmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_ehth_CustomerCareAndEnrollmentExpense_b1afa599-3c15-4111-9169-1f3e00db846c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpense_e3d71e64-b2ed-4dcf-8518-e4a269f6fea0" xlink:href="ehth-20210331.xsd#ehth_TechnologyAndContentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_ehth_TechnologyAndContentExpense_e3d71e64-b2ed-4dcf-8518-e4a269f6fea0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_dfd33d28-bb2c-4028-bb72-35e6dddeb338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_dfd33d28-bb2c-4028-bb72-35e6dddeb338" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_99958eb0-6043-4240-8f81-bed5988a6573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_99958eb0-6043-4240-8f81-bed5988a6573" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_2d7babcd-82bd-48f2-bf29-792492d6b5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_RestructuringCharges_2d7babcd-82bd-48f2-bf29-792492d6b5be" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_12ebcc61-040d-46fc-9180-1a70f265fcaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_CostsAndExpenses_12ebcc61-040d-46fc-9180-1a70f265fcaf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f51e3fd1-6033-47e8-8bce-e4ae388fe7ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_OperatingIncomeLoss_f51e3fd1-6033-47e8-8bce-e4ae388fe7ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_da38c34e-6c64-40ac-8c9e-ee0202e07c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_da38c34e-6c64-40ac-8c9e-ee0202e07c67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fc281697-24a5-4e35-9ad6-17898c1bff85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fc281697-24a5-4e35-9ad6-17898c1bff85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c6f4effc-ea53-4011-9a15-8a1ca782cde0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c6f4effc-ea53-4011-9a15-8a1ca782cde0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ea1adcc7-1a56-4014-bad2-5eac162da16e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_NetIncomeLoss_ea1adcc7-1a56-4014-bad2-5eac162da16e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_eb0923b6-89ba-4380-adf9-d263b62226af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_EarningsPerShareAbstract_eb0923b6-89ba-4380-adf9-d263b62226af" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7d888c42-1322-4e2f-91a3-9183edaaad1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eb0923b6-89ba-4380-adf9-d263b62226af" xlink:to="loc_us-gaap_EarningsPerShareBasic_7d888c42-1322-4e2f-91a3-9183edaaad1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4933061b-3e23-464f-b6b2-2fc75bc489c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eb0923b6-89ba-4380-adf9-d263b62226af" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4933061b-3e23-464f-b6b2-2fc75bc489c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_659188d2-4ef0-44af-9eb7-7d60d734b4d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_659188d2-4ef0-44af-9eb7-7d60d734b4d1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cfbb47ea-75f6-448e-aad5-0418a220f0c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_659188d2-4ef0-44af-9eb7-7d60d734b4d1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cfbb47ea-75f6-448e-aad5-0418a220f0c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af6039e0-8cda-4ef7-97c7-acde84251afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_659188d2-4ef0-44af-9eb7-7d60d734b4d1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af6039e0-8cda-4ef7-97c7-acde84251afc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af15f62-1edb-422e-b6af-091e8a5686e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af15f62-1edb-422e-b6af-091e8a5686e6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ec113c94-c9a4-498d-b2bc-d37b2a2be7a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_c080add4-2003-49d7-9033-73f58bfcb8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af15f62-1edb-422e-b6af-091e8a5686e6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_c080add4-2003-49d7-9033-73f58bfcb8c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_20160645-cc6b-4f97-ab7b-e742fe355f48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af15f62-1edb-422e-b6af-091e8a5686e6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_20160645-cc6b-4f97-ab7b-e742fe355f48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_dab9484e-b630-4d00-b423-e5c76a5d967f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af15f62-1edb-422e-b6af-091e8a5686e6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_dab9484e-b630-4d00-b423-e5c76a5d967f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_596208f5-0bc1-4af6-b345-e063d4de8fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_StatementTable_596208f5-0bc1-4af6-b345-e063d4de8fd8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_002d6bab-0980-4583-821d-9fd07664ec8c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_596208f5-0bc1-4af6-b345-e063d4de8fd8" xlink:to="loc_srt_ProductOrServiceAxis_002d6bab-0980-4583-821d-9fd07664ec8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_002d6bab-0980-4583-821d-9fd07664ec8c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_002d6bab-0980-4583-821d-9fd07664ec8c" xlink:to="loc_srt_ProductsAndServicesDomain_002d6bab-0980-4583-821d-9fd07664ec8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fab88f3d-0373-4010-a66c-dff7ae062495" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_002d6bab-0980-4583-821d-9fd07664ec8c" xlink:to="loc_srt_ProductsAndServicesDomain_fab88f3d-0373-4010-a66c-dff7ae062495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_d0927e4b-6ee6-44c5-85d0-02650ad55f2a" xlink:href="ehth-20210331.xsd#ehth_CommissionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fab88f3d-0373-4010-a66c-dff7ae062495" xlink:to="loc_ehth_CommissionMember_d0927e4b-6ee6-44c5-85d0-02650ad55f2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_c79b6fcb-f6d0-4bfc-9c0a-b40eb76e0b3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fab88f3d-0373-4010-a66c-dff7ae062495" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_c79b6fcb-f6d0-4bfc-9c0a-b40eb76e0b3e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i00208841801146f69c0bebe17630a71e_CondensedConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_213ab002-ec72-4327-913e-d39d32fdd6f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_213ab002-ec72-4327-913e-d39d32fdd6f4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_7a3c3114-8752-4c20-b5dd-c39f1cbe32fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_SharesOutstanding_7a3c3114-8752-4c20-b5dd-c39f1cbe32fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_870a3701-0226-4328-9768-8e67d0f818ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockholdersEquity_870a3701-0226-4328-9768-8e67d0f818ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_1fdce8cb-ff72-4d22-a887-0f5a7b461560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_1fdce8cb-ff72-4d22-a887-0f5a7b461560" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b804da4e-6a43-4504-95c8-638a5be25126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b804da4e-6a43-4504-95c8-638a5be25126" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_49dc2c1a-1390-466b-86bc-117ff5ff01e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_49dc2c1a-1390-466b-86bc-117ff5ff01e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_43ae3074-bee7-40b9-b287-aab85016e372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_43ae3074-bee7-40b9-b287-aab85016e372" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_626a3f4e-cde7-4784-9882-4eb0de9214d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_626a3f4e-cde7-4784-9882-4eb0de9214d7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1cebedb2-2171-484a-a5ef-cc2aa4af749a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1cebedb2-2171-484a-a5ef-cc2aa4af749a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_395d83d2-f3d5-4072-b390-bc4044d872a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_395d83d2-f3d5-4072-b390-bc4044d872a1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_12b8a968-0661-49d0-a20d-cb0ccfe45e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_NetIncomeLoss_12b8a968-0661-49d0-a20d-cb0ccfe45e95" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ec93c144-ea95-4ad3-ba6a-ab2d62504f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ec93c144-ea95-4ad3-ba6a-ab2d62504f3f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fa8a2335-b703-42a0-a0d6-58caefb77830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fa8a2335-b703-42a0-a0d6-58caefb77830" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_de343b3a-39a9-49f0-9e75-cad2261292ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_de343b3a-39a9-49f0-9e75-cad2261292ce" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b2cd912f-2427-42e1-949f-7fc66e9ce91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b2cd912f-2427-42e1-949f-7fc66e9ce91e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_6226ffa6-0c22-45fa-8432-b9358c70b5ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2e04daf9-8c56-4149-aaf7-42c512d0d5d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e531fe9a-6c97-4ffb-9ba5-7247420db28b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_213ab002-ec72-4327-913e-d39d32fdd6f4" xlink:to="loc_us-gaap_StatementTable_e531fe9a-6c97-4ffb-9ba5-7247420db28b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6d607bd9-a6d4-428f-986b-31451f9acac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e531fe9a-6c97-4ffb-9ba5-7247420db28b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6d607bd9-a6d4-428f-986b-31451f9acac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6d607bd9-a6d4-428f-986b-31451f9acac3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6d607bd9-a6d4-428f-986b-31451f9acac3" xlink:to="loc_us-gaap_EquityComponentDomain_6d607bd9-a6d4-428f-986b-31451f9acac3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6d607bd9-a6d4-428f-986b-31451f9acac3" xlink:to="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_707bf22e-527a-44c7-be65-9e1c69168de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:to="loc_us-gaap_CommonStockMember_707bf22e-527a-44c7-be65-9e1c69168de0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3cdadf6c-74d6-4540-821c-aacf9734869a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3cdadf6c-74d6-4540-821c-aacf9734869a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_72cc1ab4-1558-4ff0-86f0-b37cce479950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:to="loc_us-gaap_TreasuryStockMember_72cc1ab4-1558-4ff0-86f0-b37cce479950" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d685c5f7-e83d-4d70-920a-e68420b9526e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:to="loc_us-gaap_RetainedEarningsMember_d685c5f7-e83d-4d70-920a-e68420b9526e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3d43a22-c9b0-421c-9518-e62da92f871f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3d43a22-c9b0-421c-9518-e62da92f871f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7cedc64e-0b00-44ec-9f6e-a8129b17d1a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e531fe9a-6c97-4ffb-9ba5-7247420db28b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7cedc64e-0b00-44ec-9f6e-a8129b17d1a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7cedc64e-0b00-44ec-9f6e-a8129b17d1a3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7cedc64e-0b00-44ec-9f6e-a8129b17d1a3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7cedc64e-0b00-44ec-9f6e-a8129b17d1a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f917d872-5524-427f-9070-b76adb3dccf9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7cedc64e-0b00-44ec-9f6e-a8129b17d1a3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f917d872-5524-427f-9070-b76adb3dccf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_abac1b23-e05b-4b3a-88d0-93bf6530db67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f917d872-5524-427f-9070-b76adb3dccf9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_abac1b23-e05b-4b3a-88d0-93bf6530db67" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="i269faf66663f450db181f6904d6fa925_CondensedConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies" xlink:type="simple" xlink:href="ehth-20210331.xsd#SummaryofBusinessandSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies" xlink:type="extended" id="iea22879c6b3a4a1d8905e7576c6484a9_SummaryofBusinessandSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ehth-20210331.xsd#SummaryofBusinessandSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies" xlink:type="extended" id="ic093ffc3bbfd4ff18292349229beb6ce_SummaryofBusinessandSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ie93f6ee80e5642bd997631247fcb59a8_SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NumberOfHealthInsuranceCarriers_638fec46-1dbd-4078-a3b0-fbd86cce1ad7" xlink:href="ehth-20210331.xsd#ehth_NumberOfHealthInsuranceCarriers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:to="loc_ehth_NumberOfHealthInsuranceCarriers_638fec46-1dbd-4078-a3b0-fbd86cce1ad7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_569eadec-3f58-4641-818c-cc0ebd9fc43f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_569eadec-3f58-4641-818c-cc0ebd9fc43f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3c0c7076-8001-414d-a615-b2a438406d9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3c0c7076-8001-414d-a615-b2a438406d9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_815496f4-7348-4509-a2f7-36a056714fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:to="loc_us-gaap_CostOfRevenue_815496f4-7348-4509-a2f7-36a056714fe0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6c14a147-d60e-4010-8c32-fac9510188d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:to="loc_us-gaap_NetIncomeLoss_6c14a147-d60e-4010-8c32-fac9510188d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_99b1c0cc-c661-4644-b37a-21293eb656ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_99b1c0cc-c661-4644-b37a-21293eb656ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5d6753d9-f401-4d7b-b273-0b8a4c3f2b3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_99b1c0cc-c661-4644-b37a-21293eb656ca" xlink:to="loc_srt_ProductOrServiceAxis_5d6753d9-f401-4d7b-b273-0b8a4c3f2b3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5d6753d9-f401-4d7b-b273-0b8a4c3f2b3b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5d6753d9-f401-4d7b-b273-0b8a4c3f2b3b" xlink:to="loc_srt_ProductsAndServicesDomain_5d6753d9-f401-4d7b-b273-0b8a4c3f2b3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92b67595-0dcc-48ba-a0b1-58e9d1cc823d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5d6753d9-f401-4d7b-b273-0b8a4c3f2b3b" xlink:to="loc_srt_ProductsAndServicesDomain_92b67595-0dcc-48ba-a0b1-58e9d1cc823d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_85982d69-beab-4add-be84-11070be49d9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_92b67595-0dcc-48ba-a0b1-58e9d1cc823d" xlink:to="loc_us-gaap_LicenseMember_85982d69-beab-4add-be84-11070be49d9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_f754df41-e5dd-4e71-a1db-c84b9292e13f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_99b1c0cc-c661-4644-b37a-21293eb656ca" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_f754df41-e5dd-4e71-a1db-c84b9292e13f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_f754df41-e5dd-4e71-a1db-c84b9292e13f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_f754df41-e5dd-4e71-a1db-c84b9292e13f" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_f754df41-e5dd-4e71-a1db-c84b9292e13f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_89df0927-eba2-429d-a188-750093238fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_f754df41-e5dd-4e71-a1db-c84b9292e13f" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_89df0927-eba2-429d-a188-750093238fe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_f760ec5c-ebd0-4780-aff4-c69e5bc9720b" xlink:href="ehth-20210331.xsd#ehth_UnderRecognitionOfStockBasedCompensationExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_89df0927-eba2-429d-a188-750093238fe9" xlink:to="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_f760ec5c-ebd0-4780-aff4-c69e5bc9720b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OverRecognitionOfLicensingCostsMember_a1f00b61-578f-4574-860f-7214d1b188f7" xlink:href="ehth-20210331.xsd#ehth_OverRecognitionOfLicensingCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_89df0927-eba2-429d-a188-750093238fe9" xlink:to="loc_ehth_OverRecognitionOfLicensingCostsMember_a1f00b61-578f-4574-860f-7214d1b188f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OutOfPeriodAdjustmentsMember_29377a7c-879d-4b94-b42c-a69044a9b104" xlink:href="ehth-20210331.xsd#ehth_OutOfPeriodAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_89df0927-eba2-429d-a188-750093238fe9" xlink:to="loc_ehth_OutOfPeriodAdjustmentsMember_29377a7c-879d-4b94-b42c-a69044a9b104" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Revenue" xlink:type="simple" xlink:href="ehth-20210331.xsd#Revenue"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/Revenue" xlink:type="extended" id="i288e158cae5744e29ad8586a223ead87_Revenue"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#RevenueTables"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/RevenueTables" xlink:type="extended" id="i870ce0f7ee504ef4bbbdf27bdb2036b0_RevenueTables"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#RevenueDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="extended" id="ia70760f9c1584d9a829ceb0c3602da96_RevenueDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_7bb5c695-d57f-49cf-b726-21ac8ed54ddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_615edb39-d6cd-454d-888c-fc119b377f9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7bb5c695-d57f-49cf-b726-21ac8ed54ddf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_615edb39-d6cd-454d-888c-fc119b377f9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7bb5c695-d57f-49cf-b726-21ac8ed54ddf" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c362b24a-3b78-4207-bce7-9818db283a7c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:to="loc_srt_ProductOrServiceAxis_c362b24a-3b78-4207-bce7-9818db283a7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c362b24a-3b78-4207-bce7-9818db283a7c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c362b24a-3b78-4207-bce7-9818db283a7c" xlink:to="loc_srt_ProductsAndServicesDomain_c362b24a-3b78-4207-bce7-9818db283a7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c362b24a-3b78-4207-bce7-9818db283a7c" xlink:to="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareMember_6ce12d5c-7a1f-49ba-8e14-6fbb191962d1" xlink:href="ehth-20210331.xsd#ehth_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_MedicareMember_6ce12d5c-7a1f-49ba-8e14-6fbb191962d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualandFamilyMember_a4bf2aa2-7f74-4f85-b1e2-25cb5522b3b8" xlink:href="ehth-20210331.xsd#ehth_IndividualandFamilyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_IndividualandFamilyMember_a4bf2aa2-7f74-4f85-b1e2-25cb5522b3b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AncillariesMember_351f3232-6d1b-4bf9-855d-83467242a9f0" xlink:href="ehth-20210331.xsd#ehth_AncillariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_AncillariesMember_351f3232-6d1b-4bf9-855d-83467242a9f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SmallBusinessMember_c4b053ce-1415-4138-b91b-0be75f50f3f8" xlink:href="ehth-20210331.xsd#ehth_SmallBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_SmallBusinessMember_c4b053ce-1415-4138-b91b-0be75f50f3f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionBonusMember_085351c4-01a2-45d0-b4cc-84571c436e39" xlink:href="ehth-20210331.xsd#ehth_CommissionBonusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_CommissionBonusMember_085351c4-01a2-45d0-b4cc-84571c436e39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_ae009481-61cc-4e79-becf-e356489ba472" xlink:href="ehth-20210331.xsd#ehth_CommissionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_CommissionMember_ae009481-61cc-4e79-becf-e356489ba472" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_82ed355c-e244-4c75-9340-ab94b2833da8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_82ed355c-e244-4c75-9340-ab94b2833da8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareAxis_76a802ec-588c-4b32-b616-166f5aacadaa" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedMedicareAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:to="loc_ehth_DisaggregatedMedicareAxis_76a802ec-588c-4b32-b616-166f5aacadaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareDomain_76a802ec-588c-4b32-b616-166f5aacadaa_default" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedMedicareDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ehth_DisaggregatedMedicareAxis_76a802ec-588c-4b32-b616-166f5aacadaa" xlink:to="loc_ehth_DisaggregatedMedicareDomain_76a802ec-588c-4b32-b616-166f5aacadaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareDomain_4f985b09-5bfe-4353-8302-357c3c85ebd2" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedMedicareDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ehth_DisaggregatedMedicareAxis_76a802ec-588c-4b32-b616-166f5aacadaa" xlink:to="loc_ehth_DisaggregatedMedicareDomain_4f985b09-5bfe-4353-8302-357c3c85ebd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareAdvantageMember_9c96b201-c782-41ce-aab1-1eb4af82feee" xlink:href="ehth-20210331.xsd#ehth_MedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedMedicareDomain_4f985b09-5bfe-4353-8302-357c3c85ebd2" xlink:to="loc_ehth_MedicareAdvantageMember_9c96b201-c782-41ce-aab1-1eb4af82feee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSupplementMember_3d15e6a6-44e0-4315-9386-5247f0450b47" xlink:href="ehth-20210331.xsd#ehth_MedicareSupplementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedMedicareDomain_4f985b09-5bfe-4353-8302-357c3c85ebd2" xlink:to="loc_ehth_MedicareSupplementMember_3d15e6a6-44e0-4315-9386-5247f0450b47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicarePartDMember_79a2535e-681c-4e46-abfd-4f0aceee2fcc" xlink:href="ehth-20210331.xsd#ehth_MedicarePartDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedMedicareDomain_4f985b09-5bfe-4353-8302-357c3c85ebd2" xlink:to="loc_ehth_MedicarePartDMember_79a2535e-681c-4e46-abfd-4f0aceee2fcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyAxis_06228ef3-27cc-4ed5-b01e-30cb95b39543" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedIndividualandFamilyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:to="loc_ehth_DisaggregatedIndividualandFamilyAxis_06228ef3-27cc-4ed5-b01e-30cb95b39543" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyDomain_06228ef3-27cc-4ed5-b01e-30cb95b39543_default" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedIndividualandFamilyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyAxis_06228ef3-27cc-4ed5-b01e-30cb95b39543" xlink:to="loc_ehth_DisaggregatedIndividualandFamilyDomain_06228ef3-27cc-4ed5-b01e-30cb95b39543_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyDomain_7683a089-dacb-42df-a633-de3a767b04f1" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedIndividualandFamilyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyAxis_06228ef3-27cc-4ed5-b01e-30cb95b39543" xlink:to="loc_ehth_DisaggregatedIndividualandFamilyDomain_7683a089-dacb-42df-a633-de3a767b04f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NonQualifiedHealthPlansMember_3401642b-1f3f-4321-b049-73a5b0cccaee" xlink:href="ehth-20210331.xsd#ehth_NonQualifiedHealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyDomain_7683a089-dacb-42df-a633-de3a767b04f1" xlink:to="loc_ehth_NonQualifiedHealthPlansMember_3401642b-1f3f-4321-b049-73a5b0cccaee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_QualifiedHealthPlansMember_2b704a6a-f4e3-4783-a090-86e828f9eaf0" xlink:href="ehth-20210331.xsd#ehth_QualifiedHealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyDomain_7683a089-dacb-42df-a633-de3a767b04f1" xlink:to="loc_ehth_QualifiedHealthPlansMember_2b704a6a-f4e3-4783-a090-86e828f9eaf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesAxis_4808dddd-7171-44c9-8fdc-38b6ab4bebef" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedAncillariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:to="loc_ehth_DisaggregatedAncillariesAxis_4808dddd-7171-44c9-8fdc-38b6ab4bebef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesDomain_4808dddd-7171-44c9-8fdc-38b6ab4bebef_default" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedAncillariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ehth_DisaggregatedAncillariesAxis_4808dddd-7171-44c9-8fdc-38b6ab4bebef" xlink:to="loc_ehth_DisaggregatedAncillariesDomain_4808dddd-7171-44c9-8fdc-38b6ab4bebef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedAncillariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ehth_DisaggregatedAncillariesAxis_4808dddd-7171-44c9-8fdc-38b6ab4bebef" xlink:to="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ShorttermMember_06ad068e-a303-41d7-b3e0-0011e2e63cb8" xlink:href="ehth-20210331.xsd#ehth_ShorttermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:to="loc_ehth_ShorttermMember_06ad068e-a303-41d7-b3e0-0011e2e63cb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DentalMember_64b51fdd-b6f2-4baa-8471-e427ca37e332" xlink:href="ehth-20210331.xsd#ehth_DentalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:to="loc_ehth_DentalMember_64b51fdd-b6f2-4baa-8471-e427ca37e332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_VisionMember_0ed6a22c-fba8-46b7-88e4-a98c8d7b2de4" xlink:href="ehth-20210331.xsd#ehth_VisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:to="loc_ehth_VisionMember_0ed6a22c-fba8-46b7-88e4-a98c8d7b2de4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OtherMember_d8900bb7-3a7f-45b4-917e-34fd2c0464d3" xlink:href="ehth-20210331.xsd#ehth_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:to="loc_ehth_OtherMember_d8900bb7-3a7f-45b4-917e-34fd2c0464d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherAxis_c4790ec3-3705-45e3-a6fc-7644adad870f" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedOtherAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:to="loc_ehth_DisaggregatedOtherAxis_c4790ec3-3705-45e3-a6fc-7644adad870f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherDomain_c4790ec3-3705-45e3-a6fc-7644adad870f_default" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedOtherDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ehth_DisaggregatedOtherAxis_c4790ec3-3705-45e3-a6fc-7644adad870f" xlink:to="loc_ehth_DisaggregatedOtherDomain_c4790ec3-3705-45e3-a6fc-7644adad870f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherDomain_4ca4e52d-cd90-40d0-aca9-26e5b3719a09" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedOtherDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ehth_DisaggregatedOtherAxis_c4790ec3-3705-45e3-a6fc-7644adad870f" xlink:to="loc_ehth_DisaggregatedOtherDomain_4ca4e52d-cd90-40d0-aca9-26e5b3719a09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SponsorshipAndAdvertisingMember_cfbee2b5-3802-4bc2-b79b-6356a8f60bcf" xlink:href="ehth-20210331.xsd#ehth_SponsorshipAndAdvertisingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedOtherDomain_4ca4e52d-cd90-40d0-aca9-26e5b3719a09" xlink:to="loc_ehth_SponsorshipAndAdvertisingMember_cfbee2b5-3802-4bc2-b79b-6356a8f60bcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MiscellaneousOtherMember_1e486291-a182-4e1b-b65e-20aeb5700a2b" xlink:href="ehth-20210331.xsd#ehth_MiscellaneousOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedOtherDomain_4ca4e52d-cd90-40d0-aca9-26e5b3719a09" xlink:to="loc_ehth_MiscellaneousOtherMember_1e486291-a182-4e1b-b65e-20aeb5700a2b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#RevenueCommissionRevenuebySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails" xlink:type="extended" id="i6dab9d00f80f4780966b67507987f98f_RevenueCommissionRevenuebySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bad9f09-bad0-4a32-b5e4-dd069b10c30d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bad9f09-bad0-4a32-b5e4-dd069b10c30d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_51053ca7-4a4f-4cd2-9ae9-de3ff1db686e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:to="loc_us-gaap_EarningsPerShareBasic_51053ca7-4a4f-4cd2-9ae9-de3ff1db686e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e0c86d4a-ab30-4923-9874-7529a74436e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e0c86d4a-ab30-4923-9874-7529a74436e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_d4d48cc9-1e7c-4d27-b5f6-5779d2ad1f15" xlink:href="ehth-20210331.xsd#ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:to="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_d4d48cc9-1e7c-4d27-b5f6-5779d2ad1f15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d46c4676-bb03-42d4-8df2-eab919dc0921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d46c4676-bb03-42d4-8df2-eab919dc0921" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_07e5d227-d02d-4071-9c3b-ba8cd79ddea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46c4676-bb03-42d4-8df2-eab919dc0921" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_07e5d227-d02d-4071-9c3b-ba8cd79ddea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_07e5d227-d02d-4071-9c3b-ba8cd79ddea2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07e5d227-d02d-4071-9c3b-ba8cd79ddea2" xlink:to="loc_us-gaap_SegmentDomain_07e5d227-d02d-4071-9c3b-ba8cd79ddea2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1b38edba-ab72-4b93-b999-3d17cf330824" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07e5d227-d02d-4071-9c3b-ba8cd79ddea2" xlink:to="loc_us-gaap_SegmentDomain_1b38edba-ab72-4b93-b999-3d17cf330824" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_94a9057a-5fe9-4bbe-94fd-5412b91fa3ef" xlink:href="ehth-20210331.xsd#ehth_MedicareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1b38edba-ab72-4b93-b999-3d17cf330824" xlink:to="loc_ehth_MedicareSegmentMember_94a9057a-5fe9-4bbe-94fd-5412b91fa3ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_47099c53-8647-4a4d-ba77-f1f804ab9d7f" xlink:href="ehth-20210331.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1b38edba-ab72-4b93-b999-3d17cf330824" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_47099c53-8647-4a4d-ba77-f1f804ab9d7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f66994d6-6a90-480c-acaf-5125f38ab95c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46c4676-bb03-42d4-8df2-eab919dc0921" xlink:to="loc_srt_ProductOrServiceAxis_f66994d6-6a90-480c-acaf-5125f38ab95c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f66994d6-6a90-480c-acaf-5125f38ab95c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f66994d6-6a90-480c-acaf-5125f38ab95c" xlink:to="loc_srt_ProductsAndServicesDomain_f66994d6-6a90-480c-acaf-5125f38ab95c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_223f78af-5ee3-48f0-8b5c-19029a772a88" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f66994d6-6a90-480c-acaf-5125f38ab95c" xlink:to="loc_srt_ProductsAndServicesDomain_223f78af-5ee3-48f0-8b5c-19029a772a88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_fe385dba-69b5-4ee9-94e0-783dfa2c0ea7" xlink:href="ehth-20210331.xsd#ehth_CommissionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_223f78af-5ee3-48f0-8b5c-19029a772a88" xlink:to="loc_ehth_CommissionMember_fe385dba-69b5-4ee9-94e0-783dfa2c0ea7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_718a3177-b08a-4ab0-b1d0-1b264be1f546" xlink:href="ehth-20210331.xsd#ehth_CommissionMembersApprovedDuringCurrentPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_CommissionMember_fe385dba-69b5-4ee9-94e0-783dfa2c0ea7" xlink:to="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_718a3177-b08a-4ab0-b1d0-1b264be1f546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_42ca2b74-6c0f-494b-bc90-00302ed50440" xlink:href="ehth-20210331.xsd#ehth_CommissionMembersApprovedInPriorPeriodsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_CommissionMember_fe385dba-69b5-4ee9-94e0-783dfa2c0ea7" xlink:to="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_42ca2b74-6c0f-494b-bc90-00302ed50440" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionRevenueFromRenewalsMember_85b4ef15-0ad1-4cd9-9d89-0816052c2f42" xlink:href="ehth-20210331.xsd#ehth_CommissionRevenueFromRenewalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_CommissionMember_fe385dba-69b5-4ee9-94e0-783dfa2c0ea7" xlink:to="loc_ehth_CommissionRevenueFromRenewalsMember_85b4ef15-0ad1-4cd9-9d89-0816052c2f42" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformation"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation" xlink:type="extended" id="ibce2ade1768d4262b0cffde98b53fd16_SupplementalFinancialStatementInformation"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationTables"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables" xlink:type="extended" id="id6cfae3cc5a2494ea444f9b6dc1fd31c_SupplementalFinancialStatementInformationTables"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended" id="i0928c895129a4af29f2b01b9054d4b9d_SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails" xlink:type="extended" id="id708a4184dbd4832b42335868aa76812_SupplementalFinancialStatementInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_2b267348-8348-40c1-98c3-c41847b80c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_10298691-cccc-42da-bda8-57dd4ee1cb87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_2b267348-8348-40c1-98c3-c41847b80c0e" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_10298691-cccc-42da-bda8-57dd4ee1cb87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Deposits_e0a78298-89d8-4541-aca9-009168beed34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Deposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_2b267348-8348-40c1-98c3-c41847b80c0e" xlink:to="loc_us-gaap_Deposits_e0a78298-89d8-4541-aca9-009168beed34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_32e04b84-62a8-467d-b6c4-2af27804daaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_2b267348-8348-40c1-98c3-c41847b80c0e" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_32e04b84-62a8-467d-b6c4-2af27804daaa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c44fc3c6-913f-4ff9-8f15-6efbefe2de8a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_32e04b84-62a8-467d-b6c4-2af27804daaa" xlink:to="loc_srt_StatementGeographicalAxis_c44fc3c6-913f-4ff9-8f15-6efbefe2de8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c44fc3c6-913f-4ff9-8f15-6efbefe2de8a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c44fc3c6-913f-4ff9-8f15-6efbefe2de8a" xlink:to="loc_srt_SegmentGeographicalDomain_c44fc3c6-913f-4ff9-8f15-6efbefe2de8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_90d96f8a-0626-455a-ba31-a2cd142d748c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c44fc3c6-913f-4ff9-8f15-6efbefe2de8a" xlink:to="loc_srt_SegmentGeographicalDomain_90d96f8a-0626-455a-ba31-a2cd142d748c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_3c55e9e6-c4fb-4a03-bfc8-03aacf9a22cb" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_90d96f8a-0626-455a-ba31-a2cd142d748c" xlink:to="loc_country_CN_3c55e9e6-c4fb-4a03-bfc8-03aacf9a22cb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails" xlink:type="extended" id="i9eca9f3ed9644a90b91b031e8b52c4d5_SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" xlink:type="extended" id="i0c92ea0a460c448bbf7a7d40b8e7d87f_SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_da15c0a9-5141-4c8f-8bdf-dc3573c2cb04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:href="ehth-20210331.xsd#ehth_ChangeInContractWithCustomerAssetRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_da15c0a9-5141-4c8f-8bdf-dc3573c2cb04" xlink:to="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_43c1114b-b9ca-4397-b3df-a64ede9e4646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_43c1114b-b9ca-4397-b3df-a64ede9e4646" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5e918f9b-1f7d-41e1-8972-7389b99388d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5e918f9b-1f7d-41e1-8972-7389b99388d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCommissionsReceived_e27ca655-d782-4886-b54c-b88ce028caa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCommissionsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:to="loc_us-gaap_ProceedsFromCommissionsReceived_e27ca655-d782-4886-b54c-b88ce028caa0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_47098b15-068a-4b61-970d-9a3746a616fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:to="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_47098b15-068a-4b61-970d-9a3746a616fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_7f55d798-2d39-4cef-baed-241efd27fdea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_31d06de6-7cf6-4370-ae35-e19037c9a9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_da15c0a9-5141-4c8f-8bdf-dc3573c2cb04" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_31d06de6-7cf6-4370-ae35-e19037c9a9d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_106ddee1-d0dc-4f6a-befa-7b2abcc2c198" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_31d06de6-7cf6-4370-ae35-e19037c9a9d2" xlink:to="loc_srt_ProductOrServiceAxis_106ddee1-d0dc-4f6a-befa-7b2abcc2c198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_106ddee1-d0dc-4f6a-befa-7b2abcc2c198_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_106ddee1-d0dc-4f6a-befa-7b2abcc2c198" xlink:to="loc_srt_ProductsAndServicesDomain_106ddee1-d0dc-4f6a-befa-7b2abcc2c198_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b539f349-9cdf-4cfe-a9b6-9bdddb024df3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_106ddee1-d0dc-4f6a-befa-7b2abcc2c198" xlink:to="loc_srt_ProductsAndServicesDomain_b539f349-9cdf-4cfe-a9b6-9bdddb024df3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_dcfc54f9-6813-433d-ae48-3abf2da279ec" xlink:href="ehth-20210331.xsd#ehth_CommissionMembersApprovedDuringCurrentPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b539f349-9cdf-4cfe-a9b6-9bdddb024df3" xlink:to="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_dcfc54f9-6813-433d-ae48-3abf2da279ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionRevenueFromRenewalsMember_24dc9a54-2a45-4450-af03-04fe3febdf55" xlink:href="ehth-20210331.xsd#ehth_CommissionRevenueFromRenewalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b539f349-9cdf-4cfe-a9b6-9bdddb024df3" xlink:to="loc_ehth_CommissionRevenueFromRenewalsMember_24dc9a54-2a45-4450-af03-04fe3febdf55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_77497bc3-5148-4edd-91f7-77eb7841e48c" xlink:href="ehth-20210331.xsd#ehth_CommissionMembersApprovedInPriorPeriodsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b539f349-9cdf-4cfe-a9b6-9bdddb024df3" xlink:to="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_77497bc3-5148-4edd-91f7-77eb7841e48c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b900ffbe-a707-401b-ad02-db92052f5a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_31d06de6-7cf6-4370-ae35-e19037c9a9d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b900ffbe-a707-401b-ad02-db92052f5a60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b900ffbe-a707-401b-ad02-db92052f5a60_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b900ffbe-a707-401b-ad02-db92052f5a60" xlink:to="loc_us-gaap_SegmentDomain_b900ffbe-a707-401b-ad02-db92052f5a60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_78885c00-8543-4a4b-8e42-95ac70427eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b900ffbe-a707-401b-ad02-db92052f5a60" xlink:to="loc_us-gaap_SegmentDomain_78885c00-8543-4a4b-8e42-95ac70427eda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_6ae982b1-83ed-4869-a4b8-8b819d2ce3b7" xlink:href="ehth-20210331.xsd#ehth_MedicareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_78885c00-8543-4a4b-8e42-95ac70427eda" xlink:to="loc_ehth_MedicareSegmentMember_6ae982b1-83ed-4869-a4b8-8b819d2ce3b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_76db284a-cd12-45db-8ce4-24e05bcb02b0" xlink:href="ehth-20210331.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_78885c00-8543-4a4b-8e42-95ac70427eda" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_76db284a-cd12-45db-8ce4-24e05bcb02b0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" xlink:type="extended" id="i2159621e276049ad968d7e2196d936d6_SupplementalFinancialStatementInformationScheduleofCreditRiskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_2f923c25-c063-475f-947f-43f33238f8db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b76b31fa-07ce-44d0-8417-c97957cee4a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2f923c25-c063-475f-947f-43f33238f8db" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b76b31fa-07ce-44d0-8417-c97957cee4a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_000a8dc4-865b-4176-bc6e-ed5e6ec9a5bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2f923c25-c063-475f-947f-43f33238f8db" xlink:to="loc_us-gaap_ConcentrationRiskTable_000a8dc4-865b-4176-bc6e-ed5e6ec9a5bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6c8b2357-da03-4710-befa-898f87f45186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_000a8dc4-865b-4176-bc6e-ed5e6ec9a5bb" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6c8b2357-da03-4710-befa-898f87f45186" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6c8b2357-da03-4710-befa-898f87f45186_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6c8b2357-da03-4710-befa-898f87f45186" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6c8b2357-da03-4710-befa-898f87f45186_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3ae66425-fea2-4350-b7d1-0ce218f5524e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6c8b2357-da03-4710-befa-898f87f45186" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3ae66425-fea2-4350-b7d1-0ce218f5524e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_f8c3a603-743c-448e-aab5-4e90b350670b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3ae66425-fea2-4350-b7d1-0ce218f5524e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_f8c3a603-743c-448e-aab5-4e90b350670b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_01714594-7385-4e1a-a400-6967467ab3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_000a8dc4-865b-4176-bc6e-ed5e6ec9a5bb" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_01714594-7385-4e1a-a400-6967467ab3ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_01714594-7385-4e1a-a400-6967467ab3ef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_01714594-7385-4e1a-a400-6967467ab3ef" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_01714594-7385-4e1a-a400-6967467ab3ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ffbac08a-42c6-48cf-989d-c251b9dd29b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_01714594-7385-4e1a-a400-6967467ab3ef" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ffbac08a-42c6-48cf-989d-c251b9dd29b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_2c14b746-2243-4554-8b23-9803aa4ca3b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ffbac08a-42c6-48cf-989d-c251b9dd29b2" xlink:to="loc_us-gaap_AccountsReceivableMember_2c14b746-2243-4554-8b23-9803aa4ca3b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_0b82c4be-13cf-43fc-b940-565aecf93fbc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_000a8dc4-865b-4176-bc6e-ed5e6ec9a5bb" xlink:to="loc_srt_MajorCustomersAxis_0b82c4be-13cf-43fc-b940-565aecf93fbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0b82c4be-13cf-43fc-b940-565aecf93fbc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_0b82c4be-13cf-43fc-b940-565aecf93fbc" xlink:to="loc_srt_NameOfMajorCustomerDomain_0b82c4be-13cf-43fc-b940-565aecf93fbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_0b82c4be-13cf-43fc-b940-565aecf93fbc" xlink:to="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnitedhealthcareMember_282ab83e-3915-499d-98ca-58b8441f3667" xlink:href="ehth-20210331.xsd#ehth_UnitedhealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:to="loc_ehth_UnitedhealthcareMember_282ab83e-3915-499d-98ca-58b8441f3667" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_HumanaMember_058ba648-94ec-4583-8e3b-2bca5c84a5de" xlink:href="ehth-20210331.xsd#ehth_HumanaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:to="loc_ehth_HumanaMember_058ba648-94ec-4583-8e3b-2bca5c84a5de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AetnaMember_b7d11d8d-f3a2-463e-8e99-990e94efcfb2" xlink:href="ehth-20210331.xsd#ehth_AetnaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:to="loc_ehth_AetnaMember_b7d11d8d-f3a2-463e-8e99-990e94efcfb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CenteneMember_fc529622-0249-4b4d-bc33-cf201a8f6601" xlink:href="ehth-20210331.xsd#ehth_CenteneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:to="loc_ehth_CenteneMember_fc529622-0249-4b4d-bc33-cf201a8f6601" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended" id="i678aa3b1af194759a767c9fce837b4ad_SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurements" xlink:type="extended" id="ia647920eb5e94d868a653bfd7233429d_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i7e900625581047a8bc0ea08293e4aed8_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsSummaryofFinancialAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="extended" id="ibd2737bde85149d78231edf5b6457539_FairValueMeasurementsSummaryofFinancialAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9d5a24e6-4b00-46b1-afa5-68520bebc18c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1aab5528-3b4a-4953-9611-de7511ef077a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9d5a24e6-4b00-46b1-afa5-68520bebc18c" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1aab5528-3b4a-4953-9611-de7511ef077a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3b1b99c6-6c2f-4b45-8baa-e33b2b6a2740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1aab5528-3b4a-4953-9611-de7511ef077a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3b1b99c6-6c2f-4b45-8baa-e33b2b6a2740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c1acdb3e-f035-4ef0-9236-95bf0858a01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1aab5528-3b4a-4953-9611-de7511ef077a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c1acdb3e-f035-4ef0-9236-95bf0858a01c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_a65871e6-ee6d-47a0-8ec4-04ba25dbb8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1aab5528-3b4a-4953-9611-de7511ef077a" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_a65871e6-ee6d-47a0-8ec4-04ba25dbb8d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9d5a24e6-4b00-46b1-afa5-68520bebc18c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_7c5de598-1c01-4657-b8b8-0849ad8ba3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_7c5de598-1c01-4657-b8b8-0849ad8ba3d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_7c5de598-1c01-4657-b8b8-0849ad8ba3d9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_7c5de598-1c01-4657-b8b8-0849ad8ba3d9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_7c5de598-1c01-4657-b8b8-0849ad8ba3d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1140dec4-2ec6-4843-8b3f-42853655be2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_7c5de598-1c01-4657-b8b8-0849ad8ba3d9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1140dec4-2ec6-4843-8b3f-42853655be2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_5cbcd17c-a1ab-4d25-9cc3-102794c72642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1140dec4-2ec6-4843-8b3f-42853655be2c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_5cbcd17c-a1ab-4d25-9cc3-102794c72642" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_327331d5-f7ad-45a8-9a28-ce57f328c9a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1140dec4-2ec6-4843-8b3f-42853655be2c" xlink:to="loc_us-gaap_CommercialPaperMember_327331d5-f7ad-45a8-9a28-ce57f328c9a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_60a848e9-baa7-4e1c-a3ae-1af5db89ddfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_60a848e9-baa7-4e1c-a3ae-1af5db89ddfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_60a848e9-baa7-4e1c-a3ae-1af5db89ddfd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_60a848e9-baa7-4e1c-a3ae-1af5db89ddfd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_60a848e9-baa7-4e1c-a3ae-1af5db89ddfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c6177bd-9b84-4b79-bf5c-d16494f008de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_60a848e9-baa7-4e1c-a3ae-1af5db89ddfd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c6177bd-9b84-4b79-bf5c-d16494f008de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c5c2c038-bbb8-45ac-bda3-e6ef3406a866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c6177bd-9b84-4b79-bf5c-d16494f008de" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c5c2c038-bbb8-45ac-bda3-e6ef3406a866" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_2db32a92-4c4e-478d-89b1-6d524e6aeb09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c6177bd-9b84-4b79-bf5c-d16494f008de" xlink:to="loc_us-gaap_CommercialPaperMember_2db32a92-4c4e-478d-89b1-6d524e6aeb09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_f867fbd1-2184-4508-aaca-de7373df1e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_f867fbd1-2184-4508-aaca-de7373df1e7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f867fbd1-2184-4508-aaca-de7373df1e7a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_f867fbd1-2184-4508-aaca-de7373df1e7a" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f867fbd1-2184-4508-aaca-de7373df1e7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7697865a-20d6-4a7f-a091-46fb512e0a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_f867fbd1-2184-4508-aaca-de7373df1e7a" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7697865a-20d6-4a7f-a091-46fb512e0a49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6f092bcc-c619-431d-a069-eee34abf933e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7697865a-20d6-4a7f-a091-46fb512e0a49" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6f092bcc-c619-431d-a069-eee34abf933e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9d78e119-83ec-48c5-8f3e-d555e6bfec5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6f092bcc-c619-431d-a069-eee34abf933e" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9d78e119-83ec-48c5-8f3e-d555e6bfec5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b26c5671-06fb-4da1-b5cf-18022ba1f9db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6f092bcc-c619-431d-a069-eee34abf933e" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b26c5671-06fb-4da1-b5cf-18022ba1f9db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7c27818-c3bb-4116-8155-35c80ed0c8ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7c27818-c3bb-4116-8155-35c80ed0c8ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7c27818-c3bb-4116-8155-35c80ed0c8ec_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7c27818-c3bb-4116-8155-35c80ed0c8ec" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7c27818-c3bb-4116-8155-35c80ed0c8ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_085131f0-9d49-4aa5-bb6a-e50e13aa7668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7c27818-c3bb-4116-8155-35c80ed0c8ec" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_085131f0-9d49-4aa5-bb6a-e50e13aa7668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d7b20bf6-3514-4b09-a7de-029582ad91bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_085131f0-9d49-4aa5-bb6a-e50e13aa7668" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d7b20bf6-3514-4b09-a7de-029582ad91bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_898d4f1a-973b-4279-8343-04116afd2c88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_085131f0-9d49-4aa5-bb6a-e50e13aa7668" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_898d4f1a-973b-4279-8343-04116afd2c88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1fc10d7c-560b-48cf-ae28-19a07823106b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_085131f0-9d49-4aa5-bb6a-e50e13aa7668" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1fc10d7c-560b-48cf-ae28-19a07823106b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7cb92c21-62f4-4f53-adb2-b4d3ef74cece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7cb92c21-62f4-4f53-adb2-b4d3ef74cece" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7cb92c21-62f4-4f53-adb2-b4d3ef74cece_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7cb92c21-62f4-4f53-adb2-b4d3ef74cece" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7cb92c21-62f4-4f53-adb2-b4d3ef74cece_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffabea3d-c65e-4995-bd41-6dfafad84d0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7cb92c21-62f4-4f53-adb2-b4d3ef74cece" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffabea3d-c65e-4995-bd41-6dfafad84d0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_0a5a3d7e-8682-4628-a555-03ec950fc114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffabea3d-c65e-4995-bd41-6dfafad84d0c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_0a5a3d7e-8682-4628-a555-03ec950fc114" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsContractualMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails" xlink:type="extended" id="i68bc5dcfbcfc48de842eddaedcff63cc_FairValueMeasurementsContractualMaturitiesDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsUnrealizedGainsandLossesDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="extended" id="i5b1fd4da890b4d52934da7363c8f97ad_FairValueMeasurementsUnrealizedGainsandLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_058ef8c4-bc7a-46dc-b861-b0bceec009d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_058ef8c4-bc7a-46dc-b861-b0bceec009d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_5497da41-965a-4441-bf11-4b6bdb41f17c" xlink:href="ehth-20210331.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_5497da41-965a-4441-bf11-4b6bdb41f17c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_853b1c73-82a2-4dde-85cf-e47cade28a87" xlink:href="ehth-20210331.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_853b1c73-82a2-4dde-85cf-e47cade28a87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_790e480b-f968-4f91-854c-1eeea9f44cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_790e480b-f968-4f91-854c-1eeea9f44cff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_e95f59d4-e5b8-42fb-9708-e38ec0a594b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_e95f59d4-e5b8-42fb-9708-e38ec0a594b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_2bcb0a49-9057-4f4a-a2e5-7da5c6c0b584" xlink:href="ehth-20210331.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_2bcb0a49-9057-4f4a-a2e5-7da5c6c0b584" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_1e44e15c-8c1c-4176-b2dc-74c94efef7bc" xlink:href="ehth-20210331.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_1e44e15c-8c1c-4176-b2dc-74c94efef7bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a7d13db6-177e-42a9-9544-852ca93ec7a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a7d13db6-177e-42a9-9544-852ca93ec7a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_8a0f2646-4a0b-4a2b-a6df-2b6b5305511b" xlink:href="ehth-20210331.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_8a0f2646-4a0b-4a2b-a6df-2b6b5305511b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0562657e-2a82-4bc5-bd2a-03c7b14e3046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0562657e-2a82-4bc5-bd2a-03c7b14e3046" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f83ccc29-f685-4d3a-86e3-512adf91e915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f83ccc29-f685-4d3a-86e3-512adf91e915" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_6be50c32-27da-48c8-bc6e-cfb98c1e952a" xlink:href="ehth-20210331.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_6be50c32-27da-48c8-bc6e-cfb98c1e952a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d033d205-2c12-40ec-8bc5-887fdfc58821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d033d205-2c12-40ec-8bc5-887fdfc58821" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6e110da0-23cc-4b1e-bbc7-acdd78e4d1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d033d205-2c12-40ec-8bc5-887fdfc58821" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6e110da0-23cc-4b1e-bbc7-acdd78e4d1d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e110da0-23cc-4b1e-bbc7-acdd78e4d1d1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6e110da0-23cc-4b1e-bbc7-acdd78e4d1d1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e110da0-23cc-4b1e-bbc7-acdd78e4d1d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_228ca439-12fc-4dfc-826a-1921bae461e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6e110da0-23cc-4b1e-bbc7-acdd78e4d1d1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_228ca439-12fc-4dfc-826a-1921bae461e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cd005b12-1627-4255-8c9d-11c019711382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_228ca439-12fc-4dfc-826a-1921bae461e3" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cd005b12-1627-4255-8c9d-11c019711382" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e3847ca9-b095-437d-88a6-4cd04d9b0666" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_228ca439-12fc-4dfc-826a-1921bae461e3" xlink:to="loc_us-gaap_CommercialPaperMember_e3847ca9-b095-437d-88a6-4cd04d9b0666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_bb964405-b31d-4228-88b1-521c1a0e4e32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d033d205-2c12-40ec-8bc5-887fdfc58821" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_bb964405-b31d-4228-88b1-521c1a0e4e32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bb964405-b31d-4228-88b1-521c1a0e4e32_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_bb964405-b31d-4228-88b1-521c1a0e4e32" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bb964405-b31d-4228-88b1-521c1a0e4e32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6174a86-98c3-4f65-8ab0-ed1b20b15b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_bb964405-b31d-4228-88b1-521c1a0e4e32" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6174a86-98c3-4f65-8ab0-ed1b20b15b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_247025f1-c655-4daf-9d79-4d7969a1d98c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6174a86-98c3-4f65-8ab0-ed1b20b15b0c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_247025f1-c655-4daf-9d79-4d7969a1d98c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_cbd46dae-fa5f-4d3c-9cd2-cc592b831853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6174a86-98c3-4f65-8ab0-ed1b20b15b0c" xlink:to="loc_us-gaap_CommercialPaperMember_cbd46dae-fa5f-4d3c-9cd2-cc592b831853" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="id2d95582fd914c86922e019c2154aa4a_FairValueMeasurementsNarrativeDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Equity" xlink:type="simple" xlink:href="ehth-20210331.xsd#Equity"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/Equity" xlink:type="extended" id="i2c5153731d6a4410aeacc84d406e1042_Equity"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#EquityTables"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/EquityTables" xlink:type="extended" id="i42b3be9cafda4883a96d871ef51dd712_EquityTables"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#EquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/EquityNarrativeDetails" xlink:type="extended" id="ida15a5e6b6314b46b3f54866362cf3ea_EquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_78f3f0b3-acd6-4b1e-9105-bc6e979627ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_78f3f0b3-acd6-4b1e-9105-bc6e979627ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_2ee2c167-9798-4ac6-875b-962cb21a7f30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_2ee2c167-9798-4ac6-875b-962cb21a7f30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_77a919e8-3a88-43e6-9648-125ced5600f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_77a919e8-3a88-43e6-9648-125ced5600f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_0a5b32cf-a991-4e7b-bccb-2ab33e60fdbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_0a5b32cf-a991-4e7b-bccb-2ab33e60fdbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_5bbe2f65-6f5d-4355-84d0-96b722f4a7c1" xlink:href="ehth-20210331.xsd#ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_5bbe2f65-6f5d-4355-84d0-96b722f4a7c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_55e726de-9058-4d8e-b2b1-06b9a1b12bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_us-gaap_TreasuryStockShares_55e726de-9058-4d8e-b2b1-06b9a1b12bdd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_85e357ba-76f3-4af2-98c7-98895252bf90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_85e357ba-76f3-4af2-98c7-98895252bf90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_41fce998-cbc3-4230-b3df-91229af42b21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_85e357ba-76f3-4af2-98c7-98895252bf90" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_41fce998-cbc3-4230-b3df-91229af42b21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_41fce998-cbc3-4230-b3df-91229af42b21_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_41fce998-cbc3-4230-b3df-91229af42b21" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_41fce998-cbc3-4230-b3df-91229af42b21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a84b0deb-0d13-489c-82bf-8a1b745cf85b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_41fce998-cbc3-4230-b3df-91229af42b21" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a84b0deb-0d13-489c-82bf-8a1b745cf85b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreviousRepurchaseProgramsMember_32e5b9db-d7c2-466a-bf09-ee12bbc8a500" xlink:href="ehth-20210331.xsd#ehth_PreviousRepurchaseProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a84b0deb-0d13-489c-82bf-8a1b745cf85b" xlink:to="loc_ehth_PreviousRepurchaseProgramsMember_32e5b9db-d7c2-466a-bf09-ee12bbc8a500" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_a7fbeb17-d12d-40d5-b7be-500b1b8eb31f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_85e357ba-76f3-4af2-98c7-98895252bf90" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_a7fbeb17-d12d-40d5-b7be-500b1b8eb31f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a7fbeb17-d12d-40d5-b7be-500b1b8eb31f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a7fbeb17-d12d-40d5-b7be-500b1b8eb31f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a7fbeb17-d12d-40d5-b7be-500b1b8eb31f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_88ec2638-a3d5-4ec0-9005-05d1a82fcec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a7fbeb17-d12d-40d5-b7be-500b1b8eb31f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_88ec2638-a3d5-4ec0-9005-05d1a82fcec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_c4f963e2-ab61-4c8d-a2bf-17e1bc65b80e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_88ec2638-a3d5-4ec0-9005-05d1a82fcec7" xlink:to="loc_us-gaap_OverAllotmentOptionMember_c4f963e2-ab61-4c8d-a2bf-17e1bc65b80e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#EquityScheduleofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended" id="i05d8f4270c024a56b9f85181e046c7ed_EquityScheduleofStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_61322745-e716-4365-839b-1b115c6741fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_892b5103-342c-4525-b809-18882e6c97a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_61322745-e716-4365-839b-1b115c6741fe" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_892b5103-342c-4525-b809-18882e6c97a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_916d8e7f-ca3a-42e9-b95d-1e4ce1a3e794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_61322745-e716-4365-839b-1b115c6741fe" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_916d8e7f-ca3a-42e9-b95d-1e4ce1a3e794" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_4190c5cd-8dc5-448d-8472-83b4ee8644bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_61322745-e716-4365-839b-1b115c6741fe" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_4190c5cd-8dc5-448d-8472-83b4ee8644bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7990df95-a042-4f7e-ba59-6512c1aeb7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_61322745-e716-4365-839b-1b115c6741fe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7990df95-a042-4f7e-ba59-6512c1aeb7fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_74590c54-deef-443b-a3bc-3b746802ed30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7990df95-a042-4f7e-ba59-6512c1aeb7fa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_74590c54-deef-443b-a3bc-3b746802ed30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_74590c54-deef-443b-a3bc-3b746802ed30_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_74590c54-deef-443b-a3bc-3b746802ed30" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_74590c54-deef-443b-a3bc-3b746802ed30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_74590c54-deef-443b-a3bc-3b746802ed30" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_ab96426a-168e-4617-a1c2-a6f55fe125ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_ab96426a-168e-4617-a1c2-a6f55fe125ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpenseMember_e2eaf0e8-178c-4fd6-896d-2700485d36af" xlink:href="ehth-20210331.xsd#ehth_CustomerCareAndEnrollmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:to="loc_ehth_CustomerCareAndEnrollmentExpenseMember_e2eaf0e8-178c-4fd6-896d-2700485d36af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpenseMember_005817c6-4407-4d8e-a943-1d5da1e243ce" xlink:href="ehth-20210331.xsd#ehth_TechnologyAndContentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:to="loc_ehth_TechnologyAndContentExpenseMember_005817c6-4407-4d8e-a943-1d5da1e243ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4971ca4b-d07c-42ca-b623-cb3c0f9ca374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4971ca4b-d07c-42ca-b623-cb3c0f9ca374" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_757e79d0-0725-4444-aea1-1e0528386e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7990df95-a042-4f7e-ba59-6512c1aeb7fa" xlink:to="loc_us-gaap_AwardTypeAxis_757e79d0-0725-4444-aea1-1e0528386e7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_757e79d0-0725-4444-aea1-1e0528386e7b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_757e79d0-0725-4444-aea1-1e0528386e7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_757e79d0-0725-4444-aea1-1e0528386e7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2dd0065-b365-4890-9b71-bfe8c0bcf5ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_757e79d0-0725-4444-aea1-1e0528386e7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2dd0065-b365-4890-9b71-bfe8c0bcf5ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_483e1f9a-3183-4dd2-b453-bca8e7a3fb0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2dd0065-b365-4890-9b71-bfe8c0bcf5ed" xlink:to="loc_us-gaap_EmployeeStockOptionMember_483e1f9a-3183-4dd2-b453-bca8e7a3fb0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_56263e24-a1ca-4a4e-ba95-fc1c2f18acbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2dd0065-b365-4890-9b71-bfe8c0bcf5ed" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_56263e24-a1ca-4a4e-ba95-fc1c2f18acbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_9c490a9e-ab08-49bc-aa10-a012c0ea5219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2dd0065-b365-4890-9b71-bfe8c0bcf5ed" xlink:to="loc_us-gaap_EmployeeStockMember_9c490a9e-ab08-49bc-aa10-a012c0ea5219" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShare"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShare" xlink:type="extended" id="i74867fb0d10f49c5987e45fe4f252844_NetIncomeLossPerShare"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShareTables"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables" xlink:type="extended" id="i472f4a5aeec447e0a891d7c9b1cf6282_NetIncomeLossPerShareTables"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails" xlink:type="extended" id="ief7f6e799a2e4f45ab7fce4d2b9b5970_NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" xlink:type="extended" id="ia1663d29f74f46de8432c681f8946754_NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9e18c1cd-b934-4e7a-9e3c-5a84ea67e2bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5d7ec5aa-e15d-4b63-8051-d75d17e5786c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9e18c1cd-b934-4e7a-9e3c-5a84ea67e2bc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5d7ec5aa-e15d-4b63-8051-d75d17e5786c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_095393aa-82b8-4bdd-8fd4-c9eac79612fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9e18c1cd-b934-4e7a-9e3c-5a84ea67e2bc" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_095393aa-82b8-4bdd-8fd4-c9eac79612fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca7d5327-b4a7-4a68-90cb-25656de31fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_095393aa-82b8-4bdd-8fd4-c9eac79612fc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca7d5327-b4a7-4a68-90cb-25656de31fb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ca7d5327-b4a7-4a68-90cb-25656de31fb8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca7d5327-b4a7-4a68-90cb-25656de31fb8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ca7d5327-b4a7-4a68-90cb-25656de31fb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_72310601-e220-4252-92a1-9775eb8445d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca7d5327-b4a7-4a68-90cb-25656de31fb8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_72310601-e220-4252-92a1-9775eb8445d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_236f7180-377f-484a-a7d6-295a24f82aed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_72310601-e220-4252-92a1-9775eb8445d6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_236f7180-377f-484a-a7d6-295a24f82aed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ee67b374-f6e9-4e70-a31b-7d87889199f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_72310601-e220-4252-92a1-9775eb8445d6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ee67b374-f6e9-4e70-a31b-7d87889199f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_ab08466e-27be-4fd7-b860-e955ee3b896c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_72310601-e220-4252-92a1-9775eb8445d6" xlink:to="loc_us-gaap_EmployeeStockMember_ab08466e-27be-4fd7-b860-e955ee3b896c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="ehth-20210331.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingencies" xlink:type="extended" id="i72cf19527df544a3a4dca84da5252173_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#CommitmentsandContingenciesTables"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables" xlink:type="extended" id="id0c671734cc44317bc3faed5a350e1af_CommitmentsandContingenciesTables"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ibc07d1d8650f4c2496675cad340bcc06_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_1573c6e4-7755-4edb-a97e-a8fb39a2d406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_1573c6e4-7755-4edb-a97e-a8fb39a2d406" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_f9a40d73-b774-497c-bb93-e16211bb169b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_f9a40d73-b774-497c-bb93-e16211bb169b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_6944bb09-f45a-444e-badc-f86fbd28b1dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligationDueInSecondYear_6944bb09-f45a-444e-badc-f86fbd28b1dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_78afa947-a657-499a-9dc5-01e348e1ef0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligationDueInThirdYear_78afa947-a657-499a-9dc5-01e348e1ef0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_9d7f9106-b897-442c-b668-90077908234d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligationDueInFourthYear_9d7f9106-b897-442c-b668-90077908234d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ContractualObligationToBePaidAfterYearFour_af5d4591-23db-4b9a-8377-53743ea86c53" xlink:href="ehth-20210331.xsd#ehth_ContractualObligationToBePaidAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_ehth_ContractualObligationToBePaidAfterYearFour_af5d4591-23db-4b9a-8377-53743ea86c53" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_20c842a3-1589-4339-b731-d6a859636b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligation_20c842a3-1589-4339-b731-d6a859636b83" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_db5c891b-8590-4974-9990-b2fa13d919c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_db5c891b-8590-4974-9990-b2fa13d919c2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_f38a67be-9f70-4fd2-beeb-8f7a9dde9dd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_f38a67be-9f70-4fd2-beeb-8f7a9dde9dd3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_efd404f8-aba1-4757-83fe-fc1ce3b00135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_LossContingenciesTable_efd404f8-aba1-4757-83fe-fc1ce3b00135" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_5b4a1b22-8037-46cd-9ead-885f81f8dce7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_efd404f8-aba1-4757-83fe-fc1ce3b00135" xlink:to="loc_srt_LitigationCaseAxis_5b4a1b22-8037-46cd-9ead-885f81f8dce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_5b4a1b22-8037-46cd-9ead-885f81f8dce7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_5b4a1b22-8037-46cd-9ead-885f81f8dce7" xlink:to="loc_srt_LitigationCaseTypeDomain_5b4a1b22-8037-46cd-9ead-885f81f8dce7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_875b4df9-cc6b-4efb-9df0-37df0ce36aea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_5b4a1b22-8037-46cd-9ead-885f81f8dce7" xlink:to="loc_srt_LitigationCaseTypeDomain_875b4df9-cc6b-4efb-9df0-37df0ce36aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LeViasCompliantMember_10078ff4-3112-4eb2-9997-29c2388ee456" xlink:href="ehth-20210331.xsd#ehth_LeViasCompliantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_875b4df9-cc6b-4efb-9df0-37df0ce36aea" xlink:to="loc_ehth_LeViasCompliantMember_10078ff4-3112-4eb2-9997-29c2388ee456" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformation"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformation" xlink:type="extended" id="ia6b5b7ae8bb245c390704a9f8b949e03_SegmentandGeographicInformation"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationTables"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables" xlink:type="extended" id="i368991b7f96c4a399adf9d668787294c_SegmentandGeographicInformationTables"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationSegmentOperatingResultsDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="extended" id="i98ec9912e1ee4e4cb5860262017765b6_SegmentandGeographicInformationSegmentOperatingResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_da4f1fa6-5b60-44a6-a668-ca3a1c0dc810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_NumberOfOperatingSegments_da4f1fa6-5b60-44a6-a668-ca3a1c0dc810" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1676ef41-ac5a-4381-8593-f57933947f69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1676ef41-ac5a-4381-8593-f57933947f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SegmentOperatingIncomeLoss_8de63d99-8e8d-4ada-8c60-979687350151" xlink:href="ehth-20210331.xsd#ehth_SegmentOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_ehth_SegmentOperatingIncomeLoss_8de63d99-8e8d-4ada-8c60-979687350151" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_f8df7d9f-b0f4-4cb2-97a5-2d98de1ace8d" xlink:href="ehth-20210331.xsd#ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_f8df7d9f-b0f4-4cb2-97a5-2d98de1ace8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_54ea00ce-6dd4-4219-af6f-064204549a33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_54ea00ce-6dd4-4219-af6f-064204549a33" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0d5ed8ab-1fa4-4d99-bcbb-53822afe2f29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0d5ed8ab-1fa4-4d99-bcbb-53822afe2f29" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9fad5dc5-1346-42ae-a491-48dfcbfb73ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_RestructuringCharges_9fad5dc5-1346-42ae-a491-48dfcbfb73ea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2179e551-36ad-4bd6-86c1-3c9c1f74d906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2179e551-36ad-4bd6-86c1-3c9c1f74d906" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_47d7ce7d-650b-4863-9fa8-ab430354d74a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_47d7ce7d-650b-4863-9fa8-ab430354d74a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_7a1a4632-28dd-48ef-932b-78a46a5bca6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_7a1a4632-28dd-48ef-932b-78a46a5bca6b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d59b7e7e-b4df-4a5f-a309-395545f373ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d59b7e7e-b4df-4a5f-a309-395545f373ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b7a17b5e-7855-4d57-8f9b-792ff1bf5722" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d59b7e7e-b4df-4a5f-a309-395545f373ae" xlink:to="loc_srt_ConsolidationItemsAxis_b7a17b5e-7855-4d57-8f9b-792ff1bf5722" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b7a17b5e-7855-4d57-8f9b-792ff1bf5722_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b7a17b5e-7855-4d57-8f9b-792ff1bf5722" xlink:to="loc_srt_ConsolidationItemsDomain_b7a17b5e-7855-4d57-8f9b-792ff1bf5722_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_dd3eaec1-947b-4989-acf3-635932a900af" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b7a17b5e-7855-4d57-8f9b-792ff1bf5722" xlink:to="loc_srt_ConsolidationItemsDomain_dd3eaec1-947b-4989-acf3-635932a900af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d864e87a-3b43-4e4d-bfe3-df7e885425d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_dd3eaec1-947b-4989-acf3-635932a900af" xlink:to="loc_us-gaap_OperatingSegmentsMember_d864e87a-3b43-4e4d-bfe3-df7e885425d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_101044cd-573e-41d5-ab17-3a33eaa8edbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_dd3eaec1-947b-4989-acf3-635932a900af" xlink:to="loc_us-gaap_CorporateNonSegmentMember_101044cd-573e-41d5-ab17-3a33eaa8edbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_21103b5b-b996-46df-b0fd-4025355296d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d59b7e7e-b4df-4a5f-a309-395545f373ae" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_21103b5b-b996-46df-b0fd-4025355296d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_21103b5b-b996-46df-b0fd-4025355296d0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_21103b5b-b996-46df-b0fd-4025355296d0" xlink:to="loc_us-gaap_SegmentDomain_21103b5b-b996-46df-b0fd-4025355296d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c28ba86d-e103-4146-8b00-010337138f81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_21103b5b-b996-46df-b0fd-4025355296d0" xlink:to="loc_us-gaap_SegmentDomain_c28ba86d-e103-4146-8b00-010337138f81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_0d1dfff8-fa90-47e1-b698-733de80de0fa" xlink:href="ehth-20210331.xsd#ehth_MedicareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c28ba86d-e103-4146-8b00-010337138f81" xlink:to="loc_ehth_MedicareSegmentMember_0d1dfff8-fa90-47e1-b698-733de80de0fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_4908fd4c-ce94-4796-b66b-2ab017381d62" xlink:href="ehth-20210331.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c28ba86d-e103-4146-8b00-010337138f81" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_4908fd4c-ce94-4796-b66b-2ab017381d62" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" xlink:type="extended" id="i122fc64c044e47eea8b64985e95d7114_SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e916f443-5dc7-487e-9b84-38adaeac8a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_db2d3994-e9ef-4b23-a3ab-4c800be55837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e916f443-5dc7-487e-9b84-38adaeac8a96" xlink:to="loc_us-gaap_NoncurrentAssets_db2d3994-e9ef-4b23-a3ab-4c800be55837" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_651c18a7-8cee-4bdf-995d-d080e54fd014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e916f443-5dc7-487e-9b84-38adaeac8a96" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_651c18a7-8cee-4bdf-995d-d080e54fd014" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9ed612fe-940e-419f-839c-82982e83cae0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_651c18a7-8cee-4bdf-995d-d080e54fd014" xlink:to="loc_srt_StatementGeographicalAxis_9ed612fe-940e-419f-839c-82982e83cae0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9ed612fe-940e-419f-839c-82982e83cae0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9ed612fe-940e-419f-839c-82982e83cae0" xlink:to="loc_srt_SegmentGeographicalDomain_9ed612fe-940e-419f-839c-82982e83cae0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3701ba82-dac9-4dc0-a396-8b81285e123e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9ed612fe-940e-419f-839c-82982e83cae0" xlink:to="loc_srt_SegmentGeographicalDomain_3701ba82-dac9-4dc0-a396-8b81285e123e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e20af6f2-d4d5-44d6-99b8-9fe4cfcef9fa" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3701ba82-dac9-4dc0-a396-8b81285e123e" xlink:to="loc_country_US_e20af6f2-d4d5-44d6-99b8-9fe4cfcef9fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_56eae7d5-56b0-442d-90f8-7cf7dcb59823" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3701ba82-dac9-4dc0-a396-8b81285e123e" xlink:to="loc_country_CN_56eae7d5-56b0-442d-90f8-7cf7dcb59823" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" xlink:type="extended" id="i0e613a5d777b4e449f8fbbb4dd8ff6d2_SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_2e4119a5-cbf3-4130-a676-5578ad81158e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_cd2b02ea-b8fd-443c-b2d7-432f0c2db9e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_2e4119a5-cbf3-4130-a676-5578ad81158e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_cd2b02ea-b8fd-443c-b2d7-432f0c2db9e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ded60994-1c93-4b39-b24a-dabac5d39cc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_2e4119a5-cbf3-4130-a676-5578ad81158e" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ded60994-1c93-4b39-b24a-dabac5d39cc7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_26dd8a31-d47b-4299-aacc-457224bf8406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ded60994-1c93-4b39-b24a-dabac5d39cc7" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_26dd8a31-d47b-4299-aacc-457224bf8406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_26dd8a31-d47b-4299-aacc-457224bf8406_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_26dd8a31-d47b-4299-aacc-457224bf8406" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_26dd8a31-d47b-4299-aacc-457224bf8406_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f1b74769-dedb-4919-8d81-49a94a839307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_26dd8a31-d47b-4299-aacc-457224bf8406" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f1b74769-dedb-4919-8d81-49a94a839307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_bfe596ff-18d4-4fa5-9490-5dd4439fee4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f1b74769-dedb-4919-8d81-49a94a839307" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_bfe596ff-18d4-4fa5-9490-5dd4439fee4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e81f327-e318-4d62-889f-82120dde6035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ded60994-1c93-4b39-b24a-dabac5d39cc7" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e81f327-e318-4d62-889f-82120dde6035" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9e81f327-e318-4d62-889f-82120dde6035_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e81f327-e318-4d62-889f-82120dde6035" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9e81f327-e318-4d62-889f-82120dde6035_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9fa154a3-6871-4941-9b8b-4b83f076a8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e81f327-e318-4d62-889f-82120dde6035" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9fa154a3-6871-4941-9b8b-4b83f076a8d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_bb0bb0e7-15c6-4d3d-ae2c-13ee41eee97c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9fa154a3-6871-4941-9b8b-4b83f076a8d2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_bb0bb0e7-15c6-4d3d-ae2c-13ee41eee97c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_32920781-973f-42f8-91b2-1f4a79225d54" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ded60994-1c93-4b39-b24a-dabac5d39cc7" xlink:to="loc_srt_MajorCustomersAxis_32920781-973f-42f8-91b2-1f4a79225d54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_32920781-973f-42f8-91b2-1f4a79225d54_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_32920781-973f-42f8-91b2-1f4a79225d54" xlink:to="loc_srt_NameOfMajorCustomerDomain_32920781-973f-42f8-91b2-1f4a79225d54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_32920781-973f-42f8-91b2-1f4a79225d54" xlink:to="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnitedhealthcareMember_4b6b2c9a-0e29-441c-accb-c7e8748f3577" xlink:href="ehth-20210331.xsd#ehth_UnitedhealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:to="loc_ehth_UnitedhealthcareMember_4b6b2c9a-0e29-441c-accb-c7e8748f3577" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AetnaMember_36499837-86d8-44f8-8e9a-bd1437bd0760" xlink:href="ehth-20210331.xsd#ehth_AetnaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:to="loc_ehth_AetnaMember_36499837-86d8-44f8-8e9a-bd1437bd0760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_HumanaMember_f3c69670-f996-4b86-9153-b70e9de44c39" xlink:href="ehth-20210331.xsd#ehth_HumanaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:to="loc_ehth_HumanaMember_f3c69670-f996-4b86-9153-b70e9de44c39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CenteneMember_4add09b4-e9cf-4617-9c4a-144a2256fb1c" xlink:href="ehth-20210331.xsd#ehth_CenteneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:to="loc_ehth_CenteneMember_4add09b4-e9cf-4617-9c4a-144a2256fb1c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Leases" xlink:type="simple" xlink:href="ehth-20210331.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/Leases" xlink:type="extended" id="iae602f27bf8c4349bf5f9ae900e3c3ff_Leases"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/LeasesTables" xlink:type="extended" id="i71cf0a2a3029434ba2b41b58abc7f242_LeasesTables"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i40135f16ef514ec8828e8563c48db984_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_6d4a46f1-f0ab-4fb0-9894-238e4c3ebd13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_b182853f-e526-439d-b153-6f862d863089" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6d4a46f1-f0ab-4fb0-9894-238e4c3ebd13" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_b182853f-e526-439d-b153-6f862d863089" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_a156d9b3-b3aa-4727-9d64-43444262ba9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6d4a46f1-f0ab-4fb0-9894-238e4c3ebd13" xlink:to="loc_us-gaap_OperatingLeaseCost_a156d9b3-b3aa-4727-9d64-43444262ba9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_21bef8e3-6441-4bba-b9dc-03eedd775abe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6d4a46f1-f0ab-4fb0-9894-238e4c3ebd13" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_21bef8e3-6441-4bba-b9dc-03eedd775abe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_64c885a3-81c2-4ab8-98db-e95b7f497b11" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_21bef8e3-6441-4bba-b9dc-03eedd775abe" xlink:to="loc_srt_RangeAxis_64c885a3-81c2-4ab8-98db-e95b7f497b11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_64c885a3-81c2-4ab8-98db-e95b7f497b11_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_64c885a3-81c2-4ab8-98db-e95b7f497b11" xlink:to="loc_srt_RangeMember_64c885a3-81c2-4ab8-98db-e95b7f497b11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f8783938-8a0c-4a8b-85c4-838b2c2f2d12" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_64c885a3-81c2-4ab8-98db-e95b7f497b11" xlink:to="loc_srt_RangeMember_f8783938-8a0c-4a8b-85c4-838b2c2f2d12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_258249da-31aa-45f0-9700-36e34659811e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f8783938-8a0c-4a8b-85c4-838b2c2f2d12" xlink:to="loc_srt_MinimumMember_258249da-31aa-45f0-9700-36e34659811e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c584b0cd-7874-4f28-897e-25063a507be4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f8783938-8a0c-4a8b-85c4-838b2c2f2d12" xlink:to="loc_srt_MaximumMember_c584b0cd-7874-4f28-897e-25063a507be4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i790d02232da84bf79a2ccc288ee6acca_LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesSupplementalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails" xlink:type="extended" id="i2eaab2db8ee242df918f4d5c8e3237b2_LeasesSupplementalInformationDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended" id="ib0fd794300ef41029ca90fc81a438991_LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Restructuring" xlink:type="simple" xlink:href="ehth-20210331.xsd#Restructuring"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/Restructuring" xlink:type="extended" id="i6af892c122e1457392b697c79e95b0d4_Restructuring"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RestructuringDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#RestructuringDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/RestructuringDetails" xlink:type="extended" id="i626413b67239442a88363211e8b04c26_RestructuringDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Debt" xlink:type="simple" xlink:href="ehth-20210331.xsd#Debt"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/Debt" xlink:type="extended" id="i9b6c7767ea4d424eacf9ba7ffa6fdf6c_Debt"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/DebtDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#DebtDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/DebtDetails" xlink:type="extended" id="if5b0d1b30da34cfc8277c6c72e65f963_DebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_ad678947-5584-46bb-82e1-65438f84852e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_ad678947-5584-46bb-82e1-65438f84852e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage_bd12ec2a-303d-4154-a51f-ddbd1198f39d" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityBorrowingBasePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage_bd12ec2a-303d-4154-a51f-ddbd1198f39d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_17bdbf01-0b91-4408-84e2-70645f8bdbe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_17bdbf01-0b91-4408-84e2-70645f8bdbe3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityFacilityFeePercentage_d151526f-266b-441c-ba7d-d8a785ae9e6e" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityFacilityFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityFacilityFeePercentage_d151526f-266b-441c-ba7d-d8a785ae9e6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d7ea5845-fee9-4768-8882-7a39a6814030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d7ea5845-fee9-4768-8882-7a39a6814030" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_c2474642-4be4-4500-8c71-d111e92a7898" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_c2474642-4be4-4500-8c71-d111e92a7898" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_fbfb034d-8d65-4e86-bd36-f79d19a1a487" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_fbfb034d-8d65-4e86-bd36-f79d19a1a487" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_cfdfe685-0c3b-4cf7-b09f-428f01b9c770" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMinimumLiquidity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_cfdfe685-0c3b-4cf7-b09f-428f01b9c770" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_c699b7e1-b05e-479d-9d33-70c05253ebc5" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMaximumLiquidity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_c699b7e1-b05e-479d-9d33-70c05253ebc5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_72865001-7f75-4b3d-98dc-777fff7223dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_72865001-7f75-4b3d-98dc-777fff7223dc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_cada4d4c-4785-4d72-8f8c-a0d2f4170230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_us-gaap_LineOfCredit_cada4d4c-4785-4d72-8f8c-a0d2f4170230" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_46fa6864-35dd-42b3-8a8d-8decb250ac34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_us-gaap_DebtInstrumentTable_46fa6864-35dd-42b3-8a8d-8decb250ac34" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageAxis_24cb2a29-525d-45b5-a4e2-6c1e9900c00d" xlink:href="ehth-20210331.xsd#ehth_BorrowingBasePercentageAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_46fa6864-35dd-42b3-8a8d-8decb250ac34" xlink:to="loc_ehth_BorrowingBasePercentageAxis_24cb2a29-525d-45b5-a4e2-6c1e9900c00d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageDomain_24cb2a29-525d-45b5-a4e2-6c1e9900c00d_default" xlink:href="ehth-20210331.xsd#ehth_BorrowingBasePercentageDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ehth_BorrowingBasePercentageAxis_24cb2a29-525d-45b5-a4e2-6c1e9900c00d" xlink:to="loc_ehth_BorrowingBasePercentageDomain_24cb2a29-525d-45b5-a4e2-6c1e9900c00d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageDomain_8922d550-0f7c-4590-b632-ebd84aa91aa1" xlink:href="ehth-20210331.xsd#ehth_BorrowingBasePercentageDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ehth_BorrowingBasePercentageAxis_24cb2a29-525d-45b5-a4e2-6c1e9900c00d" xlink:to="loc_ehth_BorrowingBasePercentageDomain_8922d550-0f7c-4590-b632-ebd84aa91aa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_05a8b7bd-6c26-483b-8900-058057255ace" xlink:href="ehth-20210331.xsd#ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_BorrowingBasePercentageDomain_8922d550-0f7c-4590-b632-ebd84aa91aa1" xlink:to="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_05a8b7bd-6c26-483b-8900-058057255ace" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_51cdfec4-5072-46ae-a2ab-b072b63530f6" xlink:href="ehth-20210331.xsd#ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_BorrowingBasePercentageDomain_8922d550-0f7c-4590-b632-ebd84aa91aa1" xlink:to="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_51cdfec4-5072-46ae-a2ab-b072b63530f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_7048f510-bf35-4783-b6ee-b565f6e590d9" xlink:href="ehth-20210331.xsd#ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_BorrowingBasePercentageDomain_8922d550-0f7c-4590-b632-ebd84aa91aa1" xlink:to="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_7048f510-bf35-4783-b6ee-b565f6e590d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d6c2d978-596e-4de5-b2ec-35ecb576abff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_46fa6864-35dd-42b3-8a8d-8decb250ac34" xlink:to="loc_us-gaap_CreditFacilityAxis_d6c2d978-596e-4de5-b2ec-35ecb576abff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d6c2d978-596e-4de5-b2ec-35ecb576abff_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d6c2d978-596e-4de5-b2ec-35ecb576abff" xlink:to="loc_us-gaap_CreditFacilityDomain_d6c2d978-596e-4de5-b2ec-35ecb576abff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_989cf5e9-dd74-4e07-a21e-df7c4f875dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d6c2d978-596e-4de5-b2ec-35ecb576abff" xlink:to="loc_us-gaap_CreditFacilityDomain_989cf5e9-dd74-4e07-a21e-df7c4f875dec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_472b1075-97e8-476c-96fc-034c952db4b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_989cf5e9-dd74-4e07-a21e-df7c4f875dec" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_472b1075-97e8-476c-96fc-034c952db4b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_1351b0c6-c95d-465d-bc3e-13c23d8de6da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_989cf5e9-dd74-4e07-a21e-df7c4f875dec" xlink:to="loc_us-gaap_LetterOfCreditMember_1351b0c6-c95d-465d-bc3e-13c23d8de6da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_91a262e3-e992-459b-9e75-d7db257132f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_46fa6864-35dd-42b3-8a8d-8decb250ac34" xlink:to="loc_us-gaap_DebtInstrumentAxis_91a262e3-e992-459b-9e75-d7db257132f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_91a262e3-e992-459b-9e75-d7db257132f7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_91a262e3-e992-459b-9e75-d7db257132f7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_91a262e3-e992-459b-9e75-d7db257132f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_660d0faa-ba76-4ecf-84d6-8b868bb10aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_91a262e3-e992-459b-9e75-d7db257132f7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_660d0faa-ba76-4ecf-84d6-8b868bb10aa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CreditAgreementAmendmentMember_df55021f-dcf8-4ae1-b0e6-0b200d6672aa" xlink:href="ehth-20210331.xsd#ehth_CreditAgreementAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_660d0faa-ba76-4ecf-84d6-8b868bb10aa9" xlink:to="loc_ehth_CreditAgreementAmendmentMember_df55021f-dcf8-4ae1-b0e6-0b200d6672aa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxes" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxes" xlink:type="extended" id="i406653f09810461984891db17a73d43a_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesTables" xlink:type="extended" id="id55554519db546779dad68e976581731_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxesSummaryofIncomeTaxBenefitDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails" xlink:type="extended" id="ifb75e35901d54c36bab1e65cf6c1f1c7_IncomeTaxesSummaryofIncomeTaxBenefitDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="ifb2e411eb3bc4d64bbab4c70eb70afc0_IncomeTaxesNarrativeDetails"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SubsequentEvent" xlink:type="simple" xlink:href="ehth-20210331.xsd#SubsequentEvent"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SubsequentEvent" xlink:type="extended" id="i3b341fe116324ae1a221e33a342f6a5c_SubsequentEvent"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SubsequentEventDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SubsequentEventDetails" xlink:type="extended" id="ib423849d2f844b9b926c13fc1fccf298_SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a18b9b23-d989-47af-bcf0-4ece92d3ed5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a18b9b23-d989-47af-bcf0-4ece92d3ed5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b99efb5a-6322-4b13-8944-7cae1d5d0e17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b99efb5a-6322-4b13-8944-7cae1d5d0e17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_2fe9104c-3b6f-4b43-930e-be91cf84cffe" xlink:href="ehth-20210331.xsd#ehth_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:to="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_2fe9104c-3b6f-4b43-930e-be91cf84cffe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_0cf04b7c-6c9b-46d0-9d88-26b6fb5894f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_0cf04b7c-6c9b-46d0-9d88-26b6fb5894f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_037f0cfa-05d2-4801-8fee-a068c220b941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_037f0cfa-05d2-4801-8fee-a068c220b941" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_212eef98-002c-4ec6-a021-21c3049b8293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:to="loc_us-gaap_SubsequentEventTable_212eef98-002c-4ec6-a021-21c3049b8293" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a93f08c1-5cc0-463d-81d3-b1eaba650582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_212eef98-002c-4ec6-a021-21c3049b8293" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a93f08c1-5cc0-463d-81d3-b1eaba650582" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a93f08c1-5cc0-463d-81d3-b1eaba650582_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a93f08c1-5cc0-463d-81d3-b1eaba650582" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a93f08c1-5cc0-463d-81d3-b1eaba650582_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f61a21ec-0271-42c3-b178-22f1dd47a865" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a93f08c1-5cc0-463d-81d3-b1eaba650582" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f61a21ec-0271-42c3-b178-22f1dd47a865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fe307f49-ff0a-442a-a548-65b889f11533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f61a21ec-0271-42c3-b178-22f1dd47a865" xlink:to="loc_us-gaap_SubsequentEventMember_fe307f49-ff0a-442a-a548-65b889f11533" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>ehth-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:31f4f7fb-855a-4e3e-841b-479b93e1e603,g:93b223c9-0d4d-4bbf-9f72-5268ef99062c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_a1edd1d7-af75-4207-bca8-4d15675ea580_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b8ecf716-2fce-4494-8d5b-963a4cd004ae_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_808e7778-6ba6-4fd7-bf66-65c45a97406e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_10ef5506-9299-4a8e-be89-c8c294c4457c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_76dbba4b-3886-4bd5-9cb2-b1966a56b11c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:to="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_61c1d363-3993-4f8b-bf04-b805b079fc37_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_93fc89f2-89ea-4d03-8cd1-a905cf439a69_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_b8348f75-d81e-4b72-9591-4eb69b30aaf5_terseLabel_en-US" xlink:label="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission revenue from members approved during the period</link:label>
    <link:label id="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_label_en-US" xlink:label="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission, Members Approved During Current Period [Member]</link:label>
    <link:label id="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_documentation_en-US" xlink:label="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission, Members Approved During Current Period [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:href="ehth-20210331.xsd#ehth_CommissionMembersApprovedDuringCurrentPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:to="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_504e026b-7f78-4a31-b08a-66a60c70ac14_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligation_773ad15e-e697-41d0-ac8d-6446e4f4daa7_totalLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_label_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation" xlink:to="lab_us-gaap_ContractualObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f32dfd67-40f6-4fab-9151-2603a4561db4_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7e908990-4047-4221-b115-c89f96d13d12_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a15d9605-c7b6-495b-a630-0f98e8ebc9c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_4693e144-64d4-4251-bd7b-4a04c83ee7c0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes &#8211; non-current</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_68fe6d60-58c0-46d8-bf4c-0c95900a384c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ed94a368-72de-4661-9b05-e99babc68f7c_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_5f9dbeb7-cfd2-4b9e-abbd-d30a6a1ce04e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_91cced9c-c30d-460d-8539-a9a489619fbb_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing and advertising</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d314ae76-2f0f-414b-b169-608d00d9eac2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_fa3ea3ae-85ca-4367-aaa9-93e89cfe3a7d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_83b91342-823d-44d2-943a-d34f74271c37_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contract Assets - Commissions Receivable</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_05cf47dc-3291-495d-9ee3-bf972eefa98c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_188b4704-4732-4c29-a7bb-08277f40ee5f_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_ab0180cc-645b-4e57-a426-12426fb8abe4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_612a926d-8352-4eb1-878d-0fb8a92b01da_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_7a870a03-c9e6-4a1d-b5a6-7111271fed5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares to satisfy employee tax withholding obligations</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_40150caa-dae5-4ec7-b6b1-fd4969acdca1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_5479b96c-c473-4242-99bc-17b6ad40b5c9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_302ac4bc-cbb0-4ca5-85f3-22b6477bdbbd_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_37126175-7686-43a6-b9a7-588864f75114_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_d559ed18-07f1-44fb-a815-683b647432b2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_6500346f-0ba1-446b-8119-2e6137277ea6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_1b5f2add-f050-47de-86b3-eae2a8aabbf0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_c07d573b-70b4-406a-b3a9-216de3595c16_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_1220c6df-f256-447e-89c8-d35a046ea03c_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income, remainder of 2021</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6be5bf02-691f-4ae7-939f-a00d6d54d7f4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_ebe2df04-6311-4c33-9487-f6b739973018_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9200e1df-8b49-458f-bb7d-9d6b14ed0cc6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_24c25529-7a6c-4be3-b033-222405e8e4c6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares repurchased under share repurchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Deposits_ca7d5fd7-2273-4c4b-b70b-7986128344c3_terseLabel_en-US" xlink:label="lab_us-gaap_Deposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits</link:label>
    <link:label id="lab_us-gaap_Deposits_label_en-US" xlink:label="lab_us-gaap_Deposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Deposits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Deposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Deposits" xlink:to="lab_us-gaap_Deposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f44e262e-2596-4b63-8d0b-a763051c18b8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_a292c23d-bfb1-400d-9b93-83bdc863e41c_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MedicareSupplementMember_280e909c-c121-4054-9e28-ada8780330eb_terseLabel_en-US" xlink:label="lab_ehth_MedicareSupplementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement</link:label>
    <link:label id="lab_ehth_MedicareSupplementMember_label_en-US" xlink:label="lab_ehth_MedicareSupplementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement [Member]</link:label>
    <link:label id="lab_ehth_MedicareSupplementMember_documentation_en-US" xlink:label="lab_ehth_MedicareSupplementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSupplementMember" xlink:href="ehth-20210331.xsd#ehth_MedicareSupplementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MedicareSupplementMember" xlink:to="lab_ehth_MedicareSupplementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_eca42cd3-21c2-4b3f-b13d-e0c016812c3b_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_d64003db-96fc-4a85-bac5-f4ee9af271dd_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_UnitedhealthcareMember_cdba585d-3bca-4d67-9d0c-be9211c9b85b_terseLabel_en-US" xlink:label="lab_ehth_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnitedHealthcare</link:label>
    <link:label id="lab_ehth_UnitedhealthcareMember_label_en-US" xlink:label="lab_ehth_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unitedhealthcare [Member]</link:label>
    <link:label id="lab_ehth_UnitedhealthcareMember_documentation_en-US" xlink:label="lab_ehth_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnitedHealthcare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnitedhealthcareMember" xlink:href="ehth-20210331.xsd#ehth_UnitedhealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_UnitedhealthcareMember" xlink:to="lab_ehth_UnitedhealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_f3e2abf6-bf47-4384-89f2-576c90a471e1_terseLabel_en-US" xlink:label="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="ehth-20210331.xsd#ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6c46595d-6ec3-43f2-a202-3cf558f51bbe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_259f6e80-4847-4c5c-828c-c62a0f2dc315_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments in connection with leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e9cb2c31-151a-4b85-95f2-47d394062c52_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketingAndAdvertisingExpense_40059ba9-ef52-4f15-ae57-fa67ed408533_terseLabel_en-US" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing and advertising</link:label>
    <link:label id="lab_us-gaap_MarketingAndAdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing and Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketingAndAdvertisingExpense" xlink:to="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_98b6aa91-7973-4438-af2a-7b43e354260f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock_82668860-f088-4ba1-885c-9d10de999a7b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a58de51a-830d-47a0-ac82-a5e69bcc950f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_8661da5a-bb63-470a-b904-96af9be232ed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_9ccd140b-5aa3-4a3d-b6f4-429ce1d67d69_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCommissionsReceived_17d22091-deb0-47ce-a410-c847072a07cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCommissionsReceived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCommissionsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCommissionsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Commissions Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCommissionsReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCommissionsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCommissionsReceived" xlink:to="lab_us-gaap_ProceedsFromCommissionsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_0d704098-22e9-4473-b138-94ac152f04ab_terseLabel_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Three Months</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_label_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Three Months [Member]</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_documentation_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Three Months [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:href="ehth-20210331.xsd#ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:to="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_b3d80bde-9af2-4c79-8642-c211a120076b_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer revenue, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_eb86485d-c0d8-40a3-866a-0cf230ad247d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyDomain_013858ca-49aa-43e5-8f26-828232f654c6_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyDomain_label_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyDomain_documentation_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyDomain" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedIndividualandFamilyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyDomain" xlink:to="lab_ehth_DisaggregatedIndividualandFamilyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_b0f73b79-2746-4163-a129-37d60195917d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock_ac49cbbc-ec1a-4f57-8ca7-8f72bbe54529_terseLabel_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense By Award Type</link:label>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:href="ehth-20210331.xsd#ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:to="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2ac955fd-ccee-4095-afaa-8abfecaa12a7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of earnout liability (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5d20641b-87cf-4b52-9063-4118d58a3c99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_BorrowingBasePercentageAxis_e6e2af36-4fa9-4353-8a67-1bd9c8a763f8_terseLabel_en-US" xlink:label="lab_ehth_BorrowingBasePercentageAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing Base Percentage [Axis]</link:label>
    <link:label id="lab_ehth_BorrowingBasePercentageAxis_label_en-US" xlink:label="lab_ehth_BorrowingBasePercentageAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing Base Percentage [Axis]</link:label>
    <link:label id="lab_ehth_BorrowingBasePercentageAxis_documentation_en-US" xlink:label="lab_ehth_BorrowingBasePercentageAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing Base Percentage [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageAxis" xlink:href="ehth-20210331.xsd#ehth_BorrowingBasePercentageAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_BorrowingBasePercentageAxis" xlink:to="lab_ehth_BorrowingBasePercentageAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_92269e32-d3b7-44a3-87e6-71ad26e18ead_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_NonQualifiedHealthPlansMember_c337733d-6099-42f1-b2e7-20155c0ae9e7_terseLabel_en-US" xlink:label="lab_ehth_NonQualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Qualified Health Plans</link:label>
    <link:label id="lab_ehth_NonQualifiedHealthPlansMember_label_en-US" xlink:label="lab_ehth_NonQualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Qualified Health Plans [Member]</link:label>
    <link:label id="lab_ehth_NonQualifiedHealthPlansMember_documentation_en-US" xlink:label="lab_ehth_NonQualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Qualified Health Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NonQualifiedHealthPlansMember" xlink:href="ehth-20210331.xsd#ehth_NonQualifiedHealthPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_NonQualifiedHealthPlansMember" xlink:to="lab_ehth_NonQualifiedHealthPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4bbb871c-acab-4095-bdf6-69d8a15abb28_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_411c8524-1bc7-4bee-9c6b-1ffe6efb9d8f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_4ce80e6a-772c-4a23-baee-78ecbbf09865_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0a332876-8597-42de-b813-9b61f9ba5b24_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency bonds</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_fc045f1d-0f3e-4f6a-8c46-2f97221ad536_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedMedicareDomain_e089a400-4622-4e71-a403-3f6ffea49da2_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedMedicareDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Medicare [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedMedicareDomain_label_en-US" xlink:label="lab_ehth_DisaggregatedMedicareDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Medicare [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedMedicareDomain_documentation_en-US" xlink:label="lab_ehth_DisaggregatedMedicareDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Medicare [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareDomain" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedMedicareDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedMedicareDomain" xlink:to="lab_ehth_DisaggregatedMedicareDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_cd26adbe-595a-4af7-9de7-b0fd910d5d74_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_8691afa6-ec32-45b4-993e-26fa2b9cd879_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ee6167ee-d84a-4228-8cbd-064020e275d4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CommissionMember_78287893-8369-41bd-9705-a36c6e67b42a_terseLabel_en-US" xlink:label="lab_ehth_CommissionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission</link:label>
    <link:label id="lab_ehth_CommissionMember_label_en-US" xlink:label="lab_ehth_CommissionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission [Member]</link:label>
    <link:label id="lab_ehth_CommissionMember_documentation_en-US" xlink:label="lab_ehth_CommissionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember" xlink:href="ehth-20210331.xsd#ehth_CommissionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CommissionMember" xlink:to="lab_ehth_CommissionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_9f4f05c6-87f8-43dc-870b-d988881d8bff_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5bbf56ae-4271-4850-9643-6bed0f5190b6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_9b33da3f-9374-4cdf-a3f9-9b6f9c5d1a57_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_a0f45981-de2d-466b-bece-a91b785c6ca9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_30fa0600-8b5b-4ba6-ac6d-2a8d1bccd15b_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_e8ecf48b-1865-4d35-81a4-5441f1def749_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3b9d4977-06b8-4e8e-9a5e-775dfdb3cec7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ff226cd6-8a47-43bf-977d-3c3d192c7ff0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e5a09c73-e93b-4ef7-bad0-38cc92b8af92_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares used in per share amounts:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_10b9578a-fef2-4869-8ab4-7a12d0922d15_totalLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_2b16fd8d-34b2-4420-aa6f-998bb640de6c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_cfaa4d5c-89fe-401c-a5d4-178310dea996_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward" xlink:to="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_efb51413-49cd-42ba-837c-3fb451c70beb_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_8cbfbd81-5948-46dd-bcc6-d08971374319_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Assets Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_ef58cf43-67a4-4f0a-be51-e82fbb8dd8a9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CreditAgreementAmendmentMember_bcd29a78-c143-45cd-971f-71d0f2ec1d6b_terseLabel_en-US" xlink:label="lab_ehth_CreditAgreementAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Amendment</link:label>
    <link:label id="lab_ehth_CreditAgreementAmendmentMember_label_en-US" xlink:label="lab_ehth_CreditAgreementAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Amendment [Member]</link:label>
    <link:label id="lab_ehth_CreditAgreementAmendmentMember_documentation_en-US" xlink:label="lab_ehth_CreditAgreementAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CreditAgreementAmendmentMember" xlink:href="ehth-20210331.xsd#ehth_CreditAgreementAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CreditAgreementAmendmentMember" xlink:to="lab_ehth_CreditAgreementAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_3e522c04-1a68-411c-852b-92cef47a5ccd_terseLabel_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain</link:label>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="ehth-20210331.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_cae0867c-fecc-4c49-9267-0697c727eb74_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Statement Information</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_04721abf-52d8-4cea-a625-a65ee76e10a1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c5b2a30d-1e98-4bcf-9c26-11a7f5081f80_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_249fae22-0e4b-40e1-9937-d6a703dc2eaf_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_78f056ae-3e22-44a2-8089-4dcf9a39e21a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_597ae4b0-cfb2-4be4-ac14-19fe5f7e16bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_86c31680-6f96-4f4a-8549-741c9affe9fb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_284e611a-8cee-47e1-878e-71e5753bd80c_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_4f9902bb-284e-41a1-9303-4af8d110f2d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized internal-use software and website development costs</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Develop Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopSoftware" xlink:to="lab_us-gaap_PaymentsToDevelopSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd1cd3a9-b1c4-4bb8-862a-ef3de2f817e5_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_1e8f32a9-8452-4b51-8743-b3ba84a01f66_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_8eb89457-91e0-4bc9-8a47-f327f662f3dc_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_b8d1862f-f5ab-4745-8ada-b8be36f7b44a_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_aa5b7fdc-064a-4a99-b08c-ae50e0d7cdb0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_8f800c3c-9957-45c5-9e82-4246cb1fa752_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_07a78330-9721-4053-ae81-c3af2b57e6ff_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_0c9993dc-1a50-4b35-82ea-fdc3e471c6ed_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueInThirdYear_932a2144-7124-4b84-b1c2-c7f0cb7bc8ff_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInThirdYear" xlink:to="lab_us-gaap_ContractualObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_b69068b2-dba7-4c99-bccc-6b801c563013_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_11b77c80-1243-4a5a-abbb-615da530e978_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_8044d889-308e-47b5-b809-98ef129e8050_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of earnout liability</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_50b732b1-36f1-43e3-a508-3631ac20408f_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_5e5b4de2-45e3-4688-bc25-50f473ee8088_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_75eac034-acb9-496f-89a6-cac7b6fcd7f1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_de3da736-15c9-4fc1-9b0c-040efc0fc0a0_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_3a133316-a088-4579-aee2-eab3ac7865b3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in credit loss allowance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_12920a8a-87d1-4409-b396-0b42c6580de5_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_92a595d1-d7b9-4c65-b607-b7c48267decc_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_a76db68a-271d-4ba7-9be6-0ab6ab4f7123_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_e781435a-524f-4a31-924e-0157b24b1828_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_47cb8f9b-dc11-49a8-843b-3d667630c095_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_17809613-b118-4d15-bd1a-ea38d891a21c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_dd2031d5-53b9-454b-91c3-3ed66a98f796_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ShorttermMember_bbacbd01-8820-4191-b8d0-470e075268e6_terseLabel_en-US" xlink:label="lab_ehth_ShorttermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term</link:label>
    <link:label id="lab_ehth_ShorttermMember_label_en-US" xlink:label="lab_ehth_ShorttermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term [Member]</link:label>
    <link:label id="lab_ehth_ShorttermMember_documentation_en-US" xlink:label="lab_ehth_ShorttermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ShorttermMember" xlink:href="ehth-20210331.xsd#ehth_ShorttermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ShorttermMember" xlink:to="lab_ehth_ShorttermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_b59cad4b-c9e6-42cc-8561-b45af6360b51_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in equity offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_29d720f2-ef93-4c56-bf31-dcb408365230_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_012b4a36-6658-41f2-9e1d-7593d138a68c_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_290be993-1e5a-467a-a781-562e076d1bcc_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_32163d54-ed15-4d64-823a-5898ff812d9b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_a18782dd-4443-48e2-90c2-eed70273cac7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3a723ae7-47c2-4085-9c01-7063120074ef_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_3fed45e3-39d0-4631-b5e5-070b335c3c32_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_7443c21b-8166-456d-96b1-94ca0a9160bd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a34fe78f-f507-44fe-a1c5-bd1dc1d6e476_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_8df0b9fe-082f-4705-8bb8-4986ba52f301_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income, 2023</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueInNextTwelveMonths_f13f5c40-3fd5-4f88-944a-58f6491163de_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_af6150c4-7adb-4ac2-90b6-6584fd9cfbff_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from sale of stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_e6110b91-2a44-4b07-87f6-4121052e78f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_30426695-0b36-494f-91d6-9918a2a544ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Components Of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_abd3b6b8-fcfa-459f-bfe0-3f261eaa29c8_terseLabel_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Contractual Obligations</link:label>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_label_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:to="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_203b5c5c-6cc8-4550-ab4c-1c113fd924e9_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses_39f0937b-1b84-43a8-9c7a-3afc428b4abe_terseLabel_en-US" xlink:label="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued marketing expenses</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses_label_en-US" xlink:label="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Accrued Marketing Expenses</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses_documentation_en-US" xlink:label="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in accrued marketing expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:href="ehth-20210331.xsd#ehth_IncreaseDecreaseInAccruedMarketingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:to="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_BorrowingBasePercentageDomain_b207419e-f1d7-44ce-bb20-1a01f6df64f8_terseLabel_en-US" xlink:label="lab_ehth_BorrowingBasePercentageDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing Base Percentage [Domain]</link:label>
    <link:label id="lab_ehth_BorrowingBasePercentageDomain_label_en-US" xlink:label="lab_ehth_BorrowingBasePercentageDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing Base Percentage [Domain]</link:label>
    <link:label id="lab_ehth_BorrowingBasePercentageDomain_documentation_en-US" xlink:label="lab_ehth_BorrowingBasePercentageDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Borrowing Base Percentage [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageDomain" xlink:href="ehth-20210331.xsd#ehth_BorrowingBasePercentageDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_BorrowingBasePercentageDomain" xlink:to="lab_ehth_BorrowingBasePercentageDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_50ad5707-11b9-489f-85e5-c52b2a043773_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8cd7d460-fe3c-46ec-bbf9-2612605e1d37_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_b1ec08d4-b9c9-43d6-8731-0510e0394c2f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_2f0824da-bb6a-4b5c-af91-49fb88179d9c_terseLabel_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Six Months</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_label_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Six Months [Member]</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_documentation_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Six Months [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:href="ehth-20210331.xsd#ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:to="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e629e56c-cc1e-4fe0-bdce-cff74c6cd9f7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_bebc9d98-afd4-4170-8b5b-8ebde0b14e76_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which the Company is licensed to market and sell health insurance</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_d128a3e0-7195-431a-a225-9f17906a9893_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_NumberOfHealthInsuranceCarriers_9d4cf804-92be-482d-9a94-27a4f97ef74f_terseLabel_en-US" xlink:label="lab_ehth_NumberOfHealthInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of health insurance carriers (more than)</link:label>
    <link:label id="lab_ehth_NumberOfHealthInsuranceCarriers_label_en-US" xlink:label="lab_ehth_NumberOfHealthInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Health Insurance Carriers</link:label>
    <link:label id="lab_ehth_NumberOfHealthInsuranceCarriers_documentation_en-US" xlink:label="lab_ehth_NumberOfHealthInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Health Insurance Carriers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NumberOfHealthInsuranceCarriers" xlink:href="ehth-20210331.xsd#ehth_NumberOfHealthInsuranceCarriers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_NumberOfHealthInsuranceCarriers" xlink:to="lab_ehth_NumberOfHealthInsuranceCarriers" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IncrementalCommonSharesAttributableToOptions_50cbe029-882e-495e-8b3d-d93adcb6c9fb_terseLabel_en-US" xlink:label="lab_ehth_IncrementalCommonSharesAttributableToOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of common stock (in shares)</link:label>
    <link:label id="lab_ehth_IncrementalCommonSharesAttributableToOptions_label_en-US" xlink:label="lab_ehth_IncrementalCommonSharesAttributableToOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable To Options</link:label>
    <link:label id="lab_ehth_IncrementalCommonSharesAttributableToOptions_documentation_en-US" xlink:label="lab_ehth_IncrementalCommonSharesAttributableToOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable To Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncrementalCommonSharesAttributableToOptions" xlink:href="ehth-20210331.xsd#ehth_IncrementalCommonSharesAttributableToOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IncrementalCommonSharesAttributableToOptions" xlink:to="lab_ehth_IncrementalCommonSharesAttributableToOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_53dcf06c-4bdc-47cd-9b66-80bb2442f965_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_eaf4fd52-e68c-49de-bccf-31fd867a5e7d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_d2ceb0a2-378a-43aa-8d13-488366e538e6_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_521e5c9c-a143-427e-882d-cff1f087bc64_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_03199836-b10f-453b-b153-7ca5cef38cfe_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_185a4856-fc06-4542-8531-4292b161b53c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_49176529-0f16-42e6-a11a-3720164c5e16_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_ac0805c0-e201-4331-b88b-9cb36158a12c_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_9da9b51a-9354-48ba-b58f-7a277fe6f287_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_a287fda6-36c7-41e6-be3c-776edb6fa4a4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized holding gain (loss) for available for sales debt securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_062d2916-e194-47da-a47c-672877131763_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_66b9e21b-60df-4a38-bad5-f15d56049566_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Prepaid Expenses And Other Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_0b87bfd6-f65d-4f12-be50-ca3154230d4b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_1b266620-91a1-4ba4-8376-5da660cec2cb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_024d55f7-b8f1-492b-b55e-8aa7792e021a_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e4628d8a-6735-4edd-8aaf-1eeb0696fad3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_68809d09-6bc8-4663-97d2-ab4eb3f3646c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_9c6da8eb-765f-404b-9d81-578c864112fa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ContractualObligationToBePaidAfterYearFour_3b3d6871-a31d-4597-92b2-21ebc03e13f2_terseLabel_en-US" xlink:label="lab_ehth_ContractualObligationToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ehth_ContractualObligationToBePaidAfterYearFour_label_en-US" xlink:label="lab_ehth_ContractualObligationToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, After Year Four</link:label>
    <link:label id="lab_ehth_ContractualObligationToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_ehth_ContractualObligationToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ContractualObligationToBePaidAfterYearFour" xlink:href="ehth-20210331.xsd#ehth_ContractualObligationToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ContractualObligationToBePaidAfterYearFour" xlink:to="lab_ehth_ContractualObligationToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock_67855aab-a732-4665-8932-8bee20976b27_terseLabel_en-US" xlink:label="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business</link:label>
    <link:label id="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business, Policy [Policy Text Block]</link:label>
    <link:label id="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:href="ehth-20210331.xsd#ehth_DescriptionOfBusinessPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:to="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_181637e7-38bd-4d77-a3ec-c54393190376_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_e74cd6ca-32b0-4bb4-9310-ca9aed18ac1b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from exercise of common stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_603c9884-cd55-41cd-b58f-0947f8b5d657_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in allowance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_86c636ec-aacc-4549-a29e-678152e9c58f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LeViasCompliantMember_46f1cad4-ecc9-4e81-9808-12c46580b864_terseLabel_en-US" xlink:label="lab_ehth_LeViasCompliantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Le'Vias Compliant</link:label>
    <link:label id="lab_ehth_LeViasCompliantMember_label_en-US" xlink:label="lab_ehth_LeViasCompliantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Le'Vias Compliant [Member]</link:label>
    <link:label id="lab_ehth_LeViasCompliantMember_documentation_en-US" xlink:label="lab_ehth_LeViasCompliantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Le'Vias Compliant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LeViasCompliantMember" xlink:href="ehth-20210331.xsd#ehth_LeViasCompliantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LeViasCompliantMember" xlink:to="lab_ehth_LeViasCompliantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_d8e5f167-2e0d-437c-83b2-723d586c01b9_negatedLabel_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Loss</link:label>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="ehth-20210331.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_54c8512c-d3b1-4111-bf57-999ee783370a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_078f3f50-d6c0-49d3-9474-87df1af757a4_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_e793117a-09b4-4b06-8ff9-b5b6e7f3d69b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_55a17ebd-e11c-4a2e-b527-a5d47d5ba6bb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_SponsorshipAndAdvertisingMember_7905d00c-ee1e-48e2-bedd-efb24869583a_terseLabel_en-US" xlink:label="lab_ehth_SponsorshipAndAdvertisingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sponsorship and Advertising Revenue</link:label>
    <link:label id="lab_ehth_SponsorshipAndAdvertisingMember_label_en-US" xlink:label="lab_ehth_SponsorshipAndAdvertisingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sponsorship And Advertising [Member]</link:label>
    <link:label id="lab_ehth_SponsorshipAndAdvertisingMember_documentation_en-US" xlink:label="lab_ehth_SponsorshipAndAdvertisingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sponsorship And Advertising</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SponsorshipAndAdvertisingMember" xlink:href="ehth-20210331.xsd#ehth_SponsorshipAndAdvertisingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_SponsorshipAndAdvertisingMember" xlink:to="lab_ehth_SponsorshipAndAdvertisingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_a953fc4d-a290-4c61-9cd1-c10af0b6f785_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Contractual Maturities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_bd7322b9-e519-489e-a5c3-ce277449f781_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities &#8211; non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_12485b7f-14f8-4822-ab87-c57960b6035c_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_948c5607-9bf6-402b-a741-612e00389716_totalLabel_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_label_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities, Amortized Cost</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_documentation_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:href="ehth-20210331.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:to="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7563f82-75be-4dd7-a6c5-d4c14e6b7f43_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_a353ec8b-ca46-4577-8206-b55da591477d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies, Estimates and Judgments</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_8621997a-68bb-48d5-9816-11ce643600a7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_QualifiedHealthPlansMember_7e8f192b-d292-4b26-94f8-4fa3523dae59_terseLabel_en-US" xlink:label="lab_ehth_QualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Health Plans</link:label>
    <link:label id="lab_ehth_QualifiedHealthPlansMember_label_en-US" xlink:label="lab_ehth_QualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Health Plans [Member]</link:label>
    <link:label id="lab_ehth_QualifiedHealthPlansMember_documentation_en-US" xlink:label="lab_ehth_QualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Health Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_QualifiedHealthPlansMember" xlink:href="ehth-20210331.xsd#ehth_QualifiedHealthPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_QualifiedHealthPlansMember" xlink:to="lab_ehth_QualifiedHealthPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_bf667480-5a75-4433-a773-4d8df89f67a1_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MedicareMember_ed480fc0-3c2a-406e-9474-821f61dcfe94_terseLabel_en-US" xlink:label="lab_ehth_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_ehth_MedicareMember_label_en-US" xlink:label="lab_ehth_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:label id="lab_ehth_MedicareMember_documentation_en-US" xlink:label="lab_ehth_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareMember" xlink:href="ehth-20210331.xsd#ehth_MedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MedicareMember" xlink:to="lab_ehth_MedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_598c9d77-a06a-48b2-a5b1-f9e8ca415af8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseMember_465c2ece-f617-4dc7-89b6-07aaac8d78ba_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License</link:label>
    <link:label id="lab_us-gaap_LicenseMember_label_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember" xlink:to="lab_us-gaap_LicenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f950d875-e8b9-4f76-a017-4a6b38be9376_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment and other assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8c28ad9f-edab-4d7d-ac3c-8ee60d06d6eb_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_4154e981-e41e-4c07-90bc-94927b6d2445_negatedTerseLabel_en-US" xlink:label="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_label_en-US" xlink:label="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated Share-based Compensation Expense, Net Of Restructuring Reversal Expense</link:label>
    <link:label id="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_documentation_en-US" xlink:label="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated Share-based Compensation Expense, Net Of Restructuring Reversal Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:href="ehth-20210331.xsd#ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:to="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_8ad5b482-77d4-43f5-8635-7dbc66ba3741_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpenseMember_406b6aad-f604-413f-8b97-2326a1d6d9e7_terseLabel_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer care and enrollment</link:label>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpenseMember_label_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Care And Enrollment Expense [Member]</link:label>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpenseMember_documentation_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Care And Enrollment Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:href="ehth-20210331.xsd#ehth_CustomerCareAndEnrollmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:to="lab_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0f5b7e27-a449-493e-af88-00fe2bcdde93_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_465a9d1e-0a59-40fc-a63d-068e8bbd4ede_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_70b25b47-3165-4a9a-a62a-2c348a4acc87_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant, minimum cash and cash equivalents</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Minimum Cash And Cash Equivalents</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Minimum Cash And Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:to="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_dea7a582-47ab-4fc7-bf19-a1646efedc62_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue by Segment</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_eddfa5ec-8bb9-441f-b8c1-2a9136cd3fca_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_b9ba3c95-e467-47a6-85fc-3451d922dd92_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1b7109c3-f897-46b5-9afb-13fd6f4c8f7e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount capitalized in internal-use software</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_574a45ba-427d-44b5-b087-f56af1506047_terseLabel_en-US" xlink:label="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total workforce</link:label>
    <link:label id="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_label_en-US" xlink:label="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Number Of Positions Eliminated, Percentage Of Total Workforce</link:label>
    <link:label id="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_documentation_en-US" xlink:label="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Number Of Positions Eliminated, Percentage Of Total Workforce</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:href="ehth-20210331.xsd#ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:to="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MedicareAdvantageMember_ad0b39f4-16cf-4994-bd54-41d1c2b0c768_terseLabel_en-US" xlink:label="lab_ehth_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage</link:label>
    <link:label id="lab_ehth_MedicareAdvantageMember_label_en-US" xlink:label="lab_ehth_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage [Member]</link:label>
    <link:label id="lab_ehth_MedicareAdvantageMember_documentation_en-US" xlink:label="lab_ehth_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareAdvantageMember" xlink:href="ehth-20210331.xsd#ehth_MedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MedicareAdvantageMember" xlink:to="lab_ehth_MedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_8b876d45-1bdf-4e05-82b2-af895340cd45_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_2cfc2182-b1f3-4184-afdf-d8e9314be771_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Unrealized Gains and Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_2042c562-5853-4187-a798-ba8055f39a1a_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum liquidity</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Maximum Liquidity</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Maximum Liquidity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMaximumLiquidity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:to="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8a663ff2-45e5-41cf-8c4e-f10dfcf85296_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage_05e61d53-0cd1-4ff5-8b4e-f4a6b874498d_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing base percentage</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Borrowing Base, Percentage</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Borrowing Base, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityBorrowingBasePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:to="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_502196ec-b249-4fdd-9049-fbac387cc61a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_cc19d06b-9c22-4cf5-aa56-8dba4bb5e136_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_49a81af4-3d95-4d5b-a4b3-0fe5bc286f47_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_1e4b7344-48db-4c50-8584-53b090199b3e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_3138b427-c580-437e-ba56-ecfb4240c5f0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_cbdc1db4-7e7b-4585-98ce-2f36624c0cf3_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_90479fc4-8d3a-47c5-a704-6791450bc26c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_93278e43-33ea-4b04-bd13-0cea395aa4e1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_cea0615d-7c26-4c4b-bc95-e684d2cf09d0_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_ecef67b4-2ba7-4fc0-a5fe-f48277f871bd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities &#8211; current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_AssetsAndLiabilitiesLesseeTableTextBlock_878088b2-b235-4d55-af4f-274fe0c268ac_terseLabel_en-US" xlink:label="lab_ehth_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_ehth_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_ehth_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_ehth_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_ehth_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="ehth-20210331.xsd#ehth_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_ehth_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_62af98a1-09cf-47fe-be8a-ed11958bece3_terseLabel_en-US" xlink:label="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Under-Recognition Of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_label_en-US" xlink:label="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Under-Recognition Of Stock-Based Compensation Expense [Member]</link:label>
    <link:label id="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_documentation_en-US" xlink:label="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Under-Recognition Of Stock-Based Compensation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:href="ehth-20210331.xsd#ehth_UnderRecognitionOfStockBasedCompensationExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:to="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_9873a8f6-db77-491b-93fa-2982e8061852_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets &#8211; commissions receivable &#8211; non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_928ecd36-faff-483c-a97c-0511a9f254c5_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_2290adc0-0553-4e2b-9959-91507c8cf788_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_52abc5b8-e927-4a6c-9991-13c8a99852e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_1e30691c-d8ca-4323-92cb-b9bdb3b92f71_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_b2ad7b75-508d-4ce0-a33e-0a268bdf63ab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ec849453-218b-4ece-955d-27fe76b3b533_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_f37541d6-21e8-42ad-90d9-e9d32722e1be_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_5950470b-18e8-4130-81fd-6f27a0075ffd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from redemption and maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_65b11a14-e9d9-498e-bd9a-44ab1149a909_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_768efb11-f928-498a-abee-1806674c03d1_verboseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect from the adoption of ASU 2016-13</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_AncillariesMember_13e4ec0f-119b-415c-857a-c05ae21c5bd5_terseLabel_en-US" xlink:label="lab_ehth_AncillariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillary</link:label>
    <link:label id="lab_ehth_AncillariesMember_label_en-US" xlink:label="lab_ehth_AncillariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillaries [Member]</link:label>
    <link:label id="lab_ehth_AncillariesMember_documentation_en-US" xlink:label="lab_ehth_AncillariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AncillariesMember" xlink:href="ehth-20210331.xsd#ehth_AncillariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_AncillariesMember" xlink:to="lab_ehth_AncillariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_010ee111-c578-4858-89c0-9d719f058a31_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_2561f3f9-c70f-42b9-8153-25d1cf028617_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_c3d9f416-98ef-41d7-9445-0820a369f80b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3f0ddc12-b96e-413d-b3b2-63914ee2b2da_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate used to recognize operating lease right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_f5d9218e-6d32-4c35-a510-59e39a02aedb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_b162307d-a5f3-44dd-bfc9-f66acdc2706d_negatedTerseLabel_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Loss</link:label>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="ehth-20210331.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_47523ca0-676d-41ff-ae94-2a10c173d120_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_f34f3c27-ff47-4aac-bbc2-46429460c48c_terseLabel_en-US" xlink:label="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares that were previously surrendered by employees to satisfy tax withholdings (in shares)</link:label>
    <link:label id="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_label_en-US" xlink:label="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares Outstanding, Shares Acquired, Previously Cancelled Vested Shares Withheld For Tax Purposes</link:label>
    <link:label id="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_documentation_en-US" xlink:label="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares Outstanding, Shares Acquired, Previously Cancelled Vested Shares Withheld For Tax Purposes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:href="ehth-20210331.xsd#ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:to="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_c4729edb-bb85-4158-9faa-6c2b77e4aede_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in 1 year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_61260729-5a24-4016-889c-9ffd5ad1a4e2_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_abbbe32e-9ba6-493a-a67d-281c32b7c144_terseLabel_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain</link:label>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_label_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Gains, before Tax</link:label>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_documentation_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Gains, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:href="ehth-20210331.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:to="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_974a9d49-f2f6-4f91-a37a-8cb853a0c4e4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_1c3d5753-2875-4d98-8f3a-2369fd510a58_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1f15bf36-a0dc-45ee-a902-8df371e4afc0_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_0959fd4d-bfa5-45ee-9608-2c40992024ce_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_edf6d71a-17f9-4091-98a9-0573a4148a17_negatedTerseLabel_en-US" xlink:label="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in revenue</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="ehth-20210331.xsd#ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_46d7aabb-05a0-4911-ba74-bcfb3aad8882_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_AccruedMarketingExpenses_9c875364-5cfc-4a01-b1f7-c589e509ec3c_terseLabel_en-US" xlink:label="lab_ehth_AccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued marketing expenses</link:label>
    <link:label id="lab_ehth_AccruedMarketingExpenses_label_en-US" xlink:label="lab_ehth_AccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Expenses.</link:label>
    <link:label id="lab_ehth_AccruedMarketingExpenses_documentation_en-US" xlink:label="lab_ehth_AccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total carrying values as of the balance sheet date of liabilities incurred through that date and payable for obligations related to marketing and advertising services received from vendors. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AccruedMarketingExpenses" xlink:href="ehth-20210331.xsd#ehth_AccruedMarketingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_AccruedMarketingExpenses" xlink:to="lab_ehth_AccruedMarketingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_115a9f79-b006-49ee-a727-972e82f52071_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3e2a7219-0b74-47aa-b445-154a6f2cb7d2_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Loss</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_aa3f4ac9-74c1-4d45-9459-b71e07751931_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_8df156fb-cd21-4ef3-b4d3-160566571b9d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_358aaa87-26ba-473f-893e-a7af484c80ec_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_VisionMember_8970c355-ee84-49d7-a038-a9ac030885ba_terseLabel_en-US" xlink:label="lab_ehth_VisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision</link:label>
    <link:label id="lab_ehth_VisionMember_label_en-US" xlink:label="lab_ehth_VisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision [Member]</link:label>
    <link:label id="lab_ehth_VisionMember_documentation_en-US" xlink:label="lab_ehth_VisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_VisionMember" xlink:href="ehth-20210331.xsd#ehth_VisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_VisionMember" xlink:to="lab_ehth_VisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_56428054-b679-4326-bdd8-7cbf914250c0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_ee41a202-7ff7-4d6c-8abf-ef700ab2215a_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_c80fb640-15cf-4ee8-93c6-e1f78067e7b6_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_3a1be533-1d4a-4b7e-a2fa-ab860ddac2de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Revenue By Major Customers</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cd216a2c-91df-4673-9a8f-99ef7eb62b4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4a7c6bb6-739c-4676-831e-68a0840ea24a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in 1 year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_cb1c0abc-0994-4de7-97f1-98f428d6e799_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_SeasonalityPolicyPolicyTextBlock_a752ec9a-70f6-46bb-9e40-48da6c0ee0d6_terseLabel_en-US" xlink:label="lab_ehth_SeasonalityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seasonality</link:label>
    <link:label id="lab_ehth_SeasonalityPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ehth_SeasonalityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seasonality Policy [Policy Text Block]</link:label>
    <link:label id="lab_ehth_SeasonalityPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ehth_SeasonalityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seasonality Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SeasonalityPolicyPolicyTextBlock" xlink:href="ehth-20210331.xsd#ehth_SeasonalityPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_SeasonalityPolicyPolicyTextBlock" xlink:to="lab_ehth_SeasonalityPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_69ef50cf-ba08-4022-98c1-86581eec336f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_7c15d19d-8332-4adc-b7f6-30afef4385ce_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_9225778d-1fa8-4bb1-afb3-96dc538d7fc3_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_dd2e72c5-9515-451f-9311-b839d937b483_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_727a7af4-29c9-41c8-ba04-8c2f552b4e15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_TechnologyAndContentExpense_08fbc914-f067-441f-9763-cb8d9faedd92_terseLabel_en-US" xlink:label="lab_ehth_TechnologyAndContentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology and content</link:label>
    <link:label id="lab_ehth_TechnologyAndContentExpense_label_en-US" xlink:label="lab_ehth_TechnologyAndContentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology And Content Expense</link:label>
    <link:label id="lab_ehth_TechnologyAndContentExpense_documentation_en-US" xlink:label="lab_ehth_TechnologyAndContentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total expense recognized in the period for technology and content. Technology and content expenses consist primarily of compensation and benefits costs for personnel associated with developing and enhancing our website technology as well as maintaining our website.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpense" xlink:href="ehth-20210331.xsd#ehth_TechnologyAndContentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_TechnologyAndContentExpense" xlink:to="lab_ehth_TechnologyAndContentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_50e34fe0-cf36-400f-b57a-5cd574b18271_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_16997e18-f157-4b9b-8b3e-e6e8e4ad72db_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_cf619be9-2df7-44be-bf98-050f19bb24ce_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_a6831be9-c717-49c0-ade0-2b4fe75a27e3_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period Of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_ee8df5ae-b382-4c23-804f-5367ac6d8ae2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:to="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_242a3779-4fe8-495c-a1a5-bd950fb018d5_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_4c2e9542-bdae-4fe0-8cef-2eafd3cf4108_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_68b97b3b-2c78-4526-8756-f6557b43c73e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_26952785-e0c7-45eb-939e-98013fa49708_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total common stock shares used in diluted share calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_b9b9a1b0-4b03-4707-9f24-1b2fe5fb4013_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_ef1fdb11-948e-44c6-a9ef-fda9f2b37589_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_cdab5a30-e533-4156-bbf5-c10880dfbaf5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ae3ceed2-e0e2-48bf-af37-85cf81eb0b57_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share - basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_OverRecognitionOfLicensingCostsMember_c0facf14-8545-45e7-be3e-5e4d18986903_terseLabel_en-US" xlink:label="lab_ehth_OverRecognitionOfLicensingCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Recognition Of Licensing Costs</link:label>
    <link:label id="lab_ehth_OverRecognitionOfLicensingCostsMember_label_en-US" xlink:label="lab_ehth_OverRecognitionOfLicensingCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Recognition Of Licensing Costs [Member]</link:label>
    <link:label id="lab_ehth_OverRecognitionOfLicensingCostsMember_documentation_en-US" xlink:label="lab_ehth_OverRecognitionOfLicensingCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Recognition Of Licensing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OverRecognitionOfLicensingCostsMember" xlink:href="ehth-20210331.xsd#ehth_OverRecognitionOfLicensingCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_OverRecognitionOfLicensingCostsMember" xlink:to="lab_ehth_OverRecognitionOfLicensingCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_71ab013e-f3ca-4a36-b349-34ecf3904748_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_0d109cde-1814-432b-b7f7-82312f6104b5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_71a09f15-28f2-4ff9-85ab-423a4ef5e481_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_673cdef8-f6b7-470b-9395-2c0690a6ba4a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term of operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ChangeInContractWithCustomerAssetRollForward_196616f2-9b72-4295-8863-3f2bccae647a_terseLabel_en-US" xlink:label="lab_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_ehth_ChangeInContractWithCustomerAssetRollForward_label_en-US" xlink:label="lab_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_ehth_ChangeInContractWithCustomerAssetRollForward_documentation_en-US" xlink:label="lab_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:href="ehth-20210331.xsd#ehth_ChangeInContractWithCustomerAssetRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:to="lab_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedAncillariesDomain_bdacdacc-c2f1-4e1b-9b77-c173be1cc110_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedAncillariesDomain_label_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedAncillariesDomain_documentation_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesDomain" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedAncillariesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedAncillariesDomain" xlink:to="lab_ehth_DisaggregatedAncillariesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IncreaseDecreaseInCommissionsReceivable_d172a844-a397-483a-9042-4c8f1e41a7a7_terseLabel_en-US" xlink:label="lab_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets &#8211; commissions receivable</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInCommissionsReceivable_label_en-US" xlink:label="lab_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Commissions Receivable</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInCommissionsReceivable_documentation_en-US" xlink:label="lab_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Commissions Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:href="ehth-20210331.xsd#ehth_IncreaseDecreaseInCommissionsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:to="lab_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_043093c0-f6a6-4939-a814-f42763268fb4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_e1d050fc-6755-416a-94a1-86699bcf4cbb_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_b708ff42-84e0-4a06-82f5-a7205fee77e3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1e041eea-7648-4405-88e4-00f3561494be_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_bd4aeb84-e317-413b-aa57-04423aa9f476_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_8fa1dffc-2299-4aef-9a5e-70a41ccbe05a_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_4e6c5c76-e1de-4835-876d-998bf7ffa645_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_a3be147d-bf93-47dc-bf2a-87ade964d949_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_bf2451a9-dfa2-40af-9d03-6fab6687bc82_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_38710155-2fe1-4264-8146-341a99c820fe_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of internally developed software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_0e21a2a6-ec83-4317-ad50-bab90ff9b32f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_9cdd0b22-552e-4fca-a11f-37328184c18f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_12967140-3412-4133-9678-dacfbb07cadb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_OutOfPeriodAdjustmentsMember_c2b5da89-8a84-49fa-b0dd-4e93c450a89d_terseLabel_en-US" xlink:label="lab_ehth_OutOfPeriodAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Out-Of-Period Adjustments</link:label>
    <link:label id="lab_ehth_OutOfPeriodAdjustmentsMember_label_en-US" xlink:label="lab_ehth_OutOfPeriodAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Out-Of-Period Adjustments [Member]</link:label>
    <link:label id="lab_ehth_OutOfPeriodAdjustmentsMember_documentation_en-US" xlink:label="lab_ehth_OutOfPeriodAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Out-Of-Period Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OutOfPeriodAdjustmentsMember" xlink:href="ehth-20210331.xsd#ehth_OutOfPeriodAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_OutOfPeriodAdjustmentsMember" xlink:to="lab_ehth_OutOfPeriodAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c0efef5e-4900-4e1f-80ad-1eafe1a94ac4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3d231e3-1e9d-4ebf-9ce5-39f7ca9feafb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_cc56213c-b452-41fd-a422-7ce189294fd6_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_4748a2f1-3e78-43f4-9057-ac475ba7c9bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_68d9c15c-2024-479a-90c2-fb94148c9efd_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_d5893426-62c2-43d3-a429-addd8b676f52_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_6f1cd1b7-256e-4477-a8de-16c9faea064c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueInFourthYear_e188fcb4-885b-4f96-a775-e5f7596aa9dc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInFourthYear" xlink:to="lab_us-gaap_ContractualObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_6a8d9328-011d-4ec6-aff3-d2a0b6042360_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_0f7998a1-cf40-4d8f-a844-bc29e5d39df3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_52d03f33-19fe-44a7-b879-bc4194512bd1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_03e8d4b5-2478-4b5d-b646-5db08abbea78_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_190b9609-0bf9-4a3b-8414-ec1d06f68c59_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_285660d0-387a-44ba-9507-f914e9e993c7_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2706ffb7-cbbd-45aa-80b6-0a8e2ed41cd7_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_686f2d16-aadf-41c3-9508-a069b3849f4e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_a3a6a84d-e101-4c35-ae2f-fe22f9fa3e03_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Positions eliminated</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CenteneMember_fd15c1ec-da32-451b-b05c-b06070916064_terseLabel_en-US" xlink:label="lab_ehth_CenteneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centene</link:label>
    <link:label id="lab_ehth_CenteneMember_label_en-US" xlink:label="lab_ehth_CenteneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centene [Member]</link:label>
    <link:label id="lab_ehth_CenteneMember_documentation_en-US" xlink:label="lab_ehth_CenteneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centene</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CenteneMember" xlink:href="ehth-20210331.xsd#ehth_CenteneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CenteneMember" xlink:to="lab_ehth_CenteneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_190b80ab-5ff6-4c46-bd87-80d38d994e69_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_14bce9a8-baf4-4a6b-8530-992228a85242_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant, maximum cash and cash equivalents</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Maximum Cash And Cash Equivalents</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Maximum Cash And Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:to="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_OtherMember_e533b01c-3f5b-4306-a0dd-54dd09bbc091_terseLabel_en-US" xlink:label="lab_ehth_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ehth_OtherMember_label_en-US" xlink:label="lab_ehth_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_ehth_OtherMember_documentation_en-US" xlink:label="lab_ehth_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OtherMember" xlink:href="ehth-20210331.xsd#ehth_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_OtherMember" xlink:to="lab_ehth_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_6e284674-d602-444c-9f63-0640ac0b2176_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember_d6844091-1ee0-4216-a881-7730ecea6c00_terseLabel_en-US" xlink:label="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net commission revenue adjustments from members approved in prior period</link:label>
    <link:label id="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember_label_en-US" xlink:label="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission, Members Approved In Prior Periods [Member]</link:label>
    <link:label id="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember_documentation_en-US" xlink:label="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission, Members Approved In Prior Periods [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:href="ehth-20210331.xsd#ehth_CommissionMembersApprovedInPriorPeriodsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:to="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7f3887bc-e3ac-490c-8b9d-4b011d94ee0c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_f6655d34-86f0-4901-b7e0-308ed8d74d27_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3f4ef206-2781-4040-a6a6-93a28c3cb7f8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_37a63329-edec-4e52-b9cc-41c304f521ad_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_fef7b4f4-f3f1-4b6c-9ce4-2429323a7637_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Credit Risk</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_34bf6745-255d-4466-8229-d3ba76b177f3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_785f3ae4-c956-4aaf-8d0c-7cb7fd997b2f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_HumanaMember_eb0e73d8-fb64-4e05-b4e1-936ecc705b1e_terseLabel_en-US" xlink:label="lab_ehth_HumanaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Humana</link:label>
    <link:label id="lab_ehth_HumanaMember_label_en-US" xlink:label="lab_ehth_HumanaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Humana [Member]</link:label>
    <link:label id="lab_ehth_HumanaMember_documentation_en-US" xlink:label="lab_ehth_HumanaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Humana [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_HumanaMember" xlink:href="ehth-20210331.xsd#ehth_HumanaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_HumanaMember" xlink:to="lab_ehth_HumanaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8957eb22-6049-477b-8ab2-1dfb47f8badc_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_88a71030-c455-4b9d-8d0f-b071432f61f8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_fca82bf8-5dc4-4503-9b26-5f64acfec507_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_e7cc1fa6-0db8-4498-b50d-baf401a45828_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_33e721ad-db00-49c9-8127-3301ce02a0d9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock_686f46ac-1f82-47f7-900c-3a72490eca63_terseLabel_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense By Operating Function</link:label>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock_label_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense By Operating Function [Table Text Block]</link:label>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock_documentation_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense By Operating Function [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:href="ehth-20210331.xsd#ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:to="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_f415fb4c-281c-4697-80d6-9bb4e503eb49_totalLabel_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_label_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_documentation_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:href="ehth-20210331.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:to="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_5a0adb24-bf2b-4710-86e0-8c7155ec3f06_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ae06a17f-2b9c-44c1-a91c-a6fdc2183ad9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7bb4cb6c-fc8b-4256-bfe8-096f2bbaee27_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8448e570-3fcf-410b-9f1d-2afdde7e2175_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_a4ec777b-f99c-44d7-adff-9deb95c5ff18_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_01d06a91-2fa7-4e06-8431-bf672acab9c5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CommissionBonusMember_92fe0787-34e2-4454-9da1-8ed5fa94840b_terseLabel_en-US" xlink:label="lab_ehth_CommissionBonusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Bonus</link:label>
    <link:label id="lab_ehth_CommissionBonusMember_label_en-US" xlink:label="lab_ehth_CommissionBonusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Bonus [Member]</link:label>
    <link:label id="lab_ehth_CommissionBonusMember_documentation_en-US" xlink:label="lab_ehth_CommissionBonusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Bonus [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionBonusMember" xlink:href="ehth-20210331.xsd#ehth_CommissionBonusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CommissionBonusMember" xlink:to="lab_ehth_CommissionBonusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_42c8d4d1-0b31-4a40-a038-1005ab0d79ed_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2d68fa2d-07db-48b3-abd3-8af352fdcec9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_58913526-a38f-487d-bc3c-1f4f63b3c65a_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eed7d5e0-dbf7-4685-a2f1-1fc3fa66f6de_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_cca54dc3-1e81-4a3d-8ba6-b87046d1404f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_f1a3bf98-5019-4469-8981-4c1b44b5001b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_32c2f2aa-74c9-468b-bf88-ccce88d51d5f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b106f69b-4846-4425-9499-7a98c3833991_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_5f87b077-4249-4d33-aefb-ec92953b8496_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MiscellaneousOtherMember_5d1ba202-af7a-4634-9095-741080cc75f9_terseLabel_en-US" xlink:label="lab_ehth_MiscellaneousOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ehth_MiscellaneousOtherMember_label_en-US" xlink:label="lab_ehth_MiscellaneousOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous Other [Member]</link:label>
    <link:label id="lab_ehth_MiscellaneousOtherMember_documentation_en-US" xlink:label="lab_ehth_MiscellaneousOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MiscellaneousOtherMember" xlink:href="ehth-20210331.xsd#ehth_MiscellaneousOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MiscellaneousOtherMember" xlink:to="lab_ehth_MiscellaneousOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f99e374a-45f0-4748-87bf-da9b280aeca6_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_39f9750c-19a4-483e-984b-673a66581be5_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_102255ae-1cf5-4c93-b4f5-7b21348ab17b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_6e6c4ff0-fb7c-40cd-b59c-b76dfbff425c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_351c28b3-5f22-4709-97aa-89ec1556722e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_3ae09deb-358a-49fe-9f1e-fb2ecd5cc2e3_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_SegmentOperatingIncomeLoss_957374ed-792e-481a-b4c3-41d1ee19a5d1_terseLabel_en-US" xlink:label="lab_ehth_SegmentOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment profit (loss)</link:label>
    <link:label id="lab_ehth_SegmentOperatingIncomeLoss_label_en-US" xlink:label="lab_ehth_SegmentOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Income (Loss)</link:label>
    <link:label id="lab_ehth_SegmentOperatingIncomeLoss_documentation_en-US" xlink:label="lab_ehth_SegmentOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SegmentOperatingIncomeLoss" xlink:href="ehth-20210331.xsd#ehth_SegmentOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_SegmentOperatingIncomeLoss" xlink:to="lab_ehth_SegmentOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_91c916fe-b067-406d-98e0-13069bfa05a4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_PreviousRepurchaseProgramsMember_cfddb52d-b8d8-4a1c-91d2-3d4334353a2d_terseLabel_en-US" xlink:label="lab_ehth_PreviousRepurchaseProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previous share repurchase programs</link:label>
    <link:label id="lab_ehth_PreviousRepurchaseProgramsMember_label_en-US" xlink:label="lab_ehth_PreviousRepurchaseProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previous Repurchase Programs [Member]</link:label>
    <link:label id="lab_ehth_PreviousRepurchaseProgramsMember_documentation_en-US" xlink:label="lab_ehth_PreviousRepurchaseProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previous Repurchase Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreviousRepurchaseProgramsMember" xlink:href="ehth-20210331.xsd#ehth_PreviousRepurchaseProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_PreviousRepurchaseProgramsMember" xlink:to="lab_ehth_PreviousRepurchaseProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_814195c7-b8a7-4f63-83c9-e2c76b105717_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_871fc155-27cb-49b2-b04f-0fbe0c2a42a7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_8427af47-288a-4cf1-8029-54616f5a1e38_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityFacilityFeePercentage_e2927bea-7fa2-4d0c-91b3-a27ed86d8724_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility fee percentage</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityFacilityFeePercentage_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Facility Fee Percentage</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityFacilityFeePercentage_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Facility Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityFacilityFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:to="lab_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_TechnologyAndContentExpenseMember_1999b0f1-4b2c-42b3-8b78-e8ee2ff9a590_terseLabel_en-US" xlink:label="lab_ehth_TechnologyAndContentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology and content</link:label>
    <link:label id="lab_ehth_TechnologyAndContentExpenseMember_label_en-US" xlink:label="lab_ehth_TechnologyAndContentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology And Content Expense [Member]</link:label>
    <link:label id="lab_ehth_TechnologyAndContentExpenseMember_documentation_en-US" xlink:label="lab_ehth_TechnologyAndContentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology And Content Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpenseMember" xlink:href="ehth-20210331.xsd#ehth_TechnologyAndContentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_TechnologyAndContentExpenseMember" xlink:to="lab_ehth_TechnologyAndContentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedOtherAxis_33d5490b-56b4-418c-aafd-636fd06ad24d_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedOtherAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedOtherAxis_label_en-US" xlink:label="lab_ehth_DisaggregatedOtherAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedOtherAxis_documentation_en-US" xlink:label="lab_ehth_DisaggregatedOtherAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherAxis" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedOtherAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedOtherAxis" xlink:to="lab_ehth_DisaggregatedOtherAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_fab9f89b-989f-46c5-aa52-e90d2738937d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_098b566d-22b5-4923-a49e-2a849bf83837_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_cde27ca6-09c2-4583-8414-83fb1191f417_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_5a5aa9d6-893b-4b2d-8a61-8bbf29e7d2ab_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_54342ac9-8c61-4a40-8d3e-1eefeb663c48_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income, 2022</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8cd8c6f2-b75d-4494-8ba3-f6ece63cf9cc_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in equity offering (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_11486aeb-0781-428a-bc99-068d74931cf4_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_4f796b7f-2897-4efd-84e3-98ade610a1fb_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_SmallBusinessMember_b11db23f-908a-464f-8281-98ba3bb5dcb5_terseLabel_en-US" xlink:label="lab_ehth_SmallBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Small Business</link:label>
    <link:label id="lab_ehth_SmallBusinessMember_label_en-US" xlink:label="lab_ehth_SmallBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Small Business [Member]</link:label>
    <link:label id="lab_ehth_SmallBusinessMember_documentation_en-US" xlink:label="lab_ehth_SmallBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Small Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SmallBusinessMember" xlink:href="ehth-20210331.xsd#ehth_SmallBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_SmallBusinessMember" xlink:to="lab_ehth_SmallBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_822292ba-9cbc-4226-9529-20955087f399_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets &#8211; commissions receivable &#8211; current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_7b20123b-58b0-4c0b-b590-51eb07bfd043_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_3dfcf4e0-9faf-47ea-b468-3b90af427e30_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fbda38ac-790a-4e84-845a-c44fcf664290_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with equity incentive plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9ae056b9-106b-44f3-a4ff-507dc377d311_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_39a51ce2-50e4-4de0-a9f8-90f31bca2657_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_28d23808-261a-4fb1-a38c-88be8d29674a_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_17206771-3971-4769-bd9d-82457631cf43_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b4470625-5a19-4a62-9eaa-cd89c861362b_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_e44d9c3d-26bc-4cab-8ae0-f146f2610607_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_e46624ee-641c-4520-a011-64a3c37c9695_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_1b9d25f2-457e-4d88-9e07-0a57d38c0639_terseLabel_en-US" xlink:label="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual, Family and Small Business</link:label>
    <link:label id="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_label_en-US" xlink:label="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual, Family, And Small Business Segments [Member]</link:label>
    <link:label id="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_documentation_en-US" xlink:label="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual, Family, And Small Business Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:href="ehth-20210331.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:to="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_21e78cbe-5fb7-4bee-9316-b3df9f056868_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f929aa2-7ff6-4456-a16e-2f1e1cc770a4_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in per share calculation - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_8352b99b-69ef-430a-9491-1f234a00bb2d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities in net loss positions</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_73d196d3-4202-4494-b9b0-c2d19f2cc698_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares to satisfy employee tax withholding obligations</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cash Used to Settle Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_15f17658-3bd4-413b-b755-14dc3b71a791_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0da677b5-ad86-44e8-8808-921bc281083a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_0ab1d3d6-d59c-4a30-a323-0d5b1959fcbc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_e6e69bfd-8dc3-4b0c-b4c4-578acdb62e78_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_cab26e5c-02e1-48b0-936f-0440d35dddd1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9a985c5a-46fd-4bbd-8806-8aeb03410e29_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_46f553e0-82e8-439c-a1b6-a140adb5296b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_7f8b6059-8207-4e59-a7b4-869bdb8986f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CommissionRevenueFromRenewalsMember_88b5079d-23d0-4ce8-b8b1-ca73275877fb_terseLabel_en-US" xlink:label="lab_ehth_CommissionRevenueFromRenewalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission revenue from renewals of small business members during the period</link:label>
    <link:label id="lab_ehth_CommissionRevenueFromRenewalsMember_label_en-US" xlink:label="lab_ehth_CommissionRevenueFromRenewalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Revenue From Renewals [Member]</link:label>
    <link:label id="lab_ehth_CommissionRevenueFromRenewalsMember_documentation_en-US" xlink:label="lab_ehth_CommissionRevenueFromRenewalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Revenue From Renewals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionRevenueFromRenewalsMember" xlink:href="ehth-20210331.xsd#ehth_CommissionRevenueFromRenewalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CommissionRevenueFromRenewalsMember" xlink:to="lab_ehth_CommissionRevenueFromRenewalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyAxis_4c131810-497f-49f9-aff7-3988022c4352_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyAxis_label_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyAxis_documentation_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyAxis" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedIndividualandFamilyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyAxis" xlink:to="lab_ehth_DisaggregatedIndividualandFamilyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_8764cb91-0c10-481e-9489-b3be8ef761e0_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_15f36ce6-bedd-4b37-b9a9-a36a73bd2814_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_770c8ac8-3aab-4931-a8c1-e5e60f999dfb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_64419a9d-5189-493e-a9b2-eee5317adc5a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedMedicareAxis_292477f9-b074-449e-802a-ff759f81837b_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedMedicareAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Medicare [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedMedicareAxis_label_en-US" xlink:label="lab_ehth_DisaggregatedMedicareAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Medicare [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedMedicareAxis_documentation_en-US" xlink:label="lab_ehth_DisaggregatedMedicareAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disagregated Medicare [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareAxis" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedMedicareAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedMedicareAxis" xlink:to="lab_ehth_DisaggregatedMedicareAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b6674bd9-9c40-481c-a679-36f31a62e9bc_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_65f5bea2-2abd-4d91-ba86-140d46342460_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b9dbbb28-0519-4f18-a5b6-7ca624225d0f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_5b328c4d-0d31-4288-9b2f-fc3fcbdf05f3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueInSecondYear_375ffac0-d9f4-433d-adb7-95d5c64020e7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInSecondYear" xlink:to="lab_us-gaap_ContractualObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_d0ce4dd7-7225-46c7-b745-ef15ab097f1a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5650c311-931a-402a-9087-8913cd17d4f6_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share - diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8f8f66d3-f011-478c-aca3-2dcb1281f231_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_e14e868e-e7f6-455c-a370-f28eee91a284_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period Of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_10f02d6f-5c08-4c4a-9f37-5ffeb6b58428_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_78535655-ed45-490b-8ead-2bc8b814fa3c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_7e1024ed-a63d-45a9-9d54-3fb64d797b72_terseLabel_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Preceding Three Months</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_label_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Preceding Three Months [Member]</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_documentation_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Preceding Three Months [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:href="ehth-20210331.xsd#ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:to="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7a872dd6-5d2f-45f5-af91-7ced90f88fec_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ece5e640-a0cb-4f03-91aa-5494d52705e1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with equity incentive plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedAncillariesAxis_d2e86bd4-6f07-43ae-bc33-d740fd1ea00e_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedAncillariesAxis_label_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedAncillariesAxis_documentation_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesAxis" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedAncillariesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedAncillariesAxis" xlink:to="lab_ehth_DisaggregatedAncillariesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_de90b729-e8b2-4201-a53d-8e9889c50680_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpense_1c1537bd-b053-4e96-9e43-7b4db9cb6efc_terseLabel_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer care and enrollment</link:label>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpense_label_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Care And Enrollment Expense</link:label>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpense_documentation_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total expense recognized in the period related to providing customer care and enrollment services. These services include pre-sales assistance to applicants who call our customer care center and enrollment services to applicants during the underwriting process.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpense" xlink:href="ehth-20210331.xsd#ehth_CustomerCareAndEnrollmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CustomerCareAndEnrollmentExpense" xlink:to="lab_ehth_CustomerCareAndEnrollmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b27e6fd5-c28e-47f7-9b19-b7c9cd683b01_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MedicarePartDMember_dd256d3f-3bfc-4744-ab0b-4e2b65999110_terseLabel_en-US" xlink:label="lab_ehth_MedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D</link:label>
    <link:label id="lab_ehth_MedicarePartDMember_label_en-US" xlink:label="lab_ehth_MedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D [Member]</link:label>
    <link:label id="lab_ehth_MedicarePartDMember_documentation_en-US" xlink:label="lab_ehth_MedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicarePartDMember" xlink:href="ehth-20210331.xsd#ehth_MedicarePartDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MedicarePartDMember" xlink:to="lab_ehth_MedicarePartDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_18488208-72d0-491a-a0e2-19ca9cbad98d_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedOtherDomain_15ba7091-860a-4ad1-b975-5b40d2a229dc_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedOtherDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedOtherDomain_label_en-US" xlink:label="lab_ehth_DisaggregatedOtherDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedOtherDomain_documentation_en-US" xlink:label="lab_ehth_DisaggregatedOtherDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherDomain" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedOtherDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedOtherDomain" xlink:to="lab_ehth_DisaggregatedOtherDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_f8ec066b-b379-4dbb-a84c-73c96ddc9f84_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_AetnaMember_b53dd768-2ec7-468f-8036-6dc18ce91fb8_terseLabel_en-US" xlink:label="lab_ehth_AetnaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna</link:label>
    <link:label id="lab_ehth_AetnaMember_label_en-US" xlink:label="lab_ehth_AetnaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna [Member]</link:label>
    <link:label id="lab_ehth_AetnaMember_documentation_en-US" xlink:label="lab_ehth_AetnaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AetnaMember" xlink:href="ehth-20210331.xsd#ehth_AetnaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_AetnaMember" xlink:to="lab_ehth_AetnaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock_eddb1453-9377-456f-8a09-807082dbd9bc_terseLabel_en-US" xlink:label="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Long Lived Assets By Geographical Areas</link:label>
    <link:label id="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Long Lived Assets By Geographical Areas [Table Text Block]</link:label>
    <link:label id="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock_documentation_en-US" xlink:label="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Long Lived Assets By Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="ehth-20210331.xsd#ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DentalMember_839258af-8262-42ce-bcc9-e330a1703e82_terseLabel_en-US" xlink:label="lab_ehth_DentalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dental</link:label>
    <link:label id="lab_ehth_DentalMember_label_en-US" xlink:label="lab_ehth_DentalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dental [Member]</link:label>
    <link:label id="lab_ehth_DentalMember_documentation_en-US" xlink:label="lab_ehth_DentalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dental [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DentalMember" xlink:href="ehth-20210331.xsd#ehth_DentalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DentalMember" xlink:to="lab_ehth_DentalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_086cc433-58ea-45c7-8711-41a3fb8f58bc_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MedicareSegmentMember_aaef73c3-2e1c-4e8c-bd59-33b26a03d1df_terseLabel_en-US" xlink:label="lab_ehth_MedicareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_ehth_MedicareSegmentMember_label_en-US" xlink:label="lab_ehth_MedicareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Segment [Member]</link:label>
    <link:label id="lab_ehth_MedicareSegmentMember_documentation_en-US" xlink:label="lab_ehth_MedicareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember" xlink:href="ehth-20210331.xsd#ehth_MedicareSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MedicareSegmentMember" xlink:to="lab_ehth_MedicareSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_34244c8a-b49e-4d09-bd0c-c43e8b507b19_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_198ec864-9aa2-4fb7-83f3-538868c8b70a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related contingent payments</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_PrepaidMaintenanceContractsCurrent_2c7c0b1b-24a7-4c66-b030-9fda8089682f_terseLabel_en-US" xlink:label="lab_ehth_PrepaidMaintenanceContractsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid maintenance contracts</link:label>
    <link:label id="lab_ehth_PrepaidMaintenanceContractsCurrent_label_en-US" xlink:label="lab_ehth_PrepaidMaintenanceContractsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Maintenance Contracts Current</link:label>
    <link:label id="lab_ehth_PrepaidMaintenanceContractsCurrent_documentation_en-US" xlink:label="lab_ehth_PrepaidMaintenanceContractsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Maintenance Contracts (Current)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PrepaidMaintenanceContractsCurrent" xlink:href="ehth-20210331.xsd#ehth_PrepaidMaintenanceContractsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_PrepaidMaintenanceContractsCurrent" xlink:to="lab_ehth_PrepaidMaintenanceContractsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e38de110-4707-4444-bd64-7a40a4664c34_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_1cf16e51-00aa-4157-99e4-65803f45baa8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New claims filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_40dc686c-c9db-4af6-adad-639d73bf8fb9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_683d342d-de5c-421b-9638-a8c643c2fbf1_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Business and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_36d07ae9-b723-4ef1-b9b8-2ce3e1a4f8ec_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c2c74457-c949-4683-8ae1-5912935b1c93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a88bc8c1-724c-4bbe-8fe7-c4d11c87283c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_d08e3c1a-293c-4c17-bd3e-096260457734_terseLabel_en-US" xlink:label="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from sale of stock</link:label>
    <link:label id="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_label_en-US" xlink:label="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Consideration Received On Transaction, Gross</link:label>
    <link:label id="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_documentation_en-US" xlink:label="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Consideration Received On Transaction, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:href="ehth-20210331.xsd#ehth_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:to="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a8e29023-3738-41fe-9942-9d7bea5b57ed_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_53251965-8d02-492b-8516-b91dbfa2e0ea_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_8994a109-64db-4e34-bcfd-3e9acab44d58_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Contingencies and Guarantees [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:to="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_2e4dad7a-9921-41d8-a393-bacc7d537d71_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_5201b5b9-4bdb-489d-9a8e-adee3391b113_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_37d24f64-1f8a-4bbe-8fdf-ec4a55a52e90_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_25643f96-d259-4efa-ace6-ab2661e33ef8_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IndividualandFamilyMember_14ae94ad-f22a-45b3-88c2-3f50d7df9345_terseLabel_en-US" xlink:label="lab_ehth_IndividualandFamilyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual and Family</link:label>
    <link:label id="lab_ehth_IndividualandFamilyMember_label_en-US" xlink:label="lab_ehth_IndividualandFamilyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual and Family [Member]</link:label>
    <link:label id="lab_ehth_IndividualandFamilyMember_documentation_en-US" xlink:label="lab_ehth_IndividualandFamilyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual and Family [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualandFamilyMember" xlink:href="ehth-20210331.xsd#ehth_IndividualandFamilyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IndividualandFamilyMember" xlink:to="lab_ehth_IndividualandFamilyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_a83bce05-c1bf-4087-b489-b917144be355_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_3fe78d93-0185-47ab-991e-fa39dd1f0588_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_e89f03b3-a187-47fb-b8cc-2be362461954_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_2b959a95-9714-42e1-8142-6be5baf03bff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_3f88bb75-4a71-468a-a4f5-b91e7b31fa83_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares to satisfy employee tax withholding obligations (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f50569ec-9afa-44fc-a53a-dba450706d66_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncement</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ce4c10a1-9907-49e9-9a0d-898a23beaf07_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Impact</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_f4e0cfbd-e3de-4180-b5f6-3d6c2c758d7e_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum liquidity</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Minimum Liquidity</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Minimum Liquidity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMinimumLiquidity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:to="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>ehth-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:31f4f7fb-855a-4e3e-841b-479b93e1e603,g:93b223c9-0d4d-4bbf-9f72-5268ef99062c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="simple" xlink:href="ehth-20210331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_154769e1-4e0b-4330-bc2f-8a2a475ae35d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_DocumentType_154769e1-4e0b-4330-bc2f-8a2a475ae35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_3006ed35-a99e-4298-9f38-802a239f99db" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_DocumentQuarterlyReport_3006ed35-a99e-4298-9f38-802a239f99db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3ffb8202-a7ed-4b7c-b007-bde13efbfb9d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_DocumentPeriodEndDate_3ffb8202-a7ed-4b7c-b007-bde13efbfb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_83657344-8dfe-4dde-af2c-93c70cae467a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_DocumentTransitionReport_83657344-8dfe-4dde-af2c-93c70cae467a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ef255400-3592-4a32-8dd0-a91a43d068e1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityFileNumber_ef255400-3592-4a32-8dd0-a91a43d068e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7f4d82c0-781d-41f7-b23a-f1912d0a5a70" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityRegistrantName_7f4d82c0-781d-41f7-b23a-f1912d0a5a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ee2198ce-6299-42d9-91fa-124672b7141a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ee2198ce-6299-42d9-91fa-124672b7141a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a3501120-78c2-4995-b648-487899c5cf85" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityTaxIdentificationNumber_a3501120-78c2-4995-b648-487899c5cf85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_12525c30-7281-48a0-8709-4ad495e063a3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityAddressAddressLine1_12525c30-7281-48a0-8709-4ad495e063a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5bf1ad32-3e3d-4246-885b-149d2b8e126c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityAddressCityOrTown_5bf1ad32-3e3d-4246-885b-149d2b8e126c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c6f50c27-21b1-4038-905e-f9c714949228" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityAddressStateOrProvince_c6f50c27-21b1-4038-905e-f9c714949228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a6669298-9974-41b0-84c7-b5bd5066eef7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityAddressPostalZipCode_a6669298-9974-41b0-84c7-b5bd5066eef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_871f49bf-8abe-4853-94c9-5b3e6a4d03ec" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_CityAreaCode_871f49bf-8abe-4853-94c9-5b3e6a4d03ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_940a6d2a-6a08-4ca1-b769-0c4fd036557a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_LocalPhoneNumber_940a6d2a-6a08-4ca1-b769-0c4fd036557a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ef510bd1-807b-482d-88d9-adde23aae2af" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_Security12bTitle_ef510bd1-807b-482d-88d9-adde23aae2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_743dd7d1-40db-4fe4-a3fd-7c37c7c1b87c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_TradingSymbol_743dd7d1-40db-4fe4-a3fd-7c37c7c1b87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_adcd0b53-ed7e-4fcf-bdd3-652ba9101521" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_SecurityExchangeName_adcd0b53-ed7e-4fcf-bdd3-652ba9101521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ba559db0-16d3-439d-9094-8646017e3688" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityCurrentReportingStatus_ba559db0-16d3-439d-9094-8646017e3688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_3c3c4fde-dafd-4611-920f-1043670cbcfc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityInteractiveDataCurrent_3c3c4fde-dafd-4611-920f-1043670cbcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_ce1481f4-e0a3-496c-b598-c2413eac18a1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityFilerCategory_ce1481f4-e0a3-496c-b598-c2413eac18a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_191808ca-881d-4784-854a-8befa8fd581e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntitySmallBusiness_191808ca-881d-4784-854a-8befa8fd581e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_61ba8e7c-aae0-428b-bc33-1dfaf12a74a9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityEmergingGrowthCompany_61ba8e7c-aae0-428b-bc33-1dfaf12a74a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2e111a3e-59b4-4c7e-b6bc-cbdcad20bf32" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityShellCompany_2e111a3e-59b4-4c7e-b6bc-cbdcad20bf32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2c0a477c-b3d8-4f62-86c8-1af3af0481b1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2c0a477c-b3d8-4f62-86c8-1af3af0481b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ff6987b5-03f5-45da-a6f6-2759bdb896a0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_AmendmentFlag_ff6987b5-03f5-45da-a6f6-2759bdb896a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a8d20f1f-b58b-4319-b4da-2f9a837438f6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_DocumentFiscalYearFocus_a8d20f1f-b58b-4319-b4da-2f9a837438f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_582032c9-b79c-41b9-99f3-aac5f7300563" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_582032c9-b79c-41b9-99f3-aac5f7300563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f86c17e3-277d-4f9d-9abe-2e3a23b9b065" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_EntityCentralIndexKey_f86c17e3-277d-4f9d-9abe-2e3a23b9b065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3002a48b-36ee-4e60-b1c0-f1f0a1ad1168" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b52441b7-092a-4273-96c1-cf167322ce5e" xlink:to="loc_dei_CurrentFiscalYearEndDate_3002a48b-36ee-4e60-b1c0-f1f0a1ad1168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6f83ebc9-dc72-4b31-bd8b-3b203b9bf8bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a24affad-bf6b-4239-abf7-84e6e6a91460" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f83ebc9-dc72-4b31-bd8b-3b203b9bf8bf" xlink:to="loc_us-gaap_AssetsAbstract_a24affad-bf6b-4239-abf7-84e6e6a91460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_cc10f2ff-fc55-42c1-a706-5c7909217122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a24affad-bf6b-4239-abf7-84e6e6a91460" xlink:to="loc_us-gaap_AssetsCurrentAbstract_cc10f2ff-fc55-42c1-a706-5c7909217122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4ae48aff-c66a-4bc5-9d41-0c5c4a58822a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc10f2ff-fc55-42c1-a706-5c7909217122" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4ae48aff-c66a-4bc5-9d41-0c5c4a58822a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_6ea1dc8e-273f-4df0-ac13-00cacb7d0988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc10f2ff-fc55-42c1-a706-5c7909217122" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_6ea1dc8e-273f-4df0-ac13-00cacb7d0988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_27fd23e0-5b23-48b6-b1a8-c0056a9f027c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc10f2ff-fc55-42c1-a706-5c7909217122" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_27fd23e0-5b23-48b6-b1a8-c0056a9f027c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_7ba7ab09-1046-4960-a774-e2f3eade20ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc10f2ff-fc55-42c1-a706-5c7909217122" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_7ba7ab09-1046-4960-a774-e2f3eade20ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_213fcfe8-3459-42fd-98aa-b848dff0462a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc10f2ff-fc55-42c1-a706-5c7909217122" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_213fcfe8-3459-42fd-98aa-b848dff0462a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d89e1d3b-64e2-4a00-9f13-7c971aec3213" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc10f2ff-fc55-42c1-a706-5c7909217122" xlink:to="loc_us-gaap_AssetsCurrent_d89e1d3b-64e2-4a00-9f13-7c971aec3213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_f25e2e45-4be9-4d22-ae31-9b684b7e0485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a24affad-bf6b-4239-abf7-84e6e6a91460" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_f25e2e45-4be9-4d22-ae31-9b684b7e0485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_00c89161-8303-44d5-87f2-1819dcbdd052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a24affad-bf6b-4239-abf7-84e6e6a91460" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_00c89161-8303-44d5-87f2-1819dcbdd052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e935a858-13bd-4e53-8e66-64043d3fff4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a24affad-bf6b-4239-abf7-84e6e6a91460" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e935a858-13bd-4e53-8e66-64043d3fff4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_29fe0004-f462-400d-a082-30672393fc79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a24affad-bf6b-4239-abf7-84e6e6a91460" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_29fe0004-f462-400d-a082-30672393fc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7d5fb14d-0530-408f-ba27-7653166564eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a24affad-bf6b-4239-abf7-84e6e6a91460" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7d5fb14d-0530-408f-ba27-7653166564eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1c141c93-01f3-425d-b27e-f031c24515db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a24affad-bf6b-4239-abf7-84e6e6a91460" xlink:to="loc_us-gaap_Goodwill_1c141c93-01f3-425d-b27e-f031c24515db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_652d581b-ed4e-43f1-a01d-3b4cf8ecf134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a24affad-bf6b-4239-abf7-84e6e6a91460" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_652d581b-ed4e-43f1-a01d-3b4cf8ecf134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_443954b1-c4b8-41c5-bae3-4a9b3b6dbd19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a24affad-bf6b-4239-abf7-84e6e6a91460" xlink:to="loc_us-gaap_Assets_443954b1-c4b8-41c5-bae3-4a9b3b6dbd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53958a81-b7a3-43db-abf4-b75cb0a0e2f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f83ebc9-dc72-4b31-bd8b-3b203b9bf8bf" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53958a81-b7a3-43db-abf4-b75cb0a0e2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d0bfd3bd-0c53-40c4-978e-ddd18d87fa96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53958a81-b7a3-43db-abf4-b75cb0a0e2f1" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d0bfd3bd-0c53-40c4-978e-ddd18d87fa96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_00b57cff-4619-45ff-9324-2ab3c3bf4458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0bfd3bd-0c53-40c4-978e-ddd18d87fa96" xlink:to="loc_us-gaap_AccountsPayableCurrent_00b57cff-4619-45ff-9324-2ab3c3bf4458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a1b9f29d-3369-4ece-a8e6-abb0e4292bda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0bfd3bd-0c53-40c4-978e-ddd18d87fa96" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a1b9f29d-3369-4ece-a8e6-abb0e4292bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AccruedMarketingExpenses_37e50ca7-b72c-41e3-973c-b1670881a207" xlink:href="ehth-20210331.xsd#ehth_AccruedMarketingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0bfd3bd-0c53-40c4-978e-ddd18d87fa96" xlink:to="loc_ehth_AccruedMarketingExpenses_37e50ca7-b72c-41e3-973c-b1670881a207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2d854d7a-9380-41f2-8420-6a84ada0cf5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0bfd3bd-0c53-40c4-978e-ddd18d87fa96" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2d854d7a-9380-41f2-8420-6a84ada0cf5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9f433e8f-880d-4511-8941-76f2f53e2b50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0bfd3bd-0c53-40c4-978e-ddd18d87fa96" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9f433e8f-880d-4511-8941-76f2f53e2b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_04b41b68-16f0-4cf7-a3e3-5f57618c0588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0bfd3bd-0c53-40c4-978e-ddd18d87fa96" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_04b41b68-16f0-4cf7-a3e3-5f57618c0588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2bc33575-4329-406d-926f-05003f83969d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d0bfd3bd-0c53-40c4-978e-ddd18d87fa96" xlink:to="loc_us-gaap_LiabilitiesCurrent_2bc33575-4329-406d-926f-05003f83969d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a3233954-2161-4679-b32c-9369086a40a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53958a81-b7a3-43db-abf4-b75cb0a0e2f1" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a3233954-2161-4679-b32c-9369086a40a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b5ea025e-8d0f-4123-a3b2-39ce5dcc83f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53958a81-b7a3-43db-abf4-b75cb0a0e2f1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b5ea025e-8d0f-4123-a3b2-39ce5dcc83f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1a4afb0b-a0df-4a8d-996d-c746ff7367b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53958a81-b7a3-43db-abf4-b75cb0a0e2f1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1a4afb0b-a0df-4a8d-996d-c746ff7367b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_40afa2e1-bcc1-4810-8999-52e81552a1d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53958a81-b7a3-43db-abf4-b75cb0a0e2f1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_40afa2e1-bcc1-4810-8999-52e81552a1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3dd448d5-6ea4-4027-ae29-648003aa5779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53958a81-b7a3-43db-abf4-b75cb0a0e2f1" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3dd448d5-6ea4-4027-ae29-648003aa5779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_27449eb8-bd00-4915-a214-174c8f2dd6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3dd448d5-6ea4-4027-ae29-648003aa5779" xlink:to="loc_us-gaap_CommonStockValue_27449eb8-bd00-4915-a214-174c8f2dd6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1c2dff2b-9b3f-4db6-b533-05156bdf6e63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3dd448d5-6ea4-4027-ae29-648003aa5779" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1c2dff2b-9b3f-4db6-b533-05156bdf6e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_00df327c-6c23-46ee-be3e-eb3407f57e49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3dd448d5-6ea4-4027-ae29-648003aa5779" xlink:to="loc_us-gaap_TreasuryStockValue_00df327c-6c23-46ee-be3e-eb3407f57e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29dc465f-853c-482e-8eb0-3420aecc90a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3dd448d5-6ea4-4027-ae29-648003aa5779" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29dc465f-853c-482e-8eb0-3420aecc90a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cb51e0f3-aeb4-4ef8-9148-e974b97cf61a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3dd448d5-6ea4-4027-ae29-648003aa5779" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cb51e0f3-aeb4-4ef8-9148-e974b97cf61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_934efe2a-5578-43d4-bbe8-4df6a64e4994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3dd448d5-6ea4-4027-ae29-648003aa5779" xlink:to="loc_us-gaap_StockholdersEquity_934efe2a-5578-43d4-bbe8-4df6a64e4994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8e6ec697-d74e-4397-93aa-dc541bcde2cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53958a81-b7a3-43db-abf4-b75cb0a0e2f1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8e6ec697-d74e-4397-93aa-dc541bcde2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_45d34db2-d128-4ed4-8194-3a15bc19d9a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_596208f5-0bc1-4af6-b345-e063d4de8fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_45d34db2-d128-4ed4-8194-3a15bc19d9a7" xlink:to="loc_us-gaap_StatementTable_596208f5-0bc1-4af6-b345-e063d4de8fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_002d6bab-0980-4583-821d-9fd07664ec8c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_596208f5-0bc1-4af6-b345-e063d4de8fd8" xlink:to="loc_srt_ProductOrServiceAxis_002d6bab-0980-4583-821d-9fd07664ec8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fab88f3d-0373-4010-a66c-dff7ae062495" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_002d6bab-0980-4583-821d-9fd07664ec8c" xlink:to="loc_srt_ProductsAndServicesDomain_fab88f3d-0373-4010-a66c-dff7ae062495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_d0927e4b-6ee6-44c5-85d0-02650ad55f2a" xlink:href="ehth-20210331.xsd#ehth_CommissionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fab88f3d-0373-4010-a66c-dff7ae062495" xlink:to="loc_ehth_CommissionMember_d0927e4b-6ee6-44c5-85d0-02650ad55f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_c79b6fcb-f6d0-4bfc-9c0a-b40eb76e0b3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fab88f3d-0373-4010-a66c-dff7ae062495" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_c79b6fcb-f6d0-4bfc-9c0a-b40eb76e0b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_596208f5-0bc1-4af6-b345-e063d4de8fd8" xlink:to="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_58efee66-0ea0-405f-aa57-eb44103e2f1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_RevenuesAbstract_58efee66-0ea0-405f-aa57-eb44103e2f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_09e08f93-a124-47bf-878f-9c080e1ec997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_58efee66-0ea0-405f-aa57-eb44103e2f1d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_09e08f93-a124-47bf-878f-9c080e1ec997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_7181f955-342d-40a4-ac5f-c295189d1aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_CostOfRevenue_7181f955-342d-40a4-ac5f-c295189d1aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_69ab45df-7b2c-46f3-9eb5-cdecff260d8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_69ab45df-7b2c-46f3-9eb5-cdecff260d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpense_b1afa599-3c15-4111-9169-1f3e00db846c" xlink:href="ehth-20210331.xsd#ehth_CustomerCareAndEnrollmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_ehth_CustomerCareAndEnrollmentExpense_b1afa599-3c15-4111-9169-1f3e00db846c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpense_e3d71e64-b2ed-4dcf-8518-e4a269f6fea0" xlink:href="ehth-20210331.xsd#ehth_TechnologyAndContentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_ehth_TechnologyAndContentExpense_e3d71e64-b2ed-4dcf-8518-e4a269f6fea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_dfd33d28-bb2c-4028-bb72-35e6dddeb338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_dfd33d28-bb2c-4028-bb72-35e6dddeb338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_99958eb0-6043-4240-8f81-bed5988a6573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_99958eb0-6043-4240-8f81-bed5988a6573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_2d7babcd-82bd-48f2-bf29-792492d6b5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_RestructuringCharges_2d7babcd-82bd-48f2-bf29-792492d6b5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_12ebcc61-040d-46fc-9180-1a70f265fcaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_36a1a3a2-c078-425c-9734-497d06c35d79" xlink:to="loc_us-gaap_CostsAndExpenses_12ebcc61-040d-46fc-9180-1a70f265fcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f51e3fd1-6033-47e8-8bce-e4ae388fe7ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_OperatingIncomeLoss_f51e3fd1-6033-47e8-8bce-e4ae388fe7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_da38c34e-6c64-40ac-8c9e-ee0202e07c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_da38c34e-6c64-40ac-8c9e-ee0202e07c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fc281697-24a5-4e35-9ad6-17898c1bff85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fc281697-24a5-4e35-9ad6-17898c1bff85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c6f4effc-ea53-4011-9a15-8a1ca782cde0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c6f4effc-ea53-4011-9a15-8a1ca782cde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ea1adcc7-1a56-4014-bad2-5eac162da16e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_NetIncomeLoss_ea1adcc7-1a56-4014-bad2-5eac162da16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_eb0923b6-89ba-4380-adf9-d263b62226af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_EarningsPerShareAbstract_eb0923b6-89ba-4380-adf9-d263b62226af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7d888c42-1322-4e2f-91a3-9183edaaad1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eb0923b6-89ba-4380-adf9-d263b62226af" xlink:to="loc_us-gaap_EarningsPerShareBasic_7d888c42-1322-4e2f-91a3-9183edaaad1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4933061b-3e23-464f-b6b2-2fc75bc489c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eb0923b6-89ba-4380-adf9-d263b62226af" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4933061b-3e23-464f-b6b2-2fc75bc489c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_659188d2-4ef0-44af-9eb7-7d60d734b4d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_659188d2-4ef0-44af-9eb7-7d60d734b4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cfbb47ea-75f6-448e-aad5-0418a220f0c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_659188d2-4ef0-44af-9eb7-7d60d734b4d1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cfbb47ea-75f6-448e-aad5-0418a220f0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af6039e0-8cda-4ef7-97c7-acde84251afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_659188d2-4ef0-44af-9eb7-7d60d734b4d1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af6039e0-8cda-4ef7-97c7-acde84251afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af15f62-1edb-422e-b6af-091e8a5686e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6227c809-fa0c-4bbe-bd2b-62a2a5948bed" xlink:to="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af15f62-1edb-422e-b6af-091e8a5686e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ec113c94-c9a4-498d-b2bc-d37b2a2be7a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af15f62-1edb-422e-b6af-091e8a5686e6" xlink:to="loc_us-gaap_NetIncomeLoss_ec113c94-c9a4-498d-b2bc-d37b2a2be7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_c080add4-2003-49d7-9033-73f58bfcb8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af15f62-1edb-422e-b6af-091e8a5686e6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_c080add4-2003-49d7-9033-73f58bfcb8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_20160645-cc6b-4f97-ab7b-e742fe355f48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af15f62-1edb-422e-b6af-091e8a5686e6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_20160645-cc6b-4f97-ab7b-e742fe355f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_dab9484e-b630-4d00-b423-e5c76a5d967f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af15f62-1edb-422e-b6af-091e8a5686e6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_dab9484e-b630-4d00-b423-e5c76a5d967f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_78c5e475-f782-48e1-9e13-62a802d1e6e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e531fe9a-6c97-4ffb-9ba5-7247420db28b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_78c5e475-f782-48e1-9e13-62a802d1e6e1" xlink:to="loc_us-gaap_StatementTable_e531fe9a-6c97-4ffb-9ba5-7247420db28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6d607bd9-a6d4-428f-986b-31451f9acac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e531fe9a-6c97-4ffb-9ba5-7247420db28b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6d607bd9-a6d4-428f-986b-31451f9acac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6d607bd9-a6d4-428f-986b-31451f9acac3" xlink:to="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_707bf22e-527a-44c7-be65-9e1c69168de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:to="loc_us-gaap_CommonStockMember_707bf22e-527a-44c7-be65-9e1c69168de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3cdadf6c-74d6-4540-821c-aacf9734869a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3cdadf6c-74d6-4540-821c-aacf9734869a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_72cc1ab4-1558-4ff0-86f0-b37cce479950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:to="loc_us-gaap_TreasuryStockMember_72cc1ab4-1558-4ff0-86f0-b37cce479950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d685c5f7-e83d-4d70-920a-e68420b9526e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:to="loc_us-gaap_RetainedEarningsMember_d685c5f7-e83d-4d70-920a-e68420b9526e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3d43a22-c9b0-421c-9518-e62da92f871f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f4f44580-4e5a-4952-8f36-6ba10fb9cc0a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3d43a22-c9b0-421c-9518-e62da92f871f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7cedc64e-0b00-44ec-9f6e-a8129b17d1a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e531fe9a-6c97-4ffb-9ba5-7247420db28b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7cedc64e-0b00-44ec-9f6e-a8129b17d1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f917d872-5524-427f-9070-b76adb3dccf9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7cedc64e-0b00-44ec-9f6e-a8129b17d1a3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f917d872-5524-427f-9070-b76adb3dccf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_abac1b23-e05b-4b3a-88d0-93bf6530db67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f917d872-5524-427f-9070-b76adb3dccf9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_abac1b23-e05b-4b3a-88d0-93bf6530db67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_213ab002-ec72-4327-913e-d39d32fdd6f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e531fe9a-6c97-4ffb-9ba5-7247420db28b" xlink:to="loc_us-gaap_StatementLineItems_213ab002-ec72-4327-913e-d39d32fdd6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_213ab002-ec72-4327-913e-d39d32fdd6f4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_7a3c3114-8752-4c20-b5dd-c39f1cbe32fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_SharesOutstanding_7a3c3114-8752-4c20-b5dd-c39f1cbe32fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_870a3701-0226-4328-9768-8e67d0f818ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockholdersEquity_870a3701-0226-4328-9768-8e67d0f818ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_1fdce8cb-ff72-4d22-a887-0f5a7b461560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_1fdce8cb-ff72-4d22-a887-0f5a7b461560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b804da4e-6a43-4504-95c8-638a5be25126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b804da4e-6a43-4504-95c8-638a5be25126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_49dc2c1a-1390-466b-86bc-117ff5ff01e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_49dc2c1a-1390-466b-86bc-117ff5ff01e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_43ae3074-bee7-40b9-b287-aab85016e372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_43ae3074-bee7-40b9-b287-aab85016e372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_626a3f4e-cde7-4784-9882-4eb0de9214d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_626a3f4e-cde7-4784-9882-4eb0de9214d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1cebedb2-2171-484a-a5ef-cc2aa4af749a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1cebedb2-2171-484a-a5ef-cc2aa4af749a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_395d83d2-f3d5-4072-b390-bc4044d872a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_395d83d2-f3d5-4072-b390-bc4044d872a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_12b8a968-0661-49d0-a20d-cb0ccfe45e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_NetIncomeLoss_12b8a968-0661-49d0-a20d-cb0ccfe45e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ec93c144-ea95-4ad3-ba6a-ab2d62504f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ec93c144-ea95-4ad3-ba6a-ab2d62504f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fa8a2335-b703-42a0-a0d6-58caefb77830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fa8a2335-b703-42a0-a0d6-58caefb77830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_de343b3a-39a9-49f0-9e75-cad2261292ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_de343b3a-39a9-49f0-9e75-cad2261292ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b2cd912f-2427-42e1-949f-7fc66e9ce91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b2cd912f-2427-42e1-949f-7fc66e9ce91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_6226ffa6-0c22-45fa-8432-b9358c70b5ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_SharesOutstanding_6226ffa6-0c22-45fa-8432-b9358c70b5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2e04daf9-8c56-4149-aaf7-42c512d0d5d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2dc46ecf-b315-415f-8ca4-e83205780dce" xlink:to="loc_us-gaap_StockholdersEquity_2e04daf9-8c56-4149-aaf7-42c512d0d5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ehth-20210331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a1e0f215-73cb-4eee-b778-9462839d3799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f8dcd3f4-9af0-49d2-aaf5-01ef5c995403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1e0f215-73cb-4eee-b778-9462839d3799" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f8dcd3f4-9af0-49d2-aaf5-01ef5c995403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a2d9eb2d-73d4-4b0c-8baf-a3c557609f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f8dcd3f4-9af0-49d2-aaf5-01ef5c995403" xlink:to="loc_us-gaap_NetIncomeLoss_a2d9eb2d-73d4-4b0c-8baf-a3c557609f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7c336ff5-f929-4dd4-8b51-a34cff9160df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f8dcd3f4-9af0-49d2-aaf5-01ef5c995403" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7c336ff5-f929-4dd4-8b51-a34cff9160df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_58830488-3e76-43a3-8fbe-6f6336b99c5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7c336ff5-f929-4dd4-8b51-a34cff9160df" xlink:to="loc_us-gaap_Depreciation_58830488-3e76-43a3-8fbe-6f6336b99c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_7f3d48e6-8930-4331-88dd-24cd2ed923c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7c336ff5-f929-4dd4-8b51-a34cff9160df" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_7f3d48e6-8930-4331-88dd-24cd2ed923c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8b3312d1-b6ae-47b6-84fc-53c24bf7a052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7c336ff5-f929-4dd4-8b51-a34cff9160df" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8b3312d1-b6ae-47b6-84fc-53c24bf7a052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e2d5cf74-a513-42d0-acb2-265045b6486a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7c336ff5-f929-4dd4-8b51-a34cff9160df" xlink:to="loc_us-gaap_ShareBasedCompensation_e2d5cf74-a513-42d0-acb2-265045b6486a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7f1aca71-653e-4859-9e8e-42f54209a17f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7c336ff5-f929-4dd4-8b51-a34cff9160df" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7f1aca71-653e-4859-9e8e-42f54209a17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_80fa4f32-9f44-411d-af0b-e9d264f58744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7c336ff5-f929-4dd4-8b51-a34cff9160df" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_80fa4f32-9f44-411d-af0b-e9d264f58744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2cb1569d-1513-4f48-8b63-383dcb9638f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7c336ff5-f929-4dd4-8b51-a34cff9160df" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2cb1569d-1513-4f48-8b63-383dcb9638f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dbeb7b4a-95c9-42df-a196-62718d09f5f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2cb1569d-1513-4f48-8b63-383dcb9638f7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dbeb7b4a-95c9-42df-a196-62718d09f5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInCommissionsReceivable_3d53485c-838e-4540-8286-4a77b38905ee" xlink:href="ehth-20210331.xsd#ehth_IncreaseDecreaseInCommissionsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2cb1569d-1513-4f48-8b63-383dcb9638f7" xlink:to="loc_ehth_IncreaseDecreaseInCommissionsReceivable_3d53485c-838e-4540-8286-4a77b38905ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_68f36802-0aa3-4eff-ad2b-454a240566ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2cb1569d-1513-4f48-8b63-383dcb9638f7" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_68f36802-0aa3-4eff-ad2b-454a240566ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b38c8bc8-f221-4aea-b06e-cd4b8572302d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2cb1569d-1513-4f48-8b63-383dcb9638f7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b38c8bc8-f221-4aea-b06e-cd4b8572302d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_eedcef06-1b68-49bc-9fde-9c3c230e37e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2cb1569d-1513-4f48-8b63-383dcb9638f7" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_eedcef06-1b68-49bc-9fde-9c3c230e37e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses_5f4fb924-90b2-4d1b-b8d4-4ef293d432cf" xlink:href="ehth-20210331.xsd#ehth_IncreaseDecreaseInAccruedMarketingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2cb1569d-1513-4f48-8b63-383dcb9638f7" xlink:to="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses_5f4fb924-90b2-4d1b-b8d4-4ef293d432cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_dbc54ad2-17ab-4ebc-8b77-ec56d4e8c4ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2cb1569d-1513-4f48-8b63-383dcb9638f7" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_dbc54ad2-17ab-4ebc-8b77-ec56d4e8c4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_a988684a-eefc-42fc-957c-36738e34e34c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2cb1569d-1513-4f48-8b63-383dcb9638f7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_a988684a-eefc-42fc-957c-36738e34e34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3965c0d7-2ee6-48f1-ab55-787d94800c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f8dcd3f4-9af0-49d2-aaf5-01ef5c995403" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3965c0d7-2ee6-48f1-ab55-787d94800c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3fc4ffaa-c05d-476f-ac7e-49bcb2b23d19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1e0f215-73cb-4eee-b778-9462839d3799" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3fc4ffaa-c05d-476f-ac7e-49bcb2b23d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_9316ffa8-b2f6-4be9-a565-f1218cab902b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3fc4ffaa-c05d-476f-ac7e-49bcb2b23d19" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_9316ffa8-b2f6-4be9-a565-f1218cab902b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_64a2b365-05fe-4c35-a160-09afb4f9c1da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3fc4ffaa-c05d-476f-ac7e-49bcb2b23d19" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_64a2b365-05fe-4c35-a160-09afb4f9c1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_636f8b6b-63cf-4489-9d40-679264be1299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3fc4ffaa-c05d-476f-ac7e-49bcb2b23d19" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_636f8b6b-63cf-4489-9d40-679264be1299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_b38bd558-3087-437b-8951-1fbe35d7f81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3fc4ffaa-c05d-476f-ac7e-49bcb2b23d19" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_b38bd558-3087-437b-8951-1fbe35d7f81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec4ffc03-0482-4854-8604-59bc32da6c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3fc4ffaa-c05d-476f-ac7e-49bcb2b23d19" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec4ffc03-0482-4854-8604-59bc32da6c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ecd91b-bf93-4901-bbd8-30043650763f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1e0f215-73cb-4eee-b778-9462839d3799" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ecd91b-bf93-4901-bbd8-30043650763f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_d24c33bb-e5ef-48ab-b2bc-2d7dacda2e56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ecd91b-bf93-4901-bbd8-30043650763f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_d24c33bb-e5ef-48ab-b2bc-2d7dacda2e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_521b2906-3599-405a-b769-312350443734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ecd91b-bf93-4901-bbd8-30043650763f" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_521b2906-3599-405a-b769-312350443734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_65a0c61a-7a95-4d41-b02c-bf1d6ce3ebcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ecd91b-bf93-4901-bbd8-30043650763f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_65a0c61a-7a95-4d41-b02c-bf1d6ce3ebcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b373d1b3-827b-4c11-87ed-127a2f22a805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ecd91b-bf93-4901-bbd8-30043650763f" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b373d1b3-827b-4c11-87ed-127a2f22a805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_aef042ce-1488-4bc1-a3d8-cee4fb0e1174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ecd91b-bf93-4901-bbd8-30043650763f" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_aef042ce-1488-4bc1-a3d8-cee4fb0e1174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6526d62-1ff7-4ce9-8258-b03293701a77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1ecd91b-bf93-4901-bbd8-30043650763f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6526d62-1ff7-4ce9-8258-b03293701a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8af9c608-cbfa-4f9c-a800-f8d466f685aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1e0f215-73cb-4eee-b778-9462839d3799" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8af9c608-cbfa-4f9c-a800-f8d466f685aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3d980109-42a8-46e4-ad61-f3a6a7246cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1e0f215-73cb-4eee-b778-9462839d3799" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3d980109-42a8-46e4-ad61-f3a6a7246cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f86867e9-88c1-48ff-b50e-348feb26d733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1e0f215-73cb-4eee-b778-9462839d3799" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f86867e9-88c1-48ff-b50e-348feb26d733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6284b8cf-c729-4335-98ef-85a5bc94d85d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a1e0f215-73cb-4eee-b778-9462839d3799" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6284b8cf-c729-4335-98ef-85a5bc94d85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies" xlink:type="simple" xlink:href="ehth-20210331.xsd#SummaryofBusinessandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a5a14842-622b-4ac7-9e0b-4e7b75e870e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_90d84891-625b-48e9-b2a5-0bc1f6b908fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a5a14842-622b-4ac7-9e0b-4e7b75e870e7" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_90d84891-625b-48e9-b2a5-0bc1f6b908fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ehth-20210331.xsd#SummaryofBusinessandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1eb750b7-7027-4a37-8bb9-08246492ebdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DescriptionOfBusinessPolicyPolicyTextBlock_51e5c0be-fde5-4f05-9247-ddc41d104cf7" xlink:href="ehth-20210331.xsd#ehth_DescriptionOfBusinessPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1eb750b7-7027-4a37-8bb9-08246492ebdb" xlink:to="loc_ehth_DescriptionOfBusinessPolicyPolicyTextBlock_51e5c0be-fde5-4f05-9247-ddc41d104cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c277de34-a7f1-4d4c-8e8d-8f98caccb8c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1eb750b7-7027-4a37-8bb9-08246492ebdb" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c277de34-a7f1-4d4c-8e8d-8f98caccb8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_70e786a9-545f-480c-a281-129c2cf51126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1eb750b7-7027-4a37-8bb9-08246492ebdb" xlink:to="loc_us-gaap_UseOfEstimates_70e786a9-545f-480c-a281-129c2cf51126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SeasonalityPolicyPolicyTextBlock_8cd12595-837d-45a3-b14e-285d7ad29a6d" xlink:href="ehth-20210331.xsd#ehth_SeasonalityPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1eb750b7-7027-4a37-8bb9-08246492ebdb" xlink:to="loc_ehth_SeasonalityPolicyPolicyTextBlock_8cd12595-837d-45a3-b14e-285d7ad29a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9fd58a7d-2364-4bb7-9f4e-078881fe4b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1eb750b7-7027-4a37-8bb9-08246492ebdb" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9fd58a7d-2364-4bb7-9f4e-078881fe4b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f6bf3aa8-8291-4fef-9701-746963b41e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_99b1c0cc-c661-4644-b37a-21293eb656ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f6bf3aa8-8291-4fef-9701-746963b41e78" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_99b1c0cc-c661-4644-b37a-21293eb656ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5d6753d9-f401-4d7b-b273-0b8a4c3f2b3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_99b1c0cc-c661-4644-b37a-21293eb656ca" xlink:to="loc_srt_ProductOrServiceAxis_5d6753d9-f401-4d7b-b273-0b8a4c3f2b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92b67595-0dcc-48ba-a0b1-58e9d1cc823d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5d6753d9-f401-4d7b-b273-0b8a4c3f2b3b" xlink:to="loc_srt_ProductsAndServicesDomain_92b67595-0dcc-48ba-a0b1-58e9d1cc823d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_85982d69-beab-4add-be84-11070be49d9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_92b67595-0dcc-48ba-a0b1-58e9d1cc823d" xlink:to="loc_us-gaap_LicenseMember_85982d69-beab-4add-be84-11070be49d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_f754df41-e5dd-4e71-a1db-c84b9292e13f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_99b1c0cc-c661-4644-b37a-21293eb656ca" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_f754df41-e5dd-4e71-a1db-c84b9292e13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_89df0927-eba2-429d-a188-750093238fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_f754df41-e5dd-4e71-a1db-c84b9292e13f" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_89df0927-eba2-429d-a188-750093238fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_f760ec5c-ebd0-4780-aff4-c69e5bc9720b" xlink:href="ehth-20210331.xsd#ehth_UnderRecognitionOfStockBasedCompensationExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_89df0927-eba2-429d-a188-750093238fe9" xlink:to="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_f760ec5c-ebd0-4780-aff4-c69e5bc9720b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OverRecognitionOfLicensingCostsMember_a1f00b61-578f-4574-860f-7214d1b188f7" xlink:href="ehth-20210331.xsd#ehth_OverRecognitionOfLicensingCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_89df0927-eba2-429d-a188-750093238fe9" xlink:to="loc_ehth_OverRecognitionOfLicensingCostsMember_a1f00b61-578f-4574-860f-7214d1b188f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OutOfPeriodAdjustmentsMember_29377a7c-879d-4b94-b42c-a69044a9b104" xlink:href="ehth-20210331.xsd#ehth_OutOfPeriodAdjustmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_89df0927-eba2-429d-a188-750093238fe9" xlink:to="loc_ehth_OutOfPeriodAdjustmentsMember_29377a7c-879d-4b94-b42c-a69044a9b104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_99b1c0cc-c661-4644-b37a-21293eb656ca" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NumberOfHealthInsuranceCarriers_638fec46-1dbd-4078-a3b0-fbd86cce1ad7" xlink:href="ehth-20210331.xsd#ehth_NumberOfHealthInsuranceCarriers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:to="loc_ehth_NumberOfHealthInsuranceCarriers_638fec46-1dbd-4078-a3b0-fbd86cce1ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_569eadec-3f58-4641-818c-cc0ebd9fc43f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_569eadec-3f58-4641-818c-cc0ebd9fc43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3c0c7076-8001-414d-a615-b2a438406d9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3c0c7076-8001-414d-a615-b2a438406d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_815496f4-7348-4509-a2f7-36a056714fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:to="loc_us-gaap_CostOfRevenue_815496f4-7348-4509-a2f7-36a056714fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6c14a147-d60e-4010-8c32-fac9510188d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_41b521e1-0906-4bb8-b93b-dacccf56e7bd" xlink:to="loc_us-gaap_NetIncomeLoss_6c14a147-d60e-4010-8c32-fac9510188d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Revenue" xlink:type="simple" xlink:href="ehth-20210331.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6a723333-3d51-4286-a613-15a030170388" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_90766fe8-49d7-4ddc-9794-c0c6ae500392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6a723333-3d51-4286-a613-15a030170388" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_90766fe8-49d7-4ddc-9794-c0c6ae500392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_49ed2932-d6ea-4ea6-819b-51f1708d2ae6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_fa5f6e91-886b-4536-aff8-bf09c50ac6ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_49ed2932-d6ea-4ea6-819b-51f1708d2ae6" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_fa5f6e91-886b-4536-aff8-bf09c50ac6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#RevenueDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_23ec7083-8452-42c6-b0ce-9bdacf245b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_23ec7083-8452-42c6-b0ce-9bdacf245b28" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c362b24a-3b78-4207-bce7-9818db283a7c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:to="loc_srt_ProductOrServiceAxis_c362b24a-3b78-4207-bce7-9818db283a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c362b24a-3b78-4207-bce7-9818db283a7c" xlink:to="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareMember_6ce12d5c-7a1f-49ba-8e14-6fbb191962d1" xlink:href="ehth-20210331.xsd#ehth_MedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_MedicareMember_6ce12d5c-7a1f-49ba-8e14-6fbb191962d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualandFamilyMember_a4bf2aa2-7f74-4f85-b1e2-25cb5522b3b8" xlink:href="ehth-20210331.xsd#ehth_IndividualandFamilyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_IndividualandFamilyMember_a4bf2aa2-7f74-4f85-b1e2-25cb5522b3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AncillariesMember_351f3232-6d1b-4bf9-855d-83467242a9f0" xlink:href="ehth-20210331.xsd#ehth_AncillariesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_AncillariesMember_351f3232-6d1b-4bf9-855d-83467242a9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SmallBusinessMember_c4b053ce-1415-4138-b91b-0be75f50f3f8" xlink:href="ehth-20210331.xsd#ehth_SmallBusinessMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_SmallBusinessMember_c4b053ce-1415-4138-b91b-0be75f50f3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionBonusMember_085351c4-01a2-45d0-b4cc-84571c436e39" xlink:href="ehth-20210331.xsd#ehth_CommissionBonusMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_CommissionBonusMember_085351c4-01a2-45d0-b4cc-84571c436e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_ae009481-61cc-4e79-becf-e356489ba472" xlink:href="ehth-20210331.xsd#ehth_CommissionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_ehth_CommissionMember_ae009481-61cc-4e79-becf-e356489ba472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_82ed355c-e244-4c75-9340-ab94b2833da8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5bffda16-b08c-47d8-ade6-c17dff941522" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_82ed355c-e244-4c75-9340-ab94b2833da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareAxis_76a802ec-588c-4b32-b616-166f5aacadaa" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedMedicareAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:to="loc_ehth_DisaggregatedMedicareAxis_76a802ec-588c-4b32-b616-166f5aacadaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareDomain_4f985b09-5bfe-4353-8302-357c3c85ebd2" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedMedicareDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedMedicareAxis_76a802ec-588c-4b32-b616-166f5aacadaa" xlink:to="loc_ehth_DisaggregatedMedicareDomain_4f985b09-5bfe-4353-8302-357c3c85ebd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareAdvantageMember_9c96b201-c782-41ce-aab1-1eb4af82feee" xlink:href="ehth-20210331.xsd#ehth_MedicareAdvantageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedMedicareDomain_4f985b09-5bfe-4353-8302-357c3c85ebd2" xlink:to="loc_ehth_MedicareAdvantageMember_9c96b201-c782-41ce-aab1-1eb4af82feee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSupplementMember_3d15e6a6-44e0-4315-9386-5247f0450b47" xlink:href="ehth-20210331.xsd#ehth_MedicareSupplementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedMedicareDomain_4f985b09-5bfe-4353-8302-357c3c85ebd2" xlink:to="loc_ehth_MedicareSupplementMember_3d15e6a6-44e0-4315-9386-5247f0450b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicarePartDMember_79a2535e-681c-4e46-abfd-4f0aceee2fcc" xlink:href="ehth-20210331.xsd#ehth_MedicarePartDMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedMedicareDomain_4f985b09-5bfe-4353-8302-357c3c85ebd2" xlink:to="loc_ehth_MedicarePartDMember_79a2535e-681c-4e46-abfd-4f0aceee2fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyAxis_06228ef3-27cc-4ed5-b01e-30cb95b39543" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedIndividualandFamilyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:to="loc_ehth_DisaggregatedIndividualandFamilyAxis_06228ef3-27cc-4ed5-b01e-30cb95b39543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyDomain_7683a089-dacb-42df-a633-de3a767b04f1" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedIndividualandFamilyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyAxis_06228ef3-27cc-4ed5-b01e-30cb95b39543" xlink:to="loc_ehth_DisaggregatedIndividualandFamilyDomain_7683a089-dacb-42df-a633-de3a767b04f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NonQualifiedHealthPlansMember_3401642b-1f3f-4321-b049-73a5b0cccaee" xlink:href="ehth-20210331.xsd#ehth_NonQualifiedHealthPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyDomain_7683a089-dacb-42df-a633-de3a767b04f1" xlink:to="loc_ehth_NonQualifiedHealthPlansMember_3401642b-1f3f-4321-b049-73a5b0cccaee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_QualifiedHealthPlansMember_2b704a6a-f4e3-4783-a090-86e828f9eaf0" xlink:href="ehth-20210331.xsd#ehth_QualifiedHealthPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyDomain_7683a089-dacb-42df-a633-de3a767b04f1" xlink:to="loc_ehth_QualifiedHealthPlansMember_2b704a6a-f4e3-4783-a090-86e828f9eaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesAxis_4808dddd-7171-44c9-8fdc-38b6ab4bebef" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedAncillariesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:to="loc_ehth_DisaggregatedAncillariesAxis_4808dddd-7171-44c9-8fdc-38b6ab4bebef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedAncillariesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedAncillariesAxis_4808dddd-7171-44c9-8fdc-38b6ab4bebef" xlink:to="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ShorttermMember_06ad068e-a303-41d7-b3e0-0011e2e63cb8" xlink:href="ehth-20210331.xsd#ehth_ShorttermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:to="loc_ehth_ShorttermMember_06ad068e-a303-41d7-b3e0-0011e2e63cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DentalMember_64b51fdd-b6f2-4baa-8471-e427ca37e332" xlink:href="ehth-20210331.xsd#ehth_DentalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:to="loc_ehth_DentalMember_64b51fdd-b6f2-4baa-8471-e427ca37e332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_VisionMember_0ed6a22c-fba8-46b7-88e4-a98c8d7b2de4" xlink:href="ehth-20210331.xsd#ehth_VisionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:to="loc_ehth_VisionMember_0ed6a22c-fba8-46b7-88e4-a98c8d7b2de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OtherMember_d8900bb7-3a7f-45b4-917e-34fd2c0464d3" xlink:href="ehth-20210331.xsd#ehth_OtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_282834ef-fc23-4af4-b58f-0529f7ee528e" xlink:to="loc_ehth_OtherMember_d8900bb7-3a7f-45b4-917e-34fd2c0464d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherAxis_c4790ec3-3705-45e3-a6fc-7644adad870f" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedOtherAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:to="loc_ehth_DisaggregatedOtherAxis_c4790ec3-3705-45e3-a6fc-7644adad870f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherDomain_4ca4e52d-cd90-40d0-aca9-26e5b3719a09" xlink:href="ehth-20210331.xsd#ehth_DisaggregatedOtherDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedOtherAxis_c4790ec3-3705-45e3-a6fc-7644adad870f" xlink:to="loc_ehth_DisaggregatedOtherDomain_4ca4e52d-cd90-40d0-aca9-26e5b3719a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SponsorshipAndAdvertisingMember_cfbee2b5-3802-4bc2-b79b-6356a8f60bcf" xlink:href="ehth-20210331.xsd#ehth_SponsorshipAndAdvertisingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedOtherDomain_4ca4e52d-cd90-40d0-aca9-26e5b3719a09" xlink:to="loc_ehth_SponsorshipAndAdvertisingMember_cfbee2b5-3802-4bc2-b79b-6356a8f60bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MiscellaneousOtherMember_1e486291-a182-4e1b-b65e-20aeb5700a2b" xlink:href="ehth-20210331.xsd#ehth_MiscellaneousOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedOtherDomain_4ca4e52d-cd90-40d0-aca9-26e5b3719a09" xlink:to="loc_ehth_MiscellaneousOtherMember_1e486291-a182-4e1b-b65e-20aeb5700a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_7bb5c695-d57f-49cf-b726-21ac8ed54ddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a9dadf00-aec0-4484-8a7d-02ea99b859ee" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_7bb5c695-d57f-49cf-b726-21ac8ed54ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_615edb39-d6cd-454d-888c-fc119b377f9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7bb5c695-d57f-49cf-b726-21ac8ed54ddf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_615edb39-d6cd-454d-888c-fc119b377f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#RevenueCommissionRevenuebySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7dbf7fc1-b37f-436f-a1f7-aad9b3dfecf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d46c4676-bb03-42d4-8df2-eab919dc0921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7dbf7fc1-b37f-436f-a1f7-aad9b3dfecf3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d46c4676-bb03-42d4-8df2-eab919dc0921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_07e5d227-d02d-4071-9c3b-ba8cd79ddea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46c4676-bb03-42d4-8df2-eab919dc0921" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_07e5d227-d02d-4071-9c3b-ba8cd79ddea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1b38edba-ab72-4b93-b999-3d17cf330824" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07e5d227-d02d-4071-9c3b-ba8cd79ddea2" xlink:to="loc_us-gaap_SegmentDomain_1b38edba-ab72-4b93-b999-3d17cf330824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_94a9057a-5fe9-4bbe-94fd-5412b91fa3ef" xlink:href="ehth-20210331.xsd#ehth_MedicareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1b38edba-ab72-4b93-b999-3d17cf330824" xlink:to="loc_ehth_MedicareSegmentMember_94a9057a-5fe9-4bbe-94fd-5412b91fa3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_47099c53-8647-4a4d-ba77-f1f804ab9d7f" xlink:href="ehth-20210331.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1b38edba-ab72-4b93-b999-3d17cf330824" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_47099c53-8647-4a4d-ba77-f1f804ab9d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f66994d6-6a90-480c-acaf-5125f38ab95c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46c4676-bb03-42d4-8df2-eab919dc0921" xlink:to="loc_srt_ProductOrServiceAxis_f66994d6-6a90-480c-acaf-5125f38ab95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_223f78af-5ee3-48f0-8b5c-19029a772a88" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f66994d6-6a90-480c-acaf-5125f38ab95c" xlink:to="loc_srt_ProductsAndServicesDomain_223f78af-5ee3-48f0-8b5c-19029a772a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_fe385dba-69b5-4ee9-94e0-783dfa2c0ea7" xlink:href="ehth-20210331.xsd#ehth_CommissionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_223f78af-5ee3-48f0-8b5c-19029a772a88" xlink:to="loc_ehth_CommissionMember_fe385dba-69b5-4ee9-94e0-783dfa2c0ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_718a3177-b08a-4ab0-b1d0-1b264be1f546" xlink:href="ehth-20210331.xsd#ehth_CommissionMembersApprovedDuringCurrentPeriodMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_CommissionMember_fe385dba-69b5-4ee9-94e0-783dfa2c0ea7" xlink:to="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_718a3177-b08a-4ab0-b1d0-1b264be1f546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_42ca2b74-6c0f-494b-bc90-00302ed50440" xlink:href="ehth-20210331.xsd#ehth_CommissionMembersApprovedInPriorPeriodsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_CommissionMember_fe385dba-69b5-4ee9-94e0-783dfa2c0ea7" xlink:to="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_42ca2b74-6c0f-494b-bc90-00302ed50440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionRevenueFromRenewalsMember_85b4ef15-0ad1-4cd9-9d89-0816052c2f42" xlink:href="ehth-20210331.xsd#ehth_CommissionRevenueFromRenewalsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_CommissionMember_fe385dba-69b5-4ee9-94e0-783dfa2c0ea7" xlink:to="loc_ehth_CommissionRevenueFromRenewalsMember_85b4ef15-0ad1-4cd9-9d89-0816052c2f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d46c4676-bb03-42d4-8df2-eab919dc0921" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bad9f09-bad0-4a32-b5e4-dd069b10c30d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5bad9f09-bad0-4a32-b5e4-dd069b10c30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_51053ca7-4a4f-4cd2-9ae9-de3ff1db686e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:to="loc_us-gaap_EarningsPerShareBasic_51053ca7-4a4f-4cd2-9ae9-de3ff1db686e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e0c86d4a-ab30-4923-9874-7529a74436e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e0c86d4a-ab30-4923-9874-7529a74436e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_d4d48cc9-1e7c-4d27-b5f6-5779d2ad1f15" xlink:href="ehth-20210331.xsd#ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_005fcc76-da5c-49c6-a496-c00c9d183c2c" xlink:to="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_d4d48cc9-1e7c-4d27-b5f6-5779d2ad1f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformation"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7c6ffab3-9a45-46c1-9856-24e4ba63af95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_aa877733-6a8a-423d-bba1-b14e6ef723a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7c6ffab3-9a45-46c1-9856-24e4ba63af95" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_aa877733-6a8a-423d-bba1-b14e6ef723a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6ea6d0c4-781b-429c-8205-ddc12b9d7600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_3a5a9904-7bf5-4826-b5ab-b4dce892f876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6ea6d0c4-781b-429c-8205-ddc12b9d7600" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_3a5a9904-7bf5-4826-b5ab-b4dce892f876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_09039300-c079-4f5f-9b40-1ec97f8cee2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6ea6d0c4-781b-429c-8205-ddc12b9d7600" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_09039300-c079-4f5f-9b40-1ec97f8cee2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock_fabb6a10-dc06-4852-a985-08f61438e82b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6ea6d0c4-781b-429c-8205-ddc12b9d7600" xlink:to="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock_fabb6a10-dc06-4852-a985-08f61438e82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1449f44c-28c9-4d8f-81c2-46e13347b3f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6ea6d0c4-781b-429c-8205-ddc12b9d7600" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1449f44c-28c9-4d8f-81c2-46e13347b3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_18aeaaae-44e8-4c55-bebf-eb94699b2738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6ea6d0c4-781b-429c-8205-ddc12b9d7600" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_18aeaaae-44e8-4c55-bebf-eb94699b2738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_c7deface-ddf7-4594-a5a2-5df673734fdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6ea6d0c4-781b-429c-8205-ddc12b9d7600" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_c7deface-ddf7-4594-a5a2-5df673734fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14a609a1-e946-4a86-9bfb-6a90cb25217f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_8c7f4e29-ac55-49f5-9848-898ecaa15d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14a609a1-e946-4a86-9bfb-6a90cb25217f" xlink:to="loc_us-gaap_Cash_8c7f4e29-ac55-49f5-9848-898ecaa15d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_a72c9a61-2e41-4ff0-9914-dcab4cf8065b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14a609a1-e946-4a86-9bfb-6a90cb25217f" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_a72c9a61-2e41-4ff0-9914-dcab4cf8065b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_74211bda-fafd-4fec-bf3d-5498dd534e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14a609a1-e946-4a86-9bfb-6a90cb25217f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_74211bda-fafd-4fec-bf3d-5498dd534e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_0b3a8a40-d74e-4cff-8158-4b5c9b09a062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14a609a1-e946-4a86-9bfb-6a90cb25217f" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_0b3a8a40-d74e-4cff-8158-4b5c9b09a062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ac9e49b-bff4-45ce-9571-51b5b790304c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_14a609a1-e946-4a86-9bfb-6a90cb25217f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ac9e49b-bff4-45ce-9571-51b5b790304c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_69aed083-3acd-40ce-847f-a21f58344ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_32e04b84-62a8-467d-b6c4-2af27804daaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_69aed083-3acd-40ce-847f-a21f58344ea2" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_32e04b84-62a8-467d-b6c4-2af27804daaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c44fc3c6-913f-4ff9-8f15-6efbefe2de8a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_32e04b84-62a8-467d-b6c4-2af27804daaa" xlink:to="loc_srt_StatementGeographicalAxis_c44fc3c6-913f-4ff9-8f15-6efbefe2de8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_90d96f8a-0626-455a-ba31-a2cd142d748c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c44fc3c6-913f-4ff9-8f15-6efbefe2de8a" xlink:to="loc_srt_SegmentGeographicalDomain_90d96f8a-0626-455a-ba31-a2cd142d748c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_3c55e9e6-c4fb-4a03-bfc8-03aacf9a22cb" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_90d96f8a-0626-455a-ba31-a2cd142d748c" xlink:to="loc_country_CN_3c55e9e6-c4fb-4a03-bfc8-03aacf9a22cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_2b267348-8348-40c1-98c3-c41847b80c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_32e04b84-62a8-467d-b6c4-2af27804daaa" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_2b267348-8348-40c1-98c3-c41847b80c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_10298691-cccc-42da-bda8-57dd4ee1cb87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_2b267348-8348-40c1-98c3-c41847b80c0e" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_10298691-cccc-42da-bda8-57dd4ee1cb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Deposits_e0a78298-89d8-4541-aca9-009168beed34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Deposits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_2b267348-8348-40c1-98c3-c41847b80c0e" xlink:to="loc_us-gaap_Deposits_e0a78298-89d8-4541-aca9-009168beed34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc635968-398b-4938-972c-cbced9017335" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_dd40f5f4-dc76-4c6c-949c-949e6370c089" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc635968-398b-4938-972c-cbced9017335" xlink:to="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_dd40f5f4-dc76-4c6c-949c-949e6370c089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_db5722f5-f57f-4e60-acc7-ef84e0bf9378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_dd40f5f4-dc76-4c6c-949c-949e6370c089" xlink:to="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_db5722f5-f57f-4e60-acc7-ef84e0bf9378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_6bc409b5-e219-44e6-b7f4-5556b5673304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_dd40f5f4-dc76-4c6c-949c-949e6370c089" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_6bc409b5-e219-44e6-b7f4-5556b5673304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_29ef00fa-d9c9-4421-92e0-685b9eb42d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_dd40f5f4-dc76-4c6c-949c-949e6370c089" xlink:to="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_29ef00fa-d9c9-4421-92e0-685b9eb42d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_a3ef5e8c-ade2-43ed-8283-1097ab3b41fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_31d06de6-7cf6-4370-ae35-e19037c9a9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_a3ef5e8c-ade2-43ed-8283-1097ab3b41fb" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_31d06de6-7cf6-4370-ae35-e19037c9a9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_106ddee1-d0dc-4f6a-befa-7b2abcc2c198" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_31d06de6-7cf6-4370-ae35-e19037c9a9d2" xlink:to="loc_srt_ProductOrServiceAxis_106ddee1-d0dc-4f6a-befa-7b2abcc2c198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b539f349-9cdf-4cfe-a9b6-9bdddb024df3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_106ddee1-d0dc-4f6a-befa-7b2abcc2c198" xlink:to="loc_srt_ProductsAndServicesDomain_b539f349-9cdf-4cfe-a9b6-9bdddb024df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_dcfc54f9-6813-433d-ae48-3abf2da279ec" xlink:href="ehth-20210331.xsd#ehth_CommissionMembersApprovedDuringCurrentPeriodMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b539f349-9cdf-4cfe-a9b6-9bdddb024df3" xlink:to="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_dcfc54f9-6813-433d-ae48-3abf2da279ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionRevenueFromRenewalsMember_24dc9a54-2a45-4450-af03-04fe3febdf55" xlink:href="ehth-20210331.xsd#ehth_CommissionRevenueFromRenewalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b539f349-9cdf-4cfe-a9b6-9bdddb024df3" xlink:to="loc_ehth_CommissionRevenueFromRenewalsMember_24dc9a54-2a45-4450-af03-04fe3febdf55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_77497bc3-5148-4edd-91f7-77eb7841e48c" xlink:href="ehth-20210331.xsd#ehth_CommissionMembersApprovedInPriorPeriodsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b539f349-9cdf-4cfe-a9b6-9bdddb024df3" xlink:to="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_77497bc3-5148-4edd-91f7-77eb7841e48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b900ffbe-a707-401b-ad02-db92052f5a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_31d06de6-7cf6-4370-ae35-e19037c9a9d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b900ffbe-a707-401b-ad02-db92052f5a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_78885c00-8543-4a4b-8e42-95ac70427eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b900ffbe-a707-401b-ad02-db92052f5a60" xlink:to="loc_us-gaap_SegmentDomain_78885c00-8543-4a4b-8e42-95ac70427eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_6ae982b1-83ed-4869-a4b8-8b819d2ce3b7" xlink:href="ehth-20210331.xsd#ehth_MedicareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_78885c00-8543-4a4b-8e42-95ac70427eda" xlink:to="loc_ehth_MedicareSegmentMember_6ae982b1-83ed-4869-a4b8-8b819d2ce3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_76db284a-cd12-45db-8ce4-24e05bcb02b0" xlink:href="ehth-20210331.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_78885c00-8543-4a4b-8e42-95ac70427eda" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_76db284a-cd12-45db-8ce4-24e05bcb02b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_da15c0a9-5141-4c8f-8bdf-dc3573c2cb04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_31d06de6-7cf6-4370-ae35-e19037c9a9d2" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_da15c0a9-5141-4c8f-8bdf-dc3573c2cb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:href="ehth-20210331.xsd#ehth_ChangeInContractWithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_da15c0a9-5141-4c8f-8bdf-dc3573c2cb04" xlink:to="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_43c1114b-b9ca-4397-b3df-a64ede9e4646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_43c1114b-b9ca-4397-b3df-a64ede9e4646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5e918f9b-1f7d-41e1-8972-7389b99388d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5e918f9b-1f7d-41e1-8972-7389b99388d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCommissionsReceived_e27ca655-d782-4886-b54c-b88ce028caa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCommissionsReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:to="loc_us-gaap_ProceedsFromCommissionsReceived_e27ca655-d782-4886-b54c-b88ce028caa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_47098b15-068a-4b61-970d-9a3746a616fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:to="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_47098b15-068a-4b61-970d-9a3746a616fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_7f55d798-2d39-4cef-baed-241efd27fdea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_f9ec1297-586b-41c0-bd84-fc1af9b453fc" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_7f55d798-2d39-4cef-baed-241efd27fdea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6c03cc8f-ad40-4c21-9016-fc65e0e9abce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_000a8dc4-865b-4176-bc6e-ed5e6ec9a5bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6c03cc8f-ad40-4c21-9016-fc65e0e9abce" xlink:to="loc_us-gaap_ConcentrationRiskTable_000a8dc4-865b-4176-bc6e-ed5e6ec9a5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6c8b2357-da03-4710-befa-898f87f45186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_000a8dc4-865b-4176-bc6e-ed5e6ec9a5bb" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6c8b2357-da03-4710-befa-898f87f45186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3ae66425-fea2-4350-b7d1-0ce218f5524e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6c8b2357-da03-4710-befa-898f87f45186" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3ae66425-fea2-4350-b7d1-0ce218f5524e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_f8c3a603-743c-448e-aab5-4e90b350670b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3ae66425-fea2-4350-b7d1-0ce218f5524e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_f8c3a603-743c-448e-aab5-4e90b350670b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_01714594-7385-4e1a-a400-6967467ab3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_000a8dc4-865b-4176-bc6e-ed5e6ec9a5bb" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_01714594-7385-4e1a-a400-6967467ab3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ffbac08a-42c6-48cf-989d-c251b9dd29b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_01714594-7385-4e1a-a400-6967467ab3ef" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ffbac08a-42c6-48cf-989d-c251b9dd29b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_2c14b746-2243-4554-8b23-9803aa4ca3b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ffbac08a-42c6-48cf-989d-c251b9dd29b2" xlink:to="loc_us-gaap_AccountsReceivableMember_2c14b746-2243-4554-8b23-9803aa4ca3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_0b82c4be-13cf-43fc-b940-565aecf93fbc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_000a8dc4-865b-4176-bc6e-ed5e6ec9a5bb" xlink:to="loc_srt_MajorCustomersAxis_0b82c4be-13cf-43fc-b940-565aecf93fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_0b82c4be-13cf-43fc-b940-565aecf93fbc" xlink:to="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnitedhealthcareMember_282ab83e-3915-499d-98ca-58b8441f3667" xlink:href="ehth-20210331.xsd#ehth_UnitedhealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:to="loc_ehth_UnitedhealthcareMember_282ab83e-3915-499d-98ca-58b8441f3667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_HumanaMember_058ba648-94ec-4583-8e3b-2bca5c84a5de" xlink:href="ehth-20210331.xsd#ehth_HumanaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:to="loc_ehth_HumanaMember_058ba648-94ec-4583-8e3b-2bca5c84a5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AetnaMember_b7d11d8d-f3a2-463e-8e99-990e94efcfb2" xlink:href="ehth-20210331.xsd#ehth_AetnaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:to="loc_ehth_AetnaMember_b7d11d8d-f3a2-463e-8e99-990e94efcfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CenteneMember_fc529622-0249-4b4d-bc33-cf201a8f6601" xlink:href="ehth-20210331.xsd#ehth_CenteneMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b2ba11ff-cf0c-4958-afa5-5eb277121f79" xlink:to="loc_ehth_CenteneMember_fc529622-0249-4b4d-bc33-cf201a8f6601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_2f923c25-c063-475f-947f-43f33238f8db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_000a8dc4-865b-4176-bc6e-ed5e6ec9a5bb" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_2f923c25-c063-475f-947f-43f33238f8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b76b31fa-07ce-44d0-8417-c97957cee4a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2f923c25-c063-475f-947f-43f33238f8db" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b76b31fa-07ce-44d0-8417-c97957cee4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_e8a57aee-f457-40af-bd1f-844586aaa623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PrepaidMaintenanceContractsCurrent_9bf9a5f4-03d7-43f9-837d-725cf78aa30b" xlink:href="ehth-20210331.xsd#ehth_PrepaidMaintenanceContractsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_e8a57aee-f457-40af-bd1f-844586aaa623" xlink:to="loc_ehth_PrepaidMaintenanceContractsCurrent_9bf9a5f4-03d7-43f9-837d-725cf78aa30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_87348ec2-786b-4343-b377-b24b2ae29ced" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_e8a57aee-f457-40af-bd1f-844586aaa623" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_87348ec2-786b-4343-b377-b24b2ae29ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_0093b4e3-1cdd-4edf-ae5a-6e09670ee54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_e8a57aee-f457-40af-bd1f-844586aaa623" xlink:to="loc_us-gaap_PrepaidInsurance_0093b4e3-1cdd-4edf-ae5a-6e09670ee54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_798c62d1-2940-4382-9fa0-5926eb8895e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_e8a57aee-f457-40af-bd1f-844586aaa623" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_798c62d1-2940-4382-9fa0-5926eb8895e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_483bcca4-36b6-4e7d-8223-fcdf262e6365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_e8a57aee-f457-40af-bd1f-844586aaa623" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_483bcca4-36b6-4e7d-8223-fcdf262e6365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_10e8d9de-fedc-41ef-9f82-3bba6fe73e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_8f32f6d7-c5dd-450f-818d-45e653d7dee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_10e8d9de-fedc-41ef-9f82-3bba6fe73e78" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_8f32f6d7-c5dd-450f-818d-45e653d7dee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_eb7015de-d4f4-4e6e-bb37-4239b408283f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_6edd8e1b-9eab-437c-a051-c5011ea30b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_eb7015de-d4f4-4e6e-bb37-4239b408283f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_6edd8e1b-9eab-437c-a051-c5011ea30b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_73d583a5-5913-4f0c-9368-656c3f5d80f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_eb7015de-d4f4-4e6e-bb37-4239b408283f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_73d583a5-5913-4f0c-9368-656c3f5d80f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_662991c5-c5c1-49a7-9575-e62609172428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_eb7015de-d4f4-4e6e-bb37-4239b408283f" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_662991c5-c5c1-49a7-9575-e62609172428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_db44bad8-4289-4ad5-8f29-3d08f4af1f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_eb7015de-d4f4-4e6e-bb37-4239b408283f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_db44bad8-4289-4ad5-8f29-3d08f4af1f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsSummaryofFinancialAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c14bdc36-3883-4f53-936b-b17d5071514a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c14bdc36-3883-4f53-936b-b17d5071514a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_7c5de598-1c01-4657-b8b8-0849ad8ba3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_7c5de598-1c01-4657-b8b8-0849ad8ba3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1140dec4-2ec6-4843-8b3f-42853655be2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_7c5de598-1c01-4657-b8b8-0849ad8ba3d9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1140dec4-2ec6-4843-8b3f-42853655be2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_5cbcd17c-a1ab-4d25-9cc3-102794c72642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1140dec4-2ec6-4843-8b3f-42853655be2c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_5cbcd17c-a1ab-4d25-9cc3-102794c72642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_327331d5-f7ad-45a8-9a28-ce57f328c9a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1140dec4-2ec6-4843-8b3f-42853655be2c" xlink:to="loc_us-gaap_CommercialPaperMember_327331d5-f7ad-45a8-9a28-ce57f328c9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_60a848e9-baa7-4e1c-a3ae-1af5db89ddfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_60a848e9-baa7-4e1c-a3ae-1af5db89ddfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c6177bd-9b84-4b79-bf5c-d16494f008de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_60a848e9-baa7-4e1c-a3ae-1af5db89ddfd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c6177bd-9b84-4b79-bf5c-d16494f008de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c5c2c038-bbb8-45ac-bda3-e6ef3406a866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c6177bd-9b84-4b79-bf5c-d16494f008de" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c5c2c038-bbb8-45ac-bda3-e6ef3406a866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_2db32a92-4c4e-478d-89b1-6d524e6aeb09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c6177bd-9b84-4b79-bf5c-d16494f008de" xlink:to="loc_us-gaap_CommercialPaperMember_2db32a92-4c4e-478d-89b1-6d524e6aeb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_f867fbd1-2184-4508-aaca-de7373df1e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_f867fbd1-2184-4508-aaca-de7373df1e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7697865a-20d6-4a7f-a091-46fb512e0a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_f867fbd1-2184-4508-aaca-de7373df1e7a" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7697865a-20d6-4a7f-a091-46fb512e0a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6f092bcc-c619-431d-a069-eee34abf933e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7697865a-20d6-4a7f-a091-46fb512e0a49" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6f092bcc-c619-431d-a069-eee34abf933e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9d78e119-83ec-48c5-8f3e-d555e6bfec5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6f092bcc-c619-431d-a069-eee34abf933e" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9d78e119-83ec-48c5-8f3e-d555e6bfec5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b26c5671-06fb-4da1-b5cf-18022ba1f9db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6f092bcc-c619-431d-a069-eee34abf933e" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b26c5671-06fb-4da1-b5cf-18022ba1f9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7c27818-c3bb-4116-8155-35c80ed0c8ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7c27818-c3bb-4116-8155-35c80ed0c8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_085131f0-9d49-4aa5-bb6a-e50e13aa7668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7c27818-c3bb-4116-8155-35c80ed0c8ec" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_085131f0-9d49-4aa5-bb6a-e50e13aa7668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d7b20bf6-3514-4b09-a7de-029582ad91bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_085131f0-9d49-4aa5-bb6a-e50e13aa7668" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d7b20bf6-3514-4b09-a7de-029582ad91bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_898d4f1a-973b-4279-8343-04116afd2c88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_085131f0-9d49-4aa5-bb6a-e50e13aa7668" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_898d4f1a-973b-4279-8343-04116afd2c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1fc10d7c-560b-48cf-ae28-19a07823106b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_085131f0-9d49-4aa5-bb6a-e50e13aa7668" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1fc10d7c-560b-48cf-ae28-19a07823106b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7cb92c21-62f4-4f53-adb2-b4d3ef74cece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7cb92c21-62f4-4f53-adb2-b4d3ef74cece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffabea3d-c65e-4995-bd41-6dfafad84d0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7cb92c21-62f4-4f53-adb2-b4d3ef74cece" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffabea3d-c65e-4995-bd41-6dfafad84d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_0a5a3d7e-8682-4628-a555-03ec950fc114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffabea3d-c65e-4995-bd41-6dfafad84d0c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_0a5a3d7e-8682-4628-a555-03ec950fc114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9d5a24e6-4b00-46b1-afa5-68520bebc18c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5399782b-9713-42cf-a588-bfc15d6f951f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9d5a24e6-4b00-46b1-afa5-68520bebc18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1aab5528-3b4a-4953-9611-de7511ef077a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9d5a24e6-4b00-46b1-afa5-68520bebc18c" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1aab5528-3b4a-4953-9611-de7511ef077a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3b1b99c6-6c2f-4b45-8baa-e33b2b6a2740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1aab5528-3b4a-4953-9611-de7511ef077a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3b1b99c6-6c2f-4b45-8baa-e33b2b6a2740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c1acdb3e-f035-4ef0-9236-95bf0858a01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1aab5528-3b4a-4953-9611-de7511ef077a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c1acdb3e-f035-4ef0-9236-95bf0858a01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_a65871e6-ee6d-47a0-8ec4-04ba25dbb8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1aab5528-3b4a-4953-9611-de7511ef077a" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_a65871e6-ee6d-47a0-8ec4-04ba25dbb8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsContractualMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_04df74be-1a32-4b47-ab4a-6955fd1ccc77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_03da7305-1698-4879-b368-efec443f8b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04df74be-1a32-4b47-ab4a-6955fd1ccc77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_03da7305-1698-4879-b368-efec443f8b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_1eb714ed-3c2a-4bbb-b1e1-8a54c2f885e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_03da7305-1698-4879-b368-efec443f8b5f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_1eb714ed-3c2a-4bbb-b1e1-8a54c2f885e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_42fd6698-f3f3-4a8b-b089-909cd98c4dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04df74be-1a32-4b47-ab4a-6955fd1ccc77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_42fd6698-f3f3-4a8b-b089-909cd98c4dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a9d64c8b-8a32-41d6-99a6-c0e57dfe41db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_42fd6698-f3f3-4a8b-b089-909cd98c4dc0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a9d64c8b-8a32-41d6-99a6-c0e57dfe41db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsUnrealizedGainsandLossesDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_00e7c079-e807-4f2f-8b78-dc189f3b9318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d033d205-2c12-40ec-8bc5-887fdfc58821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_00e7c079-e807-4f2f-8b78-dc189f3b9318" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d033d205-2c12-40ec-8bc5-887fdfc58821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6e110da0-23cc-4b1e-bbc7-acdd78e4d1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d033d205-2c12-40ec-8bc5-887fdfc58821" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6e110da0-23cc-4b1e-bbc7-acdd78e4d1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_228ca439-12fc-4dfc-826a-1921bae461e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6e110da0-23cc-4b1e-bbc7-acdd78e4d1d1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_228ca439-12fc-4dfc-826a-1921bae461e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cd005b12-1627-4255-8c9d-11c019711382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_228ca439-12fc-4dfc-826a-1921bae461e3" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cd005b12-1627-4255-8c9d-11c019711382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e3847ca9-b095-437d-88a6-4cd04d9b0666" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_228ca439-12fc-4dfc-826a-1921bae461e3" xlink:to="loc_us-gaap_CommercialPaperMember_e3847ca9-b095-437d-88a6-4cd04d9b0666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_bb964405-b31d-4228-88b1-521c1a0e4e32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d033d205-2c12-40ec-8bc5-887fdfc58821" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_bb964405-b31d-4228-88b1-521c1a0e4e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6174a86-98c3-4f65-8ab0-ed1b20b15b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_bb964405-b31d-4228-88b1-521c1a0e4e32" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6174a86-98c3-4f65-8ab0-ed1b20b15b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_247025f1-c655-4daf-9d79-4d7969a1d98c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6174a86-98c3-4f65-8ab0-ed1b20b15b0c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_247025f1-c655-4daf-9d79-4d7969a1d98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_cbd46dae-fa5f-4d3c-9cd2-cc592b831853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b6174a86-98c3-4f65-8ab0-ed1b20b15b0c" xlink:to="loc_us-gaap_CommercialPaperMember_cbd46dae-fa5f-4d3c-9cd2-cc592b831853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d033d205-2c12-40ec-8bc5-887fdfc58821" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_058ef8c4-bc7a-46dc-b861-b0bceec009d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_058ef8c4-bc7a-46dc-b861-b0bceec009d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_5497da41-965a-4441-bf11-4b6bdb41f17c" xlink:href="ehth-20210331.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_5497da41-965a-4441-bf11-4b6bdb41f17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_853b1c73-82a2-4dde-85cf-e47cade28a87" xlink:href="ehth-20210331.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_853b1c73-82a2-4dde-85cf-e47cade28a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_790e480b-f968-4f91-854c-1eeea9f44cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_e8225606-f1fd-41ae-8eb6-d21dc7d0ada9" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_790e480b-f968-4f91-854c-1eeea9f44cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_e95f59d4-e5b8-42fb-9708-e38ec0a594b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_e95f59d4-e5b8-42fb-9708-e38ec0a594b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_2bcb0a49-9057-4f4a-a2e5-7da5c6c0b584" xlink:href="ehth-20210331.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_2bcb0a49-9057-4f4a-a2e5-7da5c6c0b584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_1e44e15c-8c1c-4176-b2dc-74c94efef7bc" xlink:href="ehth-20210331.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_1e44e15c-8c1c-4176-b2dc-74c94efef7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a7d13db6-177e-42a9-9544-852ca93ec7a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_67930691-12d1-4781-ac93-99090ad4d7f7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a7d13db6-177e-42a9-9544-852ca93ec7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_8a0f2646-4a0b-4a2b-a6df-2b6b5305511b" xlink:href="ehth-20210331.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_8a0f2646-4a0b-4a2b-a6df-2b6b5305511b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0562657e-2a82-4bc5-bd2a-03c7b14e3046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0562657e-2a82-4bc5-bd2a-03c7b14e3046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f83ccc29-f685-4d3a-86e3-512adf91e915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f83ccc29-f685-4d3a-86e3-512adf91e915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_6be50c32-27da-48c8-bc6e-cfb98c1e952a" xlink:href="ehth-20210331.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_256e7c28-a615-43dd-b035-4ecd7ff6047e" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_6be50c32-27da-48c8-bc6e-cfb98c1e952a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsUnrealizedGainsandLossesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a6116057-e3eb-4a6e-bb90-69a1197db6f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_57d43899-ce84-4bf1-a0a8-fae73a15d1d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a6116057-e3eb-4a6e-bb90-69a1197db6f4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_57d43899-ce84-4bf1-a0a8-fae73a15d1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Equity" xlink:type="simple" xlink:href="ehth-20210331.xsd#Equity"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1f9e9f71-6727-4bb0-bf7c-4633018204bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_69e10c6e-3f97-4529-a516-651797a5a426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1f9e9f71-6727-4bb0-bf7c-4633018204bc" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_69e10c6e-3f97-4529-a516-651797a5a426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#EquityTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/EquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_d1745ca7-72f8-4cdd-ba12-8f9abe8b3034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock_01170a45-8093-428e-9215-73de5b17424d" xlink:href="ehth-20210331.xsd#ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d1745ca7-72f8-4cdd-ba12-8f9abe8b3034" xlink:to="loc_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock_01170a45-8093-428e-9215-73de5b17424d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock_a5dc4092-825d-462a-883d-7fed249ac755" xlink:href="ehth-20210331.xsd#ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d1745ca7-72f8-4cdd-ba12-8f9abe8b3034" xlink:to="loc_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock_a5dc4092-825d-462a-883d-7fed249ac755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#EquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/EquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_972b728c-9e36-485a-9815-49f8439cab11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_85e357ba-76f3-4af2-98c7-98895252bf90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_972b728c-9e36-485a-9815-49f8439cab11" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_85e357ba-76f3-4af2-98c7-98895252bf90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_41fce998-cbc3-4230-b3df-91229af42b21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_85e357ba-76f3-4af2-98c7-98895252bf90" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_41fce998-cbc3-4230-b3df-91229af42b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a84b0deb-0d13-489c-82bf-8a1b745cf85b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_41fce998-cbc3-4230-b3df-91229af42b21" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a84b0deb-0d13-489c-82bf-8a1b745cf85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreviousRepurchaseProgramsMember_32e5b9db-d7c2-466a-bf09-ee12bbc8a500" xlink:href="ehth-20210331.xsd#ehth_PreviousRepurchaseProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a84b0deb-0d13-489c-82bf-8a1b745cf85b" xlink:to="loc_ehth_PreviousRepurchaseProgramsMember_32e5b9db-d7c2-466a-bf09-ee12bbc8a500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_a7fbeb17-d12d-40d5-b7be-500b1b8eb31f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_85e357ba-76f3-4af2-98c7-98895252bf90" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_a7fbeb17-d12d-40d5-b7be-500b1b8eb31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_88ec2638-a3d5-4ec0-9005-05d1a82fcec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a7fbeb17-d12d-40d5-b7be-500b1b8eb31f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_88ec2638-a3d5-4ec0-9005-05d1a82fcec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_c4f963e2-ab61-4c8d-a2bf-17e1bc65b80e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_88ec2638-a3d5-4ec0-9005-05d1a82fcec7" xlink:to="loc_us-gaap_OverAllotmentOptionMember_c4f963e2-ab61-4c8d-a2bf-17e1bc65b80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_85e357ba-76f3-4af2-98c7-98895252bf90" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_78f3f0b3-acd6-4b1e-9105-bc6e979627ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_78f3f0b3-acd6-4b1e-9105-bc6e979627ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_2ee2c167-9798-4ac6-875b-962cb21a7f30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_2ee2c167-9798-4ac6-875b-962cb21a7f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_77a919e8-3a88-43e6-9648-125ced5600f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_77a919e8-3a88-43e6-9648-125ced5600f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_0a5b32cf-a991-4e7b-bccb-2ab33e60fdbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_0a5b32cf-a991-4e7b-bccb-2ab33e60fdbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_5bbe2f65-6f5d-4355-84d0-96b722f4a7c1" xlink:href="ehth-20210331.xsd#ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_5bbe2f65-6f5d-4355-84d0-96b722f4a7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_55e726de-9058-4d8e-b2b1-06b9a1b12bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d86961fe-7fa3-4f2f-a177-f459afb359b9" xlink:to="loc_us-gaap_TreasuryStockShares_55e726de-9058-4d8e-b2b1-06b9a1b12bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#EquityScheduleofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_80b22a34-b497-4f55-8638-a1f62c3acd0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7990df95-a042-4f7e-ba59-6512c1aeb7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_80b22a34-b497-4f55-8638-a1f62c3acd0f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7990df95-a042-4f7e-ba59-6512c1aeb7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_74590c54-deef-443b-a3bc-3b746802ed30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7990df95-a042-4f7e-ba59-6512c1aeb7fa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_74590c54-deef-443b-a3bc-3b746802ed30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_74590c54-deef-443b-a3bc-3b746802ed30" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_ab96426a-168e-4617-a1c2-a6f55fe125ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_ab96426a-168e-4617-a1c2-a6f55fe125ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpenseMember_e2eaf0e8-178c-4fd6-896d-2700485d36af" xlink:href="ehth-20210331.xsd#ehth_CustomerCareAndEnrollmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:to="loc_ehth_CustomerCareAndEnrollmentExpenseMember_e2eaf0e8-178c-4fd6-896d-2700485d36af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpenseMember_005817c6-4407-4d8e-a943-1d5da1e243ce" xlink:href="ehth-20210331.xsd#ehth_TechnologyAndContentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:to="loc_ehth_TechnologyAndContentExpenseMember_005817c6-4407-4d8e-a943-1d5da1e243ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4971ca4b-d07c-42ca-b623-cb3c0f9ca374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8223eb9c-8f9a-4c32-93ca-bccbf333a279" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4971ca4b-d07c-42ca-b623-cb3c0f9ca374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_757e79d0-0725-4444-aea1-1e0528386e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7990df95-a042-4f7e-ba59-6512c1aeb7fa" xlink:to="loc_us-gaap_AwardTypeAxis_757e79d0-0725-4444-aea1-1e0528386e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2dd0065-b365-4890-9b71-bfe8c0bcf5ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_757e79d0-0725-4444-aea1-1e0528386e7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2dd0065-b365-4890-9b71-bfe8c0bcf5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_483e1f9a-3183-4dd2-b453-bca8e7a3fb0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2dd0065-b365-4890-9b71-bfe8c0bcf5ed" xlink:to="loc_us-gaap_EmployeeStockOptionMember_483e1f9a-3183-4dd2-b453-bca8e7a3fb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_56263e24-a1ca-4a4e-ba95-fc1c2f18acbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2dd0065-b365-4890-9b71-bfe8c0bcf5ed" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_56263e24-a1ca-4a4e-ba95-fc1c2f18acbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_9c490a9e-ab08-49bc-aa10-a012c0ea5219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2dd0065-b365-4890-9b71-bfe8c0bcf5ed" xlink:to="loc_us-gaap_EmployeeStockMember_9c490a9e-ab08-49bc-aa10-a012c0ea5219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_61322745-e716-4365-839b-1b115c6741fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7990df95-a042-4f7e-ba59-6512c1aeb7fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_61322745-e716-4365-839b-1b115c6741fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_892b5103-342c-4525-b809-18882e6c97a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_61322745-e716-4365-839b-1b115c6741fe" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_892b5103-342c-4525-b809-18882e6c97a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_916d8e7f-ca3a-42e9-b95d-1e4ce1a3e794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_61322745-e716-4365-839b-1b115c6741fe" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_916d8e7f-ca3a-42e9-b95d-1e4ce1a3e794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_4190c5cd-8dc5-448d-8472-83b4ee8644bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_61322745-e716-4365-839b-1b115c6741fe" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_4190c5cd-8dc5-448d-8472-83b4ee8644bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e4ab7db2-8fcf-4d42-bedd-3d64baff1cd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_992bf75d-159f-4d64-a067-297652841ed0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e4ab7db2-8fcf-4d42-bedd-3d64baff1cd7" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_992bf75d-159f-4d64-a067-297652841ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_86922919-ec4c-49f8-a5d6-27c01c11fcde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2acc0ca6-ae6e-4581-ac20-cc2c5f5d9b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86922919-ec4c-49f8-a5d6-27c01c11fcde" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2acc0ca6-ae6e-4581-ac20-cc2c5f5d9b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_b879b6ce-2345-4513-b8af-a0f631daedf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86922919-ec4c-49f8-a5d6-27c01c11fcde" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_b879b6ce-2345-4513-b8af-a0f631daedf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bb16a96c-552f-4e1b-9c4b-db12c9c75483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5123c73f-ead7-4c99-a214-7b9722714429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bb16a96c-552f-4e1b-9c4b-db12c9c75483" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5123c73f-ead7-4c99-a214-7b9722714429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_eed6cb76-41c4-417d-90cf-164259754fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5123c73f-ead7-4c99-a214-7b9722714429" xlink:to="loc_us-gaap_NetIncomeLoss_eed6cb76-41c4-417d-90cf-164259754fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_175650d3-4b53-42d5-93c9-779a8d421aec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bb16a96c-552f-4e1b-9c4b-db12c9c75483" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_175650d3-4b53-42d5-93c9-779a8d421aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_038247b4-b07f-49c4-ab5b-62c836b81f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_175650d3-4b53-42d5-93c9-779a8d421aec" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_038247b4-b07f-49c4-ab5b-62c836b81f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncrementalCommonSharesAttributableToOptions_12ceb830-cb0e-45e6-8e52-98eadae7536c" xlink:href="ehth-20210331.xsd#ehth_IncrementalCommonSharesAttributableToOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_175650d3-4b53-42d5-93c9-779a8d421aec" xlink:to="loc_ehth_IncrementalCommonSharesAttributableToOptions_12ceb830-cb0e-45e6-8e52-98eadae7536c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0c548894-2130-42bf-94f7-21fc60607b1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_175650d3-4b53-42d5-93c9-779a8d421aec" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0c548894-2130-42bf-94f7-21fc60607b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e229a7d2-dc58-410e-8bd2-5ea4c1277882" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bb16a96c-552f-4e1b-9c4b-db12c9c75483" xlink:to="loc_us-gaap_EarningsPerShareBasic_e229a7d2-dc58-410e-8bd2-5ea4c1277882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_90db77f6-dc6d-40bb-b517-9888e0f31e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bb16a96c-552f-4e1b-9c4b-db12c9c75483" xlink:to="loc_us-gaap_EarningsPerShareDiluted_90db77f6-dc6d-40bb-b517-9888e0f31e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c658285b-1d19-4048-bacb-b6c675892615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_095393aa-82b8-4bdd-8fd4-c9eac79612fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c658285b-1d19-4048-bacb-b6c675892615" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_095393aa-82b8-4bdd-8fd4-c9eac79612fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca7d5327-b4a7-4a68-90cb-25656de31fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_095393aa-82b8-4bdd-8fd4-c9eac79612fc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca7d5327-b4a7-4a68-90cb-25656de31fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_72310601-e220-4252-92a1-9775eb8445d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ca7d5327-b4a7-4a68-90cb-25656de31fb8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_72310601-e220-4252-92a1-9775eb8445d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_236f7180-377f-484a-a7d6-295a24f82aed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_72310601-e220-4252-92a1-9775eb8445d6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_236f7180-377f-484a-a7d6-295a24f82aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ee67b374-f6e9-4e70-a31b-7d87889199f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_72310601-e220-4252-92a1-9775eb8445d6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ee67b374-f6e9-4e70-a31b-7d87889199f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_ab08466e-27be-4fd7-b860-e955ee3b896c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_72310601-e220-4252-92a1-9775eb8445d6" xlink:to="loc_us-gaap_EmployeeStockMember_ab08466e-27be-4fd7-b860-e955ee3b896c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9e18c1cd-b934-4e7a-9e3c-5a84ea67e2bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_095393aa-82b8-4bdd-8fd4-c9eac79612fc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9e18c1cd-b934-4e7a-9e3c-5a84ea67e2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5d7ec5aa-e15d-4b63-8051-d75d17e5786c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9e18c1cd-b934-4e7a-9e3c-5a84ea67e2bc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5d7ec5aa-e15d-4b63-8051-d75d17e5786c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="ehth-20210331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cf06eb99-f67a-4597-9e3e-15656da5954a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_1eab98d2-c5a1-493f-b065-723772146c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cf06eb99-f67a-4597-9e3e-15656da5954a" xlink:to="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_1eab98d2-c5a1-493f-b065-723772146c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_39bdc0d9-2dda-4650-bcfe-c47f66c1294a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_31b3fea0-e64e-4b6f-951c-3c5ce7f01ff4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_39bdc0d9-2dda-4650-bcfe-c47f66c1294a" xlink:to="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_31b3fea0-e64e-4b6f-951c-3c5ce7f01ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f7341d1a-6cc5-4481-9f19-7a9f830d4ea9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_efd404f8-aba1-4757-83fe-fc1ce3b00135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f7341d1a-6cc5-4481-9f19-7a9f830d4ea9" xlink:to="loc_us-gaap_LossContingenciesTable_efd404f8-aba1-4757-83fe-fc1ce3b00135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_5b4a1b22-8037-46cd-9ead-885f81f8dce7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_efd404f8-aba1-4757-83fe-fc1ce3b00135" xlink:to="loc_srt_LitigationCaseAxis_5b4a1b22-8037-46cd-9ead-885f81f8dce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_875b4df9-cc6b-4efb-9df0-37df0ce36aea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_5b4a1b22-8037-46cd-9ead-885f81f8dce7" xlink:to="loc_srt_LitigationCaseTypeDomain_875b4df9-cc6b-4efb-9df0-37df0ce36aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LeViasCompliantMember_10078ff4-3112-4eb2-9997-29c2388ee456" xlink:href="ehth-20210331.xsd#ehth_LeViasCompliantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_875b4df9-cc6b-4efb-9df0-37df0ce36aea" xlink:to="loc_ehth_LeViasCompliantMember_10078ff4-3112-4eb2-9997-29c2388ee456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_efd404f8-aba1-4757-83fe-fc1ce3b00135" xlink:to="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_1573c6e4-7755-4edb-a97e-a8fb39a2d406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_1573c6e4-7755-4edb-a97e-a8fb39a2d406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_f9a40d73-b774-497c-bb93-e16211bb169b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_f9a40d73-b774-497c-bb93-e16211bb169b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_6944bb09-f45a-444e-badc-f86fbd28b1dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligationDueInSecondYear_6944bb09-f45a-444e-badc-f86fbd28b1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_78afa947-a657-499a-9dc5-01e348e1ef0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligationDueInThirdYear_78afa947-a657-499a-9dc5-01e348e1ef0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_9d7f9106-b897-442c-b668-90077908234d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligationDueInFourthYear_9d7f9106-b897-442c-b668-90077908234d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ContractualObligationToBePaidAfterYearFour_af5d4591-23db-4b9a-8377-53743ea86c53" xlink:href="ehth-20210331.xsd#ehth_ContractualObligationToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_ehth_ContractualObligationToBePaidAfterYearFour_af5d4591-23db-4b9a-8377-53743ea86c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_20c842a3-1589-4339-b731-d6a859636b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_ContractualObligation_20c842a3-1589-4339-b731-d6a859636b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_db5c891b-8590-4974-9990-b2fa13d919c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_db5c891b-8590-4974-9990-b2fa13d919c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_f38a67be-9f70-4fd2-beeb-8f7a9dde9dd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7e94beb6-72cf-4167-a7a0-219c48f8aa83" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_f38a67be-9f70-4fd2-beeb-8f7a9dde9dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3f418cca-5d64-4195-a650-89ede976a3cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_02841acd-3f61-4b1f-8554-10537f6354dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3f418cca-5d64-4195-a650-89ede976a3cd" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_02841acd-3f61-4b1f-8554-10537f6354dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b452348a-c12d-4526-9607-fd9f7a01c12e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3ad37f72-031e-466b-a2af-b96fb73ac575" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b452348a-c12d-4526-9607-fd9f7a01c12e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3ad37f72-031e-466b-a2af-b96fb73ac575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock_f55c1a12-fbb2-43a8-a361-d65abe7657df" xlink:href="ehth-20210331.xsd#ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b452348a-c12d-4526-9607-fd9f7a01c12e" xlink:to="loc_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock_f55c1a12-fbb2-43a8-a361-d65abe7657df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_55944d12-70ae-42ed-96e4-50014abc08bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b452348a-c12d-4526-9607-fd9f7a01c12e" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_55944d12-70ae-42ed-96e4-50014abc08bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationSegmentOperatingResultsDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c65c40ed-a0fd-4ff4-923b-3ce35d7062be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d59b7e7e-b4df-4a5f-a309-395545f373ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c65c40ed-a0fd-4ff4-923b-3ce35d7062be" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d59b7e7e-b4df-4a5f-a309-395545f373ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b7a17b5e-7855-4d57-8f9b-792ff1bf5722" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d59b7e7e-b4df-4a5f-a309-395545f373ae" xlink:to="loc_srt_ConsolidationItemsAxis_b7a17b5e-7855-4d57-8f9b-792ff1bf5722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_dd3eaec1-947b-4989-acf3-635932a900af" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b7a17b5e-7855-4d57-8f9b-792ff1bf5722" xlink:to="loc_srt_ConsolidationItemsDomain_dd3eaec1-947b-4989-acf3-635932a900af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d864e87a-3b43-4e4d-bfe3-df7e885425d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_dd3eaec1-947b-4989-acf3-635932a900af" xlink:to="loc_us-gaap_OperatingSegmentsMember_d864e87a-3b43-4e4d-bfe3-df7e885425d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_101044cd-573e-41d5-ab17-3a33eaa8edbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_dd3eaec1-947b-4989-acf3-635932a900af" xlink:to="loc_us-gaap_CorporateNonSegmentMember_101044cd-573e-41d5-ab17-3a33eaa8edbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_21103b5b-b996-46df-b0fd-4025355296d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d59b7e7e-b4df-4a5f-a309-395545f373ae" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_21103b5b-b996-46df-b0fd-4025355296d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c28ba86d-e103-4146-8b00-010337138f81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_21103b5b-b996-46df-b0fd-4025355296d0" xlink:to="loc_us-gaap_SegmentDomain_c28ba86d-e103-4146-8b00-010337138f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_0d1dfff8-fa90-47e1-b698-733de80de0fa" xlink:href="ehth-20210331.xsd#ehth_MedicareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c28ba86d-e103-4146-8b00-010337138f81" xlink:to="loc_ehth_MedicareSegmentMember_0d1dfff8-fa90-47e1-b698-733de80de0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_4908fd4c-ce94-4796-b66b-2ab017381d62" xlink:href="ehth-20210331.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c28ba86d-e103-4146-8b00-010337138f81" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_4908fd4c-ce94-4796-b66b-2ab017381d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d59b7e7e-b4df-4a5f-a309-395545f373ae" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_da4f1fa6-5b60-44a6-a668-ca3a1c0dc810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_NumberOfOperatingSegments_da4f1fa6-5b60-44a6-a668-ca3a1c0dc810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1676ef41-ac5a-4381-8593-f57933947f69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1676ef41-ac5a-4381-8593-f57933947f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SegmentOperatingIncomeLoss_8de63d99-8e8d-4ada-8c60-979687350151" xlink:href="ehth-20210331.xsd#ehth_SegmentOperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_ehth_SegmentOperatingIncomeLoss_8de63d99-8e8d-4ada-8c60-979687350151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_f8df7d9f-b0f4-4cb2-97a5-2d98de1ace8d" xlink:href="ehth-20210331.xsd#ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_f8df7d9f-b0f4-4cb2-97a5-2d98de1ace8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_54ea00ce-6dd4-4219-af6f-064204549a33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_54ea00ce-6dd4-4219-af6f-064204549a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0d5ed8ab-1fa4-4d99-bcbb-53822afe2f29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0d5ed8ab-1fa4-4d99-bcbb-53822afe2f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9fad5dc5-1346-42ae-a491-48dfcbfb73ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_RestructuringCharges_9fad5dc5-1346-42ae-a491-48dfcbfb73ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2179e551-36ad-4bd6-86c1-3c9c1f74d906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2179e551-36ad-4bd6-86c1-3c9c1f74d906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_47d7ce7d-650b-4863-9fa8-ab430354d74a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_47d7ce7d-650b-4863-9fa8-ab430354d74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_7a1a4632-28dd-48ef-932b-78a46a5bca6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e1e4816-6989-4d26-b35e-6d7fee3ebc53" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_7a1a4632-28dd-48ef-932b-78a46a5bca6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ff676157-0001-4b24-8257-5355a35b6221" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_651c18a7-8cee-4bdf-995d-d080e54fd014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ff676157-0001-4b24-8257-5355a35b6221" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_651c18a7-8cee-4bdf-995d-d080e54fd014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9ed612fe-940e-419f-839c-82982e83cae0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_651c18a7-8cee-4bdf-995d-d080e54fd014" xlink:to="loc_srt_StatementGeographicalAxis_9ed612fe-940e-419f-839c-82982e83cae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3701ba82-dac9-4dc0-a396-8b81285e123e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9ed612fe-940e-419f-839c-82982e83cae0" xlink:to="loc_srt_SegmentGeographicalDomain_3701ba82-dac9-4dc0-a396-8b81285e123e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e20af6f2-d4d5-44d6-99b8-9fe4cfcef9fa" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3701ba82-dac9-4dc0-a396-8b81285e123e" xlink:to="loc_country_US_e20af6f2-d4d5-44d6-99b8-9fe4cfcef9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_56eae7d5-56b0-442d-90f8-7cf7dcb59823" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3701ba82-dac9-4dc0-a396-8b81285e123e" xlink:to="loc_country_CN_56eae7d5-56b0-442d-90f8-7cf7dcb59823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e916f443-5dc7-487e-9b84-38adaeac8a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_651c18a7-8cee-4bdf-995d-d080e54fd014" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e916f443-5dc7-487e-9b84-38adaeac8a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_db2d3994-e9ef-4b23-a3ab-4c800be55837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e916f443-5dc7-487e-9b84-38adaeac8a96" xlink:to="loc_us-gaap_NoncurrentAssets_db2d3994-e9ef-4b23-a3ab-4c800be55837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_532f898b-2bad-4258-82ac-712a93367e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ded60994-1c93-4b39-b24a-dabac5d39cc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_532f898b-2bad-4258-82ac-712a93367e55" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ded60994-1c93-4b39-b24a-dabac5d39cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_26dd8a31-d47b-4299-aacc-457224bf8406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ded60994-1c93-4b39-b24a-dabac5d39cc7" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_26dd8a31-d47b-4299-aacc-457224bf8406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f1b74769-dedb-4919-8d81-49a94a839307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_26dd8a31-d47b-4299-aacc-457224bf8406" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f1b74769-dedb-4919-8d81-49a94a839307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_bfe596ff-18d4-4fa5-9490-5dd4439fee4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f1b74769-dedb-4919-8d81-49a94a839307" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_bfe596ff-18d4-4fa5-9490-5dd4439fee4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e81f327-e318-4d62-889f-82120dde6035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ded60994-1c93-4b39-b24a-dabac5d39cc7" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e81f327-e318-4d62-889f-82120dde6035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9fa154a3-6871-4941-9b8b-4b83f076a8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e81f327-e318-4d62-889f-82120dde6035" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9fa154a3-6871-4941-9b8b-4b83f076a8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_bb0bb0e7-15c6-4d3d-ae2c-13ee41eee97c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9fa154a3-6871-4941-9b8b-4b83f076a8d2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_bb0bb0e7-15c6-4d3d-ae2c-13ee41eee97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_32920781-973f-42f8-91b2-1f4a79225d54" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ded60994-1c93-4b39-b24a-dabac5d39cc7" xlink:to="loc_srt_MajorCustomersAxis_32920781-973f-42f8-91b2-1f4a79225d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_32920781-973f-42f8-91b2-1f4a79225d54" xlink:to="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnitedhealthcareMember_4b6b2c9a-0e29-441c-accb-c7e8748f3577" xlink:href="ehth-20210331.xsd#ehth_UnitedhealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:to="loc_ehth_UnitedhealthcareMember_4b6b2c9a-0e29-441c-accb-c7e8748f3577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AetnaMember_36499837-86d8-44f8-8e9a-bd1437bd0760" xlink:href="ehth-20210331.xsd#ehth_AetnaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:to="loc_ehth_AetnaMember_36499837-86d8-44f8-8e9a-bd1437bd0760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_HumanaMember_f3c69670-f996-4b86-9153-b70e9de44c39" xlink:href="ehth-20210331.xsd#ehth_HumanaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:to="loc_ehth_HumanaMember_f3c69670-f996-4b86-9153-b70e9de44c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CenteneMember_4add09b4-e9cf-4617-9c4a-144a2256fb1c" xlink:href="ehth-20210331.xsd#ehth_CenteneMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_042fd448-ad8c-4d6d-af14-4cb2fcb4fa17" xlink:to="loc_ehth_CenteneMember_4add09b4-e9cf-4617-9c4a-144a2256fb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_2e4119a5-cbf3-4130-a676-5578ad81158e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ded60994-1c93-4b39-b24a-dabac5d39cc7" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_2e4119a5-cbf3-4130-a676-5578ad81158e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_cd2b02ea-b8fd-443c-b2d7-432f0c2db9e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_2e4119a5-cbf3-4130-a676-5578ad81158e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_cd2b02ea-b8fd-443c-b2d7-432f0c2db9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Leases" xlink:type="simple" xlink:href="ehth-20210331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2fe101c6-7209-4457-a492-9a9ecd469b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_8b6ac066-7f5d-4b71-854e-dbfe049e39be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2fe101c6-7209-4457-a492-9a9ecd469b47" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_8b6ac066-7f5d-4b71-854e-dbfe049e39be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d27e655d-9edf-4e08-b8f8-c27434eb5511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AssetsAndLiabilitiesLesseeTableTextBlock_a3725ddf-95e4-476a-8ae8-a47be9f65b35" xlink:href="ehth-20210331.xsd#ehth_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d27e655d-9edf-4e08-b8f8-c27434eb5511" xlink:to="loc_ehth_AssetsAndLiabilitiesLesseeTableTextBlock_a3725ddf-95e4-476a-8ae8-a47be9f65b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_95b9f96a-ecf8-484c-8aca-c2ef978f44c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d27e655d-9edf-4e08-b8f8-c27434eb5511" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_95b9f96a-ecf8-484c-8aca-c2ef978f44c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_796f37a4-87ba-46e6-8942-b35852d489b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d27e655d-9edf-4e08-b8f8-c27434eb5511" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_796f37a4-87ba-46e6-8942-b35852d489b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b7076ad5-2439-401c-ad6e-bae4f9e2173c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_21bef8e3-6441-4bba-b9dc-03eedd775abe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b7076ad5-2439-401c-ad6e-bae4f9e2173c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_21bef8e3-6441-4bba-b9dc-03eedd775abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_64c885a3-81c2-4ab8-98db-e95b7f497b11" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_21bef8e3-6441-4bba-b9dc-03eedd775abe" xlink:to="loc_srt_RangeAxis_64c885a3-81c2-4ab8-98db-e95b7f497b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f8783938-8a0c-4a8b-85c4-838b2c2f2d12" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_64c885a3-81c2-4ab8-98db-e95b7f497b11" xlink:to="loc_srt_RangeMember_f8783938-8a0c-4a8b-85c4-838b2c2f2d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_258249da-31aa-45f0-9700-36e34659811e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f8783938-8a0c-4a8b-85c4-838b2c2f2d12" xlink:to="loc_srt_MinimumMember_258249da-31aa-45f0-9700-36e34659811e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c584b0cd-7874-4f28-897e-25063a507be4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f8783938-8a0c-4a8b-85c4-838b2c2f2d12" xlink:to="loc_srt_MaximumMember_c584b0cd-7874-4f28-897e-25063a507be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_6d4a46f1-f0ab-4fb0-9894-238e4c3ebd13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_21bef8e3-6441-4bba-b9dc-03eedd775abe" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_6d4a46f1-f0ab-4fb0-9894-238e4c3ebd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_b182853f-e526-439d-b153-6f862d863089" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6d4a46f1-f0ab-4fb0-9894-238e4c3ebd13" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_b182853f-e526-439d-b153-6f862d863089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_a156d9b3-b3aa-4727-9d64-43444262ba9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6d4a46f1-f0ab-4fb0-9894-238e4c3ebd13" xlink:to="loc_us-gaap_OperatingLeaseCost_a156d9b3-b3aa-4727-9d64-43444262ba9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_042e39cf-e902-43b0-9634-02246a7be428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d1496606-5c78-4c71-aa55-d9014999a900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_042e39cf-e902-43b0-9634-02246a7be428" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d1496606-5c78-4c71-aa55-d9014999a900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_52bdd406-9c96-42e3-a65a-6cbf60fe2b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_042e39cf-e902-43b0-9634-02246a7be428" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_52bdd406-9c96-42e3-a65a-6cbf60fe2b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_364913b8-c4d6-4fb8-9042-a1292ce8d35d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_042e39cf-e902-43b0-9634-02246a7be428" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_364913b8-c4d6-4fb8-9042-a1292ce8d35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6fd634e9-c012-4212-8f5c-419309127e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_042e39cf-e902-43b0-9634-02246a7be428" xlink:to="loc_us-gaap_OperatingLeaseLiability_6fd634e9-c012-4212-8f5c-419309127e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesSupplementalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f9257354-ad2c-4cf1-ba65-a7c3bea45376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_e4c1e141-d696-46d5-9e65-8108507291b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f9257354-ad2c-4cf1-ba65-a7c3bea45376" xlink:to="loc_us-gaap_OperatingLeasePayments_e4c1e141-d696-46d5-9e65-8108507291b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e475a3a2-9d90-4896-851c-d21d5fd952e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f9257354-ad2c-4cf1-ba65-a7c3bea45376" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e475a3a2-9d90-4896-851c-d21d5fd952e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1a44d91c-81bd-4176-99a6-05a6da2d066f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f9257354-ad2c-4cf1-ba65-a7c3bea45376" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1a44d91c-81bd-4176-99a6-05a6da2d066f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9bd1f2e2-efe4-4468-9064-d9244082908f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_56c6e711-2390-4c14-b78d-ef1eb0b6a715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd1f2e2-efe4-4468-9064-d9244082908f" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_56c6e711-2390-4c14-b78d-ef1eb0b6a715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_913f986a-8b61-4fea-bdb1-f5be0389157d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_56c6e711-2390-4c14-b78d-ef1eb0b6a715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_913f986a-8b61-4fea-bdb1-f5be0389157d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8e05622c-d66d-4edd-b8b1-bd2ce7a7093f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_56c6e711-2390-4c14-b78d-ef1eb0b6a715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8e05622c-d66d-4edd-b8b1-bd2ce7a7093f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7c89f7e4-e91c-45f9-8e06-f32ea344a447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_56c6e711-2390-4c14-b78d-ef1eb0b6a715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7c89f7e4-e91c-45f9-8e06-f32ea344a447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5232efef-c15a-4067-baa3-2e74da2e3674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_56c6e711-2390-4c14-b78d-ef1eb0b6a715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5232efef-c15a-4067-baa3-2e74da2e3674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_98086998-42c2-4502-a6cb-7f8bff7eac7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_56c6e711-2390-4c14-b78d-ef1eb0b6a715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_98086998-42c2-4502-a6cb-7f8bff7eac7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_f5036610-5df4-44af-9be6-bc0aa526e77e" xlink:href="ehth-20210331.xsd#ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_56c6e711-2390-4c14-b78d-ef1eb0b6a715" xlink:to="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_f5036610-5df4-44af-9be6-bc0aa526e77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d8b9a2ac-10d8-4705-8478-a00eec8f7c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_56c6e711-2390-4c14-b78d-ef1eb0b6a715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d8b9a2ac-10d8-4705-8478-a00eec8f7c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_35435689-ddbc-4547-b57a-8181b3e56e9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_56c6e711-2390-4c14-b78d-ef1eb0b6a715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_35435689-ddbc-4547-b57a-8181b3e56e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_69b71da3-ca07-4859-9246-2153bd598edf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_56c6e711-2390-4c14-b78d-ef1eb0b6a715" xlink:to="loc_us-gaap_OperatingLeaseLiability_69b71da3-ca07-4859-9246-2153bd598edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_6bfedf27-37d1-45a9-8beb-26715602ac97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd1f2e2-efe4-4468-9064-d9244082908f" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_6bfedf27-37d1-45a9-8beb-26715602ac97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_4bdc4739-222d-4e64-9d43-3c456ccb1684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd1f2e2-efe4-4468-9064-d9244082908f" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_4bdc4739-222d-4e64-9d43-3c456ccb1684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_70fd2f03-4504-468f-9e8f-e7c572718fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd1f2e2-efe4-4468-9064-d9244082908f" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_70fd2f03-4504-468f-9e8f-e7c572718fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="ehth-20210331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Restructuring" xlink:type="simple" xlink:href="ehth-20210331.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9d747f84-95fd-46b6-9fd5-6a83814724d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_60c8ceda-825b-44c8-84b2-856127e2cbd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9d747f84-95fd-46b6-9fd5-6a83814724d5" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_60c8ceda-825b-44c8-84b2-856127e2cbd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RestructuringDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#RestructuringDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/RestructuringDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_66c5e990-f370-4b28-a86f-2e6c0e81d513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_ff3eaf61-4817-4e9f-9623-970ce3dd9b50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_66c5e990-f370-4b28-a86f-2e6c0e81d513" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_ff3eaf61-4817-4e9f-9623-970ce3dd9b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_7c98ec38-cc42-4360-a0d5-08b09e353593" xlink:href="ehth-20210331.xsd#ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_66c5e990-f370-4b28-a86f-2e6c0e81d513" xlink:to="loc_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_7c98ec38-cc42-4360-a0d5-08b09e353593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_2b18cb28-f341-4f17-82a1-f50e9d110e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_66c5e990-f370-4b28-a86f-2e6c0e81d513" xlink:to="loc_us-gaap_RestructuringCharges_2b18cb28-f341-4f17-82a1-f50e9d110e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_1b6eaa6b-84a2-40b2-88b6-da9f6dc8dc1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_66c5e990-f370-4b28-a86f-2e6c0e81d513" xlink:to="loc_us-gaap_RestructuringReserve_1b6eaa6b-84a2-40b2-88b6-da9f6dc8dc1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Debt" xlink:type="simple" xlink:href="ehth-20210331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_54852012-c3d5-465e-91f0-1fe455be6a4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_fe477c84-0bf8-4b2d-89cf-e6f05dc9df18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_54852012-c3d5-465e-91f0-1fe455be6a4e" xlink:to="loc_us-gaap_LongTermDebtTextBlock_fe477c84-0bf8-4b2d-89cf-e6f05dc9df18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/DebtDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#DebtDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1d0dcbeb-49f6-44a5-9d58-d227201a58ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_46fa6864-35dd-42b3-8a8d-8decb250ac34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1d0dcbeb-49f6-44a5-9d58-d227201a58ad" xlink:to="loc_us-gaap_DebtInstrumentTable_46fa6864-35dd-42b3-8a8d-8decb250ac34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageAxis_24cb2a29-525d-45b5-a4e2-6c1e9900c00d" xlink:href="ehth-20210331.xsd#ehth_BorrowingBasePercentageAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_46fa6864-35dd-42b3-8a8d-8decb250ac34" xlink:to="loc_ehth_BorrowingBasePercentageAxis_24cb2a29-525d-45b5-a4e2-6c1e9900c00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageDomain_8922d550-0f7c-4590-b632-ebd84aa91aa1" xlink:href="ehth-20210331.xsd#ehth_BorrowingBasePercentageDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_BorrowingBasePercentageAxis_24cb2a29-525d-45b5-a4e2-6c1e9900c00d" xlink:to="loc_ehth_BorrowingBasePercentageDomain_8922d550-0f7c-4590-b632-ebd84aa91aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_05a8b7bd-6c26-483b-8900-058057255ace" xlink:href="ehth-20210331.xsd#ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_BorrowingBasePercentageDomain_8922d550-0f7c-4590-b632-ebd84aa91aa1" xlink:to="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_05a8b7bd-6c26-483b-8900-058057255ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_51cdfec4-5072-46ae-a2ab-b072b63530f6" xlink:href="ehth-20210331.xsd#ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_BorrowingBasePercentageDomain_8922d550-0f7c-4590-b632-ebd84aa91aa1" xlink:to="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_51cdfec4-5072-46ae-a2ab-b072b63530f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_7048f510-bf35-4783-b6ee-b565f6e590d9" xlink:href="ehth-20210331.xsd#ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_BorrowingBasePercentageDomain_8922d550-0f7c-4590-b632-ebd84aa91aa1" xlink:to="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_7048f510-bf35-4783-b6ee-b565f6e590d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d6c2d978-596e-4de5-b2ec-35ecb576abff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_46fa6864-35dd-42b3-8a8d-8decb250ac34" xlink:to="loc_us-gaap_CreditFacilityAxis_d6c2d978-596e-4de5-b2ec-35ecb576abff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_989cf5e9-dd74-4e07-a21e-df7c4f875dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d6c2d978-596e-4de5-b2ec-35ecb576abff" xlink:to="loc_us-gaap_CreditFacilityDomain_989cf5e9-dd74-4e07-a21e-df7c4f875dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_472b1075-97e8-476c-96fc-034c952db4b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_989cf5e9-dd74-4e07-a21e-df7c4f875dec" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_472b1075-97e8-476c-96fc-034c952db4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_1351b0c6-c95d-465d-bc3e-13c23d8de6da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_989cf5e9-dd74-4e07-a21e-df7c4f875dec" xlink:to="loc_us-gaap_LetterOfCreditMember_1351b0c6-c95d-465d-bc3e-13c23d8de6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_91a262e3-e992-459b-9e75-d7db257132f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_46fa6864-35dd-42b3-8a8d-8decb250ac34" xlink:to="loc_us-gaap_DebtInstrumentAxis_91a262e3-e992-459b-9e75-d7db257132f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_660d0faa-ba76-4ecf-84d6-8b868bb10aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_91a262e3-e992-459b-9e75-d7db257132f7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_660d0faa-ba76-4ecf-84d6-8b868bb10aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CreditAgreementAmendmentMember_df55021f-dcf8-4ae1-b0e6-0b200d6672aa" xlink:href="ehth-20210331.xsd#ehth_CreditAgreementAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_660d0faa-ba76-4ecf-84d6-8b868bb10aa9" xlink:to="loc_ehth_CreditAgreementAmendmentMember_df55021f-dcf8-4ae1-b0e6-0b200d6672aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_46fa6864-35dd-42b3-8a8d-8decb250ac34" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_ad678947-5584-46bb-82e1-65438f84852e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_ad678947-5584-46bb-82e1-65438f84852e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage_bd12ec2a-303d-4154-a51f-ddbd1198f39d" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityBorrowingBasePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage_bd12ec2a-303d-4154-a51f-ddbd1198f39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_17bdbf01-0b91-4408-84e2-70645f8bdbe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_17bdbf01-0b91-4408-84e2-70645f8bdbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityFacilityFeePercentage_d151526f-266b-441c-ba7d-d8a785ae9e6e" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityFacilityFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityFacilityFeePercentage_d151526f-266b-441c-ba7d-d8a785ae9e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d7ea5845-fee9-4768-8882-7a39a6814030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d7ea5845-fee9-4768-8882-7a39a6814030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_c2474642-4be4-4500-8c71-d111e92a7898" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_c2474642-4be4-4500-8c71-d111e92a7898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_fbfb034d-8d65-4e86-bd36-f79d19a1a487" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_fbfb034d-8d65-4e86-bd36-f79d19a1a487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_cfdfe685-0c3b-4cf7-b09f-428f01b9c770" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMinimumLiquidity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_cfdfe685-0c3b-4cf7-b09f-428f01b9c770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_c699b7e1-b05e-479d-9d33-70c05253ebc5" xlink:href="ehth-20210331.xsd#ehth_LineOfCreditFacilityCovenantMaximumLiquidity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_c699b7e1-b05e-479d-9d33-70c05253ebc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_72865001-7f75-4b3d-98dc-777fff7223dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_72865001-7f75-4b3d-98dc-777fff7223dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_cada4d4c-4785-4d72-8f8c-a0d2f4170230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3549421e-e146-4b9b-b459-942e048877e8" xlink:to="loc_us-gaap_LineOfCredit_cada4d4c-4785-4d72-8f8c-a0d2f4170230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxes" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f9310c1f-c9d8-4cb0-9468-95b6437a46eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_bf0915e0-9feb-4dff-a44a-f2b8ff1b3737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9310c1f-c9d8-4cb0-9468-95b6437a46eb" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_bf0915e0-9feb-4dff-a44a-f2b8ff1b3737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1a7e4394-6229-4a60-a0d4-ea564d7b9a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ef525811-86dd-4d56-b49b-26b100cb6be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1a7e4394-6229-4a60-a0d4-ea564d7b9a1c" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ef525811-86dd-4d56-b49b-26b100cb6be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxesSummaryofIncomeTaxBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_eb2bfd66-9562-4f67-ab0b-690e7d19d434" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7c10b1a3-5cc8-40a8-a0b3-3b18e01f6970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb2bfd66-9562-4f67-ab0b-690e7d19d434" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7c10b1a3-5cc8-40a8-a0b3-3b18e01f6970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8e6c17a1-a919-4539-aa98-4d7de876c8e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb2bfd66-9562-4f67-ab0b-690e7d19d434" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8e6c17a1-a919-4539-aa98-4d7de876c8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1895be89-2f4b-445b-8620-d697c6f4b1c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb2bfd66-9562-4f67-ab0b-690e7d19d434" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1895be89-2f4b-445b-8620-d697c6f4b1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1c977e94-2b3e-447a-8c31-5b72fecc1e48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_09b2f92f-d3d7-4e57-93bb-b59068ac4f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1c977e94-2b3e-447a-8c31-5b72fecc1e48" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_09b2f92f-d3d7-4e57-93bb-b59068ac4f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d4ebfcd7-dbac-45f9-9ab3-085f6dd4fdca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1c977e94-2b3e-447a-8c31-5b72fecc1e48" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d4ebfcd7-dbac-45f9-9ab3-085f6dd4fdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SubsequentEvent" xlink:type="simple" xlink:href="ehth-20210331.xsd#SubsequentEvent"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SubsequentEvent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_bf03b510-a23e-45ac-b4e6-41c00c3a8516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_15677af2-8e7e-40fb-8d36-11827a33b2bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_bf03b510-a23e-45ac-b4e6-41c00c3a8516" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_15677af2-8e7e-40fb-8d36-11827a33b2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="ehth-20210331.xsd#SubsequentEventDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SubsequentEventDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_3eb99eda-0ba4-4c1a-8f46-911c4756c957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_212eef98-002c-4ec6-a021-21c3049b8293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_3eb99eda-0ba4-4c1a-8f46-911c4756c957" xlink:to="loc_us-gaap_SubsequentEventTable_212eef98-002c-4ec6-a021-21c3049b8293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a93f08c1-5cc0-463d-81d3-b1eaba650582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_212eef98-002c-4ec6-a021-21c3049b8293" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a93f08c1-5cc0-463d-81d3-b1eaba650582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f61a21ec-0271-42c3-b178-22f1dd47a865" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a93f08c1-5cc0-463d-81d3-b1eaba650582" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f61a21ec-0271-42c3-b178-22f1dd47a865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fe307f49-ff0a-442a-a548-65b889f11533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f61a21ec-0271-42c3-b178-22f1dd47a865" xlink:to="loc_us-gaap_SubsequentEventMember_fe307f49-ff0a-442a-a548-65b889f11533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_212eef98-002c-4ec6-a021-21c3049b8293" xlink:to="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a18b9b23-d989-47af-bcf0-4ece92d3ed5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a18b9b23-d989-47af-bcf0-4ece92d3ed5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b99efb5a-6322-4b13-8944-7cae1d5d0e17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b99efb5a-6322-4b13-8944-7cae1d5d0e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_2fe9104c-3b6f-4b43-930e-be91cf84cffe" xlink:href="ehth-20210331.xsd#ehth_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:to="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_2fe9104c-3b6f-4b43-930e-be91cf84cffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_0cf04b7c-6c9b-46d0-9d88-26b6fb5894f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_0cf04b7c-6c9b-46d0-9d88-26b6fb5894f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_037f0cfa-05d2-4801-8fee-a068c220b941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_449edf1a-92b3-4d9b-be05-7672b9e8525a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_037f0cfa-05d2-4801-8fee-a068c220b941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>ehth-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:ehth="http://www.ehealthinsurance.com/20210331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ehth-20210331.xsd" xlink:type="simple"/>
    <context id="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6bb60180d74e484091d2db3e841cf5d9_I20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="i5dc87305aa114463a821897ca747dcca_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i491c8af6fa2b4e68be4acd9338800eb3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8337239e8dda4274bdb5081198725cf8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9a17b2f577fb4a0994b259f4a7c00fac_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8680ff82e8684663ac818bd969dadd40_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5fe1a9fc09dc4d98894c2f05859cd3f1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib63247d699eb44bfb201774d6fef56b5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29014aa44f224a9e8e5ca25d6c81661b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibacf081650de495da52a05e4eed69d81_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if350613e6abd438882a29524ad8a5858_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5a91006c9d446fbb4d678b836971da0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieeba31f3c1b84580993db317c01046dd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i74c4a51c8df7461fb85f66341986ca02_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i65cdbe8443b34580b8422ede51568ad8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iadef4a55d90e438a8f79adf8bc288200_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib464d05e6c054ac8bcb58e7dcb4504fe_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7881058e6391413da79a1df94978a40a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia5468c73d2e34194b9c572c7aba7dfbe_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id1c5c1ce40314084a6517c4ee8f604b7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i571009d8684244af94c420ce801431c3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i85b5b55d4a9c4f76ac527000958b9eae_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7a043e2b26b14ab29cc5ac268c78e6cb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i28f6aba0243b421b803fe3861b663e07_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8d29d5730c7349ea9d1ef955dd844f0d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icf42840deb504490a24f18226ae769ac_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i464582b3717f48fb8fb924189caabeae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i283d90d05c8744f3a67f23305e4f839c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1405f1905b0c495f9efd2474b8fadded_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie89c5f32945844b5b95944d102880a24_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0466642154754b80bcf918c034fb3b1d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if6b1b9ba849b4eb49f00439861a88682_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie6107d03659748ec91163598cd67842f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibce1977df45a4166aacac2533753fef2_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iffa4ea2bf46843c8a3b8c76230e7aece_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i77e456c86a2c4c2298f67ccceb97b818_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i98e488604a58499a810b6c51f24f6985_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i51bc9d212152476f9e50aaa3f71da0a8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i96bc1b9468db422cbae505e283d62180_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i18dcb5c7e7f74362b1df0c50dfaf35c3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3222346a5aab4a859b8e9a0c70c4fccb_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i94e4cd2c63294501a97ce58cbb8f0ad9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id2018b7213bd4f93a2804c6b1e207d62_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:UnderRecognitionOfStockBasedCompensationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i12b84f6b238d4f379f4615fedc93f6c7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:OverRecognitionOfLicensingCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c0615329c3645ffb15c379b3b25d3f0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:OutOfPeriodAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic074a03c1a5d4d7a95fc6e02d21edc3c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8f37dc2286ab479b9deeec6ddbc3c296_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia56162d3488f4c19a21ddf86ec0517c5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i914b51c6a88d43f39d8a45d6ac452f9e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2bfdbea61c3f4e42a23d93df8eba5745_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6a43b88c46a14d2586a38ff40e44b3e1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3af61ab21d2346a89f9a5ad7aa6ccc38_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia3c7487c68db4d359d42ffe4d98f76dc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i98825a9b9bd74beab1e1565f9d8c3a39_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0c1c83a033544814919a8b29643cf827_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if0df0a17281e45098fa957d99e0eda7e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i766e68295a1640f6bfa0ebbffa00c23d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i38748c1b62c34305b0a1a89a4df6b8df_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia063259a108742fa90b79bd2bb186380_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5cb65108e971405598e91d213801b128_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i69d8365ca0b4435c8c9fc4bfcb26c1e5_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8437e53979d64bf498cbace5ca6b66f7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3b8fb9dde9d741ea8f3aa61c942f3b55_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i73b6352f11b648d2b4bf5b5a9da1bc8e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if4b97cd36b9948c1b9d6366c24f2829f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie3aa9fda678445a3bd10fe0b7fd75046_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i056610eba6074846ae406d019066f627_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1faf373456cf44dc92cec480bfe789a7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id0a023d993134272a9b194c6b2030640_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibeba0cba96b145f09097dbdfa7c23a18_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8d34909e75b34d79ba8c25ed29d1868c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2c7afb8d32cb44aaad349d4aed1c13de_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if1a4a92ac7d845c1abccf7a138083679_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i19c1136bfda347ce93cbbd8ef6c0fd36_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i086deedc14e2467498f875d11fdb3e28_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i392771caeedf4c20a1e28f80da41f0a1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i12c4bfe5dd12406b951b26fdaa6cc5f3_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i258c42ec705f4ce991947aa47fbbbf47_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie95c786e8b374e319d0e49801d852c1d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7447592d6f934de2add1f16c34c68de4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0569d360651844759fd84f9324b1f5fc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0dd2975216654605bebf75779fff0768_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i82877d4449c844be8040697eb7839adb_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ide29d460660a40fc90b884baf4856429_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1f0172f4e15b46b8a18d6d683e1893e9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4cba655be2dc465f92495dc76b412c95_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifb2d1cb13bc848d4926601ef8f33c966_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie454fda4a6da410c90ae24e2c79aa917_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib2561ea4ce6f450684892494464adbb2_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1ead011a22aa4528839846da9fa5ebba_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a9a800e930241a2b680d5d254a9937d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i673d5b337f984e35bd708e9c6d0ad645_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib431ec26de88456f8bb27169dbd5532e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6501103b1abc4417b6d24bb9f56e71a3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibcc531094265425da2fe8fba9f7dd2bd_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i32bc9e31d57342a5a9f949dcac3eea99_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i734d6738ac914fbf9d7214b291481a87_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i33ff039155da47c1bac390800f28d958_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id999ede8247d4775b2a9495082649e71_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc9590a5ab4145079eec4462d026a62f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ieffd4f331de646efb6782e0777c3b8c2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8b23f8c9553a4acb92f22c678a011ded_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id93a27ec2b354123ac129b85e58d6a9a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ice1fcaf5d15c4b1ea8e6b1988490be33_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i40741e0095b1456aac94b2215f85e8da_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6501121272e7438dbfacad9d5f209af7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iffc7786d6a3b4b88a4fe78c3c639b879_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ida736d90cfd14b6287fb18903e493b76_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7c282c2b9a3a4f2da838e7c285e04bde_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i88b0f87d92a74c6aa41c7e6b1c891758_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic62f4e5ed1c64cc5aa09a9d6a29086c8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i82364b4b38294beeabf364cb83d2dfb2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibcc2eede21d74403b2556f36cea8967e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i745034ccac204d289da6154afd851a9b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c027fa629114f34973fe988abef44d2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a0875b0633646fe8e4a223242ab0547_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib0b72a5d261d4ed3a6a247dab5e66565_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic698507ebbbe479bafd6c12cc0b40d70_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i41d2536fcee54432bbf4d763116ab430_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id692f7a929c543f88a8ba8e371f1ec69_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifad24860642c447f8be6b0786b6192d9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0448f7480d204667af54338f775f2ae4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie6e65f9607874cf7b91a607047873439_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i78e297ab8ca948aeaf86a525f773e4dc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i838a01c8c51c489fb25f65450a703cb5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie413cb59abe441fba3e0b2a4bb9dc04e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7e6a517c6ba84088a72a30f5e9d287b3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iaf9be97cab2640ed84bd86ad77f9d205_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2f32284f7468465fad0a56de1b2e5c6b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia4c8e440d2f64e6399fa1adc1002bb2e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2303fe7994cf42d1b268b27bc2a7c119_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8935e0f0e3b647c0bca26a9f197dc6ef_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i593cfa44a23f4636b9ad96eb4e4a80e1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i929513fba5e248fb98922bd0516e124c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i02a6624511a64fcf98ef80ed91927f61_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4d2f66f410ea4bf19367fa5bed725fe8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1adbea6e18d34c05afe06e141815262b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifc820c7319514d4cbf55712548350db5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8d090e9d3465481c959ca1ca4c0ad0bf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i14c5f8eba33b414c8e7ed0c7d2de5aa6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5665cbe280f449b7906c5831fa1e3d59_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7a5410f369fa4fe6b29e53a1e38b9c4e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i48cb251ac11344e78669d7f080d49c43_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7fb33dbb73bf4f02a5ffec5640fa31c9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5ea53ab5f7ec479683fa4b9a5645b576_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6ed7325f8ced428d818fce32b031d79b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i18ff6074d86849a5b23047e339437eda_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie93a9074eb224ae4ab49ad9db008e5ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i73e0b97fc5864480b5903a29a54557b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c9b517443d64a00aba7aff3b698c11f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id666b5ba6f9f42f8a0cf56c4b398bcc8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife7ea5f7ec2b4816b3f9a85e81ea156b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4befba2d3d44fb1a621a7790ad0356c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5df54f27e2e4404d8fe0cd357e46301e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8882a30cac444bf5ba856bd4a8372177_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54823e65473645c194940e0076f74ff5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e8dec4452ff4308b5fbdd90aeed6dc9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib59dd70dd25942cd92be78336520da90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc2244c603b14657b34cf7227bbd7fe5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i96477b91e6c046df98a6eb283930c399_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib988b174dc5b49888bc9c12a66f95b33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id971a56afa2d46c58587cf6f00f48794_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8499f20cd2c1456a840c92df3935eb19_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5beec7c5934346d88793a58261bd3ed7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i64b2eec84ef04575a0d89d957828316e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i16def725ed4c4de287be9546b21381c4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i94c20d249a134eafba8d1b1e39d25904_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i655b0d8763b747d280d873a86aa886f2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i961aaf7e9dd04265a6efcb537457ced7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if92b4bb5fc794dd1bc6e637bdad2d099_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9e97394555f148638042ce9215c2d1dc_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8b0d49f69d854783b426b4a82d9b7617_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ehth:PreviousRepurchaseProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id010efd09ca848fea67ac7a219d97b98_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6023935a90c0449daef342cb4a899125_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic87e10e1f657440db47c80a44d54eb25_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9e7aff4671154fc19c202272ab565eea_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5ba493194d8a487984964d8793886556_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ica2d0bfff5854068ac9d5627ff476134_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1d267c47dbbb4319b6f0bd3c335192ad_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia264f014078a40918be67135b664845e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i07cea5b44a3a459e9e229df532ff47f5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2735879a981f4934a31a2ff030996122_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i87ef0c3e12a247ffb3645a639fa9a28d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ieb78056511e744e692b0f0a6870a2b54_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0ffef56a313d4362acff848ae985e050_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifed776c5bdf242e8b71b1bd21709ceb6_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if080cb3649dc43f092dd38c47b2c3694_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i61773e2e91094158a69f52208476be9c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3729439cfe534105b22358a497155089_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4f10282c4a164b3ba49248e358109fda_D20200408-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2020-04-08</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="idba160cc7e824a82bf89be1c244ad874_D20200707-20201013">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2020-07-07</startDate>
            <endDate>2020-10-13</endDate>
        </period>
    </context>
    <context id="i63e707f4d80c456a88c23a8539ab5605_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ehth:LeViasCompliantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="i847b02865e0e482289ce85c02f9b4e61_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i45589c5d091d42fa856a74b05e6a684b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iece3c4feb7ba4852ae934e622f0fc222_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id5f5742b50c34e6eb0d14c32db2d8983_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i96a1c3f122b54e5c910199f9e10062ae_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i58d74f4f4ee14e1fba9c88300782d7ff_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id7766c8b514940a3adac069dcabfa7f5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0dcc0aaf01a44218b29859ee8d52669f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iae135e664d984295bbf64c3bbe7c4a11_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i33ac7f7fd03c47acb53fa3d4bb1753db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i023ce78002434d8cad1d8f97aa442d34_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4d88e2c29bd4ed1a1c6b4b23e1884dc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i220bb9cb676540b4aeb3a914e250fe06_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id8a052d919884528be429b16feacfa3c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3966096b4cf940f5ab5e3bdf08677217_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="icd072559e8714571bf142682157e4908_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1ac77c183dc946279d677be3a4d4156e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i44a77aea53a9467e962038a9620c620b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i07cffec9adda4d338d0d362e4623e96b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7d18c978c29e46f2a12a23d7312bca62_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iae1734dfbd7b4fffa4a61071f126a5be_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie0964fabcb4d4203950f730100ea33dc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5cf30dc17def4256a761123e6f60a569_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="if2923c5383c841499a972300bbf7f35a_I20180917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-17</instant>
        </period>
    </context>
    <context id="ie6844992191446ce8e5eb767a6d14280_I20180917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-17</instant>
        </period>
    </context>
    <context id="i071c226c04364e0c9c1937a5320495ed_I20191220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-20</instant>
        </period>
    </context>
    <context id="ic7fc3ad8803c48dba5b19cd94571052d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesPrecedingThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id2de67982b8047c4945d793ade8e4b30_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesSucceedingThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idb110a0ed8474c12b0f9d57120ec9b8b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesSucceedingSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib22aa805134544d8b3f646ee20f2d401_D20180917-20180917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-17</startDate>
            <endDate>2018-09-17</endDate>
        </period>
    </context>
    <context id="i44dd187585b74e779c773066ae7d855f_D20191220-20191220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-20</startDate>
            <endDate>2019-12-20</endDate>
        </period>
    </context>
    <context id="iccd604bc2ad5443287367d09698c1237_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i30714fb2e7da43798055174115a19c9f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia6cae47fd71f4a738ddcb10f68e682c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2c1d434f2124892a124c74f776eff75_D20210430-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="ib293ecab870b425a8366eb79aa2bf444_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="insurance_carrier">
        <measure>ehth:insurance_carrier</measure>
    </unit>
    <unit id="state">
        <measure>ehth:state</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="security">
        <measure>ehth:security</measure>
    </unit>
    <unit id="claim">
        <measure>ehth:claim</measure>
    </unit>
    <unit id="plaintiff">
        <measure>ehth:plaintiff</measure>
    </unit>
    <unit id="segment">
        <measure>ehth:segment</measure>
    </unit>
    <unit id="employee">
        <measure>ehth:employee</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80L2ZyYWc6OTU0N2MwOTExMTE5NGE0YmI1MzBjM2RiNTczMDRlMzQvdGFibGU6NjE5YWIxM2E2NTA1NGM3NThiZjU5ZDJmMThhOTA5ZDEvdGFibGVyYW5nZTo2MTlhYjEzYTY1MDU0Yzc1OGJmNTlkMmYxOGE5MDlkMV8zLTEtMS0xLTA_56e36d41-5799-48ef-94ed-dc4c39d1bf52">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80L2ZyYWc6OTU0N2MwOTExMTE5NGE0YmI1MzBjM2RiNTczMDRlMzQvdGFibGU6NjE5YWIxM2E2NTA1NGM3NThiZjU5ZDJmMThhOTA5ZDEvdGFibGVyYW5nZTo2MTlhYjEzYTY1MDU0Yzc1OGJmNTlkMmYxOGE5MDlkMV81LTEtMS0xLTA_822a49fc-af97-42d3-bfd4-e1d023b71cab">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80L2ZyYWc6OTU0N2MwOTExMTE5NGE0YmI1MzBjM2RiNTczMDRlMzQvdGFibGU6NjE5YWIxM2E2NTA1NGM3NThiZjU5ZDJmMThhOTA5ZDEvdGFibGVyYW5nZTo2MTlhYjEzYTY1MDU0Yzc1OGJmNTlkMmYxOGE5MDlkMV82LTEtMS0xLTA_bea6982d-b3f0-4285-a345-4ec7ab0aadfd">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80L2ZyYWc6OTU0N2MwOTExMTE5NGE0YmI1MzBjM2RiNTczMDRlMzQvdGFibGU6NjE5YWIxM2E2NTA1NGM3NThiZjU5ZDJmMThhOTA5ZDEvdGFibGVyYW5nZTo2MTlhYjEzYTY1MDU0Yzc1OGJmNTlkMmYxOGE5MDlkMV85LTEtMS0xLTA_4a976d86-abd0-4143-bf90-50dbb6baab2b">0001333493</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80L2ZyYWc6OTU0N2MwOTExMTE5NGE0YmI1MzBjM2RiNTczMDRlMzQvdGFibGU6NjE5YWIxM2E2NTA1NGM3NThiZjU5ZDJmMThhOTA5ZDEvdGFibGVyYW5nZTo2MTlhYjEzYTY1MDU0Yzc1OGJmNTlkMmYxOGE5MDlkMV8xMC0xLTEtMS0w_584e6462-314d-4197-b317-4db9cb35500d">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i1405f1905b0c495f9efd2474b8fadded_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC0wLTEtMS0xNjk5_9cb35bf6-6ad9-454a-94f9-8fd78c9d7e52">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <dei:DocumentType
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMjk4_276392c5-b761-4f7c-b803-605293dd2bd0">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzAy_d0b528e1-7e41-4a68-9a7f-f26cb5658e1f">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMTI_2e26b6f0-6653-4d8d-a166-daef17c57f4a">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMjk5_944572c7-0ee3-422a-953b-4735f4eb3081">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzA2_8f32a161-82a0-4009-896e-846328ddd63f">001-33071</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzEw_9c9e3fec-13b7-4240-a19c-efe6b49a0e6f">EHEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6NThlNWQ2ZTYzMDBjNGM5NWFiYTI2MTc4MjYxZDkyMmYvdGFibGVyYW5nZTo1OGU1ZDZlNjMwMGM0Yzk1YWJhMjYxNzgyNjFkOTIyZl8wLTAtMS0xLTA_820620df-5e88-4102-ab25-9395e48c9818">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6NThlNWQ2ZTYzMDBjNGM5NWFiYTI2MTc4MjYxZDkyMmYvdGFibGVyYW5nZTo1OGU1ZDZlNjMwMGM0Yzk1YWJhMjYxNzgyNjFkOTIyZl8wLTItMS0xLTA_5e930886-13d3-496a-8a8f-d0b96ea0da20">56-2357876</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzEx_67c43767-9e51-4310-9026-1202b5b56e2f">2625 AUGUSTINE DRIVE, SECOND FLOOR</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzA3_890c7dd3-b3a7-4344-a1f1-da175dd1850b">SANTA CLARA</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzAz_4a7f862f-22d0-4b48-bf59-6787a9aafea2">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzA4_6cb3845e-94f1-4f65-855c-972e98494205">95054</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzAw_6ae4424a-d4ed-4fdd-9376-4e7e0b0a096d">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl82NTU_b9338edc-9283-41f9-9744-6dfb12f6bf3d">584-2700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6MDU1ODlkYTE4YzIxNDI5OGI1MWE3YTZhZmEwZjljMDQvdGFibGVyYW5nZTowNTU4OWRhMThjMjE0Mjk4YjUxYTdhNmFmYTBmOWMwNF8xLTAtMS0xLTA_390c4bc3-8cbd-41c3-baa9-2d4449fe2e41">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6MDU1ODlkYTE4YzIxNDI5OGI1MWE3YTZhZmEwZjljMDQvdGFibGVyYW5nZTowNTU4OWRhMThjMjE0Mjk4YjUxYTdhNmFmYTBmOWMwNF8xLTEtMS0xLTA_b9be5e06-1e73-4ae1-af34-f3a2598ce0f8">EHTH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6MDU1ODlkYTE4YzIxNDI5OGI1MWE3YTZhZmEwZjljMDQvdGFibGVyYW5nZTowNTU4OWRhMThjMjE0Mjk4YjUxYTdhNmFmYTBmOWMwNF8xLTItMS0xLTA_fbf25cb4-57e4-44c0-9dee-ae0b214ecd6b">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzAx_8829ef7b-5029-4ffe-9324-c0df24b11caf">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzA0_2272842b-9b37-4d80-83ee-5238abaffa4f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6NmQ2ZGIzZGU5ZGE1NDYzMjk4YTZjMDQ5MjIzNjBjZDkvdGFibGVyYW5nZTo2ZDZkYjNkZTlkYTU0NjMyOThhNmMwNDkyMjM2MGNkOV8wLTAtMS0xLTA_c1146e34-39b3-414b-93a6-646d36d933f1">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6NmQ2ZGIzZGU5ZGE1NDYzMjk4YTZjMDQ5MjIzNjBjZDkvdGFibGVyYW5nZTo2ZDZkYjNkZTlkYTU0NjMyOThhNmMwNDkyMjM2MGNkOV8xLTQtMS0xLTA_092ac9ae-3c57-42df-84f6-9d75518ebf5e">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGFibGU6NmQ2ZGIzZGU5ZGE1NDYzMjk4YTZjMDQ5MjIzNjBjZDkvdGFibGVyYW5nZTo2ZDZkYjNkZTlkYTU0NjMyOThhNmMwNDkyMjM2MGNkOV8yLTQtMS0xLTA_03050c13-2f2a-4cf0-b66e-77472e750c1f">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMzEy_a4e79d7a-4c38-4114-aa77-620b65f869e8">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i6bb60180d74e484091d2db3e841cf5d9_I20210423"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xL2ZyYWc6ODllYzBjOTE0M2FlNDZkZTkwYzQ1MTZmNWYxYTc2OGYvdGV4dHJlZ2lvbjo4OWVjMGM5MTQzYWU0NmRlOTBjNDUxNmY1ZjFhNzY4Zl8yMjg2_e770d036-534a-4168-bf4b-3397028cd08d"
      unitRef="shares">26091024</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMy0xLTEtMS0w_56dbd1b4-d64c-481a-b035-aee0f2f8bc10"
      unitRef="usd">92250000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMy0zLTEtMS0w_550dcca8-0b33-41c2-9fe0-8fdbd26b8b6f"
      unitRef="usd">43759000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNC0xLTEtMS0w_ddacd028-d433-4392-81d4-828b1c74202a"
      unitRef="usd">33922000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNC0zLTEtMS0w_caff7d44-29dd-46ba-a000-e3190f9ada09"
      unitRef="usd">49620000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNS0xLTEtMS0w_a3d0a606-3761-40ad-82c0-77e23082499d"
      unitRef="usd">1847000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNS0zLTEtMS0w_22f9cdbf-e3f5-49e1-b7e1-41d774897199"
      unitRef="usd">1799000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNi0xLTEtMS0w_d18d5010-f1bd-4e38-b21e-f6dd312e9327"
      unitRef="usd">180276000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNi0zLTEtMS0w_90fcff5e-ed04-42ed-bb22-baa80de4e546"
      unitRef="usd">219153000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNy0xLTEtMS0w_6365c71c-d211-4538-91a5-70262c53a4c8"
      unitRef="usd">12325000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNy0zLTEtMS0w_47472dea-e155-46b5-9eec-3a13f4349a1b"
      unitRef="usd">16661000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfOC0xLTEtMS0w_0ea98d0f-7d53-4c12-ae5d-ed0fa1fe409f"
      unitRef="usd">320620000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfOC0zLTEtMS0w_b1110285-eb8f-40ae-9427-f507bd375fb7"
      unitRef="usd">330992000</us-gaap:AssetsCurrent>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfOS0xLTEtMS0w_002c3e2a-67c4-4b1d-af8b-82a1c228e46f"
      unitRef="usd">561571000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfOS0zLTEtMS0w_c6cf253d-2c59-43ca-aca6-bcd4e49c689b"
      unitRef="usd">573252000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTAtMS0xLTEtMA_e76eeb2d-3e82-4583-bb66-3c17df85359b"
      unitRef="usd">14869000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTAtMy0xLTEtMA_15f0c373-7e47-4b27-a7a1-ca94b2426db5"
      unitRef="usd">14609000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTItMS0xLTEtMA_836798cd-1595-483c-a0cf-0015532f60a8"
      unitRef="usd">41284000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTItMy0xLTEtMA_de57290b-db4e-4924-989f-08e76e4d3a03"
      unitRef="usd">42558000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTMtMS0xLTEtMA_61d24d8d-86e7-4826-9b5d-02595ef4f166"
      unitRef="usd">3354000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTMtMy0xLTEtMA_dd9f2caf-34b5-41ff-8068-7f12742d8226"
      unitRef="usd">3354000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTUtMS0xLTEtMA_5c5c6727-37ea-4e39-b917-e685c8f0207b"
      unitRef="usd">8393000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTUtMy0xLTEtMA_ffeaa154-7bb9-4a01-8216-060c2a2d2f68"
      unitRef="usd">8569000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTYtMS0xLTEtMA_b2f99ced-5dc5-4b5d-891d-3298447fd890"
      unitRef="usd">40233000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTYtMy0xLTEtMA_b2f3cb57-8234-4895-ab0b-85aa07457838"
      unitRef="usd">40233000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTctMS0xLTEtNTY1OQ_a1902ca6-860f-46b0-b8df-6a14fd201bd8"
      unitRef="usd">27471000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTctMy0xLTEtNTY1OQ_ff5bd5e6-217c-4137-bec4-e37d762f2bf9"
      unitRef="usd">26455000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTctMS0xLTEtMA_cef373aa-eacb-4126-a322-f8734b6a8fa9"
      unitRef="usd">1017795000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMTctMy0xLTEtMA_9216e76c-8153-4e92-8cad-150836b4c4a6"
      unitRef="usd">1040022000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjAtMS0xLTEtMA_3718178c-1026-4d97-8349-b24be358daf4"
      unitRef="usd">10944000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjAtMy0xLTEtMA_0fbe341b-cbe0-4cbb-bba9-08cd05de63a4"
      unitRef="usd">36921000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjEtMS0xLTEtMA_e6bfd5b3-71bc-4108-930e-a43ef5617ba3"
      unitRef="usd">24630000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjEtMy0xLTEtMA_785e7b2c-8736-4269-b76a-85e87324fda3"
      unitRef="usd">20542000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <ehth:AccruedMarketingExpenses
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjItMS0xLTEtMA_26c699c8-dd0d-4ac5-a7b5-2a6e0cf175fc"
      unitRef="usd">11076000</ehth:AccruedMarketingExpenses>
    <ehth:AccruedMarketingExpenses
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjItMy0xLTEtMA_7af6e1e8-8b91-4930-8129-ba46ed380cf4"
      unitRef="usd">17788000</ehth:AccruedMarketingExpenses>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjQtMS0xLTEtMA_cff55501-87fd-427f-94d0-6f5b36959265"
      unitRef="usd">5316000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjQtMy0xLTEtMA_b2084996-28f9-4463-b76d-1c8615afbbf7"
      unitRef="usd">5192000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjUtMS0xLTEtMA_490095dd-ac81-447d-bcd2-f379e35891da"
      unitRef="usd">877000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjUtMy0xLTEtMA_856be86f-6dc9-489c-ace0-8715eb1d4f6c"
      unitRef="usd">308000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjYtMS0xLTEtMA_ba898f44-dac4-4ca7-98e3-43179655c9e7"
      unitRef="usd">4270000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjYtMy0xLTEtMA_1fd0841d-2461-4537-b9c5-f28a1f2fecfe"
      unitRef="usd">3657000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjctMS0xLTEtMA_27aa8d91-7c59-43b6-81f5-c740d7fefafa"
      unitRef="usd">57113000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMjctMy0xLTEtMA_4c1fdfc0-0d42-4b89-9066-03bc17ba6848"
      unitRef="usd">84408000</us-gaap:LiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzAtMS0xLTEtMzk1NQ_205bc82a-93ca-4810-b3e3-f011aba7f981"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzAtMy0xLTEtMzk1NQ_23c8e2c2-cbb5-41d6-95d6-bf8eacf5668b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzAtMS0xLTEtMA_39924617-d7fc-4b99-838b-9e38419c6d8e"
      unitRef="usd">71748000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzAtMy0xLTEtMA_1280c484-f3e6-4fca-b742-5a05b5d20a3b"
      unitRef="usd">72317000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzEtMS0xLTEtMA_496ca180-8081-4a9c-8eb6-e9929a74a304"
      unitRef="usd">39984000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzEtMy0xLTEtMA_e18e48e9-ddcc-4896-9828-c3395c9d91b7"
      unitRef="usd">41369000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzItMS0xLTEtMA_dd4b61a6-0cb8-4008-baf1-9628f0029be1"
      unitRef="usd">5025000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzItMy0xLTEtMA_50a4ccdf-3789-488e-b21e-e6bb1d7c04d0"
      unitRef="usd">4370000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommonStockValue
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzQtMS0xLTEtMA_6ea0fc9c-6b15-4347-b8df-b8e7e0671210"
      unitRef="usd">38000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzQtMy0xLTEtMA_3856be7b-7ef8-4469-b109-a14197bc142d"
      unitRef="usd">38000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzUtMS0xLTEtMA_c4753180-4391-4005-a8dc-e4b87fc5c4a9"
      unitRef="usd">728213000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzUtMy0xLTEtMA_9a37d9b7-c11f-4d67-b983-f15e149a970f"
      unitRef="usd">721013000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockValue
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzYtMS0xLTEtMA_eafcc37f-540a-4577-a5bf-86463b221ec0"
      unitRef="usd">199998000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzYtMy0xLTEtMA_5bd67c59-5de6-49fa-9803-531311afbb16"
      unitRef="usd">199998000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzctMS0xLTEtMA_45e3520b-16c4-4c4c-9051-89a725b5cc0b"
      unitRef="usd">315355000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzctMy0xLTEtMA_8baefbe3-3a0f-44f3-ad3f-90ee55c4dd4c"
      unitRef="usd">316155000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzgtMS0xLTEtMA_58524719-3772-41b8-bfcf-e9797708925c"
      unitRef="usd">317000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzgtMy0xLTEtMA_b575f019-d831-4fcd-9db2-863121775af4"
      unitRef="usd">350000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzktMS0xLTEtMA_3e229e80-2ff6-4600-9d07-296ae8c373df"
      unitRef="usd">843925000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfMzktMy0xLTEtMA_480d3696-d03b-40ee-9df8-95184bb15d85"
      unitRef="usd">837558000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNDAtMS0xLTEtMA_62be2324-614e-4759-b9ee-26695593e02e"
      unitRef="usd">1017795000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xNi9mcmFnOjhiODQwMmU1NzRlOTRjM2FhYzEzYmJhZjU0MzhiNGViL3RhYmxlOmUyZDA5YjA5MzJjNzRjN2Y4MDA2MmNmNjc3MGY0MjBkL3RhYmxlcmFuZ2U6ZTJkMDliMDkzMmM3NGM3ZjgwMDYyY2Y2NzcwZjQyMGRfNDAtMy0xLTEtMA_b3fd2453-cf28-4dca-81f9-6cfaa7e25f6f"
      unitRef="usd">1040022000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8337239e8dda4274bdb5081198725cf8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMy01LTEtMS0w_a09d72bc-da1e-48e5-8e11-96dda546d589"
      unitRef="usd">127052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a17b2f577fb4a0994b259f4a7c00fac_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMy03LTEtMS0w_3ddba876-2275-4db6-9ea8-f241cb616bd1"
      unitRef="usd">99669000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8680ff82e8684663ac818bd969dadd40_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNC01LTEtMS0w_72f8f999-e883-4667-85d3-1e875d29b7a9"
      unitRef="usd">7162000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5fe1a9fc09dc4d98894c2f05859cd3f1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNC03LTEtMS0w_86510bca-8308-4d35-8ab0-5a81fb581960"
      unitRef="usd">6739000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNS01LTEtMS0w_ed10dc91-cf1f-479e-88ad-d64d03dd9ad7"
      unitRef="usd">134214000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNS03LTEtMS0w_f7105567-d787-46d9-9773-ea4f2a610e8f"
      unitRef="usd">106408000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNy01LTEtMS0w_b7d9ccef-0995-4844-a2dc-0c862f8f4af3"
      unitRef="usd">996000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfNy03LTEtMS0w_175ceec2-384f-4218-80f4-f6e226d462c9"
      unitRef="usd">1138000</us-gaap:CostOfRevenue>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfOC01LTEtMS0w_640e70f0-efac-4199-a99b-708180dfceb1"
      unitRef="usd">50874000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfOC03LTEtMS0w_22dbd097-dafe-4652-b454-9742be218013"
      unitRef="usd">37764000</us-gaap:MarketingAndAdvertisingExpense>
    <ehth:CustomerCareAndEnrollmentExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfOS01LTEtMS0w_b45b41be-e5bc-469d-9571-c3a108de83b3"
      unitRef="usd">34162000</ehth:CustomerCareAndEnrollmentExpense>
    <ehth:CustomerCareAndEnrollmentExpense
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfOS03LTEtMS0w_3bec271e-fa70-4bfe-9fe4-8af965ba76e8"
      unitRef="usd">30535000</ehth:CustomerCareAndEnrollmentExpense>
    <ehth:TechnologyAndContentExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTAtNS0xLTEtMA_57da72f0-3fde-4879-8018-d2feb0b0b9da"
      unitRef="usd">23163000</ehth:TechnologyAndContentExpense>
    <ehth:TechnologyAndContentExpense
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTAtNy0xLTEtMA_65d2aef2-07de-4fd1-9e73-0d103192ebc7"
      unitRef="usd">15740000</ehth:TechnologyAndContentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTEtNS0xLTEtMA_001ab001-adba-4e8b-beee-881078461cb3"
      unitRef="usd">23054000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTEtNy0xLTEtMA_7ea4fc7e-16ba-46e8-8035-c636e2702a4e"
      unitRef="usd">19653000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTItNS0xLTEtMA_cc7674b6-415f-4188-82b7-7c781133babf"
      unitRef="usd">176000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTItNy0xLTEtMA_61ec6930-b340-4ff6-9d88-49b72cb9b250"
      unitRef="usd">547000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RestructuringCharges
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTQtNS0xLTEtMA_c4ce929e-9bed-469e-a983-e96a8a3ca3ba"
      unitRef="usd">2431000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTQtNy0xLTEtMA_d0161363-8282-4986-a043-a56f03d96c0b"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:CostsAndExpenses
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTYtNS0xLTEtMA_f2d8dc75-f281-402a-87fe-97741ba20121"
      unitRef="usd">134856000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTYtNy0xLTEtMA_c680586b-f5c1-4b9a-8479-6f670e313880"
      unitRef="usd">105377000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTctNS0xLTEtMA_5c242220-bac1-4106-8c32-53badd11ed78"
      unitRef="usd">-642000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTctNy0xLTEtMA_f417c0b6-f6a8-438f-bf7b-6d268b7653b9"
      unitRef="usd">1031000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTgtNS0xLTEtMA_d41eb882-09bd-4a03-88ec-17a2978fba44"
      unitRef="usd">150000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTgtNy0xLTEtMA_d4a5f518-e6bb-4fe4-8dc9-3e73682e6830"
      unitRef="usd">373000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTktNS0xLTEtMA_4375c594-1b77-4411-99d0-8430c1448420"
      unitRef="usd">-492000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMTktNy0xLTEtMA_cf54e09b-d026-42cd-818b-b2f199eb3f31"
      unitRef="usd">1404000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjAtNS0xLTEtMA_e261a109-09ae-4675-91df-3444c48a0eed"
      unitRef="usd">308000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjAtNy0xLTEtMA_ad71807b-d889-4056-a702-c6fffc652e00"
      unitRef="usd">-2048000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjEtNS0xLTEtMA_72e3fa8e-9bda-4351-be96-adfb3d76df23"
      unitRef="usd">-800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjEtNy0xLTEtMA_27aae8ce-30c4-45b5-bd4b-f50a9954532f"
      unitRef="usd">3452000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjQtNS0xLTEtMA_8c77c357-a7e8-44ac-8148-1845aaf591d8"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjQtNy0xLTEtMA_d313b3ce-e8ab-430c-8f5d-98b467b3ce65"
      unitRef="usdPerShare">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjUtNS0xLTEtMA_1942de4f-32a7-4afd-8335-136cd972de98"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjUtNy0xLTEtMA_e64f5a11-89a4-4dde-8fdd-b6048cb94ca5"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjctNS0xLTEtMA_b627536b-3eae-499a-a159-a5745da3e9a4"
      unitRef="shares">26620000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjctNy0xLTEtMA_ef7759fb-5c80-4aca-ad7a-64e1ebdf2425"
      unitRef="shares">24719000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjgtNS0xLTEtMA_4481ab83-c178-4469-8ccf-fdd59cd4c93f"
      unitRef="shares">26620000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMjgtNy0xLTEtMA_7e3b7034-4ea7-4fc8-aeda-d52bfee63965"
      unitRef="shares">26179000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzAtNS0xLTEtMA_86ed6cb7-01b7-46c9-8852-28017815a1d3"
      unitRef="usd">-800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzAtNy0xLTEtMA_d55ede7a-a3ee-4360-876a-9b57db2fd090"
      unitRef="usd">3452000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzEtNS0xLTEtMA_0d9b115d-0b6b-4a4f-aac8-a3069583309b"
      unitRef="usd">-16000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzEtNy0xLTEtMA_856cdad7-84a2-4026-ac3c-a19444edcc91"
      unitRef="usd">25000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzItNS0xLTEtMA_b3552d73-af7b-463f-bdfa-54081f86915f"
      unitRef="usd">-17000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzItNy0xLTEtMA_818b18cb-6894-4e78-a61c-47bfd14b6672"
      unitRef="usd">-31000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzMtNS0xLTEtMA_e6381d2f-b828-4789-8290-a5ddbed5db59"
      unitRef="usd">-833000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xOS9mcmFnOmM1OGJlY2Q0MzNiNDQyNzNiMTgzMDllYjc4NGRmMGFmL3RhYmxlOmVmYjczODY2NjNmYzQ3OGI4YjY5ZGJhN2YwNWU5MTJiL3RhYmxlcmFuZ2U6ZWZiNzM4NjY2M2ZjNDc4YjhiNjlkYmE3ZjA1ZTkxMmJfMzMtNy0xLTEtMA_52c5293d-10df-4ba2-aa81-7ea485d92cfc"
      unitRef="usd">3446000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="ib63247d699eb44bfb201774d6fef56b5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy0xLTEtMS0w_2a4bfc61-455b-47c1-9310-0af35ddc0c16"
      unitRef="shares">37755000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib63247d699eb44bfb201774d6fef56b5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy0zLTEtMS0w_2a19317b-1ca9-4e2d-9812-0c83eb7957ae"
      unitRef="usd">38000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i29014aa44f224a9e8e5ca25d6c81661b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy01LTEtMS0w_fe6e745e-532e-4cf2-bca7-28d38bb7c31b"
      unitRef="usd">721013000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ibacf081650de495da52a05e4eed69d81_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy03LTEtMS0w_154206c7-bee9-4541-996c-2ea8614ab302"
      unitRef="shares">11831000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ibacf081650de495da52a05e4eed69d81_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy05LTEtMS0w_b35012c2-544d-4aad-baba-65e100ac4057"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if350613e6abd438882a29524ad8a5858_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy0xMS0xLTEtMA_00d29ea6-b6d8-41c7-adb1-4f7673791092"
      unitRef="usd">316155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if5a91006c9d446fbb4d678b836971da0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy0xMy0xLTEtMA_9c64f48e-cf29-411b-b378-e0e084102441"
      unitRef="usd">350000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMy0xNS0xLTEtMA_cef78aab-bf84-478d-8326-6770c28d5cd2"
      unitRef="usd">837558000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ieeba31f3c1b84580993db317c01046dd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNS0xLTEtMS0w_fc51235a-3ae4-4384-9d70-a0a256fb851c"
      unitRef="shares">238000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i74c4a51c8df7461fb85f66341986ca02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNS01LTEtMS0w_d8071f21-0079-49cd-af53-45528cb8cd89"
      unitRef="usd">285000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNS0xNS0xLTEtMA_334e7272-2ef0-4c4d-a5c0-be7588b3f872"
      unitRef="usd">285000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i74c4a51c8df7461fb85f66341986ca02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNi01LTEtMS0w_54aa02be-aaee-40dd-a91a-6914f45dfc21"
      unitRef="usd">5037000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i65cdbe8443b34580b8422ede51568ad8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNi03LTEtMS0w_01e52a1c-4d4f-4583-8b8d-20d1e707b91f"
      unitRef="shares">81000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfNi0xNS0xLTEtMA_7a5a5d6a-302d-451e-b5ea-97b791390904"
      unitRef="usd">5037000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i74c4a51c8df7461fb85f66341986ca02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfOS01LTEtMS0w_5adfc382-6c4e-4c84-9178-c0806e037a46"
      unitRef="usd">11952000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfOS0xNS0xLTEtMA_feb71c06-b6e1-4095-9972-6da5ca0d38e8"
      unitRef="usd">11952000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iadef4a55d90e438a8f79adf8bc288200_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTAtMTMtMS0xLTA_1b982b1f-2f1f-4399-8e6b-79de79a2633f"
      unitRef="usd">-33000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTAtMTUtMS0xLTA_fd2031fa-9b47-4007-bd3b-92b6a78bb902"
      unitRef="usd">-33000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ib464d05e6c054ac8bcb58e7dcb4504fe_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTEtMTEtMS0xLTA_cccd84d3-06b4-4d82-a324-b57d9579c9fb"
      unitRef="usd">-800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTEtMTUtMS0xLTA_deda504c-3541-422c-b2af-8a64583b0027"
      unitRef="usd">-800000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i7881058e6391413da79a1df94978a40a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItMS0xLTEtMA_18f3cbd8-540a-47df-a51b-c33f3d5e1ff4"
      unitRef="shares">37993000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7881058e6391413da79a1df94978a40a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItMy0xLTEtMA_b1d19692-3c4d-496d-8971-21ada99a0be5"
      unitRef="usd">38000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia5468c73d2e34194b9c572c7aba7dfbe_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItNS0xLTEtMA_f94441ab-9d38-43f5-a2e7-4165700c26f8"
      unitRef="usd">728213000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="id1c5c1ce40314084a6517c4ee8f604b7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItNy0xLTEtMA_3260308c-d7e0-4140-9ef2-5d7f63ec13ce"
      unitRef="shares">11912000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id1c5c1ce40314084a6517c4ee8f604b7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItOS0xLTEtMA_385c6750-8d63-4099-a6fc-bf19ddb721f9"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i571009d8684244af94c420ce801431c3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItMTEtMS0xLTA_f83e976d-652a-4eab-9edf-36775036991d"
      unitRef="usd">315355000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i85b5b55d4a9c4f76ac527000958b9eae_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItMTMtMS0xLTA_6155efc2-f569-45b3-b5d4-5f5010b1f3d2"
      unitRef="usd">317000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjY4NmExZTg3NzJiYTRkZWQ5NDdkMGJiYzIyNGNiZGE1L3RhYmxlcmFuZ2U6Njg2YTFlODc3MmJhNGRlZDk0N2QwYmJjMjI0Y2JkYTVfMTItMTUtMS0xLTA_6575788b-4f36-4a08-aebf-102c0901b51d"
      unitRef="usd">843925000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i7a043e2b26b14ab29cc5ac268c78e6cb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy0xLTEtMS0w_69091c22-1550-4da8-b6de-a834a31d5807"
      unitRef="shares">34752000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7a043e2b26b14ab29cc5ac268c78e6cb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy0zLTEtMS0w_dc920ecf-51fd-46d5-af99-77478a3a777e"
      unitRef="usd">35000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i28f6aba0243b421b803fe3861b663e07_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy01LTEtMS0w_157ce630-5b13-4ee0-94c7-b9463e7c083b"
      unitRef="usd">455159000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i8d29d5730c7349ea9d1ef955dd844f0d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy03LTEtMS0w_5ac29b01-6ebe-44a3-9162-d208c04b0e36"
      unitRef="shares">11616000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8d29d5730c7349ea9d1ef955dd844f0d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy05LTEtMS0w_a657cec7-892e-47fc-965d-673837b1defd"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icf42840deb504490a24f18226ae769ac_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy0xMS0xLTEtMA_2c51ae99-4bef-4ccf-98f1-b8d01b526ef0"
      unitRef="usd">271852000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i464582b3717f48fb8fb924189caabeae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy0xMy0xLTEtMA_4b888386-80ac-4924-8dad-005a639424f2"
      unitRef="usd">116000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i283d90d05c8744f3a67f23305e4f839c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMy0xNS0xLTEtMA_a445f698-32a4-4bab-a731-b176c44f13b9"
      unitRef="usd">527164000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie89c5f32945844b5b95944d102880a24_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC0xMS0xLTEtMTcwNg_76279445-1e3d-4894-aae7-3344456fcb81"
      unitRef="usd">-1147000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0466642154754b80bcf918c034fb3b1d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC0xNS0xLTEtMTcwNg_f195f095-374b-4266-9d51-f4347687cc7a"
      unitRef="usd">-1147000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if6b1b9ba849b4eb49f00439861a88682_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC0xLTEtMS0w_0464d43e-a0c7-48af-a5fd-b97b249dac01"
      unitRef="shares">141000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie6107d03659748ec91163598cd67842f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC01LTEtMS0w_a6f407cc-af51-4260-828b-92344c5440e6"
      unitRef="usd">1091000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNC0xNS0xLTEtMA_8179ea9b-22d3-4fcf-86a6-65f35e7be87a"
      unitRef="usd">1091000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie6107d03659748ec91163598cd67842f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNS01LTEtMS0w_0147696e-258e-4c45-aa90-534bec813cde"
      unitRef="usd">4375000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ibce1977df45a4166aacac2533753fef2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNS03LTEtMS0w_15f1b400-9cd3-4c79-bb76-ad07503b6cbf"
      unitRef="shares">33000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNS0xNS0xLTEtMA_36f7c1cb-993a-49b8-ad47-5a1e49518f60"
      unitRef="usd">4375000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="if6b1b9ba849b4eb49f00439861a88682_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNi0xLTEtMS0w_159f57d1-ecaa-4cdd-8852-cee180aca30f"
      unitRef="shares">2070000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if6b1b9ba849b4eb49f00439861a88682_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNi0zLTEtMS0w_64e4c161-f8b8-422c-af82-3ad60d83f439"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ie6107d03659748ec91163598cd67842f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNi01LTEtMS0w_a1dc97f8-13ee-423c-9e42-b3af4335e19c"
      unitRef="usd">228022000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNi0xNS0xLTEtMA_21cdd065-4a93-486e-9eb3-390d09f06d2b"
      unitRef="usd">228024000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="if6b1b9ba849b4eb49f00439861a88682_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNy0xLTEtMS0w_9bf8ac72-701e-473f-9366-656e1c248c7d"
      unitRef="shares">295000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ie6107d03659748ec91163598cd67842f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNy01LTEtMS0w_c381e34d-a707-466d-89e7-acaeb075f4f1"
      unitRef="usd">28521000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfNy0xNS0xLTEtMA_b121706a-82fe-41a1-9a03-9ce656b9e061"
      unitRef="usd">28521000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie6107d03659748ec91163598cd67842f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfOC01LTEtMS0w_d622f170-98a6-42e8-8c73-5a5034256cd4"
      unitRef="usd">8962000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfOC0xNS0xLTEtMA_be1027aa-6750-42ea-8790-d0b6af56091d"
      unitRef="usd">8962000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iffa4ea2bf46843c8a3b8c76230e7aece_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfOS0xMy0xLTEtMA_99a103f8-d6ba-441c-bd2e-16def571c76d"
      unitRef="usd">-6000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfOS0xNS0xLTEtMA_dc07e7f4-ca4c-4dd6-948a-7e8077dcfab4"
      unitRef="usd">-6000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i77e456c86a2c4c2298f67ccceb97b818_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTAtMTEtMS0xLTA_cbfeb036-f95b-4926-b913-702a58242e6d"
      unitRef="usd">3452000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTAtMTUtMS0xLTA_8916680e-b9b8-4265-8f7b-e06a343f5925"
      unitRef="usd">3452000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i98e488604a58499a810b6c51f24f6985_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtMS0xLTEtMA_ffab2215-26e2-47ef-80c8-3e83304a7215"
      unitRef="shares">37258000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i98e488604a58499a810b6c51f24f6985_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtMy0xLTEtMA_e08f3f9b-dad8-4805-a6e9-3d6d226e179f"
      unitRef="usd">37000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i51bc9d212152476f9e50aaa3f71da0a8_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtNS0xLTEtMA_495b1fce-ea0d-4a4e-be08-2bc0bbab57bb"
      unitRef="usd">717380000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i96bc1b9468db422cbae505e283d62180_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtNy0xLTEtMA_ec78a8d9-1872-4032-b994-6960885da232"
      unitRef="shares">11649000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i96bc1b9468db422cbae505e283d62180_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtOS0xLTEtMA_434a8295-377c-4a7f-9ec9-8ea951a58f14"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18dcb5c7e7f74362b1df0c50dfaf35c3_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtMTEtMS0xLTA_a41c448c-cf4e-41f2-905a-0cb41e6cc6c7"
      unitRef="usd">274157000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3222346a5aab4a859b8e9a0c70c4fccb_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtMTMtMS0xLTA_cb80c552-04d5-4a6b-9121-a9ea7d7493d9"
      unitRef="usd">110000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i94e4cd2c63294501a97ce58cbb8f0ad9_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yNS9mcmFnOjVmNzk2NGNiZmVlMTQ2ZDdiNTY1MmJiM2U1MDMyMjYzL3RhYmxlOjg5YzBkZjU2M2IxZDQzNTlhMDk0OWRlNDgxMDUxZDhmL3RhYmxlcmFuZ2U6ODljMGRmNTYzYjFkNDM1OWEwOTQ5ZGU0ODEwNTFkOGZfMTEtMTUtMS0xLTA_b55f2b0e-7918-4631-8330-48ef68fc04fa"
      unitRef="usd">791686000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMy0xLTEtMS0w_29aaf876-4f14-4893-ae05-c604170503a5"
      unitRef="usd">-800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMy0zLTEtMS0w_f530d72b-99d5-443f-8383-eff616246a72"
      unitRef="usd">3452000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNS0xLTEtMS0w_d208fffb-ace6-4d41-b3d7-443328fdd215"
      unitRef="usd">1138000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNS0zLTEtMS0w_9e7a6ce1-b455-4747-9d8e-1e4d0e2d9f32"
      unitRef="usd">823000</us-gaap:Depreciation>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNi0xLTEtMS0w_87aa06ad-070f-40f5-ba3a-06f057cd51aa"
      unitRef="usd">2806000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNi0zLTEtMS0w_246594f4-1cba-4508-9b0f-038d75a14071"
      unitRef="usd">1501000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNy0xLTEtMS0w_d8597281-d58c-4ea1-9788-c9dc8c77d661"
      unitRef="usd">176000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNy0zLTEtMS0w_36fcc184-0c6f-4792-8b44-b3c9a48c392b"
      unitRef="usd">547000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ShareBasedCompensation
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfOC0xLTEtMS0w_bedb75e8-ed44-4d19-873c-7136e072a5d6"
      unitRef="usd">11402000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfOC0zLTEtMS0w_24031bc6-c4ba-4f32-9c50-2973824c6625"
      unitRef="usd">8714000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfOS0xLTEtMS0w_49b5bff6-3fd3-411c-8405-2d82df3929c3"
      unitRef="usd">-570000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfOS0zLTEtMS0w_34675c1d-19f8-4177-8cae-23d00d5dd00f"
      unitRef="usd">-2141000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTItMS0xLTEtMA_6971c7ac-60f1-4973-8d20-58b9eef1ace1"
      unitRef="usd">-420000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTItMy0xLTEtMA_3bf6ae8b-8495-4988-a0b5-6a3f2819c7ed"
      unitRef="usd">-223000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTQtMS0xLTEtMA_6d6762de-5581-4793-874c-0a55ec9af53c"
      unitRef="usd">48000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTQtMy0xLTEtMA_8f89fcb0-1edc-419f-989b-2140c2440bc9"
      unitRef="usd">-1664000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <ehth:IncreaseDecreaseInCommissionsReceivable
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTUtMS0xLTEtMA_6e19712d-8d2a-4cec-a23d-2deae2916fe6"
      unitRef="usd">50635000</ehth:IncreaseDecreaseInCommissionsReceivable>
    <ehth:IncreaseDecreaseInCommissionsReceivable
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTUtMy0xLTEtMA_2753324d-4d64-48ac-9707-416f29d35a88"
      unitRef="usd">26873000</ehth:IncreaseDecreaseInCommissionsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTYtMS0xLTEtMA_35db2fe7-0841-4996-bf5e-4e1d8455fb96"
      unitRef="usd">-4225000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTYtMy0xLTEtMA_a76654c9-8260-4ff2-b138-59bda7a3d9f3"
      unitRef="usd">159000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTctMS0xLTEtMA_d08c3f68-b588-4daa-9a1d-4b2b81df59ee"
      unitRef="usd">-25826000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTctMy0xLTEtMA_4ada8fb8-fdf7-4162-ad7a-307986865af9"
      unitRef="usd">-16279000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTgtMS0xLTEtMA_146dab59-712e-411c-bf5a-8ea41f07f7e3"
      unitRef="usd">4088000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTgtMy0xLTEtMA_770f1ea6-0b68-446d-ba09-d5e061517674"
      unitRef="usd">-11104000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <ehth:IncreaseDecreaseInAccruedMarketingExpenses
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTktMS0xLTEtMA_a0b4c5c1-7373-451f-a947-b44200534230"
      unitRef="usd">-6712000</ehth:IncreaseDecreaseInAccruedMarketingExpenses>
    <ehth:IncreaseDecreaseInAccruedMarketingExpenses
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMTktMy0xLTEtMA_e1715479-fd3f-4e9b-81ac-9181df3d732f"
      unitRef="usd">-7329000</ehth:IncreaseDecreaseInAccruedMarketingExpenses>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjAtMS0xLTEtMA_0d0dfe04-765d-480e-a3ac-33126ffb9d7c"
      unitRef="usd">570000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjAtMy0xLTEtMA_caa5b2d6-2cc5-4861-90bd-0adac4faab45"
      unitRef="usd">113000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjEtMS0xLTEtMA_dd62545d-acc5-4157-bc3d-48274c00dbc9"
      unitRef="usd">1305000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjEtMy0xLTEtMA_1652ffa0-8f06-4097-bbf4-d99475885aff"
      unitRef="usd">2009000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjItMS0xLTEtMA_22ae50ba-edf7-4eb8-863a-95828e4b3ddf"
      unitRef="usd">42809000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjItMy0xLTEtMA_34b50b29-2f0f-41b1-a0ae-643be7e3967d"
      unitRef="usd">8907000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjQtMS0xLTEtMA_30beed28-9c7c-4677-ae1f-a778c6a3d343"
      unitRef="usd">3242000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjQtMy0xLTEtMA_f44552f1-edbe-472b-a1e9-e929d2a103fc"
      unitRef="usd">3564000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjUtMS0xLTEtMA_2181ae59-f3a7-4242-8968-767edbf196d3"
      unitRef="usd">1899000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjUtMy0xLTEtMA_6ca176d5-52df-486e-961f-449fcaf9bc13"
      unitRef="usd">2508000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjYtMS0xLTEtMA_30326a7c-b177-4d82-99e8-5cf8072dd667"
      unitRef="usd">7771000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjYtMy0xLTEtMA_79471e20-63e7-42d5-b27c-048f2c9f0815"
      unitRef="usd">58064000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjctMS0xLTEtMA_d539b716-9ed0-4fa4-885c-aa51eeed13d2"
      unitRef="usd">23409000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMjctMy0xLTEtMA_cecbb599-bf46-4a52-9b4e-83f7187a6e36"
      unitRef="usd">0</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzAtMS0xLTEtMA_a08725d2-baf2-461d-8318-99519afd15ac"
      unitRef="usd">10497000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzAtMy0xLTEtMA_5e90f19a-6237-4db8-8fab-132a83fe6376"
      unitRef="usd">-64136000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzItMS0xLTEtMA_d39b62d7-274e-4907-9b67-2db15a13956b"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzItMy0xLTEtMA_6fe2e0c5-2aea-4ad4-a0a9-954291e59f1e"
      unitRef="usd">228024000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzMtMS0xLTEtMA_8c0db310-9d51-4448-8858-be030cc6ae11"
      unitRef="usd">285000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzMtMy0xLTEtMA_5e525846-7e23-4bc1-8c84-2560dff75962"
      unitRef="usd">1091000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzQtMS0xLTEtMA_5c79f08f-d28a-4cf1-9ce9-f36e28029d90"
      unitRef="usd">-5037000</us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards>
    <us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzQtMy0xLTEtMA_0945737c-9bca-4ead-910c-593fe1a807fb"
      unitRef="usd">-4375000</us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzgtMS0xLTEtMA_a5627426-fa23-478c-acab-e37c5ad4a742"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzgtMy0xLTEtMA_22d7319f-1020-47e8-aec9-9b48a30afb3e"
      unitRef="usd">8751000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzktMS0xLTEtMA_69eb7e05-00f5-40d0-ba94-76ad6b20cdb1"
      unitRef="usd">38000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfMzktMy0xLTEtMA_656aae58-22c9-4c89-9605-2f23f89edd70"
      unitRef="usd">58000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDAtMS0xLTEtMA_b7731e0e-6ef7-4c27-b220-ae32d566cf51"
      unitRef="usd">-4790000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDAtMy0xLTEtMA_c94f62ff-3e2c-4ea2-a895-71c6d4974558"
      unitRef="usd">215931000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDEtMS0xLTEtMA_5873a946-ba7c-47c5-8531-e29bcde9a77d"
      unitRef="usd">-25000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDEtMy0xLTEtMA_903021ef-d2ef-442a-9e80-e44b7ac76843"
      unitRef="usd">-2000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDItMS0xLTEtMA_6d45a968-f1f0-454f-8090-5483b2aa3863"
      unitRef="usd">48491000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDItMy0xLTEtMA_688c3998-cad8-43f5-90d6-599d37ba4213"
      unitRef="usd">160700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDMtMS0xLTEtMA_f929aa45-c2da-4c82-b6fa-fa97752f37a1"
      unitRef="usd">47113000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i283d90d05c8744f3a67f23305e4f839c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDMtMy0xLTEtMA_595d257f-e887-4fbb-8441-281c270646ce"
      unitRef="usd">26820000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDQtMS0xLTEtMA_29bb993f-96c3-4be5-8e91-f75f62f4299c"
      unitRef="usd">95604000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i94e4cd2c63294501a97ce58cbb8f0ad9_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8yOC9mcmFnOjM5OGZjZmY0NWU1NzQ1OGJiZTU2YWI4OWIzNWVhMjIzL3RhYmxlOjcxNTJjNDA1MGFjZTQ3MTk4ZDYyZDhhNTVhNDAzNzFkL3RhYmxlcmFuZ2U6NzE1MmM0MDUwYWNlNDcxOThkNjJkOGE1NWE0MDM3MWRfNDQtMy0xLTEtMA_c8ec4f09-514d-41ef-8f61-3c3420e13ec0"
      unitRef="usd">187520000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyODI_760b23e8-8358-4665-9d36-618ddd22ad5c">Summary of Business and Significant Accounting Policies&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;eHealth, Inc. (the &#x201c;Company,&#x201d; &#x201c;eHealth,&#x201d; &#x201c;we&#x201d; or &#x201c;us&#x201d;) is a leading health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform is designed to meet the consumer wherever they prefer to engage with us, and enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over 200 health insurance carriers across all fifty states and the District of Columbia.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Basis of Presentation &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The accompanying condensed consolidated balance sheets as of March 31, 2021 and December 31, 2020 and the condensed consolidated statements of comprehensive income (loss), stockholders&#x2019; equity, and cash flows for the three months ended March 31, 2021 and 2020, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2020 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 26, 2021. The accompanying financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and reflect all normal recurring adjustments that are necessary to present fairly the results for the interim periods presented. The condensed consolidated financial statements include the accounts of eHealth, Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with those rules and regulations. Certain prior period amounts have been reclassified to conform with our current period presentation. However, we believe that the disclosures made are adequate to make the information not misleading. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 and include all adjustments necessary for the fair presentation of our financial position as of March 31, 2021 and December 31, 2020, and our results of operations for the periods presented. Our financial position as of March 31, 2021 and results of operations and cash flows for the three months ended March 31, 2021 were not materially impacted by the COVID-19 pandemic but the Company is continuously assessing the evolving situation related to the pandemic. The results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for any subsequent period or for the year ending December 31, 2021 and therefore should not be relied upon as an indicator of future results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2020, we identified certain errors, including a $3.0&#160;million under-recognition of stock-based compensation expense and a $1.5&#160;million over-recognition of licensing costs for the year ended December 31, 2020. We adjusted for these items in the first quarter of 2021 and the adjustments reduced our net income (loss) by approximately $1.5&#160;million in our Condensed Consolidated Statement of Comprehensive Income (Loss) for the three months ended March 31, 2021.&lt;/span&gt;&lt;span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluated the effects of these out-of-period adjustments, both qualitatively and quantitatively, and concluded that the errors and the correction thereof were immaterial both individually and in the aggregate to the current reporting period and the periods in which they originated, including quarterly reporting.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies, Estimates and Judgments &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates, judgments and &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to, but not limited to, the useful lives of intangible assets, fair value of investments, recoverability of intangible assets, the commissions we expect to collect for each approved member cohort, valuation allowance for deferred income taxes, provision (benefit) for income taxes and the assumptions used in determining stock-based compensation. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. Actual results may differ from these estimates. There have been no material changes to our significant accounting policies discussed in our Annual Report on Form 10-K for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Seasonality &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Open enrollment periods drive the seasonality of our business. A greater number of our Medicare-related health insurance plans are sold in our fourth quarter during the Medicare annual enrollment period when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, our Medicare plan-related commission revenue is highest in our fourth quarter. Any changes or additional enrollment periods may change the seasonality of our business. For instance, due to the reintroduction of the Medicare Advantage open enrollment period that takes place in the first quarter of the year, our first quarter is generally the second-highest revenue generating quarter.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of our individual and family health insurance plans are sold in the fourth quarter during the annual open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. Individuals and families generally are not able to purchase individual and family health insurance outside of these open enrollment periods, unless they qualify for a special enrollment period as a result of certain qualifying events, such as losing employer-sponsored health insurance or moving to another state due to the recent COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Income Taxes (Topic 740) &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;In December 2019, the FASB issued ASU No. 2019-12, Income Tax, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;, which aims to simplify the accounting for income taxes. We adopted this guidance in the first quarter of 2021 and it did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; In October 2020, the FASB issued ASU No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;. ASU 2020-10 is intended to facilitate codification updates for technical corrections, such as conforming amendments, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements. It contains amendments that improve the consistency of the codification by including all disclosure guidance in the appropriate disclosure section and other updates that varies in nature. We adopted this guidance in the first quarter of 2021 with no material impact on our condensed consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Debt with Conversion and Other Options (Topic 470) and Contracts in Entity's Own Equity (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; &#x2013; In June 2020, the FASB issued ASU No. 2020-06 to simplify the accounting for convertible instruments and improve the usefulness and relevance of information regarding convertible instruments. This ASU reduces the number of accounting models for converting debt instruments and convertible preferred stock. ASU No. 2020-06 is effective for us in 2022, with early adoption permitted. We have early adopted this guidance in the first quarter of 2021 and it did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <ehth:DescriptionOfBusinessPolicyPolicyTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyNzY_ba3831e8-28a7-4200-a216-0f92c9983cb0">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;eHealth, Inc. (the &#x201c;Company,&#x201d; &#x201c;eHealth,&#x201d; &#x201c;we&#x201d; or &#x201c;us&#x201d;) is a leading health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform is designed to meet the consumer wherever they prefer to engage with us, and enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over 200 health insurance carriers across all fifty states and the District of Columbia.&lt;/span&gt;</ehth:DescriptionOfBusinessPolicyPolicyTextBlock>
    <ehth:NumberOfHealthInsuranceCarriers
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTMwMA_b04b5d47-6586-490a-8c14-756968dcddbd"
      unitRef="insurance_carrier">200</ehth:NumberOfHealthInsuranceCarriers>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTM0MA_1db0b858-fa4d-464f-b371-d2a41628f0d4"
      unitRef="state">50</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyNjk_0922650f-0ce0-4702-b49d-c355d981de97">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Basis of Presentation &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The accompanying condensed consolidated balance sheets as of March 31, 2021 and December 31, 2020 and the condensed consolidated statements of comprehensive income (loss), stockholders&#x2019; equity, and cash flows for the three months ended March 31, 2021 and 2020, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2020 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 26, 2021. The accompanying financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and reflect all normal recurring adjustments that are necessary to present fairly the results for the interim periods presented. The condensed consolidated financial statements include the accounts of eHealth, Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with those rules and regulations. Certain prior period amounts have been reclassified to conform with our current period presentation. However, we believe that the disclosures made are adequate to make the information not misleading. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 and include all adjustments necessary for the fair presentation of our financial position as of March 31, 2021 and December 31, 2020, and our results of operations for the periods presented. Our financial position as of March 31, 2021 and results of operations and cash flows for the three months ended March 31, 2021 were not materially impacted by the COVID-19 pandemic but the Company is continuously assessing the evolving situation related to the pandemic. The results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for any subsequent period or for the year ending December 31, 2021 and therefore should not be relied upon as an indicator of future results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2020, we identified certain errors, including a $3.0&#160;million under-recognition of stock-based compensation expense and a $1.5&#160;million over-recognition of licensing costs for the year ended December 31, 2020. We adjusted for these items in the first quarter of 2021 and the adjustments reduced our net income (loss) by approximately $1.5&#160;million in our Condensed Consolidated Statement of Comprehensive Income (Loss) for the three months ended March 31, 2021.&lt;/span&gt;&lt;span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluated the effects of these out-of-period adjustments, both qualitatively and quantitatively, and concluded that the errors and the correction thereof were immaterial both individually and in the aggregate to the current reporting period and the periods in which they originated, including quarterly reporting.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id2018b7213bd4f93a2804c6b1e207d62_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTA5OTUxMTkxODY5Mw_f8f52893-0037-44ce-9040-00cb777e4c6d"
      unitRef="usd">3000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:CostOfRevenue
      contextRef="i12b84f6b238d4f379f4615fedc93f6c7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTA5OTUxMTkxODY3OQ_b0608125-a5f7-41b2-9e38-88cc35fc6735"
      unitRef="usd">1500000</us-gaap:CostOfRevenue>
    <us-gaap:NetIncomeLoss
      contextRef="i5c0615329c3645ffb15c379b3b25d3f0_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTA5OTUxMTkyMDU0MA_d7fa8b8e-e522-476a-b9fc-770c921ab50b"
      unitRef="usd">-1500000</us-gaap:NetIncomeLoss>
    <us-gaap:UseOfEstimates
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyNzA_6c332c41-f6d3-4ccf-bde4-49d7a4e02887">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies, Estimates and Judgments &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates, judgments and &lt;/span&gt;assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to, but not limited to, the useful lives of intangible assets, fair value of investments, recoverability of intangible assets, the commissions we expect to collect for each approved member cohort, valuation allowance for deferred income taxes, provision (benefit) for income taxes and the assumptions used in determining stock-based compensation. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. Actual results may differ from these estimates.</us-gaap:UseOfEstimates>
    <ehth:SeasonalityPolicyPolicyTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyODQ_fc376c5d-e7f8-44f3-9aa8-a0609bb3a603">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Seasonality &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Open enrollment periods drive the seasonality of our business. A greater number of our Medicare-related health insurance plans are sold in our fourth quarter during the Medicare annual enrollment period when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, our Medicare plan-related commission revenue is highest in our fourth quarter. Any changes or additional enrollment periods may change the seasonality of our business. For instance, due to the reintroduction of the Medicare Advantage open enrollment period that takes place in the first quarter of the year, our first quarter is generally the second-highest revenue generating quarter.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of our individual and family health insurance plans are sold in the fourth quarter during the annual open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. Individuals and families generally are not able to purchase individual and family health insurance outside of these open enrollment periods, unless they qualify for a special enrollment period as a result of certain qualifying events, such as losing employer-sponsored health insurance or moving to another state due to the recent COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;</ehth:SeasonalityPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNC9mcmFnOjJkOGFhYjUyMGY3ZjQ2NzhhNzJkMzczNGNhODJkOTFiL3RleHRyZWdpb246MmQ4YWFiNTIwZjdmNDY3OGE3MmQzNzM0Y2E4MmQ5MWJfMTAyNjc_03fd60b8-d8cb-4c0e-aa7d-c5d8bebb24af">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Income Taxes (Topic 740) &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;In December 2019, the FASB issued ASU No. 2019-12, Income Tax, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;, which aims to simplify the accounting for income taxes. We adopted this guidance in the first quarter of 2021 and it did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; In October 2020, the FASB issued ASU No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;. ASU 2020-10 is intended to facilitate codification updates for technical corrections, such as conforming amendments, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements. It contains amendments that improve the consistency of the codification by including all disclosure guidance in the appropriate disclosure section and other updates that varies in nature. We adopted this guidance in the first quarter of 2021 with no material impact on our condensed consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Debt with Conversion and Other Options (Topic 470) and Contracts in Entity's Own Equity (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; &#x2013; In June 2020, the FASB issued ASU No. 2020-06 to simplify the accounting for convertible instruments and improve the usefulness and relevance of information regarding convertible instruments. This ASU reduces the number of accounting models for converting debt instruments and convertible preferred stock. ASU No. 2020-06 is effective for us in 2022, with early adoption permitted. We have early adopted this guidance in the first quarter of 2021 and it did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfMjE5OTAyMzI5MDE4OA_22953f38-6662-44bb-ba12-b87f8f0aef4b">Revenue&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below depicts the disaggregation of revenue by product and is consistent with how we evaluate our financial performance (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Supplement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Part D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Individual and Family &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-Qualified Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Qualified Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Individual and Family&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ancillary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dental&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Ancillary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commission Bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sponsorship and Advertising Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Other Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;We define our individual and family plan offerings as major medical individual and family health insurance plans, which does not include Medicare-related, small business or ancillary plans. Individual and family health insurance plans include both qualified and non-qualified plans. Qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are offered through the government-run health insurance exchange in the relevant jurisdiction. Non-qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are not offered through the exchange in the relevant jurisdiction. Individuals that purchase non-qualified health plans cannot receive a subsidy in connection with the purchase of non-qualified plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commission revenue by segment is presented in the table below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Members Approved During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Commission Revenue from Members Approved in Prior Periods&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Medicare Segment Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Individual, Family and Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Members Approved During the Period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Renewals of Small Business Members During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Commission Revenue from Members Approved in Prior Periods &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total IFP/SMB Segment Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Commission Revenue from Members Approved During the Period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Renewals of Small Business Members During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Net Commission Revenue from Members Approved in Prior Periods &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;These amounts include commission bonus revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;These amounts reflect our revised estimates of cash collections for certain members approved prior to the relevant reporting period that are recognized as adjustments to revenue within the relevant reporting period. The net adjustment revenue includes both increases in revenue for certain prior period cohorts as well as reductions in revenue for certain prior period cohorts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;The impacts of total net commission revenue from members approved in prior periods were $0.12 and $0.42 per basic share, respectively, or $0.12 and $0.40 per diluted share, respectively, for the three months ended March 31, 2021 and 2020, respectively. The total reductions to revenue from members approved in prior periods were $0.9 million&lt;/span&gt;&lt;span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;for the three months ended March 31, 2021 and immaterial for the three months ended March 31, 2020. These reductions to revenue primarily related to the Individual, Family and Small Business segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfOTI4OQ_2bab8d77-688a-45f9-b66f-714f96147da6">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below depicts the disaggregation of revenue by product and is consistent with how we evaluate our financial performance (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Supplement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Part D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Individual and Family &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-Qualified Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Qualified Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Individual and Family&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ancillary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dental&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Ancillary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commission Bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sponsorship and Advertising Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Other Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;We define our individual and family plan offerings as major medical individual and family health insurance plans, which does not include Medicare-related, small business or ancillary plans. Individual and family health insurance plans include both qualified and non-qualified plans. Qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are offered through the government-run health insurance exchange in the relevant jurisdiction. Non-qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are not offered through the exchange in the relevant jurisdiction. Individuals that purchase non-qualified health plans cannot receive a subsidy in connection with the purchase of non-qualified plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commission revenue by segment is presented in the table below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Members Approved During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Commission Revenue from Members Approved in Prior Periods&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Medicare Segment Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Individual, Family and Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Members Approved During the Period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Renewals of Small Business Members During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Commission Revenue from Members Approved in Prior Periods &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total IFP/SMB Segment Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Commission Revenue from Members Approved During the Period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Renewals of Small Business Members During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Net Commission Revenue from Members Approved in Prior Periods &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;These amounts include commission bonus revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;These amounts reflect our revised estimates of cash collections for certain members approved prior to the relevant reporting period that are recognized as adjustments to revenue within the relevant reporting period. The net adjustment revenue includes both increases in revenue for certain prior period cohorts as well as reductions in revenue for certain prior period cohorts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;The impacts of total net commission revenue from members approved in prior periods were $0.12 and $0.42 per basic share, respectively, or $0.12 and $0.40 per diluted share, respectively, for the three months ended March 31, 2021 and 2020, respectively. The total reductions to revenue from members approved in prior periods were $0.9 million&lt;/span&gt;&lt;span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;for the three months ended March 31, 2021 and immaterial for the three months ended March 31, 2020. These reductions to revenue primarily related to the Individual, Family and Small Business segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic074a03c1a5d4d7a95fc6e02d21edc3c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMy01LTEtMS0w_904a7708-bba8-4ef4-ac9a-770ef624b448"
      unitRef="usd">103525000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f37dc2286ab479b9deeec6ddbc3c296_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMy03LTEtMS0w_2e21fab0-6522-4558-96d1-b8d0b42799d4"
      unitRef="usd">68347000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia56162d3488f4c19a21ddf86ec0517c5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNC01LTEtMS0w_73ecf0c1-bc9e-4610-babf-2083d0f9f10a"
      unitRef="usd">8222000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i914b51c6a88d43f39d8a45d6ac452f9e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNC03LTEtMS0w_aca2f416-5466-412a-814d-653f7c34ed18"
      unitRef="usd">15170000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bfdbea61c3f4e42a23d93df8eba5745_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNS01LTEtMS0w_2d9477c0-ae16-4d8b-8da4-fe6ff6c822e9"
      unitRef="usd">1736000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a43b88c46a14d2586a38ff40e44b3e1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNS03LTEtMS0w_44f499fc-0394-4244-8f5b-92773b648878"
      unitRef="usd">5661000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3af61ab21d2346a89f9a5ad7aa6ccc38_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNi01LTEtMS0w_2b349e13-bd44-4fc2-9c70-79eff71b4320"
      unitRef="usd">113483000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3c7487c68db4d359d42ffe4d98f76dc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfNi03LTEtMS0w_72abc466-1b37-43be-94fa-4a4426ed5879"
      unitRef="usd">89178000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98825a9b9bd74beab1e1565f9d8c3a39_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfOC01LTEtMS0w_e242942e-a94a-4ecd-9246-735d45d40458"
      unitRef="usd">3367000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c1c83a033544814919a8b29643cf827_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfOC03LTEtMS0w_a3fd5629-379a-429e-b955-400e2f7ed672"
      unitRef="usd">1446000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0df0a17281e45098fa957d99e0eda7e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfOS01LTEtMS0w_6b8c13c8-7e2f-4996-94cb-a43e21f4a22e"
      unitRef="usd">2100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i766e68295a1640f6bfa0ebbffa00c23d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfOS03LTEtMS0w_7799db9d-648a-479b-816e-aeadd51764be"
      unitRef="usd">1210000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38748c1b62c34305b0a1a89a4df6b8df_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTAtNS0xLTEtMA_c9284165-5671-4aee-942b-81a2d4b55796"
      unitRef="usd">5467000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia063259a108742fa90b79bd2bb186380_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTAtNy0xLTEtMA_111a3316-9500-403d-9224-78dfe71b70e5"
      unitRef="usd">2656000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5cb65108e971405598e91d213801b128_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTItNS0xLTEtMA_772538aa-0e6e-4f27-9e16-44e574815866"
      unitRef="usd">1756000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69d8365ca0b4435c8c9fc4bfcb26c1e5_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTItNy0xLTEtMA_47ba4d31-fdc1-4bee-bf3d-280bd8909c6a"
      unitRef="usd">2216000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8437e53979d64bf498cbace5ca6b66f7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTMtNS0xLTEtMA_a49f623b-3a13-4443-8c48-de215abd9509"
      unitRef="usd">1728000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b8fb9dde9d741ea8f3aa61c942f3b55_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTMtNy0xLTEtMA_dc6205b2-edd1-49e0-9d40-cb0262b4b6bb"
      unitRef="usd">743000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73b6352f11b648d2b4bf5b5a9da1bc8e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTQtNS0xLTEtMA_964e1652-d11d-4043-862f-f9d510721a1c"
      unitRef="usd">205000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4b97cd36b9948c1b9d6366c24f2829f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTQtNy0xLTEtMA_34bb003f-2f72-476a-9e01-1e18cd59b224"
      unitRef="usd">243000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3aa9fda678445a3bd10fe0b7fd75046_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTUtNS0xLTEtMA_473bce12-2373-4503-8335-ffa9f2e8e042"
      unitRef="usd">35000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i056610eba6074846ae406d019066f627_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTUtNy0xLTEtMA_9035accf-48e3-419f-965b-3dde1fa75493"
      unitRef="usd">1049000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1faf373456cf44dc92cec480bfe789a7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTYtNS0xLTEtMA_a2af46a5-643b-45aa-b752-4c9d21f5fd02"
      unitRef="usd">3724000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0a023d993134272a9b194c6b2030640_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTYtNy0xLTEtMA_f4279a71-aecc-4687-aa0c-4f4cd832b6be"
      unitRef="usd">4251000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibeba0cba96b145f09097dbdfa7c23a18_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTctNS0xLTEtMA_b8b1786c-61b3-42b1-bc18-bbc51789ca21"
      unitRef="usd">3223000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d34909e75b34d79ba8c25ed29d1868c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTctNy0xLTEtMA_6fe27807-a556-4c90-ac29-172eecb9e5a2"
      unitRef="usd">2971000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c7afb8d32cb44aaad349d4aed1c13de_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTgtNS0xLTEtMA_e7d97bb2-5140-4c46-b821-cca652519a2b"
      unitRef="usd">1155000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1a4a92ac7d845c1abccf7a138083679_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTgtNy0xLTEtMA_2b218ea1-ae4b-4630-bdf3-6b834a38da79"
      unitRef="usd">613000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8337239e8dda4274bdb5081198725cf8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTktNS0xLTEtMA_cc830ac2-0ca3-4860-9278-1366afb66d90"
      unitRef="usd">127052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a17b2f577fb4a0994b259f4a7c00fac_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMTktNy0xLTEtMA_7ca5f58d-96c8-4f79-ad55-d3ed08e8b058"
      unitRef="usd">99669000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19c1136bfda347ce93cbbd8ef6c0fd36_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjEtNS0xLTEtMjg5_13126855-dc41-4dd5-b518-fd996102a8b9"
      unitRef="usd">5814000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i086deedc14e2467498f875d11fdb3e28_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjEtNy0xLTEtMjg5_876c7267-5a3f-4874-8b15-24211a6eed7c"
      unitRef="usd">5890000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i392771caeedf4c20a1e28f80da41f0a1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjItNS0xLTEtMjg5_cf2a668a-4ad9-49c6-b877-3dfe47cd638c"
      unitRef="usd">1348000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12c4bfe5dd12406b951b26fdaa6cc5f3_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjItNy0xLTEtMjg5_5098ddb0-6197-4bfc-b855-8742fb9761d7"
      unitRef="usd">849000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8680ff82e8684663ac818bd969dadd40_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjAtNS0xLTEtMA_b1d5738b-f76e-417d-ad1d-5ff92b6018ad"
      unitRef="usd">7162000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5fe1a9fc09dc4d98894c2f05859cd3f1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjAtNy0xLTEtMA_f1a12999-18da-460e-8101-107ecc11d8bb"
      unitRef="usd">6739000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjEtNS0xLTEtMA_8ff72da2-9090-4cf8-b572-03d276d2fb81"
      unitRef="usd">134214000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjU0NTdlYWMzOTg5NTQxMzk4MjAyNjQ2NjUwYWUyYTZjL3RhYmxlcmFuZ2U6NTQ1N2VhYzM5ODk1NDEzOTgyMDI2NDY2NTBhZTJhNmNfMjEtNy0xLTEtMA_5d17b2a7-33a2-4f92-a5cf-16a53dbc5f45"
      unitRef="usd">106408000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i258c42ec705f4ce991947aa47fbbbf47_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMy01LTEtMS0w_41346393-8e9d-45fb-8a82-e44a8869ff14"
      unitRef="usd">114678000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie95c786e8b374e319d0e49801d852c1d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMy03LTEtMS0w_8c1e22ad-b3fa-447a-a998-9737557e89a2"
      unitRef="usd">81125000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7447592d6f934de2add1f16c34c68de4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNC01LTEtMS0w_677b793b-5d8a-461a-b894-74c1d56190ef"
      unitRef="usd">14000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0569d360651844759fd84f9324b1f5fc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNC03LTEtMS0w_fdb7e8a9-33a8-470f-aa32-72fb55ea0f36"
      unitRef="usd">8979000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0dd2975216654605bebf75779fff0768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNS01LTEtMS0w_f654b376-3953-430a-8cf1-b87c4bc0e578"
      unitRef="usd">114692000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82877d4449c844be8040697eb7839adb_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNS03LTEtMS0w_4a711268-cb9e-46e4-9241-abb322f25c45"
      unitRef="usd">90104000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide29d460660a40fc90b884baf4856429_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNy01LTEtMS0w_ec6fdaeb-560c-4963-b9e0-2547ce1cbdf4"
      unitRef="usd">6395000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f0172f4e15b46b8a18d6d683e1893e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfNy03LTEtMS0w_0a0dbe2e-dedb-41c7-98cf-db5ef1507900"
      unitRef="usd">5796000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4cba655be2dc465f92495dc76b412c95_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOC01LTEtMS00Njcw_376baa27-8f71-43ae-9788-ac4483413a5d"
      unitRef="usd">2687000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb2d1cb13bc848d4926601ef8f33c966_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOC03LTEtMS00Njcw_9e49d45e-f12e-43b4-a32b-46965d232b0d"
      unitRef="usd">2396000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie454fda4a6da410c90ae24e2c79aa917_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOC01LTEtMS0w_41cc5866-e2ca-4f6a-b684-6082648fb2db"
      unitRef="usd">3278000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2561ea4ce6f450684892494464adbb2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOC03LTEtMS0w_4cfaff8a-bf0f-49a7-945e-6b3eef837af1"
      unitRef="usd">1373000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ead011a22aa4528839846da9fa5ebba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOS01LTEtMS0w_61d95c55-8054-4f28-9f30-d1b1fb5819ba"
      unitRef="usd">12360000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a9a800e930241a2b680d5d254a9937d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfOS03LTEtMS0w_bae3b922-b733-4199-9704-9d4b047a1dd2"
      unitRef="usd">9565000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i673d5b337f984e35bd708e9c6d0ad645_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTEtNS0xLTEtMA_08ca2e5b-12f7-4dbf-80fe-0916efe8c9fe"
      unitRef="usd">121073000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib431ec26de88456f8bb27169dbd5532e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTEtNy0xLTEtMA_8d17c961-80e2-4753-931d-b07ac8af3003"
      unitRef="usd">86921000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6501103b1abc4417b6d24bb9f56e71a3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTMtNS0xLTEtNjkyNg_24ca3690-8f88-4dfa-b31b-984897925480"
      unitRef="usd">2687000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcc531094265425da2fe8fba9f7dd2bd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTMtNy0xLTEtNjkyNg_c080fec1-ec20-46ef-83e9-b8b9db8a06c5"
      unitRef="usd">2396000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32bc9e31d57342a5a9f949dcac3eea99_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTItNS0xLTEtMA_ab8c5819-30c5-410e-b342-21d76023b45a"
      unitRef="usd">3292000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i734d6738ac914fbf9d7214b291481a87_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTItNy0xLTEtMA_984f0b9e-1abd-4ca2-8ef3-b6a99000ab72"
      unitRef="usd">10352000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8337239e8dda4274bdb5081198725cf8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTMtNS0xLTEtMA_f532aadb-427f-4cdb-9fa9-52a88ac776d0"
      unitRef="usd">127052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a17b2f577fb4a0994b259f4a7c00fac_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RhYmxlOjcwYzdiMGY3NjgyMjQzMjRhNjRiNjE5NGQwN2E5OWRlL3RhYmxlcmFuZ2U6NzBjN2IwZjc2ODIyNDMyNGE2NGI2MTk0ZDA3YTk5ZGVfMTMtNy0xLTEtMA_4374419a-a696-4e62-8096-aacd8c1aad5a"
      unitRef="usd">99669000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="i32bc9e31d57342a5a9f949dcac3eea99_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfODkzNg_7cf2ce08-5503-40d8-b220-3fc44bbf8b91"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i734d6738ac914fbf9d7214b291481a87_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfODk0Mw_298cc321-12b0-4a10-bf1f-d7a0178c5ad3"
      unitRef="usdPerShare">0.42</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i32bc9e31d57342a5a9f949dcac3eea99_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfOTAwMw_dcc6078b-21e2-438e-bc39-8f79f35543fd"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i734d6738ac914fbf9d7214b291481a87_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfMzI5ODUzNDg5NTE4MA_c3585eff-0c35-4215-bc7a-a805fced09e5"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareDiluted>
    <ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie454fda4a6da410c90ae24e2c79aa917_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8zNy9mcmFnOjM1MTZiODU0MGM1MTQ5ZGZhNTg3NDI1NjMwMTA3MzE5L3RleHRyZWdpb246MzUxNmI4NTQwYzUxNDlkZmE1ODc0MjU2MzAxMDczMTlfMzI5ODUzNDkxODQ0NQ_9964e644-ac5d-4d35-b924-f95c646a24dd"
      unitRef="usd">900000</ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDIwNQ_57305c83-3ecd-463c-9f30-864448d773a8">Supplemental Financial Statement Information&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all investments with an original maturity of 90 days or less from the date of purchase to be cash equivalents. Cash and cash equivalents are stated at fair value. We also invest in marketable securities that are measured and recorded at fair value. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further discussion about our marketable securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2021 and December 31, 2020, we had $3.4 million of restricted cash which was classified as a non-current asset on our Condensed Consolidated Balance Sheets. This amount collateralizes letters of credit related to certain lease commitments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Assets and Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not require collateral or other security for our contract assets and accounts receivable. We believe the potential for collection issues with any of our customers was minimal as of March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We estimate an allowance for credit losses using relevant available information from internal and external sources, related to past events, current conditions, and reasonable and supportable forecasts. Specifically, for the purpose of measuring the probability of default parameters, we utilize Capital IQ&#x2019;s, Standard &amp;amp; Poor&#x2019;s and Moody&#x2019;s analytics. Our estimates of loss given default are determined by using our historical collections data as well as historical information obtained through our research and review of other insurance related companies. Our estimated exposure at default is determined by applying these internal and external data sources to our commission receivable balances. As such, we apply an immediate reversion method and revert to historical loss information when computing our credit loss exposure. Credit loss expenses are assessed quarterly and included in general and administrative expense on our Condensed Consolidated Statement of Comprehensive Income (Loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We considered the impact of recent events and global economic conditions when evaluating the appropriate adjustments to our allowance for credit losses as of March 31, 2021. Determining the extent of these adjustments in the three months ended March 31, 2021 was especially challenging because we do not have any historical loss information for a period of similar economic uncertainty. We also considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the allowance for credit losses for the three months ended March 31, 2021 is summarized as follows (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.199%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contract assets &#x2013; commission receivable activities, net of credit loss allowances&#160;are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Medicare Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;IFP/SMB Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from members approved during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from renewals of small business members during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net commission revenue adjustments from members approved in prior period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash receipts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in credit loss allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Medicare Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;IFP/SMB Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from members approved during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from renewals of small business members during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net commission revenue adjustments from members approved in prior period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash receipts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in credit loss allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;560,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments that are exposed to concentrations of credit risk principally consist of cash, cash equivalents, marketable securities, contract assets &#x2013; commissions receivable, and accounts receivable. We invest our cash and cash equivalents with major banks and financial institutions and, at times, such investments are in excess of federally insured limits. We also have deposits with major banks in China that are denominated in both U.S. dollars and Chinese Yuan Renminbi and are not insured by the U.S. federal government. The deposits in China were $3.5&#160;million as of March 31, 2021. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information regarding our marketable securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not require collateral or other security for either our contract assets or accounts receivable. Carriers that represented 10% or more of our total contract assets and accounts receivable balance are summarized as of the dates presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UnitedHealthCare &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Humana&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aetna&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centene &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Percentages include the carriers' subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the contract assets and accounts receivable of WellCare are included in the percentage calculation for March 31, 2021 and December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid Expenses and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Current&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets &#x2013; Our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prepaid expenses and other current assets are summarized as of the periods presented as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid maintenance contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDE5MA_db892946-4683-4444-ba86-4b2c5a41d143">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDE5Nw_b151988c-36f7-40db-bb41-471d58bcbfd1">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:Cash
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMS0xLTEtMS0w_c95ebc0d-3609-455d-8785-8df4559cda44"
      unitRef="usd">72326000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMS0zLTEtMS0w_cd8cca08-4250-4903-b043-114e220eaa8d"
      unitRef="usd">39552000</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMi0xLTEtMS0w_47ae4b10-ff8e-4aec-9968-941f9b139c14"
      unitRef="usd">19924000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMi0zLTEtMS0w_af049e99-3773-4163-886d-41785d0c7196"
      unitRef="usd">4207000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMy0xLTEtMS01Nzk_d3032a91-687e-4d55-beab-5af989bc79c5"
      unitRef="usd">92250000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMy0zLTEtMS01Nzk_0c74210c-c116-4e98-8d3f-93ffd091edcf"
      unitRef="usd">43759000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMy0xLTEtMS0w_7a99379e-8726-49cc-b2a2-7f8c9eb44056"
      unitRef="usd">3354000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfMy0zLTEtMS0w_b8f3ce07-3b90-4a61-abe6-d414184d1e4d"
      unitRef="usd">3354000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfNC0xLTEtMS0w_f058d99f-a443-4b98-990a-c2c9bae48230"
      unitRef="usd">95604000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmI3MDQ1YjZlMzIzYjRhYWViMGEzMmUwZTA3MzFmMWMzL3RhYmxlcmFuZ2U6YjcwNDViNmUzMjNiNGFhZWIwYTMyZTBlMDczMWYxYzNfNC0zLTEtMS0w_031078c1-8803-43cb-b0e1-02cb467702f7"
      unitRef="usd">47113000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNTMw_1e8f0e7c-7b92-4562-9d04-1705b01cb453"
      unitRef="usd">3400000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNTMw_9caa1a27-6cc5-4d58-ac31-6221f02e425f"
      unitRef="usd">3400000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfMjE5OTAyMzI2MTYzMQ_141265cf-e07b-48e2-ab49-c966aeb11e9b">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the allowance for credit losses for the three months ended March 31, 2021 is summarized as follows (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.199%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock>
    <us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjQxYjg1NzlkNzI0NjQ0MmZiYzFkZmZhOTlmOTRlOGRkL3RhYmxlcmFuZ2U6NDFiODU3OWQ3MjQ2NDQyZmJjMWRmZmE5OWY5NGU4ZGRfMi0xLTEtMS0zNTY_4dc1b4db-9531-4fe8-8440-c5fd15279252"
      unitRef="usd">2026000</us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjQxYjg1NzlkNzI0NjQ0MmZiYzFkZmZhOTlmOTRlOGRkL3RhYmxlcmFuZ2U6NDFiODU3OWQ3MjQ2NDQyZmJjMWRmZmE5OWY5NGU4ZGRfNi0xLTEtMS00NzYw_3afd2c35-fbd2-4989-9e0a-68e586f9b79d"
      unitRef="usd">78000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjQxYjg1NzlkNzI0NjQ0MmZiYzFkZmZhOTlmOTRlOGRkL3RhYmxlcmFuZ2U6NDFiODU3OWQ3MjQ2NDQyZmJjMWRmZmE5OWY5NGU4ZGRfOC0xLTEtMS0zNTY_dce2b1fb-467e-46a8-9a0d-fad988af04c4"
      unitRef="usd">1948000</us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDE4Ng_00f4c813-ec17-45aa-9c59-c3a228f9e3dd">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contract assets &#x2013; commission receivable activities, net of credit loss allowances&#160;are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Medicare Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;IFP/SMB Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from members approved during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from renewals of small business members during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net commission revenue adjustments from members approved in prior period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash receipts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in credit loss allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Medicare Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;IFP/SMB Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from members approved during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from renewals of small business members during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net commission revenue adjustments from members approved in prior period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash receipts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in credit loss allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;560,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;(1)Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item.</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i33ff039155da47c1bac390800f28d958_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMi0xLTEtMS0w_32c82531-3807-4e82-8b8d-a36f16caf3e0"
      unitRef="usd">739637000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="id999ede8247d4775b2a9495082649e71_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMi0zLTEtMS0w_a4239ced-efd4-41fd-b08e-0c3aa3354319"
      unitRef="usd">52768000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMi01LTEtMS0w_2dada280-34a0-4a6c-878a-ac63ee36525e"
      unitRef="usd">792405000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i258c42ec705f4ce991947aa47fbbbf47_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMy0xLTEtMS0w_8d08c9df-4024-48f9-a0b6-01a6020b58e4"
      unitRef="usd">114678000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide29d460660a40fc90b884baf4856429_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMy0zLTEtMS0w_95cf9c24-4d9f-495a-bbcc-1a67027fa877"
      unitRef="usd">6395000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i673d5b337f984e35bd708e9c6d0ad645_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfMy01LTEtMS0w_a42f4a3d-d694-49c4-8c16-6b16828d4cfe"
      unitRef="usd">121073000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc9590a5ab4145079eec4462d026a62f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC0xLTEtMS01NjE1_cfd617b1-f3a7-4b4c-9a6f-95ccbc6fa870"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4cba655be2dc465f92495dc76b412c95_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC0zLTEtMS01NjE1_629deb74-82eb-48af-a5fc-ac67be61edc3"
      unitRef="usd">2687000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6501103b1abc4417b6d24bb9f56e71a3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC01LTEtMS01NjE1_ea9c47be-a72e-4106-932c-d2067cc0c904"
      unitRef="usd">2687000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7447592d6f934de2add1f16c34c68de4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC0xLTEtMS0w_627b45a8-1c25-4ca3-af60-e937142ead9b"
      unitRef="usd">14000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie454fda4a6da410c90ae24e2c79aa917_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC0zLTEtMS0w_bff76894-7a54-4eb1-a050-4827146896db"
      unitRef="usd">3278000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32bc9e31d57342a5a9f949dcac3eea99_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNC01LTEtMS0w_c9b7830d-a473-4eb6-8a09-1cdf18a5c69d"
      unitRef="usd">3292000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="ieffd4f331de646efb6782e0777c3b8c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNS0xLTEtMS0w_22158226-fdae-49bc-ad2e-3e7291f83be2"
      unitRef="usd">165520000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="i8b23f8c9553a4acb92f22c678a011ded_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNS0zLTEtMS0w_9207f5d2-4f54-4562-8251-aba4db902b6c"
      unitRef="usd">12012000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNS01LTEtMS0w_966bc4f4-435a-4454-b6dc-c3f825a693c0"
      unitRef="usd">177532000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="ieffd4f331de646efb6782e0777c3b8c2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNi0xLTEtMS0w_36d67474-b338-4855-be6c-32fde30714bf"
      unitRef="usd">-72000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i8b23f8c9553a4acb92f22c678a011ded_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNi0zLTEtMS0w_db7c60d4-79a5-4049-9758-d3151e3b920b"
      unitRef="usd">-6000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNi01LTEtMS0w_ec070507-2db2-4240-b63b-a1473a1dd254"
      unitRef="usd">-78000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="id93a27ec2b354123ac129b85e58d6a9a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNy0xLTEtMS0w_ff99ae60-b835-4c80-87fd-16540962a49c"
      unitRef="usd">688737000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ice1fcaf5d15c4b1ea8e6b1988490be33_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNy0zLTEtMS0w_393bd74e-5658-4d49-9aa7-62470a0bacc8"
      unitRef="usd">53110000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmYzZjIyNmE0N2U0MzQ0Nzc5NjE0ZWI5MzlkM2UyOGM0L3RhYmxlcmFuZ2U6ZjNmMjI2YTQ3ZTQzNDQ3Nzk2MTRlYjkzOWQzZTI4YzRfNy01LTEtMS0w_f55e397f-4bf5-4b36-95d3-ba686402d6f4"
      unitRef="usd">741847000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i40741e0095b1456aac94b2215f85e8da_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMi0xLTEtMS0w_0974e004-25b0-4442-b02e-3ddfa8b5e0d0"
      unitRef="usd">550922000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i6501121272e7438dbfacad9d5f209af7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMi0zLTEtMS0w_07ea16fb-a01b-44a8-b50a-559b4fd717f7"
      unitRef="usd">38300000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i283d90d05c8744f3a67f23305e4f839c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMi01LTEtMS0w_005bb259-2c2c-44cf-ac71-a0309703d432"
      unitRef="usd">589222000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie95c786e8b374e319d0e49801d852c1d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMy0xLTEtMS0w_3616fd20-2d16-4e5f-a2dc-d55a29be6b68"
      unitRef="usd">81125000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f0172f4e15b46b8a18d6d683e1893e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMy0zLTEtMS0w_afcfe323-43b7-4179-ae20-95f896f45cf2"
      unitRef="usd">5796000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib431ec26de88456f8bb27169dbd5532e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfMy01LTEtMS0w_5bb40364-d1e9-4b90-9537-5bdb52068c4f"
      unitRef="usd">86921000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffc7786d6a3b4b88a4fe78c3c639b879_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC0xLTEtMS01NjIw_348300b8-3048-427f-9d28-b2840b29a7b4"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb2d1cb13bc848d4926601ef8f33c966_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC0zLTEtMS01NjIw_a2753472-c69c-4377-888a-acbc40af3c90"
      unitRef="usd">2396000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcc531094265425da2fe8fba9f7dd2bd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC01LTEtMS01NjIw_3bda2770-703b-4d92-9819-d9e449244286"
      unitRef="usd">2396000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0569d360651844759fd84f9324b1f5fc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC0xLTEtMS0w_a869f6b7-c9aa-4b4c-88cd-309c63aac521"
      unitRef="usd">8979000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2561ea4ce6f450684892494464adbb2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC0zLTEtMS0w_7aa95694-adf9-41fa-820a-a531baaa06b7"
      unitRef="usd">1373000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i734d6738ac914fbf9d7214b291481a87_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNC01LTEtMS0w_54fbcb1b-ed0b-43c7-abec-09a290ee5f77"
      unitRef="usd">10352000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="ida736d90cfd14b6287fb18903e493b76_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNS0xLTEtMS0w_aa919d48-c747-4f5f-99d4-61ddf128cf1a"
      unitRef="usd">112731000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="i7c282c2b9a3a4f2da838e7c285e04bde_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNS0zLTEtMS0w_c42d9ee5-0545-4181-94ec-5835cd3d02f3"
      unitRef="usd">13811000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNS01LTEtMS0w_f2b3adfb-723b-4c2b-8e03-139f364f62f6"
      unitRef="usd">126542000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="ida736d90cfd14b6287fb18903e493b76_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNi0xLTEtMS0w_f74e006f-64d3-47e0-bc8b-d5f53348981e"
      unitRef="usd">-1574000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i7c282c2b9a3a4f2da838e7c285e04bde_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNi0zLTEtMS0w_bc75af91-cd79-4b6d-b89a-f44573396f99"
      unitRef="usd">-58000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNi01LTEtMS0w_cb891a9e-f2c0-4401-8052-b5ad946edecb"
      unitRef="usd">-1632000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i88b0f87d92a74c6aa41c7e6b1c891758_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNy0xLTEtMS0w_595ebbed-0c10-4b66-8a8a-f63eb9b4314d"
      unitRef="usd">526721000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ic62f4e5ed1c64cc5aa09a9d6a29086c8_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNy0zLTEtMS0w_4d7ec6e5-ffe6-4721-9a3c-ef050157a54c"
      unitRef="usd">33996000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i94e4cd2c63294501a97ce58cbb8f0ad9_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOmQ5YjgzY2VkY2Q1OTQ1Y2NhZjllZjY0NWYwMjA5M2E0L3RhYmxlcmFuZ2U6ZDliODNjZWRjZDU5NDVjY2FmOWVmNjQ1ZjAyMDkzYTRfNy01LTEtMS0w_e55334bb-300c-49a8-8f61-eeea56be33f7"
      unitRef="usd">560717000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:Deposits
      contextRef="i82364b4b38294beeabf364cb83d2dfb2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfMzY0Nw_0e9b2e60-e86e-40ea-8bfa-5255e3a7ca51"
      unitRef="usd">3500000</us-gaap:Deposits>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDE4Nw_eae5a30d-cfee-4ff7-94f7-5b00a6a1bc5c">Carriers that represented 10% or more of our total contract assets and accounts receivable balance are summarized as of the dates presented below:&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UnitedHealthCare &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Humana&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aetna&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centene &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Percentages include the carriers' subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the contract assets and accounts receivable of WellCare are included in the percentage calculation for March 31, 2021 and December 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibcc2eede21d74403b2556f36cea8967e_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMS0xLTEtMS00Njk1_2ddbbf07-c5d5-434c-b772-c150ee5758c0"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i745034ccac204d289da6154afd851a9b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMS0zLTEtMS00Njk1_b01de63f-1122-4214-8307-cf6c0ba24199"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1c027fa629114f34973fe988abef44d2_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMS0xLTEtMS0w_415a982c-786c-4516-89d1-32e4dd316148"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5a0875b0633646fe8e4a223242ab0547_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMS0zLTEtMS0w_29298a1f-3186-49ae-93bc-971224a163e5"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib0b72a5d261d4ed3a6a247dab5e66565_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMi0xLTEtMS0w_92f8414c-0ac2-457f-8306-50661871df87"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic698507ebbbe479bafd6c12cc0b40d70_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfMi0zLTEtMS0w_a33095df-6257-491f-9bde-294eaba4daa8"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i41d2536fcee54432bbf4d763116ab430_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfNC0xLTEtMS02NzE2_27bb63b6-9ac4-4aae-b194-84a8e19c3ed5"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id692f7a929c543f88a8ba8e371f1ec69_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjljNjFjNmVmMDE0ZjRhMDVhYmE1NTk3NmI1N2IyYmQ5L3RhYmxlcmFuZ2U6OWM2MWM2ZWYwMTRmNGEwNWFiYTU1OTc2YjU3YjJiZDlfNC0zLTEtMS02NzIw_b0a3f894-f17a-40c8-96c5-7363f3b65df3"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RleHRyZWdpb246NjhmZWYwNjI0MTZiNDNlYzllYmNlNmUzMWQyYTg2ZTJfNDE4OA_57b868cf-f55c-4654-9907-335d24a7a69f">Our prepaid expenses and other current assets are summarized as of the periods presented as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid maintenance contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <ehth:PrepaidMaintenanceContractsCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMS0xLTEtMS0w_f6384927-aa16-4843-ab69-ebb7a3c6afe6"
      unitRef="usd">6583000</ehth:PrepaidMaintenanceContractsCurrent>
    <ehth:PrepaidMaintenanceContractsCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMS0zLTEtMS0w_a3ec2414-333e-4229-a7da-84ec5edbd9fd"
      unitRef="usd">7715000</ehth:PrepaidMaintenanceContractsCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMi0xLTEtMS0w_0ecead4e-19d2-4bc1-a6f6-cd5290d14c5f"
      unitRef="usd">4095000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMi0zLTEtMS0w_cbe56538-8f5b-4ed3-93ff-8a2dced0484b"
      unitRef="usd">6628000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidInsurance
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMy0xLTEtMS0w_00daac50-4a30-4842-97b2-0070b6522eed"
      unitRef="usd">1031000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfMy0zLTEtMS0w_421c3ca5-6fec-4210-9c30-dfbf9b051713"
      unitRef="usd">1672000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfNi0xLTEtMS0w_de0456d2-778a-46a6-8f82-e85abd37cb01"
      unitRef="usd">616000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfNi0zLTEtMS0w_8ebda092-c9cc-4ea5-ae4f-2c6f8f5d74a3"
      unitRef="usd">646000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfNy0xLTEtMS0w_e84522f9-695e-448e-85f6-38a3f25182d8"
      unitRef="usd">12325000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80My9mcmFnOjY4ZmVmMDYyNDE2YjQzZWM5ZWJjZTZlMzFkMmE4NmUyL3RhYmxlOjY2MzYyNGJhMjFjMDRhN2ViZjE1ZDZlMDc1ZWJjZGE4L3RhYmxlcmFuZ2U6NjYzNjI0YmEyMWMwNGE3ZWJmMTVkNmUwNzVlYmNkYThfNy0zLTEtMS0w_653988bc-a5a0-4959-98d3-34346b4438e9"
      unitRef="usd">16661000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMzEyMw_2dd6541c-0f08-4153-89d0-0e4b42435b92">Fair Value Measurements&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We define fair value as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques we use to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. We classify the inputs used to measure fair value into the following hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unobservable inputs for the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial assets measured at fair value on a recurring basis are summarized below by their classification within the fair value hierarchy as of the dates presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cash equivalents were invested in money market funds and commercial paper with original maturity of 90 days or less were classified as Level 1. We endeavor to utilize the best available information in measuring fair value. We used observable prices in active markets in determining the classification of our money market funds as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2021, our Level 2 assets included our available for sale marketable securities, which consisted of commercial paper and agency bonds with maturity less than one year. We classify our marketable debt securities within Level 2 in the fair value hierarchy, because we use quoted market prices to the extent available or alternative pricing sources and models utilizing market observable inputs to determine fair value. Our portfolio primarily consisted of financial instruments with a credit rating of AA or equivalent by S&amp;amp;P Rating and Moody's Investor Services. There were no transfers between the hierarchy levels during the three months ended March 31, 2021 and year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our cash equivalents and available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1 year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized gains and losses on available-for-sale debt securities that are not credit related are included in accumulated other comprehensive income and summarized as follows as of March 31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As of March 31, 2021, there were twelve securities in net loss positions and their unrealized losses were immaterial. We did not record any credit losses regarding our available-for-sales debt securities during the three months ended March 31, 2021. We do not intend to sell these securities and it is more likely than not that we will not be required to sell these securities before the recovery of their amortized cost basis.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMzEyMQ_249d6bd3-495d-4319-8d44-54aebe9a41c1">We classify the inputs used to measure fair value into the following hierarchy:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unobservable inputs for the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMzEzMw_1397981d-2bc6-4a08-b4e1-d37188fabe4b">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial assets measured at fair value on a recurring basis are summarized below by their classification within the fair value hierarchy as of the dates presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ifad24860642c447f8be6b0786b6192d9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNC0xLTEtMS0w_df75e609-120f-4996-946b-1504c244da28"
      unitRef="usd">5602000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0448f7480d204667af54338f775f2ae4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNC0zLTEtMS0w_fbcfb11e-ddb2-4f20-9341-b23f1594c0c9"
      unitRef="usd">5602000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie6e65f9607874cf7b91a607047873439_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNC01LTEtMS0w_854a17fa-2575-4e79-9043-a331d46e9d38"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i78e297ab8ca948aeaf86a525f773e4dc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNC03LTEtMS0w_82a07798-bbce-4e2f-874f-0c3218c8bb97"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i838a01c8c51c489fb25f65450a703cb5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNC05LTEtMS0w_d3aee546-5894-4a34-a806-a241f3633fd2"
      unitRef="usd">5602000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie413cb59abe441fba3e0b2a4bb9dc04e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNS0xLTEtMS0w_70e93ebe-14ef-4701-a147-b2d5df20b768"
      unitRef="usd">14322000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7e6a517c6ba84088a72a30f5e9d287b3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNS0zLTEtMS0w_dbcf9b11-24a5-4a8b-959f-34792f008262"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iaf9be97cab2640ed84bd86ad77f9d205_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNS01LTEtMS0w_da9624c2-5d7b-48ff-9d20-25ac1605a4d4"
      unitRef="usd">14322000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2f32284f7468465fad0a56de1b2e5c6b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNS03LTEtMS0w_27d21aa2-4596-4da9-8fe1-0c7068104727"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia4c8e440d2f64e6399fa1adc1002bb2e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfNS05LTEtMS0w_a58bcd50-0768-4984-9991-ba96387e99fb"
      unitRef="usd">14322000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i2303fe7994cf42d1b268b27bc2a7c119_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC0xLTEtMS02ODAy_ec15a47a-25dc-4f9d-97d6-7766e51fc699"
      unitRef="usd">26826000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8935e0f0e3b647c0bca26a9f197dc6ef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC0zLTEtMS02ODAy_fe5ca7b4-b158-45be-a9c5-c5187f87d530"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i593cfa44a23f4636b9ad96eb4e4a80e1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC01LTEtMS02ODAy_f820f652-4088-43db-a85b-27bc0d894b1a"
      unitRef="usd">26826000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i929513fba5e248fb98922bd0516e124c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC03LTEtMS02ODAy_16c84a36-82ca-42f2-932c-a7542854d0fb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i02a6624511a64fcf98ef80ed91927f61_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC05LTEtMS02ODAy_c85f6f62-ca54-40ee-97ff-17f5f8786780"
      unitRef="usd">26826000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4d2f66f410ea4bf19367fa5bed725fe8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC0xLTEtMS0w_6b3bdc96-b6c3-4941-95b3-61c3e2c98435"
      unitRef="usd">7096000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i1adbea6e18d34c05afe06e141815262b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC0zLTEtMS0w_43d947c3-0d58-44fa-b527-2c19ac66b03c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ifc820c7319514d4cbf55712548350db5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC01LTEtMS0w_f36a8de2-6b14-4efa-b445-5e50024fb8aa"
      unitRef="usd">7096000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8d090e9d3465481c959ca1ca4c0ad0bf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC03LTEtMS0w_c3195110-a9be-43e7-a8aa-0b21a1c83c6c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i14c5f8eba33b414c8e7ed0c7d2de5aa6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfOC05LTEtMS0w_9bc05b1b-f205-4d00-a6a0-260ff20e50a1"
      unitRef="usd">7096000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5665cbe280f449b7906c5831fa1e3d59_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfMTMtMS0xLTEtMA_fd28195b-0971-4daa-89ed-ed5261e07796"
      unitRef="usd">53846000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7a5410f369fa4fe6b29e53a1e38b9c4e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfMTMtMy0xLTEtMA_f8bbd352-c364-43fc-aadc-c025d972b2b7"
      unitRef="usd">5602000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i48cb251ac11344e78669d7f080d49c43_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfMTMtNS0xLTEtMA_4eb4de71-1eed-44ab-acbe-9334a00b42b0"
      unitRef="usd">48244000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7fb33dbb73bf4f02a5ffec5640fa31c9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfMTMtNy0xLTEtMA_bb39a76f-d8b0-4186-b5d2-b1b229cc5e55"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5ea53ab5f7ec479683fa4b9a5645b576_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOjVkZjc0OGJmZjhlYjRkMDdiYzk2YjFiZjRhYjFhNTI1L3RhYmxlcmFuZ2U6NWRmNzQ4YmZmOGViNGQwN2JjOTZiMWJmNGFiMWE1MjVfMTMtOS0xLTEtMA_822bcdf6-2199-485d-9969-047e7da6c1af"
      unitRef="usd">53846000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6ed7325f8ced428d818fce32b031d79b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNC0xLTEtMS02Nzg_8275f305-a815-4ef1-82f9-92e0a482bd8f"
      unitRef="usd">4207000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i18ff6074d86849a5b23047e339437eda_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNC0zLTEtMS02Nzg_b82f2342-9908-4558-9e8e-a2be4513324c"
      unitRef="usd">4207000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie93a9074eb224ae4ab49ad9db008e5ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNC01LTEtMS02Nzg_665aa89c-264e-4885-ae60-20a151ef1138"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i73e0b97fc5864480b5903a29a54557b2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNC03LTEtMS02Nzg_d4ca89b6-a917-484d-af37-1c5ac2c87c4f"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4c9b517443d64a00aba7aff3b698c11f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNC05LTEtMS02Nzg_ca62fdb6-78a4-487b-948b-8cdec1a7d76e"
      unitRef="usd">4207000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="id666b5ba6f9f42f8a0cf56c4b398bcc8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy0xLTEtMS02ODA3_5159737c-7c8e-40da-8ae7-c60d2cd5fd43"
      unitRef="usd">35423000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ife7ea5f7ec2b4816b3f9a85e81ea156b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy0zLTEtMS02ODA3_ea2e837e-7a79-4a44-a9fb-d1f1feddb323"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic4befba2d3d44fb1a621a7790ad0356c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy01LTEtMS02ODA3_f536512d-606d-4325-bdf9-2303bcfb8281"
      unitRef="usd">35423000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i5df54f27e2e4404d8fe0cd357e46301e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy03LTEtMS02ODA3_f4250876-b78d-4019-90bd-4e1e010a1d3e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8882a30cac444bf5ba856bd4a8372177_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy05LTEtMS02ODA3_e6d8af74-2372-4fe3-ab9f-a70666fd24d7"
      unitRef="usd">35423000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i54823e65473645c194940e0076f74ff5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy0xLTEtMS02Nzg_1bbe19bc-3507-48d0-a0e0-c17c423f02e9"
      unitRef="usd">14197000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8e8dec4452ff4308b5fbdd90aeed6dc9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy0zLTEtMS02Nzg_5aae3f76-5ba6-4761-a38a-6b16d7552fd7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ib59dd70dd25942cd92be78336520da90_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy01LTEtMS02Nzg_bd5bc0be-2002-4e79-ad01-58a0f0fb218e"
      unitRef="usd">14197000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ifc2244c603b14657b34cf7227bbd7fe5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy03LTEtMS02Nzg_860deb72-3eaf-415e-825d-04044cfed8b4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i96477b91e6c046df98a6eb283930c399_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfNy05LTEtMS02Nzg_97153d9d-1a2f-4e27-8f78-a7485ada2d5f"
      unitRef="usd">14197000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib988b174dc5b49888bc9c12a66f95b33_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfMTItMS0xLTEtNjc4_540818cd-1b6a-46c6-a8ec-d9413be5c5c0"
      unitRef="usd">53827000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id971a56afa2d46c58587cf6f00f48794_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfMTItMy0xLTEtNjc4_363d9606-271b-4ce9-94b8-136fb287ab1a"
      unitRef="usd">4207000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8499f20cd2c1456a840c92df3935eb19_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfMTItNS0xLTEtNjc4_74c063f7-cd0a-4cf3-929c-3fc1816bc69d"
      unitRef="usd">49620000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5beec7c5934346d88793a58261bd3ed7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfMTItNy0xLTEtNjc4_307b3f39-623a-4e7e-8f36-cd846d6cf94e"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i64b2eec84ef04575a0d89d957828316e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmM4ODkzYzc3ZGVhMTQzNmI4NWEwMjFlNDE3MDg1YjFkL3RhYmxlcmFuZ2U6Yzg4OTNjNzdkZWExNDM2Yjg1YTAyMWU0MTcwODViMWRfMTItOS0xLTEtNjc4_e8ecc28d-6fc3-4d96-bea6-7e48b855af10"
      unitRef="usd">53827000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMzEzNQ_08ea8077-7f9f-404c-b85d-00ec08fbbf4d">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our cash equivalents and available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1 year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmIxNGM1NmYwOWQ1MTQ3ZTFhNzFhNzcyN2Y4OTI3ZDE5L3RhYmxlcmFuZ2U6YjE0YzU2ZjA5ZDUxNDdlMWE3MWE3NzI3Zjg5MjdkMTlfMi0xLTEtMS0w_87ba402a-35e2-4a0d-9906-3fd894062fbc"
      unitRef="usd">53827000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmIxNGM1NmYwOWQ1MTQ3ZTFhNzFhNzcyN2Y4OTI3ZDE5L3RhYmxlcmFuZ2U6YjE0YzU2ZjA5ZDUxNDdlMWE3MWE3NzI3Zjg5MjdkMTlfMi0zLTEtMS0w_296f6849-c2d1-4d54-97e8-1e2432c0f5c4"
      unitRef="usd">53846000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMzEzNg_36ccc5bb-3cbb-4c3a-b0c9-228db0c2814c">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized gains and losses on available-for-sale debt securities that are not credit related are included in accumulated other comprehensive income and summarized as follows as of March 31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i16def725ed4c4de287be9546b21381c4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMi0xLTEtMS0w_d116c566-4421-4da9-8aa4-ce3be5b559c7"
      unitRef="usd">5602000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax
      contextRef="i16def725ed4c4de287be9546b21381c4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMi0zLTEtMS0w_234ae823-5a21-4e95-9dbd-dceaa9ca5b48"
      unitRef="usd">0</ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax>
    <ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i16def725ed4c4de287be9546b21381c4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMi01LTEtMS0w_b66d3f7d-11ab-4033-a0e0-441aef7b178c"
      unitRef="usd">0</ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i16def725ed4c4de287be9546b21381c4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMi03LTEtMS0w_1cf0e514-d13b-4009-8769-de409f8ecdf9"
      unitRef="usd">5602000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i94c20d249a134eafba8d1b1e39d25904_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMy0xLTEtMS0w_9ecab1b6-f202-4462-800a-d40989a79981"
      unitRef="usd">14323000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax
      contextRef="i94c20d249a134eafba8d1b1e39d25904_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMy0zLTEtMS0w_88dfe776-7533-4e01-9aff-0761cb62cfdf"
      unitRef="usd">0</ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax>
    <ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i94c20d249a134eafba8d1b1e39d25904_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMy01LTEtMS0w_d26ed9ee-6c52-4695-ab30-66fbfc40c9c4"
      unitRef="usd">1000</ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i94c20d249a134eafba8d1b1e39d25904_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMy03LTEtMS0w_ca7e28d1-a979-43af-86ee-b88f8e32f740"
      unitRef="usd">14322000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="i655b0d8763b747d280d873a86aa886f2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi0xLTEtMS03MDQw_c8b6b15a-0fe0-460b-bcd9-b77e41c1eed9"
      unitRef="usd">26805000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i655b0d8763b747d280d873a86aa886f2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi0zLTEtMS03MDQw_039e2d71-9eca-4db8-9bde-ea0e5f6db408"
      unitRef="usd">21000</ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i655b0d8763b747d280d873a86aa886f2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi01LTEtMS03MDQw_cbaee8ff-c499-4bdd-8a3c-d59d769df0bc"
      unitRef="usd">0</ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i655b0d8763b747d280d873a86aa886f2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi03LTEtMS03MDQw_0dd3bc3f-f0db-475e-a8fd-94afbd543083"
      unitRef="usd">26826000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="i961aaf7e9dd04265a6efcb537457ced7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi0xLTEtMS0w_ccf6724b-fbee-46bd-bab6-d47e61de518a"
      unitRef="usd">7097000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i961aaf7e9dd04265a6efcb537457ced7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi0zLTEtMS0w_798c58bd-2c0e-497d-95b3-e0596d92449f"
      unitRef="usd">0</ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i961aaf7e9dd04265a6efcb537457ced7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi01LTEtMS0w_cc1a6ab7-126b-4d6c-8ce3-8dd70fc05de7"
      unitRef="usd">1000</ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i961aaf7e9dd04265a6efcb537457ced7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfNi03LTEtMS0w_d400ec48-dce9-423c-bd70-b3572c089a9c"
      unitRef="usd">7096000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMTEtMS0xLTEtMA_280ceb39-a93d-4cc9-9da8-7847388cc85c"
      unitRef="usd">53827000</ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMTEtMy0xLTEtMA_8d5ac1fa-8b07-4d8e-a517-eaf939c7f9f5"
      unitRef="usd">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMTEtNS0xLTEtMA_60dcf50d-7025-453c-b22c-7a5a498e9d60"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <ehth:CashCashEquivalentsAndAvailableForSaleDebtSecurities
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RhYmxlOmU4MGM1OThjYjFiODRkNGFiMWY2ZmFjMjFiODljZjYxL3RhYmxlcmFuZ2U6ZTgwYzU5OGNiMWI4NGQ0YWIxZjZmYWMyMWI4OWNmNjFfMTEtNy0xLTEtMA_58fec773-1499-4211-acc7-f9a9c2fac79a"
      unitRef="usd">53846000</ehth:CashCashEquivalentsAndAvailableForSaleDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80Ni9mcmFnOjlmY2EyZGFiZWJjOTQzNmZhZGVhNzYyZTEyOTY5MzM3L3RleHRyZWdpb246OWZjYTJkYWJlYmM5NDM2ZmFkZWE3NjJlMTI5NjkzMzdfMjAwNg_4057aa9b-c8d2-46d0-bdcb-377932cc8593"
      unitRef="security">12</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMTU5MQ_c63cfb45-c803-4cef-9754-1acbcc24a9c7">Equity&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Public Offering of Common Stock &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to an effective registration statement that was filed on December 17, 2018, and amended on January 22, 2019 and March 2, 2020, we entered into an underwriting agreement in March 2020 to issue a total of 2.1 million shares of common stock, which included the exercise in full of the underwriters&#x2019; option to purchase 0.3 million additional shares of common stock, at a price to the public of&#160;$115.00&#160;per share in March 2020. Net proceeds from the offering were approximately&#160;$228.0 million&#160;after deducting underwriting discounts, commissions and expenses of the offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Repurchase Programs &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no stock repurchase activity during the three months ended March 31, 2021. In addition to 10.7 million shares repurchased under our previous repurchase programs, we have in treasury 1.2 million shares as of March 31, 2021 that were previously surrendered by employees to satisfy tax withholding due in connection with the vesting of certain restricted stock units. As of March 31, 2021 and December 31, 2020, we had a total of 11.9 million shares and 11.8 million shares, respectively, held in treasury.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. Such repurchased shares are held in treasury and are presented using the cost method.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our stock-based compensation expense is summarized as follows by award types (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Amounts include market-based and performance-based RSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock-based compensation expense by operating function for the periods presented below&#160;(in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing and advertising&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer care and enrollment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology and content&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount capitalized in internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="if92b4bb5fc794dd1bc6e637bdad2d099_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMjYx_68abf339-996c-4382-85b6-b880915a3e6d"
      unitRef="shares">2100000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i9e97394555f148638042ce9215c2d1dc_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMzY0_3f72e875-4065-4342-ad2b-4d394beb9582"
      unitRef="shares">300000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i94e4cd2c63294501a97ce58cbb8f0ad9_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfNDMw_2bc6b8c0-5141-435c-86c4-7c564c91cbd7"
      unitRef="usdPerShare">115.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="if92b4bb5fc794dd1bc6e637bdad2d099_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfNDk0_7e8e5b19-0670-4759-9dad-fd98f6d02937"
      unitRef="usd">228000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfNzI1_40e4ffbf-531f-420d-acd8-68508f5c2125"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8b0d49f69d854783b426b4a82d9b7617_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfNzcz_6896479c-d5d3-4c42-bd00-7842d1bb6af2"
      unitRef="shares">10700000</us-gaap:TreasuryStockSharesAcquired>
    <ehth:TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfODU1_8929da78-76e2-4f40-b48e-e2d95e70de63"
      unitRef="shares">1200000</ehth:TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes>
    <us-gaap:TreasuryStockShares
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMTA1Mg_b6f349c1-a2f5-43b6-b6a4-4cd9a2c2e84f"
      unitRef="shares">11900000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMTA2Ng_6b164591-28b1-4ee4-b6aa-23fbb0374435"
      unitRef="shares">11800000</us-gaap:TreasuryStockShares>
    <ehth:ScheduleOfStockBasedCompensationExpenseTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMTYwNA_428bfa74-53c1-4c55-9873-10546778542a">Our stock-based compensation expense is summarized as follows by award types (in thousands):&#160;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Amounts include market-based and performance-based RSUs.&lt;/span&gt;&lt;/div&gt;</ehth:ScheduleOfStockBasedCompensationExpenseTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id010efd09ca848fea67ac7a219d97b98_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfMi01LTEtMS0w_0da347b6-e86b-4c04-acfd-62fbd81cb77e"
      unitRef="usd">180000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6023935a90c0449daef342cb4a899125_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfMi03LTEtMS0w_cc4cb6c2-d74b-4262-a60a-7a2a680696a9"
      unitRef="usd">306000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic87e10e1f657440db47c80a44d54eb25_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfMy01LTEtMS0w_caf9ebd6-b22a-4e91-a60d-62f65fca88bd"
      unitRef="usd">10719000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9e7aff4671154fc19c202272ab565eea_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfMy03LTEtMS0w_1fc6dd72-9715-4709-b1ff-f5c1843d21d5"
      unitRef="usd">8408000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5ba493194d8a487984964d8793886556_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfNC01LTEtMS04Mjk_255ff8e0-98e8-42f1-a6fe-5a4e0deb46bb"
      unitRef="usd">503000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ica2d0bfff5854068ac9d5627ff476134_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfNC03LTEtMS04Mjk_56c5f2f6-7512-4461-8918-6393f79071cd"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfNC01LTEtMS0w_de029cad-c4b1-4b18-9944-9e5a7b462577"
      unitRef="usd">11402000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOjcwMGIwMDM4OGE3MjQxYWFhNjNlOTYyMTI5N2UzOGQ0L3RhYmxlcmFuZ2U6NzAwYjAwMzg4YTcyNDFhYWE2M2U5NjIxMjk3ZTM4ZDRfNC03LTEtMS0w_e6da83aa-cfb9-4bf2-bfbf-331be80c3030"
      unitRef="usd">8714000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ehth:ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RleHRyZWdpb246ODc3N2EzODdhYjcyNGQzMzhkNjc5ZTg3MjFjMjA2ODNfMTYxNQ_03ae5e97-6926-42ef-b1f0-32b5903fb076">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock-based compensation expense by operating function for the periods presented below&#160;(in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing and advertising&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer care and enrollment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology and content&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount capitalized in internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ehth:ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1d267c47dbbb4319b6f0bd3c335192ad_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfMi01LTEtMS0w_e5dec307-d324-4926-b71d-fe826fa037de"
      unitRef="usd">2485000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia264f014078a40918be67135b664845e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfMi03LTEtMS0w_f616b178-2cc7-4757-bd0f-c50c77befe8a"
      unitRef="usd">1730000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i07cea5b44a3a459e9e229df532ff47f5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfMy01LTEtMS0w_bbd277c5-5320-4f8a-8729-e572ad642e0e"
      unitRef="usd">469000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2735879a981f4934a31a2ff030996122_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfMy03LTEtMS0w_bbf10f8b-71ba-4893-8d81-c10eb1c9b587"
      unitRef="usd">662000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i87ef0c3e12a247ffb3645a639fa9a28d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNC01LTEtMS0w_322f3119-6b13-4d5a-8589-19b1d74eed75"
      unitRef="usd">2743000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ieb78056511e744e692b0f0a6870a2b54_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNC03LTEtMS0w_263bd51e-5965-4a5e-baa2-c8fed4abd300"
      unitRef="usd">1617000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0ffef56a313d4362acff848ae985e050_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNS01LTEtMS0w_251d65f1-8029-48e6-9544-66ef56c27dda"
      unitRef="usd">5705000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifed776c5bdf242e8b71b1bd21709ceb6_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNS03LTEtMS0w_01ddd54b-9833-457d-8612-a52b4ef984ee"
      unitRef="usd">4705000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNy01LTEtMS0w_84421387-642d-4667-bb2f-25b543abce71"
      unitRef="usd">11402000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfNy03LTEtMS0w_101d96fe-5302-4144-a4ad-157baad10f98"
      unitRef="usd">8714000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfOC01LTEtMS0w_9a49754c-a4d8-4e76-b776-ef99f4963100"
      unitRef="usd">550000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfOC03LTEtMS0w_1f9ef317-2ff3-4f1b-b1d5-b1266eaf801c"
      unitRef="usd">248000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfOS01LTEtMS0w_a7a10a33-5d71-4166-8c52-7a4743c890aa"
      unitRef="usd">11952000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV80OS9mcmFnOjg3NzdhMzg3YWI3MjRkMzM4ZDY3OWU4NzIxYzIwNjgzL3RhYmxlOmQxOWQwOGMyOTkwNDRkNWRiNTUwOWZhOTNiOTIxZjkxL3RhYmxlcmFuZ2U6ZDE5ZDA4YzI5OTA0NGQ1ZGI1NTA5ZmE5M2I5MjFmOTFfOS03LTEtMS0w_07a1c844-7bb0-47a0-98d9-50213901d532"
      unitRef="usd">8962000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RleHRyZWdpb246ZWRlYzg4OTBjYTc4NDJiY2IxNzc4NGEyMzE1ZGU3N2ZfMTE5MA_15e95c02-01bd-41ac-a7fb-92e823404f8f">Net Income (Loss) Per Share&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding for the period. Diluted net income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all potential dilutive common stock equivalent shares, including options, restricted stock units and shares to be issued under our ESPP. The dilutive effect of outstanding awards is reflected in diluted net income (loss) per share by application of the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in per share calculation &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in diluted share calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) per share &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) per share &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each of the three months ended March 31, 2021 and 2020, we had securities outstanding that could potentially dilute per share amounts, but the shares from the assumed conversion or exercise of these securities were excluded in the computation of diluted net income (loss) per share as their effect would have been anti-dilutive. The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;There were no antidilutive shares for this period.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RleHRyZWdpb246ZWRlYzg4OTBjYTc4NDJiY2IxNzc4NGEyMzE1ZGU3N2ZfMTE5Mw_1037c1ea-7267-476f-bc20-1d1f75186f36">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in per share calculation &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in diluted share calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) per share &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) per share &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMy01LTEtMS0w_96ef9022-56b1-4261-a5dd-fbdef43cbf7f"
      unitRef="usd">-800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMy03LTEtMS0w_d495799d-7044-463e-af94-8d19373644e1"
      unitRef="usd">3452000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfNC01LTEtMS0w_fe10d664-822d-47ed-9e3d-e100847f3a13"
      unitRef="shares">26620000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfNC03LTEtMS0w_c619f736-baf6-4c56-b818-c19e0d588dd3"
      unitRef="shares">24719000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <ehth:IncrementalCommonSharesAttributableToOptions
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfOS01LTEtMS0w_9184ffe6-8d59-4fc6-99eb-1b31fcf83272"
      unitRef="shares">0</ehth:IncrementalCommonSharesAttributableToOptions>
    <ehth:IncrementalCommonSharesAttributableToOptions
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfOS03LTEtMS0w_5da47b3b-cbba-416c-889b-2237a6b3521d"
      unitRef="shares">1460000</ehth:IncrementalCommonSharesAttributableToOptions>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTAtNS0xLTEtMA_8db31232-338d-4b0c-9f27-d1978a9ac6c5"
      unitRef="shares">26620000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTAtNy0xLTEtMA_7daf109b-7d82-4b0d-879e-90a03f0c2a5a"
      unitRef="shares">26179000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTEtNS0xLTEtOTAyOA_582f9794-0c4f-42d2-869c-c6112418d246"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTEtNy0xLTEtOTAyOA_4d1d135e-39ee-466a-8ca4-e0572158cd03"
      unitRef="usdPerShare">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTEtNS0xLTEtMA_e800b090-e366-4130-b6cb-757d8f2287f6"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmIwNjcxODg2OWEzYTQ5NjY5NWM3ZTQxMjUyYTRlOGE5L3RhYmxlcmFuZ2U6YjA2NzE4ODY5YTNhNDk2Njk1YzdlNDEyNTJhNGU4YTlfMTEtNy0xLTEtMA_efee8aa3-6f4f-4e51-8b68-fdae422870f2"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RleHRyZWdpb246ZWRlYzg4OTBjYTc4NDJiY2IxNzc4NGEyMzE1ZGU3N2ZfMTE5NQ_fc532791-abf2-48ac-b0eb-c6e632d93fa5">The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share consisted of the following (in thousands):&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;There were no antidilutive shares for this period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if080cb3649dc43f092dd38c47b2c3694_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmFjMDQzMTQ5NGMzZTQ0MWI5MDZiMjNjMDYzYTY0OTQ0L3RhYmxlcmFuZ2U6YWMwNDMxNDk0YzNlNDQxYjkwNmIyM2MwNjNhNjQ5NDRfMi01LTEtMS0w_4fccd44d-cddd-4660-83b8-1c5dc2d3c280"
      unitRef="shares">363000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i61773e2e91094158a69f52208476be9c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmFjMDQzMTQ5NGMzZTQ0MWI5MDZiMjNjMDYzYTY0OTQ0L3RhYmxlcmFuZ2U6YWMwNDMxNDk0YzNlNDQxYjkwNmIyM2MwNjNhNjQ5NDRfMy01LTEtMS0w_66e3f9a7-0e70-4776-a3bc-840a6dd6ebc7"
      unitRef="shares">1090000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3729439cfe534105b22358a497155089_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmFjMDQzMTQ5NGMzZTQ0MWI5MDZiMjNjMDYzYTY0OTQ0L3RhYmxlcmFuZ2U6YWMwNDMxNDk0YzNlNDQxYjkwNmIyM2MwNjNhNjQ5NDRfNC01LTEtMS00ODg0_34e9e3e5-65fa-4e8b-b7be-3fcc2621f36a"
      unitRef="shares">7000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81Mi9mcmFnOmVkZWM4ODkwY2E3ODQyYmNiMTc3ODRhMjMxNWRlNzdmL3RhYmxlOmFjMDQzMTQ5NGMzZTQ0MWI5MDZiMjNjMDYzYTY0OTQ0L3RhYmxlcmFuZ2U6YWMwNDMxNDk0YzNlNDQxYjkwNmIyM2MwNjNhNjQ5NDRfNC01LTEtMS0w_62a880ac-c09e-4af3-abf9-873ce268d3e5"
      unitRef="shares">1460000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RleHRyZWdpb246ZDllMmNiYzUzZTI2NGNkMmExNzk4OGQwNTQ2MmEzMjBfNzMzMg_d508b87a-162e-4eaf-8e9a-7db69b5b33cc">Commitments and Contingencies&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Service and Licensing Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into service and licensing agreements with third party vendors to provide various services, including network access, equipment maintenance, and software licensing. As the benefits of these agreements are experienced uniformly over the applicable contractual periods, we record the related service and licensing expenses on a straight-line basis, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our future minimum payments under non-cancellable contractual service and licensing obligations as of March 31, 2021 (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;For the Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for commitments related to our operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;From time to time, we receive inquiries from governmental bodies and also may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our condensed consolidated financial statements. An estimated loss contingency is accrued in the condensed consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. There was no material litigation-related accrual during the three months ended March 31, 2021. Legal proceedings or other contingencies could result in material costs, even if we ultimately prevail.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Securities Class Action &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2013; On April 8, 2020 and April 30, 2020, two purported class action lawsuits were filed against us, our chief executive officer, Scott N. Flanders, our chief financial officer, Derek N. Yung, and our then-chief operating officer, David K. Francis, in the United States District Court for the Northern District of California. The cases are captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Patel v. eHealth, Inc., et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;., Case No. 5:20-cv-02395 (N.D. Cal.) and Bertrand v. eHealth, Inc. et al., Case No. 4:20-cv-02967 (N.D. Cal.). The complaints allege, among other things, that we and Messrs. Flanders, Yung and Francis made materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn and our profitability during the alleged class period of March 19, 2018 to April 7, 2020. The complaints allege that we and Messrs. Flanders, Yung and Francis violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The complaints seek compensatory and (in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Patel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; lawsuit) punitive damages, attorneys&#x2019; fees and costs, and such other relief as the court deems proper. On June 24, 2020, the Court consolidated the above-referenced matters under the caption&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; In re eHealth Securities Litig.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, Master File No. 4:20-cv-02395-JST (N.D. Cal.). The Court also appointed a lead plaintiff and lead counsel for the consolidated matter. The lead plaintiff filed an amended complaint on August 25, 2020, which Defendants moved to dismiss.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The motion to dismiss has been fully briefed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Derivative Actions &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 7, 2020 and October 13, 2020, two derivative lawsuits were filed against our chief executive officer, Mr. Flanders, our chief financial officer, Mr. Yung, our then-chief operating officer, Mr. Francis, and the members of our Board of Directors (collectively, the &#x201c;Individual Defendants&#x201d;), in the United States District Court for the Northern District of California and the Superior Court of California, County of Santa Clara. The cases are captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Chernet v. Flanders et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;., Case No. 3:20-cv-04477-SK (N.D. Cal.), and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Lincolnshire Police Pension Fund v. Flanders et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, Case No. 20CV371555 (Cal. Super. Ct.), and also name the Company as a nominal defendant. The complaints allege, among other things, that beginning on March 19, 2018, the Individual Defendants made or caused the Company to make materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn, profitability, and internal controls. Both complaints purport to assert claims for breach of fiduciary duty, unjust enrichment and waste of corporate assets. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Chernet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; lawsuit also alleges that the Individual Defendants violated Sections 14(a), 10(b), and 20(a) of the Securities Exchange Act of 1934, and asserts claims for abuse of control and gross mismanagement. The complaints seek damages, restitution, attorneys&#x2019; fees and costs, and certain measures with respect to the Company&#x2019;s corporate governance and internal procedures, and (in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Lincolnshire&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; lawsuit) equitable and/or injunctive relief. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Chernet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Lincolnshire&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; lawsuits have both been stayed pending the resolution of the motion to dismiss in the Securities Class Action, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;In re eHealth Securities Litig&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;., Master File No. 4:20-cv-02395-JST (N.D. Cal.).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;The Gonzalez and Le&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Vias Complaints&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &#x2013; On April 6, 2018, a former employee, Lupita Gonzalez, filed a complaint against us in the Superior Court of the State of California for the County of Sacramento (the &#x201c;Gonzalez Complaint&#x201d;). On July 1, 2019, two other current or former employees, Michael Le&#x2019;Vias and Ramona Meadows, filed a related complaint against us and eHealth Ins. Serv. Co., in the Superior Court of the State of California for the County of Santa Clara (the &#x201c;Le&#x2019;Vias Complaint&#x201d;). Both complaints asserted claims under the California Private Attorney General Act (&#x201c;PAGA&#x201d;) on behalf of all current and former hourly-paid or non-exempt employees who work or have worked for us in California, based on alleged failures to comply with California wage and hour laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The parties have entered into a court-approved settlement agreement that resolves both matters related to the Gonzalez and Le'Vias Complaints, and Plaintiffs Michael Le&#x2019;Vias and Ramona Meadows have sought dismissal with prejudice of the Le&#x2019;Vias Complaint. Upon the completion of the distribution of the settlement funds in accordance with the settlement agreement and the court order approving the settlement agreement, the parties will seek a dismissal with prejudice of the Gonzalez Complaint.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock>
    <srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RleHRyZWdpb246ZDllMmNiYzUzZTI2NGNkMmExNzk4OGQwNTQ2MmEzMjBfMzI5ODUzNDg5NzgxMA_ca58c1a0-4751-4241-b2e4-8e59943c7541">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our future minimum payments under non-cancellable contractual service and licensing obligations as of March 31, 2021 (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;For the Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
    <us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfMS0xLTEtMS0zMDY3_229f6674-be75-412a-9a40-966ea495ad0e"
      unitRef="usd">4246000</us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear>
    <us-gaap:ContractualObligationDueInNextTwelveMonths
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfMi0xLTEtMS0zMDY3_df046319-1a0c-4472-b2f0-7885ab8e7fc8"
      unitRef="usd">3472000</us-gaap:ContractualObligationDueInNextTwelveMonths>
    <us-gaap:ContractualObligationDueInSecondYear
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfMy0xLTEtMS0zMDY3_80923a0a-d5a5-4b66-83ff-b5e4e4767723"
      unitRef="usd">2745000</us-gaap:ContractualObligationDueInSecondYear>
    <us-gaap:ContractualObligationDueInThirdYear
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfNC0xLTEtMS0zMDY3_8308964f-0053-48b7-aaaf-01a42a1f06cd"
      unitRef="usd">2056000</us-gaap:ContractualObligationDueInThirdYear>
    <us-gaap:ContractualObligationDueInFourthYear
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfNS0xLTEtMS0zMDY3_70d6f197-a369-4af3-8074-797ee4b5f126"
      unitRef="usd">1353000</us-gaap:ContractualObligationDueInFourthYear>
    <ehth:ContractualObligationToBePaidAfterYearFour
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfNi0xLTEtMS0zMDY3_c600303d-90e2-4815-9ad0-5b2a537d3188"
      unitRef="usd">1353000</ehth:ContractualObligationToBePaidAfterYearFour>
    <us-gaap:ContractualObligation
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RhYmxlOjE3YjZhMmRhMzI3NDRjNzY4YjBmODdlZjk3MjhiM2Y1L3RhYmxlcmFuZ2U6MTdiNmEyZGEzMjc0NGM3NjhiMGY4N2VmOTcyOGIzZjVfNy0xLTEtMS0zMDY3_992b75d1-2e54-4cc6-86f7-f7ccb60d6002"
      unitRef="usd">15225000</us-gaap:ContractualObligation>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i4f10282c4a164b3ba49248e358109fda_D20200408-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RleHRyZWdpb246ZDllMmNiYzUzZTI2NGNkMmExNzk4OGQwNTQ2MmEzMjBfODIw_09376d1a-4459-45c2-b617-5bb12ec1ec0c"
      unitRef="claim">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="idba160cc7e824a82bf89be1c244ad874_D20200707-20201013"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RleHRyZWdpb246ZDllMmNiYzUzZTI2NGNkMmExNzk4OGQwNTQ2MmEzMjBfMjQ0Mw_c2071c95-10dd-4ce5-916b-1bda806a9102"
      unitRef="plaintiff">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i63e707f4d80c456a88c23a8539ab5605_D20190701-20190701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81NS9mcmFnOmQ5ZTJjYmM1M2UyNjRjZDJhMTc5ODhkMDU0NjJhMzIwL3RleHRyZWdpb246ZDllMmNiYzUzZTI2NGNkMmExNzk4OGQwNTQ2MmEzMjBfMjE5OTAyMzI4Mzg0MA_81360787-97f3-4e73-95f5-de784952c3b0"
      unitRef="plaintiff">2</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMTczNA_5de8e58b-4576-4455-9860-956848fc82ab">Segment and Geographic Information&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We report segment information based on how our chief executive officer, who is our chief operating decision maker ("CODM"), regularly reviews our operating results, allocates resources and makes decisions regarding our business operations. The performance measures of our segments include total revenue and profit. Our business structure is comprised &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of&#160;two&#160;operating segments: Medicare and Individual, Family and Small Business. Please refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Business and Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Notes to Consolidated Financial Statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in Part II, Item 8 of the Annual Report on Form 10-K for the year ended December 31, 2020 for our accounting policies relating to operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of our operating segments are summarized for the periods presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual, Family and Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment profit:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare segment profit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual, Family and Small Business segment profit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $2.8 million and $1.5 million for the first quarter of 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Depreciation and amortization has been adjusted to include amortization of software development costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no inter-segment revenue transactions for the periods presented. With the exception of contract assets &#x2013; commissions receivable, which is presented by segment in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Supplemental Financial Statement Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, our CODM does not separately evaluate assets by segment, and therefore, assets by segment are not presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Geographic Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our long-lived assets primarily consist of property and equipment and internally-developed software. Our long-lived assets are attributed to the geographic location in which they are located. Long-lived assets by geographical area are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:58.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all revenue for the three months ended March 31, 2021 and 2020&#160;was generated from customers located in the United States. Carriers representing 10% or more of our total revenue are summarized as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UnitedHealthcare &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aetna &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Humana&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centene &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;__________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Percentages include the carriers' subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the revenue of WellCare is included in the percentage calculation for March 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMzg4_ad1e2c3e-8ae6-4e69-b21d-897fad968a41"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMTczNw_90e2f23f-eb13-4187-86ff-a042d4df1995">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of our operating segments are summarized for the periods presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual, Family and Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment profit:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare segment profit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual, Family and Small Business segment profit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $2.8 million and $1.5 million for the first quarter of 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;(2)Depreciation and amortization has been adjusted to include amortization of software development costs.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i847b02865e0e482289ce85c02f9b4e61_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMy01LTEtMS0w_535332cf-3bca-465c-abb0-1b3592b7b1b8"
      unitRef="usd">121021000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45589c5d091d42fa856a74b05e6a684b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMy03LTEtMS0w_9f3560fd-dc33-484c-b019-d410e7507696"
      unitRef="usd">96151000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iece3c4feb7ba4852ae934e622f0fc222_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfNC01LTEtMS0w_657eb802-3d42-420b-8097-ad33bedc2e29"
      unitRef="usd">13193000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5f5742b50c34e6eb0d14c32db2d8983_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfNC03LTEtMS0w_7968f943-c00e-4271-92d9-896979408210"
      unitRef="usd">10257000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96a1c3f122b54e5c910199f9e10062ae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfNS01LTEtMS0w_7a584177-232a-4731-bcc2-637a8a109ec3"
      unitRef="usd">134214000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58d74f4f4ee14e1fba9c88300782d7ff_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfNS03LTEtMS0w_399f05af-db1d-4bad-bac2-f0b90d4ecb55"
      unitRef="usd">106408000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i847b02865e0e482289ce85c02f9b4e61_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfOC01LTEtMS0w_65b8bb7c-08b3-4a40-ae9e-3e9fcdd58364"
      unitRef="usd">24545000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i45589c5d091d42fa856a74b05e6a684b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfOC03LTEtMS0w_07029c9f-2a31-4113-933e-6f2716b5e6af"
      unitRef="usd">23136000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="iece3c4feb7ba4852ae934e622f0fc222_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfOS01LTEtMS0w_e74f64bf-d63c-47d6-9b71-41dc993678a1"
      unitRef="usd">8052000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="id5f5742b50c34e6eb0d14c32db2d8983_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfOS03LTEtMS0w_10a41953-a543-4156-9b9f-2f6928441528"
      unitRef="usd">2928000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i96a1c3f122b54e5c910199f9e10062ae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTAtNS0xLTEtMA_97cd3769-51d9-4f4a-8ac4-701c304947fc"
      unitRef="usd">32597000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i58d74f4f4ee14e1fba9c88300782d7ff_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTAtNy0xLTEtMA_65cc5114-e504-49a2-8e3f-3f4ad0760e37"
      unitRef="usd">26064000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="id7766c8b514940a3adac069dcabfa7f5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTEtNS0xLTEtMA_7c81e199-5742-4e0f-bf3a-7445947003de"
      unitRef="usd">-15286000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i0dcc0aaf01a44218b29859ee8d52669f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTEtNy0xLTEtMA_319e748b-8b43-4ea8-9607-d179d0cceb16"
      unitRef="usd">-13448000</ehth:SegmentOperatingIncomeLoss>
    <ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTItNS0xLTEtMA_ca89e8ab-611a-47f8-b966-80daddc93b16"
      unitRef="usd">11402000</ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense>
    <ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTItNy0xLTEtMA_be40a789-5f88-4943-a641-95e89e4fc203"
      unitRef="usd">8714000</ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTQtNS0xLTEtMA_37750635-f3f1-4d37-84e5-32182249a704"
      unitRef="usd">3944000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTQtNy0xLTEtMA_b8f1b728-97ef-4a6c-a0c8-07ba132288e3"
      unitRef="usd">2324000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTUtNS0xLTEtMA_6b74d58d-b5c1-45c4-a0fd-7016cd0f4a7a"
      unitRef="usd">176000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTUtNy0xLTEtMA_2a46e1bb-161a-4a6d-86f7-0863ddcde4cd"
      unitRef="usd">547000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RestructuringCharges
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTctNS0xLTEtMA_3f3eebb8-f425-4968-82d5-d197c0c1b296"
      unitRef="usd">2431000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTctNy0xLTEtMA_00970ade-415d-4b49-8b37-177d34abb5f4"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTgtNS0xLTEtMA_2955f440-73b1-47e0-b73a-8eada4335b9e"
      unitRef="usd">150000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTgtNy0xLTEtMA_30c42ff8-0935-46e6-b90b-dd163b9be742"
      unitRef="usd">373000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTktNS0xLTEtMA_90205d53-609e-4c2e-880e-2929f4509ef3"
      unitRef="usd">-492000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjFhZjBjNWNjN2E4OTRiMWE4NWE2NTI1ZDhiYjA5MDJjL3RhYmxlcmFuZ2U6MWFmMGM1Y2M3YTg5NGIxYTg1YTY1MjVkOGJiMDkwMmNfMTktNy0xLTEtMA_dab9d3b9-d955-4956-9ec7-2fc2f8d561dc"
      unitRef="usd">1404000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMzI5ODUzNDg4NzE0MA_34dbc85c-1b35-49dd-95cf-9058e95fee4a"
      unitRef="usd">2800000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMzI5ODUzNDg4NzE0OA_2ff3e3c9-be99-4c8a-a56c-1c2f1847dd89"
      unitRef="usd">1500000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <ehth:ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMTc0NA_ad85f3ed-87b2-4279-b291-c6a8086d7439">Long-lived assets by geographical area are summarized as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ehth:ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="iae135e664d984295bbf64c3bbe7c4a11_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMS0xLTEtMS0w_cbdcdb3a-99e1-4dae-9c46-03274de2ea25"
      unitRef="usd">41829000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i33ac7f7fd03c47acb53fa3d4bb1753db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMS0zLTEtMS0w_af8c8104-a09b-4e7b-8aa2-5f044c1fe01b"
      unitRef="usd">40500000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i82364b4b38294beeabf364cb83d2dfb2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMi0xLTEtMS0w_3e0502ef-4f0f-4653-8c5c-c7e37fbf9f09"
      unitRef="usd">511000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i023ce78002434d8cad1d8f97aa442d34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMi0zLTEtMS0w_658c47f0-700e-400b-afbb-02fc9bb68872"
      unitRef="usd">565000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMy0xLTEtMS0w_150c33b1-e89b-44d2-8c91-f0a13d518869"
      unitRef="usd">42340000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOjIzM2QxZjIwNWNjODQxY2JhMGM2MTY1NzNhYWVhMjNlL3RhYmxlcmFuZ2U6MjMzZDFmMjA1Y2M4NDFjYmEwYzYxNjU3M2FhZWEyM2VfMy0zLTEtMS0w_2693dc91-f647-4bb6-a26b-4ee29055f827"
      unitRef="usd">41065000</us-gaap:NoncurrentAssets>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RleHRyZWdpb246MTUwNWZlMWJlY2E2NDlkMjhkNWUzYTE2YmRlMzQwMDFfMTczMg_cb40dbaa-04b8-44b5-974e-53a4b0a894b7">Carriers representing 10% or more of our total revenue are summarized as follows:&#160;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UnitedHealthcare &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aetna &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Humana&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centene &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;__________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Percentages include the carriers' subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the revenue of WellCare is included in the percentage calculation for March 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie4d88e2c29bd4ed1a1c6b4b23e1884dc_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfMy01LTEtMS0w_58ec4ecb-4b23-4264-841f-9f7c03899af1"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i220bb9cb676540b4aeb3a914e250fe06_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfMy03LTEtMS0w_d919a465-1ac9-4def-89c4-fd29f60bb78c"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id8a052d919884528be429b16feacfa3c_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNC01LTEtMS0w_deb19de2-2508-45b8-9ef6-ec04514d0267"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3966096b4cf940f5ab5e3bdf08677217_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNC03LTEtMS0w_6aa4bad2-7aba-4868-9de3-8ced16efbb4c"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icd072559e8714571bf142682157e4908_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNS01LTEtMS00ODk2_ba3416be-5ea5-448a-802d-e30e44dde7f3"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1ac77c183dc946279d677be3a4d4156e_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNS03LTEtMS00ODk2_ebf250f4-864f-48b9-a697-451e18e31113"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i44a77aea53a9467e962038a9620c620b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNS01LTEtMS02ODQ2_20e470e2-bf2b-4f43-8b60-c33977e4d19e"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i07cffec9adda4d338d0d362e4623e96b_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV81OC9mcmFnOjE1MDVmZTFiZWNhNjQ5ZDI4ZDVlM2ExNmJkZTM0MDAxL3RhYmxlOmU0NWEwNTUxNGM2ODRjOWE4Y2YxZDk4NGU1NTZlNWQ3L3RhYmxlcmFuZ2U6ZTQ1YTA1NTE0YzY4NGM5YThjZjFkOTg0ZTU1NmU1ZDdfNS03LTEtMS02ODQ2_28a672c9-4fb4-44bd-9d0b-98c593e0b4c7"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMjY0Mw_1b20d1ea-c6f7-4df1-a9f8-39ad89427d35">Leases&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our leases have remaining lease terms of 3 to 9 years. Certain of these leases have free or escalating rent payment provisions. We recognize lease expense on a straight-line basis over the terms of the leases, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. Most leases include options to renew, and the exercise of these options is at our discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease expenses were $2.0 million and $2.1 million for the three months ended March 31, 2021 and 2020, respectively and sublease income was immaterial for both periods.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the lease-related assets and liabilities recorded on the Condensed Consolidated Balance Sheets as of the dates presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities &#x2013; current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities &#x2013; non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,090&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate used to recognize operating lease right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2021, maturities of operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Noncancellable sublease income for the remainder of 2021 and years ending December 31, 2022 and 2023 of $0.9 million, $0.4 million and $0.4 million, respectively, is not included in the table above.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="i7d18c978c29e46f2a12a23d7312bca62_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg4NjAyNA_b3213c1d-6f87-4e3b-848b-c696d6fdbac9">P3Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="iae1734dfbd7b4fffa4a61071f126a5be_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg4NjAzMQ_0a1a8c62-a141-402f-a45a-dc5f56c4e620">P9Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:OperatingLeaseCost
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg4OTQ3Mw_1f705772-5fde-4f2d-a740-88ea7a41dce3"
      unitRef="usd">2000000.0</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg4OTQ4NQ_b0ba23d5-74fe-46bf-86af-dd9c84b1e86b"
      unitRef="usd">2100000</us-gaap:OperatingLeaseCost>
    <ehth:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMjE5OTAyMzI2Mjc3NQ_b8c0af47-8b6f-4813-934b-76e0652ce211">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the lease-related assets and liabilities recorded on the Condensed Consolidated Balance Sheets as of the dates presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities &#x2013; current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities &#x2013; non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ehth:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfMS0xLTEtMS05NzE_4c34d8a1-966c-40fa-84fb-ce5f927ef040"
      unitRef="usd">41284000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfMS0zLTEtMS05NzE_3d4e6b3f-1e4f-49b8-bbac-d06df687a81b"
      unitRef="usd">42558000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfMy0xLTEtMS05NzE_169fd719-cf78-4bf5-ab51-a6efb300efc9"
      unitRef="usd">5316000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfMy0zLTEtMS05NzE_5ef28a4f-f5aa-4afe-82a5-7ec44cd58847"
      unitRef="usd">5192000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfNC0xLTEtMS05NzE_0948f462-8fbf-4b5a-b041-4349c49287e4"
      unitRef="usd">39984000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfNC0zLTEtMS05NzE_a3e7cf4b-1aea-43a6-966e-24bacfa8bdc8"
      unitRef="usd">41369000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfNS0xLTEtMS0xMDkx_632fdf82-0385-453b-8bc6-ea58994216fe"
      unitRef="usd">45300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjI0MGQ2MzcwZTMzNzQxZTQ4YzBmMWIyNDZmY2Q1NzQ0L3RhYmxlcmFuZ2U6MjQwZDYzNzBlMzM3NDFlNDhjMGYxYjI0NmZjZDU3NDRfNS0zLTEtMS0xMDkx_a9b664fa-baf2-46c8-be15-21505d193b1e"
      unitRef="usd">46561000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMjE5OTAyMzI2Mjc3Nw_96b0f6b5-7c6a-4973-9318-3e0fca44f4b0">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,090&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate used to recognize operating lease right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfMS0xLTEtMS0xMTA4_77af5a36-73ea-4849-8ee9-b5905e3d7a1f"
      unitRef="usd">1900000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ie0964fabcb4d4203950f730100ea33dc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfMS0zLTEtMS0xMTA4_f2ab41f8-4b76-4db6-b68f-2a6ad40c4ce8"
      unitRef="usd">7090000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfMy0xLTEtMS0xMTA4_bf49ab92-1b00-488d-9e21-f2339197ff28">P7Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfMy0zLTEtMS0xMTA4_d1a2a473-7a3b-4ff9-bd70-cb999d474951">P7Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfNC0xLTEtMS0xMTA4_fbe1331a-68b8-454a-a79a-a4acbe76b708"
      unitRef="number">0.054</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i491c8af6fa2b4e68be4acd9338800eb3_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjNiNzYwMGYwOGUzNzRkMDY4ZDY5YjhjMDg0ODlmMTRlL3RhYmxlcmFuZ2U6M2I3NjAwZjA4ZTM3NGQwNjhkNjliOGMwODQ4OWYxNGVfNC0zLTEtMS0xMTA4_741885a9-4918-4701-8ad5-95449a8dd134"
      unitRef="number">0.054</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMjY0OA_57756754-c418-4762-9b69-58c5cbbb104d">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2021, maturities of operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Noncancellable sublease income for the remainder of 2021 and years ending December 31, 2022 and 2023 of $0.9 million, $0.4 million and $0.4 million, respectively, is not included in the table above.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfMS0xLTEtMS0w_d6d1d686-9c2a-4269-82f4-e975424fb4cb"
      unitRef="usd">5744000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfMi0xLTEtMS0w_e184ee17-f680-4d7b-a505-d2c13031f9f6"
      unitRef="usd">7701000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfMy0xLTEtMS0w_a468b84c-0271-430d-a193-12c206266bf4"
      unitRef="usd">8033000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfNC0xLTEtMS0w_72a20fb0-9a29-4c91-83e2-5dd81fc0de22"
      unitRef="usd">7832000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfNS0xLTEtMS0w_d65cf7d3-1958-423c-9b3c-b01bf2e9fef7"
      unitRef="usd">8009000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <ehth:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfNi0xLTEtMS0w_962f8aa7-ec5c-4e18-9d65-d0e22578a24d"
      unitRef="usd">19407000</ehth:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfNy0xLTEtMS0w_a0f7f7de-29fb-48f4-ae97-530e71badf58"
      unitRef="usd">56726000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfOC0xLTEtMS0w_adde07fe-13fd-440c-9ec7-629d093044f7"
      unitRef="usd">11426000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RhYmxlOjY0M2YzMzgyZDQzOTQ0MzVhZDllNWE1OTNhNjczMGNmL3RhYmxlcmFuZ2U6NjQzZjMzODJkNDM5NDQzNWFkOWU1YTU5M2E2NzMwY2ZfOS0xLTEtMS0w_b42dac45-596f-4dbd-8ffc-52d307f29bed"
      unitRef="usd">45300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg5MDQ1NA_3f6a132e-13b2-49bc-a140-056d9c78bf69"
      unitRef="usd">900000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg5MDQ1OA_e0d42a3f-de9f-4882-b8a4-f912e5339e22"
      unitRef="usd">400000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82MS9mcmFnOjBkYzJhMGEzNzczMzRiZTI5Nzk5MzlhZTFhMDBmZDNkL3RleHRyZWdpb246MGRjMmEwYTM3NzMzNGJlMjk3OTkzOWFlMWEwMGZkM2RfMzI5ODUzNDg5MDQ2Mg_37f22fad-afdf-49fc-854d-4a3bac1a3fab"
      unitRef="usd">400000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82NC9mcmFnOjg0ZTk0ZjFkNDcyYTQxMTk4MjA3YjU0NmRiNjZhYjYxL3RleHRyZWdpb246ODRlOTRmMWQ0NzJhNDExOTgyMDdiNTQ2ZGI2NmFiNjFfOTI1_872c8f28-888d-423c-aeee-15f2576a6a05">Restructuring&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, we eliminated approximately 89 full-time positions, primarily in the United States, representing approximately 5% of our workforce, primarily within our customer care and enrollment group, and to a lesser extent, in our marketing and advertising, technology and content, and general and administrative groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total pre-tax restructuring charges for the three months ended March 31, 2021 were $2.4&#160;million, which primarily related to employee termination benefits. Substantially all of the restructuring charges resulted in cash expenditures. The restructuring activities were completed by March&#160;31, 2021. Accrued restructuring charges balance was $0.3&#160;million as of March 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="i5cf30dc17def4256a761123e6f60a569_D20210201-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82NC9mcmFnOjg0ZTk0ZjFkNDcyYTQxMTk4MjA3YjU0NmRiNjZhYjYxL3RleHRyZWdpb246ODRlOTRmMWQ0NzJhNDExOTgyMDdiNTQ2ZGI2NmFiNjFfNDM5ODA0NjUxMjU0OA_1e0d8f36-1f88-4ef8-91fa-f53880448622"
      unitRef="employee">89</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <ehth:RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce
      contextRef="i5cf30dc17def4256a761123e6f60a569_D20210201-20210228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82NC9mcmFnOjg0ZTk0ZjFkNDcyYTQxMTk4MjA3YjU0NmRiNjZhYjYxL3RleHRyZWdpb246ODRlOTRmMWQ0NzJhNDExOTgyMDdiNTQ2ZGI2NmFiNjFfNDM5ODA0NjUxMjU1Mg_7618e21a-49a0-4d93-b40a-634d8a3cbcb2"
      unitRef="number">0.05</ehth:RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce>
    <us-gaap:RestructuringCharges
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82NC9mcmFnOjg0ZTk0ZjFkNDcyYTQxMTk4MjA3YjU0NmRiNjZhYjYxL3RleHRyZWdpb246ODRlOTRmMWQ0NzJhNDExOTgyMDdiNTQ2ZGI2NmFiNjFfMzI5ODUzNDg4NTY1OA_2bd86cdb-41be-4b4f-8990-90ef2dad16b5"
      unitRef="usd">2400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV82NC9mcmFnOjg0ZTk0ZjFkNDcyYTQxMTk4MjA3YjU0NmRiNjZhYjYxL3RleHRyZWdpb246ODRlOTRmMWQ0NzJhNDExOTgyMDdiNTQ2ZGI2NmFiNjFfNDM5ODA0NjUxMjk2MQ_7c26e24b-c75b-468f-a746-1743c20ee93b"
      unitRef="usd">300000</us-gaap:RestructuringReserve>
    <us-gaap:LongTermDebtTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzg4Ng_c69418eb-c3b2-4831-baa9-f24b6bc5c72f">Debt&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 17, 2018, we entered into a Credit Agreement with Royal Bank of Canada (&#x201c;RBC&#x201d;), as administrative agent and collateral agent (the &#x201c;Credit Agreement&#x201d;). The Credit Agreement provides for a $40.0 million secured asset-backed revolving credit facility with a $5.0 million letter of credit sub-facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 20, 2019, we amended our revolving credit facility agreement with RBC (the &#x201c;Amendment&#x201d;) and increased the borrowing amount from $40.0 to $75.0&#160;million. The maturity date has been extended to December 20, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The borrowing base under the Credit Agreement is comprised of an amount equal to (a) the lesser of (i) eighty percent (80%) of Eligible Commissions Receivables (as defined in the Credit Agreement) we actually collected during the immediately preceding period of three months or (ii) eighty percent (80%) of our Eligible Commission Receivables for the immediately succeeding period of three months, plus (b) fifty percent (50%) of our Eligible Commission Receivables for the immediately succeeding period of six months (excluding the immediately succeeding period of three months), in each case subject to reserves established by RBC (the &#x201c;Borrowing Base&#x201d;). The proceeds of the loans under the Credit Agreement may be used for working capital and general corporate purposes. The borrowers have the right to prepay the loans under the Credit Agreement in whole or in part at any time without penalty. Subject to availability under the Borrowing Base, amounts repaid may be reborrowed. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts not borrowed under the Credit Agreement will be subject to a commitment fee of 0.5% per annum on the daily unused portion of the credit facility, to be paid in arrears on the first business day of each calendar quarter. At the closing of the Credit Agreement, we paid a one-time facility fee of 1.75% of the total commitments of $40.0&#160;million. We also paid a one-time closing fee of 0.5% of the new commitment of $75.0&#160;million in connection with the Amendment. The Company is also obligated to pay other customary administration fees for a credit facility of this size and type. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The availability under the credit facility was up to the lesser of $40.0 million or the Borrowing Base in the original credit agreement. The Amendment increased the availability up to the lesser of $75.0 million or the Borrowing Base, which may be reduced from time to time pursuant to the Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial covenants in the original Credit Agreement required that we maintain Excess Availability (as defined in the Credit Agreement) at or above $6.0 million at any time. The Amendment also changed the financial covenants to require us to maintain at least $6.0&#160;million of Excess Availability at all times or, if greater, up to $11.3&#160;million depending on our borrowing base as determined by eligible past and future commissions receivable. In addition, the Amendment also included changes in the payment conditions to, among other things, require us to have at least $10.0&#160;million of liquidity or, if greater, up to $18.8&#160;million depending on our borrowing base as determined by eligible past and future commissions receivable, in order for us to make certain permitted acquisitions, investments, distributions and payments of indebtedness. The Amendment also stated the seasonal amount thresholds used in connection with the cash dominion and field examination covenants in the Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We incurred $1.2 million of issuance costs in connection with the Credit Agreement, which were capitalized as part of other assets on our Consolidated Balance Sheet in the period we entered into the Credit Agreement. The Amendment did not change the interest rate. In connection with the Amendment, we incurred closing costs totaling $0.5&#160;million, which were capitalized and recorded as other assets on our Condensed Consolidated Balance Sheet as of March 31, 2021. The remaining balance of unamortized issuance costs was $0.7&#160;million as of March 31, 2021 and December 31, 2020. &lt;/span&gt;&lt;/div&gt;As of March 31, 2021, we had no outstanding borrowings under our revolving credit facility.</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="if2923c5383c841499a972300bbf7f35a_I20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjE0_aefea080-84a4-4a00-b2a9-b5d6727e3d1e"
      unitRef="usd">40000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="ie6844992191446ce8e5eb767a6d14280_I20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjcx_beb4cfee-96b7-4b2e-9eee-c37199381ce1"
      unitRef="usd">5000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="if2923c5383c841499a972300bbf7f35a_I20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfNDQ3_4623fc3c-464c-403b-8422-38543a3f744d"
      unitRef="usd">40000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfNDUz_e0bf5c1a-a60a-46a3-b9af-2b4f9605fe99"
      unitRef="usd">75000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <ehth:LineOfCreditFacilityBorrowingBasePercentage
      contextRef="ic7fc3ad8803c48dba5b19cd94571052d_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfNjM1_00038003-e390-43c9-9435-f8019919983b"
      unitRef="number">0.80</ehth:LineOfCreditFacilityBorrowingBasePercentage>
    <ehth:LineOfCreditFacilityBorrowingBasePercentage
      contextRef="id2de67982b8047c4945d793ade8e4b30_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfODE3_619e64ce-fbc5-411e-bab6-0d1e89a80ff9"
      unitRef="number">0.80</ehth:LineOfCreditFacilityBorrowingBasePercentage>
    <ehth:LineOfCreditFacilityBorrowingBasePercentage
      contextRef="idb110a0ed8474c12b0f9d57120ec9b8b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfOTM5_4bc484d3-1a5d-46b7-bae5-ea21539cbf8c"
      unitRef="number">0.50</ehth:LineOfCreditFacilityBorrowingBasePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ib22aa805134544d8b3f646ee20f2d401_D20180917-20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMTU4NA_b9414283-b868-4d5b-b30a-ddfe334c1be5"
      unitRef="number">0.005</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <ehth:LineOfCreditFacilityFacilityFeePercentage
      contextRef="ib22aa805134544d8b3f646ee20f2d401_D20180917-20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMTc3MA_e1b64455-0985-402a-97e7-59f50298100e"
      unitRef="number">0.0175</ehth:LineOfCreditFacilityFacilityFeePercentage>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="if2923c5383c841499a972300bbf7f35a_I20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMTgwMQ_d11c0e50-5e67-4098-b1c2-bc21d2d9e003"
      unitRef="usd">40000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <ehth:LineOfCreditFacilityFacilityFeePercentage
      contextRef="i44dd187585b74e779c773066ae7d855f_D20191220-20191220"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMTg0NA_8cf54cd4-3a7a-44a6-9ec3-442d827b4504"
      unitRef="number">0.005</ehth:LineOfCreditFacilityFacilityFeePercentage>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMTg3Mg_a95e1796-50bb-4bbb-8bb8-fd49557cf602"
      unitRef="usd">75000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if2923c5383c841499a972300bbf7f35a_I20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjA4Nw_725ad32f-8321-414d-b8aa-ce311ac5f62a"
      unitRef="usd">40000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjI0Nw_6c789cf6-ec68-48ae-97f0-6362b2db637d"
      unitRef="usd">75000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents
      contextRef="if2923c5383c841499a972300bbf7f35a_I20180917"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjQ5NQ_08371b06-08a0-426d-9ad3-ae2fdd9ea448"
      unitRef="usd">6000000.0</ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents>
    <ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents
      contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjU5Nw_0debb5d8-1c2d-4ed4-bdd1-af0067611d89"
      unitRef="usd">6000000.0</ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents>
    <ehth:LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents
      contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjY1OA_78b5626c-e5a0-47c4-af77-1c1677bf95d6"
      unitRef="usd">11300000</ehth:LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents>
    <ehth:LineOfCreditFacilityCovenantMinimumLiquidity
      contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjg4Ng_0983a624-7bc5-467b-9f29-1db8402529f7"
      unitRef="usd">10000000.0</ehth:LineOfCreditFacilityCovenantMinimumLiquidity>
    <ehth:LineOfCreditFacilityCovenantMaximumLiquidity
      contextRef="i071c226c04364e0c9c1937a5320495ed_I20191220"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMjkyNA_22dfe116-336d-44b0-b8df-f623ae4fe04f"
      unitRef="usd">18800000</ehth:LineOfCreditFacilityCovenantMaximumLiquidity>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="if2923c5383c841499a972300bbf7f35a_I20180917"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzMwOA_5608df47-a6fd-4054-8e18-082e0e18220b"
      unitRef="usd">1200000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="iccd604bc2ad5443287367d09698c1237_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzYyMA_aab632b3-3e99-482f-b32f-b5f50fe701b8"
      unitRef="usd">500000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i30714fb2e7da43798055174115a19c9f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzc3Ng_2db2b319-7705-405b-bbe1-9002d7bcd51a"
      unitRef="usd">700000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ia6cae47fd71f4a738ddcb10f68e682c4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzc3Ng_5beb566a-a93a-4adb-a39c-adb4c4e53d3b"
      unitRef="usd">700000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LineOfCredit
      contextRef="i5dc87305aa114463a821897ca747dcca_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83MC9mcmFnOjI2ODRjZDVhMDEyYzRiNTU5YjNlMmUzZTU2NjBiMjQ5L3RleHRyZWdpb246MjY4NGNkNWEwMTJjNGI1NTliM2UyZTNlNTY2MGIyNDlfMzgyMg_f4cfa0e4-2e8d-455c-9f9c-25d88b8302d9"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfMjg2Mw_be636c83-35a7-411c-885c-15f2ee46abfc">Income Taxes &lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes our provision for (benefit from) income taxes and our effective tax rates for the periods presented below (in thousands, except effective tax rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the three months ended March 31, 2021, we recognized a provision for income taxes of $0.3&#160;million, representing an effective tax rate of (62.6)%, which was lower than the statutory federal tax rate due primarily to one-time state tax adjustments. For the three months ended March 31, 2020, we recognized a benefit from income taxes of $2.0&#160;million, representing an effective tax rate of (145.9)%, which was lower than the statutory federal tax rate due primarily to stock-based compensation windfalls.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assessing the realizability of our deferred tax assets is dependent upon several factors, including the likelihood and amount, if any, of future taxable income in relevant jurisdictions during the periods in which those temporary differences become deductible. We forecast taxable income by considering all available positive and negative evidence, including our history of operating income and losses and our financial plans and estimates that we use to manage the business. These assumptions require significant judgment about future taxable income. As a result, the amount of deferred tax assets considered realizable is subject to adjustment in future periods if estimates of future taxable income change. We continue to recognize our &lt;/span&gt;&lt;/div&gt;deferred tax assets as of March 31, 2021, as we believe it is more likely than not that the net deferred tax assets will be realized, with the exception of certain net operating losses and credits that are expected to expire unutilized which have a valuation allowance.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfMjg2Nw_2a69526c-866f-4207-a7e8-934314e67175">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes our provision for (benefit from) income taxes and our effective tax rates for the periods presented below (in thousands, except effective tax rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfMi01LTEtMS0w_55af4cd6-6eed-4785-bffb-e9e3cb52640b"
      unitRef="usd">-492000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfMi03LTEtMS0w_1544120c-7aba-4a4d-a87a-d1941e92b0e1"
      unitRef="usd">1404000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfMy01LTEtMS0w_ac19f13f-3d18-40ac-96c2-abbdfdda31cb"
      unitRef="usd">308000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfMy03LTEtMS0w_3a96b4cf-6166-48cf-a1d0-760b0405e091"
      unitRef="usd">-2048000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfNC01LTEtMS0w_ac09a784-9344-4654-b6a3-1becaa9cdbcf"
      unitRef="number">-0.626</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RhYmxlOjdhY2ZjMDRiOTM0NDRhZjI4NzU4ZDZjYTdhNjdjMTFiL3RhYmxlcmFuZ2U6N2FjZmMwNGI5MzQ0NGFmMjg3NThkNmNhN2E2N2MxMWJfNC03LTEtMS0w_817e60ff-63f4-40de-980d-6696db9eb668"
      unitRef="number">-1.459</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfNzY0_5935a5af-1139-4af3-9212-cd05ac121bf8"
      unitRef="usd">300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfODA2_ac09a784-9344-4654-b6a3-1becaa9cdbcf"
      unitRef="number">-0.626</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfMTA0Ng_f3f36a12-31c2-4f93-ab21-2a1bbd78cf31"
      unitRef="usd">-2000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6e9f1381cfdc4ef4b315b101fe190466_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV83My9mcmFnOmFkYTI1MWJmY2EyYzRiNTNhMmE4Zjk1ZDk2ZTRkZjhlL3RleHRyZWdpb246YWRhMjUxYmZjYTJjNGI1M2EyYThmOTVkOTZlNGRmOGVfMTA4OA_817e60ff-63f4-40de-980d-6696db9eb668"
      unitRef="number">-1.459</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjU2MzA1_56d59c64-0779-4c42-b741-79ce4201d288">Subsequent Event On April 30, 2021, we issued and sold to Echelon Health SPV, LP ("H.I.G."), an investment vehicle of H.I.G. Capital, in a private placement, 2,250,000 shares of our newly designated Series A convertible preferred stock, in par value of $0.001 per share (&#x201c;Series A Preferred Stock&#x201d;), at an aggregate purchase price of $225.0&#160;million, at a price of $100 per share. We received $216.2&#160;million in proceeds from the private placement with H.I.G., net of sales commissions and certain transaction fees.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ib2c1d434f2124892a124c74f776eff75_D20210430-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjU2MzA5_7bc5e910-a220-4aaf-87bd-78de3936650c"
      unitRef="shares">2250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib293ecab870b425a8366eb79aa2bf444_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjU4Mzk5_dbff6f42-3684-4733-8df0-d967bef885e7"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <ehth:SaleOfStockConsiderationReceivedOnTransactionGross
      contextRef="ib2c1d434f2124892a124c74f776eff75_D20210430-20210430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjU2MzIw_0ce5af13-77eb-463e-a390-14f893b3cb2a"
      unitRef="usd">225000000.0</ehth:SaleOfStockConsiderationReceivedOnTransactionGross>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ib293ecab870b425a8366eb79aa2bf444_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjU4NDA3_16a2b338-0999-4e8c-a644-919eddd4c46d"
      unitRef="usdPerShare">100</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ib2c1d434f2124892a124c74f776eff75_D20210430-20210430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUzNGU1YjBkOTk1NDQwMDE5Nzc2ZDk1MzhiODkzZjcxL3NlYzo1MzRlNWIwZDk5NTQ0MDAxOTc3NmQ5NTM4Yjg5M2Y3MV8xMjUzL2ZyYWc6NDM3YTIzMTRmNzMxNDY1NWEwMzExNzc0MmYwNjA1NTIvdGV4dHJlZ2lvbjo0MzdhMjMxNGY3MzE0NjU1YTAzMTE3NzQyZjA2MDU1Ml8yMTk5MDIzMjYzMjc2_2a67a5a1-561c-4fd4-9241-014f65b430c3"
      unitRef="usd">216200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814420960472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 23, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EHEALTH, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2357876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2625 AUGUSTINE DRIVE, SECOND FLOOR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">SANTA CLARA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">584-2700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EHTH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,091,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001333493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814417635976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 92,250<span></span>
</td>
<td class="nump">$ 43,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">33,922<span></span>
</td>
<td class="nump">49,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,847<span></span>
</td>
<td class="nump">1,799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets &#8211; commissions receivable &#8211; current</a></td>
<td class="nump">180,276<span></span>
</td>
<td class="nump">219,153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">12,325<span></span>
</td>
<td class="nump">16,661<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">320,620<span></span>
</td>
<td class="nump">330,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetNoncurrent', window );">Contract assets &#8211; commissions receivable &#8211; non-current</a></td>
<td class="nump">561,571<span></span>
</td>
<td class="nump">573,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">14,869<span></span>
</td>
<td class="nump">14,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">41,284<span></span>
</td>
<td class="nump">42,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">3,354<span></span>
</td>
<td class="nump">3,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">8,393<span></span>
</td>
<td class="nump">8,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">40,233<span></span>
</td>
<td class="nump">40,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">27,471<span></span>
</td>
<td class="nump">26,455<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,017,795<span></span>
</td>
<td class="nump">1,040,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">10,944<span></span>
</td>
<td class="nump">36,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">24,630<span></span>
</td>
<td class="nump">20,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_AccruedMarketingExpenses', window );">Accrued marketing expenses</a></td>
<td class="nump">11,076<span></span>
</td>
<td class="nump">17,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities &#8211; current</a></td>
<td class="nump">5,316<span></span>
</td>
<td class="nump">5,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">877<span></span>
</td>
<td class="nump">308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">4,270<span></span>
</td>
<td class="nump">3,657<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">57,113<span></span>
</td>
<td class="nump">84,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes &#8211; non-current</a></td>
<td class="nump">71,748<span></span>
</td>
<td class="nump">72,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities &#8211; non-current</a></td>
<td class="nump">39,984<span></span>
</td>
<td class="nump">41,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">5,025<span></span>
</td>
<td class="nump">4,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">728,213<span></span>
</td>
<td class="nump">721,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost</a></td>
<td class="num">(199,998)<span></span>
</td>
<td class="num">(199,998)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">315,355<span></span>
</td>
<td class="nump">316,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">317<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">843,925<span></span>
</td>
<td class="nump">837,558<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,017,795<span></span>
</td>
<td class="nump">$ 1,040,022<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_AccruedMarketingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total carrying values as of the balance sheet date of liabilities incurred through that date and payable for obligations related to marketing and advertising services received from vendors. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_AccruedMarketingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814417605672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 134,214<span></span>
</td>
<td class="nump">$ 106,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">996<span></span>
</td>
<td class="nump">1,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Marketing and advertising</a></td>
<td class="nump">50,874<span></span>
</td>
<td class="nump">37,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CustomerCareAndEnrollmentExpense', window );">Customer care and enrollment</a></td>
<td class="nump">34,162<span></span>
</td>
<td class="nump">30,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_TechnologyAndContentExpense', window );">Technology and content</a></td>
<td class="nump">23,163<span></span>
</td>
<td class="nump">15,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">23,054<span></span>
</td>
<td class="nump">19,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">2,431<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">134,856<span></span>
</td>
<td class="nump">105,377<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="num">(642)<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before provision for (benefit from) income taxes</a></td>
<td class="num">(492)<span></span>
</td>
<td class="nump">1,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="nump">308<span></span>
</td>
<td class="num">(2,048)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (800)<span></span>
</td>
<td class="nump">$ 3,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average number of shares used in per share amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">26,620<span></span>
</td>
<td class="nump">24,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">26,620<span></span>
</td>
<td class="nump">26,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (800)<span></span>
</td>
<td class="nump">$ 3,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized holding gain (loss) for available for sales debt securities, net of tax</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="num">(833)<span></span>
</td>
<td class="nump">3,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMember', window );">Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">127,052<span></span>
</td>
<td class="nump">99,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 7,162<span></span>
</td>
<td class="nump">$ 6,739<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CustomerCareAndEnrollmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period related to providing customer care and enrollment services. These services include pre-sales assistance to applicants who call our customer care center and enrollment services to applicants during the underwriting process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CustomerCareAndEnrollmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_TechnologyAndContentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for technology and content. Technology and content expenses consist primarily of compensation and benefits costs for personnel associated with developing and enhancing our website technology as well as maintaining our website.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_TechnologyAndContentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814418442040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative effect from the adoption of ASU 2016-13</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative effect from the adoption of ASU 2016-13</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 527,164<span></span>
</td>
<td class="num">$ (1,147)<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 455,159<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">$ 271,852<span></span>
</td>
<td class="num">$ (1,147)<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans</a></td>
<td class="nump">1,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations</a></td>
<td class="num">(4,375)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,375)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">8,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">3,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued in equity offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued in equity offering</a></td>
<td class="nump">228,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">228,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Settlement of earnout liability (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Settlement of earnout liability</a></td>
<td class="nump">28,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Mar. 31, 2020</a></td>
<td class="nump">791,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">717,380<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">274,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2020</a></td>
<td class="nump">837,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">721,013<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">316,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans</a></td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations</a></td>
<td class="num">(5,037)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,037)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">11,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Mar. 31, 2021</a></td>
<td class="nump">$ 843,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 728,213<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">$ 315,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 317<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814418498392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (800)<span></span>
</td>
<td class="nump">$ 3,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization</a></td>
<td class="nump">1,138<span></span>
</td>
<td class="nump">823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Amortization of internally developed software</a></td>
<td class="nump">2,806<span></span>
</td>
<td class="nump">1,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">11,402<span></span>
</td>
<td class="nump">8,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(570)<span></span>
</td>
<td class="num">(2,141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">420<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(48)<span></span>
</td>
<td class="nump">1,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_IncreaseDecreaseInCommissionsReceivable', window );">Contract assets &#8211; commissions receivable</a></td>
<td class="nump">50,635<span></span>
</td>
<td class="nump">26,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other assets</a></td>
<td class="nump">4,225<span></span>
</td>
<td class="num">(159)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(25,826)<span></span>
</td>
<td class="num">(16,279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="nump">4,088<span></span>
</td>
<td class="num">(11,104)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_IncreaseDecreaseInAccruedMarketingExpenses', window );">Accrued marketing expenses</a></td>
<td class="num">(6,712)<span></span>
</td>
<td class="num">(7,329)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">570<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">2,009<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">42,809<span></span>
</td>
<td class="nump">8,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopSoftware', window );">Capitalized internal-use software and website development costs</a></td>
<td class="num">(3,242)<span></span>
</td>
<td class="num">(3,564)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment and other assets</a></td>
<td class="num">(1,899)<span></span>
</td>
<td class="num">(2,508)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(7,771)<span></span>
</td>
<td class="num">(58,064)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from redemption and maturities of marketable securities</a></td>
<td class="nump">23,409<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">10,497<span></span>
</td>
<td class="num">(64,136)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">228,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from exercise of common stock options</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards', window );">Repurchase of shares to satisfy employee tax withholding obligations</a></td>
<td class="num">(5,037)<span></span>
</td>
<td class="num">(4,375)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Acquisition-related contingent payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,751)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Principal payments in connection with leases</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(4,790)<span></span>
</td>
<td class="nump">215,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">48,491<span></span>
</td>
<td class="nump">160,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">47,113<span></span>
</td>
<td class="nump">26,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">$ 95,604<span></span>
</td>
<td class="nump">$ 187,520<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_IncreaseDecreaseInAccruedMarketingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in accrued marketing expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_IncreaseDecreaseInAccruedMarketingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_IncreaseDecreaseInCommissionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Commissions Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_IncreaseDecreaseInCommissionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415873720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Business and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Business and Significant Accounting Policies</a></td>
<td class="text">Summary of Business and Significant Accounting Policies<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eHealth, Inc. (the &#8220;Company,&#8221; &#8220;eHealth,&#8221; &#8220;we&#8221; or &#8220;us&#8221;) is a leading health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform is designed to meet the consumer wherever they prefer to engage with us, and enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over 200 health insurance carriers across all fifty states and the District of Columbia.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Basis of Presentation &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accompanying condensed consolidated balance sheets as of March 31, 2021 and December 31, 2020 and the condensed consolidated statements of comprehensive income (loss), stockholders&#8217; equity, and cash flows for the three months ended March 31, 2021 and 2020, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2020 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 26, 2021. The accompanying financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and reflect all normal recurring adjustments that are necessary to present fairly the results for the interim periods presented. The condensed consolidated financial statements include the accounts of eHealth, Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with those rules and regulations. Certain prior period amounts have been reclassified to conform with our current period presentation. However, we believe that the disclosures made are adequate to make the information not misleading. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 and include all adjustments necessary for the fair presentation of our financial position as of March 31, 2021 and December 31, 2020, and our results of operations for the periods presented. Our financial position as of March 31, 2021 and results of operations and cash flows for the three months ended March 31, 2021 were not materially impacted by the COVID-19 pandemic but the Company is continuously assessing the evolving situation related to the pandemic. The results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for any subsequent period or for the year ending December 31, 2021 and therefore should not be relied upon as an indicator of future results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2020, we identified certain errors, including a $3.0&#160;million under-recognition of stock-based compensation expense and a $1.5&#160;million over-recognition of licensing costs for the year ended December 31, 2020. We adjusted for these items in the first quarter of 2021 and the adjustments reduced our net income (loss) by approximately $1.5&#160;million in our Condensed Consolidated Statement of Comprehensive Income (Loss) for the three months ended March 31, 2021.</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluated the effects of these out-of-period adjustments, both qualitatively and quantitatively, and concluded that the errors and the correction thereof were immaterial both individually and in the aggregate to the current reporting period and the periods in which they originated, including quarterly reporting.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies, Estimates and Judgments &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates, judgments and </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to, but not limited to, the useful lives of intangible assets, fair value of investments, recoverability of intangible assets, the commissions we expect to collect for each approved member cohort, valuation allowance for deferred income taxes, provision (benefit) for income taxes and the assumptions used in determining stock-based compensation. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. Actual results may differ from these estimates. There have been no material changes to our significant accounting policies discussed in our Annual Report on Form 10-K for the year ended December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Seasonality &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open enrollment periods drive the seasonality of our business. A greater number of our Medicare-related health insurance plans are sold in our fourth quarter during the Medicare annual enrollment period when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, our Medicare plan-related commission revenue is highest in our fourth quarter. Any changes or additional enrollment periods may change the seasonality of our business. For instance, due to the reintroduction of the Medicare Advantage open enrollment period that takes place in the first quarter of the year, our first quarter is generally the second-highest revenue generating quarter.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our individual and family health insurance plans are sold in the fourth quarter during the annual open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. Individuals and families generally are not able to purchase individual and family health insurance outside of these open enrollment periods, unless they qualify for a special enrollment period as a result of certain qualifying events, such as losing employer-sponsored health insurance or moving to another state due to the recent COVID-19 pandemic.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncement</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Income Taxes (Topic 740) &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In December 2019, the FASB issued ASU No. 2019-12, Income Tax, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">, which aims to simplify the accounting for income taxes. We adopted this guidance in the first quarter of 2021 and it did not have a material impact on our condensed consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">. ASU 2020-10 is intended to facilitate codification updates for technical corrections, such as conforming amendments, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements. It contains amendments that improve the consistency of the codification by including all disclosure guidance in the appropriate disclosure section and other updates that varies in nature. We adopted this guidance in the first quarter of 2021 with no material impact on our condensed consolidated financial statements and disclosures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Debt with Conversion and Other Options (Topic 470) and Contracts in Entity's Own Equity (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> &#8211; In June 2020, the FASB issued ASU No. 2020-06 to simplify the accounting for convertible instruments and improve the usefulness and relevance of information regarding convertible instruments. This ASU reduces the number of accounting models for converting debt instruments and convertible preferred stock. ASU No. 2020-06 is effective for us in 2022, with early adoption permitted. We have early adopted this guidance in the first quarter of 2021 and it did not have a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814422060616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below depicts the disaggregation of revenue by product and is consistent with how we evaluate our financial performance (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual and Family </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Health Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Individual and Family</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ancillary</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Ancillary</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commission Bonus</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,052&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,669&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsorship and Advertising Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,739&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,214&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">We define our individual and family plan offerings as major medical individual and family health insurance plans, which does not include Medicare-related, small business or ancillary plans. Individual and family health insurance plans include both qualified and non-qualified plans. Qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are offered through the government-run health insurance exchange in the relevant jurisdiction. Non-qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are not offered through the exchange in the relevant jurisdiction. Individuals that purchase non-qualified health plans cannot receive a subsidy in connection with the purchase of non-qualified plans.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commission revenue by segment is presented in the table below (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare Segment Commission Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual, Family and Small Business</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total IFP/SMB Segment Commission Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,052&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,669&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts include commission bonus revenue.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts reflect our revised estimates of cash collections for certain members approved prior to the relevant reporting period that are recognized as adjustments to revenue within the relevant reporting period. The net adjustment revenue includes both increases in revenue for certain prior period cohorts as well as reductions in revenue for certain prior period cohorts. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">The impacts of total net commission revenue from members approved in prior periods were $0.12 and $0.42 per basic share, respectively, or $0.12 and $0.40 per diluted share, respectively, for the three months ended March 31, 2021 and 2020, respectively. The total reductions to revenue from members approved in prior periods were $0.9 million</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for the three months ended March 31, 2021 and immaterial for the three months ended March 31, 2020. These reductions to revenue primarily related to the Individual, Family and Small Business segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415965944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statement Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Supplemental Financial Statement Information</a></td>
<td class="text">Supplemental Financial Statement Information<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all investments with an original maturity of 90 days or less from the date of purchase to be cash equivalents. Cash and cash equivalents are stated at fair value. We also invest in marketable securities that are measured and recorded at fair value. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion about our marketable securities. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.078%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021 and December 31, 2020, we had $3.4 million of restricted cash which was classified as a non-current asset on our Condensed Consolidated Balance Sheets. This amount collateralizes letters of credit related to certain lease commitments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Accounts Receivable</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not require collateral or other security for our contract assets and accounts receivable. We believe the potential for collection issues with any of our customers was minimal as of March 31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimate an allowance for credit losses using relevant available information from internal and external sources, related to past events, current conditions, and reasonable and supportable forecasts. Specifically, for the purpose of measuring the probability of default parameters, we utilize Capital IQ&#8217;s, Standard &amp; Poor&#8217;s and Moody&#8217;s analytics. Our estimates of loss given default are determined by using our historical collections data as well as historical information obtained through our research and review of other insurance related companies. Our estimated exposure at default is determined by applying these internal and external data sources to our commission receivable balances. As such, we apply an immediate reversion method and revert to historical loss information when computing our credit loss exposure. Credit loss expenses are assessed quarterly and included in general and administrative expense on our Condensed Consolidated Statement of Comprehensive Income (Loss). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered the impact of recent events and global economic conditions when evaluating the appropriate adjustments to our allowance for credit losses as of March 31, 2021. Determining the extent of these adjustments in the three months ended March 31, 2021 was especially challenging because we do not have any historical loss information for a period of similar economic uncertainty. We also considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the allowance for credit losses for the three months ended March 31, 2021 is summarized as follows (in thousands):&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.199%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract assets &#8211; commission receivable activities, net of credit loss allowances&#160;are summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue adjustments from members approved in prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,012)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,737&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,110&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue adjustments from members approved in prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,811)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126,542)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,721&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,996&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">560,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments that are exposed to concentrations of credit risk principally consist of cash, cash equivalents, marketable securities, contract assets &#8211; commissions receivable, and accounts receivable. We invest our cash and cash equivalents with major banks and financial institutions and, at times, such investments are in excess of federally insured limits. We also have deposits with major banks in China that are denominated in both U.S. dollars and Chinese Yuan Renminbi and are not insured by the U.S. federal government. The deposits in China were $3.5&#160;million as of March 31, 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information regarding our marketable securities.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not require collateral or other security for either our contract assets or accounts receivable. Carriers that represented 10% or more of our total contract assets and accounts receivable balance are summarized as of the dates presented below:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthCare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the contract assets and accounts receivable of WellCare are included in the percentage calculation for March 31, 2021 and December 31, 2020.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid Expenses and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets &#8211; Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prepaid expenses and other current assets are summarized as of the periods presented as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid maintenance contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415691096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define fair value as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques we use to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. We classify the inputs used to measure fair value into the following hierarchy:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:90.129%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for identical assets or liabilities.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs for the asset or liability.</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial assets measured at fair value on a recurring basis are summarized below by their classification within the fair value hierarchy as of the dates presented below (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,846&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,244&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,846&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.366%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.142%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,620&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash equivalents were invested in money market funds and commercial paper with original maturity of 90 days or less were classified as Level 1. We endeavor to utilize the best available information in measuring fair value. We used observable prices in active markets in determining the classification of our money market funds as Level 1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, our Level 2 assets included our available for sale marketable securities, which consisted of commercial paper and agency bonds with maturity less than one year. We classify our marketable debt securities within Level 2 in the fair value hierarchy, because we use quoted market prices to the extent available or alternative pricing sources and models utilizing market observable inputs to determine fair value. Our portfolio primarily consisted of financial instruments with a credit rating of AA or equivalent by S&amp;P Rating and Moody's Investor Services. There were no transfers between the hierarchy levels during the three months ended March 31, 2021 and year ended December 31, 2020. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash equivalents and available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains and losses on available-for-sale debt securities that are not credit related are included in accumulated other comprehensive income and summarized as follows as of March 31, 2021 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,846&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>As of March 31, 2021, there were twelve securities in net loss positions and their unrealized losses were immaterial. We did not record any credit losses regarding our available-for-sales debt securities during the three months ended March 31, 2021. We do not intend to sell these securities and it is more likely than not that we will not be required to sell these securities before the recovery of their amortized cost basis.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415745864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Equity</a></td>
<td class="text">Equity<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Offering of Common Stock &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to an effective registration statement that was filed on December 17, 2018, and amended on January 22, 2019 and March 2, 2020, we entered into an underwriting agreement in March 2020 to issue a total of 2.1 million shares of common stock, which included the exercise in full of the underwriters&#8217; option to purchase 0.3 million additional shares of common stock, at a price to the public of&#160;$115.00&#160;per share in March 2020. Net proceeds from the offering were approximately&#160;$228.0 million&#160;after deducting underwriting discounts, commissions and expenses of the offering.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Programs &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no stock repurchase activity during the three months ended March 31, 2021. In addition to 10.7 million shares repurchased under our previous repurchase programs, we have in treasury 1.2 million shares as of March 31, 2021 that were previously surrendered by employees to satisfy tax withholding due in connection with the vesting of certain restricted stock units. As of March 31, 2021 and December 31, 2020, we had a total of 11.9 million shares and 11.8 million shares, respectively, held in treasury.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. Such repurchased shares are held in treasury and are presented using the cost method.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock-based compensation expense is summarized as follows by award types (in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units*</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,402&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Amounts include market-based and performance-based RSUs.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense by operating function for the periods presented below&#160;(in thousands):&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount capitalized in internal-use software</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,952&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814414389064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text">Net Income (Loss) Per Share<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding for the period. Diluted net income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all potential dilutive common stock equivalent shares, including options, restricted stock units and shares to be issued under our ESPP. The dilutive effect of outstanding awards is reflected in diluted net income (loss) per share by application of the treasury stock method.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share amounts):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation &#8211; basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of common stock</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in diluted share calculation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per share &#8211; basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per share &#8211; diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each of the three months ended March 31, 2021 and 2020, we had securities outstanding that could potentially dilute per share amounts, but the shares from the assumed conversion or exercise of these securities were excluded in the computation of diluted net income (loss) per share as their effect would have been anti-dilutive. The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,460&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;There were no antidilutive shares for this period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814414077896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service and Licensing Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into service and licensing agreements with third party vendors to provide various services, including network access, equipment maintenance, and software licensing. As the benefits of these agreements are experienced uniformly over the applicable contractual periods, we record the related service and licensing expenses on a straight-line basis, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future minimum payments under non-cancellable contractual service and licensing obligations as of March 31, 2021 (in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,225&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for commitments related to our operating leases.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, we receive inquiries from governmental bodies and also may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our condensed consolidated financial statements. An estimated loss contingency is accrued in the condensed consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. There was no material litigation-related accrual during the three months ended March 31, 2021. Legal proceedings or other contingencies could result in material costs, even if we ultimately prevail.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Securities Class Action </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8211; On April 8, 2020 and April 30, 2020, two purported class action lawsuits were filed against us, our chief executive officer, Scott N. Flanders, our chief financial officer, Derek N. Yung, and our then-chief operating officer, David K. Francis, in the United States District Court for the Northern District of California. The cases are captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Patel v. eHealth, Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">., Case No. 5:20-cv-02395 (N.D. Cal.) and Bertrand v. eHealth, Inc. et al., Case No. 4:20-cv-02967 (N.D. Cal.). The complaints allege, among other things, that we and Messrs. Flanders, Yung and Francis made materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn and our profitability during the alleged class period of March 19, 2018 to April 7, 2020. The complaints allege that we and Messrs. Flanders, Yung and Francis violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The complaints seek compensatory and (in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Patel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuit) punitive damages, attorneys&#8217; fees and costs, and such other relief as the court deems proper. On June 24, 2020, the Court consolidated the above-referenced matters under the caption</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> In re eHealth Securities Litig.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Master File No. 4:20-cv-02395-JST (N.D. Cal.). The Court also appointed a lead plaintiff and lead counsel for the consolidated matter. The lead plaintiff filed an amended complaint on August 25, 2020, which Defendants moved to dismiss.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The motion to dismiss has been fully briefed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Derivative Actions &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 7, 2020 and October 13, 2020, two derivative lawsuits were filed against our chief executive officer, Mr. Flanders, our chief financial officer, Mr. Yung, our then-chief operating officer, Mr. Francis, and the members of our Board of Directors (collectively, the &#8220;Individual Defendants&#8221;), in the United States District Court for the Northern District of California and the Superior Court of California, County of Santa Clara. The cases are captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet v. Flanders et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">., Case No. 3:20-cv-04477-SK (N.D. Cal.), and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire Police Pension Fund v. Flanders et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Case No. 20CV371555 (Cal. Super. Ct.), and also name the Company as a nominal defendant. The complaints allege, among other things, that beginning on March 19, 2018, the Individual Defendants made or caused the Company to make materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn, profitability, and internal controls. Both complaints purport to assert claims for breach of fiduciary duty, unjust enrichment and waste of corporate assets. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuit also alleges that the Individual Defendants violated Sections 14(a), 10(b), and 20(a) of the Securities Exchange Act of 1934, and asserts claims for abuse of control and gross mismanagement. The complaints seek damages, restitution, attorneys&#8217; fees and costs, and certain measures with respect to the Company&#8217;s corporate governance and internal procedures, and (in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuit) equitable and/or injunctive relief. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuits have both been stayed pending the resolution of the motion to dismiss in the Securities Class Action, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re eHealth Securities Litig</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">., Master File No. 4:20-cv-02395-JST (N.D. Cal.).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The Gonzalez and Le</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Vias Complaints</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; On April 6, 2018, a former employee, Lupita Gonzalez, filed a complaint against us in the Superior Court of the State of California for the County of Sacramento (the &#8220;Gonzalez Complaint&#8221;). On July 1, 2019, two other current or former employees, Michael Le&#8217;Vias and Ramona Meadows, filed a related complaint against us and eHealth Ins. Serv. Co., in the Superior Court of the State of California for the County of Santa Clara (the &#8220;Le&#8217;Vias Complaint&#8221;). Both complaints asserted claims under the California Private Attorney General Act (&#8220;PAGA&#8221;) on behalf of all current and former hourly-paid or non-exempt employees who work or have worked for us in California, based on alleged failures to comply with California wage and hour laws.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties have entered into a court-approved settlement agreement that resolves both matters related to the Gonzalez and Le'Vias Complaints, and Plaintiffs Michael Le&#8217;Vias and Ramona Meadows have sought dismissal with prejudice of the Le&#8217;Vias Complaint. Upon the completion of the distribution of the settlement funds in accordance with the settlement agreement and the court order approving the settlement agreement, the parties will seek a dismissal with prejudice of the Gonzalez Complaint.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments, contingencies, and guarantees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI http://asc.fasb.org/topic&amp;trid=2155896<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814414415704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographic Information</a></td>
<td class="text">Segment and Geographic Information<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Segments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report segment information based on how our chief executive officer, who is our chief operating decision maker ("CODM"), regularly reviews our operating results, allocates resources and makes decisions regarding our business operations. The performance measures of our segments include total revenue and profit. Our business structure is comprised </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of&#160;two&#160;operating segments: Medicare and Individual, Family and Small Business. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Business and Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Part II, Item 8 of the Annual Report on Form 10-K for the year ended December 31, 2020 for our accounting policies relating to operating segments.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of our operating segments are summarized for the periods presented below (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,408&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment profit:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,064&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,714)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,944)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(492)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $2.8 million and $1.5 million for the first quarter of 2021 and 2020, respectively.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Depreciation and amortization has been adjusted to include amortization of software development costs. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no inter-segment revenue transactions for the periods presented. With the exception of contract assets &#8211; commissions receivable, which is presented by segment in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Financial Statement Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our CODM does not separately evaluate assets by segment, and therefore, assets by segment are not presented. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-lived assets primarily consist of property and equipment and internally-developed software. Our long-lived assets are attributed to the geographic location in which they are located. Long-lived assets by geographical area are summarized as follows (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,340&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,065&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all revenue for the three months ended March 31, 2021 and 2020&#160;was generated from customers located in the United States. Carriers representing 10% or more of our total revenue are summarized as follows:&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the revenue of WellCare is included in the percentage calculation for March 31, 2021 and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415731752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases have remaining lease terms of 3 to 9 years. Certain of these leases have free or escalating rent payment provisions. We recognize lease expense on a straight-line basis over the terms of the leases, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. Most leases include options to renew, and the exercise of these options is at our discretion.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expenses were $2.0 million and $2.1 million for the three months ended March 31, 2021 and 2020, respectively and sublease income was immaterial for both periods.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the lease-related assets and liabilities recorded on the Condensed Consolidated Balance Sheets as of the dates presented below (in thousands):</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities &#8211; current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities &#8211; non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,561&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases are as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,090</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term of operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate used to recognize operating lease right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, maturities of operating lease liabilities are as follows (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Noncancellable sublease income for the remainder of 2021 and years ending December 31, 2022 and 2023 of $0.9 million, $0.4 million and $0.4 million, respectively, is not included in the table above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415988648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring</a></td>
<td class="text">Restructuring<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, we eliminated approximately 89 full-time positions, primarily in the United States, representing approximately 5% of our workforce, primarily within our customer care and enrollment group, and to a lesser extent, in our marketing and advertising, technology and content, and general and administrative groups.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total pre-tax restructuring charges for the three months ended March 31, 2021 were $2.4&#160;million, which primarily related to employee termination benefits. Substantially all of the restructuring charges resulted in cash expenditures. The restructuring activities were completed by March&#160;31, 2021. Accrued restructuring charges balance was $0.3&#160;million as of March 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814414351592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 17, 2018, we entered into a Credit Agreement with Royal Bank of Canada (&#8220;RBC&#8221;), as administrative agent and collateral agent (the &#8220;Credit Agreement&#8221;). The Credit Agreement provides for a $40.0 million secured asset-backed revolving credit facility with a $5.0 million letter of credit sub-facility. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2019, we amended our revolving credit facility agreement with RBC (the &#8220;Amendment&#8221;) and increased the borrowing amount from $40.0 to $75.0&#160;million. The maturity date has been extended to December 20, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowing base under the Credit Agreement is comprised of an amount equal to (a) the lesser of (i) eighty percent (80%) of Eligible Commissions Receivables (as defined in the Credit Agreement) we actually collected during the immediately preceding period of three months or (ii) eighty percent (80%) of our Eligible Commission Receivables for the immediately succeeding period of three months, plus (b) fifty percent (50%) of our Eligible Commission Receivables for the immediately succeeding period of six months (excluding the immediately succeeding period of three months), in each case subject to reserves established by RBC (the &#8220;Borrowing Base&#8221;). The proceeds of the loans under the Credit Agreement may be used for working capital and general corporate purposes. The borrowers have the right to prepay the loans under the Credit Agreement in whole or in part at any time without penalty. Subject to availability under the Borrowing Base, amounts repaid may be reborrowed. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts not borrowed under the Credit Agreement will be subject to a commitment fee of 0.5% per annum on the daily unused portion of the credit facility, to be paid in arrears on the first business day of each calendar quarter. At the closing of the Credit Agreement, we paid a one-time facility fee of 1.75% of the total commitments of $40.0&#160;million. We also paid a one-time closing fee of 0.5% of the new commitment of $75.0&#160;million in connection with the Amendment. The Company is also obligated to pay other customary administration fees for a credit facility of this size and type. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability under the credit facility was up to the lesser of $40.0 million or the Borrowing Base in the original credit agreement. The Amendment increased the availability up to the lesser of $75.0 million or the Borrowing Base, which may be reduced from time to time pursuant to the Credit Agreement.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial covenants in the original Credit Agreement required that we maintain Excess Availability (as defined in the Credit Agreement) at or above $6.0 million at any time. The Amendment also changed the financial covenants to require us to maintain at least $6.0&#160;million of Excess Availability at all times or, if greater, up to $11.3&#160;million depending on our borrowing base as determined by eligible past and future commissions receivable. In addition, the Amendment also included changes in the payment conditions to, among other things, require us to have at least $10.0&#160;million of liquidity or, if greater, up to $18.8&#160;million depending on our borrowing base as determined by eligible past and future commissions receivable, in order for us to make certain permitted acquisitions, investments, distributions and payments of indebtedness. The Amendment also stated the seasonal amount thresholds used in connection with the cash dominion and field examination covenants in the Credit Agreement. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred $1.2 million of issuance costs in connection with the Credit Agreement, which were capitalized as part of other assets on our Consolidated Balance Sheet in the period we entered into the Credit Agreement. The Amendment did not change the interest rate. In connection with the Amendment, we incurred closing costs totaling $0.5&#160;million, which were capitalized and recorded as other assets on our Condensed Consolidated Balance Sheet as of March 31, 2021. The remaining balance of unamortized issuance costs was $0.7&#160;million as of March 31, 2021 and December 31, 2020. </span></div>As of March 31, 2021, we had no outstanding borrowings under our revolving credit facility.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814422060616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes our provision for (benefit from) income taxes and our effective tax rates for the periods presented below (in thousands, except effective tax rate):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(492)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three months ended March 31, 2021, we recognized a provision for income taxes of $0.3&#160;million, representing an effective tax rate of (62.6)%, which was lower than the statutory federal tax rate due primarily to one-time state tax adjustments. For the three months ended March 31, 2020, we recognized a benefit from income taxes of $2.0&#160;million, representing an effective tax rate of (145.9)%, which was lower than the statutory federal tax rate due primarily to stock-based compensation windfalls.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assessing the realizability of our deferred tax assets is dependent upon several factors, including the likelihood and amount, if any, of future taxable income in relevant jurisdictions during the periods in which those temporary differences become deductible. We forecast taxable income by considering all available positive and negative evidence, including our history of operating income and losses and our financial plans and estimates that we use to manage the business. These assumptions require significant judgment about future taxable income. As a result, the amount of deferred tax assets considered realizable is subject to adjustment in future periods if estimates of future taxable income change. We continue to recognize our </span></div>deferred tax assets as of March 31, 2021, as we believe it is more likely than not that the net deferred tax assets will be realized, with the exception of certain net operating losses and credits that are expected to expire unutilized which have a valuation allowance.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415884648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">Subsequent Event On April 30, 2021, we issued and sold to Echelon Health SPV, LP ("H.I.G."), an investment vehicle of H.I.G. Capital, in a private placement, 2,250,000 shares of our newly designated Series A convertible preferred stock, in par value of $0.001 per share (&#8220;Series A Preferred Stock&#8221;), at an aggregate purchase price of $225.0&#160;million, at a price of $100 per share. We received $216.2&#160;million in proceeds from the private placement with H.I.G., net of sales commissions and certain transaction fees.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814342492696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Business and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DescriptionOfBusinessPolicyPolicyTextBlock', window );">Description of Business</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eHealth, Inc. (the &#8220;Company,&#8221; &#8220;eHealth,&#8221; &#8220;we&#8221; or &#8220;us&#8221;) is a leading health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform is designed to meet the consumer wherever they prefer to engage with us, and enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over 200 health insurance carriers across all fifty states and the District of Columbia.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Basis of Presentation &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accompanying condensed consolidated balance sheets as of March 31, 2021 and December 31, 2020 and the condensed consolidated statements of comprehensive income (loss), stockholders&#8217; equity, and cash flows for the three months ended March 31, 2021 and 2020, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2020 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 26, 2021. The accompanying financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and reflect all normal recurring adjustments that are necessary to present fairly the results for the interim periods presented. The condensed consolidated financial statements include the accounts of eHealth, Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with those rules and regulations. Certain prior period amounts have been reclassified to conform with our current period presentation. However, we believe that the disclosures made are adequate to make the information not misleading. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 and include all adjustments necessary for the fair presentation of our financial position as of March 31, 2021 and December 31, 2020, and our results of operations for the periods presented. Our financial position as of March 31, 2021 and results of operations and cash flows for the three months ended March 31, 2021 were not materially impacted by the COVID-19 pandemic but the Company is continuously assessing the evolving situation related to the pandemic. The results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for any subsequent period or for the year ending December 31, 2021 and therefore should not be relied upon as an indicator of future results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2020, we identified certain errors, including a $3.0&#160;million under-recognition of stock-based compensation expense and a $1.5&#160;million over-recognition of licensing costs for the year ended December 31, 2020. We adjusted for these items in the first quarter of 2021 and the adjustments reduced our net income (loss) by approximately $1.5&#160;million in our Condensed Consolidated Statement of Comprehensive Income (Loss) for the three months ended March 31, 2021.</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluated the effects of these out-of-period adjustments, both qualitatively and quantitatively, and concluded that the errors and the correction thereof were immaterial both individually and in the aggregate to the current reporting period and the periods in which they originated, including quarterly reporting.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Significant Accounting Policies, Estimates and Judgments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies, Estimates and Judgments &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates, judgments and </span>assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to, but not limited to, the useful lives of intangible assets, fair value of investments, recoverability of intangible assets, the commissions we expect to collect for each approved member cohort, valuation allowance for deferred income taxes, provision (benefit) for income taxes and the assumptions used in determining stock-based compensation. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. Actual results may differ from these estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SeasonalityPolicyPolicyTextBlock', window );">Seasonality</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Seasonality &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open enrollment periods drive the seasonality of our business. A greater number of our Medicare-related health insurance plans are sold in our fourth quarter during the Medicare annual enrollment period when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, our Medicare plan-related commission revenue is highest in our fourth quarter. Any changes or additional enrollment periods may change the seasonality of our business. For instance, due to the reintroduction of the Medicare Advantage open enrollment period that takes place in the first quarter of the year, our first quarter is generally the second-highest revenue generating quarter.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our individual and family health insurance plans are sold in the fourth quarter during the annual open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. Individuals and families generally are not able to purchase individual and family health insurance outside of these open enrollment periods, unless they qualify for a special enrollment period as a result of certain qualifying events, such as losing employer-sponsored health insurance or moving to another state due to the recent COVID-19 pandemic.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncement</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncement</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Income Taxes (Topic 740) &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In December 2019, the FASB issued ASU No. 2019-12, Income Tax, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">, which aims to simplify the accounting for income taxes. We adopted this guidance in the first quarter of 2021 and it did not have a material impact on our condensed consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">. ASU 2020-10 is intended to facilitate codification updates for technical corrections, such as conforming amendments, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements. It contains amendments that improve the consistency of the codification by including all disclosure guidance in the appropriate disclosure section and other updates that varies in nature. We adopted this guidance in the first quarter of 2021 with no material impact on our condensed consolidated financial statements and disclosures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Debt with Conversion and Other Options (Topic 470) and Contracts in Entity's Own Equity (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> &#8211; In June 2020, the FASB issued ASU No. 2020-06 to simplify the accounting for convertible instruments and improve the usefulness and relevance of information regarding convertible instruments. This ASU reduces the number of accounting models for converting debt instruments and convertible preferred stock. ASU No. 2020-06 is effective for us in 2022, with early adoption permitted. We have early adopted this guidance in the first quarter of 2021 and it did not have a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DescriptionOfBusinessPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description Of Business, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DescriptionOfBusinessPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_SeasonalityPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Seasonality Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_SeasonalityPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415884088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue by Segment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below depicts the disaggregation of revenue by product and is consistent with how we evaluate our financial performance (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual and Family </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Health Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Individual and Family</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ancillary</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Ancillary</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commission Bonus</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,052&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,669&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsorship and Advertising Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,739&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,214&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">We define our individual and family plan offerings as major medical individual and family health insurance plans, which does not include Medicare-related, small business or ancillary plans. Individual and family health insurance plans include both qualified and non-qualified plans. Qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are offered through the government-run health insurance exchange in the relevant jurisdiction. Non-qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are not offered through the exchange in the relevant jurisdiction. Individuals that purchase non-qualified health plans cannot receive a subsidy in connection with the purchase of non-qualified plans.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commission revenue by segment is presented in the table below (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare Segment Commission Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual, Family and Small Business</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total IFP/SMB Segment Commission Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,052&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,669&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts include commission bonus revenue.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts reflect our revised estimates of cash collections for certain members approved prior to the relevant reporting period that are recognized as adjustments to revenue within the relevant reporting period. The net adjustment revenue includes both increases in revenue for certain prior period cohorts as well as reductions in revenue for certain prior period cohorts. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">The impacts of total net commission revenue from members approved in prior periods were $0.12 and $0.42 per basic share, respectively, or $0.12 and $0.40 per diluted share, respectively, for the three months ended March 31, 2021 and 2020, respectively. The total reductions to revenue from members approved in prior periods were $0.9 million</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for the three months ended March 31, 2021 and immaterial for the three months ended March 31, 2020. These reductions to revenue primarily related to the Individual, Family and Small Business segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415932648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statement Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule Of Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.078%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.078%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock', window );">Schedule of Change in Allowance for Credit Loss</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the allowance for credit losses for the three months ended March 31, 2021 is summarized as follows (in thousands):&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.199%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Contract Assets - Commissions Receivable</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract assets &#8211; commission receivable activities, net of credit loss allowances&#160;are summarized as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue adjustments from members approved in prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,012)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,737&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,110&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue adjustments from members approved in prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,811)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126,542)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,721&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,996&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">560,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div>(1)Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of Credit Risk</a></td>
<td class="text">Carriers that represented 10% or more of our total contract assets and accounts receivable balance are summarized as of the dates presented below:<div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthCare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the contract assets and accounts receivable of WellCare are included in the percentage calculation for March 31, 2021 and December 31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule Of Prepaid Expenses And Other Current Assets</a></td>
<td class="text">Our prepaid expenses and other current assets are summarized as of the periods presented as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid maintenance contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814416358920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">We classify the inputs used to measure fair value into the following hierarchy:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:90.129%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for identical assets or liabilities.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs for the asset or liability.</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Summary of Financial Assets Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial assets measured at fair value on a recurring basis are summarized below by their classification within the fair value hierarchy as of the dates presented below (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,846&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,244&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,846&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.366%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.142%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,620&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Summary of Contractual Maturities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash equivalents and available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Unrealized Gains and Losses</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains and losses on available-for-sale debt securities that are not credit related are included in accumulated other comprehensive income and summarized as follows as of March 31, 2021 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,846&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814414338584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock', window );">Schedule Of Stock-Based Compensation Expense By Award Type</a></td>
<td class="text">Our stock-based compensation expense is summarized as follows by award types (in thousands):&#160;<div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units*</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,402&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Amounts include market-based and performance-based RSUs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock', window );">Schedule Of Stock-Based Compensation Expense By Operating Function</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense by operating function for the periods presented below&#160;(in thousands):&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount capitalized in internal-use software</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,952&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Stock-Based Compensation Expense By Operating Function [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Stock-Based Compensation Expense [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814433435320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Income (Loss) Per Share</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share amounts):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation &#8211; basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of common stock</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in diluted share calculation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per share &#8211; basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per share &#8211; diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share consisted of the following (in thousands):<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,460&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;There were no antidilutive shares for this period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415646376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Contractual Obligations</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future minimum payments under non-cancellable contractual service and licensing obligations as of March 31, 2021 (in thousands):&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,225&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 303<br> -Paragraph (a)<br> -Subparagraph (5)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814414460200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of our operating segments are summarized for the periods presented below (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,408&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment profit:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,064&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,714)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,944)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(492)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $2.8 million and $1.5 million for the first quarter of 2021 and 2020, respectively.</span></div>(2)Depreciation and amortization has been adjusted to include amortization of software development costs.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule Of Long Lived Assets By Geographical Areas</a></td>
<td class="text">Long-lived assets by geographical area are summarized as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,340&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,065&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule Of Revenue By Major Customers</a></td>
<td class="text">Carriers representing 10% or more of our total revenue are summarized as follows:&#160;<div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the revenue of WellCare is included in the percentage calculation for March 31, 2021 and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Long Lived Assets By Geographical Areas [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415771240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Supplemental Balance Sheet Information</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the lease-related assets and liabilities recorded on the Condensed Consolidated Balance Sheets as of the dates presented below (in thousands):</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities &#8211; current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities &#8211; non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,561&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Supplemental Information</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases are as follows (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,090</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term of operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate used to recognize operating lease right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, maturities of operating lease liabilities are as follows (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Noncancellable sublease income for the remainder of 2021 and years ending December 31, 2022 and 2023 of $0.9 million, $0.4 million and $0.4 million, respectively, is not included in the table above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814414074712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule Of Components Of Income Tax Expense</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes our provision for (benefit from) income taxes and our effective tax rates for the periods presented below (in thousands, except effective tax rate):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(492)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814416751640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Business and Significant Accounting Policies - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>state </div>
<div>insurance_carrier</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_NumberOfHealthInsuranceCarriers', window );">Number of health insurance carriers (more than) | insurance_carrier</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which the Company is licensed to market and sell health insurance | state</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 11,402<span></span>
</td>
<td class="nump">$ 8,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">996<span></span>
</td>
<td class="nump">1,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Decrease in net income (loss)</a></td>
<td class="nump">800<span></span>
</td>
<td class="num">$ (3,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_UnderRecognitionOfStockBasedCompensationExpenseMember', window );">Under-Recognition Of Stock-Based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_OutOfPeriodAdjustmentsMember', window );">Out-Of-Period Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Decrease in net income (loss)</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">License | Over-Recognition Of Licensing Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_NumberOfHealthInsuranceCarriers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Health Insurance Carriers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_NumberOfHealthInsuranceCarriers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_UnderRecognitionOfStockBasedCompensationExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_UnderRecognitionOfStockBasedCompensationExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_OutOfPeriodAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_OutOfPeriodAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_OverRecognitionOfLicensingCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_OverRecognitionOfLicensingCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814425417608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 134,214<span></span>
</td>
<td class="nump">$ 106,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_MedicareMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">113,483<span></span>
</td>
<td class="nump">89,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_MedicareMember', window );">Medicare | Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">103,525<span></span>
</td>
<td class="nump">68,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_MedicareMember', window );">Medicare | Medicare Supplement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">8,222<span></span>
</td>
<td class="nump">15,170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_MedicareMember', window );">Medicare | Medicare Part D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,736<span></span>
</td>
<td class="nump">5,661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_IndividualandFamilyMember', window );">Individual and Family</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">5,467<span></span>
</td>
<td class="nump">2,656<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_IndividualandFamilyMember', window );">Individual and Family | Non-Qualified Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,367<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_IndividualandFamilyMember', window );">Individual and Family | Qualified Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">1,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_AncillariesMember', window );">Ancillary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,724<span></span>
</td>
<td class="nump">4,251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_AncillariesMember', window );">Ancillary | Short-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,756<span></span>
</td>
<td class="nump">2,216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_AncillariesMember', window );">Ancillary | Dental</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,728<span></span>
</td>
<td class="nump">743<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_AncillariesMember', window );">Ancillary | Vision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_AncillariesMember', window );">Ancillary | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_SmallBusinessMember', window );">Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,223<span></span>
</td>
<td class="nump">2,971<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionBonusMember', window );">Commission Bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,155<span></span>
</td>
<td class="nump">613<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMember', window );">Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">127,052<span></span>
</td>
<td class="nump">99,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">7,162<span></span>
</td>
<td class="nump">6,739<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Sponsorship and Advertising Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">5,814<span></span>
</td>
<td class="nump">5,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,348<span></span>
</td>
<td class="nump">$ 849<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedMedicareAxis=ehth_MedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedMedicareAxis=ehth_MedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedMedicareAxis=ehth_MedicareSupplementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedMedicareAxis=ehth_MedicareSupplementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedMedicareAxis=ehth_MedicarePartDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedMedicareAxis=ehth_MedicarePartDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_IndividualandFamilyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_IndividualandFamilyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedIndividualandFamilyAxis=ehth_NonQualifiedHealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedIndividualandFamilyAxis=ehth_NonQualifiedHealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedIndividualandFamilyAxis=ehth_QualifiedHealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedIndividualandFamilyAxis=ehth_QualifiedHealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_AncillariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_AncillariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedAncillariesAxis=ehth_ShorttermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedAncillariesAxis=ehth_ShorttermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedAncillariesAxis=ehth_DentalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedAncillariesAxis=ehth_DentalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedAncillariesAxis=ehth_VisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedAncillariesAxis=ehth_VisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedAncillariesAxis=ehth_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedAncillariesAxis=ehth_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_SmallBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_SmallBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionBonusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionBonusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedOtherAxis=ehth_SponsorshipAndAdvertisingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedOtherAxis=ehth_SponsorshipAndAdvertisingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedOtherAxis=ehth_MiscellaneousOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedOtherAxis=ehth_MiscellaneousOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814418571352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Commission Revenue by Segment (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 134,214<span></span>
</td>
<td class="nump">$ 106,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMember', window );">Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 127,052<span></span>
</td>
<td class="nump">$ 99,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember', window );">Commission revenue from members approved during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">121,073<span></span>
</td>
<td class="nump">86,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember', window );">Net commission revenue adjustments from members approved in prior period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,292<span></span>
</td>
<td class="nump">$ 10,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember', window );">Commission revenue from renewals of small business members during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 2,687<span></span>
</td>
<td class="nump">$ 2,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember', window );">Medicare | Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">114,692<span></span>
</td>
<td class="nump">90,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember', window );">Medicare | Commission revenue from members approved during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">114,678<span></span>
</td>
<td class="nump">81,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember', window );">Medicare | Net commission revenue adjustments from members approved in prior period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">8,979<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember', window );">Medicare | Commission revenue from renewals of small business members during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember', window );">Individual, Family and Small Business | Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">12,360<span></span>
</td>
<td class="nump">9,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember', window );">Individual, Family and Small Business | Commission revenue from members approved during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">6,395<span></span>
</td>
<td class="nump">5,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember', window );">Individual, Family and Small Business | Net commission revenue adjustments from members approved in prior period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,278<span></span>
</td>
<td class="nump">1,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax', window );">Decrease in revenue</a></td>
<td class="num">(900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember', window );">Individual, Family and Small Business | Commission revenue from renewals of small business members during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 2,687<span></span>
</td>
<td class="nump">$ 2,396<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814418304712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 72,326<span></span>
</td>
<td class="nump">$ 39,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">19,924<span></span>
</td>
<td class="nump">4,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">92,250<span></span>
</td>
<td class="nump">43,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">3,354<span></span>
</td>
<td class="nump">3,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 95,604<span></span>
</td>
<td class="nump">$ 47,113<span></span>
</td>
<td class="nump">$ 187,520<span></span>
</td>
<td class="nump">$ 26,820<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814342388536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Statement Information - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 3,354<span></span>
</td>
<td class="nump">$ 3,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposits</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Deposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Deposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415750760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward', window );"><strong>Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss', window );">Beginning balance</a></td>
<td class="nump">$ 2,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Change in allowance</a></td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss', window );">Ending balance</a></td>
<td class="nump">$ 1,948<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814418494088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Beginning balance</a></td>
<td class="nump">$ 792,405<span></span>
</td>
<td class="nump">$ 589,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">134,214<span></span>
</td>
<td class="nump">106,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCommissionsReceived', window );">Cash receipts</a></td>
<td class="num">(177,532)<span></span>
</td>
<td class="num">(126,542)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease', window );">Change in credit loss allowance</a></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(1,632)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Ending balance</a></td>
<td class="nump">741,847<span></span>
</td>
<td class="nump">560,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Beginning balance</a></td>
<td class="nump">739,637<span></span>
</td>
<td class="nump">550,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCommissionsReceived', window );">Cash receipts</a></td>
<td class="num">(165,520)<span></span>
</td>
<td class="num">(112,731)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease', window );">Change in credit loss allowance</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(1,574)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Ending balance</a></td>
<td class="nump">688,737<span></span>
</td>
<td class="nump">526,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember', window );">Individual, Family and Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Beginning balance</a></td>
<td class="nump">52,768<span></span>
</td>
<td class="nump">38,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCommissionsReceived', window );">Cash receipts</a></td>
<td class="num">(12,012)<span></span>
</td>
<td class="num">(13,811)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease', window );">Change in credit loss allowance</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Ending balance</a></td>
<td class="nump">53,110<span></span>
</td>
<td class="nump">33,996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember', window );">Commission revenue from members approved during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">121,073<span></span>
</td>
<td class="nump">86,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember', window );">Commission revenue from members approved during the period | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">114,678<span></span>
</td>
<td class="nump">81,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember', window );">Commission revenue from members approved during the period | Individual, Family and Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">6,395<span></span>
</td>
<td class="nump">5,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember', window );">Commission revenue from renewals of small business members during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,687<span></span>
</td>
<td class="nump">2,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember', window );">Commission revenue from renewals of small business members during the period | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember', window );">Commission revenue from renewals of small business members during the period | Individual, Family and Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,687<span></span>
</td>
<td class="nump">2,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember', window );">Net commission revenue adjustments from members approved in prior period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,292<span></span>
</td>
<td class="nump">10,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember', window );">Net commission revenue adjustments from members approved in prior period | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">8,979<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember', window );">Net commission revenue adjustments from members approved in prior period | Individual, Family and Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,278<span></span>
</td>
<td class="nump">$ 1,373<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ChangeInContractWithCustomerAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ChangeInContractWithCustomerAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in allowance for credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCommissionsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for commissions during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCommissionsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814416405720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statement Information - Schedule of Credit Risk (Details) - Customer Concentration Risk - Accounts Receivable<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Humana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Aetna</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Centene</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_UnitedhealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_UnitedhealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_HumanaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_HumanaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_AetnaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_AetnaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_CenteneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_CenteneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814417504232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_PrepaidMaintenanceContractsCurrent', window );">Prepaid maintenance contracts</a></td>
<td class="nump">$ 6,583<span></span>
</td>
<td class="nump">$ 7,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">4,095<span></span>
</td>
<td class="nump">6,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">1,031<span></span>
</td>
<td class="nump">1,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Others</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">646<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 12,325<span></span>
</td>
<td class="nump">$ 16,661<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_PrepaidMaintenanceContractsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Maintenance Contracts (Current)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_PrepaidMaintenanceContractsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814425164296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Financial Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">$ 33,922<span></span>
</td>
<td class="nump">$ 49,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">5,602<span></span>
</td>
<td class="nump">4,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">48,244<span></span>
</td>
<td class="nump">49,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">53,846<span></span>
</td>
<td class="nump">53,827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">53,846<span></span>
</td>
<td class="nump">53,827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">26,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">26,826<span></span>
</td>
<td class="nump">35,423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Carrying Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">26,826<span></span>
</td>
<td class="nump">35,423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Fair Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">26,826<span></span>
</td>
<td class="nump">35,423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">7,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">7,096<span></span>
</td>
<td class="nump">14,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Carrying Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">7,096<span></span>
</td>
<td class="nump">14,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Fair Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">7,096<span></span>
</td>
<td class="nump">14,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">5,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">5,602<span></span>
</td>
<td class="nump">4,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Carrying Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">5,602<span></span>
</td>
<td class="nump">4,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Fair Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">5,602<span></span>
</td>
<td class="nump">$ 4,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">14,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">14,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Carrying Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">14,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Fair Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 14,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814418550200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Contractual Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in 1 year</a></td>
<td class="nump">$ 53,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in 1 year</a></td>
<td class="nump">$ 53,846<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814417919352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Unrealized Gains and Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 92,250<span></span>
</td>
<td class="nump">$ 43,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">33,922<span></span>
</td>
<td class="nump">$ 49,620<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost', window );">Total</a></td>
<td class="nump">53,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities', window );">Fair Value</a></td>
<td class="nump">53,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">5,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">5,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">14,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">14,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Amortized Cost</a></td>
<td class="nump">26,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">26,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Amortized Cost</a></td>
<td class="nump">7,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">$ 7,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Accumulated Gross Unrealized Gains, before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents And Available-For-Sale Debt Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents And Available-For-Sale Debt Securities, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814414343448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of securities in net loss positions</a></td>
<td class="nump">12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814417500664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares issued (in shares)</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share)</a></td>
<td class="nump">$ 115.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from sale of stock</a></td>
<td class="nump">$ 228.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of shares repurchased under share repurchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes', window );">Treasury shares that were previously surrendered by employees to satisfy tax withholdings (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900,000<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares issued (in shares)</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=ehth_PreviousRepurchaseProgramsMember', window );">Previous share repurchase programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of shares repurchased under share repurchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares Outstanding, Shares Acquired, Previously Cancelled Vested Shares Withheld For Tax Purposes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=ehth_PreviousRepurchaseProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=ehth_PreviousRepurchaseProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814416644264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Schedule of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 11,402<span></span>
</td>
<td class="nump">$ 8,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Amount capitalized in internal-use software</a></td>
<td class="nump">550<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Total stock-based compensation</a></td>
<td class="nump">11,952<span></span>
</td>
<td class="nump">8,962<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Common stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">10,719<span></span>
</td>
<td class="nump">8,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">503<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Marketing and advertising</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,485<span></span>
</td>
<td class="nump">1,730<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ehth_CustomerCareAndEnrollmentExpenseMember', window );">Customer care and enrollment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ehth_TechnologyAndContentExpenseMember', window );">Technology and content</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,743<span></span>
</td>
<td class="nump">1,617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 5,705<span></span>
</td>
<td class="nump">$ 4,705<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ehth_CustomerCareAndEnrollmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ehth_CustomerCareAndEnrollmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ehth_TechnologyAndContentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ehth_TechnologyAndContentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814418065896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Computation of Basic and Diluted Net Income per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (800)<span></span>
</td>
<td class="nump">$ 3,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in per share calculation - basic (in shares)</a></td>
<td class="nump">26,620<span></span>
</td>
<td class="nump">24,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_IncrementalCommonSharesAttributableToOptions', window );">Dilutive effect of common stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,460<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total common stock shares used in diluted share calculation (in shares)</a></td>
<td class="nump">26,620<span></span>
</td>
<td class="nump">26,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per share - basic (in usd per share)</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share - diluted (in usd per share)</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_IncrementalCommonSharesAttributableToOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental Common Shares Attributable To Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_IncrementalCommonSharesAttributableToOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814417960648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">1,460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Common stock options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">1,090<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814418009928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2019 </div>
<div>plaintiff</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 13, 2020 </div>
<div>plaintiff</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInNextTwelveMonths', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInSecondYear', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInThirdYear', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFourthYear', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ContractualObligationToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,353<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">New claims filed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=ehth_LeViasCompliantMember', window );">Le'Vias Compliant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ContractualObligationToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual Obligation, to be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ContractualObligationToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ehth_LeViasCompliantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ehth_LeViasCompliantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814416987448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information - Segment Operating Results (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 134,214<span></span>
</td>
<td class="nump">$ 106,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense', window );">Stock-based compensation expense</a></td>
<td class="num">(11,402)<span></span>
</td>
<td class="num">(8,714)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(3,944)<span></span>
</td>
<td class="num">(2,324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="num">(176)<span></span>
</td>
<td class="num">(547)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="num">(2,431)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before provision for (benefit from) income taxes</a></td>
<td class="num">(492)<span></span>
</td>
<td class="nump">1,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Amortization of internally developed software</a></td>
<td class="nump">2,806<span></span>
</td>
<td class="nump">1,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">134,214<span></span>
</td>
<td class="nump">106,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SegmentOperatingIncomeLoss', window );">Segment profit (loss)</a></td>
<td class="nump">32,597<span></span>
</td>
<td class="nump">26,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">121,021<span></span>
</td>
<td class="nump">96,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SegmentOperatingIncomeLoss', window );">Segment profit (loss)</a></td>
<td class="nump">24,545<span></span>
</td>
<td class="nump">23,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Individual, Family and Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">13,193<span></span>
</td>
<td class="nump">10,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SegmentOperatingIncomeLoss', window );">Segment profit (loss)</a></td>
<td class="nump">8,052<span></span>
</td>
<td class="nump">2,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SegmentOperatingIncomeLoss', window );">Segment profit (loss)</a></td>
<td class="num">$ (15,286)<span></span>
</td>
<td class="num">$ (13,448)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allocated Share-based Compensation Expense, Net Of Restructuring Reversal Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_SegmentOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_SegmentOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814434484088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 42,340<span></span>
</td>
<td class="nump">$ 41,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">41,829<span></span>
</td>
<td class="nump">40,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 511<span></span>
</td>
<td class="nump">$ 565<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814422131624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information - Schedule of Revenue by Major Customers (Details) - Customer Concentration Risk - Revenue<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Aetna</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Humana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Centene</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_UnitedhealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_UnitedhealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_AetnaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_AetnaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_HumanaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_HumanaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_CenteneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_CenteneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814417078072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814414348232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 41,284<span></span>
</td>
<td class="nump">$ 42,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities &#8211; current</a></td>
<td class="nump">5,316<span></span>
</td>
<td class="nump">5,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities &#8211; non-current</a></td>
<td class="nump">39,984<span></span>
</td>
<td class="nump">41,369<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 45,300<span></span>
</td>
<td class="nump">$ 46,561<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814342370968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 7,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term of operating leases</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate used to recognize operating lease right-of-use-assets</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814433019544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">$ 5,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">7,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">8,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">7,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">8,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">19,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">56,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(11,426)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">45,300<span></span>
</td>
<td class="nump">$ 46,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear', window );">Sublease income, remainder of 2021</a></td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths', window );">Sublease income, 2022</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears', window );">Sublease income, 2023</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814342436328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>employee</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Positions eliminated | employee</a></td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce', window );">Percentage of total workforce</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,431<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Accrued restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Related Cost, Number Of Positions Eliminated, Percentage Of Total Workforce</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814433224712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 20, 2019</div></th>
<th class="th"><div>Sep. 17, 2018</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings under line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ehth_CreditAgreementAmendmentMember', window );">Credit Agreement Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="nump">$ 75,000,000.0<span></span>
</td>
<td class="nump">$ 40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityFacilityFeePercentage', window );">Facility fee percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 75,000,000.0<span></span>
</td>
<td class="nump">$ 40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents', window );">Covenant, minimum cash and cash equivalents</a></td>
<td class="nump">6,000,000.0<span></span>
</td>
<td class="nump">6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents', window );">Covenant, maximum cash and cash equivalents</a></td>
<td class="nump">11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityCovenantMinimumLiquidity', window );">Minimum liquidity</a></td>
<td class="nump">10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityCovenantMaximumLiquidity', window );">Maximum liquidity</a></td>
<td class="nump">$ 18,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Credit Agreement Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember', window );">Eligible Commissions Receivables, Preceding Three Months | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityBorrowingBasePercentage', window );">Borrowing base percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember', window );">Eligible Commissions Receivables, Succeeding Three Months | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityBorrowingBasePercentage', window );">Borrowing base percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember', window );">Eligible Commissions Receivables, Succeeding Six Months | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityBorrowingBasePercentage', window );">Borrowing base percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityBorrowingBasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Borrowing Base, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityBorrowingBasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Covenant, Maximum Cash And Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityCovenantMaximumLiquidity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Covenant, Maximum Liquidity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityCovenantMaximumLiquidity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Covenant, Minimum Cash And Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityCovenantMinimumLiquidity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Covenant, Minimum Liquidity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityCovenantMinimumLiquidity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityFacilityFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Facility Fee Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityFacilityFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ehth_CreditAgreementAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ehth_CreditAgreementAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814342369288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Income Tax Benefit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before provision for (benefit from) income taxes</a></td>
<td class="num">$ (492)<span></span>
</td>
<td class="nump">$ 1,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="nump">$ 308<span></span>
</td>
<td class="num">$ (2,048)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="num">(62.60%)<span></span>
</td>
<td class="num">(145.90%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814415891912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="nump">$ 308<span></span>
</td>
<td class="num">$ (2,048)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="num">(62.60%)<span></span>
</td>
<td class="num">(145.90%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814431501304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares issued (in shares)</a></td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SaleOfStockConsiderationReceivedOnTransactionGross', window );">Gross proceeds from sale of stock</a></td>
<td class="nump">$ 225.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share)</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from sale of stock</a></td>
<td class="nump">$ 216.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_SaleOfStockConsiderationReceivedOnTransactionGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Consideration Received On Transaction, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_SaleOfStockConsiderationReceivedOnTransactionGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139814414453976">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MHY:37PCTSS-?F+POFQ95? TC@_<)3(3L?_'H;Y38=C\:W FE1-U=;C@#^=H
MOE\+H5YO].\0P^].JW\ 4$L#!!0    (  .(JE(QI?.L[@4  (T7   8
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M96MH63GLU1JO3+<"[ !@XDR9>JBTP 1VN'6HZ;QK&EJJ@FL&6ACFZGSP2,G
M^ 2AHZ.].\"-,E<&]N^-#[C%4I*QUD ($Z+Z..C&QNN9:AV^Z26$K/6B,;?/
M)6'>F1HN\ZQ/%Q06TV;6J\8NC:JLKX8V1%J>1!KUMETT*Z\CE(;VO;<F4EC0
MIG%M?7W8:Q^O@6%7P.;>U),5=$.J1-+7FY7VNUTA K%ZM:DLVR$,?>]\A#$
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MBNI9TXA<R7O3;HQ$P-2@.:I*1YG&HBMBZ23TDK18-E>OC&<*<-.^M0T5H&F
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M-5"?51D)3:G$J=*&5YU!<F!M./%[5C3,<)*-HI6H6)4*5E#-E3O]5<KIC:C
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MN+(;L+Z2TO0?EL'P0GC^/U!+ P04    "  #B*I20RY&H_\*  !R'0  &
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MZ!$+V7 /&3VXN6R/=4Q[6'+\Y(%WE97\Q=!!;OTI,,&;,=&^"1[C5424']L
MLI5(^(TC+HH7XJX^9Y0;.+]5.5%=1F(X."I!EF@;U]$B9EPYL.'T,6,@;5W
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M6)'X J SEQH RE1Z4:&*2C;''QE D0^G6\V7;6@M:2$1Z^%M.4FVV@<G7AW
M-YC*;SB5-S-HPO#RVTC5[A:;(WM7+8EQCM'B_>&&MO#VZP[OES@AV+%6,PP3
MYG.!K_,9L\[P-=Z;B^]'%GC/_@'#U]:S.NZ024H3R9TSU#3WE[C**W_F5S>L
M4UQ24GK3GS.MSH%M:.U$T@;0;5AP-KS?@F@=C9:+OZ*+[?L/Z&@;K9<M,R]=
M8E93;V^P_^\WE_ZA0*=_9%LY7E/8WE%:B8"R7HF]:'^5$[M>AGNMSPRH:,8?
M4RR&KRJ<_^+0/&V^UXS]9XH5N?_8@]&;4:9E,$76_L'Q84<8_P'%WSA=\D>+
MB79.YWR9@L1W1"+ \ZG&CAEN2$'S%>OJ'U!+ P04    "  #B*I2%EK4I\D%
M   R#0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6R=5VUOVS80_BL'
M+]A+X=J2;,=.F@1(VFSK@+9!DJX?AF&@I;-%1!)5DHKC_?H])"7%29L4:SXX
M$GFOSSUWI(XV2M^8G-G275E4YGB06UL?CL<FS;D49J1JKK"S4KH4%J]Z/3:U
M9I%YI;(8)U&T/RZ%K 8G1W[M0I\<J<86LN(+3:8I2Z&W9URHS?$@'G0+EW*=
M6[<P/CFJQ9JOV'ZL+S3>QKV53)9<&:DJTKPZ'IS&AV=3)^\%_I2\,3O/Y#)9
M*G7C7MYFQX/(!<0%I]99$/AWRZ^Y*)PAA/&YM3GH73K%W>?.^J\^=^2R%(9?
MJ^*3S&Q^/%@,*..5: I[J3:_<YO/S-E+56'\+VV"[&0^H+0Q5I6M,B(H917^
MB[L6AQV%1?2$0M(J)#[NX,A'^498<7*DU8:TDX8U]^!3]=H(3E:N*%=68U="
MSYZ<?VZDW1Z-+6RYE7':ZIT%O>0)O0F]4Y7-#9U7&6</]<>(H0\DZ0(Y2YXU
M^$[H$4WB(251$C]C;](G-O'V)D_8N[(JO<E5D;$V/U%(D]XKR_37Z=)8#3K\
M_8R;:>]FZMU,_S=^S^JY7CLTM4CY>(!F,JQO>= :HXMF6<B4/JQ6K&6U)K6B
MUZHLP6&?%/WXPR*)XU>0TZ81E26K2%3$D/<<1[.LI4O1\]Y881EM!+%<6-H(
M0RM9<$;8>\,IETO6%,\=\/%B"$,9"8AG0>(/435H5DH2+W#@]U&K-">_DD1#
MVC#!/&MHR"K$TD!?;[2T+GZQUAPBD%6G"T47MC2F81)XM*)PB2:C&#0O"A]Y
M+@"-6TU#^L:E#W^YA E9I47CHK0Y_-^Q3J5AYV'5%-Z46^_C  L\;/-7I&J/
M"[S7#6)!2U,TFO1>199))X!XG@H , JJM4S967%^ZE R2.[%\6P4150#5:__
M,.D1O<>DK;5*F3-40JO2&U!=L3? D40-B3N)H</%EO:29#&*[@-<(1M,GJQ)
M/;P/L,ZD255363/T,0-?J!A?-;[#)#<AGUV7HY96E]SC<:'56HO2]%3[Q)2+
MC"H5( ##>ED_5QUML\8GX$S;'!6G,DR(P*4 0=?@(WI[C[0#,8Y&\\>%OW>2
MA21)-1K8\:U4S>ZVP]/'Z[F8BUL/NL4A91IP-QXECTT+C\+#F-K^</AW/@ ^
M+&B7@6/W<DM<UH7:,DP@:(,.,ZLM67&'L6US-VY\$1H?0*JJJCU\W*Y'YI:-
M;7LZ96UQ:B(/]*I,+1P$<)M*XJ"ETZ_%Z K9=VV[&K5I9[N-%,>C@R^RAC+6
M%X_6ARZ$.LR.8CNDG(ML%\ 1X0!$G3VQ7/# O5:&6XYU??%$O;X@3%<L-#^6
M4Z4=/99!JW9L $R&K2W"S,C0!!UET1=H,[$L0#$M,@9U&Z"SZ[A+%55\G$>8
M;:&\QDTL.#0=95-E+)5L<Y6U#?'RS!O$Z'5]$X;I>>BAOB\^= F^# FDN\)M
MP[D\PYU'_@L1-W]5@<N0<7P2&Z$QPK8U8O[9Q9J#=HC3_')(U[Z+=L_9QVSP
M8_3U;@W"<#.T1_$BPN\DVD=C?XU@+]!SPSDF^F(XC19T?G5Q0;-H$E)+7M&U
M9](WDX.C& 82/"Q@;DK_='_T@DY+/XNZ68V+B[YAVYISU<"4]!?+*N5V]?+J
M([A_C8H$E'Q]?,5[#,VWHP*RN+>Z$Q#JJZ8*70A785IC[BE,WWL>+-WM]'L+
M\,YGY4\Z1[#L%HTM/;'V<$A.%S,'TG ^0:G\A0Z-D3H:^J%<::3IB3[=/Z#]
M_82N.<TK5:AU("RFB'7;R7 ^G<#.?CRGW[A"<D7K#]?"]KC'X)L-Y]&,IO[W
M>TL8RH8@:PD#GK5 1KHS'L?BRP8Z1JWLQB4QFT643!??\N5]',R"CP-D^;6[
MUWCG'@N4UOZV;LC/G7"E[5?[#X+3< ^^%P]?$ZC)6J(/"EY!%8?+;$ ZW-##
MBU6UOQ4OE45)_&..CQK63@#[*X6[8OOB'/2?22?_ 5!+ P04    "  #B*I2
M!BN+,7D$  #?"P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6RM5FUO
MXS8,_BM$-@R]0RYV[#1]N31 WPX[8%<$S6W[, R#8C.Q4%GR27+3_OM1DNTD
M;=H5Q?(AMFSRX?-0)*W)6ND[4R!:>"B%-&>]PMKJ-(I,5F#)S$!5*.G-4NF2
M65KJ560JC2SW3J6(DC@>1R7CLC>=^&<S/9VHV@HN<:;!U&7)].,%"K4^ZPU[
M[8-;OBJL>Q!-)Q5;X1SM[]5,TRKJ4')>HC1<2="X/.N=#T\O1L[>&_S!<6VV
M[L$I62AUYQ9?\[->[ BAP,PZ!$:7>[Q$(1P0T?C18/:ZD,YQ^[Y%_^*UDY8%
M,WBIQ)\\M\59[[@'.2Y9+>RM6O^*C9Y#AY<I8?P_K(-M&O<@JXU59>-,#$HN
MPY4]-'G8<CA^R2%I'!+/.P3R+*^89=.)5FO0SIK0W(V7ZKV)')=N4^96TUM.
M?G9Z0_O^56:J1#CX31GS 6:H85XPC9/(4@!G%F4-V$4 2UX 2^&;DK8P<"US
MS'?](R+6L4M:=A?)JX#?F!Y .NQ#$B?#5_#23FWJ\=(7\*Z9EERNS$8D_'6^
M,%93<?S]"OZHPQ]Y_-'_D\UW@\$%,SP#21:\L1#>HB(+XRVX 7I1U19S6#Q"
MSN]Y3M+W^-!;6R"L?0%C_HG=HZ9^!%F7"X)32P=44@=Y8 /4VL8RZ=%H*GAG
MBLM5/H K+GS$]S!S.,_]=B,\)0LODB6"[2W^J/D]$RCM/@EYK=OH[U6Q(@D$
M@<LES1JP"I@04"E+$3D3I)#@:/9T>;0JNWO.JN]BB=J34I6;6?2(GEO-,Q<E
MN-626^/5-5HHW,+1,379U-1XE(5:P_5\-AO =U+5A6_X48ZV];,UT[EQ>F@>
MNF%),%P&K__( 6T&JRK!,^8G+ &[+%KZ.)A:/S:$2[2%2ZJCLE2"O@(^W6PA
M$ R2%MIA6WC/D- .;.&+W$E]"YD#(DV1:D,.E#A\R+"R6^]9J6IIS8=38J(1
M=T85T*#)BF[2N+\8;NJ2:LLJ?0HWS^+^# ?'<>RN:7]TF, 52D7C.9C/P\[4
M)J1RPR%C(JM%$/C+3\?)</BY49F,^V.*F8SZ1\.34("[6[93.]XW^0S#_F@<
M/PW7)NMYR#;(N#\\.MDC:D-TEQR)C0=QZM3&@^'H39XMBUW?%.A;"L@HV6VU
M^,THPV;@OLUP!> VI$]=#P4C89A1SUK^I)%MP2REJ1;YIO?$8T/D>2'T85%;
M3Z%II*56I5\SZJ42W?B0-%W\\<.1?D"=<8,-<8/;/-9(P%1RU+YA$_:4\UN*
MF!GGR76[\6LOIZ I1TV.;JI9_JEMZ-!3F\FWT]7;AMVH<!G:I=J)?@=9RH_A
MQEDU>[EI[YUF?'/+?83+[2IOAB"DXQ1DQ.!V_RP<]N.3V!NXF0='_O:[LC1Y
M0W^X]3_M#SZZK&D,>9#*9^IIHL)'AT9B\T78=S2(M@Y=-"A6_FCI/@I47.'\
MU3WM3J_GX="V,0]'7TK%BI-0@4MRC0='ASW0X3@9%E95_@BW4)8.A/ZVH!,X
M:F= [Y>*"KY9N #=F7[Z+U!+ P04    "  #B*I2+)[S[G,+  #!'0  &0
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MJ53C6(7%;J< 6J^;-3S;R1YD&NWU!OMIK+/[#DGPW=@"0(]6,OWTB:/PU'_
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M4 K*IZ5+\KL5LVD;^;G=HY>F=05(T#)(!LG].(IEL=8TI*!*V$5 'HF:OT?
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M!8 AW"AI2P/7LL#B6_V0C.DM2IXL6B0G 6^8/H-A/( D2N(3>,/>PZ''&[Z
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M6K)HO '=EUJ[@^(#]&M[\1=02P,$%     @  XBJ4G(NS1J(!0  L P  !D
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MD&/!&F$?U.8#[NHY<WR9$L9_8=/ZIF<!9(VQJMJ!*8.*RW9EV]T[' #&\2N
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M3)F*TV%.#9V,E-R!LJ,1S3XX,5TTIL^%7?>E4?B68YR9+,OU!KF"::'QI=9
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M<4%)2$5JH'^?<:YV+VD'Q:W:\#]02P,$%     @  XBJ4B;"'Z/C @  A @
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MS\I2I_AE22,5M3.@^XU2=KMQ!,.03G\!4$L#!!0    (  .(JE(NN_Q6N@4
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M&/UC/7D]F0<JV8)G?Z2)VMY,H@E(V)KN,G7/#[^R9D)^%6_%,UG_!8?&UIN
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M#/3O:\[5XTTU0'L4//\/4$L#!!0    (  .(JE(!L8 .X (  )<*   9
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M&D-GEB^57+M?LFEBHX"DE3:R:,"HH&"B?M*7)A%[ .0Y#$@:0/(O8-@!Z#>
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M K^LI:JHP:G:^+I60 L'JK@?!4'J5Y0);SIV:PLU'<O&<"9@H8ANJHJJO[?
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MHY$&V9L9O1Q@7 #M[[3&H^.FN7N+DM]02P,$%     @  XBJ4C'RL;_P P
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M@P@8$^B\<BZ<@O@XQM$N?@-02P,$%     @  XBJ4F:64%Z* P  Z@L  !D
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MQE[,4UG\@D,EZP] G$O%LTI9(\@H*__Q2Y6((P4T[E% E0)J*\ >A:!2"(I
M2V1%6'=8X=E4\ ,01EI;,P]%;@IM'0UE9AF72NBW5.NIV9)L]*(H@%D"?B9\
M(_!N2V-PS\H*,9F^!*]"GW=$Z#FV 4]$ZCQ)<'9'%*:I/ <? &7@RY;G4IN2
M4T]I<,:%%U= YB40U ,D  ^<J:T$/[&$)*?ZG@ZJC@R]1C9'3H,/6%R! %X
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M4CPK'K<$)T08 ?U^S;EZ'1@']273[%]02P,$%     @  XBJ4H RQHV' @
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ME,&]0+(N2R)>YE#PS=3#WG9A0;-<F05_-JE(!DM0#]6]T#._8TEI"4Q2SI"
M]=2[PI<Q'AJ /?&=PD;NC9&1LN+\T4QNTZD7F(R@@$09"J(?3Q!#41@FG<>?
MEM3K8AK@_GC+_L6*UV)61$+,BQ\T5?G4._=0"FM2%VK!-S?0"AH9OH07TOZB
M37LV\%!22\7+%JPS*"EKGN2YO8@]@.8Y# A;0/@6,.P!1"T@LD*;S*RL:Z+(
M;"+X!@ES6K.9@;T;B]9J*#,V+I70NU3CU&P)F39%(<)2]!5X)DB5TP3=LN8-
M,3?]"2WURY/6!2"^1@MX E8#6KV@._*;"Q3;)$%(]/X:%*&%_* AVU44<Y;H
M *+A6E#YJ'=;DHFOM 23B)^TZ<Z;=,.>="-TQYG*)?K,4DA?XWTMO=,?;O7/
M0R?A'1$#%.&/* Q"?""?^-_A@2.=J+,CLGS#'KX'1A6D-T *E2=$@(-RV%$.
M+6740]G>]<<W=J&?W_1!=*N@E+\<849=F)$S\X8]V;*+;=0*A/%?EX1#;KLY
MPW 0!.\.N?+_N%>BSCI19TZB*U",.'C&'<_XE!Z<=V'.3^"!FS/$?1ZX<7AT
MQ(.+3M2%D^BF+HG3!!SL:EUP2AOP7E'%)S#B""D>]SEQ#'AQQ H<[H2%3JI8
M9P_,59;PKM3AZ*1N[ H@'I["#3<I[JU-QX '_E"-,'_O,ZX3S6QW(U'":Z::
M+UJWVG505[9O>+,^-YV5;0]V-$U;IK]7&642%;#6E,%@K NI:#J=9J)X99N%
M%5?ZMNPPU]TA"'- [Z\Y5]N)"=#UF[._4$L#!!0    (  .(JE+XC4.DC (
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M>>./T+!LCL%FHD5E3Y*UT' NV6$!7PXB30$\WPJA7R;F<.J^1=E?4$L#!!0
M   (  .(JE)!<;&UM@(  % '   9    >&PO=V]R:W-H965T<R]S:&5E=#4R
M+GAM;)55;4_;,!#^*Z>(22"M39J^,%!;"=I-0QH:HF-\F/;!32Z)16)GMM/"
M?OW.3AHZ5J+Q)?'+/<_=<V>?IUNI'G2&:."QR(6>>9DQY;GOZRC#@NF^+%'0
M3B)5P0Q-5>KK4B&+':C(_3 ()G[!N/#F4[=VH^9369F<"[Q1H*NB8.KI$G.Y
MG7D#;[=PR]/,V 5_/BU9BBLT=^6-HIG?LL2\0*&Y%* PF7D7@_/%Q-H[@^\<
MMWIO#%;)6LH'.[F*9UY@ \(<(V,9&/TVN, \MT04QJ^&TVM=6N#^>,?^R6DG
M+6NF<2'S>QZ;;.9]\"#&A%6YN97;S]CH&5N^2.;:?6';V 8>1)4VLFC %$'!
M1?UGCTT>]@#$<Q@0-H#P!2!\#3!L $,GM([,R5HRP^93);>@K#6QV8'+C4.3
M&BYL%5=&T2XGG)E_0<J!AAZLJK+,D>IC6 Y7HCX?-M''2S2,Y_J$C.Y62S@^
M.H$CX *^9;+23,1ZZAN*Q/+Y4>/ULO8:ON)U"-=2F$S#1Q%C? "_Z,8/P@X"
MGU+0YB'<Y>$R[&2\9JH/P\%["(-P<"B@;O@2HQ8>=(0S;,LR='S#[K+\N%AK
MH^BH_^S@'+6<(\<Y>H7S:XF*2BI2B)C.@*YT0G=80Z)D ;+=S)WK0S6MZ2>.
MWG:'S7QP%I#:S7Z>_C4Z#<Z>C?Z*?-Q&/NZ,_-Y=1HQ[;$-1IDCMPS:H-EHP
MJ$A"\E\JNEV=PA,R=0BX^"\@A%#4)Y/.:,R>=$?A)JW\R=ODQUQ'LA(&2"Q"
MI3$&(RDID4P%_XTOTP#*XGLRZ9%ICVF-YF!FNJ,8]T?!NT-Y>3.L3H*_U[0*
M5*GKY1J<L+I_M:OM<W'ANJ3_;%Z_-71Y4RXTJ4T(&O1/J52J[M_UQ,C2M<"U
M--10W3"C)P^5-:#]1$JSFU@'[2,Z_P-02P,$%     @  XBJ4C HE$WS @
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MB,WM7GTK =<+U/,M8_)CH$_C]NMK\1]02P,$%     @  XBJ4FT*I\BK @
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M;BB#WA<C5];CI=YHL78=NA3:]+M;%F8BH[0.YCP70N\V-D [XY-_4$L#!!0
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MV^'7U,*Q@P?[<-^$H(H#J>) '%_WK7'X_=W,0%<:$O6GA;];\7<=?^\0/^6
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M>6OJ[CV?#7^R7+T"4$L! A0#%     @  XBJ4@=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  #B*I2
M0E8;]NX    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    "  #B*I2F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  .(JE)!:"UE2P4
M 'L5   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX
M;6Q02P$"% ,4    "  #B*I2^)95!U4&  "#&@  &               @(&.
M#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @  XBJ4C&E
M\ZSN!0  C1<  !@              ("!&10  'AL+W=O<FMS:&5E=',O<VAE
M970S+GAM;%!+ 0(4 Q0    (  .(JE*<*MF02P8   (=   8
M  " @3T:  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    "  #
MB*I24P^<=3L'  #3'   &               @(&^(   >&PO=V]R:W-H965T
M<R]S:&5E=#4N>&UL4$L! A0#%     @  XBJ4G/@'\Q(#@  YR@  !@
M         ("!+R@  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0
M   (  .(JE)%R *,.@<  "T4   8              " @:TV  !X;"]W;W)K
M<VAE971S+W-H965T-RYX;6Q02P$"% ,4    "  #B*I20RY&H_\*  !R'0
M&               @($=/@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!
M A0#%     @  XBJ4J?LKI>Y!@  T1(  !@              ("!4DD  'AL
M+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (  .(JE(66M2GR04
M #(-   9              " @4%0  !X;"]W;W)K<VAE971S+W-H965T,3 N
M>&UL4$L! A0#%     @  XBJ4@8KBS%Y!   WPL  !D              ("!
M058  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    "  #B*I2
M+)[S[G,+  #!'0  &0              @('Q6@  >&PO=V]R:W-H965T<R]S
M:&5E=#$R+GAM;%!+ 0(4 Q0    (  .(JE).B"_W;0<  'X1   9
M      " @9MF  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%
M  @  XBJ4ARJAY_A!   < L  !D              ("!/VX  'AL+W=O<FMS
M:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    "  #B*I2JJV5_C0#   4!P
M&0              @(%7<P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+
M 0(4 Q0    (  .(JE+?";X0EP<   04   9              " @<)V  !X
M;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @  XBJ4G&7N%N)
M!   O@H  !D              ("!D'X  'AL+W=O<FMS:&5E=',O<VAE970Q
M-RYX;6Q02P$"% ,4    "  #B*I2-N#FQ_P"  !4!@  &0
M@(%0@P  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (  .(
MJE(7YL^T=0T  &$G   9              " @8.&  !X;"]W;W)K<VAE971S
M+W-H965T,3DN>&UL4$L! A0#%     @  XBJ4C?S*,M&!P  2Q0  !D
M         ("!+Y0  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
M    "  #B*I2CY(T/6H&  "O$P  &0              @(&LFP  >&PO=V]R
M:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (  .(JE*_2>N"!@4  "8/
M   9              " @4VB  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL
M4$L! A0#%     @  XBJ4I65GO*? P  <P@  !D              ("!BJ<
M 'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  #B*I2@NA]
M YP#  #6"   &0              @(%@JP  >&PO=V]R:W-H965T<R]S:&5E
M=#(T+GAM;%!+ 0(4 Q0    (  .(JE)3&IP_N (  ,(%   9
M  " @3.O  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @
M XBJ4G(NS1J(!0  L P  !D              ("!(K(  'AL+W=O<FMS:&5E
M=',O<VAE970R-BYX;6Q02P$"% ,4    "  #B*I2SR$-VT8$  "'"@  &0
M            @('AMP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4
M Q0    (  .(JE+01UU1IP(  .<%   9              " @5Z\  !X;"]W
M;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @  XBJ4D1Z.LGW P
M>0T  !D              ("!/+\  'AL+W=O<FMS:&5E=',O<VAE970R.2YX
M;6Q02P$"% ,4    "  #B*I203<T4VP%   ='@  &0              @(%J
MPP  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (  .(JE)<
MYWLZ+@4  &$;   9              " @0W)  !X;"]W;W)K<VAE971S+W-H
M965T,S$N>&UL4$L! A0#%     @  XBJ4B;"'Z/C @  A @  !D
M     ("!<LX  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  .(JE+A4GK6OP(  %$'   9              "
M@<'?  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @  XBJ
M4G8!LZ%%!@  92H  !D              ("!M^(  'AL+W=O<FMS:&5E=',O
M<VAE970S."YX;6Q02P$"% ,4    "  #B*I2Y>\9% P"  "7!   &0
M        @($SZ0  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0
M   (  .(JE(Q\K&_\ ,  )L1   9              " @7;K  !X;"]W;W)K
M<VAE971S+W-H965T-# N>&UL4$L! A0#%     @  XBJ4@GI&"#P 0  Y@,
M !D              ("!G>\  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q0
M2P$"% ,4    "  #B*I29I907HH#  #J"P  &0              @('$\0
M>&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (  .(JE*TH;/%
M(P0  #X2   9              " @87U  !X;"]W;W)K<VAE971S+W-H965T
M-#,N>&UL4$L! A0#%     @  XBJ4MTA'DPI P  C D  !D
M ("!W_D  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    "  #
MB*I2W>D DLD"  !C"0  &0              @($__0  >&PO=V]R:W-H965T
M<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    (  .(JE*YAC8O_ (  *H)   9
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M970U,"YX;6Q02P$"% ,4    "  #B*I2JUB<+(@"  "7!@  &0
M    @($($0$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    (
M  .(JE)!<;&UM@(  % '   9              " @<<3 0!X;"]W;W)K<VAE
M971S+W-H965T-3(N>&UL4$L! A0#%     @  XBJ4C HE$WS @  B0D  !D
M             ("!M!8! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"
M% ,4    "  #B*I2;0JGR*L"  !N!P  &0              @('>&0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (  .(JE+[4*(R4@0
M  ,4   9              " @< < 0!X;"]W;W)K<VAE971S+W-H965T-34N
M>&UL4$L! A0#%     @  XBJ4K+TH9V; @  S@8  !D              ("!
M22$! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    "  #B*I2
M5FDP&G$"  #O!0  &0              @($;) $ >&PO=V]R:W-H965T<R]S
M:&5E=#4W+GAM;%!+ 0(4 Q0    (  .(JE(Q[\<>U (  !\)   9
M      " @<,F 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%
M  @  XBJ4MI<^+WA 0  5 0  !D              ("!SBD! 'AL+W=O<FMS
M:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    "  #B*I230X%<A<#  "*$0
M#0              @ 'F*P$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (  .(
MJE*7BKL<P    !,"   +              "  2@O 0!?<F5L<R\N<F5L<U!+
M 0(4 Q0    (  .(JE*7;MU0I@0  .DF   /              "  1$P 0!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  #B*I2678!^/4!   X(P  &@
M            @ 'D- $ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    "  #B*I2%\C,&]L!  #1(@  $P              @ $1-P$ 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     0P!# $P2   =.0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>230</ContextCount>
  <ElementCount>319</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>76</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary of Business and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies</Role>
      <ShortName>Summary of Business and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Supplemental Financial Statement Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation</Role>
      <ShortName>Supplemental Financial Statement Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2116104 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2122105 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2126106 - Disclosure - Net Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/NetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2130107 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2133108 - Disclosure - Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SegmentandGeographicInformation</Role>
      <ShortName>Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2138109 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2144110 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2146111 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2148112 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2152113 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of Business and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Business and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/Revenue</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Supplemental Financial Statement Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables</Role>
      <ShortName>Supplemental Financial Statement Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2317303 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/FairValueMeasurements</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2323304 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/Equity</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2327305 - Disclosure - Net Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/NetIncomeLossPerShare</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2331306 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/CommitmentsandContingencies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2334307 - Disclosure - Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables</Role>
      <ShortName>Segment and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/SegmentandGeographicInformation</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2339308 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/Leases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2349309 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/IncomeTaxes</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Summary of Business and Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Business and Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Revenue - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Revenue - Commission Revenue by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails</Role>
      <ShortName>Revenue - Commission Revenue by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Supplemental Financial Statement Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails</Role>
      <ShortName>Supplemental Financial Statement Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails</Role>
      <ShortName>Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails</Role>
      <ShortName>Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - Supplemental Financial Statement Information - Schedule of Credit Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails</Role>
      <ShortName>Supplemental Financial Statement Information - Schedule of Credit Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Fair Value Measurements - Summary of Financial Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Financial Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - Fair Value Measurements - Contractual Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails</Role>
      <ShortName>Fair Value Measurements - Contractual Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - Fair Value Measurements - Unrealized Gains and Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails</Role>
      <ShortName>Fair Value Measurements - Unrealized Gains and Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2421413 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2424414 - Disclosure - Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/EquityNarrativeDetails</Role>
      <ShortName>Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2425415 - Disclosure - Equity - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Equity - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2428416 - Disclosure - Net Income (Loss) Per Share - Computation of Basic and Diluted Net Income per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails</Role>
      <ShortName>Net Income (Loss) Per Share - Computation of Basic and Diluted Net Income per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2429417 - Disclosure - Net Income (Loss) Per Share - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails</Role>
      <ShortName>Net Income (Loss) Per Share - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2432418 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2435419 - Disclosure - Segment and Geographic Information - Segment Operating Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails</Role>
      <ShortName>Segment and Geographic Information - Segment Operating Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails</Role>
      <ShortName>Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2437421 - Disclosure - Segment and Geographic Information - Schedule of Revenue by Major Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails</Role>
      <ShortName>Segment and Geographic Information - Schedule of Revenue by Major Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2442424 - Disclosure - Leases - Supplemental Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails</Role>
      <ShortName>Leases - Supplemental Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2443425 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2445426 - Disclosure - Restructuring (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/RestructuringDetails</Role>
      <ShortName>Restructuring (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/Restructuring</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2447427 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/Debt</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2450428 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails</Role>
      <ShortName>Income Taxes - Summary of Income Tax Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2451429 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2453430 - Disclosure - Subsequent Event (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SubsequentEventDetails</Role>
      <ShortName>Subsequent Event (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/SubsequentEvent</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="ehth-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - ehth-20210331.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - ehth-20210331.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="ehth-20210331.htm">ehth-20210331.htm</File>
    <File>a2021q1ex311.htm</File>
    <File>a2021q1ex312.htm</File>
    <File>a2021q1ex321.htm</File>
    <File>a2021q1ex322.htm</File>
    <File>ehth-20210331.xsd</File>
    <File>ehth-20210331_cal.xml</File>
    <File>ehth-20210331_def.xml</File>
    <File>ehth-20210331_lab.xml</File>
    <File>ehth-20210331_pre.xml</File>
    <File>exhibit105severanceagreeme.htm</File>
    <File>exhibit106severanceagreeme.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>78
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ehth-20210331.htm": {
   "axisCustom": 5,
   "axisStandard": 25,
   "contextCount": 230,
   "dts": {
    "calculationLink": {
     "local": [
      "ehth-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ehth-20210331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "ehth-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ehth-20210331_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ehth-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ehth-20210331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 461,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 6
   },
   "keyCustom": 34,
   "keyStandard": 285,
   "memberCustom": 37,
   "memberStandard": 35,
   "nsprefix": "ehth",
   "nsuri": "http://www.ehealthinsurance.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.ehealthinsurance.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122105 - Disclosure - Equity",
     "role": "http://www.ehealthinsurance.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126106 - Disclosure - Net Income (Loss) Per Share",
     "role": "http://www.ehealthinsurance.com/role/NetIncomeLossPerShare",
     "shortName": "Net Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130107 - Disclosure - Commitments and Contingencies",
     "role": "http://www.ehealthinsurance.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133108 - Disclosure - Segment and Geographic Information",
     "role": "http://www.ehealthinsurance.com/role/SegmentandGeographicInformation",
     "shortName": "Segment and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138109 - Disclosure - Leases",
     "role": "http://www.ehealthinsurance.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144110 - Disclosure - Restructuring",
     "role": "http://www.ehealthinsurance.com/role/Restructuring",
     "shortName": "Restructuring",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146111 - Disclosure - Debt",
     "role": "http://www.ehealthinsurance.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148112 - Disclosure - Income Taxes",
     "role": "http://www.ehealthinsurance.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152113 - Disclosure - Subsequent Event",
     "role": "http://www.ehealthinsurance.com/role/SubsequentEvent",
     "shortName": "Subsequent Event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ehth:DescriptionOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of Business and Significant Accounting Policies (Policies)",
     "role": "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Business and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ehth:DescriptionOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Revenue (Tables)",
     "role": "http://www.ehealthinsurance.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Supplemental Financial Statement Information (Tables)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables",
     "shortName": "Supplemental Financial Statement Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317303 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ehth:ScheduleOfStockBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323304 - Disclosure - Equity (Tables)",
     "role": "http://www.ehealthinsurance.com/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ehth:ScheduleOfStockBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327305 - Disclosure - Net Income (Loss) Per Share (Tables)",
     "role": "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables",
     "shortName": "Net Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331306 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334307 - Disclosure - Segment and Geographic Information (Tables)",
     "role": "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables",
     "shortName": "Segment and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ehth:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339308 - Disclosure - Leases (Tables)",
     "role": "http://www.ehealthinsurance.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ehth:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349309 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.ehealthinsurance.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ehth:DescriptionOfBusinessPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ehth:NumberOfHealthInsuranceCarriers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "insurance_carrier",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Summary of Business and Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Business and Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ehth:DescriptionOfBusinessPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ehth:NumberOfHealthInsuranceCarriers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "insurance_carrier",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:MarketingAndAdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Revenue - Disaggregation of Revenue (Details)",
     "role": "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
     "shortName": "Revenue - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i3af61ab21d2346a89f9a5ad7aa6ccc38_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Revenue - Commission Revenue by Segment (Details)",
     "role": "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
     "shortName": "Revenue - Commission Revenue by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i32bc9e31d57342a5a9f949dcac3eea99_D20210101-20210331",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Supplemental Financial Statement Information - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails",
     "shortName": "Supplemental Financial Statement Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i82364b4b38294beeabf364cb83d2dfb2_I20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Deposits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i491c8af6fa2b4e68be4acd9338800eb3_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails",
     "shortName": "Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i491c8af6fa2b4e68be4acd9338800eb3_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i491c8af6fa2b4e68be4acd9338800eb3_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails",
     "shortName": "Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i491c8af6fa2b4e68be4acd9338800eb3_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibcc2eede21d74403b2556f36cea8967e_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - Supplemental Financial Statement Information - Schedule of Credit Risk (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails",
     "shortName": "Supplemental Financial Statement Information - Schedule of Credit Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibcc2eede21d74403b2556f36cea8967e_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "ehth:PrepaidMaintenanceContractsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "ehth:PrepaidMaintenanceContractsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Fair Value Measurements - Summary of Financial Assets (Details)",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
     "shortName": "Fair Value Measurements - Summary of Financial Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i7a5410f369fa4fe6b29e53a1e38b9c4e_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - Fair Value Measurements - Contractual Maturities (Details)",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails",
     "shortName": "Fair Value Measurements - Contractual Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i7a043e2b26b14ab29cc5ac268c78e6cb_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
     "role": "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i7a043e2b26b14ab29cc5ac268c78e6cb_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - Fair Value Measurements - Unrealized Gains and Losses (Details)",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails",
     "shortName": "Fair Value Measurements - Unrealized Gains and Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421413 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "if92b4bb5fc794dd1bc6e637bdad2d099_D20200301-20200331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424414 - Disclosure - Equity - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/EquityNarrativeDetails",
     "shortName": "Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ehth:ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425415 - Disclosure - Equity - Schedule of Stock-Based Compensation Expense (Details)",
     "role": "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
     "shortName": "Equity - Schedule of Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ehth:ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428416 - Disclosure - Net Income (Loss) Per Share - Computation of Basic and Diluted Net Income per Share (Details)",
     "role": "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails",
     "shortName": "Net Income (Loss) Per Share - Computation of Basic and Diluted Net Income per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ehth:IncrementalCommonSharesAttributableToOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429417 - Disclosure - Net Income (Loss) Per Share - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details)",
     "role": "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails",
     "shortName": "Net Income (Loss) Per Share - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432418 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435419 - Disclosure - Segment and Geographic Information - Segment Operating Results (Details)",
     "role": "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
     "shortName": "Segment and Geographic Information - Segment Operating Results (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details)",
     "role": "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
     "shortName": "Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ie4d88e2c29bd4ed1a1c6b4b23e1884dc_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437421 - Disclosure - Segment and Geographic Information - Schedule of Revenue by Major Customers (Details)",
     "role": "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
     "shortName": "Segment and Geographic Information - Schedule of Revenue by Major Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ie4d88e2c29bd4ed1a1c6b4b23e1884dc_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ehth:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442424 - Disclosure - Leases - Supplemental Information (Details)",
     "role": "http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails",
     "shortName": "Leases - Supplemental Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443425 - Disclosure - Leases - Maturities of Lease Liabilities (Details)",
     "role": "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5cf30dc17def4256a761123e6f60a569_D20210201-20210228",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated",
      "reportCount": 1,
      "unique": true,
      "unitRef": "employee",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445426 - Disclosure - Restructuring (Details)",
     "role": "http://www.ehealthinsurance.com/role/RestructuringDetails",
     "shortName": "Restructuring (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5cf30dc17def4256a761123e6f60a569_D20210201-20210228",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated",
      "reportCount": 1,
      "unique": true,
      "unitRef": "employee",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447427 - Disclosure - Debt (Details)",
     "role": "http://www.ehealthinsurance.com/role/DebtDetails",
     "shortName": "Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "i5dc87305aa114463a821897ca747dcca_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450428 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Details)",
     "role": "http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails",
     "shortName": "Income Taxes - Summary of Income Tax Benefit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451429 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "if92b4bb5fc794dd1bc6e637bdad2d099_D20200301-20200331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453430 - Disclosure - Subsequent Event (Details)",
     "role": "http://www.ehealthinsurance.com/role/SubsequentEventDetails",
     "shortName": "Subsequent Event (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ib2c1d434f2124892a124c74f776eff75_D20210430-20210430",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary of Business and Significant Accounting Policies",
     "role": "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies",
     "shortName": "Summary of Business and Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Revenue",
     "role": "http://www.ehealthinsurance.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Supplemental Financial Statement Information",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation",
     "shortName": "Supplemental Financial Statement Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116104 - Disclosure - Fair Value Measurements",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210331.htm",
      "contextRef": "ibbe44bc40eb9483a9a9b6460f8f0bd74_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - ehth-20210331.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - ehth-20210331.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 76,
   "tag": {
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "China"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ehth_AccruedMarketingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total carrying values as of the balance sheet date of liabilities incurred through that date and payable for obligations related to marketing and advertising services received from vendors. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Expenses.",
        "terseLabel": "Accrued marketing expenses"
       }
      }
     },
     "localname": "AccruedMarketingExpenses",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_AetnaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aetna [Member]",
        "label": "Aetna [Member]",
        "terseLabel": "Aetna"
       }
      }
     },
     "localname": "AetnaMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocated Share-based Compensation Expense, Net Of Restructuring Reversal Expense",
        "label": "Allocated Share-based Compensation Expense, Net Of Restructuring Reversal Expense",
        "negatedTerseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_AncillariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ancillaries [Member]",
        "label": "Ancillaries [Member]",
        "terseLabel": "Ancillary"
       }
      }
     },
     "localname": "AncillariesMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ehth_BorrowingBasePercentageAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing Base Percentage [Axis]",
        "label": "Borrowing Base Percentage [Axis]",
        "terseLabel": "Borrowing Base Percentage [Axis]"
       }
      }
     },
     "localname": "BorrowingBasePercentageAxis",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_BorrowingBasePercentageDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Borrowing Base Percentage [Axis]",
        "label": "Borrowing Base Percentage [Domain]",
        "terseLabel": "Borrowing Base Percentage [Domain]"
       }
      }
     },
     "localname": "BorrowingBasePercentageDomain",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Accumulated Gross Unrealized Gains, before Tax",
        "label": "Cash And Cash Equivalents, Accumulated Gross Unrealized Gains, before Tax",
        "terseLabel": "Unrealized Gain"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax",
        "label": "Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Unrealized Loss"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 3.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents And Available-For-Sale Debt Securities",
        "label": "Cash, Cash Equivalents And Available-For-Sale Debt Securities",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "CashCashEquivalentsAndAvailableForSaleDebtSecurities",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents And Available-For-Sale Debt Securities, Amortized Cost",
        "label": "Cash, Cash Equivalents And Available-For-Sale Debt Securities, Amortized Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CenteneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Centene",
        "label": "Centene [Member]",
        "terseLabel": "Centene"
       }
      }
     },
     "localname": "CenteneMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_ChangeInContractWithCustomerAssetRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract with Customer, Asset",
        "label": "Change in Contract with Customer, Asset [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Asset [Roll Forward]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerAssetRollForward",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_CommissionBonusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission Bonus [Member]",
        "label": "Commission Bonus [Member]",
        "terseLabel": "Commission Bonus"
       }
      }
     },
     "localname": "CommissionBonusMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CommissionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission [Member]",
        "label": "Commission [Member]",
        "terseLabel": "Commission"
       }
      }
     },
     "localname": "CommissionMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CommissionMembersApprovedDuringCurrentPeriodMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission, Members Approved During Current Period [Member]",
        "label": "Commission, Members Approved During Current Period [Member]",
        "terseLabel": "Commission revenue from members approved during the period"
       }
      }
     },
     "localname": "CommissionMembersApprovedDuringCurrentPeriodMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CommissionMembersApprovedInPriorPeriodsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission, Members Approved In Prior Periods [Member]",
        "label": "Commission, Members Approved In Prior Periods [Member]",
        "terseLabel": "Net commission revenue adjustments from members approved in prior period"
       }
      }
     },
     "localname": "CommissionMembersApprovedInPriorPeriodsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CommissionRevenueFromRenewalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission Revenue From Renewals",
        "label": "Commission Revenue From Renewals [Member]",
        "terseLabel": "Commission revenue from renewals of small business members during the period"
       }
      }
     },
     "localname": "CommissionRevenueFromRenewalsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_ContractualObligationToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual Obligation, to be Paid, After Year Four",
        "label": "Contractual Obligation, to be Paid, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "ContractualObligationToBePaidAfterYearFour",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CreditAgreementAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement Amendment",
        "label": "Credit Agreement Amendment [Member]",
        "terseLabel": "Credit Agreement Amendment"
       }
      }
     },
     "localname": "CreditAgreementAmendmentMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CustomerCareAndEnrollmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period related to providing customer care and enrollment services. These services include pre-sales assistance to applicants who call our customer care center and enrollment services to applicants during the underwriting process.",
        "label": "Customer Care And Enrollment Expense",
        "terseLabel": "Customer care and enrollment"
       }
      }
     },
     "localname": "CustomerCareAndEnrollmentExpense",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CustomerCareAndEnrollmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Care And Enrollment Expense [Member]",
        "label": "Customer Care And Enrollment Expense [Member]",
        "terseLabel": "Customer care and enrollment"
       }
      }
     },
     "localname": "CustomerCareAndEnrollmentExpenseMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Gain, Before Tax",
        "label": "Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Gain, Before Tax",
        "terseLabel": "Unrealized Gain"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedLabel": "Unrealized Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_DentalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dental [Member]",
        "label": "Dental [Member]",
        "terseLabel": "Dental"
       }
      }
     },
     "localname": "DentalMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_DescriptionOfBusinessPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description Of Business, Policy",
        "label": "Description Of Business, Policy [Policy Text Block]",
        "terseLabel": "Description of Business"
       }
      }
     },
     "localname": "DescriptionOfBusinessPolicyPolicyTextBlock",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ehth_DisaggregatedAncillariesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Ancillaries [Axis]",
        "label": "Disaggregated Ancillaries [Axis]",
        "terseLabel": "Disaggregated Ancillaries [Axis]"
       }
      }
     },
     "localname": "DisaggregatedAncillariesAxis",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_DisaggregatedAncillariesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Ancillaries [Axis]",
        "label": "Disaggregated Ancillaries [Domain]",
        "terseLabel": "Disaggregated Ancillaries [Domain]"
       }
      }
     },
     "localname": "DisaggregatedAncillariesDomain",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_DisaggregatedIndividualandFamilyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Individual and Family [Axis]",
        "label": "Disaggregated Individual and Family [Axis]",
        "terseLabel": "Disaggregated Individual and Family [Axis]"
       }
      }
     },
     "localname": "DisaggregatedIndividualandFamilyAxis",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_DisaggregatedIndividualandFamilyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Individual and Family [Axis]",
        "label": "Disaggregated Individual and Family [Domain]",
        "terseLabel": "Disaggregated Individual and Family [Domain]"
       }
      }
     },
     "localname": "DisaggregatedIndividualandFamilyDomain",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_DisaggregatedMedicareAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disagregated Medicare [Axis]",
        "label": "Disaggregated Medicare [Axis]",
        "terseLabel": "Disaggregated Medicare [Axis]"
       }
      }
     },
     "localname": "DisaggregatedMedicareAxis",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_DisaggregatedMedicareDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Medicare [Axis]",
        "label": "Disaggregated Medicare [Domain]",
        "terseLabel": "Disaggregated Medicare [Domain]"
       }
      }
     },
     "localname": "DisaggregatedMedicareDomain",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_DisaggregatedOtherAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Other",
        "label": "Disaggregated Other [Axis]",
        "terseLabel": "Disaggregated Other [Axis]"
       }
      }
     },
     "localname": "DisaggregatedOtherAxis",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_DisaggregatedOtherDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Other",
        "label": "Disaggregated Other [Domain]",
        "terseLabel": "Disaggregated Other [Domain]"
       }
      }
     },
     "localname": "DisaggregatedOtherDomain",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eligible Commissions Receivables, Preceding Three Months [Member]",
        "label": "Eligible Commissions Receivables, Preceding Three Months [Member]",
        "terseLabel": "Eligible Commissions Receivables, Preceding Three Months"
       }
      }
     },
     "localname": "EligibleCommissionsReceivablesPrecedingThreeMonthsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eligible Commissions Receivables, Succeeding Six Months [Member]",
        "label": "Eligible Commissions Receivables, Succeeding Six Months [Member]",
        "terseLabel": "Eligible Commissions Receivables, Succeeding Six Months"
       }
      }
     },
     "localname": "EligibleCommissionsReceivablesSucceedingSixMonthsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eligible Commissions Receivables, Succeeding Three Months [Member]",
        "label": "Eligible Commissions Receivables, Succeeding Three Months [Member]",
        "terseLabel": "Eligible Commissions Receivables, Succeeding Three Months"
       }
      }
     },
     "localname": "EligibleCommissionsReceivablesSucceedingThreeMonthsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_HumanaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Humana [Member]",
        "label": "Humana [Member]",
        "terseLabel": "Humana"
       }
      }
     },
     "localname": "HumanaMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_IncreaseDecreaseInAccruedMarketingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in accrued marketing expenses.",
        "label": "Increase Decrease In Accrued Marketing Expenses",
        "terseLabel": "Accrued marketing expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedMarketingExpenses",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_IncreaseDecreaseInCommissionsReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Commissions Receivable",
        "label": "Increase (Decrease) In Commissions Receivable",
        "terseLabel": "Contract assets \u2013 commissions receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInCommissionsReceivable",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax",
        "label": "Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax",
        "negatedTerseLabel": "Decrease in revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_IncrementalCommonSharesAttributableToOptions": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Common Shares Attributable To Options",
        "label": "Incremental Common Shares Attributable To Options",
        "terseLabel": "Dilutive effect of common stock (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToOptions",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ehth_IndividualFamilyAndSmallBusinessSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual, Family, And Small Business Segments [Member]",
        "label": "Individual, Family, And Small Business Segments [Member]",
        "terseLabel": "Individual, Family and Small Business"
       }
      }
     },
     "localname": "IndividualFamilyAndSmallBusinessSegmentsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_IndividualandFamilyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual and Family [Member]",
        "label": "Individual and Family [Member]",
        "terseLabel": "Individual and Family"
       }
      }
     },
     "localname": "IndividualandFamilyMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_LeViasCompliantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Le'Vias Compliant [Member]",
        "label": "Le'Vias Compliant [Member]",
        "terseLabel": "Le'Vias Compliant"
       }
      }
     },
     "localname": "LeViasCompliantMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_LineOfCreditFacilityBorrowingBasePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Borrowing Base, Percentage",
        "label": "Line Of Credit Facility, Borrowing Base, Percentage",
        "terseLabel": "Borrowing base percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityBorrowingBasePercentage",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Covenant, Maximum Cash And Cash Equivalents",
        "label": "Line Of Credit Facility, Covenant, Maximum Cash And Cash Equivalents",
        "terseLabel": "Covenant, maximum cash and cash equivalents"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_LineOfCreditFacilityCovenantMaximumLiquidity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Covenant, Maximum Liquidity",
        "label": "Line Of Credit Facility, Covenant, Maximum Liquidity",
        "terseLabel": "Maximum liquidity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantMaximumLiquidity",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Covenant, Minimum Cash And Cash Equivalents",
        "label": "Line Of Credit Facility, Covenant, Minimum Cash And Cash Equivalents",
        "terseLabel": "Covenant, minimum cash and cash equivalents"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_LineOfCreditFacilityCovenantMinimumLiquidity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Covenant, Minimum Liquidity",
        "label": "Line Of Credit Facility, Covenant, Minimum Liquidity",
        "terseLabel": "Minimum liquidity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantMinimumLiquidity",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_LineOfCreditFacilityFacilityFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Facility Fee Percentage",
        "label": "Line Of Credit Facility, Facility Fee Percentage",
        "terseLabel": "Facility fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityFacilityFeePercentage",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_MedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Advantage [Member]",
        "label": "Medicare Advantage [Member]",
        "terseLabel": "Medicare Advantage"
       }
      }
     },
     "localname": "MedicareAdvantageMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_MedicareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare [Member]",
        "label": "Medicare [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "MedicareMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_MedicarePartDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Part D [Member]",
        "label": "Medicare Part D [Member]",
        "terseLabel": "Medicare Part D"
       }
      }
     },
     "localname": "MedicarePartDMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_MedicareSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Segment [Member]",
        "label": "Medicare Segment [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "MedicareSegmentMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_MedicareSupplementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Supplement [Member]",
        "label": "Medicare Supplement [Member]",
        "terseLabel": "Medicare Supplement"
       }
      }
     },
     "localname": "MedicareSupplementMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_MiscellaneousOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Miscellaneous Other",
        "label": "Miscellaneous Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "MiscellaneousOtherMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_NonQualifiedHealthPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Qualified Health Plans [Member]",
        "label": "Non-Qualified Health Plans [Member]",
        "terseLabel": "Non-Qualified Health Plans"
       }
      }
     },
     "localname": "NonQualifiedHealthPlansMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_NumberOfHealthInsuranceCarriers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Health Insurance Carriers",
        "label": "Number Of Health Insurance Carriers",
        "terseLabel": "Number of health insurance carriers (more than)"
       }
      }
     },
     "localname": "NumberOfHealthInsuranceCarriers",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ehth_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other [Member]",
        "label": "Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_OutOfPeriodAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Out-Of-Period Adjustments",
        "label": "Out-Of-Period Adjustments [Member]",
        "terseLabel": "Out-Of-Period Adjustments"
       }
      }
     },
     "localname": "OutOfPeriodAdjustmentsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_OverRecognitionOfLicensingCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Over-Recognition Of Licensing Costs",
        "label": "Over-Recognition Of Licensing Costs [Member]",
        "terseLabel": "Over-Recognition Of Licensing Costs"
       }
      }
     },
     "localname": "OverRecognitionOfLicensingCostsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_PrepaidMaintenanceContractsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Maintenance Contracts (Current)",
        "label": "Prepaid Maintenance Contracts Current",
        "terseLabel": "Prepaid maintenance contracts"
       }
      }
     },
     "localname": "PrepaidMaintenanceContractsCurrent",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_PreviousRepurchaseProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previous Repurchase Programs",
        "label": "Previous Repurchase Programs [Member]",
        "terseLabel": "Previous share repurchase programs"
       }
      }
     },
     "localname": "PreviousRepurchaseProgramsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_QualifiedHealthPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Qualified Health Plans [Member]",
        "label": "Qualified Health Plans [Member]",
        "terseLabel": "Qualified Health Plans"
       }
      }
     },
     "localname": "QualifiedHealthPlansMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring And Related Cost, Number Of Positions Eliminated, Percentage Of Total Workforce",
        "label": "Restructuring And Related Cost, Number Of Positions Eliminated, Percentage Of Total Workforce",
        "terseLabel": "Percentage of total workforce"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_SaleOfStockConsiderationReceivedOnTransactionGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Consideration Received On Transaction, Gross",
        "label": "Sale Of Stock, Consideration Received On Transaction, Gross",
        "terseLabel": "Gross proceeds from sale of stock"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransactionGross",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Long Lived Assets By Geographical Areas [Table Text Block]",
        "label": "Schedule Of Long Lived Assets By Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule Of Long Lived Assets By Geographical Areas"
       }
      }
     },
     "localname": "ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Stock-Based Compensation Expense By Operating Function [Table Text Block]",
        "label": "Schedule Of Stock-Based Compensation Expense By Operating Function [Table Text Block]",
        "terseLabel": "Schedule Of Stock-Based Compensation Expense By Operating Function"
       }
      }
     },
     "localname": "ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Stock-Based Compensation Expense [Table Text Block]",
        "label": "Schedule Of Stock-Based Compensation Expense [Table Text Block]",
        "terseLabel": "Schedule Of Stock-Based Compensation Expense By Award Type"
       }
      }
     },
     "localname": "ScheduleOfStockBasedCompensationExpenseTableTextBlock",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ehth_SeasonalityPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Seasonality Policy [Policy Text Block]",
        "label": "Seasonality Policy [Policy Text Block]",
        "terseLabel": "Seasonality"
       }
      }
     },
     "localname": "SeasonalityPolicyPolicyTextBlock",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ehth_SegmentOperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Operating Income (Loss)",
        "label": "Segment Operating Income (Loss)",
        "terseLabel": "Segment profit (loss)"
       }
      }
     },
     "localname": "SegmentOperatingIncomeLoss",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_ShorttermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term [Member]",
        "label": "Short-term [Member]",
        "terseLabel": "Short-term"
       }
      }
     },
     "localname": "ShorttermMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_SmallBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Small Business [Member]",
        "label": "Small Business [Member]",
        "terseLabel": "Small Business"
       }
      }
     },
     "localname": "SmallBusinessMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_SponsorshipAndAdvertisingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sponsorship And Advertising",
        "label": "Sponsorship And Advertising [Member]",
        "terseLabel": "Sponsorship and Advertising Revenue"
       }
      }
     },
     "localname": "SponsorshipAndAdvertisingMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_TechnologyAndContentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period for technology and content. Technology and content expenses consist primarily of compensation and benefits costs for personnel associated with developing and enhancing our website technology as well as maintaining our website.",
        "label": "Technology And Content Expense",
        "terseLabel": "Technology and content"
       }
      }
     },
     "localname": "TechnologyAndContentExpense",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_TechnologyAndContentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology And Content Expense [Member]",
        "label": "Technology And Content Expense [Member]",
        "terseLabel": "Technology and content"
       }
      }
     },
     "localname": "TechnologyAndContentExpenseMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares Outstanding, Shares Acquired, Previously Cancelled Vested Shares Withheld For Tax Purposes",
        "label": "Treasury Stock, Shares Outstanding, Shares Acquired, Previously Cancelled Vested Shares Withheld For Tax Purposes",
        "terseLabel": "Treasury shares that were previously surrendered by employees to satisfy tax withholdings (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ehth_UnderRecognitionOfStockBasedCompensationExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Under-Recognition Of Stock-Based Compensation Expense",
        "label": "Under-Recognition Of Stock-Based Compensation Expense [Member]",
        "terseLabel": "Under-Recognition Of Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "UnderRecognitionOfStockBasedCompensationExpenseMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_UnitedhealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UnitedHealthcare [Member]",
        "label": "Unitedhealthcare [Member]",
        "terseLabel": "UnitedHealthcare"
       }
      }
     },
     "localname": "UnitedhealthcareMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_VisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vision [Member]",
        "label": "Vision [Member]",
        "terseLabel": "Vision"
       }
      }
     },
     "localname": "VisionMember",
     "nsuri": "http://www.ehealthinsurance.com/20210331",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r132",
      "r145",
      "r146",
      "r147",
      "r148",
      "r150",
      "r152",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r132",
      "r145",
      "r146",
      "r147",
      "r148",
      "r150",
      "r152",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.",
        "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Rental Payments for Contractual Obligations"
       }
      }
     },
     "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r88",
      "r95",
      "r182",
      "r301",
      "r302",
      "r303",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "verboseLabel": "Cumulative effect from the adoption of ASU 2016-13"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r88",
      "r95",
      "r182",
      "r301",
      "r302",
      "r303",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period Of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r88",
      "r95",
      "r182",
      "r301",
      "r302",
      "r303",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period Of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r163",
      "r262",
      "r267",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r282",
      "r283",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r417",
      "r452",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r282",
      "r283",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r417",
      "r452",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r163",
      "r262",
      "r267",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r159",
      "r262",
      "r265",
      "r418",
      "r451",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r159",
      "r262",
      "r265",
      "r418",
      "r451",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r273",
      "r282",
      "r283",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r417",
      "r452",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r273",
      "r282",
      "r283",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r417",
      "r452",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r160",
      "r161",
      "r262",
      "r266",
      "r454",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r160",
      "r161",
      "r262",
      "r266",
      "r454",
      "r472",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r89",
      "r90",
      "r91",
      "r92",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r318",
      "r319",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r3",
      "r21",
      "r165",
      "r166"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r24",
      "r45",
      "r46",
      "r47",
      "r440",
      "r464",
      "r468"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r44",
      "r47",
      "r48",
      "r84",
      "r85",
      "r87",
      "r335",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r22",
      "r304"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r84",
      "r85",
      "r87",
      "r301",
      "r302",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForErrorCorrectionDomain": {
     "auth_ref": [
      "r86",
      "r93",
      "r94",
      "r97",
      "r98",
      "r99",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of error correction.",
        "label": "Error Correction, Type [Domain]",
        "terseLabel": "Error Correction, Type [Domain]"
       }
      }
     },
     "localname": "AdjustmentsForErrorCorrectionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Repurchase of shares to satisfy employee tax withholding obligations"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r284",
      "r286",
      "r306",
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r286",
      "r292",
      "r305"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r76",
      "r207",
      "r209"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization of intangible assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r80",
      "r140",
      "r147",
      "r154",
      "r178",
      "r332",
      "r336",
      "r355",
      "r422",
      "r438"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r8",
      "r41",
      "r80",
      "r178",
      "r332",
      "r336",
      "r355"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r338"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 2.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "totalLabel": "Unrealized Gain"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r171"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 1.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTotalLabel": "Unrealized Loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r173"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in 1 year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r172",
      "r173",
      "r435"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in 1 year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r169",
      "r194"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 2.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Short-term marketable securities",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]",
        "terseLabel": "Short-term marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r287",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r483",
      "r484"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Amortization of internally developed software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r30",
      "r470",
      "r471"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r30",
      "r78"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1": {
       "order": 1.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 1.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Cash and Cash Equivalents [Line Items]",
        "terseLabel": "Cash and Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r72",
      "r78",
      "r79"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r72",
      "r356"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r38",
      "r223",
      "r427",
      "r444"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock": {
     "auth_ref": [
      "r222",
      "r231",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments, contingencies, and guarantees.",
        "label": "Commitments Contingencies and Guarantees [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsContingenciesAndGuaranteesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r84",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r51",
      "r53",
      "r54",
      "r59",
      "r431",
      "r447"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r121",
      "r122",
      "r163",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r121",
      "r122",
      "r163",
      "r352",
      "r353",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r121",
      "r122",
      "r163",
      "r352",
      "r353",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r121",
      "r122",
      "r163",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "verboseLabel": "Major customer revenue, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r119",
      "r121",
      "r122",
      "r123",
      "r352",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r121",
      "r122",
      "r163",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss": {
     "auth_ref": [
      "r185",
      "r187",
      "r189",
      "r250"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in allowance for credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Change in credit loss allowance"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAllowanceForCreditLossRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Schedule of Change in Allowance for Credit Loss"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Contract Assets - Commissions Receivable"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "auth_ref": [
      "r188",
      "r251",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "negatedTerseLabel": "Change in allowance"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r248",
      "r250",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r248",
      "r250",
      "r263"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Contract assets \u2013 commissions receivable \u2013 current"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetNoncurrent": {
     "auth_ref": [
      "r248",
      "r250",
      "r263"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Contract assets \u2013 commissions receivable \u2013 non-current"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r248",
      "r249",
      "r263"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contractual Obligation",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "ContractualObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInFourthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "ContractualObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "ContractualObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInSecondYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "ContractualObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInThirdYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "ContractualObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in remainder of current fiscal year.",
        "label": "Contractual Obligation, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r63",
      "r80",
      "r178",
      "r355"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r120",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r423",
      "r424",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r36",
      "r82",
      "r238",
      "r239",
      "r240",
      "r241",
      "r365",
      "r366",
      "r368",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent": {
     "auth_ref": [
      "r194"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1": {
       "order": 2.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Current",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Summary of Unrealized Gains and Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r176",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of securities in net loss positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r31",
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r76",
      "r81",
      "r316",
      "r322",
      "r323",
      "r324"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r309",
      "r310"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes \u2013 non-current"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Deposits": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.",
        "label": "Deposits",
        "terseLabel": "Deposits"
       }
      }
     },
     "localname": "Deposits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r76",
      "r210"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r76",
      "r135"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r262",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue by Segment"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income (loss) per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r60",
      "r93",
      "r94",
      "r95",
      "r96",
      "r97",
      "r101",
      "r103",
      "r105",
      "r106",
      "r107",
      "r111",
      "r112",
      "r432",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Net income (loss) per share - basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r60",
      "r93",
      "r94",
      "r95",
      "r96",
      "r97",
      "r103",
      "r105",
      "r106",
      "r107",
      "r111",
      "r112",
      "r432",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Net income (loss) per share - diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails",
      "http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "auth_ref": [
      "r293"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Amount capitalized in internal-use software"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards": {
     "auth_ref": [
      "r294"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.",
        "label": "Share-based Payment Arrangement, Cash Used to Settle Award",
        "terseLabel": "Repurchase of shares to satisfy employee tax withholding obligations"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Common stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r84",
      "r85",
      "r87",
      "r90",
      "r98",
      "r100",
      "r114",
      "r182",
      "r237",
      "r242",
      "r301",
      "r302",
      "r303",
      "r318",
      "r319",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r363",
      "r459",
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r86",
      "r93",
      "r94",
      "r97",
      "r98",
      "r99",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Error Correction, Type [Axis]",
        "terseLabel": "Error Correction, Type [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis.",
        "label": "Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Financial Assets Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r339",
      "r390",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r338",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r338",
      "r339",
      "r342",
      "r343",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r274",
      "r275",
      "r280",
      "r281",
      "r339",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r274",
      "r275",
      "r280",
      "r281",
      "r339",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r339",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r390",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r344",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r371",
      "r376"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Principal payments in connection with leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r174",
      "r175",
      "r186",
      "r190",
      "r191",
      "r192",
      "r193",
      "r196",
      "r197",
      "r198",
      "r199",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r203",
      "r204",
      "r421"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r56",
      "r140",
      "r146",
      "r150",
      "r153",
      "r156",
      "r419",
      "r428",
      "r433",
      "r449"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income (loss) before provision for (benefit from) income taxes",
        "totalLabel": "Income (loss) before provision for (benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r313",
      "r314",
      "r315",
      "r320",
      "r325",
      "r327",
      "r328",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r81",
      "r99",
      "r100",
      "r138",
      "r311",
      "r321",
      "r326",
      "r450"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for (benefit from) income taxes",
        "verboseLabel": "Provision for (benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails",
      "http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r206",
      "r208"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Summary of Contractual Maturities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "verboseLabel": "Schedule of Operating Lease Maturities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year One",
        "terseLabel": "Sublease income, 2022"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year",
        "terseLabel": "Sublease income, remainder of 2021"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Two",
        "terseLabel": "Sublease income, 2023"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r27",
      "r80",
      "r178",
      "r355",
      "r425",
      "r442"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r35",
      "r80",
      "r178",
      "r333",
      "r336",
      "r337",
      "r355"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicenseMember": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "License [Member]",
        "terseLabel": "License"
       }
      }
     },
     "localname": "LicenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r18",
      "r424",
      "r437"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Borrowings under line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r223",
      "r224",
      "r225",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "New claims filed"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.",
        "label": "Marketing and Advertising Expense",
        "terseLabel": "Marketing and advertising"
       }
      }
     },
     "localname": "MarketingAndAdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r72",
      "r74",
      "r77"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r49",
      "r52",
      "r57",
      "r77",
      "r80",
      "r89",
      "r93",
      "r94",
      "r95",
      "r96",
      "r99",
      "r100",
      "r104",
      "r140",
      "r146",
      "r150",
      "r153",
      "r156",
      "r178",
      "r355",
      "r429",
      "r445"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "negatedLabel": "Decrease in net income (loss)",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncement"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which the Company is licensed to market and sell health insurance"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "terseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r140",
      "r146",
      "r150",
      "r153",
      "r156"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r375",
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
      "http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Lease liabilities \u2013 current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liabilities \u2013 non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r372",
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash outflows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ehealthinsurance.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r378",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate used to recognize operating lease right-of-use-assets"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r377",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term of operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Current",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r330",
      "r331",
      "r334"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized holding gain (loss) for available for sales debt securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r50",
      "r53",
      "r55",
      "r58",
      "r237",
      "r357",
      "r362",
      "r363",
      "r430",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r34"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-Allotment Option"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Acquisition-related contingent payments"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r66",
      "r68",
      "r168"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment and other assets"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToDevelopSoftware": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Develop Software",
        "negatedTerseLabel": "Capitalized internal-use software and website development costs"
       }
      }
     },
     "localname": "PaymentsToDevelopSoftware",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r28",
      "r29"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r4",
      "r7",
      "r201",
      "r202"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidInsurance": {
     "auth_ref": [
      "r5",
      "r7",
      "r200",
      "r202"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Insurance",
        "terseLabel": "Prepaid insurance"
       }
      }
     },
     "localname": "PrepaidInsurance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCommissionsReceived": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for commissions during the current period.",
        "label": "Proceeds from Commissions Received",
        "negatedTerseLabel": "Cash receipts"
       }
      }
     },
     "localname": "ProceedsFromCommissionsReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r66",
      "r67",
      "r168"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from redemption and maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r70",
      "r296"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Net proceeds from exercise of common stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r13",
      "r14",
      "r211",
      "r443"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r9",
      "r15",
      "r79",
      "r473"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/Restructuring"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of positions eliminated during the period as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated",
        "terseLabel": "Positions eliminated"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r76",
      "r214",
      "r217",
      "r219"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "negatedTerseLabel": "Restructuring charges",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/RestructuringDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r215",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "terseLabel": "Accrued restructuring charges"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r242",
      "r304",
      "r441",
      "r463",
      "r468"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r84",
      "r85",
      "r87",
      "r90",
      "r98",
      "r100",
      "r182",
      "r301",
      "r302",
      "r303",
      "r318",
      "r319",
      "r459",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r131",
      "r132",
      "r145",
      "r151",
      "r152",
      "r159",
      "r160",
      "r163",
      "r260",
      "r262",
      "r418"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r121",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r264",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Net proceeds from sale of stock"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails",
      "http://www.ehealthinsurance.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of stock, shares issued (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails",
      "http://www.ehealthinsurance.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails",
      "http://www.ehealthinsurance.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances.",
        "label": "Schedule of Cash and Cash Equivalents [Table]",
        "terseLabel": "Schedule of Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule Of Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule Of Components Of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Basic and Diluted Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "auth_ref": [
      "r86",
      "r93",
      "r94",
      "r97",
      "r98",
      "r99",
      "r100",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.",
        "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]",
        "terseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule Of Prepaid Expenses And Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r12",
      "r79",
      "r420",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "terseLabel": "Schedule Of Revenue By Major Customers"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r140",
      "r143",
      "r149",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r140",
      "r143",
      "r149",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r287",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r119",
      "r121",
      "r122",
      "r123",
      "r352",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedule of Credit Risk"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r127",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r145",
      "r146",
      "r147",
      "r148",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r156",
      "r163",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r127",
      "r129",
      "r130",
      "r140",
      "r144",
      "r150",
      "r154",
      "r155",
      "r156",
      "r157",
      "r159",
      "r162",
      "r163",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Marketing and advertising"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r285",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount",
        "totalLabel": "Total stock-based compensation"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r247",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-based Payments [Text Block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Repurchase of shares to satisfy employee tax withholding obligations (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Business and Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r127",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r145",
      "r146",
      "r147",
      "r148",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r156",
      "r163",
      "r205",
      "r213",
      "r216",
      "r220",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r40",
      "r84",
      "r85",
      "r87",
      "r90",
      "r98",
      "r100",
      "r114",
      "r182",
      "r237",
      "r242",
      "r301",
      "r302",
      "r303",
      "r318",
      "r319",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r363",
      "r459",
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Balance Sheet Impact"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Comprehensive income (loss):"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r84",
      "r85",
      "r87",
      "r114",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r19",
      "r20",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Settlement of earnout liability (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r19",
      "r20",
      "r237",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Shares issued in equity offering (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r20",
      "r237",
      "r242",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Issuance of common stock in connection with equity incentive plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r40",
      "r237",
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Settlement of earnout liability"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r19",
      "r20",
      "r237",
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Shares issued in equity offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r40",
      "r237",
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock in connection with equity incentive plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r25",
      "r26",
      "r80",
      "r167",
      "r178",
      "r355"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r364",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r364",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r364",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r364",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r384",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Supplemental Financial Statement Information"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r174",
      "r175",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r39",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r39",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r20",
      "r237",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Number of shares repurchased under share repurchase plan (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r39",
      "r243",
      "r246"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r274",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "Agency bonds"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r115",
      "r116",
      "r117",
      "r118",
      "r124",
      "r125",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Significant Accounting Policies, Estimates and Judgments"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r102",
      "r107"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Total common stock shares used in diluted share calculation (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average number of shares used in per share amounts:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r101",
      "r107"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Shares used in per share calculation - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ehealthinsurance.com/role/NetIncomeLossPerShareComputationofBasicandDilutedNetIncomeperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "http://asc.fasb.org/topic&trid=2155896"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(k)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919396-209981"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.12)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756"
  },
  "r485": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r486": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r487": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r488": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r489": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r490": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "303",
   "Subparagraph": "(5)"
  },
  "r491": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r492": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r493": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>79
<FILENAME>0001333493-21-000069-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001333493-21-000069-xbrl.zip
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M=SPNW>D5^11V=&O)?^'SEL_6CZPW5K]K*U3XJF\07DY,^(-?NE59HKWL0D?
M<VDWNSQHQ-HU?*?GOQ@\^Q]02P,$%     @  XBJ4O74<)CZ!P  T"@  !
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M0OPO[I(QS4><O <O79<2$M$^;46#U_R-[QH-6+@+M\+5@'G J--/''DM03=
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MPZN4"5_[6FZ!?9],NHLN-,8"*.UZEP>-6+F&;_W\5X>G_P=02P,$%     @
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M+&2$57JJUUDV*K'RK&]$[=WLT3]02P,$%     @  XBJ4@@.S(DI!0  R14
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MJBO12-(<!X$KNO6:L&[,P0T+F2)(S_4FRU8EUI[5):>];CW^"U!+ P04
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M:[<-=6S2F,/N^+8S2W!W$;J]&0WR7A@,I@^X@LMF\+F#AGER:$D:V^OM(^>
M'.Z1QIZ1F#+?&<DLXD$8H9BM0$A>PVC^87]P@3H6@Y6@L!0G)F@*+$1(1"F?
M#*G9Z-=AM-7S^4GN1Z;SUG3S3NH5WNV:3N?F)<M(4YY'+AFQ'+F$JV"1Q\Q1
MXBWQ2BM:T]32X&LN_*6%P8Y&3-(H4N!. Y*TCCI@A 2PV3/EKTIR!5=>L@C_
MAH!9P-$:[92B$%<JXF6,SY0K*NF7:;Q(.&4Y3MEK#37>."2T=\9&4XWI./>Q
MY7J_..Z#-4.KWUOB8 -YYY Q$6'#&,'*$JVX#D%Y3H30R^*93V_-N?BF"9A"
MF"B8UXH1S:V- C29M4&F[E:\N&N-DQ$O%-&[D-;.';<A1)LD3G$I[5=QOOII
M=Y8&>Y3UWI0:)Z.,'D'X)4U:ZAT-]<Q:+#GU"[P]SKQM,+O$(HA0%Z1"B##*
MO'+&8Z^BEB:1G*<+G&;MGC98;RV\#0)4O K$$6T]"QZ#FA>664(#5HKY*HTO
M0^OBX(JB;%UV\L'1F_,WH>?:75,<W1PD/@F]41B/*Z8KW/"??-B>3OJ<5>QX
M2X&^7=1Q,=/TYLF_6HJ$T:8Y[!?3)UP-6=.X>/#M8#K#=NIA6T;11 BR5CLK
MI. ,66:"I49#9$,XB@%5:=)4#>V%A?9\HCME$"=>8PTDS8FR 72DQ2(&XT#&
M5(&UOVO#M3#LF4?$ZA([3R6IFFHAD ;AX:)F*')C>:#61Z2$3#M)58"J:SPO
M)I[GD^C!(TDXUT%)S+C$-F)&A"(X;?.G4952KSPOM/V:F_\UZIH?^GDE"1H;
M)Z7#BGJGF2!2>R!F&ZAAGF$NJK1VMP;T@@%Z+@S-F)'2!,,A)&1"!BT(HLJD
MOQS\;VN&GC&4UD-:AS>S[2@76G/,9XQ(NAB#T\9[8&5*E4>>"A* KBG NPH3
MTFI$+RJBY\+1TF/EM%2.:$!Q)":M3*=>4DRL,V*!\R<GW.R8WL'$>B6,\E[>
M'75G;Z='&1XS 4O*?+1>6A9C-,P(C"2.F C#;:A6U9NS"E5]0%JP:*RSH*U!
ME&B.HJ3 VR@82B^R[$YY_"F&QQZ5+:Z-9/WD0H$P6=IU^TJ!Z='I7>Z]5("[
M2)%W6/H0&4D3O 7&:6_H*)#A8KK"CDQ%(B%JT4P!=B#WER(D(VH&Q!V))M1Q
MJJA3##.MC9:$(F1ME)%RD]@#*Z2Q7#3VN&AGB^#SX5OC\@X4ZQO-T>^<Y+V#
MZR<])KU@E2&=83D+>A&*@44(UI@QX8(*/%@II!$>,Z)0M6WS/@R'H=B.XW,J
M8A)H5QTA:?--*EA :>="326$I@0QS8,O3:(Q(8^^PG)9W$6G5H6@&=C&R>BH
M\4JE>4+*6Q _6#NO4Z]N&H*K0#]!V0:^Z1=%_Q2L\"9E/0]%BA[,P=6UA)N=
M_""WG9"VB<@'Z=*T@5+(3PS\./A0P&</U^^UBQ":4$7MF<VQ7PCTS#^ ]\0'
M(;4B5B$F'0.,^;3MFP>.9I96(8_/3*"V.W(NU%A[7*Q9C)%!P2LFF<,I&YCV
M0&D$!:>MJD+WYXRQMIN?U4A[!*190HQ1B&/*.&->61H%$R$0%(EGJ%QN/=:;
M696%YUPL>E.#?F]%_HU3?VGHQ'NL)%?<2A:DU$Y*BH0P07K%>1PG54AR-:MU
MZT,M>D.Y?C_'PK53?V6Z@O,",>N(\>"CE"A)A?1("ZV@;: 5V/PL[3EW<]^S
M<2=]:;RU Q 2Y1'XPS_.NI+'6:8 L2&+EH!K&49!'"+.L608<P-AB(Z+;YG9
MN]BS!X41S@0FHY<X,B.I\MY9C*)00:2,38N[;J(&Q0U0S&XAAR4.>T99))@P
MI=-@&7.212E%B%%.%WPRBK+IAT5%1]J<K]SE>;AY G]\.PIZXX3'E\U7<X/]
M0#;_?!JQ&^;4-#ACE426$6X4%2)8J8TA-C(VW=>WMN*]R?>J8>[K9Z_RL]4B
M#/HC""P'XZ_M8'Q9'I^?O/X3_I@,%5$6TFZ_6H."@OK4X'=><ZJLTC1*_"5Q
M\>4U@^%Y!RS2S7M9.^0'[>&J),?#/TYS#TR$$?I?*^5YK_\<')O>ZS]M\0JN
M'G\>W^2;6Z4"9P:"W=YJ"H)#L7+WQ5=+8(H#*(3M#X?][JJ ,MQVHV$*EJ>7
MV'X!-9"Y?J=CC@=A=?KA#Y\/CCOF'&JWD_="5E[TQTDHAFEEW.26P_[QY5N^
M1.,W'4)]#OWT_I/#+\M#KX;^VV-:O=3H[L/H);XX]JJ\=S$]85+9Z#@E%8/K
MH.RI8OZU0E>FIQP;G_H#5E$#EV=]YS;T.[>9U-*D8N',AN^/4BW^%RK_^>/N
MY[PJ:VYV-K[KLNEQ*'V_6)V6*P+XLU@F,EG]WWO@UX-&*YPV=OI=T_O?+P:F
M-\@&X"YQ?.(@_QI6<<)N^?5T F:X3XF!245ADJSUJ;6UM[G1V-U;V]O<7?C2
M[FZN?]K9VMO:W&VLM38:F_]O_:^UUKO-QOIVL[FUN[NUW5KX5_AG;?>OK=:[
MO>W6B\;&R_67#8(XT_?D H#L'Y-?P&G+KX_^7@3=Z[W>;N\T&W\"&??ZO1;H
MN")WC0EG[X286D\;&,2S# 6KF:)&&VT%$RBJM*&4O#69=J-G4B/I0[ZZT7>E
M.DQMULJDPY3^?6XW^B?OR<[)/FV._.'FR>=W^G#[\-/7UKM/>/_PS='VWA%N
M;7P\;6YL\M971SYO'.'FUW:^O7'T]?.A.WM/6YW]KWWX;:?3^F?K%([SUMY'
MU-Q8.]O><[35_0C?FVS_\( W"3SE;W7VGGP^W__'B>V-#ES[YG![;Q,UR=M.
M:^/ST>>]H]/]KQ]Q<^]SM_7/_MG^GB/;[_9/_+N_F?_KWYW/I'-B#_ML^Y^_
M#YOOFKRY]_'K_C^?4*N[T]G>>W/8VOATUNKNX\^';]NMK_OL<T>=-P^/V!<B
M!=7$\2SM )R!AG2951"]",1!EGA/K ?9@5'VL6P2+ZUPWW;F%\'T#_!FXL[!
M'3#2-U#$;D71S $4^T77#.%J>#$06*NVW^]8D[:0MOVSV_#U<012,A2=\YUP
MW"^&SPUJ7]?.OWAD.5$!9S(P@)H1*M-&QBP2X=)&FG HKKS^[__2DHD_[D+;
M3#GH)GANIZ#&DSS[=N!^_+2VL[>Y\WZ_L;/Y87MGK_'AT\[NI[767F-ONP'-
MUAZT30U,&]L[#<Q_\[\WMM\V]O[:_.__P@+]<:59NVC2UM;WTCE84_8T#CS+
MVGC;+QK#=FC\9^I,C;&:;T#T%?SLFXDK7K[J4PJ(-&KDS?EY,$7HW>;F'\KR
M;(Z#P>?FY'M;7T@@(FWEF G!:<:\\IG!0F1I(VLL'9>1F97735.X=H/B%XU4
MU_-I6&:)R^V=NC%\2&.X5T#I\W(^^[-L#0^/^!?-&)?$R0R% )Y"B,DTIS9C
MDO+(@J5(X4EKR.;3&MZ.GG'3LK>SUMK=*EN?NF&Z;)B&%\">MDRQZ'<;Z9]A
M?P:O]: >G@6JG\L9&8VW>2<T ,<V%*M/HZQN5W6/&%-NEAV5Z47'[_G<Z.WK
M&OFB(B70\N-,$8,R0(7.E!8A4TQ0HKSW@L;4'8TSF@8^%UD#X)L]%;=C_,M#
M_IEC?Y):#/?8"0?E7F^]80N./#L7V3S]HIT.- :786HE* "&LC32GX48A&7:
MH"# 13;_VEQ[O_?7B\96:_WEO=WDT6%T$T6W^\1OFV?&#4O;-_JQ45S8O&$&
MC<%Q<&G@R3?R7B,?#AJN789UO\_1.1;!U1=V&$?KEQ+)GQG%8>(EY_1>HS@/
MN2U]R369^5W+PO*'##G]:'R)')^ED9^KANJ$.+Q9TV.3KMQF[=0M3YZBL?MA
MZX">)(0<I(R;QT7_)%'']:Z6<?.1]A8=9Q &45GFYUP?9^)<[_MJMB9O<_ON
MDVCMM>$Y'\GGO?VOS0UH/:!%:?WS-M_?VR+-/<>:A_MG4(;S9G=ZS=_P+-[[
MO-?'V_!.GS<^=UJ'S5-HB=#^UR.\_\^_V^F:UM>#\];A6WC?K7-H@4[?[ZT-
MF[OH#/[^H@@2!/F8\:!4QC BF;&$9YIJ'IAR6F&U\GHC=,RI*<+WVZ"IR]QW
MM+5VG-G*JCUSMC69T3'>;;?"(<A3>\36A4?PH"E22H T\S1C6IA,&14SCRP$
M,09YDR8Z<Y$1RJ62XAX^\?--Q1BO=V)^IB@6/](_)8I_*PFWT2\:_6$[%(W#
M49$/?.[*C@_0>?E5<BY/*PY,+_]:?K^4=X]-%0M8<5LO=U[N-B;;DQ:-ZZ[:
M:/6O5TXUIX@L2("YYGT1!H/)7^^A +B2+/A+4>;9%R$=HU+(3 >.,T8QRC0B
MP&Q0<Y9;+@*!*),(PAMKG]Y]VMW;:FTV-G:V_MY\D?IQMUL;C;?OM],(QW6*
M:]0 &R-K'3YN%WO]T]ZS@]<:_:(T<M)#(VFID0 OQC*#(\Z\P9*GQ4,<V977
MNVNMO;7&^ONUG;6;.'KQF+-[KAFJ;+2VBP\054 #5<T@X9>L]?4+,S(J06)&
MB$<9LTQE-G*="1 Q4+<F!D-67J]_8Z0GL]&'/D1^G<_Y<67#N%^R$/LBG*6*
M\9!I%M-\+,$SQ;G+M"1!*Z8907SEM>:(LP5BY)OJYW9&'@_^/<J8SP_EU[@[
M<H*RI%&/"R"!_-AT&N$LN'(W>?@9I%@8/+P#LAJ2Z[='].+4"JX5P3Q/OSW]
M(@Q4'V$F2UNK@-]ZGVF071D+,B"+#-+"K[P6'-WTVM\?DUO?]R'N^=#N]Y[E
M2"1I[7WZ8C6E*GA@4*(@E,=19VE*129\M)A$82,%PW#%,@)>L\"<>@>E78ZC
M_?=_*8+E'X/&,'3"<3)ZHU=:_44*R#NC%"8W#/@H0,R'.8ZRW&_L:!=8N<B'
M.=QP/&X4BN ;QZ-B,$H#2,-^ \XHPV9,?K._)TY/4S#6W'!U,<=.U'@$Y*%C
M)Y2_1&+V8R=$O.1R]H,G96D?>_#D*3MV?@A6A/[7N&P^N$F7U^JH!YA)9ZV\
MWLN'G7+P,QC7;KB.&0P>T %6]9<O3,DZN^==V^\\G_=N30:\2YN',]=.64H;
M0%6G[1Q^N>2S;[O[EL(A'K7W9=(PG&-B2^>JI*@9CVTT-SYAN.YH?V^3[7_=
M.FMM;/'M=UNX^<\FW=_[W/[<W3S]?-@Y;&Y\O#FV<0KB!L303KNYUSYL'L(S
M#X^@7)_@&;[=ZK[M[N^]Z6[_TSQMO55G5T?[J$8.:I]FREE0JA@^66-T1CQC
M3,=  L/C&7N U]UAWQV]:!R;HG%B.J/0^)]I)2=.LQL;@_;W1@.7PL<?%<<3
M<AQS8PWB>X!X\P+$5MO  Q(9#A)4O0DX,Y&R+%)#N%8N@!'2W*F]OVJ _N)4
MC-1\?3L+8TK"FY/&K;*3^)X:PY>#S-%&PIUE6=HI*F/,H4S[$#(3D"68!>>%
M!0D%,4W+#+SYSYB,&TU3'(5AX_W[]>]">Z9CAW,) +=Z/@V,AH8];[AV@%=/
MFT* A KEH',*]JY,*/P-_]YHFT$CYAT($TVG P?3VI(4/?YGE*?8$4)&&R8G
MP#TOPD>:AJC'JQ0F0>25V',*\!18IL-I@4+#PU&0M>G4XVFV5 A#&^4"L4'C
M-[@?N%%C, *Q-VCWTZS&Z8* 8=L,RPLO _?&J;E>RE3$\<63=_C]1</T?.,W
M,GY'"\X(Q^TAO$$ZOSP5+DJEF-PG+;,9E(4H"VD&PX9&#6_.!R\?OS-_?504
M\/SQXI[4Q W-<#2H)#W\4K?@V1>EB Y1VHPCHC,68\@T)2QSR$?"+,;.Q)77
M^V%P9\?3C):&W<_ESAZE<_Y^SVZT^C\U0#";-T^/5G_<?]G!?/K$'D:)B2J
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ML7"<E^>6##Z]</!-N#$FAY_5<34"YMB<3_W[NJ0+9\&-2MOUQR2=MKL?A@.
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M>R6G)0<;E,8>*-&*,1F]TFBKQ5"3T#H=YB\AAY63"@6MCT7KY31:J;-<)A%
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MZ>$O;SIIO.B0_/'YW=EO'PX^[*-WY+>/[T[^B@?CQ(1C]/D?8I*)G,# .+?
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MVO8^=%^6^?^=^7^X@SY?Q5R^''[XR/_1SE)NHP!A?"X/P@QH%C6HZ*5RVLO
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ML Y;S83R-K?2LB81!P]$I36<8(6*7UH'VIB27$XJH[P&K&3R2Q$E8+5F(+1
M2G%O""5;+8R;@NG"&D5V%=GUM)FJC^?/ZP35(L"6QZ1'4P*,,J.(YD"E=$F
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MCF@@-7?-VQ+1*#JD8'QI&)]($BE1Q,$(0#8Y&RPA'JQ!&CP/2&".I9"L*O&
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M^4).,Y'3P;3:4 [YM+(@T)YC8(RIO)>JP 9$D7/"!(P3.:E2?VI]$?M<2J.
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ME35!!H-&U:T>?+=SE@?HM.BYH87WE2-_XP']'O1U.*C6QFF,P_&@ HBW89W
M#$UNRL^-T*S>*>!X-V?&KX:Y=]IMY\B_;NS<MJ;FIF$ PY-/>,2R@9.7S6XZ
M/X[]O&+RI[!J^C'EWWOCAU4#/!KW,';S2AG,#2E\<923E4.3QBL_G^#+TMN
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M&99$&'C_8%XAJI(T5-^<)J]H#V  _,74KCS?<7<Q9_?/)Q%F3NX;:%W:UL\
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MXT$99[6G(@9J M%2U^F;UPT;9M1,IDB5QD#(A)!96</(>FH0431&[TP4EN:
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MP0&ULR9'X&K$%4[(6D:1HLD)$2U.3 +K:QCU4LN!KU"BJ&\=PYNX HJ#<=S
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M[QUUH4.AL/"8< *[7#X!/<C/&"^@XARV/WC9-Q^Y64"_BFX<SCUD^H#Q$AW
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M( I?.!O!C@L\,F^>+E8>EC@;X\UJ5/-(7[]4^DP&PW+GM<,BV7:_@$NCN%E
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M)+4"ZA&$0"Y:AX1-1AOGE<F)P0UM@-KTU'K1*MEX:@!8&;I2 \"2 >!R'@"
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M$1)1"(XBGBA&AG&"'&6)",,]]J;!I@:;:C"W&V!3E%&*9"2H2HK[I)PA%O[
M'/YFG"VI-YW%03\ ]C2P]$"P1&;%;@2W1"6+J% "\:@,,CCW:($M"UQ&$YC.
MO<DT)?37!I@:8'HBP*1TI$99I[TU7-MHDY964 %:$XL\^ :8:@E,; 9,U&*E
MC$;.^0C 1!,"$9,0]HP2[;5S1C7 U !3+>9V V#23%M,O/:">*Y-<H!)4G"!
MK<+,.]%8<_5%)S'S-#$;H^ 2"6UXKI_.D=58(DLY24PRE@*MGS6WRJ.SVGOS
MW_2/CN*@C.P]ML=QT-0-OM:(XR0CC\EAVT"^SK*(';4<1&SPF,<&DNH*2?.-
M-A6.AD47$>$Q(:XP099PA1P-(B2*G9*YN!U?8_3.F-34%ZXO-ZL(A@Y1/I>%
MX5AKJZAE. DPY:E6DRIKC>53-T:>>8J#\\DX0A#E5H!NH1TRPB3$N#(T8:RI
MI"NS?!I.KB\G6R"#F,O+.BHYCD%S%[2T0:D$O(P;4Z'&[#SSL 9K).6>(A&4
M0URGA/+N(2JL!U85E@?>R.7GS\TTP09KGA27FDN1;,!6R!")HU& M&[D<BT9
M>>:1I"I08BU%7!B)./ UTBD2A+W"4A/,%5V=1[+AY/IRLN5>@Z6, TV21\F,
M29;8X.%!U $W-W*YONP\<^%9H9T/ B,,AC'B1G-DC"'(@;QF6D7855=#N?SD
M.I.]Y"M7&3Y=]UR%#P?]P0B-XN!H$D)=E1S(%1/*>EVK*"7UV*DJS3.>T#->
MU&G'QN?8\Z>%ZU^1M=!H;N<V&,,L164,]XG3 *:7U(XJYZE5GI!5A/EO?+6=
M;H:^M_W!!]#,/IP#X&9TH]E?=>M&\13TMYU9L#_=V=PXW8^>",M5CEX+'O%D
M C(J2*24E%&0Y*4QKUY3N:9IG;JU-1;9JH,J#!,1)QR9DUQY[+RETII$@!J\
MC.ENOI6&I>^5I<\NL'2*PEOE.')$@%DF7$36>(&\(%HEK8)@N/&RO ">%H;Y
M9#FWE"4NF73&!B.CXY%;C2-I9'7=&9M<9&Q-<9*"HGPHC3@+#EDM',KJ%P[:
M<$=L(ZN?/U\;:@1AR5D1*=?)&6TH=0$+(B.A_(Z1V0U+WRM+LPLL3:37W#*)
M-/46<9HH,HQZ9)7@5 L><':A-K+ZV?,TIE9*R@4A5O+DD]$Q@8P.AABJDFQD
M=>T96UQ@;)_;XB9)D;>"@\".$>SJE!!128 .KJ72N(:R^D55*UE)?/.RV21/
M&IUX/JB5B1,<+7>)&"95LF!9!D5%BKI!I[JCTRS*63KF@C<2.>ESYS-.D!&.
M(4D\B]0;S9EX]5JM87-G8*I?4EC#TE.6)C:X:,%@T(%QCX5-$<-?G&@BJ*1W
M#*9JN/E!''XG^YP%PQ4P,@[9V<>314Y0A:@GQGHI'6;^&2=Y-OQ\7G_+:XJ]
M8L0(P@/W+@FA"!5<,X'#2K(B&Z9^$&??R7YBTNH0*9*.@/$0,U-S+I"( F/*
MD]/6-B+ZV;.T#MC@7#^$2V!CXHTPWA)O05S;@%US)E=G;IY%/?L2DPE&UKB(
M.(L*66!@A!TEL)V:>=F(Z)? SX1[D71TEC''20Z!5C& S XT1&&M;$1TW9EZ
M%OML'-A,CCB4*!:(!PSL+2U&5.($'X&@MJ1^(KH)?7Y"5S:;]82N;#;K"5W9
M;-83NG*50>A4U.9(ZCN=>+[?1_.FQX*3YB"39I8,5B+TQSFQI&P0LEP'H^=6
M'VV52_-LS!,AI? N4HT3Y\8I@Z47FI%D261!K"2TOR3L)@GS;H9(:[>5C9#J
M2&]C/P6JB1$.8:-(SJJV2)L84 R"2A)S#4CYZK5@:YJO*M1@%8SSR*%'#6PV
ML+F::E%6<((3DR99GJ)TU$3!,F9J9_Q*:K\UL+DRV#R=P:9V+C!!D6>2(\Z2
M1]8&CSRF(AA%'75J104H&]1L4+-!S8L19=H[*HCUA##.H])2FJ 2UCAP0,TE
M:^PUJ/D@J-F>*9L\.AXBZ)DD@HK)N77(@M& #&/<8NPX=?C5:Z[7*.<-;#:P
MV<#F:I7-Y!@+SBGF$D^86I%2]$)RG"PC_H[=8AK$7!EBSO1,YYBQ2B84M,.(
M$RV1$X$B1QREQGL1A5AUBD\#F0UD-I Y<6M&"^:X$TE%SY61FH&=[HP%T!1.
MJ)5$732XN2+<W)EIFII2YT.2B!)C$-<B(&.D09BKJ(*5GMCTC-R:Y3'7?\J2
M7_!OZ'Q]_7_+']4,W. _K\]G,_UR.I^Y%_D(E#]XM=1M1W;PN=.;SE9>1,'S
M!TV*D$U6KEH"6+6N/1[&7Z:__#H]N.OT2EXM;UJ<+RS<KR>=,#KXQ9AUA55F
MX\FYWN3QU;=DO>3PA4VKOA-XG4EY[==XG5S[W?<>J]<)4[=ZZO>_8[H9:S/6
M>QDKI\L^]4F<\C^_*W\0M[ @,WZD@0)XKEK5TDMI6E=+TEE0K[IQ),9E,?,P
MJJ59*@)C,_IXY.*@8&2M ,T0+U%ULR&I59+4G-%XG<9UA=+U6%2U..6KJ>J-
M'0Q.8;3%OU>%\-QVZLL4_'PV2_AG_!J[!6G6[M9K1YNUN_7:L6;M;K%V93AC
MC03H2[YR1:5='D&K6#)VMO+"W:5(^LH8^#XK=3>#?#*#?#(OJ!]:/;\K5YG'
M(->7R61X/"C.77>*.&N[<RM07K9V8/.,YAD-S-7ERH>N(/@0('>U&ZL%LSZ=
M=.HITOB*MB$WF?-SBT6X:HK/)J9 QJ 8%4G[&#C501.=?&3484:",E7Q-$QH
MT[]NV1B#HQ;/[]X[\RQ?URKOV>;MCULGK<.WW?;F%FMM?H:QO_VR&&.P=_:9
M[^RV#]MGX<NGCUO?VILPHD.X=G?CM/7Q']S:]2<[F_]V6A_?I_9<_Y/VV>=]
M395(# MD-1&YTA)!FB:##(W8<DU=T.G5:[Y&L:I1&8<5V4H-/#U3> (T2A(K
M'K34W%CA*,M1,XP9SE0,MH&G^L+3V3P\.0 CRCA%QN#<RD5H9**.R%(7N2",
M4>X;>&K@J09SNP$\1<.L 7B*CE)N([>.Y\XTP6&LHXA^.7AJ^G@_,#*1>622
M4EBKC4=4\HBXUJ!"18D1Q98( GH48?H9%[5KL.F98I-B$3NCDA=:<JZQ$P8S
M2T&) NFK'&VPJ9;8Q.:Q*7 /T.0DLH8HP"8>D$U,(>*%]=1KY7EJL*G!IEK,
M[28YT]XX013G+,B<;&N=538EYJ31GI#4F'7U!2@Q#U#>2IH" )32E@- *8<,
MUPYI#]M"K I*QJ=BUM7O!.+Y7=G4*VRN;*Y\T @+58^3QZO#*SX<] <C-(J#
MH\GQ8Y6C=U[=NPFW:)Y1@V?4#R&>WY4O)]QBXW/L^=/"]:\(M#B?^8OO,1&D
ME$XX*Y-)G"9ML4]">NZ8T<Y[O0(;\47VF'@H2_%T%I^PL[G!]@411C'ED?(Z
M(HZ#1=I&A;S$@?H@4N#LU6LFUCAEM;<5F]XQMV_O%E6T90T3ZK@FTK%DK!91
MDVB)D$M&'#6]H!Z%I<\NL'2T-&JF(E)6&<0MY\B:Y% @B:08@F.4/6/W=,/3
M4YX&J1R3LS2PP'ERQ$I*K%(F=W=C(+0;65UWQB87&#L))@6A 4DL ^*,"N1"
M,H@RS)Q/3E--&EG]_/E:A"1XHBK2R#GF0:>(?6!"12X9)K&1U35F:7:1I3D5
M6"N)G-+ TI@89+"#WR*)F&!+ HN-K'X!/*VUII9A;SWGW"6PL#5HW8%;T.0H
M4:J1U75G;'%1"9=!VZ0X"&=%$4^1(>M,0E9A*64*E ?U9&1U_=R2S^_*51XN
MU=O1^J9_=!0'OF.[Q;$]CH-;.5NOF/WS$PJ":\JB%%PQR84GAAN.(\9* K*D
M)!JA4'>A<"$9C#@7B7$>,8%SW&# R,)V(D^4!S&0,(WFU6O"UXBY<US.=]#A
MD0IN-VQ]KNM%#=S(N: I<8:U$\F%8+"-,<@P*;+?V&_UY.@+^5/"VL@2F&_Y
M1 QQ)0FR3%LD'9%!"=C@K.6MMO9^P](U9&DG3 @*AT"%X=0'0UU4FC$I* [6
MX$92UYVO+V0?N2"<QRXBBC%8;U$99 ,F2&B+$TZ.$AT;2?W\V3IY2CGW$C-'
MN!3*,>Z3HE0Y%U2*2RK@C:1^7$]K68A!XA"=HHA%FQ G(B)-14"88]C@%(-V
MO)'4+X"EC>1*.4.B])C+D(RV,CJJF6'8,[.D\MU(ZAHX6C-?&T4$"R8@8BGP
M=:0*Z:0TLHIK88.E0:0G(ZGKYY5\?E<VN2[-E<V5#9LT5S97-FS27-E<V;!)
M<V5S91VN7&FRG:E-T97O]&XI;-E4HSB*-E?]"(4=%<EV!L77J_I8_6@=OMM?
M%;_8MLTK7IUGXPIT1FM'% ]>. Z_:^>-)]1*F8QPC*W"%?B\.S<_D-.OM;N=
M'7YE,$W[T/-]P;$FV@=$G+2(2R^1U=&C8#AA+@HO/*YZ-]-55;A9$??4O'97
M@Z -@MXD&]PH8H6TR=( 7"BTT,HGF3!.7"O#&P2M$X*>SB$HDRP8B26BBCC$
M?33(<*<183(YJI5UQ*ZV1%@#H-^?98.A-UV@9P.CFAN3*/:!>L(!3C7'WM"0
MF&$B.K*2,^D&1E<$H^UY151QCR5+"OF 01'UB2%#C4<L>9*K*'AI L"H69.Y
MT?<CX^B+@=(&1U^@+BI<C%YY81AG7 8-^B>S0E-)7& Q+)E!>6VL7H.?J\+/
M"VHH5HZ!G$.2,IL#;2/2B4F 4PU[*'TR?.7YSXTBVJ!G@YZ+'>>XHX"?FL>$
MN5#"XJ!-,$)IJAF12]:4:%30!X'0G7D5-.KH/=4!R>09XF#5(Q>M1"IR[;00
M-I$7X0NMWW'>\[NR/*#\3UD.&/X-G:^OIQ35'A\!1OG7_Q<^G#YA;E=]!*P9
M5/O<Z07XZQ<F2WE649X;_.?U.166SUU\SN6['A!-:4;3G?&@\ N-IXN3.(A%
MI_<U#D<QP"_%47^Q:VMA>WF!+R:]%R>=T4'1!VKO]. S0- <%'Y:]%-A<!'L
MZ1"^++IQ.'F%[]KAL),Z^8AT6/P9O\9N0=:+C[&(L##V*UP\ZA?C4:<+,RI&
M![%P,*3"3D/186@54&<YD(=9'K@")\X=MY:/&P_A%7T':_2UO.\8=A76$&[)
MD/$U3J96?A)BKA'=Z>7'Y%=.!^FKU\!<^K!F5ZW(; HWW?6G02L;PSS[EAWX
M@X*1M0*$)_S,JU'-FTX/OCL]WQV'O.3PW6RW8*^*(9#8U?6WUXJ3@PX\&23X
ML%,2'KSL$H5ELK-S16TKDCNGM)*V1@>P-K _Q6FT@W+_)WMX6FW=[.TANM'<
M$,J' 0E,IP._9@J8$5-QT(F#//_3-2!%;X&N@)(S>17_'??SF"<4,2$PH-[\
M -@^V+JYE8"%L%T@LYXMJ2]?G<EM",/+M^5)'O5#[ XGQ)^_G#QYCHH[O>/Q
MJ'S)E&;C!<+/O'W<'XP22*I^?@D\ JCBX@HG8-5>N<"=WG T ,0K$2"OJBW\
M((;.J!C ,&$$</7&1A[[#"L*=UI\^'_MT?&O?Q7OJZORX%O]?CC]/\-BN\00
MN.,#C#FOR'JQ>Y YOV3_'JS. .@QQ<$0EG-T$F.UX.>K#/OY-:]"J+@Z?S<Z
M&,28V6]T,"QA(BQ09#F O/.3;S>CCT<.2&=R 5XO5L&>%R3$PA&\BYP[SW%T
MAFMFC35.<HF33M@%Q?<W\S@Q_!>5O["L?UY4*ZN%*_?BS3E(_G;Z!EZ3M9RQ
M[;8F)+]I1W$WD\,NO/^W;M]_>9KZ9C?^_O[TT\=P["B7.Q\_'>[M_O%E[^,?
MW;VCELBZXZ>CMUF/9.W#/[J@+XKVX9>SUEE(K;.ML_;?^UA'J[%22"63$,?<
M(U 4 \(X>JR3<XF#>1!!*3_.&ST89_E?/XS=S7C3[W;[)R7!5Q@Y/LJ<>P9O
MZ5\EKDM,G&(+ I1%)<HN@ILK.7]*/S/,_*F$N?X8AAV&/_]R+7/ &$"N3Q7D
M:HDF YRHUI6"#$O5M<?#^,OTEU^G6E>G5TZXO.F*TCV_GG3"Z"";>>NX,O4F
M86.3YT^^7B^_6E#KJ^^$7A?<7/LU7B?7?O>]QQ*]KC2[U6.__QW3_'X&N]QC
M?Q":]\.\2W/ITBO\*A,M^4%<"&:I(+VK])@+UN)=UV7. [:LS5CS%3L"-0(N
M#\6;_G"T3*>4'\[[Y2Q>=@X5_UX*_5Q17&RM79B;XZRE%J34QV[ID'G1OMP7
MXZH5P6O%L+"6$,XELYH2;92WBJO@O2U=M1-5^5XRV"?Z-/SUL30"=WIQ#XCV
M'/DR\#T3G^[VM_:[%FD?[9WL?/R;M';_9I]VW\+U^?_^M$WW^,[N-OL$X[WD
MTSW<PGMG_]!/AQOBT^8_W]J;H=L"G3S_OWT&]^0Q'H8OK=UN:G7."\6=[&OE
M+,?4(B8B1=SB@(S!$K$4M.%8TN3\_?ASG\6!5X.!#08^'@:>GVXU^'<S_#L[
MQS]J9)*:&^1I((@'P9%142,2*6?4XR0\K_"/RR>!?T\N^;$9<#/@FQ_\Y;\S
M1G=ZX_+XIW2(+75F,Q$"@H.4..X/._GN7P:Q6WK\9YZN_[GHA9PXU_#L%NN
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M()P 90B/M/0<*2] -S'$@Y;[ZC4A8AWC:QQFQR >2Y*X*+W608J/@!SZ/L8
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M(M\SMWBU4!_L ;D&^;W5#+=5@DJ3SI5KR70'R=3:FD9+-!8R%2$G,M5@U^M
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MXQ]%>]S/\H_HO.7_/,8]>Y1CB,D4W(A_9J#ZLF2)216N!O;A<:(^EUR9QZZ
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M,%*A88)+NJ:9)Z.9Y->QMEHDJ;4D#G4$-A>'W]!IGO@1BV-?LL0RK*%] \F
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M+7;M!!%8;V \6PM]>H-;ZZ37. R"#2I[&K8OC\>GH7-EAW?G\F1Q;1,X:RL
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M^FRL6@76>Y-F^FA4]4R[BWO4J)95RA-MHLU4]K+;1RIC?:Q.5&J^1R-]-E)
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M]8(=G9GX_WO%'>UI![[^ZORT5<] ?&,?F21O#<_+6YH=(3LG?,3QAX*/+_U
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M9Y98VCYS9O:F)2.UB^_&A^U8>S9$ZMU7KS,9,%E)DN<>36M7AKXV9ZA=7+;
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M6=8&?'#P5=&KS(X2P://#)0:[>:66VCVC5E;Y>9CH1&M*#PV6^#(MC9]H?R
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ML=[/;.$_>((#15MI4;=7JFOM-MM[5+09HSJU:B?.M1-?0G_Q[?9',M_W8$G
MC)!7] 'W0Y'Y7&3..-M4_UQ8Z:_6=];6%HU?R0VB=!!U6?1BD\7C?E:)CB^R
M+GE'UZ9^ _.T;_.=YZ&?]%FTD ?E\ LV8C?ZM_^3M#BDYF@BU? 3: [*3<3=
MJW0P%2[\D-2!__+S/8W"YD&$YMH<B[2$GLEJ82_M?+O>N/.JF!,:4W0A[9+^
M=AQ;2#?[-U<V.EJ*CK/U*L;^J^5!7(R3__^X]A-$0Y%0RKB0.\]RG[E#OM O
MR6KO$]\"G_F<.JR?XISG=<NQHZT1>5'@*3HI^_A1US["#@DO81(G?U_.:]3+
M/&E"9:?4DU^0/9-+R\/96ONI5%9A*FO0P%36M'NIK(,ZI1J/U\1H?HJR85@2
MQ&2,1?Z$29P_)FD,#+NB-6;Z_Q7WT$I4U&Z/K1L;>T$$LF.E'\'$;?[N_5X:
M-;/[Q+ W'8S*]D@H0-'%,_5\A :H)RL]67J;IKUAOUS/B>OWQQCU!H.FS+5I
M=)U5Z3MRK)3_51'8V\T)BO&:Q5CC5Q5:T]AN\B U>L/[/)3OP*+8IV9/SK8Y
MLAUM1UZ_7TM+"=>O(JYMJ#<E\^%EBDO56Y*;]^3UVL4T_P,7FV03[A>5ML4U
M9XB&TOJLE\)-JH-2#XM13('[Y%Q4V8R+Y#!4=:\FW-XU)WI_5+4LABKQ==E=
MFIUXQ;KIUW%5N<'.*:393!^/5<G!FNNCZ_1#N[H^.E-BI2DN\R=$62AO^5+'
M#&VLN#;1C?%UBJZIJGAE]ZBJ<]F2HGB*-TJ0;*Q/!JJA6\WWJ)OR>^D&%E<X
MY?J:1:LI1ZP&CEB^=MWQ<X%F:!!C,-1-X\2@KLH9B0K)7VT+^_UNQN17X(ZV
M27]_K _[4R7]2OH;)_U7: 1R%4_P4W+'010$RQ5@N%03CZ*IG:%JYYX>'DUQ
M%YOWY.6;#:HQ:MO L2F'$?=8Y<)?JFBX?M%P\_REV:QJTDP=,5_8H^VF/ZMX
MHPQOZ,;@Q'!5R:^2WP;$HTUQRGY-*LE2,3*;IL;AOY5[5@/WK+$GFJ.^/IVH
M;I?UWJ3*)K@EY\Z*.<HPQT2?C)4$UWR3.HK\ZEKF+.+P;:R71L5=\>0@:;"A
M_+0:^&F-#?(&PQ/@O2H2O^PFF>KRF&*.O1+<UT>5W0 EP1>6X.O<A[NZ!'<L
MF?8U;646EW97'EH]/+3&AGCF #RT@8K#:[U)QJ2;<;ABCC+,,=(GPZKH3B7!
ME]ZD;DIPQS)I?Q$-Z^1AY]KQ'!X&!'I57EH-O+3F!G@#O3^Z3DT-%86_FI?6
MDBA<,4<9YICIXU'5.$M)\(4WZ3J@P:M+<,?R:'=K'^;RKZ17L>.%EO?@8)<5
MT251.6LU<-::&^M-KE-P0T7CY8L=3TW#_-#-D%QQ2!F Z? Z*5>U0Z]U?Z E
MTGO$5:NWN5=/=N?)CF5^/S,>!M$BC *JP;"R@@>FXH@ZQ!&-S4:8^G!PG5MR
M*F-4>H^ZF3!2O/%J4::2X.[LTM7E6$43ZLE&/-F!CI6BEJ]_H(Z;"B=J$$Y4
M;?S7#"N(!7ZGHQ//+6I3XK/;"='*)3Y;DA*] G>T3?K[(WTP.?'$0TE_';9P
M=ITF'%<7_@XT>?CH+?PUTVY<G_-WVC+PU[&7Z'O*)ZR#3RAYJF56X68\--]5
MS8C4QAJHI%97DUI7X)"62;ZA]T\]>5+R7XL-[*;DMRI+>*#EJN:02ZAK'E/7
M_^O@ #8V;#1&ZN9PO7=(8945AQPKI:GJ=]1[ASHMPYW+T,W9T@^8M@G\1X?C
M%3/X3^UFSCRV=$+*W[V3#IP66M_5L6XM/+AV!O(WPYE*X34SA%<I/)7">U$*
M;]A7_9H;+/\JA=?6%-YORC&LV9.M##H'E3MVJ[1 $UR\EJ0%%(>4B=],O3^<
MEH_@E 1?>G\NO3=7E]L.I//^QL+8#Q,I/>6(O>Z3)2-2P1/O!R UMA]AN:Z8
M%5X6O-<M0'AS8L1^#OK46A/=3/O]4].99R".RG?4SAEN2=;C3!RB]*C2HZ52
M _IP=&+E"J5-&Z%-KU-I^.IZE(*3/X46,"3\7]MY_/-_TO^<=6+38Q,S<6+_
MS/R_9([Y&?WY/^?!G_Z\\V,\4;D9MZA6WP_&,<<YGLV\\/VM,25^/NO21KWI
MJ,3J/FQ\[N#UH_<!<ZF]P0>4]]M!S\#7M]G#X@Q' /_-2+RWR[(*S3E+3L/H
MF4B^3P>NVV,,Z$8VT\(5TY:^Z_I/^*"U!L&!1_TES-]??+O%]:$^6>-KHJBP
M'$*[<3QXVX]@UC9_]WY+*+<W?&T%#XX7Z]9Q7L4L8--9 !M.W)U(LM"V0$'7
MVG#V/O['ASC2<CPB!+VTO3&P9Q^>'#M<H2SU^B1/<6@OQY<_]^BG+2TB?IOT
M>^/I8._/_9[QMC9Q9N6(]/CR#;,W'IIEEU_AM]%@_T</O7ETLJ-2PQY)\]0B
MFW-4$<O HL@2OBI[S0KI-.P-)D4R?1UB[2E"L@H8TWZ%YU9<^QDLC:W]:@6+
ME38P=*U*'E QR/6>K.*"UYL=S;YIE F4RRQX;P#04L+UKX&K -)=)PX +?6-
MD2,G>F_1O#C\=U/E^MC&=#554WGYM0Y?37TX/;$U8&T2+4=.@!4C=X&1#7TR
M./$JX:LS\H6.K*]F^^XC#JME@;:P B92&%[@N^ZZ#=W!6YF>'8ZKEFLZ3X)6
M)=#+[M!X?)W2WIUPUK^RQ<J#3ST\D[9:P MM5U6-A;B9^F2H[A?7>X\,?5RY
M^>P9]ZCM_E6+NWJWTG:/]$F_:E"M_*L+>\#7W2/5^."5GCQG*^%);U*BZ]<%
MS,*A@OW', !--1$ELS;%0+#].9WN9/1>1IE:*V\#;Y=7C8_/2)UF9+25:'10
M-*;ZQ*A:=Z$&DE$,G(RG7 1#.P!@+(5NE%0;#8&LNW#"!):&@*3,6Y(X_?05
M:PZDB,+]K^R;_-D8P^B7 H0.AGMI49&^I[R6_=]5D*)T'MCM/&#6MUMK"0.\
MM]PGZYG_\*<\+M'QXJ5,3%CK-J6/??7\$-R4Y#3B>P<\,6=QV&<S19O61^9%
M[%50J"7Y0#N\GQ+>BWC?"ERP^]:EE_4I"M#_73N<2EL$@M"ZYE/!6OF?E$()
MR6]._A(PC4?KM17 QVS-XMJ-C2#6 /&W6?!LNV"SHU%O;):#8EX]%&C?DZ6W
M:=:;CH>O@.X=3$\;M2USG?;&L]+<?_6Y3OKEL-CGQ<2^0F*C4X#88A1V[:&;
MY2'8A[EL;SZYH72Y7UG> ZL":E7RIIX\G/EI$]Y; >7/ I0_4:FVD38[Z3W%
M426HUN)ZEGL,<Q+U*Q-6BS,Y!:5O-I3>G.C]RO4YU*T0Q<JU8^793!]7AKHK
M3E:<7#M.!IT\F)Z(@VX*)U<!2;>L78)Y(GSZ-;?V"F1XE5*O%;!\5UT[5O3)
MG4VJ<.9"3[82X3R[#KSYZEI#P=_+,,>)O7D4<[1KC ZD!ZECM3*E-3"EC;W?
M.-&-RM>QU1W4R^[16)\,3LSTJ#VZT!X-3763N]X[-.YF,RB5:5#NT=7=H\8&
MDRK1H!(-YS(HBC=JER-0>88*U_&50:T3$DEU&GI]^M1:*QN#H6Z^RH7H2D1J
M!D1$24O7I:4_UH>GMNWNC+2TG]^;P['F1)_VKY.T4DG%TIO4Y:SBGFYPM2^J
M8(QR5RN2>@F.MP@851M[8TYZ0PV^ZL+ONN8'FCEYJVMV%& ;#&Q:%M)5TK6X
M2LJVKI+BE3&J6&8%#(LRT!O<6C-M Y/U;2R_@+>C8$"&/UOPP6%O''\PF0@^
MMUOX05L&_IJ&_)79#A4FY^P!*Y*+,IHP6&]:::R/'NR/8T>6JVN_$+%II"]K
MRW6U'R,.Q.,\_DBO?54VB"&^KMCIA'^RN&8'#CRFS8%XVG#T-C=8\@)$?)YF
M;3:!_PBLL6;K.0NXKFT"!\MT(.'#,'#FD:BI0;PQAK% B3R%J]Q(=_:CY876
MPYXQ<_R'S 8?L4";P)8^:_YRR5F(4W7])Q9H?_WZ=RZ9QV;IK#UX9A\9DGG$
MWTLF "_"<D!F!+/SGE:6M)7XD&B>TBU+_3=&;U8H +@@R_X]XB&-D%12,8W\
M=CG)1&@"@M^TM?4[K&I-"W?W[:2QM?/(UON>IL$-,__"HT.$*7RAIWT!K?/*
M)79HQ**Z/\5R\T5NQT=OZ0=K*M!XI1I -!UMSH"G-9B+MHP"JI!C.WP1$;OU
M6J>ZS 0'5&3&^EM6;/R:1BPO:GSC>]P/^,K9;/>-BF=ZH=VHS1[N%:SB@EKW
M/@_Q.%,6UCK2X;3NBS_(P/%28Q9> .\X7'2"W5C/J%^X1A7L!"NNF.62.>11
M8'D+80(YQMWT<ZQ>GU:^!N:-P:M+%D@V]J, _CCG3LC06JR3[F9H'CUZS8&Q
MX=TU/*>MK$<6S^N6KRP2'BL(L&(&S:L'FD^C^!]'ISO3,#&RW =>TXL^O ;#
M!/I+ _[ ^K8T7<[ ]NVLE^IW8<TMH A,%=>(_[WQX=5GS1&DZ&GWU'DW0[A#
M"Z%Z8;*T+E4+PQ'C=Q/E@L,M_ </2XJU5)W>06R&9@Q=)5U;;/&F;%TLR&.M
M?5!J_Q)EB>$A8ER;&A_#'X!]-I9#A%^ \K-@U^:!_PT8)-ER\H8\CRW$"\AY
MI)EA6SCP+,$98'+!+@O$3 Z#1SS>+@\H(#]!4UX 8VJ^8!:(0EG@/A/'H;B0
M7\;3;Z5=F5.O*N^W)E[(?6Z9:&O10YO[_K=;?WD[CSVUS,@<^%JV>$:""6[<
M)BTLXHFE_%7D)V9X.4NG(.,CM9,I11' +5;D6_7]1"OMO77^VM@D6U7[J\%A
M9;LJZ#5IKJK:GZH^]MI/-K2JG:KVIZK]U4B*VOQD>TJ,J6I_JMJ?JO97"ZIU
ML-I?+KQ7=JP60-N.(P.;#OR;S4Z$Z+0%TZ?8N UL;.C&X&7H5<7(M=K0KC+R
MC3$TW[65A:N 75M6YN_&J->VU@,BJR[>U\39;_&3K;Q<;:C+U>KBO>(-=?'^
MR,7[AM]!R>-Y8NR]C<#$-_V>D8#8JX!V]3*HW>R5 PG@3;]N+4+GT0F?!2H?
M 9/Q# L!D+6 \7:OZ?&HPTV/+R_(-&)Y\/:O";H7P>]W*?B]G>C$_'*S6'\)
M*.8QICNC=T#S"<PF*)P_(D<(8/J"Q;F_< CM2;A8U$.V$[!%$7B:ONL3V##W
M^8(/+%:6YS&7ZZ@++8GU%7#4-7Y:@%II/+I7D4PH@SU-OJ]K"=K5!AWI^AN!
M[HZG!92U8L3W)IH#\XAAX!/B^L\"5*E#MS?BOX*BY@@)=@F_SJ/-Q@]"6KV_
M7#)4OP4JMTG,@E#6]7&&V6U?K>"M"MZJX*T*WEK7N9X9WEHB8JJEU#0=(*F
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M*^'*X32VKCW!<*XC!K?%I[^#&@\9Z+GIC!3>;>B@QI22S[/XZ:*F]CJH_TW
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MNZZ_P,;U^"=X9B%KAN* /!D??WVP G2R:*!YQ&&YG,<CPA,][>N*4/&T1*Q
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M9^'@V*&O+6%_Z7OR( J?1,B.%6HNLS@\\\3<1R8X11Z]$0Q#@I!=/*9")(W
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MLGCZA!$D.299$A\@/& JW9+K90 !7V3.AE ?>7)ZP'ND,04.!-<IQP!)POF
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MW!]\>L&8G;GFGBJ9TCIFSY7Q22:^( =?5+<A%;1O((CS<JFP<VB&7&NNG8D
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M&?^/;HRC<D+NL0M/7QC9BQ3UT $R$:\:D,MT-7U7^S[WUL\0/H/6;<O@H%'
MQ6X9(M!/N&909J^PHD[6DN4 7026I-CEX\!:\"K5%@-#DF(43DA<[G9"5>!W
M2P*IU5 O"*I*>7(.7<1%0%\<D[(:M 0H>.XU6,L0QK%$;_7XX5&  $)JAHZ+
M(@1:\;86P0O ]0_IAR6 UIL=WG'I-M6U3B[PRW_6.QXHH.8HBA8N"HS]]M>(
MA\<L' -G$ BO7\&=M3^"_JNV0EAJ:5DL3*P>SJH,1&),+2U,UA%EK]#N19PU
MT9/.:9D$E2%G,$0-)CRP&XAC1E(Q_$-Q&$<LF8+ YYD=? /886GN-<<B0)'M
MRJ)AWOAHP-FB!A<3P/9A&K$-NPT0;/]G;T^@X#*;MQ3>+YJKFM8;341($OD%
ME^_J[A24RH!B19'DUNB$:]:!)E-YF5HV.*L+S2D[[@,GBH^K,-U_ED3,*@(V
MG@#KF,SLZ+3)<RQ*?Q/_!HI+JO@]V0UGO8<Z  PV7L@\<A.=$^Y:$(5!2<7:
M734]M$_2CU?E==/B$RY,(RC%2-S4R7]4(/VN/&P#C'VK+\2Y8.XFDKA&]UZS
M+W;A 4U?AXQ+U2XO:#(,OZHX*&UW:JKGO3XY+XR-A/BQ0X0\&H.S8VLCQ*D0
MABPJIL'$,& '0;V 9)^SF6;LDP$9DX^6WI+7%(#C<!]_QMD:=VM_)@ISE:R_
M-*.Q.*746"?S7@3 ))XC@8/B*^W!YX5TU@<7B^]_#NRU3=^S;F&D(!EI[#HG
M'" C6&%)T?F<=K:Y;>TF/ZG\[9LE=I9_II;LG5?8AQV3]Z!_ 1Y+HY2@ \*<
MPXIUIY9,)R$#R;@_LM##=$TRSF<#5+ _$MY]\V&I]V% ^?EXP57D>*)2C-/S
MXB36%(DLR#R>"*O0(P7*"FI;=N#+LLDNH8&'JD8^WH.<6TN]6R&D2VU$D3[R
M)628Z'::KP4OGL&EU*T_A/0YF3CWNTRM;"< M! FH3L*+5%,5;9ED*E]<$F)
M;6FM$$7A: @E+5J4\\416D;U!OAWTQ["#Y;^E?U6=RNB3@IY-^][ (_40F&M
M4G@2O@?_W MG'JH)S7,8)7+5>@\E+0)-C^C5!O8 *)5G%&G@A4M/;@8GS4)0
M</U.%' T)4ZWE,()7%_*FJ[@;PP;JNK)N_)-N/Y 51V\%.]",?OO@<(/M"86
M3PSWF BU)10O&&A>J@TRCQY\DIRPDCN%!5)_Y_\(GC[DFKMPX<@RX0;ST+=E
M5$'[V]M_4K@!OUH9DV6=41_3P(RZKIC9&J8\NDI\[!]KD2C$# *3&K!Y;N6M
MA:Q8R[DM5!!"W$=?5Z8]VHH_9#CO+V_ T;SA7R?U).2VK0(T^G+D(TOG\@%[
M"S T0-XXO\$E],7Z< 4(!_#'MG[-$_OPYWKCSD<ZI9 2^0VH7:QOJE <.;/T
MRR@OE+]PP@P"HB#;,6TT\-XD2](E5$:'/\KX$?"CI#S#]%5#R1=6"OH[B8HO
M'5YH*U3GO7$AH,B2VD;]14WZ@2PDJ2]O9R@@E;MAE">K50BX@3(H2/#G2ACL
M"&7'D0?KEZ6%>M!(/F0DHZ1!W;D[AVYS<(R3CIA8BY.TJ&.2#>3B)"43+QEK
M"F:(VX_.>C[90)RTJ2O,65FV?HAIX>"7LJD,]I2$JV@I6G/N[7)=IXDBB3RD
M2^?,AY,'P!="6W,LZ,"U#1UGQUPHZEE>0!2,'7%HX1*I!>$FRL>08592".]*
M]&TU'ZA.OX8TVR;UAN '[/#(0%%*OL5?TZIB")!0Y+G->EW-@6%*NO3X%)F?
M1B*EKY/W\DZMB#PE /Y^][>5UGAJ7,,T(D>($-YNJV%+(-%()U('>6RY0F\9
M[Y=(;BY/. _^$:D6\[LH_YKU,=&Y3)8;E#K(WEBQ(IF#M!5BX$4G3"WX;8$W
M'HJK6ES]]@LNKMYWGTLS& &BX)608CO$@R:L&FQ&*^2\):,/@I69U$84(W&F
M7^*CTU@Z3:HLW0[QZ4CO,0(R:Q8 U =EI_P_2Z3(9F_^1CD!?X^0?950DD)R
MFCAM2(=NL A4->-!)1P&6S6+]$,V?*25%Q,+A,*=<_A0'"51[H]"D:K5D# 7
M!6KTJ#V=0<=%/R]87TZ_!H/HDN+)[>?_[NN)PBB&<7&8V@%0MI<F! 5@ZS8T
M;SBL@XB!.@=S:BK<T/ M_#K):2('50\>I:+>HEL:^N?+W6[CO\TN()(WR5$#
M;A_V2<X NW)A9>-^I_T%4D=Z,\I*B"%FFS\%VN1F?]LTQ/20#);>TECY^6'V
MXN<W!7,;9)@!BB,Y%MP0]4/&Q\1?R5\<OX5]\'ZWCUW-/XN/"T$O<8),4T R
M9)Z^^._=^9M[.?N+1J5!W1JE$.\R9DGRJCA$="8%76:S0Y-O&!Z7O-/X60LD
M3;+"+65I@^D?7Q0>I,.^=8N)@Q@@@ME^]':/>U5=L"QU#/$'6Q+5L"G!1#6'
MI'BC='E7;;,?8P>4)\%6XBT\6ZRHN.Q8;\*0YF15Z=Z"942+"[M*E/Z R&W:
M0&8#$U+>R& A>"A(2;V#]@Q4YX)74H#O GZW8?I1VK$046I;%4)YT()<H0'G
MGA-_$4R5U(V4\N5%2+EN.'F:)FJ9^"%L]'_D7B:*,A?KIB%N$6!?5*!/'J4?
M;%BN!G")3 M#@.B ^=3H,)]DL%#?:4N5X+EP!RE!J\T,TE/1Q.C"#+?(Y*H#
MH9IT-QQ;[<L<9AF/SOG 989'.F9L\SK 8;^7 J+JF_5T!0I=[1E9-< >"<4!
M:'8&?=\>9@=7MM//'S\4[M^Y3W:R7RSWA%7;]?J [#K0$T9Y.<E[1/AI:G/U
M:HQ;/NF.6%;BEKE074DLH'G6]FR@.;\TLG_GMB!$%YK<K$T%'V <9.1:RE?&
M'L$$^'U">(QU\!=Z\NC)(Z!(O(Z:AI&$M0-$:].2GP@Y]0K88=ZM@3!=$L_(
M-+DERLBM?U@$221(O_CI"[%2$X]/HG+2NG >E97ATBT030CYK6'>D2LJPG&+
M+:2Q:&4Z]&R*C-F5B(;58O_"QHY?J(KSGC;QEBU /<1=8K&?(SLGIS1%1V\Q
MX@;M "S\>V>=&VU)K/-^J\F<4SF)K9$UXU-;<[Q2:0N54I0D6XC%RG\Q*QDD
M 40$]K=0-8R*8!-'\*:F"%\G,.+64%$AY*EZI?.#D?C\.4[5"MA0C"6Q6@_%
M K]^$2X1JUFK9C'@_M%6PN9"U9;+,:WXN8''E;<SU\-.R>@.2\9\%?^]"G!Y
MR+:,;K>M&QN=<YZV$I^*=2/J#1;%D8#$TZ8^#H'/D[..U<=F#SIZ\U=_6K1R
MN[W$4:42^_5N8-,$Y1KT!W9R[Q7,\*_8?P^:(J"M@9,972\:5ICW1>W(Y-C4
M6#F/RG1>.+EZM_<VW5TTJY5R,YNYS!<G[G(+VNSS-&*CDC+$[8 Y&D7VH0^4
M4N2@331)+OGVJE8(L%]22)++T;@/I ]4.QA%>'G$QSX$[ +$I&,7Q0O>N?5K
M5;88*1!;.IY"SEW1?W?F!Z.[\U>\H5 V2%K3R]D;KVHV90OIL.G*."5I3[T"
MK$V .^;>I-\#D:/,-Z$WP2#T<O8<REY37RWRJ!D?S#*T1NQ:!-M/D!B4DV#G
MVPLLMI? 2(K*14P0IM(+PB>8P;M)Z/+E56^_>ZC>W@5&NE'V]XCOHP5.:I-=
M$TY"$*GQV9J%P2/V>$D">>H4W1-[*:APGH!#*E261W"<M$+*@X?]214\-';<
M^? -,A-(D]:,RD)<+4Z]RLE>F2,P[UK'KYF"D! U&;-\\VN3C?0!Q;:QU2)^
MTYHSRR&Q H>)&U"("H6R%!@"V0Y!&R)Q%M3PQ\%:%Y(QY4H1L8)W$NOY5X@Y
M*J2\C(]&\,$07463+LSOEQ58%?!%<3=QG#7R7;S6EPSOCIU.U"YJN@X--XD/
MOI TR<2CZCSS'J7LSKQ^X<J3%R"3G_Q9'\0[RIWCO( ,Y=[C#WC@199(< 0]
MLDVH;'ZC:.A&ZD&>#6M#O,ETPVS;RBGTQ)3P0LRK\OWQ_/\[IK9N6.M[BRW1
M5PV\^HO7_WSUX\7C[_PJ^B<%! K*.?*+J_?<5HB<];J<5L[M*OPN<<3S#R?S
M4P]1ES6UNN ?O,X N18?NE!TCND<658=\W*))3"<"+:3U)"<XD5I3N_@XXJ"
M-].0FQ[;365)S=*T(FN@@WX/1%5N:7P#)>R[70L\$3".CQ=&U2-"/@Z,'PA0
M$L/G0X4V4.J8D AQ!2;VZ%._'H'X"SIDF_8]EU;! J#I,H4%,)"JM+RZ[YL%
M3$>"[&FX#)!Y<.X0RHA+NBAGAFA<'N#)36>'[GI5KYPVWYBI"^'B1TY1O%UA
MI@2<([)RM*;#TDOY3$;4Q3?2QXOZ"<T^<D3+0D25_O>0DL8Q7+5#TY9!E'7C
M5P&'<JC%G<1%,GP!7KZY2 5ON:+*J)%=KL%Q]@!!Q-P'X[R@4A9+8&LG\PJ!
M+W%=4H)A^=O0Q>(\L;Y-/6]XFBQ*9LL^7Q9&S%"CUGD_0=@5R@YY$8^(81;U
M;)+/ZII43KLGR+[G)F#S,T"!:HK?B\6^K-HQ%V&->95H?,IS6R$,(7=X(\[>
MP4OS/M?75=O0,06)<K^7"]?.X=A+E91HFEE#Y6@SH[JD:06P/#6&FM P!AK?
M",BLH35A77F_(NKU7QS 32!Z[ -XR.7B?2<=).GOO1@/_;JA\<O0$>AL(UX'
MKB*U;^,I0:<V(M.AL<6NAR$UV'98KR@V2+Y*$^0&;<P-9"("]3=]\M6Q<\SX
M@'8@ GQ6P,;-LU >2Y)&"L)N! #6T&P@(&X)QX_==>Q%"LTW;18J!'@ZT7_2
M#P53I0U?1/#FQ.)T&C7@W9'FD[-;^4/'-)"RQ^%?W.PCTT0D@=G4H_>)7D=&
M;R/9ZFOJOT, F>%3B.**>![*1'4*_7UD.,9E%B7=Z0Q-0%O*_$=9G2-N<+!5
MX@5[.?%+O&Q:#8](57CQXQF3U(8*JQ^4LZ7.$58H[A81<AK#X91VE@7;32"B
MZ? TVS3#>4'M/,5"JK;5#;=95 ??5RQJ>&[10J\TC5K,7@;@SQN$/0I/MU^%
M*]K\SEJPH1;%9H8FR@Z@AAQJ4ICX8\(G! ]AZ:.? TU7%,83[I71[M930*E\
M1ZRA7V&F" X]\XGP(N5L"3_"]ET<*,]/P&@S'\I7RRJE=[PTL05@RJFQG-=(
MYQ&0$4B)('N<**D*GT+OBG(K4YW"L0T=';\/+V6_-6%ZPS>!!QR'3MQ]&SL5
MF (CM8.8?P+5&R6B3P[ZB>LL09B0AH4HH.9.6*#N,_/"#5.3+^)A[6:T*ZP,
M.*8CUWG<*9!L+F_YG8_K3W;3:.VMRU7F,OD_<@I0L,)I#IX]'C9H'[&<X4U[
M5=;5OTJ=5I9/>,7UOW C3-&$V,$PC\W+KB(."<O"P*04;=)D%\<2F??!5E0'
M3P,^EMXQR4.-#,)K+.8G<]!)8(Q@F>*YV$6CRWE>+X+60BN$?\*Z"]14I-/
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M11JW:F2F2173G+(D3@$?UA%[?6&CYH?>LQLPVPDP(?8VV=IBAI;<(>P:OX)
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MEJ1IET3O=^9,<].Q.X'PC"=XAW_A:^97:0O:;N["J\P/I(1ZH<!10-<!E9E
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M<A>]Q4<K:$R)0T8'&^D-#=]LP)D];.&?Y&G"3FVKWV,]*=&7]X/\OE*N$KI
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MJXL1LM#1$)O0/Z'L)9D'HK'-$*HU&"(Z;V[FWFZM;7-TYKJ0>AA?[LYO[:F
M:-5BK1 VD" D6#025D0PEN&E,ZNBRXHE6IK<,(J",OXI]LN8WFCQ03,;QIV
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MA23)# $;F,&4)P5N(;W6GM7RDHQH3%&IRLDYZUNA58V[LAZ\HC_<IB/V<YI
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M2E(JQJ$3!4Z$DW]4-5ULUF%Y"RJ2C=>XAWCO+V>0CA^_92B?K;S2DA<&VS1
M=W+/K:%6%;,48[JTY]\1#65<)$LX*X-\DTR01D_6B=XDEEI+8#]*1^ J\3&B
M'TO#]#O'SR8C.K:E=WG+/?=>Y1;)^V8]N&/0TUMM%;J(U]6N>1Y@YLV VY>;
M.V^%C^)F"8\5ES#I-$9X(9Y1BB5]T1R)3VI[3OTI7%7M-EY;FJ HUB^YI3GD
M%*'1P(F,A: SGUA,& >,<?CS54\\']0WIAZ[D1>KM;33.>=Q'$]#"/$7^<?7
MAL4-(P%Y3\)?K<NEQL,,Y CWH<"$M=$2PX*57(#42_R,N3!'2;NB<PI/R,48
MQP]<BF&"I=YS,H-A[$LY7<$SYL6RH1-FYFNJT "S&&V5-'1S]$.F %$KN9M.
MW]!>'1YM= <R"_%(63FG1V8,1OFH.@OUB;.@>7&@1(L)^3O-TW',S[$9XBB-
M+K0,7V-.'?\_78GI-<;SQ6D;FGE- :%)M22*4!>1W"&&4^A[,YV;C4^J59I1
M 5QQWL7FI%5*Y(#EO^A[DIOA% )3..J!2!Z: !ZZI%"LTJ8/]J1&LTO&XA^F
M4IIX/<[K\?1Q[ALQ[RCY<"YR^1?3G399-"\EZW('P:97,%)*6TU<L^I.7$W8
M6&Q4"EFUIC:MZ1*'<DJ>@+2AZ7AN<XAV5]-">FUSC6$?N)4>/+"K$;^T];P4
M*DL>U030*'<>EPY:@6.$*[98P^DB]S<-\&+Q*,#!X-6<CM"8=]';<F!!] ][
M^$-!6T*U8K=N&?^ Y8N,T<_8L??T<4&#A$&1\01P;88?24H!_;&8)-M/=3E/
M'4<J](>&!).(B+Y'J04ZB,MC)S'W%FA[- DHV&GQ!LB0G7A0/IPTW!7LM!E3
M7+5>>213BMD%*\60ZRI/[H.TG@O!X3_+%C1 /,?+'A"J4BAR3E D0N3S4%#6
M@O*S+[B@_&D<<LO_6VVY%)0!DP>[KN(KR2,.0$.NUI:-4J02YAS5^Q*CC349
M&I974]F/E*QXI0POLMJ#FA4CB]:/C-0#A^?Y.=% &RWYB(2] 7E*&EK^D&<(
M&*[0DG*_8U3,&")[7@%(8*D:LE.B61-'<<XR:LJL8X)#6)V4+'F:\L)BP2S1
M=GP#^XM=VURUY3:4#;VCV.R/U_F5]LE>R*_S@C(F$'*'&[;-<ECTZKXH>YYY
M.BL6^CR9 E5V<.48(A="2QU_2GZ5*4\=KW0G;$@84H97+2(:IIQL\TO@=?+5
MJI2OKB(H>Q"2?,/=J%GNZ#YATRNYP)$ <&01_4U]"_M>RLK<Q50^6,.C--@Y
MCR*L!8;)7]DZSW^(M$>.^VDEPXK831(^SG-1*&&(?>(U-3W."*! ?@MI8S.B
M<@1: 07SL:C0S91W=/9STSHHGA<CS&C43Q)-V8F[2U&^RHVS<'W92>Q#X9Q8
MV>N;F@NWDE4<O#_IRE:H'BU;@1""^VCV-\[=XI=(J=@6GI!VB,G3687O8#OZ
MWG1=G]QA2WV(B+'0F$BWP!X+1P2E$8R9 ;6K\KII9>4D;OX &YTBS>ZOS3YJ
MG3+MYE9YI39%E)E,+3_=@'YK>G:RO?R<Y\6D0L*SO77]NJ$RD%64S1QU;JDD
M9&$^N,X<,+3"QVHPFG-GPU>DFF^2W7#,ZU%P\BX0>TA7W5FN@W#B\SPUO9\E
MLK==\0"OYN'*A)AK!=,@N9QC8S<Y=]M)/S:J$4G9V$VE=@2JE-[#H\]3??IF
M1S0C=]H1CYSLM+U<*'O.&*IS\]$Y.#*G0N/R^:E10D>;\A%.3T11GYP]Q(4-
M65'MZ@5$T78 KCGQJA$>1MG\YSSUUF_'"Q#XYXN>-XJX>6B@%AW6YCVF/N%2
M6^=Z22U&SK(DC$(^$^TUY:9E;%$@.3$^R3GTB@61'K'/@(3TR(>QU=Q[5GLH
M^S-5;KA%FE6'O78GB3CR<])B"4MP1 U3=8K]#!3^QY^"5*?_#39#4<F@K:[+
MQ:&0MI"#269 MFY9MLM.&U7 7^V5J?R"@%>9K9+-&+J9Y#F4WMQO.P''^>E9
M^V:E"]PL3GEX&=IY94_Y^LIRY2=T"I&$&+MGY_2D,=A>5GQ:D'';\T>@8)73
M-=$^O'1+ %1X%_1E"<BYGJP:NK[(<HHUN9<O?Y94C-<['02IV%%;MOVD4=(-
M]6_X]&MJ(^ZT-&GR^YJJ1Y>V\X+3K0[BQY@$/%E#,\=(#_[4H6\2_C0N3\"%
M@%\C@&PC:PSH"-?W_ 1;7O1$?OV*A$YI8T'%%O)KS(0.9/(MI&,Y=PVUQCCL
MI-DEB0S,"8>$.64.J-3!@F(98KJT;SR1'+.*#':Z9IVJIP+Y4CD=3T%EZ( \
M4B/%,!R9&":W(MH "FX6&.3KR6"RQ-N$F?[@O"=1&U!5_B62<H2$7?ZV?C6B
M6L3C;POLFL>] J6#[^;J=8DE&FY[L#<H^_6>/6__PPL= &6Y$3*'_L@Y#_K3
M08LL>!:]VREJEMP+\H8QDVL>AJ?J$?47T03KX(,?(+7CCK^+D"2V3B=9%:2\
M.C"FD?)FE0[9A<KM.YF&!2X[\VC7%JD/D*)V>0'W\!_Y,*=O"&X%RRW70),)
MG^G6X^IU0^O87O5P>SJ:(/0U..10^#%R)@]&M%C\Q,;(O'-D975FES6RJ'%X
ME%M0[X$^(.5YX16'[9_6826]_(Q>/LUA\+G@'AOO$.%T3R!+-@.=W;2-^6NS
M=Y0<L4XIIT_IIR%X,EIMI(K%AO*TN.6$L<R\?I3(2/2AMS913!)[.("\9VV(
M.BGF;>.LG5T]@)-49E"Q>6Y^F@C5828NW/ 4)K8"GE1#G'1>)8HZC/\FSGQ<
M$W$&8U@'CW^+<V7-<#9?#>[ J :3XMB3Y&C>.)$]:EK%ITM1/6^@FIF.&:<O
MGA_*D#P<]S'&0XED)9V$JDB\I6V1FE=8@1>R!(RWADRJ0KTHP4_T$)FYHS2-
MEO4\<@ZB?)!D'O/.'FK%6BO^^J%6_"<O^1G*2L\=N6[*X!"5!PF3HVH7&_J2
MN9/%B"SY)NF@=,P> KU!CV+K3H]U!80=(;"<7%^X[C#M,4UI:E!AI$1&5@W[
M"(@JHL%4&;1^-,#KWQBM!(^EG$#X,:S7:J@Y)FSAM4'!))E(6L"\3^RUK_6+
M@^VHW57)XP\_1N?5O4T5W3 Y1PW!8!@06M]6W?MNY#<9/A3&*[]8^T6[M[5Q
M5 '/T^F.]@V[V ?'T@2ENX!/1A=@]CSDD,&]PNDPC-R4*>]AO2+RS!*92)>"
M)IL@TV;:%W6A^[+C:<GL[Y#PN@SY51+4R#&,AQQ&42W"ST/S@FY]]LVCK&Z&
M-C0YX_;"XWC:\,2%98/V3CC4W!6#6+H=>F:]\*D &> .RH:XDH*MZ9I5OQ?^
M0HC_8 $JW:=D?C2T\<Q+#AR8)2TJ#O#&FA%_0/^#2M=TWE<UZGW7G0*_VY;&
MB8.EM1"-N[9>NU/GM%/(/+T7T^NT30]A:&AL0J$:BZ"TK8KSBH:,$:@FB]69
M%RJR-S5QU/@ISWA'3AJ]RX]+DQMYL6TINSFZ!W>$5L0"%1'3Y98T-Y#U2%_T
MG'([IZ\[+Q?OI5#^CQI1$6_Z,7W G-MBR-T69X%B5IP[6QN+=;Z=HD7\Z]$7
M0S1-Z/\:L7HS[!Z!%6T-Z>#6>T'UDFN8/:=T_1J<E"[4.Y%H/0#7SF=ZBU4
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M=U,-9^NTQXK?#)XFQ3' C+M(D,Q-.P8P3%_G-J"%][H.\T>W\O0*,[/=.*)
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MF_:4!@U]R&-'1O7.#AJQL"]!?3NK>C(^):3RY&E4*;HEM@^/.F5,JTK:;F1
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M'04*LVI'8<2^Q>3(:L6\)0 HA)?,OHPW4QO.FQB <PJ'/K5?Q?2&?9Z)3<@
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MF7A4N#5#)EDG>3R31^V[,-V,PC3-O,JN<IQ'G5F"9R.5N]EYR49>)X78] T
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M5V]@\@IA7D?7G0>.5;><2:G!#+;R@DN-R?0C+GE2^?(:N>]%_BQ4A%G_D+&
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M;)N6FFRUIFAD>>A+\Z-3JT$-H1ET]%Q#8.*P'2"$60Y7HKVR!MV9[1JL>1H
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ML8&?+=UM6+IQ\1HXS,G[U/:&<)*5+8EI*I$@@-";G4'L@B$=:'C0H@1*F1H
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MB#4)9<;D*;W^0:>'!D;]<."[!#8JGN!W@3491Q@S9,+:P^!KNM@Y(N@UF=N
MT5P?VQ%H7?]!G$O*@?F"W0G0-/(^2:^]7G?O'TMA,ZSXL4Z%Y%B6U0HW519W
M3RUR'-QDX6OYX0V@,RC[_CI"-OL]_- ;G$,>!C%?4NVA.?:=+AW]/%7_'\GU
M^>4.OK2?CZJOG79.#WN-KW8[#WNMUSGI-G_GXD\V?^[HL'-Z=OCH-]OMG![T
M'_UF54C<ZZ[C9H_ZC[^R>+.G*UUV'R5,6RM]B%%SY.#]Q7 ^_O:B_\)+DSOZ
M^>!%2?F^/KCY[O7JCDA9RNDX/;96.EUF:KJDE%"IH%WXA .>^O#S,ME/6WK"
M+CS?BR=[Z]EV+O&ETY<T )4K:OF#^C>:.2M^'^%[^!K7+!SX"INT;&^14$_C
M4(B@/JITLG%"&*@;B-KB:.3)DVV5D('Q7F%M5GK@G5JXM\I9JCN C4\>#+]-
MTJ28C?;X#H?#,!R/WS0NR?W70UUCW8M1<5%Q,?J=WBI"U+0$]Q&@1UW&.MU%
MB_CX68W55O*_@MK8DWWX-T]R%[1"HW#(MN?U+)F%+[RI"@N48<GSF^SU_O[=
MW5U'W6%GDMSNGZ?#:70;9OOA:!*D^Z,@#_9[_7[_\*R_K^ZSUSOK]PZ.NL?=
MTY.SH[/]4?B]W^M,<W5RSZ^)O15BER\ATFZ/O LW%^C:04ZL?F'$C9G2[$$Y
MC'\F$=R>\_K%QBNY@E4GNG .YJ[V>C28R;OS\CV40CXE'4]MZI[:V:.#XU?/
M?>"W9[4)A>#@"% (NL<_9C3&^+\M>OA^Y^!!DE)ZT =)RO+%:@W @PS /?4_
M_7C0@WL^[NWSL_1[5M$G&4.[+1F%DOY_:T-/V"-_E>'[FR!E(O8_0=9'*3%
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M.KWSZN7>6?_0IJ_Q^2)"&(2,X:-">138.#!">E/U.GH7ZBL'H0>$$^H%Y6I
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MS]&!X<*@]2*8)3992F(R&JR1K-%Z<1O*WK&1&"?S\6SZT5]XW(<O)^C1$L\
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M$A6,10>?"F+!6\)-,BE(YP5-+9AP&\J6'A5Y2BS84_ 5#QYF?CB&],9W8]R
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M1F$T$0K?)7RA-'&>.8+B\28FQBUM$B'>'&+=VPT\ALP\%#( )3)XW+H MZZ
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MNE70]\?P5U$[YB,G.N%TI<#=S#)<<RQ-7$-&FS%NUL_LT(;_P8YW#L[6=K[
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MK==-MLZH'%C1]?3-+M+!ZQ3CT8-.JLBHNM1;?'L3)T[,_T-3*O;AX60C"KJ
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M46K'I2FB%DC7ZP8H+&07Z%<NV  B!]]$I9[$&,6]*.TV1G$?/DYF>J>8M<V
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ML;,<7*Q-_18URXB%/D45R46.B:GHM/5<8FZ3?'P/IG/%K<^D)),V9#4X_W=
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M?(2N;(M0/P:B6]V]]+VV)'/FW-9N<_1?V@?.0G1U:CWZQ&,J!IL4T7T[RON
M[_[(=7<??AOH[-4U:$V1N94XI;U"48T1);RJ$^XEB]HHLDC HP-5(F^2*[T3
MT2.\S6M.^*Y+ZZ/8:I!E<=W@;@'M[\3,[.V[OZ_ U:%IBKR2&ID@XQ9T-5/(
M:BE))%F$A]3F)OE>5/]4IQY9:[TSK2"%I .'0-YNY)[I$!,#$)S,7[)W.8*1
MHDTGJ[M8_JD^1S.TTX]HDF[["N=+%[Q.R[OJHW1 /NWV!_68,-L!Z49&K-/>
M.MKBL^!%AV2"=ZA-05TD635:#Q[$W*-,#^^(>-_C6LNW2[]$5_MH&$!,6COD
MX(/(+H4H4K'2R^U2[JM]XM:'UYW@<K[8"":E3H=.,,X_#T>7M*=?_8-/JQ\^
M(H>\OY>WYO%XB6RPCL45\@I" $G?DS8074FHLXPAFN#X=M:/E4V/.G*=!_]L
M/!\N, P_+Q,>9[]\2:-+6FL];6Y ?EVNGO2FD?+TBZJU5C64X8:Z@;!691F*
M(V6S&;U6,EDOB@_:.K-C*^\7WY&17D*0UPBNAH6L4?RZB>(7F(Z'XP]72_GM
M*ILLH/!D:V86@]*U%Q>P@"HQ UXC6(<R-NDLW]<"C@Z9'X=CE9!LLL-D !B*
MVA@J6L4\-X)E9[)P:)RWCU&*YTI+/XOVWHG-GYSY%F7XUU-JCUO.\JZ#!Z."
MHM5X&<FSB#DS7[)F*2 D%VP=1-4VC[>/99PJF?=1J/$9->"QY/4>N?#G7[<_
M8!'+3N"R4=*QJ,$Q#=:SP&NO2F,-60Y*E.@?X<Y^WYK.?R5[>DWM=^_O36,:
MA/2V([L9C>J K^6-[4, SW3[^E@THI.F'DGG.=3.226X)75 26JAI9$L2! L
M.&<P>JU-;C(8]#SJ]M!]Z;>J;?NP>-*;5*EL<<)SIIPK3'L-C.1@F0P&I"Y>
M0ILK_$=TD]HO>9UO1?>1_,EO11&MB\II5BR&:EES!DI$YK)WW@<10FFRZSRR
M6]&FJM$? R>ZX:S79MI:9+(V1M(ETU[I+6<8C$%4T8<VT9I'<<-YNEWB &F?
M]K:R#NX;+KH9S6"9!$Z'['+@^B$A^/L>UV/LO#/JS?M+F8H(1KI<C-:@0.<$
M7F>H'0>%4X..^'N7]>%WF0\_]#1R[W"OF7FRCJ2L4]):"1>3*G0P&E"&HX!R
MG_3[NMV\YQ5'W#QU>.II6.AR\Q,3=UED;PTO.DD=K'4F05::QY2XO8^&?FYN
MZHW2K<=>AP$=!ATQ6E8_5:;K/"9PP)D4(6E?/(!O,MAH-Z3C!]6.YU-(\TL8
MO8ZCX8>%/_/KY?QRBK^3&EQ<7JQ2:&8_7Y)"U_,GU^%EOPYG"4;_/\)T((Q3
MR:)F=/S4CG4Y,@@.&?@250!99TZV$,KQT$]_MO>D6W<'W)Z4Q28#D[>L@,"^
M'+^B#>+]GSCZC+_3SWR<#4H S;-3+#HR6G5PB<48%$-AI1 Q"AN:Y%%VA_BT
M]>IX5AIX$;N1D@D]&>>%CMM0^_7P4(>*0$U[K[F<.;'B;8E9^BAR$[>B"[CO
M0&<.9*)!H=5NC.\_#J=+B,Y#@:!IY=8X4N@ +-0F4%R@TAX%%MXD7M4!VW>@
M*X?QT*!B<S?$7R>7T_G'!<:070GDDY/?' AC;?$8[2*LRYT+W$NE3ZPKU^"^
M V4YD(D>!\ M.Q5L _A^\AS?P# _*W.<5H@5[ "*R=H$P:0B0TM'4FJOG&-&
M.:T0O$U&/>36[?G.;UX/6LJXQ1RX;4@'DB>O)2@FC ],*Q7(8%*"90O>!*ML
M;.-!;D7SS:M$?[*^JP#V6 6XO=:OK_#/%R,87LQ^'8XP+X> #W(TR0<1&0'B
MU6K6+ 3Z590%A,J!UB[;!Q2V8GLRRM$W#W=5Q?6M*JL)\6\()_UA*>1>*0^V
MAN=#<;S&Z"6+B(2W. @Y(_W_"2)/6Y ]634YCH.[2N+[59)UU'F )6NNBV<0
M03#MR$CVJN"B0!%5Y%PH<Y*8Y$DS.T^B! ?)^-PYE[/I?/ ;R7QY"+Z V;+D
MWT0-(DK)/%=D&-N464#(S'M3:EU%3MAE/ \]_8:*T.\VU6/[Z\^5T=@'GY/>
MY-ICW.LNFEK9NKH@[H)ICP3" SB_!G/:9,$^2-K)]Y$2/A7[WA&Z7 )+R9+?
M@R6RD$O-_J'_)O6V@%T:4CY"UG?D[)V*]'T$VW>+P=_POX8PJSF'HR&,YZO,
M#<&Y\Z5HHD1(0A1E-5L=DV2N*N\1M=FX>ML11MCZ^-.9=OV)?=*KS$X["NO=
M\N"'<?X;UDFBGSX.T\MQF4POEM[Z 5?_#SVRQWO_O=!OEGO::*(#]#%*;9(*
MW'$-H?@8=$"N!GNLHXGL#\^ Z?;@T_'0(1-&61_(%W8EV*1!A0#T]65KO?-.
M!IT>8J.O;)@'7K/ZZ]=D#D(U\-[BC$[;8Q)ECGOAZ3C<9^4;W :/B<B5*&BC
M0YVB\99+*[EPSIIH'^+V@5<?VVM[\?"W^&DRK0^_\=YK]XX3=.V%93;4J%Z6
MED5ED-GL"J+">"=TWE>_[8?!'>OBKX,.5^)=O70VR*"+*& 9<<29UO0KJ/<:
M=;Z22#PG+YI,O]B)Z R=?_K6CDWGOQ_I-\F@_XSC2UQ6G2PCW?\8SC^N.V,O
MJU)J?_39#.D_^3U\&0CK+!8M&*1ZPZZ\J+%-Q8IQ0:F@7;%-FD0=@/4)JE)K
MQOIV+S:W]>O>&@.?T:H< O/H,].0@?E$7T%P@2P"9;@PHI./L?L=3T@!^I1F
MCXDO"UBW1U7>&9"V:I3]"N=US-]L/KU,\\OIXHS_C-,9C-:S+,EU+BZ'PB(G
M-XIL"/*@'!@F<Z#E"4BTM$X:T1.@IZ8^Y^"I0>;,S_AIBFFX3-- ,K\7G(SK
MB$@2VO\L[VB-1N#DQ9-4,F&4(C HMC!NM>3:Z "JB377!=P3TJMFG/280W-5
M_W0#R^ORLOHB'X;D4=:SDFPQG@UF#Y&104;HZEX:4XS,*"\E%)1%MIE_?"^L
M)Z@K/?+0(+WFUL[W@C;*#S@;A +9U.1 H;0ES05DH(-@FG;"%$MTJE/H^[!B
MT@TP3U CCI9Y@RR;U_./.'TU&4]N&UOK,U *%] 88LQ"[?Y4QP+91+]-(8GB
M2&W;%*?<#^L)ZD://#1(L+FVP-<NV7!\22!7)OID/'N.)!!<_AQY8[77 [EM
M]/[A&*9?%_*AU=6[^CI_:K&^.4[I@QAHEUU"EYDU/)+:6\7HFZAWRUIQ971V
MNLFFTW!-3U _'XL&-$@,NC%^?=F4!*?O)F7^Y[('WM49+@8.!&BK)),^TT?H
ML;"@9&3.TQ^#B0ELF\JIC@"?H-HUX>:N#H4>)XWO%LGSKZN_7&;19!.BPSIM
M2>?"-)C"0/' 5#!&FZ*< FRA3@=@/=GT\-;ZU)JGQY"]1IOS;#(:YL5:%B);
MY'-$^D1<)#DY7RM4<TW:*H&^D"!+$;$8)[OD2G?*:]D.X?Q]^1J1/NE5^#TG
M.MU%M$H,Z8*I[S2W76!.G^;6!U'W\GZ$E$^E 3F3<XGD1@3MR/"JVRFDHIA5
MA@Y/")QOSM3]5IB_)]7M5,3O(]P&%=UW;F%7^5O96XW> 5-D73.-.M<Q+8KE
MXM![HZ7)3?+==^ Y;9)</V1MNNX]2+I)2X@IG7(PQU=7:2=7*7R":YTR,TXA
MTR(;<K6$8PH420$\YMC$\-R)Z DH03_2;C%/<CTK^/GEC$SHV6RMI8M=3PK!
M5321Q1 LTS8O;KO(@>+2*&-DL+E)7LR]J)ZZG=@_-0UZ/*RPK#Z-+F":3L&]
MB>8\#91[9&M3#XX6=8M]XQ:H)'T$;S-# D>;F+;,1UZ9XDHYH7SQXAOE_8%.
MQJ>B?1\)]YV^]#OF8:H#@&X=7#R+7$KQK$ MZG4H6+3!,Z=41L\S\K(1F-^1
MI[+U\6<+5AXB[TFOPNK1V%L@>CG.P\_#? FC7^%B./KZ;)S?7<!HM*FQZRFO
M@=<Y HDE#)J@DN)&:R.3$+EPRHML92=>]WOO-TMX0_'N_)#/42!S;?[\-AE_
M^&WX&?,R5^'YU^N?A]&S*4+#(H']09RP<.!("6T4$P@I2[(ZD7N M&,@^&C)
MZS 83'9"Z >+"?:'<X(" PS"%DT>K\G),>W)-@[1:Z8\9$!('D*3E(&3%!A,
MQNER.JTC<9=9/#G*K )]YQB0S/\H%9G_0,YC\IQ'-,:K+F7A^]<5; !YI%=_
M^^C"G7*"8V3==!)9=^_0&I&$!\=\0JQI&X4%^KA9YIZCT25SH?]YQ=>OWK3F
MZ3%<\5TY);?V^>J0!,QU,!3)2_,:;0J%>142\S)XB5XEP"X!G4XA_9THOJ4
MSE[43_JFH.>;GM7*;D):6;]=0/5]V;<3S>EO^WIB:])*U"?3 ^6X(#=(L@RI
M)D^D.JTD5%?("TFFIY"J2^S_,?)_SYW?*>G?1\(]TI[JM-;IU\'?WPU0\EIP
M0 AT-DSK;&E+BYZ%@CJ5A"5L!FZJE&=K,<\P_>7#Y/-/JR<N>5[]9I/FZ[>>
M]@ZG)_%/CI)=CT;F&L&+5P-C$=#1RXV-M5A69A9X\<REXG**AO1R2TG/4>R]
M>/44V-M3=H\R]C(IJ]+7^/5W^#^3Z;KBM65;AJZO/GV<93]I;$17.%JAP&3G
M7-2H=2B^Q!AUSKX4FV77Z,J#((Z<WS6>#^=?_S',N'K-K9=<NT02M1 !#$NQ
MU/"EHB_#.LN,<>04>2&,;W)IWQ%?#^U^$]9*[RKZM\/9'V_([*_L?$ Q2%E&
M+A%8]/5N1:O$HLSD&"I9>)(Y!FR2LW(?J--'7%IHRI9.P/W0T#0 <T<2SS<^
MS>=?KSR_=71^=5U/YAZO,221 LDFUI[&4@,=-Q&2R63YI2;QNAZPGRI <PHU
M.S65YX[9[/R\GG^MG=J65\F63B:H_;47V4<R! :0$M,U\U#'XMO-@=J%Z?QQ
MG!.IQT.[X($TM1G4<QO:C4Y_7:"U3-*Y!]MY4G9ZX_$A_3B2A!/K21'1:6<#
M";!.=@@B,$\;-OT*@@:O@N)-#L&3Z\<#J3WG4(]]9-]"+5;[YAV(J^2%6- $
M6PH3OO:N*'2\!QTX,SF3O1<*HNY2$;"_:MR/Z_3&=F\<;NI&CP2TF2.X^4D\
MQW'Z> '3/U;Q4B^*DHZA$I[I;"7SO@9-I9 \9[2\3;O\AX#]TU3I@; VH^(V
M\*W17=V6/(SOI$;+!L!'8[D<0>N#.M,#)Z>P8>[@+"",!L6L=W7[U:*F"=1A
M55X5[BSXW&3\SWET9G]KYI0JLP<5#53E@8:1Z\,U<OH/.B9,LB0!E1F@3$PH
M.E8%(@;79(!I)W2/P,8YBM3]6G@>P$B/YDZ]A+I]."^^$"6#Y(XLN>!4(:._
M>!9$E$P4#2[(6K#7)5VKT^7XW==_;R9,#R3TV':QHGD%%R2%6YC6]Y(=0/6=
M/K,3S>G39XZE:=)*QCWGS>P&QPD/>6">0?:I'IZT416Q; M:4B1'3?0V_^G$
MQ-^3-W,2WO<1;=^53W\G 6)>WE/7HIYU#4>T4:8 C*,,3&N1&*0467+HG?9%
M&;?!]HX2F>W//VVV14^2G_0KMKZ+H)[A? PK',KJ$+QRS-M,EFZ=5.:18,4L
MM'(QD^G".]%WXZ'?/&>'"JCO3^X_+R_@"DA1R0;K."N+^LGH+>TF1K'H.(:,
M6B<5.C%U\ZG?/%4'BZCOEN<OR,+#\=7G#3GS$&L!1IT,:85C(9&1)[0&VOAM
MB2)U(NO68[]YM@X7TD[SM4D*VF\(L\.&,*W^98\)8-NP; ZU0LMED2X6G[32
M(193 F#@'%52I0SNHCI&+H>/J+KU[WN748>!4TZDPD&"XC*0I"+(J$4T'F)R
M16HYV(7P&'F]@FD-''S&(S(3=SRI=QG>CW5#FKI.+RW"8C%"8_)>>O3&JJ1]
MCL'KP8YG'CF=N,XQP<6C?\99F@X_W:Z(LEF#MD4P8CHR72)GP9._+95'.@&0
M3NXV ZSOQW7T4.;%XZ\Z*"W>\Q;K?KS^W7N<7@RB(!8,^1MH))V!*F06ZQEH
MB[<R>ZNX;]*TOAN\,\SP[E%;[LQP[I^2!A>5M_&]F,SF Q#&YA#),E( 3#M)
M)V^V=( KK;6T,D)HTI[W+I2GI1!'BKI!M'_[:I>12"DB%H^DB.1_DKD<R:L)
M.3&N$'-VSD";YF;W8#K94/?FN\+Q(C]W)F;U =["^,,RR\=J.M\-*.9%DDQ#
M+?2A4YYL=Q-=T<%%T:6M4:>HWM5;SS;,O2\*)\>*LN>H[0+$ROWJ J/O0/V-
M]Y\^-'\@ YL<'B&^AFP6[VHZE6<>./GDX"/S)FGFE8\RD7>816\]JYNS>$^<
MO5\2]Y%:S^3]3I*ZN+Q8 9'&2QTRD)BKF6!*'=3'.5,6E;8F>"%Z*S:^]>;3
MQI0.EOVD#\'U?BW^Y0:09+R./&7FO*OIB)(6%APR:;A58+B+V..-^)=OFL&#
M!7?:2M1E^.+=Y:=/2Y,*1L]A5'_DW4?$^8T"R*,#.WN\H_>0SZ'KVPRM!9ZY
ME$IF(#Z+"R!32M)[1 LIP>"8E?;%7RO.3LW3GMQ(!(@R1^)":IE+$+[H;!*9
ML5*Y*+=PTXZ/WZ&.=9L/<38IBS_Y;0AQ.%K\R=&D='EX[\SLO:(->FH?5!>T
MXKQ.9>8R) B\)"] *Q^"&!RTML,XNC5Y[Q >;C^@1UG?@VQ#GA:*#S()*5%H
MXU20T0:77*BF(<]ZL!-C#S([0H6W/J>5!+LHII56"Q6MDRIH+<%[994DB\I'
MKI.T@X<0'R;/GS'.#Y'?XM_U**^[.#;D$Z)-SEF'H+.6&B&5$,&5 K;D8M-@
M$]'A\CA"K6[^\YZETT6)2OWF1%0\@ZJ-8;QT+I'<)%I3@E6#FP\Z+MI9G_1R
M7%6R'F+7X3QE=-!2(,/:RU;'\'_+N[KFM'(D^K[_157Z_GC9JL233*4J.TFM
ML_M*2>K6A-H$=@![)_]^6Q@GMN%B+O<*!L</&$/Y<N[I0ZLEM;H32]H$1B\B
MU]X[A[[%2F<'GL&+NG2A#^5J@3!=O8VY#@'?KNX*0+Z>+Q;S_]6FJ?&_],[J
MVR2"=3YHQPS%V4S;1$$Z^45FC:Z%?+4WLLTJ;P^0I]\%&$,I6PN_K<PR=@+8
M+J#?$;ZFP.)'*8M)HCD<9DGS:ZZ :6$TBT84!D#OB."+"O"< ^K[H9<MAZ84
MM]@BV@'U7[.;)<*]6*_F7[].5Y69M_@0N' )4J&O/D^U#;/F-'/7*)GC5IOB
MZ4ULL]-^+.++%M9I#39V@MPNU-]_/T()P@@C;6&R%H-?Y\924 4,?'3>1 QH
MGXUY^GWD9>NB(;TCGAK9I][-@N#V* D46M/X:%A!#$P[2X+UG@0;58C6"\U5
MDZ9+?4!>MGB:FV5;0GIT/W(UO\59G*TV6P-7<?GYU0SJKS=_W$QOXY=Z_&J2
MI7;::DG,((5<AG/FLQ.,!EF!09+Z@S_:KQP$X;*E<D+ZMT5CVHGF3N4=J$LJ
MB2L-S(,U3*.W+(&RK+@ (M16VOZP\RU'0WCIHAF-_FW1V-:>YOV4L$)UB;E
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M[0ODVF'Z'>C>L;SX#S9?J_>+I_6J_* I<QXW*R<)D0HCS$&:I00@%D/ 0\(
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MNZLQ<FWUWC@=%UOO/U3/^ "6%Y4K]M>J.$QUL?"NT*=JM1#/30%)@C&4+&&
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M?83%F)>K*L=CMY[34-Z2DW9?F]VQ'7"T;(XC&W:S-X[_L6>.9U46\QT35;1
MO?2$(J'"#*1I) !B40PXT^LO)4IPGH64X,2I-/"1B*FMPZ9R;*NBTXKL -+N
MI7D=/)[7JB,R[CF:9XT?-#/S6,JX^9AGK3S*PCS_R7[K^[>O?UU^4\7",.SM
MO5J(7)5O%%]M+ZS:LB,LCB.28D 2JE^XD52 $Q@#RC',*&<)CY#+JK<5/#4N
MJ'1]#OAR(1T+'%E#;<<+/@#TS!:_?0VV.@>MTH'1>O=Z?KCC<U^LAB07:]FC
M4HXK(H=$Y/Q\W_+9Y:I8BU45C54U2YB;G*9;L<J_55(V]P.9"%&200G"+%8
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M>3=57JA<?"^\SM>$[S=</Y[]F\KO'TPJZS=5L'NU?S7]:;TJ5_KK9Y)>VY0
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MV)>!BZ=EH=G]XW+Q5=V;76F3E*HRGD $8X"HD !%G $2IP+$&4<)%&G(E6,
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M&P]G*CEE^) TL3?^J!1PRK+#Y7WR,WUJ.%4CW-X7JG+.;X+[FBT[%S*B+"5
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M2!^5T]Q1.62T'B/T;?'V6IG@G_G[A50__E_U/!,)CU@<2@ 5U;3%10:HB#"
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MV!IC?FH:UFE[@L8@Q^W9%1-FN5D;9QI\;]UVRFCNS,#RU P$/S76_.RU?N0
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MS4(:IQQ 3A! ,2. BI2!F&4"180C/;IU"3M[N5-;_8V>P6.K:* :31U*O#G
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M[YY;CX'>._^JF-DXRT\F'6A=F M(_8&/RT71_OB*E7E9%Z57.*(JP0(( 15
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MO&9/N::5)EY#L0QE,HF PD0O=2H5X$)D&K],$IRR1*5.1=,ZI4UMU6^5K>I
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M?8Q^O/:V7.6/>LA/V3N6%__!YFNU^<NV$DM;NR E69PE(9#ZQ  0E3&@*$6
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MGE%1AS'J'HLX.I!SK]LXO^%,2C4Z[#2OSNBZ@9MK6YUI%TP?8U^M][C^T^8
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MW45Z>&+&L"2"A!ED5CYOAZ"Y/?R-GD>NC^LPMDYH#9U.#X"-[4FZ8&7O( X
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MG(0;X>*]K4ZGP.F[YPS9?K5)SN"'?(RGU7UW%@B17!%J"!A,4P!U3J+:,TE
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M W*$N5X6\'D.PPV*G3H29XK#E6"<\4?]#!!ZIWO(";YO4I'3.(SBA((4T1!
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M"I!*F@-(E4N+DR@#-.$2RS#-4&;5]--*^MQ>%Y52[NGZ=LAG$L>8D!CD4F8
MPC0#),H$B&4D(L;R/"30+CH^&O83Q<7KSH*[LNXK^"PV]3($C"S9;EGG^(.
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M<TP]DYW1$?SL$+X=0\\BWKT0DXF]RALX?))WCGY5]I'LA?C,%+PZX^06RXV
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M^)\_O7O]PXM%.C_#^?J'YTL,:\P__#9=?_KA;QE7?_^A+!=G/_QML?S[]$L
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M.SY$T>F65^^&ANXSE8>+LPLTO#S#Y4?:!/^R7/RV_O1\<?8YS+].#(_!H4U
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M8!M6.SW [8Z_>(,3LL E""0YI50GI'%&48?WH 4ZKK4(/#>IVWZ8I&XBP(8
M&T8?'2#K$0')G)5R68/!H,BQ%!2,(+F81CDB) 1MVQ1+'GEN?(I8L!VR!M)'
M!\BZT8?RXKJ[L$IYC YB9A3<>JXA"*Z 6Y5<$3F;-COB74+&[GXRC(*W./$'
M2[L#M#S+>5. $69OPY2\Q.?A\Y1"S@E/(I<B(OBXN9U>+Q1K*2FZY=K$7 QN
MZ^HWP!'P=GK&KEQI@ITA9-\!A#XLR=L[7WZ]L0@8>7=2V 0FU>OHM1E91(F
M42IFB[:HFFQA]TD9-\1K!)PC);X_9OP%9N;X<7.L/,Q=D768SC&_#,LY10RK
M9RF=GYUOCJTI9IVF:;W#D),RNH#3,M798!2E8F0@E6 !4_(L-'&QGR9MW%BN
M$:H&UD@'END&!YO(H39R7^(GG*^F7_ B(_)ZL:IYD#?E0_A]DJ+FR&J#5:P-
MWK$X\%PY0&]5]#85PYN<'N])Y[B!7JO-L*&N.H#B?:E-O"2J4030VKH:KE"D
M$M'55D F&$4&VS>Y=7"?E''CNT: .E+B'1S9/!7X3AP:3,9;R'9SEX*^\R05
MR$DK'E-&D9I<9WJ*L&Z. $]2 WR\;@;#VBE;\5Z7\Z\6Y0%C?9N_(QKT[O*N
M]FU[]^9XH&:^%X^_?OLU?I7.DJ)# 9D+,F)(YLQQKT &KF/B/OO0)+'S #W'
M;Y&7#_Q0*Z(GVAO!7-' 8DWHAD)1L%0:D!DRW!E=R4WJ86Z3,6[2:@C-W]\7
M#Q;SB'[4:KFN/3?R>5J_6;['Y9=IPF>_3U<4^(IL8HC ?*TSU$Z"$SR#+YE9
M0YMZ<KNTIZ#GWX (_707'@\1,'96\W!E+@:4;!_(V&S%%QRL7BS.*)J=E!"=
M*S(#D[86_7 &P9@$N10;2"Q"^5UR"/O XSX5XV!D&,7>1\F14A[[5L&F[&:U
M(N'_@F<1EY/,O+"H(@49:$"II,'I3,H51K.0M2YWVP ^<)O@[I-'5_NQFEH,
M);8. O!+D7R3R";+<,E+LCZ:DB(40QRH6!+XQ )$Q3!:@RS*+9-5!VF5]2!1
MXQQY#(^>P170 9BNMUV*+O 5?;N:&"%L<LQ#"2P1!Q$A9D&K0P01M%<N8I,"
MW/NDC'U6=K1',I"4.\#)._R"\W/\UCQ!.R*D=O!B&&KC'%V@9K$ HU*TF]2,
M0Q.4W"6D$Z_U0,7>.[@X0LK]H.1GDM.V"R_7[9=J]PSZ+]?T-_-(R\I+"%PH
M4#86<-:5:C4=0X[)^R:Q_P&TCHNUX\"Q'6G---4!&*]K.)\O5AL7X.JFZ+>D
MO D\R" @L9I%%SK5&Z/$FK>9F21U;E.?]B1EG6Q\PQBU8?70 ; J'V_*Y0J:
M6.YX\5K7H^-,JS HJ$,M(0FON?.9A]"D.>TM*L:U3 -K^%YAVJ'B[@ KU]?4
M22K/\A=<KJ>K;Y?6)\:'J'0N8&.]LVZ*!(]10\J82A&&9=<D7'N<K''-3ULT
M#:B0T?,_EYOU<Q)K%=.<'CZK=ON*F<A#(>OL02:N07'.P7/C@1>)C.7HE+F3
M47XH'_3$F\:M36L#F.%%/#9>/F#Z-%_,%A^_7M[2N\$'RFPY&@51()G5G&IE
M%'> *@CCBRD8V$Y0>>0EX]::-43)4(+M8+_Z"\Y)3+.-<3R;SJ=5-.OI%[QB
M)Y<L918.XL8^LLUW5H#4:'+.&*5L<I;Y!%WC%I*UW;&&5$D'"'MVMJ ]]S\W
MRGE3[C9IGGCO]:82TS!5V_ J!J[4RA;,VCL7C+9MRO4?)6O<NK*V^!I0(1W
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M50?PN]V'@8OH@C<.F#&\WBMG$ 3+D")+J:#2Z)MTX#N@"4:S)BJG1-3ATN\
M.H^F.W[%WS9_57M[>)FX(H$$3_()64(,AHQR%-D(S52138H$=R-O-[#],<Z
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M%W+1UMH94,':*)UG&I\\GM[GA;VU/!D43\TDWZ4E>[O$SV&:K]P*4WO2.B:
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M8HIP_:E*^</B/:[7,WQ66VFM)D8'E@P/8#?]<K,BL3*12,H\FX02X]UZC6$
M.A@'74;VK8 \CMX[ /QE2H."NEIC0(*E'VHC,!+Z\K*IV&69P1;14^1GR5^/
M$IR@H$\ESL%9S,"%#:(($1QK4B%W%-5=1OC-+/3)]-O/ < %)_BZEA^\74Z)
MJ<]UDLA%1F,2L# E$@*O+3]43/7Z$DF3-C)5(D/.;1//X5&JN@SC6V%R./UT
MD33=77J39+0PV0C@I?;!3.AI96E'.X04OL[)#?:4%2"'&L=F-9\G!F(CS760
M3[IP4=Z4E[^G3X&,_CM"^YN- U/_7X_1OH09;NZ^D1RGB=9"_8MG\WS[%S<^
M.7&A^&08K<18 M0S-B#[SZ"XK(PIQNG0Y+"T 2_CN@#-,E)C:[T#?_8H9B^Z
MJ]^O8$RS\[RI!?\FU@M13V3VCG%6KXH&VJP,*@C9<"@RF&"%,BDWZ<QZ6C;'
M]4Z:+9>.L=+!%G*<V2C..&/K+NE2';=7"D3-$"1]BY&V4BO[6QCC.C]]XGPO
M31[9Q9TDL%QW %X2J8HN%4BVMKFH(X>\PP*TU^F8O,JN3</.]N!M=C6F4_#N
MH\GO803!^_.SL[#\NB@_G:^F<URMPCR_GWZ<3\LTU1*YB]NY=5#,8C9--9Z[
MQ=QNDPCV?\F@ PF.Y'&@N03W7_,-SCIPY90 (^KE^I L>&05V#9:C<XR;!+%
M/TS2T0T1'Q/O!Y+H3[-ZBNA9=LIY3HQK8M=A'98>-+"8>#'1,U?:-$C<B;R1
M6QP/@Y=[;0^'U\Q@45HO-NZDMJX3FS>6[>-(D&71@F5UT%B0%ER,'IBC $9Y
M@3$WN:HQO.W;7 !_@:NTG'Z^:&M[)?O-&[Y>_/EMB6F..K&(4#)J4(61*R&4
MA9R3XIDSE>XVG'O@ O[N[^S6HNV#@EL7[AO)NX/$TT]A-:UELK>%=H^K)*RM
M@R,AV,+K\7 "ARZ#*]ZED!(YJTT*IG8C;^2.[,,"KJ%F.L#;7U?XIKQ<K:=G
M%'BM)M6'<"9XT$K7 B^6( C'@0N?1"J:<]$$5[?)&+EK>AO\'"'IL?O+O,>P
M6LQ#/=[?#GJ7,A?::W#29E Z2(A<(0B*BVW(P@>3=]K4GGK3R-W,&VQE@\JV
M X/R*_YV0TS+Q9R^31<S +?SYTO6+A!K0IHZI(IDZ OQQZQSCA=4T369$[PO
MH2,W+V]CE)IJZP\7(?X:EK7:Z0N^P'68SDX3*=Y[Z;@1X^,R:!\Y%A.+#,&!
M$Y[\JX(%O*75;97Q1D;%:5O]/B+'Z]Q,^H3Y?%:]@^6R%MC1.DF;^N=G\_QV
M.5TL+PX)O[7BKHGJRSSYATW[1.\C3RPE2,:04(Q2$*4-(,B;D!B--JE-1NUH
MTKN-3??!V;ULVVDU.N*NOUJN:_5^/D_K-\O+JN=GOT]7$YV-U3)[*(K5,,C6
MFR)6 HLNJ"2+B'*7! \]_P8:Z:>[2'R(@)$GR)X8 (L!M=$'FJJ@+CE8O5B<
MA>E\XD4D+L@19IG$HEP,$%CDH!WZS%-R0NYRG+H/I.Y3,0ZNAE'L?90<*>4.
MPHW71/I\A;_@6<3EQ&GO1#8>(M86AB%G^LXIX)Q9%E'Y[)O<EKE%Q>@0.5:K
MBZ%$W $^=K6_JQL&^*>O-WZX_. \/SNKKL)FU16K52Z* VIB7Z'E$'B.D)R*
M7E#$Q=O<F6[!S,A]T,;9*+M!1P<KY :7/R^6=R1R:3Z<SX5Y80%C$*"$S\22
M<V U8UX*Z0HV:6"Q VWC.GKC ^CAJ=F#:'/LU/-?YZ3 .G?JXWQZ<=RWN2!\
M[U+E98/MRTVJ6,,PZ40<9@;*.@:A%$4FPF,MV+*"W8D^'LA''_3Z;H9D#X.
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MRKXX]6(6=1;"0F9BTQ:<@T^2'-3@4K8^9PQ-^N\]2E676^@!RK\['W8P3?0
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M]D'>$Z[GB33<P?[^/*P^$3/UR\M_G$^_T&9QU<G?)MJ+M'? $P%*&6TANNB
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MQ1=<SC>"_(C$%*YNIV(O-XJDDTA,TMJ/Y%C31I$@YB !#1:IF G.-#D6WY7
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M$W&S<Y/(F3%3QS/3!^4\ Q]M'3R%+K&8BL8F%PDM%C/R;(?#L?58^<N8@NX
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MA:6MQ$Q^XSP3IUZ>2OSB71P'HB^]%,;9\F =GC\%V@Q_X)3(T (YAN,-A(J
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M)<S^D$EF&? RO1[X$E:X266L^W6J1BH3G2=%OG9I?;[Y)B@$I&]&+NA. <(
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MF!/#C3;9J(^TI*24GL&"FX$ZXC+.\/!)8S*0!=J0G,3PJ254V?862(8V=*6
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MQ4NS84UHDV?QK<QO+S":N^05X#H1/UT/HG@H[05U'RR;7[<P4K210L#J*3:
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M9K8?MLK6PU8U/]^M$1&OMTR5.7LA,IA0"%@%)>*@ZD8&*Q/QGJ;YC*/QXA$
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M*E!>0LVDX%9Y,EA1('4]?R[_8*K[.RV@TU;Y"% ,;17-$E+*>85[27-9:NA
M&5PZN0N;#V)I2RY#;']@DL3ESG$)Q6;P9H#G^E)RZ16 (U]2[2TN'X3(T\+N
M6-@6W0)),1'"DJ]A#MTOW#=:-\?*)/?4P8]?%!8.-H4G]!7!W7(%6\H,IG_B
M&::Z%R%]:S_J-D!3K@*F)0$!1YU2)W9;#<R08J34&97%X+*4_+8'&XY]ZF&$
MY2UA@DRQZ,$E'&D']Q DBL=;MIU9J&9*Y]__0++^8O_QU\^[NSVO315VF:NV
M@;F@A^#M@L2MFAZ_"+ R5?.52BU6Q'5+BQ(<>.4WJ6W5DZ]RU>KPH N?;!+M
M?E7UOWN@G<FCOAWM6E6\JVN]P25KL0:P[5V$;_ELK]/?4=U=9+W$.8 7^U\J
M^F_K#M);,"ZN+CQ.O!R8!["%<CVE5E%"3X 2FOL*E4YF=<4O^-FTGBUR^2F9
MTRF+'GJ+EJEE9EK$T[RV:^U2OX,+TM7OX:7;2<?# MI?5?#N7KSBQ1J8'5,E
MK#B:8(_HHL0C7'3!%K@-H4OU07*^47%H6< \!U'(!QD$_ESRXSA6HLP;_%T!
M153I&2 =U<AL:KN<DMC!9;>J;WC4S3CR6*F>8#7HL8<<BJ1:3V&G"( #Q(';
MAV1#.,B:2X&B[7PN0_XADA. (]+:R;_$5A_L$<UE>_1>Y2S6WU.G&YCCCM=7
M$.W.Z>"H31D_W6B!3TO7@K$JA(0?8#,^MP' C@L\=![1@=B>#W-\N>@:&DB
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M$]N4,[I>%):P!OG[9FU/;H75DQ=[3T=4?T14F!P+=G#E)PR\0$Y,=<H1R#W
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M/3@,>('VB'#3[1&=XYMYV[]Z#X]V_XG#K$+?%D:)H6C!KQ@DIS UX/J?MWF
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M_U!TWYX]_!H;_Y_9QW+T8'TL31'%>Y'XI#*J[?.)0PTWVQVZ)( BL[*2;H4
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M8JBKBOCS41PLX:]I-@O__G]02P,$%     @  XBJ4MD(5#(@.   DW(! !X
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M7IE";<&R\+] ZY!^PJ="N*Q0L^V"DJ:W$W_<:UQL79-\VKTA^%M$ L>P0E_
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M_?+DR%JFZ"@*'K2.0,2X Y@W01*A$H](!/I M@W8[\QEX(M)$N=S$'[8[HD
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M0V,W(<"( 0^_KD%[NSD6!<OQO];^5X+<@ UT\%245?QO%&3!3@6S5)ED 1R
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MI ME^XN&_ =7;JW^P%W/MS6BQ0&R?,'.&VK8H%W&&(.C10(\.CB>&?(K9%/
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M&3F)3'-^Q-:AA<DTOV$+L$Y& 84,.VP%88O?F%"K<JS_ 6L:;?.B]8O+U5%
MF\('O6U;<[A4X:.(^:P6_BCMZRTG>@%A(,F#A*  0 7K'F)+/XJD]>(\H:,:
M)W3]SCK];YY^+#V:0;'75,?YU)Q2[7.\:B^>+^][DDJ?Y,ILJ>;(BM\L]3,$
M;,/C4)ROC+5AG"#6%GH"D&;#8>'5DV;])8H7"&.I#0_18U#] 9S"?F$S:WG<
M4IB(3H*P[XX%5Z@ 62B8R]!Z95#V&A/6;<E,!Y)PVM:  E!DLMS6-2:,_#3E
M4A'8E:8(8K9KXBJR2;:D[#9?=_GC@&B*OM8EH33CP*@4KE?DA-QXEA7IJEDT
M7K63IE-+BPNR/DAN\**1W,!$S>IXZ$TS!Z>!8HTMO6B7R/XYIRACI8*Q*,H7
M)T7_22</S_(;IAW2@&.E15L-=&K7(O.)FNK91NH_KNO]B@+EU,QEN)%/ZV"]
MBUMG>*5%6/BOB1U.@ +J>F^& Y8Z/SGE)#F]@N-4I*>KRGE!XN4SU&&1- !A
M##0K-$D;DA-D.:'?6501W5<L+XV?,OUJI+]F.PL;D^EG$,%W62LC1*$D&_"C
M_)TMUJ@M5J/E>,:%B,AR'""^;AWL;5>S?R9LE<;(F (?M[^[,^B&.,M)PSC+
M^R#%)&<9*7087%ON_60M?I36XLM8G.4962#? XU&C7W#8L2:3L>NP7*F5\K"
MLRWVX-9ZHICZV3R4-@ZG;)*,8J.(6GEY;FMVV'1X%"Y0V90)I?)PA':Q0)2=
M3>4HBCMW^AF!$N5]K[#;&,!MH+GODT3E<<.P>AD[ M2J;:^HMA?[5)N_)1:X
M;-^D&DRQYDNIV"L_Z6DO!CV=E)ZF9FTX@\E'TR849KN<.U&6KB,-Q\))=V!U
M,JD&HFTYD7]%)BQO5*\%5>C D:@UWJ$4A&HF)]M0[@1@7V EZQ8]9:L<VUJW
M:TY.ZPZNZ.Z(_[;IE[0G-"[%,M;/DA1A0#.U[BE,P8B*E-_'@L'-B^4Y5Q*_
MW+1M'DV:GIP7C0E3K0).]?IL%'G5<)]P@4F*,(T"UN?&2F<61"%G#/LQ,3#R
MK[')I4:S?"0PUL26]E$&0D-QU!MW!%7T?^U[8=JO>+&%5W*DL@460R@3\W(&
MP$0F_KJ&>:96=3%BM7"SUM9R] LI7VF/;Y#HM63L%N>X;-=31 4@R(I@XI/-
M9RXWQLF!9MJT<.W'"3N?C"'1]>MK?SBSQP#9A_*W;7$OQ)U@34D04YMKAM91
M,M.J>+Q;/6Z[349T'<]$;FXTN]HM<TJ(.;SB?3)(F$CRN^\&:,A;-4IRM&,=
MML3^'D#E(\%TU1Q,U]SD=!IK"^"%7&P<RY6X@8L#\0(].:9/C9;IJ A<HJNS
M.<5RI*UJ5"]#3LA#4V05N'FYE)"+'TZQ"50,VHH$E#.XCIW9YB8(0=>A&X<!
M)SC1,(61?ONQ@.BX.2!ZN+M'\?E,4S8?H:M!-(@,D"*]S2,;/4 +M JU*S_?
MUABEOCBZ.T7]!)66*\+DD;OF0<[SL2TE:!C"'?86/Q:8G30'9HU]"-L$3.,0
M?VF H&YK4U)-GUN*=9LJ0T[1SD6Q$P*]PH.OXYL)GBH%3Q\+9$V; UDVEQ[-
M=L 90:S;M Y8D1-UP5<=0DBZG^<LMB6TJ4-4/!@Z% 5+9"7!1%>7RC,36:I[
M(A15TZA0KJV-CH$51H0D T5 <L+M"N*?SC'WXA;''"XW\/_V+#AI'^VWVP?[
M+T].3@Z/_+V3%][Q2^G+H_'QX8E_+/]]^.PG.?-JCHL"^Y[]8"]?4PA++Q+
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M>R0Q9!3?(3=*\5IN;2SIYL$12]0]SK&L@J'25!.!(OS'\B9>R7>C4C$>)BW
M$U12*#55')1MZ%R7"E A)_4-$YM+5FJV](0I/PQ3+N,%!E@GU)%SL_A"H8N<
M+EDJA#[+LUQ2<]=9@'4;;8_,(.)RC=<F> J^0V"G@I4RU4UR'E-3PW;#"C T
MIZ#/:DJ9$QYM^ZP9VF<*?' ?[W^O_]\CP?+]AL'-J=NLKE<TJVL*$.DX:=,&
MD'M0 \>6)MK26;])#^'GBVU1NE02SY. :IZ5>_*567M1A<:=D;+2ET4:)%?E
MU*U_.1W<!G!>.Q,YYTE/]S#GEY_NW#]=L^8X$I7E251M*$&;5)CUKI=VOR.
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M*^_PH@=:!=>6P* 1^MJU.Y!OT@-ET>G$;7MOWM(H'&5,(T225H1S 9,*J-8
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M4$L! A0#%     @  XBJ4F)B2*OY!P  C"@  !               ( !
M &$R,#(Q<3%E>#,Q,2YH=&U02P$"% ,4    "  #B*I2]=1PF/H'  #0*
M$               @ $G"   83(P,C%Q,65X,S$R+FAT;5!+ 0(4 Q0    (
M  .(JE*0A5V -@4  /85   0              "  4\0  !A,C R,7$Q97@S
M,C$N:'1M4$L! A0#%     @  XBJ4@@.S(DI!0  R14  !
M ( !LQ4  &$R,#(Q<3%E>#,R,BYH=&U02P$"% ,4    "  #B*I2>CP#! J;
M @!DS!P $0              @ $*&P  96AT:"TR,#(Q,#,S,2YH=&U02P$"
M% ,4    "  #B*I2P5);U(T1   FQ   $0              @ %#M@( 96AT
M:"TR,#(Q,#,S,2YX<V102P$"% ,4    "  #B*I2/+Y2/]HE  #SD@$ %0
M            @ '_QP( 96AT:"TR,#(Q,#,S,5]C86PN>&UL4$L! A0#%
M  @  XBJ4M@Z7T.P5@  "I4# !4              ( !#.X" &5H=&@M,C R
M,3 S,S%?9&5F+GAM;%!+ 0(4 Q0    (  .(JE)*KP4PZ=(  "^R"  5
M          "  >]$ P!E:'1H+3(P,C$P,S,Q7VQA8BYX;6Q02P$"% ,4
M"  #B*I2WF*IB22    "L04 %0              @ $+& 0 96AT:"TR,#(Q
M,#,S,5]P<F4N>&UL4$L! A0#%     @  XBJ4AP:]/!].@  <'\! !X
M         ( !8I@$ &5X:&EB:70Q,#5S979E<F%N8V5A9W)E96UE+FAT;5!+
M 0(4 Q0    (  .(JE+9"%0R(#@  )-R 0 >              "  1O3! !E
M>&AI8FET,3 V<V5V97)A;F-E86=R965M92YH=&U02P4&      P #  : P
&=PL%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
